Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AASS "LKRSDH, LORSDH" ENSG00000008311 "Aminoadipate-semialdehyde synthase" Q9UDR5 7 122075647-122144280 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 98.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2" "Cell line enhanced" "Detected in many" "AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020637, HPA020728, HPA020734" Enhanced Enhanced Vesicles,Mitochondria Yes No 17000 Mitochondria Vesicles "HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417" "unprognostic (4.84e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-4)" "unprognostic (6.08e-2)" "unprognostic (1.49e-2)" "unprognostic (8.00e-2)" "prognostic favorable (9.81e-4)" "unprognostic (4.48e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (1.99e-1)" "unprognostic (7.76e-3)" "unprognostic (8.56e-3)" "unprognostic (1.55e-1)" "unprognostic (6.50e-2)" "unprognostic (2.67e-1)" 13.9 9.5 7.4 4.8 11.8 1.6 11.2 2.7 9.8 16.0 8.1 12.5 8.2 2.2 16.8 11.6 6.4 14.9 6.7 12.6 8.8 3.7 14.4 35.8 9.1 3.3 15.2 5.0 36.7 10.7 14.9 10.4 7.1 9.9 9.2 3.8 9.2 5.4 10.4 11.3 4.4 5.5 9.3 12.1 5.2 9.0 5.1 13.2 0.8 7.8 8.3 3.1 11.0 9.0 1.0 0.4 3.5 0.1 0.3 1.2 0.1 0.1 0.0 15.8 25.6 13.3 8.5 6.2 4.3 4.6 4.5 6.5 7.3 0.2 0.0 0.2 3.0 5.1 2.7 18.3 8.2 6.2 0.0 6.7 5.5 3.5 4.7 10.8 0.0 1.8 7.5 0.2 5.4 5.7 12.6 10.8 7.3 1.4 10.1 3.1 0.0 0.5 0.0 25.0 0.0 1.0 8.3 8.4 0.3 2.1 1.7 1.6 0.5 1.4 0.0 2.6 21.7 0.4 0.0 4.9 8.8 2.7 4.1 4.1 2.2 1.6 0.0 3.2 0.5 3.4 3.5 0.1 0.0 0.7 0.0 0.1 0.5 0.8 0.0 0.4 1.0 1.2 0.5 0.0 0.3 0.0 0.0 0.7 0.1 7.4 11.8 2.7 7.3 8.8 3.7 15.2 5.0 9.9 13.2 8.9 28.6 1.5 8.9 5.6 6.3 8.1 7.6 0.0 7.9 14.0 15.7 9.1 0.0 1.8 9.2 9.2 1.0 0.0 1.5 2.5 9.3 5.2 3.5 98.3 1.2 11.1 2.9 19.6 1.8 5.4 17.5 1.5 11.8 0.0 2.4 8.7 2.6 2.9 23.0 7.8 2.2 19.4 21.6 6.4 1.5 4.1 4.2 2.2 1.5 3.7 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favorable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favorable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favorable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.5 19.8 5.1 16.1 8.1 4.7 10.2 6.6 6.9 10.6 11.2 7.9 21.1 6.6 8.9 7.0 12.8 13.3 7.4 13.8 4.7 8.2 8.1 5.2 7.9 9.4 5.3 4.0 13.1 8.1 10.5 12.6 5.2 3.9 10.6 14.7 27.4 9.1 7.9 28.1 15.3 7.6 3.4 9.5 22.6 7.3 3.2 23.5 7.1 5.4 4.9 9.9 7.1 20.2 6.4 4.1 8.0 5.3 6.5 9.9 2.6 7.1 9.9 9.2 4.6 4.7 14.0 9.7 10.1 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 11.9 0.6 11.7 5.2 3.3 22.7 6.7 12.7 1.4 1.2 10.4 35.3 32.5 3.3 13.7 1.8 3.4 24.1 0.0 17.6 18.5 6.5 7.1 50.6 21.2 25.1 28.6 0.0 5.5 8.1 1.9 6.1 5.9 8.5 11.8 8.7 11.2 17.7 7.8 11.7 12.8 32.9 25.8 5.9 8.8 15.4 6.5 68.4 7.5 10.6 5.1 ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0;skeletal muscle: 71.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 11.1;Intestinal endocrine cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.2;SiHa: 5.8;U-2197: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 4.0 3.8 8.2 1.9 19.1 0.8 2.1 4.0 26.0 1.4 2.1 2.3 0.0 1.1 1.2 1.3 10.5 1.4 1.7 5.7 3.4 5.1 2.5 1.2 1.8 1.4 2.8 7.6 1.1 3.3 2.4 6.1 1.2 9.9 1.8 2.1 1.3 2.6 1.2 71.8 3.8 1.8 2.1 1.8 14.8 1.8 1.5 4.0 0.0 2.4 1.9 2.3 1.5 1.7 0.7 0.5 0.0 0.2 0.0 3.0 0.2 1.0 0.0 0.2 1.5 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.3 2.9 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.6 1.9 0.1 0.0 1.2 2.7 0.9 0.1 1.0 0.6 0.2 0.0 13.2 1.0 5.8 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.4 20.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.1 3.0 0.0 2.5 0.0 0.5 0.7 1.2 0.9 0.0 0.0 0.2 0.0 1.2 0.2 8.2 19.1 4.0 26.0 3.4 5.1 2.8 7.6 9.9 4.0 0.0 1.4 0.0 0.1 2.3 5.1 3.6 0.0 2.7 0.0 3.5 0.0 0.0 0.0 3.0 1.7 2.7 7.5 0.0 3.8 0.5 0.4 0.3 2.3 0.4 0.1 11.1 10.3 1.3 0.3 4.2 0.0 0.0 0.0 0.0 3.0 2.7 3.4 4.5 3.5 0.3 2.9 6.5 4.2 0.0 1.5 5.5 0.0 0.0 5.2 0.1 AC004556.1 ENSG00000276345 Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.0" "Cell type enhanced" "Detected in many" 17 "Distal tubular cells: 26.6;Hofbauer cells: 22.3;Kupffer cells: 73.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 25.6;K-562: 21.5;MOLT-4: 24.1;NB-4: 46.5;PC-3: 43.4;WM-115: 31.2" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" 0.9 0.0 0.9 0.0 8.3 3.7 0.0 3.8 0.0 1.3 5.9 0.0 1.5 1.7 9.3 1.6 3.0 0.0 0.0 2.4 2.0 0.0 0.0 1.5 0.0 2.2 0.0 6.1 1.4 3.6 0.0 0.9 1.2 0.0 0.3 0.0 1.4 2.8 4.7 13.0 9.6 3.2 6.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 8.4 12.0 13.0 9.4 25.6 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 14.4 0.0 8.7 13.4 21.5 11.8 0.1 0.1 24.1 46.5 0.0 0.0 43.4 0.1 7.6 0.0 12.1 7.3 0.0 0.1 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 31.2 13.0 5.6 3.1 2.8 9.6 2.4 2.5 4.5 6.0 4.1 2.8 4.5 5.2 1.0 3.2 4.0 4.7 5.9 4.0 0.0 0.0 8.7 0.1 0.0 0.0 0.0 2.5 4.0 2.3 17.4 0.0 2.8 26.6 0.0 0.9 0.0 0.0 0.0 0.3 10.9 0.0 0.0 0.0 1.1 22.3 0.0 0.0 17.2 73.1 2.8 3.7 0.2 0.0 0.0 1.1 0.0 0.1 0.2 0.4 6.9 0.0 0.0 0.0 3.5 5.9 0.0 3.3 3.8 0.4 0.1 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.4 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 2.9 0.7 0.1 0.0 0.3 0.0 2.1 0.0 0.2 1.2 0.6 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 0.2 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597237-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.6;salivary gland: 29.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;monocytes: 11.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 88.7" "Group enriched" "Detected in some" 7 "cerebellum: 5.3;pons and medulla: 1.6" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 13.9 1.9 0.3 2.9 0.4 0.5 10.9 0.4 0.4 3.7 8.7 0.2 4.5 16.2 5.6 7.1 5.7 2.6 9.8 7.1 0.6 0.6 6.6 2.0 10.0 2.7 0.6 0.2 2.1 3.0 0.0 8.2 0.7 0.6 5.2 1.2 1.3 29.0 2.0 3.1 10.7 35.6 5.0 0.4 1.5 10.5 3.4 0.1 0.8 1.8 12.8 1.5 8.2 4.5 0.2 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.4 3.4 0.0 14.5 88.7 0.9 2.5 0.0 0.1 1.0 0.0 9.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 35.7 1.4 0.0 0.4 5.8 1.8 0.7 0.0 1.4 2.3 5.2 5.9 0.2 0.0 0.2 2.1 5.1 1.3 0.0 10.8 0.0 4.1 0.4 0.0 0.0 0.4 1.6 0.0 9.8 0.8 0.0 2.0 0.0 1.7 11.8 0.0 1.1 6.6 0.0 2.5 2.4 3.1 0.0 1.9 0.1 0.0 5.6 0.2 0.0 0.6 1.0 ACO1 "IREB1, IREBP, IRP1" ENSG00000122729 "Aconitase 1" P21399 9 32384603-32454769 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Lyase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 174.5;Proximal tubular cells: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019371, HPA024157" Enhanced Supported Mitochondria,Cytosol NA NA 8000000 "Mitochondria, Cytosol" "HPA019371: AB_1844519, HPA024157: AB_1844520" "unprognostic (2.11e-1)" "unprognostic (5.61e-2)" "unprognostic (8.38e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-1)" "unprognostic (3.12e-2)" "unprognostic (4.25e-3)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (1.19e-1)" "unprognostic (2.55e-1)" "unprognostic (3.08e-1)" "prognostic favorable (5.73e-5)" "unprognostic (2.54e-1)" "unprognostic (6.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.23e-2)" 41.4 27.2 9.6 7.1 9.4 1.5 30.1 8.9 8.1 9.3 19.7 6.2 6.4 21.9 12.8 14.6 12.8 7.2 8.9 15.1 6.5 7.6 40.5 80.9 9.2 9.4 6.1 6.2 14.1 27.9 8.9 8.7 11.3 7.7 10.7 9.8 11.7 11.7 9.5 11.2 5.5 28.4 14.5 6.0 6.4 13.5 11.4 5.9 6.0 18.4 7.2 5.1 13.9 11.7 4.7 7.1 21.4 8.8 4.7 7.4 6.2 9.5 8.7 6.8 10.7 53.1 28.8 3.1 18.1 44.5 8.3 6.6 9.2 3.0 1.9 5.8 18.9 22.8 1.3 13.5 17.3 16.8 6.0 3.6 14.0 9.5 10.0 26.7 1.3 5.6 25.0 5.3 21.4 15.1 25.7 21.5 7.4 5.0 4.1 23.7 2.5 7.4 6.7 7.1 6.0 9.4 5.8 10.1 1.9 31.7 8.8 0.9 2.8 18.8 0.7 1.9 7.6 4.4 3.4 23.2 30.4 10.3 10.1 4.7 2.1 3.9 3.8 21.2 4.7 2.6 21.4 8.7 2.4 7.4 8.8 6.4 4.7 5.2 5.7 7.1 4.2 6.8 7.0 1.0 4.7 7.2 3.4 2.8 6.2 9.6 9.4 8.9 8.1 6.5 7.6 6.1 6.2 7.7 5.9 3.0 25.5 7.5 6.9 3.9 18.8 39.8 45.9 8.1 9.1 22.7 21.6 39.8 16.6 14.3 6.3 18.2 29.7 0.0 35.8 17.8 21.6 11.2 2.3 174.5 13.3 31.8 4.7 14.1 12.7 5.1 21.9 7.2 6.8 2.8 32.4 30.7 23.2 21.0 21.9 160.8 13.9 19.4 22.3 6.1 16.2 4.6 44.7 8.7 26.9 7.1 ACOT8 "hACTE-III, hTE, NAP1, PTE-2, PTE1" ENSG00000101473 "Acyl-CoA thioesterase 8" O14734 20 45841721-45857406 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010261 Approved Supported Vesicles,Mitochondria NA NA Vesicles Mitochondria "CAB010261: AB_2221664" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (4.27e-1)" "unprognostic (1.03e-3)" "unprognostic (2.92e-2)" "unprognostic (4.70e-1)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" "unprognostic (2.03e-2)" "prognostic favorable (3.18e-4)" "unprognostic (2.79e-1)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (2.98e-1)" 7.0 22.6 23.5 10.9 24.3 16.5 8.7 14.4 32.6 6.8 17.1 13.5 9.9 23.3 6.5 13.1 15.8 12.2 10.1 27.0 22.8 19.3 15.3 19.0 9.7 12.1 22.1 19.0 8.3 17.4 5.9 11.4 8.1 19.5 9.6 14.3 10.4 14.4 7.3 21.7 16.7 22.2 7.3 14.6 9.1 16.7 12.8 11.1 17.1 12.4 8.6 12.2 10.9 7.2 20.5 27.0 31.0 26.2 11.2 22.5 18.8 7.7 9.3 3.2 6.4 9.0 5.5 5.6 5.3 4.3 7.4 6.9 13.6 10.8 9.7 23.9 7.2 17.1 15.2 6.1 13.1 2.5 7.2 10.7 9.7 12.5 13.0 8.1 9.3 9.1 6.4 10.1 7.1 5.1 11.0 4.5 11.4 8.6 12.1 5.2 21.8 13.2 12.1 5.6 15.2 24.9 6.4 5.9 17.4 7.8 8.8 11.0 5.2 11.6 29.8 18.1 5.2 16.4 22.8 5.2 18.3 4.1 9.4 8.7 10.3 15.2 6.1 22.7 9.8 9.7 20.0 26.2 31.0 18.8 25.0 17.1 20.5 18.1 17.0 27.0 19.3 16.1 17.3 18.7 11.2 23.4 17.0 22.5 18.8 23.5 24.3 14.4 32.6 22.8 19.3 22.1 19.0 19.5 11.1 32.8 13.1 13.4 10.4 5.5 17.5 9.4 10.2 17.4 9.1 12.2 15.7 27.1 54.7 19.6 30.4 8.2 74.4 0.0 18.1 16.7 7.2 11.9 13.9 22.2 24.7 7.9 18.5 11.6 16.5 58.7 9.2 13.0 10.1 26.2 34.3 15.2 19.9 59.6 8.1 57.5 19.5 12.9 8.5 25.9 8.7 6.9 16.2 14.6 27.0 11.6 ACSL4 "ACS4, FACL4, LACS4, MRX63, MRX68" ENSG00000068366 "Acyl-CoA synthetase long chain family member 4" O60488 X 109624244-109733403 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Alveolar cells type 2: 210.9;granulocytes: 598.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 81.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000286, HPA005552" Supported Approved "Golgi apparatus,Mitochondria" NA NA 100000 "Golgi apparatus" Mitochondria "HPA000286: AB_2665966, HPA005552: AB_1078774" "unprognostic (9.13e-2)" "unprognostic (3.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.61e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (5.32e-2)" "unprognostic (4.14e-3)" "unprognostic (1.92e-1)" "unprognostic (9.45e-2)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (4.78e-1)" "unprognostic (3.29e-2)" "prognostic favorable (5.73e-4)" 29.5 31.1 16.3 25.5 18.0 9.2 30.0 13.9 22.8 34.7 10.5 8.8 4.6 10.0 13.7 11.7 11.2 10.7 20.1 20.3 27.6 20.3 31.2 9.6 27.8 29.6 15.2 19.0 13.1 8.8 16.7 12.9 33.9 21.1 9.7 9.7 8.0 10.7 11.0 42.5 9.1 9.0 15.8 24.6 17.0 12.9 17.7 9.7 9.5 12.8 8.5 11.9 19.5 21.0 2.2 6.5 20.3 10.9 2.2 4.0 3.8 13.9 4.5 5.6 6.0 21.1 13.2 4.4 20.5 22.7 20.0 20.9 4.4 9.7 10.0 8.0 14.8 24.6 4.0 4.8 19.7 31.6 3.5 5.0 39.4 6.4 46.6 9.7 9.3 81.7 11.4 7.7 22.8 16.7 11.6 15.0 6.4 1.1 12.3 22.9 0.9 8.1 12.3 7.0 3.1 8.2 5.9 10.3 8.2 28.7 4.5 3.7 2.8 24.5 0.0 12.6 11.5 0.3 10.0 27.7 18.3 5.2 28.9 18.8 6.1 7.0 9.4 32.3 20.9 11.6 15.5 7.0 20.3 2.8 9.8 2.0 2.2 2.5 2.2 6.5 2.2 2.0 2.4 19.8 2.2 10.9 2.6 4.0 3.8 16.3 18.0 13.9 22.6 27.6 20.3 15.2 19.0 21.1 9.7 71.5 210.9 20.6 16.2 19.8 34.7 32.3 10.2 17.4 64.8 69.8 2.0 5.7 43.1 24.1 1.2 28.6 0.7 23.3 22.2 29.6 17.9 10.6 598.2 1.7 22.2 6.4 7.5 17.8 68.3 2.0 5.2 45.1 15.1 64.9 2.9 11.7 26.4 1.4 9.6 10.0 14.5 0.0 22.3 3.9 3.8 7.0 26.4 13.8 1.7 12.4 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 266.6;Paneth cells: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.6 0.3 0.2 0.0 0.8 0.1 1.0 0.3 2.3 0.0 0.2 10.6 43.3 14.2 2.6 0.6 2.1 0.1 0.0 0.0 0.2 11.9 0.0 11.1 0.4 18.5 2.8 17.2 18.8 1.9 0.0 0.2 0.0 0.8 0.8 0.0 0.0 6.5 0.0 0.0 0.0 7.9 0.0 9.8 0.4 3.9 0.0 8.7 1.2 44.2 0.0 0.3 17.3 6.6 0.0 0.0 0.0 9.7 12.5 0.1 0.1 0.7 0.7 4.7 0.0 6.9 0.4 21.6 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 11.9 43.5 21.6 7.4 3.4 0.0 1.4 12.7 5.3 33.0 0.0 3.9 1.6 0.0 12.0 65.8 24.5 266.6 0.0 5.6 1.9 1.7 5.7 17.3 79.9 16.7 0.0 39.2 16.0 19.2 29.7 14.7 23.5 3.3 4.6 84.3 0.0 29.0 93.1 11.3 0.0 1.2 0.0 1.4 1.7 1.4 1.5 0.6 14.9 90.6 41.4 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell type enhanced" "Detected in many" 15 "B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "CAPAN-2: 24.8;OE19: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA "Plasma membrane" Mitochondria "HPA074034: AB_2686654" "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favorable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.8 0.2 0.8 0.0 0.8 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 7.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 3.0 5.9 115.5 2.2 0.8 0.0 0.9 25.5 17.4 62.6 3.5 0.0 0.3 0.0 7.1 0.9 0.7 0.5 0.0 3.1 8.1 1.1 2.0 2.3 0.0 9.0 0.0 0.0 0.0 12.3 1.8 0.6 32.1 5.0 5.4 0.1 0.0 32.8 0.0 0.4 3.6 0.0 6.5 0.3 0.2 0.1 0.5 0.5 6.9 0.9 6.3 ADAMTS12 ENSG00000151388 "ADAM metallopeptidase with thrombospondin type 1 motif 12" P58397 5 33523535-33892192 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 16 "Ito cells: 17.8;Leydig cells: 20.4;Peritubular cells: 16.6;Sertoli cells: 51.8;Smooth muscle cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 20.2;hTERT-RPE1: 36.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035973, HPA075079" Uncertain Approved Nucleoli,Mitochondria "Secreted to extracellular matrix" NA NA Nucleoli Mitochondria "HPA035973: AB_10669663, HPA075079: AB_2732278" "unprognostic (6.18e-3)" "unprognostic (3.12e-4)" "unprognostic (1.05e-1)" "unprognostic (8.37e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-1)" "unprognostic (2.60e-2)" "unprognostic (3.49e-3)" "unprognostic (3.78e-3)" "unprognostic (3.39e-2)" "unprognostic (5.63e-3)" "unprognostic (1.45e-1)" "unprognostic (4.27e-7)" "unprognostic (4.45e-3)" "unprognostic (1.47e-1)" "unprognostic (5.85e-2)" "prognostic unfavorable (6.78e-4)" 13.7 5.4 0.2 2.5 0.8 0.0 17.6 0.3 1.0 6.0 3.0 2.3 2.6 0.6 13.0 4.4 1.4 3.1 5.9 1.4 0.3 0.6 2.0 2.1 9.4 4.2 1.2 0.2 4.9 8.7 1.2 0.9 5.5 2.1 6.7 1.4 2.7 4.4 4.2 4.1 2.0 1.6 9.4 6.5 0.6 1.8 5.0 0.3 0.1 2.6 4.1 1.6 4.3 7.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.4 0.3 10.4 0.0 15.4 7.3 0.0 5.4 13.9 7.1 8.8 0.0 0.0 0.0 0.0 3.7 12.6 0.3 0.2 7.0 10.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 5.8 0.0 20.2 5.3 36.2 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 12.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 12.2 15.6 0.1 3.2 1.8 1.3 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.3 1.0 0.3 0.6 1.2 0.2 2.1 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.2 3.3 0.4 0.0 0.0 0.2 0.2 12.8 0.1 0.0 0.0 0.5 0.0 0.0 17.8 0.3 2.5 20.4 0.0 6.8 0.0 0.0 6.7 0.2 0.0 16.6 2.2 0.2 51.8 14.2 0.2 1.7 0.6 0.7 0.0 0.0 0.1 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598965-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.9;epididymis: 13.1;testis: 30.6" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;pons and medulla: 20.9" "Cell type enriched" "Detected in single" 10 "myeloid DC: 2.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.6" "Cell line enriched" "Detected in single" 25 "HDLM-2: 17.9" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA036340: AB_2675071, HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.1 0.1 1.6 0.1 6.6 0.1 0.2 0.0 0.2 1.0 0.5 5.1 0.0 0.1 0.4 13.1 0.2 9.8 0.1 0.1 2.2 2.7 0.2 0.2 4.8 0.2 0.0 0.0 4.3 0.1 0.3 0.8 0.2 20.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 30.6 1.2 0.0 0.2 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 6.6 0.0 0.1 2.2 2.7 0.0 0.0 20.9 1.2 3.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 121.8 14.8 0.0 3.9 0.0 0.0 0.0 236.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.2 2.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.2 3.0 0.0 0.0 0.0 0.0 0.0 ADNP2 "KIAA0863, ZNF508" ENSG00000101544 "ADNP homeobox 2" Q6IQ32 18 80109031-80147523 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007126 Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA007126: AB_1080729" "unprognostic (4.93e-2)" "unprognostic (1.45e-1)" "unprognostic (1.05e-2)" "unprognostic (2.25e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.24e-1)" "unprognostic (6.05e-2)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "prognostic favorable (6.39e-5)" "unprognostic (8.64e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (9.90e-4)" "unprognostic (5.19e-2)" 11.3 8.8 9.1 7.6 10.4 40.5 10.9 8.4 12.5 7.7 8.6 14.4 7.1 10.8 10.2 13.5 12.5 10.0 11.1 10.2 9.8 7.0 8.4 11.3 10.3 11.6 8.0 10.4 12.7 10.4 12.7 12.4 11.4 10.4 9.2 8.2 12.6 9.1 8.9 4.0 16.5 9.7 13.1 10.1 8.7 11.2 24.4 6.7 14.3 10.1 8.1 10.4 11.3 10.8 2.4 2.3 1.7 3.0 1.4 4.4 1.5 11.2 8.8 18.4 13.5 4.2 6.0 13.9 8.2 9.3 9.7 12.3 8.2 5.7 0.1 3.2 6.5 12.2 10.3 17.9 10.5 10.6 10.2 8.9 15.8 6.8 9.0 7.7 23.1 17.7 6.1 9.9 9.9 13.6 6.5 9.8 18.2 15.2 16.8 5.7 7.9 21.2 4.7 12.5 5.0 10.3 8.0 20.6 8.0 5.8 15.1 12.6 16.1 9.3 9.1 6.4 9.4 8.9 17.6 6.5 11.6 29.1 4.8 8.9 6.0 11.0 23.4 7.8 9.7 7.8 0.0 1.1 0.7 3.4 1.7 2.4 2.4 4.4 2.9 0.6 1.1 2.4 4.1 1.7 1.4 3.0 2.3 2.1 1.5 9.1 10.4 8.4 12.5 9.8 7.0 8.0 10.4 10.4 6.7 17.9 18.1 2.9 21.0 35.0 19.0 14.9 10.2 5.3 11.4 3.5 25.5 8.0 0.0 6.8 6.7 11.3 10.7 0.0 9.5 6.7 11.4 19.3 11.5 16.3 8.2 23.8 21.4 16.0 9.7 7.2 6.9 11.0 13.5 1.8 14.4 8.6 9.0 13.9 11.0 5.7 29.2 0.0 14.5 38.4 36.9 37.8 8.1 8.6 12.1 26.2 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 121.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA069947: AB_2686219" "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.7 16.6 8.0 11.8 9.5 19.5 26.5 6.5 12.2 20.2 21.0 10.5 18.9 11.1 27.4 16.6 15.8 18.6 15.3 22.4 10.3 5.3 27.6 15.5 18.4 12.9 9.3 5.5 24.7 19.0 28.6 18.5 121.7 9.5 16.8 14.3 27.0 16.0 25.6 58.8 18.6 16.2 20.3 11.5 13.9 15.0 6.7 10.3 17.0 38.8 21.1 13.9 19.5 26.5 11.3 14.6 21.1 5.4 5.1 8.8 2.8 7.9 7.3 6.1 6.4 10.1 12.1 8.6 8.0 11.8 6.1 9.2 7.7 14.8 9.0 11.0 9.8 7.8 3.6 9.6 12.1 8.5 15.4 3.8 18.8 19.1 6.4 7.8 18.0 14.9 9.8 8.8 10.5 9.3 8.9 22.5 7.6 11.5 25.6 2.6 2.1 16.2 5.2 8.1 13.3 2.6 12.9 3.6 11.5 18.1 7.6 13.9 2.5 12.3 8.1 3.9 13.4 4.8 15.1 11.3 11.4 10.4 6.9 4.4 22.2 12.3 15.6 9.4 20.8 4.1 3.5 5.4 11.7 6.7 4.1 7.4 8.0 8.8 6.6 6.0 11.3 4.7 4.4 21.1 5.1 2.2 14.6 7.5 2.8 8.0 9.5 6.5 12.2 10.3 5.3 9.3 5.5 9.5 10.3 38.7 57.2 25.4 12.5 21.4 44.7 96.4 40.8 40.2 31.8 87.2 212.1 0.9 3.3 11.6 6.6 38.8 30.8 46.7 10.9 3.8 14.6 24.9 23.3 27.7 11.3 17.5 31.0 65.1 43.0 5.4 27.0 25.6 21.9 8.2 40.8 22.0 11.1 31.7 26.9 40.9 150.1 25.8 15.6 3.5 6.4 27.7 27.5 15.2 25.3 14.4 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551189-141655244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 37.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: AB_2682164" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 8.7 12.0 11.9 8.0 19.0 5.9 10.6 21.3 23.7 8.8 8.9 10.2 8.8 6.4 16.8 17.1 9.5 11.9 6.8 24.5 16.1 12.3 16.0 10.5 8.4 10.0 11.8 18.8 10.8 8.0 15.7 13.3 9.9 14.2 10.1 13.4 10.6 13.5 10.7 8.4 6.8 8.8 15.0 13.9 12.2 9.0 12.9 9.0 7.8 9.8 8.4 15.6 8.4 8.5 4.6 6.4 0.4 5.5 37.9 10.3 5.7 12.4 13.5 13.4 11.0 10.6 13.2 9.1 13.2 12.9 21.2 21.2 10.5 9.6 14.0 11.8 12.6 20.0 9.3 18.7 15.4 22.9 16.5 16.6 13.0 6.4 10.4 15.8 9.0 7.0 14.7 13.6 18.6 18.2 9.9 16.2 16.1 19.3 20.0 10.2 12.5 24.3 4.1 14.2 9.6 15.2 15.7 2.3 41.9 13.6 10.6 11.7 16.1 13.7 16.6 13.6 14.1 8.9 9.9 9.1 9.8 7.7 13.1 19.0 15.2 15.0 6.7 16.2 4.2 27.0 0.0 2.6 0.4 9.1 5.5 6.5 4.6 7.4 10.3 6.4 2.5 5.5 9.6 0.2 37.9 3.2 2.5 7.2 5.7 11.9 19.0 21.3 23.7 16.1 12.3 11.8 18.8 14.2 9.0 0.0 5.9 3.7 5.1 2.7 10.7 16.8 5.1 6.7 5.7 12.2 7.9 13.4 8.3 6.3 10.0 5.8 2.0 0.0 6.1 6.7 5.4 2.6 8.1 4.5 6.1 14.3 0.0 3.1 4.7 8.5 6.4 4.7 6.8 18.0 2.9 9.8 4.6 0.0 9.9 6.1 16.4 0.0 6.2 4.6 4.9 2.4 7.7 11.4 5.6 2.7 AL139260.3 ENSG00000274944 1 38864501-38881617 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.3;testis: 15.5" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 8.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA041188, HPA078331" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (8.00e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (2.00e-1)" "unprognostic (9.72e-3)" "unprognostic (4.27e-4)" "unprognostic (4.64e-7)" "unprognostic (2.59e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (9.54e-3)" "unprognostic (6.09e-6)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.32e-3)" 1.2 0.0 0.4 1.3 0.9 0.0 0.4 0.4 1.0 0.4 3.3 0.6 0.4 2.0 0.4 0.4 3.0 0.0 0.4 0.4 0.4 0.5 1.5 0.4 2.7 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.6 0.4 2.3 1.8 2.3 0.4 0.4 1.5 2.1 0.4 0.4 0.4 2.4 15.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 7.3 2.8 4.0 0.0 1.7 0.0 12.4 1.3 3.3 0.0 0.6 0.0 3.6 0.4 0.0 0.0 0.5 6.7 13.3 2.4 11.3 0.2 0.5 9.2 0.0 0.9 0.0 7.9 2.1 2.8 2.5 2.2 0.0 17.0 5.0 0.0 0.0 1.6 1.1 1.5 2.0 0.5 6.4 4.6 1.7 3.3 6.8 16.1 6.5 9.8 7.7 7.9 8.0 12.6 0.0 7.0 6.3 3.4 7.7 7.3 1.5 3.6 4.2 5.2 5.8 2.3 6.5 6.3 11.5 1.5 11.7 9.4 5.7 7.4 2.6 0.0 1.3 0.2 0.5 1.9 1.1 3.0 0.2 0.5 4.2 2.0 0.4 0.4 2.8 0.0 4.0 7.3 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 167.6;liver: 136.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 55.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favorable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 9.2 167.6 7.8 6.7 10.6 39.1 8.9 17.0 15.4 6.0 11.0 12.0 15.3 11.4 6.3 11.8 10.5 4.7 8.7 24.8 8.8 7.0 14.1 136.4 13.5 10.0 7.6 9.9 5.8 6.1 8.5 5.8 13.4 12.2 7.3 11.1 8.3 15.7 16.9 24.6 6.8 17.4 6.5 7.3 6.3 12.2 9.7 5.0 7.5 7.4 11.4 9.6 12.1 7.6 6.8 8.4 55.0 12.2 8.8 11.3 6.3 10.3 16.1 11.4 10.5 17.8 13.3 31.0 15.2 14.1 20.4 19.8 21.4 19.6 9.7 3.8 10.6 41.4 6.1 16.3 12.5 16.7 18.8 6.4 12.4 12.7 16.2 25.2 20.1 25.0 16.5 11.7 32.4 10.8 7.5 18.6 17.0 7.3 8.0 18.5 8.4 9.5 30.7 9.8 11.9 27.9 5.7 7.1 15.3 17.9 62.7 6.0 4.0 24.6 12.1 13.7 9.6 6.9 28.7 13.3 11.4 11.3 23.5 21.9 11.9 20.5 14.6 12.7 21.9 18.1 55.0 9.2 27.8 6.9 12.2 11.3 6.8 7.2 7.7 8.4 6.0 6.5 7.0 14.2 8.8 10.2 4.8 9.7 6.3 7.8 10.6 17.0 15.4 8.8 7.0 7.6 9.9 12.2 5.0 32.8 47.6 4.5 16.4 15.3 15.1 88.4 35.7 38.8 27.3 22.7 3.9 67.2 48.0 28.5 9.7 25.9 35.4 0.0 27.6 21.7 19.9 18.1 89.4 210.5 62.6 11.1 33.3 25.2 14.6 3.1 12.4 23.3 5.0 73.9 18.6 9.1 33.4 18.7 15.6 25.9 6.8 12.9 27.3 23.7 19.0 14.2 258.6 17.3 16.1 24.3 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595418 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023296, HPA053675" Enhanced Supported Mitochondria,Cytosol Yes No 140000 Mitochondria Cytosol "HPA023296: AB_1844738, HPA053675: " "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favorable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 9.0 14.2 46.0 3.4 39.1 0.8 18.8 11.0 22.5 14.0 11.5 23.1 7.2 9.5 10.5 7.5 13.5 11.9 7.8 10.8 35.0 17.3 46.5 64.4 6.4 3.1 28.7 18.5 27.6 10.8 17.7 5.9 17.7 16.9 17.6 11.2 13.7 15.0 12.2 4.5 11.9 8.1 9.8 20.2 2.8 9.0 4.9 28.4 4.0 19.4 10.1 7.4 7.2 7.1 1.3 9.7 0.7 0.3 0.1 1.8 0.6 15.0 10.0 28.3 46.8 23.5 14.0 36.1 18.1 22.4 21.1 27.2 28.0 14.5 0.0 18.5 14.1 8.8 11.3 8.8 61.1 19.4 0.0 10.6 2.9 14.9 23.8 11.5 0.0 0.0 17.1 14.4 16.4 11.8 15.6 16.8 0.0 0.0 0.0 18.5 9.9 0.6 0.0 19.1 11.1 8.5 9.0 32.1 0.0 20.0 11.5 9.6 11.5 0.0 10.0 10.5 22.7 18.0 0.6 20.4 6.1 18.9 7.0 12.4 0.0 0.0 0.0 3.3 0.0 9.8 0.7 0.3 0.1 0.2 0.0 0.3 1.3 0.3 0.2 2.7 1.1 1.8 1.0 0.3 0.1 0.0 9.7 0.1 0.6 46.0 39.1 11.0 22.5 35.0 17.3 28.7 18.5 16.9 28.4 14.9 24.0 11.8 48.6 23.0 22.4 35.5 25.5 20.1 33.0 40.1 21.6 364.8 64.6 31.9 24.9 14.7 17.8 0.0 12.1 88.6 30.8 28.6 6.9 69.5 42.5 23.8 20.8 20.9 9.4 29.5 23.6 7.4 52.3 12.6 22.1 96.8 15.1 8.6 35.0 241.4 12.2 19.4 17.3 1.0 3.1 14.1 185.9 2.5 43.7 34.8 ALKBH3 DEPC-1 ENSG00000166199 "AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase" Q96Q83 11 43880811-43920266 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 78.8;Late spermatids: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009674, HPA046489" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA009674: AB_1850460, HPA046489: AB_2679671" "unprognostic (3.53e-1)" "unprognostic (2.41e-1)" "unprognostic (7.43e-3)" "unprognostic (4.70e-2)" "unprognostic (6.94e-3)" "unprognostic (1.89e-1)" "unprognostic (7.71e-2)" "unprognostic (5.42e-2)" "unprognostic (8.56e-2)" "unprognostic (4.62e-1)" "unprognostic (5.87e-2)" "unprognostic (7.02e-2)" "unprognostic (2.09e-2)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.35e-2)" 17.6 14.2 14.3 13.2 16.7 8.6 26.5 21.2 22.7 19.1 15.7 19.5 12.8 13.2 22.6 31.2 16.2 20.0 16.4 12.5 14.3 13.4 15.6 25.8 15.1 17.3 15.0 14.4 21.8 23.5 22.1 16.6 9.1 15.6 19.1 16.6 19.5 25.5 19.1 29.1 20.2 15.0 18.3 14.8 17.8 17.0 17.3 12.1 14.5 16.4 21.4 22.2 15.2 17.4 14.9 18.5 21.2 21.0 17.1 21.3 13.8 7.4 13.0 5.2 0.0 10.1 13.0 0.0 9.1 20.2 18.3 18.0 6.1 5.8 1.1 5.8 13.7 9.9 10.2 7.1 15.7 17.0 0.0 24.9 10.9 8.8 12.8 25.1 20.0 14.6 13.7 27.3 8.1 39.4 7.6 13.1 21.5 15.4 11.9 9.0 8.9 17.9 10.3 9.5 7.9 19.1 5.2 11.2 14.0 11.0 11.7 9.7 7.8 7.0 11.1 16.7 4.8 16.1 12.3 9.2 10.4 5.8 17.0 13.0 10.8 11.3 12.1 15.5 8.5 8.5 21.2 12.9 7.1 17.0 14.1 16.2 14.4 17.4 15.1 18.5 14.9 21.3 18.9 2.3 17.1 21.0 16.3 16.2 13.8 14.3 16.7 21.2 22.7 14.3 13.4 15.0 14.4 15.6 12.1 14.9 10.4 11.1 9.1 9.2 10.0 5.6 12.7 16.0 10.3 15.7 3.9 3.1 26.6 17.0 78.8 13.7 9.2 0.0 28.4 4.0 9.7 6.6 7.0 11.3 16.7 9.5 9.1 14.7 10.7 69.5 15.0 13.1 16.9 15.4 12.7 17.2 23.0 7.0 9.9 14.1 10.5 6.5 19.6 18.7 9.5 6.1 1.8 14.9 13.1 5.0 AMBRA1 "DCAF3, FLJ20294, KIAA1736, WDR94" ENSG00000110497 "Autophagy and beclin 1 regulator 1" Q9C0C7 11 46396414-46594125 "Predicted intracellular proteins" "Autophagy, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017825, HPA038535" Approved Approved Vesicles,Mitochondria NA NA Vesicles Mitochondria "CAB017825: , HPA038535: AB_2676068" "unprognostic (1.76e-3)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.56e-1)" "unprognostic (6.00e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-3)" "unprognostic (7.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.98e-2)" "unprognostic (5.53e-3)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (2.90e-1)" "unprognostic (8.17e-2)" "unprognostic (1.61e-2)" "unprognostic (7.98e-2)" 15.4 26.4 15.8 18.4 20.6 19.4 20.5 25.6 24.6 16.6 15.4 23.5 12.0 18.9 18.7 15.1 15.5 18.0 15.5 13.1 14.5 11.4 13.7 14.6 14.7 15.0 15.5 18.4 21.4 13.7 33.5 23.2 17.8 15.8 15.3 14.0 20.2 17.0 20.4 18.7 25.8 17.0 17.4 12.7 17.4 15.7 18.9 17.4 26.3 16.9 10.8 18.2 14.6 14.9 3.4 3.0 12.9 2.9 2.0 4.5 2.2 6.9 18.8 13.0 14.0 13.8 10.4 8.1 7.0 13.4 11.4 12.0 14.2 12.2 14.1 7.2 12.3 13.6 12.7 6.5 12.3 8.5 12.2 21.1 9.6 11.9 18.0 9.0 13.8 12.3 14.3 9.8 7.2 13.8 12.5 11.8 12.3 16.4 9.8 8.4 17.2 17.5 9.7 21.7 15.8 10.3 17.3 17.8 7.8 11.0 12.6 10.5 11.7 12.0 13.9 12.7 8.9 14.3 9.4 12.5 10.6 9.5 12.2 10.4 11.1 8.8 14.8 9.4 7.8 9.3 12.9 2.9 2.2 3.8 1.5 3.2 3.4 2.8 2.9 2.8 3.4 2.9 2.6 3.4 2.0 2.6 3.0 4.5 2.2 15.8 20.6 25.6 24.6 14.5 11.4 15.5 18.4 15.8 17.4 3.0 6.4 3.4 2.2 3.7 6.6 6.7 7.6 4.0 4.5 0.0 2.0 3.2 0.0 5.9 9.3 3.7 8.8 0.0 8.0 1.8 4.1 3.4 4.6 3.2 4.5 4.8 9.2 3.1 4.4 5.2 4.9 3.1 5.0 2.8 7.2 3.0 6.7 6.8 7.4 2.9 5.6 12.9 2.7 1.8 0.9 4.0 5.7 4.9 5.2 3.4 AMMECR1 ENSG00000101935 "Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1" Q9Y4X0 X 110194186-110440233 "Disease related genes, Predicted intracellular proteins" "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 70.0;Rod photoreceptor cells: 93.5;Syncytiotrophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000590, HPA051762" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000590: AB_2666037, HPA051762: AB_2681596" "unprognostic (7.77e-2)" "unprognostic (1.93e-1)" "unprognostic (2.06e-1)" "unprognostic (5.17e-2)" "unprognostic (1.25e-1)" "unprognostic (6.87e-2)" "unprognostic (1.66e-3)" "unprognostic (6.55e-2)" "unprognostic (5.98e-2)" "prognostic favorable (6.62e-5)" "unprognostic (3.61e-2)" "unprognostic (3.96e-2)" "unprognostic (2.43e-3)" "unprognostic (3.33e-1)" "unprognostic (1.02e-1)" "prognostic favorable (8.44e-4)" "unprognostic (7.82e-2)" 7.2 6.6 2.4 10.1 4.5 17.0 5.3 2.9 6.5 6.3 6.2 3.9 5.0 4.6 5.3 6.0 15.9 6.3 6.5 3.0 3.1 2.9 7.5 8.5 5.9 5.8 2.6 3.2 12.4 7.4 5.0 9.5 22.7 6.6 4.3 6.1 9.7 6.5 7.0 3.2 14.2 7.8 4.5 2.4 9.7 5.8 4.0 2.3 12.5 6.0 11.1 11.3 6.8 8.9 4.3 2.9 1.5 4.8 1.2 6.7 1.9 11.3 5.6 4.1 2.0 4.7 7.0 4.5 7.9 7.1 6.5 9.6 8.9 8.3 6.7 3.8 10.4 5.2 5.4 13.1 8.9 6.7 4.7 5.9 9.3 12.9 1.8 11.9 7.4 3.9 3.9 15.9 7.4 13.3 3.5 5.1 3.3 25.9 20.2 4.9 9.5 3.5 2.6 18.9 9.7 11.0 7.7 4.4 11.9 11.0 9.6 6.6 3.2 13.3 13.1 11.1 5.2 3.2 7.4 2.3 4.5 2.8 13.3 7.1 4.2 4.7 10.8 6.9 15.5 15.0 1.3 1.9 1.5 3.4 1.3 4.6 3.3 6.7 5.4 2.9 4.3 4.6 3.9 1.3 1.2 4.8 1.3 4.6 1.9 2.4 4.5 2.9 6.5 3.1 2.9 2.6 3.2 6.6 2.3 0.0 9.8 8.2 3.8 8.5 29.6 3.8 5.1 5.3 3.4 3.5 49.1 19.3 19.9 8.0 0.4 4.2 7.9 70.0 10.4 9.3 11.3 5.9 2.3 6.0 6.1 1.6 14.5 25.2 7.8 0.8 11.8 4.0 3.3 7.2 10.2 5.8 9.8 0.0 16.3 8.2 93.5 12.9 4.7 1.8 6.9 23.3 72.3 10.0 9.9 11.5 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416775-49422753 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005566 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 10.9 6.6 8.0 8.8 6.0 6.6 16.7 10.4 8.4 10.0 7.4 21.3 10.9 9.2 11.1 3.4 9.7 13.0 16.6 7.4 2.0 21.4 41.2 5.6 2.3 7.6 8.3 14.5 18.5 16.3 10.4 2.5 10.7 9.1 10.1 12.2 9.8 20.0 3.8 5.4 11.0 7.1 5.8 7.9 8.1 2.6 7.4 1.7 8.7 0.4 1.8 6.2 8.1 0.7 5.4 4.7 3.2 8.9 1.6 2.3 0.1 0.5 0.7 0.1 0.4 0.0 10.4 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.2 0.1 0.4 0.1 0.2 0.2 0.0 0.3 29.9 1.1 0.0 0.1 0.3 0.7 0.0 0.4 1.1 0.1 0.2 0.0 0.0 0.1 0.3 0.2 0.2 5.4 0.0 0.1 0.0 0.1 0.2 0.7 0.2 0.0 7.9 0.1 0.0 0.6 7.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 3.2 4.7 0.0 1.9 0.1 0.6 0.0 0.0 5.4 0.7 1.6 1.5 0.3 8.9 0.7 0.5 0.0 2.3 6.6 8.8 16.7 10.4 7.4 2.0 7.6 8.3 10.7 7.4 3.0 11.6 3.7 11.4 2.5 17.2 18.3 17.8 6.7 7.9 0.0 19.6 22.7 0.0 0.7 1.7 2.7 19.7 0.0 0.6 6.5 4.7 10.1 7.0 37.3 4.4 7.9 12.2 3.1 2.7 1.6 9.8 3.5 5.0 0.0 16.2 21.5 0.5 14.0 6.0 0.7 17.7 6.5 4.3 1.4 0.4 2.4 8.6 5.7 31.1 8.6 ANAPC13 "APC13, DKFZP566D193, SWM1" ENSG00000129055 "Anaphase promoting complex subunit 13" Q9BS18 3 134477706-134486716 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 393.0;Proximal tubular cells: 267.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046114 Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA046114: AB_10961429" "unprognostic (2.84e-2)" "prognostic favorable (1.66e-4)" "unprognostic (2.98e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (3.57e-1)" "unprognostic (2.90e-1)" "unprognostic (2.28e-3)" "unprognostic (6.44e-2)" "unprognostic (4.36e-1)" "prognostic favorable (2.66e-7)" "unprognostic (3.10e-1)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.16e-1)" 35.5 29.5 29.0 10.8 24.0 9.7 26.2 14.6 26.7 21.3 20.0 14.8 19.6 13.2 18.7 46.5 24.5 19.2 19.3 37.5 25.3 36.3 47.1 54.4 22.1 17.3 33.3 13.3 30.1 36.0 29.6 34.3 34.8 29.2 29.1 18.3 23.4 30.5 22.6 36.8 14.4 25.4 20.7 23.2 19.2 20.1 20.4 12.4 14.1 44.3 22.2 13.4 27.3 16.9 25.5 26.9 69.4 30.5 18.7 30.0 22.8 21.1 13.3 21.0 17.9 35.8 47.6 16.2 27.6 25.5 20.2 19.1 16.6 12.6 14.4 60.0 40.4 24.4 12.5 19.6 19.7 29.2 7.2 9.1 14.7 10.8 27.7 25.8 24.0 10.5 31.6 21.6 20.3 38.1 22.7 31.3 14.1 19.5 12.3 63.7 27.2 12.2 23.6 14.3 36.7 13.0 9.8 16.5 26.2 39.4 13.2 8.6 14.1 24.5 9.0 24.0 23.5 22.5 23.6 21.8 28.2 11.4 39.5 12.1 13.6 14.7 29.8 17.3 13.3 24.0 28.9 28.3 24.2 16.4 30.5 21.3 25.5 24.6 21.4 26.9 18.6 30.0 25.2 69.4 18.7 29.6 20.5 20.5 22.8 29.0 24.0 14.6 26.7 25.3 36.3 33.3 13.3 29.2 12.4 32.8 43.1 47.7 44.5 37.4 40.5 107.7 56.0 49.5 20.5 80.3 11.8 81.7 393.0 47.8 34.9 60.7 30.8 0.0 47.0 87.8 59.7 60.7 17.4 58.7 70.2 19.1 39.2 50.3 63.1 66.9 46.9 40.0 92.8 13.6 36.6 50.4 36.3 39.1 41.4 267.1 26.5 19.4 61.3 39.2 65.8 44.3 58.8 34.5 32.7 45.2 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67288547-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.8" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavorable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 9.1 9.1 18.2 18.1 17.6 80.8 18.9 20.2 18.7 9.0 7.6 7.7 13.7 8.0 9.0 10.4 14.6 10.2 11.9 8.8 20.2 14.0 8.3 4.5 12.4 20.8 12.4 11.4 9.4 7.7 6.0 17.0 9.2 10.7 12.7 4.5 10.9 17.5 12.0 4.2 28.1 8.6 9.9 9.6 24.1 8.9 6.8 12.0 9.6 6.4 6.2 14.4 14.3 13.4 2.6 8.1 11.4 4.6 3.8 6.7 1.9 6.3 4.5 3.4 8.1 5.2 5.1 6.4 3.9 3.8 4.6 2.9 5.3 7.0 6.9 6.6 4.4 6.2 10.6 2.5 5.0 0.7 9.7 3.0 5.8 6.8 3.0 8.1 6.4 23.5 5.5 7.9 4.1 5.3 6.9 4.3 7.0 4.1 8.4 4.0 10.3 8.6 49.8 3.9 9.8 5.7 21.6 3.7 4.8 6.5 8.7 4.0 6.8 3.4 10.2 27.2 2.7 10.5 18.3 5.5 7.3 4.7 7.4 5.1 8.5 6.1 4.1 9.6 18.0 4.7 7.2 3.3 11.4 6.7 4.6 4.4 2.6 3.8 5.4 1.9 2.4 2.4 5.8 10.8 3.8 3.8 8.1 2.8 1.9 18.2 17.6 20.2 18.7 20.2 14.0 12.4 11.4 10.7 12.0 0.0 22.6 9.3 10.5 12.6 49.4 4.5 2.5 18.7 10.3 15.7 70.7 6.9 1.7 7.8 17.6 14.2 2.6 0.0 6.0 6.4 13.6 15.3 24.3 2.4 17.5 39.7 10.4 25.2 48.3 5.1 20.4 28.1 11.8 14.4 6.2 25.2 7.9 2.9 15.9 1.4 45.9 12.9 12.1 2.8 5.5 22.0 6.3 29.9 6.9 15.7 ANKRD44 PP6-ARS-B ENSG00000065413 "Ankyrin repeat domain 44" Q8N8A2 2 196967017-197311173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.7;lymphoid tissue: 38.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 93.2;Macrophages: 60.1;T-cells: 81.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HMC-1: 20.7;Karpas-707: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030122, HPA056549" Approved Approved "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA030122: AB_10600980, HPA056549: AB_2683170" "unprognostic (3.64e-1)" "unprognostic (1.70e-2)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-1)" "unprognostic (7.04e-5)" "unprognostic (1.97e-2)" "unprognostic (1.58e-3)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" "unprognostic (3.67e-2)" 6.0 6.0 4.9 29.4 8.8 12.5 4.3 3.7 5.1 8.6 6.7 10.8 3.9 3.2 6.5 3.9 4.3 4.9 7.6 6.4 6.4 4.7 5.6 4.5 15.4 36.7 9.4 4.7 5.1 3.5 6.0 6.1 6.4 6.4 5.0 4.8 7.4 8.0 4.7 2.9 3.0 12.6 9.6 8.0 17.8 5.6 7.1 8.9 38.2 5.1 3.0 27.0 9.0 9.8 15.7 9.4 34.7 11.4 12.0 13.4 6.3 1.0 0.6 1.6 1.7 3.9 1.6 0.3 2.5 1.1 1.3 1.2 0.4 0.6 9.0 1.1 2.1 2.3 0.1 0.6 0.5 1.0 26.6 2.3 0.3 3.2 0.1 0.2 6.5 20.7 0.8 0.3 1.3 0.1 1.9 1.7 2.2 1.5 15.0 1.9 1.5 3.1 5.3 0.2 0.3 1.7 5.7 1.9 12.3 3.1 0.8 1.7 7.4 0.8 0.6 7.0 1.3 0.9 6.4 9.3 4.6 2.5 1.3 1.8 3.7 4.4 11.4 3.1 8.2 2.6 21.8 9.5 21.0 13.1 9.8 12.4 11.6 9.8 11.1 9.4 15.7 11.3 13.4 34.7 12.0 11.4 6.2 9.3 6.3 4.9 8.8 3.7 5.1 6.4 4.7 9.4 4.7 6.4 8.9 14.9 19.2 93.2 4.0 3.1 5.0 7.8 25.5 12.0 13.6 10.4 3.9 3.9 1.7 3.0 10.6 6.7 1.1 0.0 4.0 0.7 5.8 3.2 52.0 7.4 16.4 3.2 2.4 44.2 57.8 12.9 14.4 60.1 35.4 19.8 1.1 10.8 3.8 3.5 16.6 1.1 11.1 19.4 6.1 3.0 3.6 3.1 1.1 81.3 0.8 4.3 ANKRD52 "FLJ34236, PP6-ARS-C" ENSG00000139645 "Ankyrin repeat domain 52" Q8NB46 12 56237807-56258391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043815 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA043815: AB_10961762" "unprognostic (6.25e-3)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (9.84e-2)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (6.31e-2)" 10.7 23.2 12.3 13.2 19.6 12.1 10.8 23.1 23.5 10.8 11.6 15.6 9.1 11.9 13.8 8.9 10.9 11.5 12.7 12.0 12.7 13.4 13.2 8.3 9.8 12.3 13.3 14.7 14.6 14.1 28.4 14.5 12.6 22.8 11.9 12.1 14.8 11.6 13.6 30.8 15.8 13.0 15.8 8.8 11.9 10.9 8.5 13.5 10.5 12.4 11.4 13.4 12.3 11.8 1.1 1.1 2.4 0.6 0.3 1.2 0.5 11.7 29.2 13.0 23.5 10.6 8.4 9.2 23.6 10.5 21.2 9.6 18.9 6.6 12.6 15.1 23.0 7.4 15.4 14.3 10.3 12.3 12.1 14.5 22.6 19.0 7.2 7.3 17.7 13.2 8.6 11.7 19.7 10.0 15.6 12.3 10.4 9.2 6.9 19.8 16.4 14.2 5.9 5.4 7.7 13.5 11.2 9.0 5.0 14.0 15.1 9.9 9.0 25.7 16.5 9.4 10.5 13.3 6.9 16.9 22.2 19.5 12.4 14.7 6.4 8.4 6.2 22.8 5.9 14.4 2.4 0.6 0.9 1.2 0.1 1.0 0.8 0.4 0.7 0.3 1.1 0.6 0.7 0.3 0.3 0.4 1.1 0.3 0.5 12.3 19.6 23.1 23.5 12.7 13.4 13.3 14.7 22.8 13.5 6.0 4.0 4.7 2.9 10.0 4.7 5.6 2.5 0.0 0.0 12.2 25.5 5.1 0.0 8.4 0.3 4.8 8.3 0.0 8.0 6.2 5.3 4.5 1.1 6.0 6.2 7.9 9.2 6.2 6.5 0.8 5.8 3.9 10.1 4.6 6.8 3.7 12.4 9.0 4.6 5.8 6.1 0.0 5.2 6.7 8.1 9.5 3.1 4.8 7.3 3.7 APOO "FAM121B, MGC4825, Mic23, MIC26, My025" ENSG00000184831 "Apolipoprotein O" Q9BUR5 X 23833353-23907934 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 152.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003187 Supported Approved Mitochondria,Cytosol "Secreted to blood" NA NA Mitochondria Cytosol "HPA003187: AB_1079375" "unprognostic (2.53e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.86e-2)" "unprognostic (6.38e-3)" "unprognostic (3.45e-1)" "unprognostic (2.42e-1)" "unprognostic (6.18e-2)" "unprognostic (2.95e-1)" "unprognostic (6.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "prognostic favorable (2.56e-6)" "unprognostic (2.53e-2)" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (5.88e-3)" 5.6 13.1 25.5 5.4 21.2 4.4 9.0 18.5 30.9 9.1 10.9 8.5 5.5 9.2 7.2 13.5 7.2 13.6 6.1 38.4 26.0 23.8 29.5 12.2 5.5 6.6 24.9 17.5 7.1 9.0 20.1 15.8 7.1 21.5 9.3 12.5 11.7 14.6 10.4 26.0 4.3 7.6 7.8 18.1 5.4 10.3 10.5 6.8 7.7 13.3 10.4 7.2 6.3 5.8 9.8 14.2 8.5 13.3 7.8 15.0 6.6 14.7 13.5 22.7 15.8 3.8 8.7 3.6 7.4 9.1 15.8 16.7 8.0 7.1 12.8 9.3 6.8 20.6 12.2 28.6 14.8 17.6 13.5 20.3 6.5 13.4 12.6 9.0 16.3 7.3 9.7 8.8 17.4 13.0 8.5 11.0 16.1 9.1 14.5 14.6 13.9 16.4 17.6 20.7 19.4 21.9 12.7 11.3 30.7 30.9 7.6 15.4 11.2 16.1 15.4 15.8 23.3 26.6 7.3 2.7 10.2 6.2 36.5 11.2 11.3 19.8 11.6 16.5 8.1 14.9 8.5 4.2 1.5 11.5 13.3 15.0 9.8 12.7 11.3 12.0 8.3 10.3 10.1 2.5 7.8 12.6 14.2 11.5 6.6 25.5 21.2 18.5 30.9 26.0 23.8 24.9 17.5 21.5 6.8 14.9 7.8 15.6 14.2 12.5 19.3 55.7 25.5 87.0 9.1 22.7 13.7 16.6 152.5 24.6 16.8 8.7 14.4 0.0 14.1 7.3 12.6 14.5 3.5 11.9 20.3 19.1 6.9 9.8 10.1 11.7 10.6 11.2 27.0 55.9 17.6 40.5 12.0 18.4 14.9 67.7 23.7 6.5 6.2 14.0 50.7 6.0 10.4 10.0 20.9 15.4 ARL6IP4 "SFRS20, SR-25, SRp25, SRrp37" ENSG00000182196 "ADP ribosylation factor like GTPase 6 interacting protein 4" Q66PJ3 12 122980060-122982913 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA052098 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA052098: AB_2681724" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-1)" "unprognostic (4.23e-2)" "unprognostic (2.04e-3)" "unprognostic (6.48e-4)" "unprognostic (1.06e-2)" "unprognostic (1.38e-1)" "unprognostic (8.62e-2)" "unprognostic (3.03e-5)" "unprognostic (4.01e-2)" "unprognostic (8.41e-8)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (1.43e-2)" "prognostic favorable (1.08e-4)" 42.1 59.6 63.3 35.7 46.8 55.3 40.3 36.9 55.9 36.7 43.0 32.2 38.9 43.7 33.8 30.7 38.9 42.9 40.1 57.0 42.8 40.9 45.2 59.1 33.9 51.6 45.2 38.3 50.0 94.4 30.0 34.7 29.7 35.1 38.9 24.7 39.7 59.7 41.2 131.1 30.7 44.9 64.3 36.1 38.1 41.6 35.2 27.7 35.5 39.1 43.4 39.9 39.5 39.9 54.4 72.4 58.1 81.5 46.5 59.6 61.3 49.0 53.6 35.3 23.6 24.8 32.9 27.7 28.3 34.1 42.6 32.4 26.4 20.9 46.9 35.6 35.8 19.9 26.0 28.1 45.9 19.0 41.5 29.3 77.9 47.5 51.8 47.8 42.4 34.4 34.0 37.1 32.7 43.1 46.8 46.8 37.9 34.5 22.8 34.0 57.9 49.3 77.2 27.7 29.7 34.0 37.6 38.8 55.4 36.8 41.9 34.3 41.1 26.7 44.8 65.1 16.1 58.7 55.3 41.8 24.7 45.0 23.5 35.2 49.0 23.6 53.4 35.6 49.8 30.8 32.9 58.4 58.1 47.4 72.2 51.0 54.4 57.0 52.5 72.4 50.6 55.1 49.4 16.1 46.5 81.5 49.3 59.6 61.3 63.3 46.8 36.9 55.9 42.8 40.9 45.2 38.3 35.1 27.7 86.4 116.6 229.3 258.2 181.7 102.3 0.0 173.3 87.0 80.8 200.7 41.2 248.7 437.7 251.9 151.9 255.7 444.9 46.7 552.1 221.9 252.2 285.2 160.8 400.6 340.2 92.2 214.5 213.6 390.7 256.2 206.0 341.0 357.7 480.7 268.3 146.1 343.4 291.0 170.1 721.8 106.3 174.6 249.2 209.1 156.8 177.7 200.9 256.7 288.4 330.8 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56525481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;testis: 12.6" "Group enriched" "Detected in some" 11 "Early spermatids: 81.2;Late spermatids: 192.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA072942: AB_2686561" "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 1.3 1.1 4.4 0.8 4.9 3.4 2.0 1.5 7.1 1.3 1.3 0.6 2.4 1.0 2.0 1.1 1.1 1.2 2.4 0.8 3.9 3.2 0.5 0.5 0.6 1.0 1.3 2.9 3.0 0.4 0.4 1.6 0.3 8.7 2.2 1.0 1.9 0.9 3.8 0.4 4.1 1.0 3.7 2.5 0.8 1.0 12.6 0.6 0.1 1.1 1.2 0.7 1.5 2.5 2.1 2.2 1.6 0.4 1.4 1.4 0.1 0.0 0.5 0.6 0.5 1.2 2.9 0.1 0.9 0.5 2.1 2.1 0.5 0.7 0.7 0.0 1.5 0.1 0.2 0.4 0.2 1.2 0.1 0.1 0.3 0.0 0.1 2.8 0.3 0.7 4.4 0.7 1.9 0.4 0.4 2.1 0.2 0.2 0.9 2.0 0.0 0.3 0.1 2.2 0.1 1.3 8.7 0.0 0.1 0.1 0.3 9.2 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.4 0.3 0.4 0.0 0.1 0.4 0.4 0.4 0.1 0.0 0.3 0.8 0.4 0.4 0.7 0.4 0.4 1.0 1.2 1.0 0.3 2.1 1.4 0.6 1.6 1.4 0.4 2.2 1.0 0.1 4.4 4.9 1.5 7.1 3.9 3.2 1.3 2.9 8.7 0.6 0.0 1.4 0.0 0.8 5.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 81.2 0.2 0.0 0.0 0.2 0.1 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.3 192.4 1.4 0.0 5.0 0.0 0.3 1.0 0.6 0.0 1.1 0.3 0.0 0.0 0.2 12.2 0.9 1.4 0.0 0.0 0.4 0.3 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell type enhanced" "Detected in many" 7 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 14.9 0.1 13.3 12.1 0.1 16.3 20.5 0.4 0.4 0.0 6.3 0.0 0.0 21.4 0.0 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.5 0.0 14.1 0.1 0.0 19.1 5.2 12.8 0.1 20.2 17.3 0.0 0.0 0.1 48.1 0.0 0.0 0.2 34.7 0.9 0.1 4.0 26.6 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 27.9 7.6 0.0 3.8 18.4 19.6 11.5 0.1 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 14.9 5.4 4.4 13.8 3.8 11.2 22.2 7.6 2.7 15.9 31.4 7.9 1.0 3.3 8.0 0.1 13.0 0.0 0.0 1.8 0.4 20.2 13.8 2.3 0.4 3.6 1.6 8.7 16.0 2.1 0.4 22.5 4.0 5.0 11.8 2.2 7.0 3.1 0.0 23.0 4.2 9.7 58.2 26.4 1.4 1.1 2.6 4.2 2.5 1.2 6.2 ATAD1 FLJ14600 ENSG00000138138 "ATPase family, AAA domain containing 1" Q8NBU5 10 87751512-87841343 "Enzymes, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 802.3;Late spermatids: 1314.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037569 Uncertain Approved "Nucleoli rim,Mitochondria" NA NA "Nucleoli rim" Mitochondria "HPA037569: AB_10672496" "unprognostic (9.92e-2)" "unprognostic (2.90e-1)" "unprognostic (4.05e-2)" "unprognostic (2.68e-1)" "unprognostic (3.24e-2)" "unprognostic (6.60e-3)" "unprognostic (3.38e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-1)" "unprognostic (8.45e-2)" "unprognostic (1.35e-3)" "unprognostic (1.67e-2)" "prognostic favorable (3.98e-6)" "unprognostic (2.35e-1)" "unprognostic (3.29e-1)" "unprognostic (3.45e-2)" "unprognostic (4.22e-2)" 16.2 21.3 20.4 15.1 26.2 8.0 19.4 22.4 29.8 19.2 15.9 14.4 16.0 13.5 19.6 17.0 17.3 14.8 13.3 39.9 20.4 22.2 20.6 22.1 14.1 14.2 20.4 17.1 19.1 12.6 25.6 24.9 30.2 31.2 24.3 18.4 19.8 15.8 20.4 32.1 14.4 14.1 18.4 18.2 12.5 14.0 19.8 14.7 18.0 20.1 18.5 15.7 18.9 15.2 9.0 7.3 6.7 7.6 9.8 13.5 7.4 9.9 9.4 12.0 11.4 14.5 12.8 9.1 10.1 16.7 10.4 11.7 8.4 28.8 9.6 7.7 8.4 6.1 16.5 10.0 8.6 12.1 8.5 13.5 7.9 13.1 10.4 17.2 21.4 5.4 12.7 23.9 11.0 27.3 19.0 6.9 9.7 7.6 12.5 11.5 6.0 13.7 14.5 8.9 7.7 6.6 9.4 7.6 10.5 15.9 7.6 7.6 16.7 8.9 6.3 20.2 12.7 16.6 10.1 8.4 9.5 8.4 6.4 13.1 16.8 15.4 12.3 10.5 14.9 7.3 6.7 3.8 5.7 9.2 5.9 13.5 9.0 10.3 11.4 7.3 7.6 11.8 11.6 2.2 9.8 7.6 5.5 9.3 7.4 20.4 26.2 22.4 29.8 20.4 22.2 20.4 17.1 31.2 14.7 50.6 28.3 26.2 34.8 23.8 46.9 66.0 25.5 40.2 25.0 21.0 33.4 32.0 19.9 34.6 802.3 18.5 22.5 0.0 24.4 24.9 28.9 35.7 28.8 24.5 24.0 66.7 21.9 12.9 14.8 1314.1 33.1 25.4 30.4 15.4 23.3 53.3 31.9 26.4 44.2 23.7 46.8 58.2 38.7 58.1 20.9 26.3 73.9 29.9 22.1 44.1 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA067683: AB_2685886" "unprognostic (2.85e-1)" "prognostic favorable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favorable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favorable (2.39e-7)" "prognostic favorable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 6.4 10.8 5.1 9.2 7.8 35.0 6.3 15.6 14.9 6.2 18.4 9.8 8.1 26.0 6.1 7.2 18.4 5.5 7.6 15.4 4.6 4.9 14.5 8.8 7.3 9.8 9.6 6.4 7.0 16.1 8.2 12.1 6.9 7.3 9.7 7.3 7.8 11.5 8.5 31.5 17.7 27.3 4.0 4.5 12.0 10.5 29.0 8.8 19.9 9.8 16.4 10.5 7.5 9.6 2.0 7.6 5.7 1.6 2.2 3.6 1.4 7.0 4.7 6.6 8.9 1.2 1.0 5.1 4.3 4.3 6.2 6.8 7.9 2.3 4.5 8.2 0.5 4.7 11.1 4.1 3.7 0.8 4.4 10.7 12.0 11.5 4.4 4.1 4.8 12.3 1.0 7.7 5.3 1.9 1.6 1.8 9.9 8.9 11.0 1.9 11.3 14.1 29.3 10.0 3.2 12.9 10.4 4.1 8.0 3.5 9.5 24.8 9.6 6.4 12.5 4.9 1.2 7.7 11.8 3.4 9.5 6.0 19.0 9.6 9.8 6.6 5.3 8.1 9.3 10.7 3.0 1.6 5.7 2.1 1.5 3.1 2.0 2.5 2.3 1.1 1.0 2.5 3.4 0.5 2.2 0.7 7.6 3.6 1.4 5.1 7.8 15.6 14.9 4.6 4.9 9.6 6.4 7.3 8.8 8.9 10.0 8.8 18.9 27.1 15.0 0.4 17.8 2.7 1.2 1.8 13.7 23.7 11.6 14.3 51.1 4.1 90.5 23.3 14.4 5.4 10.1 17.3 6.9 9.7 11.7 27.0 21.4 5.5 12.0 6.8 8.1 8.7 11.8 19.0 28.4 10.6 16.6 38.2 4.2 16.8 17.6 12.9 16.0 63.1 19.6 27.4 30.6 21.3 23.3 29.3 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 1400000 Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 86.7 76.6 64.6 104.3 50.9 51.7 40.9 57.6 44.9 61.9 67.1 81.3 80.2 81.4 60.8 35.7 105.4 53.5 71.4 66.0 66.2 58.6 91.7 55.1 122.5 104.8 38.4 93.9 63.1 58.9 63.7 53.8 57.0 54.2 58.9 70.6 111.7 89.7 64.8 203.9 140.4 163.0 91.9 174.2 90.2 62.9 53.9 139.1 130.5 96.5 62.1 68.5 75.4 186.6 54.5 100.7 47.0 121.9 49.9 54.5 87.2 90.0 84.0 51.4 118.1 169.8 63.1 91.9 83.7 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 20.8 44.7 0.0 0.0 0.0 0.0 0.0 0.0 93.7 67.1 366.4 0.0 700.3 1212.0 418.8 0.0 0.0 0.0 0.0 501.7 525.7 0.0 0.0 59.3 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 591.5 0.0 0.0 502.5 0.0 0.0 993.9 0.0 0.0 0.0 0.0 0.0 0.0 364.9 0.0 0.0 0.0 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1357.9;Hofbauer cells: 793.2;Proximal tubular cells: 1064.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 37.9 43.8 38.0 36.1 45.5 47.3 37.5 29.7 33.7 37.3 32.7 37.8 27.0 39.8 31.4 30.4 30.1 32.4 48.9 35.8 50.6 32.9 49.3 44.4 37.1 58.1 30.1 53.6 30.9 49.6 48.8 25.3 27.1 42.9 41.9 53.7 26.9 42.7 41.0 112.7 51.8 76.6 29.7 88.5 83.8 33.3 33.2 36.1 56.8 54.0 32.9 39.3 24.9 46.7 56.0 43.9 57.8 63.8 22.5 14.7 23.0 39.6 24.3 32.8 55.7 55.7 34.4 30.6 24.7 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 205.4 192.2 0.0 0.0 0.0 0.0 0.0 0.0 269.0 169.5 392.6 0.0 537.4 1357.9 448.4 0.0 0.0 0.0 0.0 495.8 570.0 0.0 0.0 86.0 0.0 793.2 0.0 0.0 0.0 0.0 0.0 0.0 158.5 0.0 585.3 0.0 0.0 512.8 0.0 0.0 1064.7 0.0 0.0 0.0 0.0 0.0 0.0 593.8 0.0 0.0 0.0 ATP5S "ATPW, HSU79253" ENSG00000125375 "ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)" Q99766 14 50312326-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 234.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046967, HPA062690" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA046967: AB_2679880, HPA062690: AB_2684836" "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favorable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favorable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 5.5 5.0 8.4 6.0 12.5 10.0 7.0 5.6 11.0 5.9 5.2 13.9 7.9 9.4 7.0 7.6 7.9 6.0 5.7 9.0 8.8 9.0 6.8 5.0 5.4 6.6 10.0 10.5 6.3 7.3 3.3 11.2 3.5 10.1 5.6 4.6 8.3 5.6 4.7 11.6 11.7 6.5 3.6 12.4 5.4 5.4 19.8 10.3 5.1 10.1 8.0 6.1 5.1 5.1 17.0 14.2 15.4 14.1 9.2 12.9 9.6 7.9 2.0 3.8 2.1 4.7 8.5 12.0 2.9 3.7 5.0 7.3 3.3 6.0 9.1 2.7 4.7 3.4 4.9 1.3 2.7 3.1 5.2 2.4 4.8 4.1 13.9 1.1 7.1 7.4 7.6 6.7 0.7 1.4 2.1 3.6 6.7 1.6 16.1 3.4 7.2 1.7 5.3 2.5 6.3 4.2 5.2 5.6 4.7 2.4 11.4 5.5 3.5 2.4 7.6 5.4 1.6 8.1 3.7 2.2 6.4 9.1 3.9 3.0 8.1 5.3 5.3 1.0 5.4 5.1 9.8 10.4 15.4 11.4 11.4 10.0 17.0 9.4 11.0 7.7 14.1 11.9 12.9 1.1 9.2 14.1 14.2 10.8 9.6 8.4 12.5 5.6 11.0 8.8 9.0 10.0 10.5 10.1 10.3 20.8 20.5 18.2 24.5 13.6 25.6 57.7 17.8 37.5 22.7 24.4 21.6 30.9 28.2 25.5 234.6 18.6 18.0 23.3 37.3 20.1 16.7 20.9 40.5 21.2 25.1 35.0 23.7 16.5 23.7 98.5 24.7 26.0 15.1 31.5 21.0 27.3 25.0 14.4 15.6 28.9 61.8 19.4 18.6 38.2 20.6 17.9 34.9 23.2 26.8 30.3 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria NA NA 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.5 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 4.2 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 8.6 0.0 8.6 0.0 6.9 9.4 0.2 8.0 0.0 6.7 0.0 0.1 5.9 13.7 8.9 3.1 0.0 3.4 9.9 0.0 0.0 0.2 3.8 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 0.0 0.0 0.0 0.1 0.6 40.4 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.6 37.4 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.0 0.0 2.2 9.5 0.0 32.5 3.2 28.8 1.4 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.7 0.3 4.4 0.0 0.4 41.3 5.3 0.1 0.2 0.0 0.0 0.0 AURKAIP1 "AIP, AKIP, FLJ20608" ENSG00000175756 "Aurora kinase A interacting protein 1" Q9NWT8 1 1373730-1375495 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Late spermatids: 2457.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031821 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA031821: AB_10601458" "unprognostic (9.54e-2)" "unprognostic (1.86e-2)" "unprognostic (2.77e-1)" "unprognostic (4.77e-2)" "unprognostic (2.68e-1)" "unprognostic (2.98e-2)" "unprognostic (3.31e-1)" "unprognostic (9.52e-2)" "unprognostic (2.76e-1)" "unprognostic (9.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.34e-1)" "prognostic favorable (8.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.18e-2)" "unprognostic (1.84e-1)" 26.6 29.3 30.3 19.6 30.5 20.9 16.3 17.8 40.5 14.1 27.9 18.7 18.3 33.5 14.3 18.3 25.0 14.5 22.9 55.2 25.3 23.4 35.0 59.1 14.4 17.6 29.0 23.0 14.8 41.2 16.8 18.7 23.6 21.9 17.2 13.6 20.0 35.8 20.4 115.9 20.2 29.5 15.9 18.5 16.9 24.7 73.8 12.6 16.0 27.1 41.4 20.7 18.2 15.2 53.4 81.9 82.5 67.5 36.1 61.6 59.2 38.9 23.7 13.0 23.3 11.5 14.6 24.0 23.7 15.8 37.6 26.8 41.5 36.2 20.6 35.4 16.0 18.9 28.9 17.8 31.4 10.9 24.7 50.3 16.6 31.0 38.3 22.7 21.4 22.6 19.1 14.2 26.3 10.7 11.0 20.4 19.7 32.7 28.5 21.8 29.7 26.2 76.5 24.6 24.6 67.5 30.7 16.0 44.2 29.7 10.4 41.8 31.3 17.0 59.4 56.3 8.3 25.7 50.1 15.2 23.3 29.9 27.7 34.9 37.3 34.0 43.2 32.5 31.7 15.7 60.8 67.5 70.6 51.1 53.6 48.4 53.1 53.9 53.7 58.0 53.4 50.7 49.3 82.5 36.1 46.0 81.9 61.6 59.2 30.3 30.5 17.8 40.5 25.3 23.4 29.0 23.0 21.9 12.6 44.7 60.9 130.3 137.2 144.1 107.1 195.9 180.9 89.7 56.9 157.1 60.9 351.3 573.6 261.8 1001.4 114.7 553.0 116.8 362.4 394.1 140.0 198.9 86.5 355.2 260.5 98.5 195.6 106.2 140.4 2457.2 126.0 155.3 205.8 225.4 267.9 199.3 331.2 287.5 111.4 527.2 88.0 155.2 136.5 419.6 143.7 172.8 366.4 100.2 314.0 225.6 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203543-122208952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;skin 1: 8.5" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA055261: AB_2682765" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.7 3.2 7.3 0.8 6.8 4.6 0.8 16.3 9.1 0.5 0.7 0.5 0.0 1.0 0.6 0.7 1.8 1.1 1.1 0.8 4.9 4.0 6.1 0.6 1.1 0.9 1.5 7.3 0.8 0.8 0.8 1.9 0.8 4.0 0.7 0.6 1.0 1.7 0.7 1.1 8.5 1.0 0.6 0.6 1.0 0.7 2.0 0.3 0.0 0.8 0.3 0.8 0.6 0.5 0.8 1.0 0.8 1.7 0.4 1.9 0.4 5.5 1.0 0.4 2.2 0.2 0.1 1.0 0.1 0.0 0.3 0.7 3.5 0.5 0.5 1.0 0.0 0.4 2.0 2.7 2.2 0.2 8.2 2.8 0.2 1.5 0.3 0.6 0.7 1.1 0.7 9.9 0.1 0.5 0.8 0.0 2.0 1.6 0.7 0.2 4.9 0.0 0.7 0.6 0.2 2.0 0.4 0.6 1.0 1.4 0.6 1.4 1.8 1.6 1.0 0.5 0.9 7.6 0.1 0.1 0.5 2.8 0.5 0.3 0.6 5.0 1.2 0.5 0.8 0.3 0.8 0.4 0.2 0.8 0.1 0.4 0.8 1.3 0.2 0.2 0.5 1.9 0.2 0.5 0.4 1.7 1.0 0.6 0.4 7.3 6.8 16.3 8.1 4.9 4.0 1.5 7.3 4.0 0.3 0.0 2.6 0.0 0.7 1.1 0.1 0.4 0.0 1.4 1.2 0.0 0.0 0.4 1.7 1.0 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.4 0.6 0.0 6.1 0.1 0.0 0.2 0.5 2.6 1.3 0.5 0.5 0.3 0.4 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 56.4;Hepatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Yes No Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favorable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 7.0 2.6 10.0 13.4 10.2 8.9 8.0 5.0 10.4 8.3 11.4 4.3 9.7 20.0 5.4 12.0 9.7 7.1 5.5 6.6 11.6 24.8 8.2 9.9 6.9 5.8 11.3 14.0 4.5 8.5 6.8 5.7 7.1 7.4 9.8 15.6 8.3 17.9 18.5 3.9 5.1 8.2 7.4 15.4 3.4 13.0 31.1 17.1 22.9 10.8 6.7 9.5 8.5 7.1 5.0 11.5 9.1 10.8 4.2 5.0 3.4 4.5 6.7 12.8 12.5 6.6 6.1 10.5 7.4 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 8.9 15.2 6.7 10.1 7.6 7.0 26.0 10.2 16.0 14.8 5.2 2.0 15.7 23.2 6.8 56.4 9.0 12.4 0.0 9.0 6.6 13.0 8.6 16.1 55.0 10.2 3.2 11.5 11.1 9.8 4.1 8.1 6.1 15.1 10.0 28.8 14.6 4.5 11.5 8.1 25.2 8.2 6.5 8.9 7.7 4.8 10.8 8.7 8.9 15.3 9.8 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" NA NA 16000000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038" "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.7 0.2 0.0 2.4 1.9 0.0 22.7 4.4 17.4 13.2 0.0 2.6 0.0 2.1 8.2 0.3 1.0 0.1 0.2 16.7 0.1 0.1 0.0 2.2 0.0 10.1 0.1 0.1 5.9 2.2 3.8 2.2 10.6 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.1 0.0 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 1.0 0.1 0.0 7.5 24.4 4.1 9.4 5.0 0.3 0.0 0.0 9.4 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 35.7 0.3 0.0 0.2 0.6 4.7 9.6 0.0 0.0 0.0 1.8 3.9 0.2 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.3 4.1 0.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.7 0.0 0.0 0.1 0.2 0.0 0.0 0.3 1.5 0.0 6.6 0.4 0.7 0.0 0.6 0.0 0.0 0.0 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26382898-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 467.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (7.59e-3)" 61.7 27.8 32.7 18.2 39.1 79.4 40.1 26.1 39.0 35.0 19.9 32.3 30.7 11.5 27.3 34.0 26.7 26.4 28.0 36.0 36.0 27.4 39.9 22.9 31.3 20.7 43.1 31.9 63.4 10.4 26.8 16.0 51.2 41.0 23.7 14.9 20.9 22.1 39.2 21.0 38.1 14.5 26.5 47.9 19.5 16.7 33.0 43.9 17.8 21.5 12.4 25.2 48.3 30.8 14.2 30.4 68.7 53.9 7.8 17.6 36.3 17.9 6.9 16.4 11.1 45.7 28.8 13.9 18.2 53.5 17.1 37.9 3.1 8.7 5.5 17.2 34.2 23.9 9.2 8.1 23.4 57.0 3.6 4.5 22.9 7.1 5.4 25.5 2.0 39.8 34.6 18.4 19.3 11.6 56.7 21.8 13.7 10.3 13.4 35.8 7.8 14.2 7.6 5.3 11.3 7.5 7.6 20.8 10.9 17.7 11.7 17.5 15.6 8.8 1.7 13.8 18.8 9.0 4.3 28.6 32.1 13.9 20.0 4.1 19.7 8.9 7.4 48.9 4.1 7.2 49.9 53.9 32.1 7.6 27.8 6.7 12.4 11.4 8.3 30.4 14.2 17.6 12.8 68.7 7.8 17.4 6.9 15.0 36.3 32.7 39.1 26.1 39.0 36.0 27.4 43.1 31.9 41.0 43.9 80.4 113.7 54.1 47.2 87.7 108.8 31.1 30.6 89.7 69.4 97.7 31.4 24.2 41.4 101.3 153.2 88.4 28.4 467.2 33.9 141.0 136.5 90.8 116.8 23.2 118.2 77.9 115.7 155.9 197.5 155.5 296.6 132.1 101.3 70.3 45.5 412.0 125.0 28.8 326.7 215.8 62.1 142.3 150.4 113.3 98.5 110.7 135.9 55.4 28.1 62.0 BRD8 "p120, SMAP" ENSG00000112983 "Bromodomain containing 8" Q9H0E9 5 138139766-138178986 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Spermatocytes: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001841 Supported Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA001841: AB_1845438" "unprognostic (1.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.81e-3)" "unprognostic (2.31e-2)" "unprognostic (9.01e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (1.09e-6)" "unprognostic (1.73e-1)" "unprognostic (7.01e-2)" "unprognostic (6.06e-2)" "unprognostic (1.51e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (4.29e-1)" "unprognostic (1.28e-1)" "unprognostic (2.22e-1)" "unprognostic (2.07e-2)" 11.9 14.1 21.0 10.4 22.1 14.0 18.2 28.9 24.8 17.1 15.7 21.1 14.4 11.1 20.0 31.2 13.8 18.9 12.0 11.6 16.5 16.6 15.5 14.2 14.0 13.5 18.5 16.8 24.9 17.8 19.8 37.0 17.7 22.1 17.2 18.4 15.4 14.7 18.5 15.3 16.8 12.8 18.7 16.6 16.4 14.3 54.6 20.7 25.5 20.5 7.7 15.3 14.3 14.0 9.7 10.6 17.8 9.6 20.7 15.3 8.3 11.4 15.0 26.5 42.4 19.3 18.2 24.0 17.8 19.8 25.9 27.3 22.5 25.8 11.5 17.9 16.5 26.6 13.5 27.9 17.2 28.0 20.1 20.7 15.6 35.7 15.2 10.8 9.4 16.5 13.5 11.4 20.5 18.7 20.9 16.4 21.6 13.9 14.9 17.2 12.8 19.1 15.1 11.9 13.3 7.8 18.7 21.9 14.0 17.4 16.9 23.5 11.8 21.3 9.3 16.2 37.5 16.0 17.5 10.2 12.8 14.9 8.8 15.4 13.3 14.7 15.9 9.8 14.0 11.8 12.7 9.6 11.9 14.1 6.9 14.8 9.7 12.0 12.4 10.6 9.6 15.3 15.1 17.8 20.7 7.1 7.4 11.0 8.3 21.0 22.1 28.9 24.8 16.5 16.6 18.5 16.8 22.1 20.7 23.8 28.1 13.4 8.4 6.2 29.9 31.6 12.7 40.2 37.5 26.2 35.3 22.4 16.6 14.7 69.4 21.5 13.6 23.3 10.8 10.9 16.2 15.0 22.1 15.1 10.3 28.6 30.0 11.6 14.2 29.1 29.1 15.4 23.6 36.1 19.4 28.9 14.4 14.4 22.6 9.2 33.8 25.8 10.3 193.0 44.5 6.0 21.2 15.2 18.3 6.7 BRI3BP "BNAS1, HCCR-2, HCCRBP-3, KG19" ENSG00000184992 "BRI3 binding protein" Q8WY22 12 124993700-125031231 "Predicted membrane proteins, Transporters" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 38.1;U-698: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014957 Approved Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA014957: AB_1845447" "unprognostic (1.62e-2)" "unprognostic (6.82e-2)" "unprognostic (1.53e-2)" "unprognostic (9.95e-2)" "unprognostic (4.66e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.65e-3)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (7.40e-2)" "unprognostic (4.82e-2)" "unprognostic (2.72e-3)" "unprognostic (1.44e-3)" "unprognostic (2.20e-1)" "unprognostic (9.20e-2)" "unprognostic (1.55e-1)" 3.8 3.2 10.8 12.6 13.7 4.7 6.8 13.4 16.0 3.8 16.8 8.8 2.4 22.5 2.9 3.0 10.7 5.0 9.8 3.0 11.0 10.8 8.3 7.5 3.4 14.2 10.9 10.3 2.2 11.2 9.8 4.0 2.6 10.5 3.8 17.8 4.7 4.1 3.1 2.0 8.0 21.8 3.3 12.6 7.3 9.0 2.6 7.7 11.1 5.4 4.5 17.8 3.6 4.3 2.4 5.7 9.5 2.5 1.5 1.2 0.7 9.4 12.5 4.6 4.3 4.0 2.1 5.0 6.7 1.5 4.0 1.9 7.9 6.5 38.1 7.9 1.7 2.8 11.7 10.8 6.0 3.9 7.0 5.9 17.5 5.6 7.1 0.7 25.4 22.0 0.9 3.5 4.7 2.6 1.9 1.7 13.9 6.0 2.2 4.2 10.1 13.0 11.4 2.5 10.3 4.9 8.3 7.7 8.3 6.2 14.5 6.2 4.0 8.2 9.0 3.0 1.6 16.0 21.0 2.0 3.6 3.8 3.8 6.7 7.4 13.3 46.8 3.8 9.5 9.8 4.5 2.5 9.5 1.2 1.7 1.1 1.8 0.9 0.9 2.4 2.4 0.8 1.2 3.8 1.5 1.6 5.7 0.8 0.7 10.8 13.7 13.4 16.0 11.0 10.8 10.9 10.3 10.5 7.7 8.9 7.2 26.7 7.9 10.9 35.5 6.3 45.9 8.1 5.7 8.7 13.7 8.8 3.3 9.0 23.9 3.0 55.2 0.0 9.2 18.3 5.5 8.0 18.4 25.2 17.3 23.8 7.5 3.7 28.3 128.6 1.1 15.5 10.1 3.6 39.6 13.2 14.1 35.1 3.9 10.9 25.6 0.0 5.9 0.9 8.1 15.9 4.3 8.7 67.9 7.8 BRPF3 KIAA1286 ENSG00000096070 "Bromodomain and PHD finger containing 3" Q9ULD4 6 36196744-36232790 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022787 Uncertain Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA022787: AB_1845454" "unprognostic (1.44e-1)" "unprognostic (2.24e-1)" "unprognostic (5.52e-2)" "unprognostic (2.15e-2)" "unprognostic (2.98e-1)" "unprognostic (9.51e-2)" "unprognostic (5.33e-2)" "unprognostic (3.78e-1)" "unprognostic (3.02e-2)" "unprognostic (1.07e-1)" "unprognostic (7.98e-2)" "unprognostic (3.74e-1)" "unprognostic (3.59e-2)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.28e-1)" 9.6 21.8 11.9 12.3 11.7 12.3 25.8 22.4 16.7 11.9 15.2 10.9 28.3 13.5 16.0 13.4 9.5 10.8 10.6 10.9 10.3 9.1 15.9 16.5 9.6 7.7 10.4 11.7 15.2 20.8 18.1 18.8 8.7 7.4 15.2 15.3 8.0 16.5 31.0 22.9 14.5 17.0 12.2 9.8 9.8 12.4 22.9 11.8 11.8 18.3 4.4 7.1 13.9 22.3 0.8 0.5 3.0 0.2 0.1 2.0 0.6 6.7 6.5 16.4 12.8 9.1 7.7 14.0 10.2 10.8 14.4 11.4 19.0 6.4 10.5 11.0 10.0 18.2 6.6 14.4 7.3 12.7 9.9 8.9 7.4 6.0 11.2 9.6 5.7 10.4 9.8 6.3 17.1 8.6 10.5 10.7 5.1 15.4 9.7 7.8 9.6 6.5 2.5 8.2 8.3 5.6 19.1 6.7 3.2 4.7 13.9 23.5 7.4 8.3 9.1 8.7 10.6 10.2 15.9 11.2 15.1 12.9 4.1 11.8 8.0 10.3 7.9 2.5 9.2 17.7 3.0 0.2 1.4 1.9 0.2 2.0 0.8 0.5 0.6 0.2 0.4 0.9 0.6 1.5 0.1 0.1 0.5 1.2 0.6 11.9 11.7 22.4 16.7 10.3 9.1 10.4 11.7 7.4 11.8 6.0 10.1 2.9 6.8 8.5 10.1 10.9 12.7 2.7 5.7 5.2 5.9 4.2 0.0 4.7 13.2 7.1 15.1 0.0 9.2 3.7 9.5 10.3 2.3 16.6 3.7 0.0 18.9 11.6 5.0 10.4 10.3 2.5 6.8 5.4 26.5 4.3 10.0 10.5 8.9 11.4 6.7 0.0 6.2 17.9 12.2 9.9 6.9 4.3 13.9 8.4 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299193-49327487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 104.2;tongue: 35.0" "Cell type enriched" "Detected in single" 478 "Cardiomyocytes: 47.8" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "K-562: 9.2;RH-30: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA057556: AB_2683467" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 2.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 2.0 1.7 0.1 0.0 13.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 3.3 15.3 0.1 0.0 0.0 0.3 0.0 0.0 1.1 0.0 104.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.5 35.0 3.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23094765-23100462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavorable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favorable (3.30e-5)" "unprognostic (1.63e-1)" 28.2 35.0 16.3 22.0 18.5 9.2 38.9 11.6 17.3 30.4 28.4 17.0 23.9 22.6 29.9 30.3 32.0 23.5 22.4 29.6 16.3 19.9 36.3 24.6 30.4 37.3 22.4 15.1 25.2 39.4 16.7 28.1 32.2 23.1 27.9 35.8 27.1 28.0 28.1 21.2 20.7 27.4 33.5 20.1 33.8 28.2 33.0 16.7 27.2 40.0 26.3 33.1 25.8 24.0 34.6 37.4 72.7 40.2 30.2 45.0 43.7 13.8 13.7 20.7 12.5 45.7 39.8 16.7 23.2 34.4 30.7 36.6 10.8 21.5 10.5 12.1 37.6 37.3 23.7 19.6 30.8 42.7 16.7 9.6 15.9 11.4 46.2 36.0 23.7 24.8 48.5 27.9 25.8 19.1 28.1 33.5 19.2 10.5 11.8 33.6 19.8 11.1 18.4 13.0 32.2 21.0 9.9 15.4 12.1 34.8 22.3 10.0 9.1 19.4 18.3 20.1 24.1 12.3 13.8 26.9 14.6 12.8 21.9 10.4 11.1 13.0 12.9 13.4 15.1 13.0 63.7 40.2 72.7 32.6 25.7 37.1 34.6 37.2 36.2 37.4 28.5 39.1 38.3 23.8 30.2 17.3 25.2 45.0 43.7 16.3 18.5 11.6 17.3 16.3 19.9 22.4 15.1 23.1 16.7 44.7 41.3 39.3 73.7 23.6 28.7 21.4 30.6 38.8 46.6 29.6 7.9 76.0 109.5 81.1 13.7 45.7 39.3 23.3 74.5 84.3 43.6 40.4 52.1 27.7 93.8 19.1 27.2 43.6 42.9 11.4 59.2 57.9 45.5 111.0 43.7 31.3 81.5 43.2 45.6 76.4 15.4 32.3 37.6 25.0 24.6 29.6 119.7 48.4 45.4 67.4 C19orf70 "MIC13, P117, QIL1" ENSG00000174917 "Chromosome 19 open reading frame 70" Q5XKP0 19 5678421-5680896 "Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 13 "Late spermatids: 2933.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favorable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 20.2 23.6 32.9 14.5 28.4 13.2 16.0 11.0 29.8 13.0 22.2 13.5 17.8 25.4 12.2 26.8 22.7 16.7 24.0 70.2 27.2 26.5 30.5 38.4 12.7 21.1 32.1 21.1 13.5 24.2 13.2 15.6 12.4 16.9 16.6 11.7 13.6 28.7 22.7 79.1 17.6 20.7 14.7 20.9 14.1 18.2 33.4 12.3 11.6 20.3 45.0 12.6 15.4 11.8 43.6 48.2 11.6 42.2 27.4 39.5 40.7 24.2 20.1 7.0 13.4 16.5 17.1 9.1 16.1 15.3 18.6 15.4 16.0 12.7 10.6 26.2 14.0 9.9 18.1 3.6 22.8 5.3 17.4 38.4 10.3 14.0 17.8 23.3 14.1 13.0 20.0 20.6 10.0 13.9 11.7 13.3 16.3 15.9 33.1 14.0 21.9 21.3 16.8 7.4 17.8 64.4 11.7 8.5 38.7 20.3 15.3 16.4 20.9 4.9 31.8 22.5 4.7 19.4 17.4 13.5 18.3 7.8 33.4 22.7 50.0 33.1 8.4 27.3 22.6 18.5 8.9 35.5 11.6 33.6 42.2 39.5 43.6 38.6 37.2 41.2 35.6 38.1 35.9 5.6 27.4 35.6 48.2 30.9 40.7 32.9 28.4 11.0 29.8 27.2 26.5 32.1 21.1 16.9 12.3 65.5 61.7 101.3 135.8 87.3 47.7 288.5 122.3 167.3 76.2 150.1 25.5 132.2 623.4 178.9 798.0 106.8 325.2 46.7 265.1 165.3 137.3 120.3 92.3 251.0 214.9 17.5 154.8 98.8 146.2 2933.3 115.3 157.0 163.6 263.3 176.9 49.5 211.4 214.0 112.8 383.4 42.2 109.9 170.0 106.7 73.5 109.3 105.3 94.8 219.4 109.5 C1QBP "gC1Q-R, gC1qR, HABP1, p32, SF2p32" ENSG00000108561 "Complement C1q binding protein" Q07021 17 5432777-5448830 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026483 Supported Approved "Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA 930000 "Plasma membrane" Mitochondria "HPA026483: AB_1847108" "unprognostic (2.18e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (6.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.76e-2)" "unprognostic (7.47e-2)" "unprognostic (4.62e-2)" "unprognostic (2.40e-3)" "unprognostic (6.03e-2)" "unprognostic (4.60e-3)" "unprognostic (3.08e-2)" "unprognostic (7.80e-3)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-1)" "unprognostic (3.97e-1)" 24.1 51.6 34.0 51.0 31.4 36.3 42.3 25.8 46.2 22.0 48.8 21.1 22.5 33.9 25.8 25.7 51.1 27.1 33.0 47.1 34.8 35.4 48.4 69.0 26.6 81.1 35.4 25.1 25.2 51.9 32.7 31.2 26.7 36.6 23.8 52.2 24.9 25.1 28.0 55.0 27.3 30.0 29.2 27.8 43.8 26.4 21.3 17.2 55.4 28.1 71.9 46.0 25.5 25.4 59.5 68.1 9.9 35.8 39.0 55.6 65.7 49.5 77.1 27.3 44.0 20.4 25.2 36.9 38.0 31.1 88.6 54.6 73.7 16.6 106.5 37.7 28.7 32.0 44.4 87.6 51.6 82.0 24.3 150.8 49.0 40.0 85.6 32.5 59.7 39.0 27.7 47.5 48.7 70.4 21.4 45.1 63.3 58.2 27.3 34.4 34.6 84.7 43.2 61.5 56.3 46.1 67.6 38.6 58.1 51.1 37.6 21.9 41.1 31.2 40.2 53.0 28.6 25.4 30.3 26.5 28.5 26.0 32.3 82.6 14.3 21.8 46.8 27.2 57.5 43.6 9.9 34.7 8.3 40.1 35.8 52.5 59.5 45.0 39.9 68.1 49.4 55.6 46.3 2.8 39.0 26.9 56.9 34.3 65.7 34.0 31.4 25.8 46.2 34.8 35.4 35.4 25.1 36.6 17.2 26.8 23.3 138.5 155.3 215.9 60.0 72.6 68.8 16.0 27.3 78.5 25.5 269.8 265.2 184.9 64.3 105.7 64.2 23.3 178.3 380.4 101.4 99.0 62.2 125.2 179.0 57.2 76.1 74.3 73.1 64.4 110.7 119.7 148.5 174.1 146.5 91.7 174.3 77.2 92.6 338.8 60.8 84.1 121.5 45.2 160.8 223.2 149.7 85.6 301.5 214.0 C21orf33 "D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI" ENSG00000160221 "Chromosome 21 open reading frame 33" P30042 21 44133605-44210114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 29.2;Melanocytes: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 43.8;U-266/70: 37.2;U-266/84: 31.0" HPA018517 Supported Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA 1800000 Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (9.61e-3)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-3)" "unprognostic (6.57e-2)" "unprognostic (8.19e-2)" "unprognostic (1.36e-2)" "unprognostic (8.61e-3)" "unprognostic (9.43e-2)" "unprognostic (4.60e-3)" "unprognostic (1.97e-3)" "unprognostic (1.40e-1)" "unprognostic (6.96e-2)" "unprognostic (1.30e-2)" 16.0 9.6 9.1 6.1 11.4 2.2 7.2 7.9 16.6 5.1 11.7 11.6 12.4 3.0 6.6 22.8 7.6 7.3 5.2 29.2 8.4 8.7 31.6 36.8 8.5 9.9 10.9 9.2 6.7 15.7 2.0 6.5 5.6 8.3 11.0 1.9 6.6 8.8 8.0 45.9 13.4 7.7 7.6 7.3 8.9 13.7 11.8 5.1 5.8 7.1 21.0 15.2 5.1 4.7 22.5 12.3 8.9 20.7 14.7 15.6 23.9 0.4 1.6 0.9 0.2 9.5 9.1 14.2 18.5 10.4 14.6 11.1 22.2 0.2 43.8 0.3 0.1 0.6 0.2 0.1 8.7 6.5 9.6 21.3 1.2 3.6 11.9 10.6 0.6 0.3 0.1 0.9 4.0 0.7 7.4 0.7 10.6 8.3 13.8 5.0 1.6 0.5 1.2 0.4 1.6 0.6 0.4 0.1 15.5 0.9 0.3 14.6 0.2 0.2 0.5 14.2 0.3 1.0 1.5 9.0 5.6 0.3 11.0 0.1 37.2 31.0 0.9 0.6 2.9 6.7 8.9 11.3 6.8 13.0 13.3 11.3 22.5 15.5 15.6 4.6 21.6 14.8 12.8 5.1 14.7 20.7 12.3 14.6 23.9 9.1 11.4 7.9 16.6 8.4 8.7 10.9 9.2 8.3 5.1 6.0 3.5 14.3 0.4 14.5 1.9 0.0 17.8 8.1 3.4 0.0 0.0 2.1 0.0 0.0 1.9 2.9 10.6 0.0 0.0 1.6 4.3 0.5 9.2 2.4 8.1 0.0 7.5 16.5 29.2 1.4 9.2 6.0 38.8 0.0 13.3 7.8 0.0 11.5 16.3 0.0 1.5 12.9 0.0 5.2 12.4 12.7 2.2 15.4 27.5 0.1 C2orf49 "asw, MGC5509" ENSG00000135974 "Chromosome 2 open reading frame 49" Q9BVC5 2 105337359-105349211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043846, HPA060814" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA043846: AB_2678698, HPA060814: AB_2684372" "unprognostic (4.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.06e-1)" "unprognostic (6.16e-3)" "unprognostic (2.57e-3)" "unprognostic (8.75e-3)" "unprognostic (1.89e-3)" "unprognostic (6.51e-2)" "unprognostic (5.01e-2)" "unprognostic (2.07e-1)" "unprognostic (2.56e-1)" "unprognostic (5.94e-2)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.04e-2)" 15.9 14.8 17.2 15.8 20.4 24.3 17.3 25.6 22.4 19.7 15.0 21.9 19.9 13.4 22.0 13.5 18.6 19.0 14.2 21.3 20.0 16.0 13.4 15.0 14.0 16.9 25.3 19.9 30.7 19.3 13.0 12.0 19.2 18.1 17.2 15.1 12.4 15.9 17.2 28.2 14.3 14.8 18.3 22.9 15.3 19.7 19.2 22.1 26.5 18.8 13.1 18.8 18.1 21.2 16.7 18.4 17.9 13.5 8.2 11.7 6.4 13.6 9.8 12.4 12.5 13.9 17.2 22.1 13.8 14.4 12.2 16.8 21.3 13.7 16.2 17.3 11.8 33.0 13.2 16.9 11.7 15.9 21.0 12.9 17.5 8.4 16.4 17.2 14.5 14.5 12.4 20.5 17.2 15.7 17.5 10.9 12.8 24.3 13.4 17.1 10.7 17.6 16.8 16.2 9.2 11.8 11.8 18.2 18.5 13.7 13.2 14.7 11.7 12.2 11.1 16.1 14.4 10.9 16.4 17.9 13.0 18.3 9.2 11.1 17.0 13.8 17.0 13.0 14.8 12.5 10.2 13.5 11.1 9.4 7.9 9.2 14.3 10.5 9.1 8.8 16.7 11.7 9.8 17.9 8.2 10.6 18.4 11.6 6.4 17.2 20.4 25.6 22.4 20.0 16.0 25.3 19.9 18.1 22.1 14.9 11.0 27.3 12.2 25.8 36.0 25.4 12.7 46.8 22.7 24.4 27.5 18.6 21.6 19.7 30.9 16.9 14.7 0.0 15.8 23.4 13.6 10.4 16.1 19.5 14.3 22.3 10.9 14.1 13.6 30.0 25.6 16.2 6.8 13.6 15.0 37.4 19.7 15.2 27.3 14.3 42.6 19.4 15.5 29.7 29.0 21.7 30.8 18.1 13.6 14.8 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "salivary gland: 107.9;skin 1: 42.7" "Group enriched" "Detected in some" 7 "Early spermatids: 262.3;Late spermatids: 107.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058999, HPA079692" Supported Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" NA NA "Nuclear speckles" Mitochondria "HPA058999: , HPA079692: " "unprognostic (1.72e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 5.2 2.0 0.1 0.6 0.1 0.1 0.1 0.0 0.3 0.6 0.2 0.0 0.2 3.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.0 0.1 4.3 0.4 0.4 0.0 0.2 107.9 0.4 0.6 42.7 0.1 1.0 0.1 0.1 0.0 6.5 0.2 0.2 0.1 1.1 0.6 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.1 5.1 0.0 0.0 0.0 4.6 25.5 0.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 8.7 25.5 0.0 0.0 1.8 0.0 0.1 0.0 12.4 262.3 0.0 0.0 0.0 2.9 0.1 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 107.1 1.7 0.0 3.3 1.0 0.0 6.7 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.8 18.1 1.1 0.0 0.0 0.1 CARS2 FLJ12118 ENSG00000134905 "Cysteinyl-tRNA synthetase 2, mitochondrial" Q9HA77 13 110641412-110713603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 173.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-87 MG: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041776 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA041776: AB_2677666" "unprognostic (2.34e-3)" "unprognostic (9.50e-2)" "unprognostic (6.62e-2)" "prognostic favorable (1.84e-4)" "unprognostic (1.98e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (7.82e-2)" "unprognostic (2.11e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.73e-2)" "unprognostic (3.42e-1)" "unprognostic (3.21e-1)" "unprognostic (1.71e-2)" 19.6 28.1 11.9 24.8 13.0 25.6 37.1 18.2 14.5 21.8 20.2 17.6 21.2 17.8 18.5 23.0 20.2 16.8 26.9 26.0 9.9 10.3 17.0 21.4 19.9 26.7 11.3 14.1 17.6 31.7 11.5 19.7 12.5 11.7 17.5 15.0 16.6 19.0 21.3 39.7 16.1 20.1 22.1 11.7 19.7 17.9 11.2 11.4 21.8 19.2 18.5 21.9 16.9 16.7 3.4 4.0 3.1 6.8 0.6 2.2 1.7 35.4 11.8 6.8 16.5 18.1 17.0 9.2 15.8 14.5 16.0 19.7 16.6 16.0 16.6 22.2 17.2 24.4 18.9 11.6 19.8 13.1 15.1 19.3 10.3 25.0 18.9 18.5 25.2 12.6 21.2 15.8 13.9 16.8 11.4 11.4 12.6 7.1 5.2 22.5 8.2 11.2 8.2 5.7 27.2 11.7 16.6 5.0 6.8 17.1 10.4 12.1 9.2 12.7 19.7 18.2 7.6 9.5 28.1 10.2 13.4 5.0 16.9 15.8 9.4 10.7 9.6 65.5 15.1 13.2 0.0 4.7 0.7 2.0 5.1 2.2 3.4 0.6 0.8 4.0 1.4 2.0 1.0 3.1 0.6 6.8 3.4 0.7 1.7 11.9 13.0 18.2 14.5 9.9 10.3 11.3 14.1 11.7 11.4 8.9 15.7 17.6 19.1 11.4 22.3 34.3 12.7 2.7 7.9 26.2 23.6 21.5 43.1 14.9 53.5 10.8 19.0 0.0 4.1 25.5 14.3 16.8 16.1 23.1 25.1 22.3 18.0 9.8 26.7 173.5 19.0 29.2 11.8 13.6 17.0 23.0 12.9 7.0 17.0 29.6 24.7 6.5 18.6 7.2 4.7 11.8 14.1 12.9 22.3 18.2 CASP3 "apopain, CPP32, CPP32B, Yama" ENSG00000164305 "Caspase 3" P42574 4 184627696-184649509 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 76.7;eosinophil: 62.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in all" "Karpas-707: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000091, HPA002643, CAB008381" Enhanced Approved Nucleoplasm,Mitochondria NA NA 310000 Mitochondria Nucleoplasm "CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "prognostic favorable (2.24e-4)" "unprognostic (2.29e-3)" "unprognostic (3.58e-2)" "unprognostic (9.57e-3)" "unprognostic (5.86e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (1.70e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.41e-2)" "unprognostic (5.74e-3)" "unprognostic (1.30e-1)" "unprognostic (4.05e-3)" 20.7 11.6 10.8 16.9 10.5 16.7 10.0 22.3 9.2 10.4 25.4 12.8 12.5 32.3 13.9 11.5 22.8 8.9 12.0 8.8 10.0 8.8 10.6 18.7 12.4 23.6 10.2 8.5 8.3 10.0 4.6 13.6 29.4 9.7 8.8 20.9 8.2 13.0 10.0 12.6 9.5 49.7 9.3 12.6 26.5 18.7 6.4 10.9 44.7 7.8 13.5 24.3 16.2 11.0 4.2 5.2 76.7 10.6 9.2 9.9 7.0 8.3 4.7 18.7 8.9 11.6 15.5 10.8 25.3 19.2 17.8 10.3 8.5 7.1 11.7 4.0 12.3 8.4 7.2 14.8 9.0 20.3 30.0 8.1 18.7 3.7 19.7 13.9 15.2 17.8 21.1 11.0 11.3 9.1 12.8 22.0 12.1 15.4 74.2 18.3 3.6 24.0 14.2 18.5 9.3 5.9 17.4 8.8 11.3 15.3 13.8 10.7 11.7 10.9 10.0 14.2 19.4 5.4 9.9 14.9 8.1 7.5 6.0 11.7 34.5 32.3 8.0 9.9 10.6 11.5 76.7 4.2 62.8 5.5 6.8 5.7 4.2 5.1 7.8 5.2 3.1 3.9 5.8 5.8 9.2 10.6 4.1 9.9 7.0 10.8 10.5 22.3 9.2 10.0 8.8 10.2 8.5 9.7 10.9 17.9 12.0 18.6 18.8 43.3 17.6 14.1 5.1 25.4 20.5 12.2 0.0 41.4 11.6 16.0 7.6 23.3 28.6 0.0 20.9 27.1 16.9 14.4 17.3 12.9 20.5 12.7 17.3 20.9 25.1 3.2 6.9 17.5 28.7 55.9 34.1 13.8 20.4 19.9 7.1 6.5 10.2 12.9 14.4 7.5 14.2 25.0 43.0 36.2 21.5 31.5 CASQ1 "CASQ, PDIB1" ENSG00000143318 "Calsequestrin 1" P31415 1 160190556-160201886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 320.9;tongue: 83.5" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007845, CAB015170, HPA026823" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Nucleoplasm, Mitochondria" "CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557" "unprognostic (1.87e-2)" "unprognostic (3.97e-3)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (6.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.65e-3)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (2.87e-2)" "unprognostic (3.01e-2)" "unprognostic (3.21e-3)" "unprognostic (9.04e-4)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "prognostic favorable (8.93e-5)" 6.1 0.1 0.5 0.0 0.3 0.1 0.2 0.3 2.0 0.1 0.1 0.0 0.1 0.0 0.1 11.9 3.9 0.2 0.1 4.0 0.4 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.5 0.0 1.3 0.0 0.2 4.5 0.4 320.9 0.1 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.0 0.9 83.5 4.7 0.4 0.1 0.9 0.0 0.9 0.7 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 10.6 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.2 0.2 0.0 0.0 0.0 0.1 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.0 36.1 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.9 0.7 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.9 0.1 0.1 0.9 0.2 0.1 0.0 0.3 0.0 0.5 0.3 0.3 2.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 16.7 0.0 1.4 0.0 0.0 2.0 1.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.0 13.0 0.0 0.8 1.4 1.0 0.0 3.8 0.0 0.0 0.3 CBX6 ENSG00000183741 "Chromobox 6" O95503 22 38861450-38872314 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048653 Uncertain Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA048653: AB_2680479" "unprognostic (1.65e-2)" "unprognostic (8.66e-2)" "unprognostic (6.20e-3)" "unprognostic (3.14e-3)" "unprognostic (1.56e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.90e-2)" "unprognostic (3.72e-3)" "unprognostic (5.97e-2)" "prognostic favorable (2.46e-6)" "unprognostic (2.75e-1)" "unprognostic (1.27e-3)" "unprognostic (7.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (2.26e-2)" 15.0 15.0 44.7 14.5 35.1 21.7 7.4 27.8 53.8 14.0 19.5 15.3 9.8 6.5 19.3 14.2 12.9 18.8 10.9 14.0 40.6 18.3 12.1 5.9 13.0 12.0 15.8 21.8 23.4 13.1 62.2 15.5 4.7 19.3 16.1 7.4 17.0 12.5 25.4 5.5 7.7 9.2 23.8 12.1 11.2 12.0 5.0 12.0 11.3 13.4 4.5 13.8 16.6 9.5 4.7 26.9 2.6 7.4 5.2 11.7 9.2 16.6 17.7 3.9 13.4 30.4 17.1 1.2 18.2 10.5 9.5 8.9 8.8 15.6 27.3 13.7 12.4 6.6 19.9 7.3 7.7 5.2 26.2 22.9 2.7 7.6 3.0 16.6 13.4 13.6 25.4 3.9 21.6 10.3 13.1 10.7 7.9 6.1 13.9 6.4 18.8 8.2 3.9 3.5 9.6 13.7 12.5 13.2 10.7 13.4 15.8 19.3 4.3 11.7 15.6 9.8 1.4 10.7 8.0 13.8 8.3 25.5 14.3 12.4 14.3 13.7 10.0 16.2 14.1 17.1 1.1 5.5 2.6 11.7 7.4 9.7 4.2 8.1 8.2 5.4 4.7 6.7 8.2 2.3 5.2 6.8 26.9 4.6 9.2 44.7 35.1 27.8 53.8 40.6 18.3 15.8 21.8 19.3 12.0 14.9 14.3 23.1 30.9 30.1 95.1 23.3 38.2 5.3 13.6 69.8 37.3 9.4 29.9 79.7 0.5 30.3 1.3 0.0 43.0 1.9 41.4 21.2 5.8 29.7 17.5 117.6 117.7 33.7 40.3 0.9 68.7 20.0 77.6 119.0 0.7 80.1 41.4 7.0 76.0 41.9 56.5 71.1 86.3 2.1 6.0 29.6 3.9 35.8 0.5 68.7 CCDC102B "ACY1L, AN, C18orf14, FLJ23594, HsT1731" ENSG00000150636 "Coiled-coil domain containing 102B" Q68D86 18 68715209-69055189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 33.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 113.6;Late spermatids: 49.0;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.8;BJ hTERT+: 20.8;fHDF/TERT166: 18.7;HSkMC: 11.5;Karpas-707: 7.4" "Not detected" "Not detected" "HPA040623, HPA048194" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA040623: AB_10805715, HPA048194: AB_2680309" "unprognostic (3.92e-2)" "unprognostic (1.62e-1)" "unprognostic (5.58e-2)" "unprognostic (9.50e-3)" "unprognostic (7.13e-2)" "unprognostic (3.50e-1)" "unprognostic (7.87e-3)" "unprognostic (1.36e-1)" "unprognostic (5.59e-2)" "unprognostic (8.62e-3)" "unprognostic (1.95e-1)" "unprognostic (6.04e-2)" "prognostic unfavorable (2.90e-6)" "unprognostic (2.21e-2)" "unprognostic (2.12e-2)" "unprognostic (8.00e-3)" "unprognostic (3.13e-3)" 8.7 4.2 6.4 4.7 7.1 1.3 4.4 3.2 8.0 4.2 4.8 4.9 2.9 2.3 4.0 6.4 4.7 2.9 16.9 4.7 6.0 5.4 5.9 3.3 16.4 11.5 7.0 5.0 3.3 3.1 3.2 5.0 33.7 8.7 4.0 6.1 4.0 3.2 2.2 2.1 2.9 3.9 6.4 9.3 3.3 4.7 4.3 7.0 1.7 6.8 5.0 2.9 16.9 4.0 0.9 11.5 0.4 0.3 1.3 2.6 0.3 0.0 0.0 2.9 0.2 2.7 10.8 0.2 0.6 20.8 0.2 0.3 0.1 0.3 0.1 0.4 18.7 0.3 0.2 0.1 0.2 0.3 0.9 0.3 0.6 0.0 0.9 5.3 0.1 0.3 11.5 0.4 0.3 2.6 0.4 0.1 1.4 0.0 7.4 1.7 0.0 0.4 0.2 0.6 0.1 0.3 0.9 0.2 0.3 0.1 0.0 1.3 1.1 0.1 0.0 0.0 1.2 0.2 0.9 2.9 0.4 0.2 0.1 0.2 3.2 0.2 0.5 1.5 1.2 1.8 0.0 0.1 0.4 1.4 0.3 1.3 0.6 0.8 1.1 0.3 0.9 2.6 1.6 0.0 1.3 0.2 11.5 0.3 0.3 6.4 7.1 3.2 8.0 6.0 5.4 7.0 5.0 8.7 7.0 0.0 2.1 0.5 0.6 0.6 5.6 7.4 0.0 1.4 3.4 3.5 5.9 0.7 5.0 0.6 113.6 4.5 0.0 0.0 1.5 0.5 3.6 0.5 2.3 0.6 3.0 6.4 0.0 4.3 2.2 49.0 30.0 3.1 0.0 2.8 0.2 10.8 0.3 0.3 8.5 4.5 12.2 77.6 22.5 1.6 2.7 0.5 0.2 1.0 0.4 0.5 CCDC184 "C12orf68, LOC387856" ENSG00000177875 "Coiled-coil domain containing 184" Q52MB2 12 48183584-48185926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Group enriched" "Detected in many" 4 "Early spermatids: 51.8;Sertoli cells: 45.3" "Cancer enhanced" "Detected in many" "glioma: 6.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.2;AF22: 9.9;hTERT-RPE1: 3.8;SH-SY5Y: 6.7;U-2 OS: 4.0;U-87 MG: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039947, HPA041715" Uncertain Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA039947: AB_2676764, HPA041715: AB_2677634" "unprognostic (2.02e-1)" "unprognostic (1.16e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.61e-2)" "unprognostic (4.59e-1)" "unprognostic (1.33e-2)" "unprognostic (6.65e-2)" "unprognostic (9.79e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (1.07e-1)" "unprognostic (5.87e-4)" "unprognostic (1.08e-2)" "unprognostic (2.39e-2)" "unprognostic (2.55e-1)" "unprognostic (2.36e-2)" 2.0 11.4 9.0 2.3 14.4 0.8 1.3 14.9 30.5 3.0 1.8 2.2 0.1 1.1 6.1 1.3 1.7 1.3 3.3 1.9 9.3 17.6 1.3 1.3 1.5 1.0 11.5 10.6 8.8 1.3 8.7 7.3 5.1 23.7 1.6 1.5 0.8 0.9 2.3 2.2 1.5 2.1 3.6 3.6 1.4 1.5 5.1 0.4 0.0 1.2 0.5 0.8 2.1 1.8 0.0 0.3 0.6 0.2 0.0 1.2 0.3 0.0 4.2 9.9 0.4 0.8 0.8 0.0 0.3 1.8 0.5 0.8 0.5 0.1 0.0 0.2 0.3 2.6 0.1 1.0 0.2 0.1 2.3 0.2 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.1 0.0 3.8 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 6.7 0.8 0.1 0.2 0.2 0.0 0.0 0.2 1.1 4.0 0.0 0.2 0.0 0.0 0.0 5.0 0.0 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 1.2 0.4 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 9.0 14.4 14.9 30.5 9.3 17.6 11.5 10.6 23.7 0.4 0.0 0.0 0.0 0.2 0.0 2.3 0.6 0.0 9.4 1.2 0.0 0.0 0.7 0.0 0.2 51.8 1.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.9 4.8 5.1 8.6 0.0 10.9 0.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 2.1 0.0 6.6 45.3 2.7 5.6 0.9 0.0 1.3 0.0 0.0 0.0 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047777, HPA051965" Approved Approved Nucleoli,Mitochondria No No Mitochondria Nucleoli "HPA047777: AB_2680152, HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favorable (7.29e-4)" 9.5 13.3 8.7 6.8 8.1 7.1 9.2 6.9 12.6 8.2 13.3 7.1 12.4 10.6 7.3 12.4 14.0 5.8 7.7 12.4 7.2 7.0 21.9 23.3 5.4 10.0 8.6 5.3 8.8 9.3 3.1 7.7 6.7 8.5 8.2 14.4 6.5 7.2 6.9 35.2 6.9 10.2 6.3 7.2 8.6 9.1 8.7 9.3 5.5 8.8 24.5 9.6 8.7 7.1 13.9 18.3 1.7 10.2 11.4 16.1 4.6 34.9 11.1 21.2 13.5 7.9 11.1 27.3 13.4 14.6 32.6 32.1 31.3 17.7 25.7 23.2 10.2 25.4 24.5 34.4 23.0 39.1 8.8 12.2 30.2 7.9 37.8 13.2 44.9 10.8 9.1 11.9 20.0 21.9 13.9 15.0 22.9 34.2 11.2 17.1 17.4 28.6 32.2 40.7 38.6 21.0 19.0 25.2 31.6 22.4 18.6 21.5 10.5 15.6 16.6 37.3 18.7 16.5 29.6 8.6 18.3 23.4 7.7 26.7 8.9 11.9 55.4 20.8 21.8 16.1 0.4 5.0 1.7 10.2 10.2 12.0 13.9 13.6 13.4 10.3 13.5 16.1 14.9 0.9 11.4 8.5 18.3 10.5 4.6 8.7 8.1 6.9 12.6 7.2 7.0 8.6 5.3 8.5 9.3 3.0 17.1 19.3 16.0 13.6 9.4 23.0 25.5 32.1 20.5 12.2 9.8 19.1 46.4 27.4 0.3 11.3 13.4 0.0 25.7 38.8 10.2 10.9 19.8 46.1 15.7 0.0 5.2 11.6 7.6 0.7 11.8 12.4 8.5 26.2 14.7 6.6 31.7 14.0 7.8 78.7 8.8 12.9 8.0 13.5 23.4 16.2 12.7 7.1 22.4 21.2 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609533-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 75.5;lymphoid tissue: 59.7" "Cell type enriched" "Detected in some" 4 "B-cells: 82.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 34.3;naive B-cell: 75.5" "Lineage enriched" "Detected in many" 22 "B-cells: 75.5" "Cell line enhanced" "Detected in some" "Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3" "Region enriched" "Detected in single" 7 "basal ganglia: 3.6" "Low region specificity" "Detected in single" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: AB_2679039" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 1.9 1.2 0.8 16.6 1.1 2.6 1.3 0.6 0.6 0.7 0.9 0.2 0.5 0.3 0.8 2.1 0.8 0.7 1.6 0.6 0.8 0.7 1.5 2.3 2.2 26.8 0.8 0.1 0.5 1.4 0.5 1.6 1.5 1.1 0.9 0.3 1.1 3.4 0.1 0.5 0.8 5.2 0.6 1.8 59.7 0.8 0.8 0.2 1.5 1.4 0.3 22.2 4.9 0.6 75.5 3.4 0.2 0.6 1.7 0.7 2.5 0.1 0.0 0.4 0.2 0.7 3.9 0.1 0.2 0.1 0.3 0.5 0.0 0.1 12.7 0.0 0.2 0.1 0.0 0.0 0.1 0.4 1.2 0.3 0.4 0.0 0.0 0.4 0.2 2.8 1.1 0.0 0.2 0.3 0.6 0.0 2.8 0.0 8.2 0.7 0.0 0.2 1.7 0.1 0.0 0.1 5.3 0.0 3.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.2 28.3 0.5 0.4 0.0 0.0 0.3 0.0 0.5 0.6 0.7 34.3 0.2 0.3 3.4 75.5 0.1 0.4 0.2 1.7 0.0 1.8 0.3 2.5 0.8 1.1 0.6 0.6 0.8 0.7 0.8 0.1 1.1 0.2 0.0 1.1 82.7 0.3 0.9 0.0 0.6 2.5 1.4 0.0 3.5 0.0 0.1 0.0 0.6 0.1 0.5 0.5 0.0 0.6 0.2 0.6 0.4 0.0 0.0 19.7 0.0 1.7 0.6 16.7 0.0 0.9 8.0 0.0 1.8 0.0 0.5 1.2 0.0 0.4 0.3 0.7 0.0 0.8 0.2 1.2 1.0 0.2 4.9 0.3 0.1 CDK5RAP1 "C20orf34, C42, CGI-05, HSPC167" ENSG00000101391 "CDK5 regulatory subunit associated protein 1" Q96SZ6 20 33358839-33401561 "Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066301 Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA066301: AB_2685653" "unprognostic (2.86e-1)" "unprognostic (7.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-3)" "unprognostic (2.25e-1)" "unprognostic (6.49e-2)" "unprognostic (7.68e-3)" "unprognostic (2.18e-2)" "unprognostic (5.10e-1)" "unprognostic (2.36e-1)" "unprognostic (5.90e-3)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-1)" 13.9 12.8 15.1 13.0 23.0 20.8 14.8 29.2 22.4 11.1 12.2 18.3 12.3 11.3 15.4 15.4 13.2 12.8 8.3 15.0 11.2 9.5 11.8 14.6 12.5 14.7 12.2 16.2 14.0 12.4 16.6 17.9 13.1 15.5 11.5 16.2 15.5 19.7 12.0 29.2 19.0 14.5 14.1 10.1 15.8 13.0 14.8 15.9 14.4 15.8 11.2 18.7 13.4 12.5 16.0 14.2 8.5 16.3 15.6 17.4 10.8 11.0 11.5 8.0 7.2 7.6 5.9 17.7 6.7 9.6 19.5 20.5 48.5 10.0 19.6 9.0 7.2 12.6 16.4 13.6 19.0 15.1 3.6 7.2 23.6 11.9 18.4 9.0 14.9 7.5 7.7 8.2 12.9 15.7 4.9 10.7 5.6 14.9 8.2 8.4 11.1 15.2 11.2 5.9 12.4 17.0 11.3 18.2 15.0 10.6 9.8 11.0 6.1 21.3 10.2 14.1 9.6 14.8 7.2 7.9 14.4 11.8 9.8 11.2 7.1 8.0 14.5 8.6 16.1 6.8 3.3 12.7 8.5 14.7 16.3 17.4 16.0 14.5 14.0 14.2 9.8 13.1 11.3 0.7 15.6 13.0 9.9 12.4 10.8 15.1 23.0 29.2 22.4 11.2 9.5 12.2 16.2 15.5 15.9 14.9 18.3 13.4 9.5 10.8 25.5 14.2 12.7 9.4 3.4 7.0 25.5 27.3 11.6 14.6 1.5 10.7 10.1 23.3 15.9 14.6 8.0 6.7 28.9 13.4 15.2 11.1 12.1 4.3 10.5 2.5 12.0 15.9 10.1 15.4 9.4 15.1 10.4 10.5 9.9 12.4 37.2 19.4 10.8 25.0 21.5 9.2 13.4 19.2 11.9 7.8 CFAP52 "FLJ37528, WDR16, WDRPUH" ENSG00000166596 "Cilia and flagella associated protein 52" Q8N1V2 17 9576627-9643459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 29.5;fallopian tube: 46.9;testis: 26.8" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 149.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023247, HPA030635" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023247: AB_1858797, HPA030635: " "unprognostic (1.76e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (1.68e-2)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-2)" "unprognostic (2.11e-1)" "unprognostic (3.66e-1)" "unprognostic (2.22e-2)" "unprognostic (2.66e-1)" "unprognostic (7.85e-2)" "unprognostic (1.85e-1)" "unprognostic (9.23e-2)" "unprognostic (4.50e-2)" "unprognostic (7.09e-2)" 0.4 0.6 3.7 0.4 8.4 0.4 0.4 0.3 2.5 2.6 0.4 8.5 0.1 0.9 1.3 6.4 0.4 46.9 0.5 0.4 5.9 6.0 0.5 0.4 3.9 0.3 0.5 0.5 4.8 0.3 0.7 5.4 0.5 29.5 0.5 0.3 0.7 1.3 0.5 0.3 0.5 0.9 0.3 1.1 0.4 0.4 26.8 3.5 0.0 0.8 0.0 0.3 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 1.6 1.9 0.0 0.7 1.3 0.9 0.9 0.0 0.1 0.0 0.0 0.1 3.9 0.0 0.4 0.0 1.4 2.2 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.4 0.1 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 4.8 0.0 0.7 0.3 6.2 0.2 3.3 0.0 0.1 0.4 0.9 0.8 0.0 0.7 1.3 0.0 0.9 2.9 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.7 8.4 0.3 2.5 5.9 6.0 0.5 0.5 29.5 3.5 0.0 2.9 0.0 0.2 0.0 0.4 0.3 0.0 149.9 18.2 0.0 5.9 0.5 1.7 0.0 21.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 1.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 1.8 0.2 2.0 0.0 0.0 25.2 0.3 0.0 0.8 0.0 0.0 0.1 CMPK2 "NDK, TYKi, UMP-CMPK2" ENSG00000134326 "Cytidine/uridine monophosphate kinase 2" Q5EBM0 2 6840570-6866635 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041430 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041430: AB_10796674" "unprognostic (2.37e-1)" "unprognostic (6.07e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.82e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-2)" "unprognostic (8.93e-2)" "unprognostic (6.63e-2)" "unprognostic (4.54e-3)" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (1.09e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (7.69e-2)" "unprognostic (4.32e-2)" 8.8 3.8 3.0 6.8 8.1 14.5 4.2 0.9 5.0 2.7 4.2 4.0 1.3 5.0 2.5 6.4 1.8 2.3 3.4 3.7 3.3 3.9 4.0 3.1 17.9 13.4 3.2 5.7 1.3 3.7 2.9 3.0 4.7 3.6 2.1 2.2 4.7 20.8 4.3 3.0 1.2 6.1 3.1 3.8 7.9 7.4 9.2 0.4 8.8 3.1 1.6 2.6 2.7 1.6 1.4 1.9 7.8 6.4 0.9 0.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.2 14.2 12.9 0.0 1.4 3.1 0.8 0.0 3.7 0.2 0.0 0.0 0.0 0.3 0.2 20.1 0.0 0.0 0.0 0.7 1.4 0.0 0.0 0.1 0.0 0.0 0.0 2.0 4.9 0.1 0.0 0.1 11.0 3.7 0.3 0.0 1.1 3.5 0.0 0.0 0.0 0.4 0.3 0.5 0.2 0.0 1.7 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.0 0.0 3.7 0.9 5.5 2.8 7.8 0.7 6.4 0.4 1.4 0.5 0.4 1.9 0.2 0.5 0.5 1.8 0.9 3.2 0.1 0.6 1.2 3.0 8.1 0.9 5.0 3.3 3.9 3.2 5.7 3.6 0.4 3.0 6.9 2.7 0.8 0.3 1.6 1.4 0.0 4.0 0.0 1.8 0.0 2.0 1.7 2.4 2.5 4.7 5.3 70.0 5.8 2.4 1.9 0.7 2.3 1.3 15.9 0.0 6.9 7.4 6.7 1.1 1.4 5.1 0.0 5.4 1.7 4.6 4.1 1.9 5.3 0.6 0.2 0.0 2.0 0.1 4.1 0.4 0.7 4.3 0.9 1.6 CNKSR3 "FLJ31349, MAGI1" ENSG00000153721 "CNKSR family member 3" Q6P9H4 6 154387504-154510659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 17.4" "CAB037133, HPA049651" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB037133: AB_477217, HPA049651: AB_2680841" "unprognostic (3.07e-1)" "unprognostic (3.25e-2)" "unprognostic (1.57e-1)" "unprognostic (2.34e-1)" "unprognostic (5.62e-2)" "unprognostic (1.25e-2)" "unprognostic (1.37e-1)" "unprognostic (5.78e-2)" "unprognostic (1.98e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-3)" "unprognostic (4.90e-2)" "prognostic favorable (6.00e-4)" "unprognostic (4.23e-2)" "unprognostic (8.79e-2)" "unprognostic (1.57e-3)" "unprognostic (3.38e-1)" 9.4 2.2 4.2 5.5 5.8 1.6 5.8 1.8 5.0 7.6 12.5 11.6 6.0 8.7 15.8 8.3 19.4 6.5 9.2 8.9 5.3 3.4 17.0 20.0 6.3 3.5 8.0 2.5 10.0 26.6 1.5 4.5 8.2 8.3 8.3 5.5 12.6 7.5 7.7 2.2 6.7 13.5 15.3 8.2 7.6 6.7 8.6 7.7 0.6 4.1 8.7 6.6 9.8 10.2 0.9 1.4 3.6 0.6 0.9 0.5 0.2 0.3 4.0 2.8 5.6 5.0 3.8 0.3 4.9 3.0 8.6 7.1 17.4 0.4 0.1 5.4 5.3 2.8 1.7 8.3 0.5 4.5 0.0 5.1 13.3 0.8 9.6 2.2 0.0 3.0 5.1 2.7 3.3 3.4 1.5 2.7 1.1 1.7 0.1 2.3 1.1 0.1 0.3 2.0 3.3 5.2 3.8 4.9 6.4 10.0 2.8 1.7 10.7 2.2 1.2 1.0 1.3 0.0 1.2 3.1 0.8 2.5 6.4 3.2 0.1 0.0 0.1 0.1 0.3 3.7 2.1 0.6 1.2 0.5 0.4 0.4 0.5 0.4 0.4 0.4 0.9 0.5 0.5 3.6 0.9 0.4 1.4 0.3 0.2 4.2 5.8 1.8 5.0 5.3 3.4 8.0 2.5 8.3 7.7 11.9 38.5 0.9 13.6 23.6 1.9 30.2 12.7 13.4 18.2 24.4 0.0 6.3 8.3 14.8 39.4 28.7 27.4 0.0 10.4 0.8 14.6 10.7 5.7 55.0 1.5 0.0 41.5 67.5 7.6 11.1 5.5 5.1 30.4 1.0 21.1 27.8 10.1 15.8 9.9 24.5 1.8 0.0 6.6 1.1 5.3 20.8 18.0 5.1 11.5 8.8 COA6 C1orf31 ENSG00000168275 "Cytochrome c oxidase assembly factor 6" Q5JTJ3 1 234373456-234384049 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028588 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA028588: AB_10601123" "unprognostic (6.26e-2)" "unprognostic (1.92e-1)" "unprognostic (3.05e-1)" "unprognostic (1.01e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (4.04e-3)" "unprognostic (4.89e-2)" "unprognostic (2.79e-2)" "unprognostic (6.25e-3)" "unprognostic (9.24e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (2.19e-1)" "prognostic favorable (7.12e-4)" 11.0 17.8 26.4 14.4 33.9 9.4 16.6 14.3 27.5 9.7 17.7 5.7 12.9 26.4 8.4 20.3 15.5 9.4 14.2 19.1 19.3 15.7 21.4 21.4 13.6 16.2 16.3 16.1 9.1 16.7 7.6 9.5 8.7 13.4 13.3 15.6 6.0 13.6 11.6 52.7 8.7 19.7 10.6 11.4 12.5 14.4 5.8 13.3 13.1 13.6 20.2 12.0 11.6 14.6 27.5 33.3 19.7 31.3 18.3 36.6 20.2 17.8 22.9 8.3 9.4 8.7 17.3 26.4 13.1 8.0 13.8 13.0 17.6 23.9 17.8 24.4 7.5 25.9 22.8 12.9 16.2 11.0 22.1 55.1 8.0 26.0 46.6 33.6 19.6 15.6 11.4 21.8 18.1 14.0 12.1 17.0 19.8 38.8 16.1 14.9 9.5 18.6 38.1 20.4 40.3 10.9 11.1 10.0 35.0 17.2 16.9 14.8 10.8 12.7 22.6 40.4 5.5 20.0 33.9 12.8 16.4 13.6 21.9 39.2 19.2 37.2 21.8 12.5 31.2 29.2 19.7 31.3 9.7 18.5 28.5 18.2 27.5 29.9 23.0 33.3 18.0 31.3 23.1 8.1 18.3 23.8 22.5 36.6 20.2 26.4 33.9 14.3 27.5 19.3 15.7 16.3 16.1 13.4 13.3 8.9 20.0 38.5 39.3 50.8 13.8 71.2 22.9 53.5 26.1 45.4 3.9 44.1 87.9 47.5 2.9 23.3 63.5 23.3 59.9 71.2 34.2 56.7 21.9 46.9 75.0 11.1 21.4 22.1 35.3 3.4 24.2 49.2 28.7 43.3 52.3 20.6 56.3 40.3 26.5 86.4 13.3 19.4 24.5 17.2 25.3 51.3 36.5 30.0 65.5 64.8 COA7 "C1orf163, FLJ12439, RESA1, SELRC1" ENSG00000162377 "Cytochrome c oxidase assembly factor 7 (putative)" Q96BR5 1 52684451-52698366 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028154, HPA029926" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA028154: AB_10600656, HPA029926: AB_10602173" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.30e-2)" "unprognostic (5.12e-2)" "prognostic unfavorable (7.01e-5)" "unprognostic (1.14e-1)" "unprognostic (2.27e-2)" "unprognostic (1.24e-1)" "unprognostic (4.07e-2)" "unprognostic (7.42e-2)" "unprognostic (2.49e-1)" "prognostic favorable (4.35e-4)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 8.8 8.5 9.0 6.9 10.6 4.6 9.7 7.9 16.6 6.6 10.1 7.0 4.1 10.1 8.5 6.0 9.5 6.6 5.2 8.6 7.6 9.2 12.8 15.7 5.5 4.9 8.4 12.4 6.7 19.1 7.2 7.7 7.4 10.0 4.9 10.3 4.2 6.7 5.2 26.3 8.6 7.2 8.0 7.6 6.1 7.0 4.3 7.8 2.3 9.6 9.9 5.8 6.9 7.9 3.7 5.9 3.3 8.4 2.3 3.4 2.7 12.3 7.1 6.5 10.7 10.6 9.2 14.3 9.4 7.8 11.7 9.9 8.7 4.4 28.5 6.4 5.5 14.8 9.6 15.7 13.2 15.3 8.8 15.8 24.0 11.2 10.1 13.0 23.5 8.2 10.1 11.7 13.3 16.7 5.2 8.0 8.2 21.8 5.1 8.8 8.2 7.9 12.1 28.7 13.3 20.2 15.7 22.3 20.7 10.3 12.6 14.6 7.7 13.6 17.5 17.3 9.6 10.2 16.1 8.8 9.3 12.2 12.7 12.9 10.6 26.6 13.3 4.3 17.1 7.5 3.1 5.9 1.8 2.5 8.4 3.4 3.7 2.6 2.5 5.9 1.8 2.4 2.6 3.3 2.3 4.0 2.8 1.5 2.7 9.0 10.6 7.9 16.6 7.6 9.2 8.4 12.4 10.0 7.8 6.0 11.3 4.5 15.2 10.2 7.3 12.6 5.1 2.7 7.9 3.5 3.9 14.1 23.2 9.6 0.1 8.2 8.5 0.0 11.5 12.9 7.2 10.1 0.0 11.5 12.1 15.9 2.4 4.9 4.9 0.4 6.9 8.2 1.7 9.0 5.5 7.0 9.0 5.8 7.1 14.4 9.6 6.5 7.6 3.7 12.5 11.3 13.8 4.5 9.6 10.7 COQ3 bA9819.1 ENSG00000132423 "Coenzyme Q3, methyltransferase" Q9NZJ6 6 99369400-99394204 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 37.1;Distal tubular cells: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031273, HPA031274" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA031273: AB_10611107, HPA031274: AB_10602176" "unprognostic (1.81e-2)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (4.62e-2)" "unprognostic (2.41e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.40e-1)" "unprognostic (8.77e-2)" "unprognostic (9.78e-2)" "unprognostic (1.09e-1)" "prognostic favorable (6.86e-5)" "unprognostic (4.61e-2)" "unprognostic (1.81e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" 5.2 7.8 8.6 4.2 10.8 3.2 7.5 13.6 16.3 4.5 8.9 4.5 4.3 6.9 4.3 6.8 8.2 4.5 3.0 21.7 8.2 7.5 10.2 12.4 2.9 7.1 6.9 12.0 6.0 5.7 11.6 7.4 2.5 9.8 6.8 11.0 7.3 11.7 7.6 28.0 5.8 6.3 6.6 4.6 4.8 5.2 2.3 6.0 4.1 4.3 16.8 7.0 7.5 4.6 6.6 8.0 9.4 7.4 9.7 12.5 5.3 12.0 6.9 8.4 11.9 5.5 6.2 11.6 10.4 6.5 15.8 18.3 9.6 5.2 11.8 7.0 7.8 10.2 11.2 14.0 16.3 19.3 12.5 17.9 14.4 9.5 10.3 7.2 20.8 5.7 3.9 10.0 9.3 9.4 3.5 9.6 14.6 21.9 9.0 8.4 11.9 9.1 17.4 10.2 11.9 13.4 4.5 8.6 15.7 12.4 10.5 13.2 7.0 7.2 11.2 13.6 5.9 13.7 13.7 3.4 6.9 10.1 10.6 15.8 3.2 5.9 18.6 8.8 20.2 10.1 9.4 3.3 2.4 6.0 7.4 6.8 6.6 7.6 9.5 8.0 3.1 12.5 9.5 0.5 9.7 6.3 5.2 5.5 5.3 8.6 10.8 13.6 16.3 8.2 7.5 6.9 12.0 9.8 6.0 3.0 3.0 6.1 8.0 3.9 7.1 37.1 7.6 0.0 5.7 3.5 0.0 13.0 28.2 10.0 0.4 4.5 3.2 0.0 9.3 11.0 4.1 2.0 1.1 7.8 5.7 6.4 0.0 3.7 0.6 0.0 7.5 3.3 5.0 1.8 6.5 10.4 7.0 6.0 5.6 8.8 7.8 6.5 8.2 3.4 12.4 3.8 5.3 4.4 9.0 3.1 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503274-120534434 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA049487: AB_2680789" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 14.6 21.7 15.8 16.1 16.7 7.0 29.5 15.6 21.3 12.5 16.4 13.5 21.8 15.7 12.6 16.4 14.0 15.5 13.5 31.9 14.8 13.1 26.0 39.8 17.6 19.1 17.5 15.4 15.1 28.6 14.2 13.4 18.6 19.4 12.7 17.1 11.6 17.9 17.8 58.4 11.1 13.2 14.0 18.5 14.6 12.4 16.9 15.0 17.2 17.7 30.4 15.2 10.1 17.0 21.3 27.4 9.7 19.6 25.1 28.2 22.4 15.9 25.6 23.1 6.6 30.5 23.5 15.9 19.5 12.8 20.0 12.7 10.2 13.5 16.1 23.1 20.4 14.2 17.3 20.5 21.7 20.6 20.1 12.1 21.4 15.7 16.9 24.9 23.3 13.5 22.5 23.5 18.6 22.0 31.3 17.5 31.1 21.0 11.8 23.1 20.9 13.4 26.8 20.3 11.5 19.9 25.0 23.4 23.3 25.7 12.2 17.5 14.1 14.1 7.2 26.5 25.2 36.3 19.3 17.5 13.9 15.9 10.2 12.9 25.5 21.5 18.3 15.8 22.2 16.6 9.4 19.6 9.7 18.8 19.2 18.2 21.1 20.4 19.9 27.4 21.3 28.2 22.3 2.1 25.1 17.9 18.0 24.4 22.4 15.8 16.7 15.6 21.3 14.8 13.1 17.5 15.4 19.4 15.0 11.9 10.9 16.3 10.7 6.9 11.5 26.2 15.3 16.0 7.9 14.0 13.7 60.9 39.7 25.5 42.0 11.7 17.2 23.3 17.3 38.3 14.1 8.4 17.3 37.2 40.3 4.8 14.5 16.0 15.6 14.5 15.3 13.1 21.9 36.1 14.6 11.8 12.3 23.2 17.7 52.6 14.4 6.5 10.3 13.7 15.4 7.9 48.7 17.5 29.2 7.5 COQ9 "C16orf49, DKFZP434K046" ENSG00000088682 "Coenzyme Q9" O75208 16 57447425-57461275 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 86.0" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 184.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040918 Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA040918: AB_10794154" "unprognostic (9.18e-2)" "unprognostic (3.60e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-2)" "unprognostic (2.14e-3)" "unprognostic (2.57e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-1)" "unprognostic (2.59e-1)" "unprognostic (9.78e-2)" "unprognostic (2.34e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.03e-11)" "unprognostic (7.40e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.23e-2)" 8.8 19.3 11.5 7.8 12.4 3.7 9.3 11.2 13.8 7.9 17.9 9.4 14.7 17.6 7.2 9.9 16.6 9.5 11.3 46.1 9.5 8.8 28.8 29.1 5.8 6.4 9.7 8.6 6.9 12.6 23.6 8.9 8.1 8.8 10.4 14.5 12.2 17.7 14.5 86.0 9.4 23.7 22.1 6.9 5.3 13.6 8.9 8.5 5.4 11.8 31.1 9.4 16.3 8.4 13.6 23.3 14.7 24.1 15.2 18.7 14.1 11.9 24.4 6.6 16.6 13.3 10.3 7.9 11.6 9.1 16.4 9.2 14.8 15.6 14.5 22.4 10.1 12.6 25.6 19.1 20.3 10.3 7.8 16.5 10.0 16.7 22.7 14.7 12.7 16.4 17.1 26.6 13.0 25.4 10.9 18.2 12.8 19.2 6.6 9.8 17.0 10.5 9.2 10.9 25.9 32.2 21.4 21.8 37.3 25.5 13.3 20.9 21.1 39.3 37.9 19.2 6.1 21.8 14.2 12.5 11.9 14.7 12.9 14.6 16.1 9.9 17.3 16.6 18.3 13.5 11.5 19.3 14.7 13.9 24.1 14.4 13.6 12.0 12.2 23.3 12.0 13.0 18.7 6.0 15.2 23.5 14.5 16.8 14.1 11.5 12.4 11.2 13.8 9.5 8.8 9.7 8.6 8.8 8.5 11.9 17.6 19.3 15.0 7.4 15.8 75.0 50.9 26.8 17.0 24.4 15.7 61.9 184.1 42.5 28.2 16.5 72.4 0.0 25.5 19.3 14.4 15.7 6.9 45.9 33.9 19.1 26.5 16.5 14.0 20.8 19.5 12.8 27.0 30.7 42.6 24.6 24.1 37.4 19.1 80.1 22.7 12.9 16.7 66.0 31.1 9.8 65.8 15.2 58.3 17.0 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB073545: , HPA059124: AB_2683912" "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 38.3 24.6 27.3 29.6 46.9 66.9 32.7 31.8 46.5 29.1 37.2 26.9 27.8 34.0 31.9 36.4 37.3 17.2 32.5 33.7 42.6 52.2 25.0 23.0 17.6 47.7 55.3 34.5 25.6 65.6 67.9 28.4 68.8 42.2 40.9 26.7 33.4 58.4 45.0 31.2 41.1 57.4 26.8 45.4 25.6 22.5 47.4 28.8 41.6 31.1 32.5 37.1 13.3 33.6 91.2 31.7 24.1 40.3 30.8 26.4 34.6 31.9 31.0 48.0 53.6 25.5 37.4 37.5 22.4 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 29.8 61.2 171.1 166.3 235.9 115.5 140.5 132.5 96.4 51.2 141.3 35.3 190.2 547.2 206.3 15.8 157.6 103.8 23.3 199.6 263.9 167.1 184.8 86.4 193.0 204.8 123.9 277.2 113.5 243.6 17.7 149.8 177.9 209.2 287.7 202.3 182.8 197.6 161.4 149.2 386.1 95.5 109.9 206.0 195.8 267.6 214.7 275.6 186.4 235.2 168.4 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85659708-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA021526: AB_2670738, HPA063652: AB_2685075" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 15.4 18.7 16.6 19.5 23.3 13.2 19.8 31.4 21.7 23.1 18.1 23.7 18.5 22.0 29.0 19.9 15.0 22.3 18.2 13.3 16.9 10.5 14.9 16.2 17.5 25.0 34.0 18.7 31.5 27.2 30.0 23.8 18.3 20.2 21.2 20.6 20.0 19.3 17.0 13.1 18.2 24.4 20.0 21.3 26.1 20.2 12.7 24.8 21.6 27.1 11.7 21.3 19.1 21.3 3.1 2.4 2.3 2.8 1.9 3.8 0.8 3.6 11.1 9.3 3.1 3.9 4.3 11.4 5.8 3.4 5.0 6.6 11.1 17.8 9.3 5.9 3.2 20.7 13.4 7.5 3.9 7.5 7.5 9.3 9.6 32.1 3.4 3.1 9.6 5.6 4.5 9.3 5.5 8.2 4.7 2.8 6.8 8.3 15.8 4.5 5.9 8.6 13.8 3.7 11.0 5.8 17.5 10.7 6.7 4.4 7.0 9.8 9.3 9.2 13.1 2.3 4.9 15.6 15.7 4.3 10.7 8.7 17.2 8.0 5.9 5.2 12.9 2.9 6.9 8.6 1.9 1.6 1.4 2.3 1.4 3.8 3.1 1.5 1.9 2.0 2.9 2.5 2.3 2.3 1.9 2.8 2.4 1.1 0.8 16.6 23.3 31.4 21.7 16.9 10.5 34.0 18.7 20.2 24.8 17.9 19.2 20.4 20.2 36.7 100.5 11.3 12.7 14.7 14.8 21.0 86.4 13.0 8.3 10.5 19.0 26.4 25.1 23.3 7.4 12.3 29.2 26.1 21.9 26.0 8.7 85.8 37.8 22.1 18.6 13.7 28.4 14.6 32.1 9.0 23.6 57.0 8.3 20.9 31.5 5.3 112.5 12.9 28.9 20.0 5.9 36.1 12.0 25.8 19.9 21.0 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.8;HEK 293: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446" "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favorable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.8 4.7 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.1 0.0 2.0 0.4 2.2 0.2 0.2 0.0 7.4 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.7 0.0 0.9 5.2 0.2 0.1 1.2 0.2 0.3 2.6 1.9 2.7 0.4 0.2 0.6 1.1 0.9 2.8 1.3 1.7 3.4 0.1 0.7 1.3 2.4 0.2 0.0 5.6 0.1 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 3.0 1.3 0.0 0.1 0.7 28.1 1.2 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.5 0.2 6.4 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 86.9 0.2 0.0 0.0 0.0 19.5 0.0 0.2 17.2 1.0 0.5 0.1 0.0 0.2 0.1 CTDSP2 "OS4, PSR2, SCP2" ENSG00000175215 "CTD small phosphatase 2" O14595 12 57819927-57846739 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "RH-30: 169.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052607 Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA052607: AB_2681883" "unprognostic (7.09e-2)" "unprognostic (2.45e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (4.39e-1)" "unprognostic (5.57e-2)" "unprognostic (1.05e-3)" "unprognostic (2.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" "unprognostic (1.12e-1)" "unprognostic (4.15e-1)" "unprognostic (7.38e-3)" "unprognostic (5.50e-2)" "unprognostic (6.50e-2)" "unprognostic (2.18e-1)" "unprognostic (3.11e-1)" 44.5 43.6 28.2 31.6 34.8 17.6 39.6 57.1 33.4 49.0 48.4 36.7 47.7 24.4 50.4 32.9 38.0 41.9 37.7 34.6 31.2 16.5 32.8 32.6 51.3 31.3 37.1 19.9 52.5 53.9 33.7 25.4 42.9 31.0 40.5 38.6 29.3 45.8 60.9 48.8 39.9 36.1 44.1 25.7 38.1 43.1 21.0 40.9 62.9 40.1 32.8 33.9 46.1 63.0 7.3 9.3 18.7 9.7 8.2 11.5 7.1 11.0 4.8 23.1 14.7 20.8 35.9 7.7 12.0 22.8 11.9 10.7 6.1 18.1 13.6 13.8 25.5 4.6 8.9 9.6 11.7 12.5 4.5 4.1 18.8 7.4 4.9 19.4 8.5 11.0 34.3 12.4 10.8 9.2 25.6 18.6 8.3 9.8 24.1 5.9 5.1 9.1 5.1 11.7 7.0 6.1 12.2 169.3 17.8 9.3 16.1 4.3 9.6 16.7 9.6 14.4 14.7 17.4 14.9 14.9 10.6 11.6 11.9 4.2 7.2 7.7 16.4 11.9 7.9 8.2 11.5 9.7 14.7 6.9 9.0 8.2 7.3 9.9 8.0 9.3 6.5 11.5 8.7 18.7 8.2 7.7 7.7 6.4 7.1 28.2 34.8 57.1 33.4 31.2 16.5 37.1 19.9 31.0 40.9 68.5 36.0 33.5 41.6 60.0 18.7 31.1 79.0 13.4 23.9 45.4 15.7 36.7 13.3 64.0 44.2 58.1 55.7 0.0 117.0 34.7 57.1 49.1 24.3 49.7 36.0 19.1 46.8 80.4 63.9 111.0 48.1 36.8 40.5 66.7 42.3 41.1 88.4 51.8 45.6 23.9 10.8 71.1 55.2 5.8 25.8 66.6 47.0 40.6 35.4 58.0 CTPS2 ENSG00000047230 "CTP synthase 2" Q9NRF8 X 16588003-16712936 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017437, HPA075930" Uncertain Approved Mitochondria,Cytosol NA NA 14000 "Mitochondria, Cytosol" "HPA017437: AB_1847326, HPA075930: " "unprognostic (1.40e-1)" "unprognostic (6.69e-2)" "unprognostic (3.37e-2)" "unprognostic (7.38e-2)" "unprognostic (1.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (6.57e-3)" "unprognostic (8.52e-2)" "unprognostic (4.31e-3)" "unprognostic (4.43e-1)" "unprognostic (1.89e-2)" "unprognostic (7.22e-2)" "unprognostic (6.04e-2)" "unprognostic (8.93e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.56e-4)" 10.0 12.0 7.8 11.5 11.9 7.8 13.5 14.3 9.9 17.5 13.3 14.8 10.8 15.6 22.0 10.2 9.6 12.1 11.9 7.2 8.6 7.1 8.1 13.4 8.3 7.9 9.1 6.1 17.9 14.9 22.9 8.5 8.3 9.3 12.8 12.6 14.1 11.8 9.7 5.5 9.2 12.8 14.0 12.3 7.1 11.3 4.4 10.8 11.5 11.8 8.4 10.6 11.8 11.2 1.6 3.3 1.1 6.1 3.8 2.4 1.4 7.6 7.0 11.4 9.5 5.8 4.4 0.1 4.2 3.5 6.8 6.3 7.0 8.0 0.2 13.5 4.3 6.2 6.2 16.0 7.7 8.2 0.0 10.6 4.3 9.8 10.2 3.0 3.1 0.1 4.8 2.6 6.4 5.4 7.7 9.1 0.1 6.1 0.3 6.2 10.1 0.1 2.4 19.6 2.8 8.2 0.1 6.6 2.4 7.3 8.5 7.1 13.1 13.3 1.0 7.6 12.9 18.5 8.9 5.8 3.6 1.9 9.4 3.6 0.2 0.1 25.3 2.8 2.7 3.9 0.4 1.5 1.1 1.3 0.8 2.4 1.6 2.2 1.4 3.3 1.4 1.7 1.7 0.1 3.8 6.1 2.2 2.0 1.4 7.8 11.9 14.3 9.9 8.6 7.1 9.1 6.1 9.3 10.8 8.9 7.0 3.7 5.0 2.9 4.9 5.2 10.2 4.0 9.1 5.2 0.0 2.9 3.3 8.7 2.8 4.9 6.0 0.0 8.4 6.2 3.9 4.8 5.8 7.5 4.5 6.4 10.9 6.7 4.9 5.8 8.3 2.6 8.5 9.0 7.4 3.4 10.3 11.0 3.9 2.2 4.4 6.5 4.1 0.0 0.2 3.3 1.3 3.8 8.1 4.8 CWC15 "AD002, C11orf5, Cwf15, HSPC148" ENSG00000150316 "CWC15 spliceosome associated protein homolog" Q9P013 11 94962622-94973612 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 683.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039878 Supported Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles, Mitochondria" "HPA039878: AB_2676722" "unprognostic (1.97e-1)" "unprognostic (5.51e-2)" "unprognostic (1.66e-2)" "unprognostic (8.64e-2)" "unprognostic (3.81e-1)" "unprognostic (6.85e-2)" "unprognostic (1.29e-1)" "unprognostic (1.52e-1)" "unprognostic (4.84e-3)" "prognostic favorable (9.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.44e-1)" "unprognostic (1.34e-1)" "prognostic favorable (7.17e-4)" "unprognostic (5.23e-2)" 9.5 9.6 9.9 7.9 12.0 10.6 13.5 12.4 11.9 10.1 9.2 7.2 7.7 5.8 8.6 14.9 10.0 9.2 5.5 14.1 9.8 9.6 14.0 15.6 8.8 8.7 10.3 10.1 11.8 8.6 7.5 12.1 11.1 12.6 9.5 8.1 6.4 10.2 9.1 24.4 9.0 10.1 7.3 11.7 10.7 9.5 17.2 12.4 11.2 11.2 14.7 9.6 9.8 10.6 31.8 31.3 36.8 33.0 26.1 35.8 25.7 10.8 8.8 26.3 12.5 25.0 22.8 13.7 16.3 23.0 27.4 22.7 39.3 24.8 16.8 33.1 23.1 20.3 11.4 15.9 20.6 29.4 21.3 14.0 21.1 10.5 17.7 21.5 26.3 13.1 22.6 23.7 18.3 24.5 22.8 26.6 20.5 24.8 14.6 24.6 14.3 25.3 35.6 12.6 30.5 22.2 17.2 16.0 17.7 27.2 13.1 14.9 11.6 18.0 17.8 14.1 25.5 28.6 21.3 14.6 18.0 14.4 25.0 16.2 6.9 17.6 23.2 10.1 30.4 17.5 36.8 25.1 34.5 26.8 27.3 35.8 31.8 34.6 32.8 31.3 27.6 34.4 34.7 29.5 26.1 33.0 29.7 35.4 25.7 9.9 12.0 12.4 11.9 9.8 9.6 10.3 10.1 12.6 12.4 68.5 52.8 80.4 76.4 52.7 51.9 156.1 96.8 103.1 97.8 48.8 13.7 121.9 187.3 96.3 683.1 78.7 55.1 140.2 125.1 102.3 82.2 67.4 99.6 99.5 111.8 38.1 27.3 83.4 57.4 99.0 104.4 88.5 67.4 94.6 54.4 99.4 104.3 80.6 87.4 170.4 46.4 135.8 50.5 192.5 186.1 55.8 99.8 69.1 59.8 59.2 CYB5R1 "humb5R2, NQO3A2" ENSG00000159348 "Cytochrome b5 reductase 1" Q9UHQ9 1 202961869-202967280 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.2" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010641, HPA014147" Enhanced Approved Mitochondria,Cytosol NA NA 860000 Mitochondria Cytosol "HPA010641: AB_1078600, HPA014147: AB_1847370" "unprognostic (6.36e-2)" "unprognostic (8.51e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.86e-2)" "unprognostic (4.34e-2)" "unprognostic (8.46e-2)" "unprognostic (1.28e-1)" "unprognostic (4.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.73e-2)" "unprognostic (2.33e-1)" "unprognostic (6.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.69e-1)" 9.6 14.5 7.8 5.0 8.4 3.9 16.9 6.2 11.0 11.6 7.5 8.7 10.6 4.4 10.1 32.3 13.7 16.4 9.2 33.9 7.3 9.2 15.5 18.4 10.1 11.7 10.0 9.1 10.8 11.1 16.3 11.1 63.8 11.9 10.5 5.0 15.7 14.4 10.1 119.2 28.5 6.9 10.6 7.4 10.8 18.6 20.1 6.7 11.7 13.5 26.4 10.0 13.6 10.1 20.2 21.9 25.7 33.3 17.2 26.5 28.8 8.5 5.3 4.7 9.6 43.9 10.1 46.1 17.1 16.2 11.2 10.0 4.4 10.1 5.3 14.6 17.1 6.2 47.3 3.8 14.7 7.4 7.6 9.7 3.0 6.5 5.0 15.8 2.6 7.6 16.2 48.7 12.3 6.7 9.5 7.3 6.6 8.9 9.6 40.2 10.0 3.2 2.3 3.1 7.7 10.3 5.4 22.7 11.3 10.6 10.2 4.0 5.0 9.6 32.0 13.9 10.7 14.8 5.8 7.1 12.8 5.4 4.8 9.5 9.0 10.6 2.5 14.1 4.0 9.5 11.6 33.3 25.6 16.7 24.2 22.2 13.6 19.3 17.8 21.9 20.2 26.5 18.8 25.7 17.2 15.7 15.1 19.1 28.8 7.8 8.4 6.2 11.0 7.3 9.2 10.0 9.1 11.9 6.7 20.8 24.3 13.0 30.5 166.3 19.6 98.7 33.1 58.9 20.5 27.9 27.5 100.3 6.6 35.7 4.3 29.5 11.9 23.3 41.7 159.6 29.6 19.2 27.7 36.0 54.2 9.5 18.4 23.4 39.9 5.4 27.6 33.5 60.8 9.0 10.9 56.4 53.6 10.5 29.4 32.1 25.9 12.9 34.0 24.6 2.7 137.6 245.4 17.5 14.2 47.8 CYP27A1 "CP27, CTX, CYP27" ENSG00000135929 "Cytochrome P450 family 27 subfamily A member 1" Q02318 2 218781749-218815293 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 149.0" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 367.9;Hofbauer cells: 155.3;monocytes: 143.3" "Cancer enhanced" "Detected in all" "liver cancer: 176.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 38.2;neutrophil: 30.6" "Group enriched" "Detected in many" 20 "granulocytes: 30.6;monocytes: 38.2" "Cell line enhanced" "Detected in some" "Hep G2: 74.3;HSkMC: 14.2;RPTEC TERT1: 18.9;SK-MEL-30: 30.5;WM-115: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059155 Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA059155: AB_2683933" "prognostic favorable (1.05e-4)" "unprognostic (4.21e-2)" "unprognostic (2.34e-1)" "unprognostic (1.83e-3)" "unprognostic (3.71e-3)" "unprognostic (1.31e-2)" "prognostic favorable (8.62e-6)" "unprognostic (6.04e-2)" "unprognostic (1.73e-1)" "unprognostic (4.04e-1)" "unprognostic (1.25e-3)" "unprognostic (8.76e-3)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (7.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 14.4 12.3 6.3 4.7 13.4 0.7 5.5 2.4 7.5 6.5 21.9 16.9 24.9 21.0 5.0 5.4 3.5 9.2 5.1 6.9 8.3 6.2 12.6 149.0 22.4 5.6 19.9 5.7 9.5 2.4 6.3 7.1 2.0 12.1 11.6 6.0 15.1 10.0 21.5 10.0 3.9 36.8 5.0 18.8 3.1 3.5 3.7 15.7 3.7 3.1 4.0 7.6 5.5 5.7 0.1 1.7 30.6 38.2 0.0 0.1 10.0 0.0 0.0 0.7 0.0 1.3 0.9 0.1 0.8 3.0 1.0 2.1 3.7 0.1 0.0 1.5 2.1 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.0 0.1 74.3 4.3 0.1 0.0 14.2 0.1 0.0 0.0 3.5 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.7 0.1 18.9 0.0 0.0 0.0 0.0 0.0 30.5 0.7 0.5 0.7 1.7 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.9 0.0 38.2 0.1 0.0 4.3 0.0 0.1 0.0 0.1 1.7 0.0 0.0 0.0 30.6 0.0 0.3 0.2 0.0 10.0 6.3 13.4 2.4 7.5 8.3 6.2 19.9 5.7 12.1 15.7 3.0 28.2 0.9 44.4 4.6 13.8 5.0 17.8 14.7 12.5 3.5 25.5 0.9 8.3 9.2 0.9 7.1 46.1 0.0 10.8 0.5 20.2 45.1 2.3 367.9 155.3 9.5 23.5 19.6 15.9 0.6 44.0 31.1 47.2 143.3 9.0 29.6 6.6 19.3 25.1 66.2 13.7 0.0 8.5 0.3 0.0 2.8 1.0 2.5 18.7 20.0 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "liver: 802.4" "Cell type enriched" "Detected in many" 65 "Hepatocytes: 5979.1" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.9;myeloid DC: 9.1" "Group enriched" "Detected in many" 17 "dendritic cells: 9.1;T-cells: 3.9" "Cell line enhanced" "Detected in many" "HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009128, HPA029564" Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Mitochondria" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.6 0.3 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.8 0.2 1.3 0.1 0.1 0.1 0.3 802.4 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 1.5 0.1 0.1 0.0 9.1 0.0 0.3 0.2 3.9 0.3 0.1 0.0 0.3 0.9 3.2 1.8 0.7 1.4 4.0 0.0 0.3 0.0 2.4 1.3 0.2 0.4 0.0 9.8 0.0 0.2 0.3 0.2 1.4 1.5 0.1 1.1 0.5 7.6 8.1 0.9 0.2 0.0 0.6 1.7 0.0 2.8 0.5 0.4 0.9 0.6 0.5 20.6 5.6 3.7 0.4 0.3 5.5 0.0 1.8 0.0 0.0 0.0 3.7 0.0 0.6 0.1 0.2 0.8 0.0 1.3 0.4 2.0 0.9 2.0 0.8 2.8 1.3 6.4 0.1 0.0 0.0 0.0 0.1 0.0 3.9 0.0 1.7 1.0 9.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.6 21.0 0.2 2.1 4.5 2.2 50.9 2.7 2.3 0.0 2.0 0.0 0.0 0.3 1.3 0.4 0.0 23.3 1.2 0.1 0.4 0.5 1.1 5979.1 0.0 7.9 0.0 68.2 91.8 1.9 1.4 0.0 0.0 0.0 0.0 1.0 2.6 0.0 2.5 0.0 5.2 0.0 0.5 3.6 2.2 6.6 0.1 8.7 0.0 0.0 DAP3 "bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29" ENSG00000132676 "Death associated protein 3" P51398 1 155687960-155739010 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Apoptosis "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023687 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023687: AB_1847472" "unprognostic (2.60e-1)" "unprognostic (2.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.80e-1)" "unprognostic (5.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.87e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.14e-6)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" 27.8 36.5 22.9 26.3 25.9 28.9 34.2 19.5 23.6 23.5 33.4 19.5 22.8 29.4 28.7 28.1 31.3 21.8 23.2 56.3 27.0 26.4 32.8 52.2 23.9 49.0 24.9 23.0 23.3 38.5 20.7 27.1 20.5 23.0 27.9 32.1 24.5 28.0 27.1 64.0 30.9 26.5 36.0 23.2 30.8 30.3 31.6 21.1 44.4 27.6 28.4 38.0 38.0 24.1 39.0 41.1 15.9 35.2 34.0 56.5 39.6 32.4 21.1 17.2 27.3 25.5 32.3 42.5 27.4 29.0 28.2 24.7 38.9 40.0 46.3 55.9 22.3 18.1 33.2 25.6 23.9 30.8 29.0 18.7 28.2 18.8 35.2 34.9 38.6 25.2 27.0 34.3 35.9 47.6 22.1 27.7 43.0 60.9 33.0 29.3 43.2 33.9 45.2 30.5 51.1 34.5 28.0 21.6 49.2 33.5 31.2 20.1 35.6 26.3 77.6 47.2 33.4 48.2 63.5 23.6 24.0 25.3 29.6 45.9 36.1 53.9 53.4 23.9 34.6 30.8 13.9 30.1 15.9 31.3 35.2 51.4 39.0 45.1 38.0 41.1 32.2 56.5 48.4 13.0 34.0 31.9 26.8 45.0 39.6 22.9 25.9 19.5 23.6 27.0 26.4 24.9 23.0 23.0 21.1 41.7 35.8 49.1 58.4 48.8 26.0 99.7 45.9 68.3 58.0 15.7 19.6 67.1 56.3 62.2 13.1 35.0 35.4 93.5 68.2 87.5 44.8 51.6 61.1 48.1 67.9 12.7 24.6 34.4 47.0 10.6 30.0 61.0 33.7 88.4 35.3 13.3 67.0 31.6 23.7 57.4 46.0 12.9 47.2 38.7 26.6 55.2 118.4 64.7 54.9 62.6 DARS2 FLJ10514 ENSG00000117593 "Aspartyl-tRNA synthetase 2, mitochondrial" Q6PI48 1 173824503-173858546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026506, HPA026528" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA026506: AB_1847482, HPA026528: AB_1847483" "unprognostic (3.14e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-3)" "unprognostic (4.10e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-1)" "unprognostic (6.17e-2)" "unprognostic (1.15e-1)" "prognostic favorable (1.74e-4)" "unprognostic (3.30e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (4.73e-3)" 17.0 22.2 6.3 10.1 8.1 5.4 9.0 7.5 8.6 7.8 15.1 6.7 8.3 11.7 10.4 6.1 13.4 6.4 5.9 11.2 5.5 6.0 21.9 14.8 8.2 11.0 6.4 4.2 9.5 14.9 18.1 15.3 10.9 10.0 8.5 16.6 10.2 10.2 6.2 10.6 6.0 16.1 6.2 9.0 11.4 11.3 8.4 6.9 26.1 12.2 6.3 12.5 9.7 8.1 9.3 9.0 4.8 10.7 5.0 9.3 5.2 29.0 19.4 12.1 7.5 9.2 13.1 15.5 12.8 10.6 18.5 14.2 18.2 26.1 15.7 17.5 10.2 12.2 29.8 33.4 21.6 25.3 17.9 16.4 13.6 9.7 12.6 9.0 11.5 12.4 9.5 9.9 18.7 19.1 5.9 18.4 11.9 27.5 12.4 15.4 8.0 14.6 6.5 23.4 32.5 17.4 17.2 15.4 28.9 16.8 9.7 15.9 14.5 14.0 31.3 20.2 19.0 32.8 15.2 8.1 9.5 15.0 13.1 20.4 9.7 24.5 18.2 5.5 12.7 20.5 4.4 7.0 4.8 6.6 10.7 9.3 9.3 7.2 5.8 9.0 7.3 7.7 4.8 0.7 5.0 7.4 3.7 5.1 5.2 6.3 8.1 7.5 8.6 5.5 6.0 6.4 4.2 10.0 6.9 3.0 1.9 4.3 3.6 1.5 2.2 10.5 7.6 1.4 3.4 5.2 0.0 7.3 6.6 3.9 1.9 3.2 4.5 23.3 2.3 13.0 3.4 2.3 5.7 4.3 8.9 3.2 4.1 1.3 3.5 1.0 2.8 5.0 1.7 6.4 5.0 2.4 3.6 0.0 1.4 6.4 2.7 0.0 2.3 5.7 6.4 1.4 3.5 2.9 6.0 2.5 DCAF15 "C19orf72, MGC99481" ENSG00000132017 "DDB1 and CUL4 associated factor 15" Q66K64 19 13952492-13961449 "Predicted intracellular proteins" "Immunity, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068351 Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA068351: AB_2685977" "unprognostic (6.91e-2)" "unprognostic (6.55e-3)" "unprognostic (3.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.95e-1)" "unprognostic (1.89e-2)" "unprognostic (1.83e-3)" "unprognostic (9.72e-2)" "unprognostic (8.03e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.97e-4)" "unprognostic (1.98e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (7.97e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" 10.3 6.5 10.4 15.1 8.5 27.5 11.1 20.1 13.3 13.9 12.7 8.7 8.9 10.7 11.4 8.4 14.7 11.3 10.0 11.0 12.1 7.0 11.1 13.1 14.8 19.4 9.0 8.5 10.3 8.4 11.0 10.7 18.6 8.8 10.4 8.4 9.8 10.0 9.1 13.3 21.0 13.8 8.2 7.4 21.4 9.9 41.0 6.5 29.2 10.7 16.5 23.4 9.9 12.8 2.2 2.8 5.1 2.2 0.8 3.6 1.3 15.6 9.7 25.6 14.0 2.7 4.0 11.7 10.8 7.6 22.7 22.7 17.2 6.7 14.5 12.6 10.4 13.4 14.3 16.2 10.2 8.1 17.4 28.9 17.8 16.2 17.8 5.8 14.7 26.3 5.3 9.6 16.7 7.6 8.2 11.3 23.5 18.7 21.4 9.9 23.8 26.2 27.3 30.4 10.6 15.3 24.2 9.0 9.9 12.1 12.1 16.4 16.9 9.7 7.0 8.8 11.0 9.0 19.0 7.8 15.6 11.6 24.5 20.1 15.1 16.6 15.1 10.0 21.5 13.4 1.2 2.0 5.1 2.1 2.2 1.6 2.1 1.7 2.4 1.2 2.2 0.9 2.4 4.1 0.8 1.4 2.8 3.6 1.3 10.4 8.5 20.1 13.3 12.1 7.0 9.0 8.5 8.8 6.5 0.0 0.0 16.4 8.1 4.2 15.5 0.9 5.1 0.0 2.3 8.7 7.9 10.8 1.7 9.7 4.0 8.3 6.3 0.0 9.1 12.7 6.4 4.9 1.1 3.2 13.4 14.3 7.5 9.2 6.0 7.8 17.0 8.8 1.7 14.4 6.1 8.4 7.9 7.0 11.3 3.3 13.2 6.5 4.7 25.1 23.7 8.5 11.6 12.2 6.8 9.2 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 338.2;Proximal tubular cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.5 6.0 17.8 20.1 12.5 20.3 3.8 9.3 16.1 6.1 9.5 2.4 10.5 8.1 7.4 11.1 5.5 8.0 6.6 9.4 10.2 12.2 0.7 19.3 5.4 9.6 15.6 4.2 4.0 16.0 7.3 4.8 8.1 15.1 18.0 12.9 20.1 16.0 29.0 12.1 12.0 6.2 1.1 22.4 18.2 10.2 4.7 14.4 29.8 26.6 0.8 6.7 14.0 132.5 11.1 0.5 17.0 10.9 16.3 10.3 4.9 13.5 5.5 8.1 6.1 9.5 9.8 9.6 13.1 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 71.5 50.7 52.5 52.8 36.7 12.7 229.8 79.0 71.0 51.2 68.0 2.0 44.0 338.2 106.7 118.9 49.7 161.9 0.0 82.2 42.9 47.8 37.6 48.5 196.2 104.2 30.2 100.6 52.2 85.9 33.7 79.1 96.9 81.0 80.2 84.9 41.0 80.5 101.7 48.4 333.3 6.5 71.1 40.1 118.4 23.4 35.9 34.3 71.9 118.0 55.4 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1, autophagy regulator" Q9NTK1 10 44970981-44978810 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 204.9;breast: 227.9" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 96.0;Exocrine glandular cells: 99.5;Pancreatic endocrine cells: 71.2;Syncytiotrophoblasts: 251.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 35.2;HDLM-2: 24.4;HHSteC: 63.6;HSkMC: 49.5;HUVEC TERT2: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: AB_2675685" "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavorable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 204.9 14.6 8.7 14.1 16.8 2.4 227.9 10.8 19.7 14.1 36.5 2.9 10.0 7.4 25.0 14.9 23.5 25.5 28.0 37.0 8.5 6.0 13.0 48.2 70.7 20.6 9.4 3.3 51.2 107.1 4.7 12.2 33.4 21.6 25.8 5.7 12.1 16.2 13.0 81.0 19.6 9.9 30.2 39.0 9.5 12.7 31.9 11.0 0.8 33.3 13.4 19.1 52.1 27.6 0.0 3.7 1.2 0.3 0.0 0.7 1.4 6.9 0.0 0.1 0.0 35.2 17.2 1.7 0.0 2.4 0.1 0.4 0.2 2.6 0.0 0.4 3.1 1.7 0.3 0.3 2.1 0.1 24.4 0.9 0.0 0.0 2.5 63.6 0.0 0.0 49.5 0.1 0.0 0.3 6.0 39.2 0.0 0.0 15.1 0.1 0.0 0.0 0.3 0.0 0.1 0.2 1.1 0.4 5.8 0.1 2.5 1.3 0.0 0.0 0.3 1.3 4.2 0.0 1.6 0.3 1.9 1.3 0.1 1.6 0.4 0.6 0.0 10.7 0.6 1.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.5 0.0 0.1 3.7 0.0 1.4 8.7 16.8 10.8 19.7 8.5 6.0 9.4 3.3 21.6 11.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 10.7 11.4 29.6 0.0 39.6 31.5 96.0 0.0 0.0 0.0 0.0 99.5 11.6 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 71.2 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 251.0 0.0 0.0 0.0 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 67.6;skeletal muscle: 65.0" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "myeloid DC: 17.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 17.1" "Cell line enhanced" "Detected in many" "Daudi: 30.3;RPMI-8226: 54.0;RPTEC TERT1: 44.7;U-698: 15.9" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 8.1 30.2 6.4 5.2 11.0 1.1 9.7 5.1 9.2 18.9 12.7 17.8 5.7 7.8 16.0 5.7 7.2 12.7 6.1 4.3 7.3 6.3 22.7 7.5 2.7 8.5 9.5 6.1 12.5 5.6 13.3 13.6 4.4 7.5 6.4 4.8 0.7 67.6 7.9 65.0 4.3 7.4 7.7 8.2 5.3 20.0 2.1 11.5 0.7 45.0 20.7 2.7 4.8 5.7 0.1 17.1 0.3 1.5 0.3 0.8 0.8 0.0 1.0 0.1 0.3 6.4 1.9 0.1 0.0 0.1 0.1 0.1 0.7 0.1 30.3 0.7 0.3 0.0 0.1 1.6 0.0 0.1 0.6 0.8 4.1 0.2 0.1 3.9 0.8 7.1 1.7 2.9 0.2 0.1 0.0 0.0 0.5 0.0 5.0 0.1 2.0 0.0 0.7 0.4 13.2 1.0 0.1 1.4 54.0 44.7 1.2 0.9 0.2 0.5 3.3 0.9 0.9 2.9 0.1 0.0 0.1 0.2 6.4 0.1 13.4 3.1 15.9 1.9 1.1 0.2 0.0 0.8 0.0 0.2 1.5 0.7 0.1 0.3 0.6 17.1 0.1 0.8 0.5 0.3 0.3 0.1 0.8 0.3 0.8 6.4 11.0 5.1 9.2 7.3 6.3 9.5 6.1 7.5 11.5 6.0 9.4 4.5 12.1 4.6 2.2 2.2 15.3 0.0 5.7 24.4 0.0 0.5 72.9 3.3 1.3 3.6 3.9 0.0 10.6 1.5 8.2 11.1 11.5 10.5 2.8 0.0 16.0 4.3 11.8 1.1 10.9 7.6 13.5 1.8 2.9 0.9 1.3 20.9 3.2 24.6 0.4 0.0 1.7 3.2 3.2 4.8 0.3 0.0 14.7 16.9 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8" "Region enriched" "Detected in single" 4 "cerebellum: 2.7" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 0.1 0.3 0.3 0.0 0.2 0.0 79.9 0.1 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.8 1.8 5.0 0.2 0.0 0.2 0.0 9.0 5.9 0.3 0.5 5.0 0.1 40.2 0.0 0.1 20.1 0.6 0.1 0.7 0.1 23.1 0.3 3.7 0.8 0.9 0.0 0.0 0.1 0.0 0.0 120.7 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 20.1 1.5 0.1 0.0 49.9 0.0 0.2 1.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.4 2.2 0.1 0.4 0.1 0.0 59.8 0.2 0.3 0.4 292.6 0.3 0.0 0.2 0.0 0.0 0.1 95.8 0.5 0.3 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 5.9 6.6 0.0 3.4 0.0 0.0 0.0 0.2 10.3 0.3 0.2 0.0 0.8 1.6 0.0 3.4 0.0 0.8 3.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 1.1 0.1 1.0 6.5 0.0 0.0 8.5 0.1 20.7 0.0 0.5 11.9 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12617731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8" "Group enriched" "Detected in many" 9 "dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5" "Cell line enhanced" "Detected in many" "A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favorable (2.65e-4)" "unprognostic (5.48e-2)" 22.7 4.4 6.3 6.2 8.6 2.5 30.6 4.0 7.9 16.7 16.3 3.4 9.2 13.6 7.6 15.5 19.0 12.2 11.2 16.1 6.8 8.6 12.3 45.6 11.6 8.3 9.0 4.5 11.8 20.3 0.5 8.9 11.5 9.8 16.3 5.6 20.3 11.8 14.3 10.2 5.6 18.9 11.1 9.8 4.2 12.3 5.2 4.2 3.1 40.5 5.4 5.2 21.0 9.4 0.2 8.6 2.1 0.3 13.8 33.5 15.6 4.8 27.6 0.0 12.2 16.0 1.3 3.2 1.6 0.0 0.0 0.1 3.3 56.6 0.0 1.3 16.2 4.9 22.3 6.0 3.1 0.0 0.0 9.9 4.3 2.8 15.4 2.4 0.0 0.0 8.1 3.7 0.0 0.1 55.9 5.2 0.1 6.5 0.0 0.1 0.8 1.1 0.2 1.8 5.2 11.2 0.1 0.0 5.6 0.0 9.5 0.3 0.5 9.3 30.4 1.7 3.9 2.9 1.2 3.8 0.1 0.6 8.5 0.1 0.8 0.0 0.0 6.4 0.3 52.5 2.1 0.2 0.0 33.5 0.1 24.2 0.2 18.3 15.7 8.6 0.2 31.6 19.7 1.7 13.8 0.3 1.0 0.5 15.6 6.3 8.6 4.0 7.9 6.8 8.6 9.0 4.5 9.8 4.2 89.3 49.3 3.7 141.7 22.8 0.8 31.9 38.2 58.9 55.7 19.2 17.7 22.8 19.9 81.6 86.2 36.5 70.9 23.3 142.3 39.4 26.7 66.3 15.1 157.8 60.3 0.0 24.1 62.0 40.2 235.9 21.0 19.3 6.8 17.2 30.8 13.7 112.0 49.1 9.2 39.4 2.0 0.0 30.1 1.4 1.4 23.6 22.0 22.3 29.9 124.6 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144120-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.5" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031121, HPA078401" Enhanced Approved Nucleoplasm,Mitochondria No No 63000 "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803, HPA078401: " "prognostic favorable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 15.0 24.6 12.3 10.1 10.9 10.5 17.9 10.6 12.4 11.1 30.6 10.7 57.3 20.7 11.7 19.4 12.3 9.9 15.3 17.4 11.0 11.4 22.6 27.9 13.1 13.9 14.1 8.8 13.4 17.2 40.2 17.2 6.1 17.8 83.4 13.4 9.1 113.7 93.0 123.5 9.8 48.7 9.6 15.5 11.1 32.6 4.9 11.0 6.4 24.8 16.7 10.1 12.4 15.6 26.0 56.6 121.4 32.2 37.3 50.8 54.0 52.6 15.9 9.2 20.2 47.7 18.7 11.7 17.0 43.8 6.2 13.8 8.8 35.7 5.5 10.2 15.9 15.8 22.7 12.0 23.9 9.1 38.3 11.2 13.6 7.8 14.4 25.1 16.1 0.4 13.9 28.8 9.8 33.3 11.1 11.9 14.0 4.1 11.9 15.5 15.9 9.3 15.3 4.3 31.1 16.1 9.7 12.4 6.4 27.7 18.0 19.8 24.8 17.2 26.1 37.7 11.8 18.3 7.1 8.3 30.9 10.5 8.4 9.7 4.2 1.9 9.8 16.8 15.6 21.2 80.1 32.2 71.6 50.8 22.6 49.9 26.0 36.0 43.9 27.1 21.8 20.2 38.9 121.4 37.3 29.0 56.6 29.0 54.0 12.3 10.9 10.6 12.4 11.0 11.4 14.1 8.8 17.8 11.0 50.6 96.5 40.4 57.0 30.2 23.6 16.5 147.7 46.8 59.1 82.0 78.5 22.0 16.6 184.7 1.5 65.9 155.6 0.0 145.2 76.8 60.2 242.6 172.3 147.5 88.2 39.7 44.6 30.1 58.9 2.0 76.2 101.1 102.9 178.5 77.9 88.0 174.5 89.2 79.2 41.6 54.4 84.1 70.6 1.1 3.1 22.2 17.4 135.7 66.0 41.6 DHX30 "DDX30, FLJ11214, KIAA0890" ENSG00000132153 "DExH-box helicase 30" Q7L2E3 3 47802909-47850195 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034806 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA034806: AB_10601364" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "prognostic favorable (1.37e-6)" "unprognostic (4.12e-2)" "unprognostic (1.43e-1)" "unprognostic (2.81e-1)" "unprognostic (2.22e-1)" 18.4 18.7 22.1 18.5 31.1 23.6 18.3 31.2 43.5 22.3 17.8 26.9 15.5 17.3 23.3 14.8 21.0 24.8 17.9 21.3 19.1 19.8 18.6 19.3 16.7 22.0 20.4 28.0 27.1 21.2 37.3 24.8 20.6 23.6 20.4 13.0 22.0 20.4 23.6 27.1 26.2 16.1 18.8 15.3 21.2 18.7 54.4 18.4 23.8 20.1 15.2 16.9 18.6 17.6 9.9 13.0 9.8 10.5 8.2 16.1 11.6 8.1 20.7 20.5 21.1 9.5 7.9 14.0 15.4 13.2 26.6 19.2 23.8 17.4 26.5 12.1 15.0 18.5 12.5 30.3 21.5 9.5 18.0 36.3 23.1 30.5 23.2 16.5 21.5 24.0 13.8 13.7 28.1 19.8 10.5 17.3 24.5 32.5 17.1 12.4 22.0 27.3 23.6 22.8 10.8 35.4 18.2 11.0 23.5 13.3 20.7 16.9 22.5 15.0 21.4 11.1 10.3 15.0 22.6 12.0 16.1 20.9 18.1 28.2 20.7 25.8 24.0 16.7 18.8 19.9 9.8 10.1 7.2 15.0 10.3 13.0 9.9 12.7 16.1 13.0 9.3 12.1 13.0 1.5 8.2 10.5 7.8 14.3 11.6 22.1 31.1 31.2 43.5 19.1 19.8 20.4 28.0 23.6 18.4 35.7 44.3 33.3 22.5 16.1 46.6 31.3 35.7 42.8 28.4 48.8 41.2 35.6 56.3 33.4 93.4 33.1 32.4 23.3 31.3 18.8 20.4 23.6 23.1 43.3 30.5 55.6 38.5 23.4 27.7 89.2 23.0 28.0 18.6 25.2 23.6 39.2 38.5 29.6 28.3 56.9 46.8 32.3 19.4 136.8 41.1 17.3 24.7 23.5 30.9 22.7 DLD "DLDH, GCSL, LAD" ENSG00000091140 "Dihydrolipoamide dehydrogenase" P09622 7 107890970-107931730 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 284.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044849 Supported Approved Nucleoplasm,Mitochondria NA NA 16000000 Mitochondria Nucleoplasm "HPA044849: AB_2679111" "unprognostic (2.01e-3)" "unprognostic (2.26e-1)" "unprognostic (1.27e-2)" "unprognostic (9.27e-2)" "unprognostic (5.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.48e-1)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (9.43e-2)" "unprognostic (7.35e-2)" "prognostic favorable (7.58e-9)" "unprognostic (4.08e-2)" "unprognostic (1.88e-1)" "unprognostic (4.45e-3)" "unprognostic (1.18e-1)" 25.7 37.9 14.5 12.7 25.4 12.0 15.2 16.6 27.2 13.2 28.0 10.6 12.2 20.9 13.6 9.6 25.6 11.6 12.7 69.1 16.4 14.4 40.7 37.9 11.0 13.0 16.7 20.1 15.1 14.8 24.6 22.4 15.4 29.3 14.7 26.8 12.8 19.4 14.4 71.5 13.8 29.5 23.7 10.6 17.4 23.0 10.6 10.7 18.7 17.0 31.8 16.9 20.1 11.7 13.5 30.4 45.8 37.8 22.9 19.4 20.2 40.1 32.6 18.1 31.1 26.0 23.0 20.5 23.1 19.5 26.9 20.9 38.0 22.6 39.3 39.9 24.5 44.0 26.7 36.3 32.6 40.7 26.2 21.6 27.6 43.2 27.1 20.0 45.4 28.5 26.2 23.7 28.6 15.6 17.1 32.3 33.0 68.9 29.3 29.2 45.1 37.1 32.9 21.5 48.5 23.7 26.8 29.0 53.3 36.8 60.0 22.5 23.8 37.8 64.0 34.0 37.6 24.4 38.9 20.4 29.8 24.4 57.9 35.1 22.2 42.3 26.4 28.0 48.5 30.7 36.5 22.3 45.8 17.5 28.2 18.5 13.5 17.7 17.3 30.4 12.3 18.7 19.4 14.0 22.9 37.8 10.5 16.8 20.2 14.5 25.4 16.6 27.2 16.4 14.4 16.7 20.1 29.3 10.7 26.8 16.5 23.1 30.6 27.8 45.9 284.8 61.1 37.5 18.2 75.0 21.6 94.8 192.3 59.5 3.8 30.0 47.9 46.7 49.3 49.9 26.3 23.6 26.5 77.8 61.0 20.6 29.4 27.6 36.8 5.6 21.6 34.1 35.4 65.9 39.3 31.3 37.7 56.1 39.6 134.4 33.4 25.8 43.4 41.2 52.4 28.2 90.6 27.7 64.6 28.5 DLST DLTS ENSG00000119689 "Dihydrolipoamide S-succinyltransferase" P36957 14 74881891-74903745 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003010 Supported Approved Nucleoplasm,Mitochondria NA NA 800000 "Nucleoplasm, Mitochondria" "HPA003010: AB_1078679" "unprognostic (1.62e-1)" "unprognostic (3.01e-1)" "unprognostic (2.45e-3)" "unprognostic (6.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (3.03e-1)" "unprognostic (1.37e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.13e-12)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "unprognostic (4.55e-3)" 32.2 38.6 12.0 22.7 19.9 28.5 31.3 19.1 25.6 31.2 36.0 18.5 15.9 24.7 26.3 28.3 31.4 19.2 29.7 47.6 10.8 11.8 43.7 45.1 20.8 26.7 13.5 13.7 21.5 27.1 25.8 16.2 25.2 19.7 20.9 26.8 19.2 22.3 20.1 59.2 26.9 43.2 32.9 11.4 20.8 24.3 21.0 10.4 23.5 27.2 49.8 28.4 26.9 21.1 3.8 6.3 8.4 4.3 7.7 5.3 3.2 25.8 27.0 20.7 14.6 32.5 36.9 31.7 33.8 34.4 34.6 32.4 26.5 28.1 26.3 14.4 38.8 15.6 29.2 34.8 33.4 36.6 19.0 14.6 21.5 22.6 23.2 33.6 15.2 14.8 37.7 29.3 33.5 41.4 31.2 35.6 11.9 16.4 17.9 37.5 34.7 18.0 21.6 17.7 45.7 25.4 23.1 30.4 14.5 42.9 31.8 24.6 20.9 31.9 42.6 22.0 19.3 39.0 22.0 31.5 21.1 27.6 25.7 23.1 12.7 13.2 23.1 30.8 15.8 22.0 8.4 3.0 5.0 5.0 4.3 4.5 3.8 4.5 3.9 4.7 2.7 4.0 5.3 3.0 7.7 3.9 6.3 4.4 3.2 12.0 19.9 19.1 25.6 10.8 11.8 13.5 13.7 19.7 10.4 6.0 4.5 20.7 19.3 23.5 17.5 23.4 20.4 2.7 3.4 19.2 29.5 33.7 48.0 32.5 6.2 14.6 39.3 0.0 22.3 30.6 23.8 21.8 20.7 37.3 28.4 12.7 14.3 24.5 16.2 3.4 16.7 16.5 21.9 36.1 28.3 8.5 35.0 25.9 19.4 51.5 20.0 25.8 17.9 9.3 11.7 24.8 66.5 20.3 36.1 20.8 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423500 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 3.7;Intestinal endocrine cells: 1.2" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: AB_2684911" "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.2 0.1 0.4 0.1 1.5 0.2 0.2 0.4 2.1 0.3 0.3 8.5 0.0 0.4 0.2 0.1 3.8 0.2 0.1 0.1 1.2 0.7 0.2 0.2 0.2 0.2 1.2 0.0 0.2 0.1 0.4 5.4 0.2 2.1 0.2 0.3 0.0 0.5 0.2 0.3 0.1 0.2 0.1 2.0 0.3 0.2 4.0 3.7 0.3 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 1.9 0.0 1.3 4.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 3.3 3.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.4 1.8 1.2 0.7 1.2 0.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 DNAAF3 "C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22" ENSG00000167646 "Dynein axonemal assembly factor 3" 19 55158661-55166722 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 12 "fallopian tube: 29.7;testis: 60.1" "Group enriched" "Detected in many" 6 "Early spermatids: 336.2;Late spermatids: 540.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 17.3;HEL: 20.1;K-562: 15.7;U-937: 11.4" HPA056220 Approved "Nuclear bodies,Mitochondria" No No Mitochondria "Nuclear bodies" "HPA056220: AB_2683071" "unprognostic (1.71e-2)" "unprognostic (2.67e-2)" "unprognostic (6.10e-2)" "unprognostic (9.93e-3)" "unprognostic (1.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.22e-2)" "unprognostic (1.82e-1)" "unprognostic (5.36e-2)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (2.35e-2)" "unprognostic (8.03e-2)" 0.2 1.0 0.7 0.1 1.7 0.0 0.4 0.1 0.5 1.9 0.3 2.5 1.8 0.0 0.9 3.8 0.3 29.7 0.6 2.9 1.2 1.5 2.5 1.7 3.3 0.1 0.5 0.1 3.1 0.8 1.0 0.3 0.1 2.7 0.2 0.0 0.4 0.8 0.6 0.2 0.3 0.1 0.1 0.2 0.2 0.2 60.1 0.8 0.2 1.5 0.1 0.4 0.1 0.1 0.0 0.9 0.5 0.4 0.0 0.0 1.6 5.5 4.6 0.4 4.5 0.0 0.0 0.5 0.1 0.0 0.6 0.5 0.2 2.6 6.7 1.7 0.2 1.3 6.7 0.9 1.9 0.2 0.0 17.3 20.1 0.2 0.3 0.1 8.5 2.0 0.1 2.8 1.1 1.5 0.6 0.3 3.0 15.7 9.1 0.2 3.6 0.2 0.2 0.3 6.0 10.0 10.4 0.6 2.0 3.5 0.1 0.6 1.8 0.7 0.7 1.0 0.1 5.6 0.3 0.7 0.5 2.6 2.6 0.1 0.2 1.5 0.3 3.2 11.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.7 1.7 0.1 0.5 1.2 1.5 0.5 0.1 2.7 0.8 0.0 0.3 0.0 0.0 2.9 0.0 3.3 2.5 49.5 6.8 7.0 0.0 0.0 6.6 2.0 336.2 0.3 0.0 0.0 0.9 0.1 1.1 0.2 0.0 0.2 0.2 0.0 0.0 0.6 0.0 540.3 4.0 0.2 0.0 0.0 0.0 1.9 0.2 0.0 2.8 4.3 0.0 0.0 0.0 70.4 14.7 1.1 0.0 0.0 0.0 0.1 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Supported Vesicles,Mitochondria NA NA Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: AB_2677183, HPA044229: AB_2678865" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favorable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 10.8 26.6 10.7 11.3 15.5 6.2 13.0 15.3 20.8 10.0 14.0 13.9 11.1 17.3 11.3 8.7 15.6 12.6 12.5 28.8 13.9 12.6 19.0 44.8 9.1 13.4 13.0 13.0 13.2 18.1 21.6 12.1 13.7 14.2 11.5 13.4 10.6 14.4 13.4 46.7 12.8 13.2 11.4 12.6 11.4 12.8 15.1 11.1 13.6 16.1 16.2 13.3 13.4 11.2 10.4 6.5 2.2 7.0 7.8 11.9 7.9 9.0 18.1 6.3 12.0 7.9 7.0 11.8 11.9 9.0 16.6 13.7 15.0 12.8 17.8 11.1 7.7 11.8 13.7 20.6 14.1 9.7 12.2 17.8 9.0 15.6 14.5 19.7 15.8 8.7 8.5 16.9 14.7 24.5 8.4 8.0 14.0 23.4 14.7 9.4 20.7 14.7 11.4 13.8 16.8 16.7 18.4 10.1 33.3 12.4 9.7 15.6 6.7 13.0 29.9 19.7 5.7 17.1 13.3 7.4 12.4 8.4 29.9 14.9 15.2 20.4 24.3 6.6 15.3 14.6 0.7 4.6 2.2 9.5 7.0 11.0 10.4 9.1 8.9 6.5 8.9 11.9 9.2 0.5 7.8 5.2 4.6 7.4 7.9 10.7 15.5 15.3 20.8 13.9 12.6 13.0 13.0 14.2 11.1 11.9 7.2 17.9 16.3 14.0 22.0 30.7 10.2 8.1 12.5 24.4 9.8 35.8 38.1 17.3 52.4 10.5 15.3 0.0 10.6 24.7 13.3 14.9 12.7 36.1 14.4 22.3 16.8 6.7 10.1 12.7 17.8 10.0 20.3 14.4 15.8 19.5 13.0 14.0 20.8 21.4 20.5 12.9 11.8 35.4 34.5 14.8 23.8 15.2 28.5 13.5 DND1 "MGC34750, RBMS4" ENSG00000256453 "DND microRNA-mediated repression inhibitor 1" Q8IYX4 5 140670794-140673586 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.2;testis: 12.0" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 44.0;Horizontal cells: 19.1;Spermatogonia: 26.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059723 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA059723: " 0.5 0.2 1.7 0.4 0.8 0.4 0.7 3.2 0.4 0.6 0.6 0.4 0.4 0.3 0.4 0.5 0.4 0.7 0.4 0.4 0.4 0.4 0.4 0.8 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.1 0.4 0.4 0.6 0.9 0.4 0.4 0.6 0.4 0.3 0.4 0.5 0.5 0.7 0.4 12.0 0.4 0.4 0.4 0.4 1.4 0.4 0.4 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.5 0.8 0.6 0.9 0.4 2.1 0.2 0.9 3.5 3.2 1.0 0.7 0.8 0.3 0.6 0.4 0.8 2.2 1.1 1.4 0.7 2.0 0.3 1.4 0.3 1.4 0.5 1.0 0.7 3.4 2.9 1.8 0.4 1.2 1.1 0.7 0.1 1.2 0.2 0.2 2.6 0.6 0.0 2.2 2.1 0.5 0.4 1.8 0.4 1.4 1.2 0.2 0.1 0.8 0.7 0.3 0.5 0.0 0.8 1.6 0.6 0.1 4.0 1.1 0.4 0.0 0.5 0.8 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 3.2 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 1.4 1.3 0.8 0.5 10.3 0.0 0.0 0.0 1.2 3.5 3.9 0.2 0.0 0.2 44.0 0.7 0.4 0.0 0.3 0.3 0.7 1.6 0.0 0.9 0.5 19.1 1.2 0.0 1.0 5.6 0.6 1.1 0.0 0.0 0.1 3.9 0.2 0.0 0.4 0.0 3.8 0.0 0.3 6.9 26.2 0.9 0.2 3.2 0.6 1.2 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363789 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 7.4;Collecting duct cells: 5.2;Spermatogonia: 4.8;Suprabasal keratinocytes: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 40.2;MCF7: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA062738: AB_2684857" "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.6 11.3 13.8 13.0 11.9 13.4 10.4 8.1 13.9 9.7 8.9 9.2 4.0 12.8 10.0 6.2 13.4 7.4 7.1 29.9 11.2 9.1 13.7 14.0 8.0 14.9 11.4 3.5 13.6 25.3 5.0 6.5 7.1 8.5 11.2 2.8 6.2 9.2 7.0 29.6 7.0 7.2 9.9 8.0 13.7 8.3 6.3 6.8 11.6 11.2 7.4 8.9 8.0 9.2 8.6 4.2 8.0 3.1 0.9 6.9 1.2 4.1 7.6 2.6 7.7 1.3 2.8 6.8 6.9 3.8 5.6 2.5 9.1 4.5 9.9 25.3 5.0 4.1 9.2 1.6 4.0 0.6 40.2 10.0 3.5 3.8 3.8 5.2 8.0 6.7 3.5 4.1 4.1 2.5 1.4 2.9 4.3 5.7 7.1 3.6 31.6 9.4 13.1 11.5 6.1 20.1 28.7 3.8 11.4 6.8 4.4 11.7 16.9 7.0 6.5 6.2 1.1 8.1 7.3 6.4 9.4 8.5 6.5 10.5 6.2 8.9 8.7 6.9 3.9 8.6 8.0 1.8 0.3 3.8 3.1 4.8 8.6 5.3 5.6 2.4 5.7 5.4 4.5 1.4 0.9 1.7 4.2 6.9 1.2 13.8 11.9 8.1 11.7 11.2 9.1 11.4 3.5 8.5 6.8 0.0 0.0 1.7 0.9 7.4 0.4 0.8 0.0 0.0 1.2 5.2 0.0 0.8 1.7 0.4 0.1 0.5 0.8 0.0 1.0 0.8 1.0 0.5 0.0 0.9 0.9 0.0 0.0 0.6 0.3 0.0 1.1 1.0 1.7 0.0 1.1 0.5 0.5 0.0 1.1 2.4 0.4 0.0 3.3 0.9 4.8 8.0 0.9 0.0 1.1 1.0 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Cell line enriched" "Detected in some" 4 "MCF7: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA059449: AB_2684023, HPA062780: AB_2732688" "prognostic favorable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favorable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favorable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 0.1 1.0 0.0 3.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 27.8 0.0 1.1 0.2 1.2 0.1 0.0 5.4 0.2 1.8 2.4 0.5 0.1 2.3 0.0 0.0 0.0 6.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 0.0 1.0 0.0 3.2 0.0 0.2 11.9 0.0 1.4 4.5 5.2 0.0 0.0 0.0 1.9 5.5 0.0 0.0 0.0 3.8 0.0 0.3 1.8 0.0 0.0 0.1 0.0 5.8 0.0 0.0 4.8 0.9 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.0 0.4 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 DOPEY2 "C21orf5, KIAA0933" ENSG00000142197 "Dopey family member 2" Q9Y3R5 21 36156782-36294274 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 43.1" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072065 Enhanced Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA072065: AB_2686486" "prognostic unfavorable (7.08e-4)" "unprognostic (7.68e-2)" "unprognostic (2.50e-2)" "unprognostic (1.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.38e-1)" "unprognostic (1.36e-1)" "unprognostic (3.13e-2)" "unprognostic (4.35e-2)" "unprognostic (3.01e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" 4.6 2.3 5.5 7.5 9.5 17.1 4.9 28.7 11.6 5.1 11.8 3.8 6.8 9.7 2.8 3.3 13.5 3.6 6.5 4.3 4.6 4.0 3.5 7.2 7.2 5.8 3.1 5.8 2.3 3.8 43.1 3.1 4.7 9.5 9.8 12.0 2.8 15.2 9.1 11.1 7.4 13.9 3.8 3.7 5.2 15.8 3.3 3.3 9.3 3.6 7.5 10.6 5.4 6.5 12.0 6.4 6.3 3.2 1.1 3.1 1.3 14.9 3.2 2.4 4.0 2.7 5.2 23.2 7.1 8.5 10.1 6.3 2.2 1.2 2.8 1.1 5.3 7.7 3.1 4.6 1.6 8.2 5.1 4.2 6.4 0.7 0.8 2.4 6.2 3.3 1.8 3.3 6.6 1.7 6.1 4.2 6.7 2.0 4.6 2.9 16.8 4.9 6.4 2.0 17.7 3.3 8.9 1.4 13.6 5.4 6.0 6.5 3.7 4.7 21.5 6.1 3.4 7.8 7.7 7.2 3.9 1.1 5.1 5.7 3.4 8.4 1.3 5.6 13.5 2.2 1.0 3.2 6.3 3.1 3.1 1.7 8.6 2.0 1.8 2.1 12.0 1.3 1.1 5.5 1.1 2.6 6.4 1.5 1.3 5.5 9.5 28.7 11.6 4.6 4.0 3.1 5.8 9.5 3.3 0.0 5.8 31.4 6.9 2.7 5.3 4.0 10.2 6.7 3.4 8.7 3.9 1.5 3.3 8.1 0.7 3.3 17.3 0.0 2.8 9.8 2.8 21.2 8.1 8.5 15.7 0.0 28.2 6.2 15.4 0.0 2.3 12.0 5.0 7.2 56.5 1.5 7.5 24.6 2.8 1.3 3.0 0.0 2.5 4.4 13.0 4.5 6.8 7.5 19.5 10.1 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.0" "Group enriched" "Detected in many" 6 "Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "U-266/84: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 5.7 4.3 2.6 1.6 5.2 2.1 2.4 5.2 4.5 5.6 2.6 1.4 3.1 0.7 7.8 3.4 1.3 3.7 2.4 12.9 1.8 2.4 6.0 0.3 1.1 0.8 1.7 3.1 7.3 2.3 7.4 10.9 1.2 3.0 5.7 1.2 5.1 2.3 6.3 0.5 1.4 0.9 4.3 0.7 1.1 1.5 44.0 0.9 0.5 8.4 1.4 0.7 2.7 3.1 0.1 0.0 0.1 0.0 0.1 3.4 0.4 1.2 3.1 2.8 6.6 0.7 0.0 0.3 2.1 2.2 2.9 3.8 0.4 1.0 3.4 2.2 0.9 3.6 0.5 3.3 0.3 4.4 1.7 2.0 5.4 1.4 2.0 0.6 3.9 1.7 1.5 0.1 1.4 0.0 7.4 0.8 2.6 2.2 3.4 4.7 2.1 0.2 1.6 2.5 0.5 2.5 0.1 2.3 0.0 5.6 0.5 8.5 0.9 0.8 0.3 1.2 1.2 2.4 1.1 0.6 4.0 5.2 0.6 5.4 9.1 10.4 0.0 4.3 1.9 3.6 0.1 0.0 0.0 0.6 0.0 3.4 0.0 0.1 0.6 0.0 0.1 1.0 2.7 0.0 0.1 0.0 0.0 0.0 0.4 2.6 5.2 5.2 4.5 1.8 2.4 1.7 3.1 3.0 0.9 3.0 0.0 0.0 2.9 0.5 41.9 24.2 2.5 16.0 6.8 12.2 13.7 1.1 5.0 0.4 300.2 2.3 0.0 0.0 0.0 1.1 1.0 3.0 2.3 0.0 0.3 3.2 0.0 0.0 0.0 304.6 6.6 0.0 6.8 0.0 0.0 11.1 0.2 0.0 8.1 5.6 6.2 25.8 15.6 171.9 4.1 0.4 1.1 0.0 0.0 0.9 DPYSL4 "DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186900-132205776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;heart muscle: 19.0" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 33.5;Cone photoreceptor cells: 55.0;Horizontal cells: 31.8" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 23.7;AN3-CA: 31.1;SH-SY5Y: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA049066: AB_2680619" "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.11e-4)" 1.5 4.4 11.8 2.0 12.3 1.1 1.5 8.9 32.0 1.7 1.4 6.5 0.2 1.1 6.4 2.2 1.4 1.4 2.1 19.0 13.6 9.6 1.0 1.0 1.5 1.4 9.0 9.1 3.0 1.9 1.0 5.0 1.3 6.0 4.8 1.0 4.6 1.5 4.2 2.5 1.6 1.2 2.7 8.1 2.5 1.8 6.7 4.8 0.0 1.0 0.0 1.3 1.4 0.4 0.7 0.0 0.0 0.6 1.1 2.5 0.8 0.0 6.7 23.7 31.1 0.0 0.2 0.0 2.0 0.2 1.3 0.3 0.0 0.2 0.0 0.8 1.0 2.3 0.0 4.6 4.5 0.1 0.0 0.9 0.0 0.0 2.4 4.2 0.0 4.7 2.1 2.2 0.7 0.1 0.4 2.4 0.0 0.0 0.2 3.4 1.9 0.0 0.0 4.1 0.3 2.3 0.0 0.0 3.7 0.0 0.4 3.7 32.3 0.7 0.0 4.1 1.4 0.1 0.0 3.9 5.9 9.9 0.0 5.6 0.0 1.6 0.0 9.9 0.0 0.6 0.0 0.1 0.0 1.4 0.6 0.0 0.0 1.1 0.1 0.0 0.7 2.5 0.7 0.0 1.1 0.5 0.0 0.0 0.8 11.8 12.3 8.9 18.7 13.6 9.6 9.0 9.1 6.0 4.8 0.0 0.0 0.0 0.2 0.5 33.5 14.2 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.2 4.3 0.9 0.0 0.0 0.0 0.1 2.4 0.4 0.0 0.0 0.2 31.8 1.7 0.0 0.0 7.1 3.7 0.0 1.7 0.0 0.0 7.5 0.8 0.0 4.2 0.0 12.3 0.0 4.7 4.4 2.7 0.1 0.0 0.0 0.0 0.0 EARS2 "KIAA1970, MSE1" ENSG00000103356 "Glutamyl-tRNA synthetase 2, mitochondrial" Q5JPH6 16 23522014-23557731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043289, HPA043633" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043289: AB_10963932, HPA043633: AB_10959901" "unprognostic (3.10e-2)" "unprognostic (1.60e-1)" "unprognostic (3.65e-3)" "unprognostic (4.20e-1)" "unprognostic (3.57e-1)" "unprognostic (4.64e-2)" "unprognostic (2.73e-1)" "unprognostic (2.91e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (8.09e-2)" "prognostic favorable (3.16e-6)" "unprognostic (2.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (4.29e-2)" 8.4 19.0 11.0 8.5 19.0 2.7 13.6 13.4 16.8 11.1 10.0 10.8 12.7 6.4 11.4 10.2 10.5 13.1 7.8 14.9 10.9 11.9 14.5 18.3 7.3 8.1 9.9 14.0 12.0 18.9 32.7 10.9 12.4 10.3 11.3 11.0 8.8 16.4 11.7 17.3 11.1 6.9 8.3 9.3 7.6 9.2 12.6 10.4 6.3 14.5 9.0 11.0 8.6 16.9 3.0 6.2 0.5 5.5 10.6 7.9 3.3 8.2 16.8 7.9 12.7 5.5 7.9 9.6 9.2 7.0 11.4 9.5 12.2 8.4 11.5 9.5 8.5 7.1 9.3 29.7 16.9 10.9 4.6 14.4 6.7 10.3 20.6 8.9 7.4 8.4 8.5 10.1 10.2 14.4 8.6 5.1 11.6 20.7 6.1 8.1 17.5 7.3 5.3 20.8 11.8 5.9 13.2 9.1 22.1 14.4 7.2 14.1 10.4 7.2 13.6 7.3 13.3 18.4 8.3 4.0 9.0 8.0 9.9 11.6 11.2 10.6 9.3 9.1 10.3 13.3 0.0 2.8 0.3 4.2 3.6 7.9 3.0 4.7 4.3 6.2 3.0 4.6 4.5 0.5 10.6 5.5 4.5 3.4 3.3 11.0 19.0 13.4 16.8 10.9 11.9 9.9 14.0 10.3 10.4 8.9 5.1 3.0 3.5 1.9 3.8 9.8 2.5 6.7 2.3 3.5 2.0 12.9 5.0 6.5 2.1 3.5 1.3 23.3 3.1 9.9 3.3 3.5 5.7 10.5 6.3 7.9 5.2 4.3 1.8 1.9 2.3 3.1 5.0 6.4 5.5 2.8 4.1 0.0 1.8 6.8 3.7 0.0 1.9 4.3 10.4 2.6 9.5 2.5 5.5 2.7 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115689-4135597 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.3" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 363.1;Proximal tubular cells: 504.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria NA NA "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favorable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 17.9 29.2 13.2 7.3 17.4 4.5 17.0 8.9 9.5 15.7 18.0 10.7 14.9 16.2 15.2 26.2 10.6 12.7 12.4 32.1 10.3 11.1 56.8 102.3 7.4 8.9 13.3 7.2 19.0 59.2 8.9 17.2 11.1 10.3 14.6 14.0 13.3 9.0 10.5 45.7 5.6 22.7 10.3 11.9 10.1 23.2 11.9 9.3 13.3 17.7 26.6 7.5 12.6 8.9 20.6 25.1 7.0 16.2 25.5 27.7 16.7 17.8 9.7 16.3 35.3 20.5 30.5 2.0 25.3 25.9 27.6 24.7 7.3 2.7 0.7 31.9 27.5 25.1 9.4 18.4 14.7 40.2 6.7 21.1 9.4 13.7 39.3 11.9 8.5 4.7 20.9 9.0 23.5 13.2 37.6 57.5 30.4 30.8 6.9 26.1 7.1 24.0 21.2 11.0 1.7 34.8 23.3 20.2 0.3 14.9 3.6 0.3 7.6 1.5 10.6 22.3 30.8 24.5 4.0 58.0 20.8 11.4 18.4 15.0 10.5 18.8 1.8 10.7 7.5 16.1 6.9 15.5 7.0 18.9 11.5 25.9 19.9 22.3 26.4 25.1 20.6 27.7 27.1 0.4 25.5 16.2 19.2 23.6 16.7 13.2 17.4 8.9 9.5 10.3 11.1 13.3 7.2 10.3 9.3 26.8 25.1 23.1 44.0 16.3 13.3 158.2 86.6 121.8 59.1 34.9 11.8 242.5 363.1 46.4 49.2 44.3 33.7 46.7 154.5 15.1 57.4 23.5 22.0 167.8 55.4 17.5 50.1 41.7 22.4 39.8 58.7 24.7 33.7 36.1 38.2 54.7 71.1 41.2 47.7 504.9 43.8 25.8 23.7 25.7 33.2 11.2 85.2 49.0 60.0 20.4 EFNA2 "ELF-1, EPLG6, LERK6" ENSG00000099617 "Ephrin A2" O43921 19 1286154-1300237 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.0;intestine: 30.3;liver: 14.2" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 1.3;Cardiomyocytes: 4.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;BEWO: 5.1;Hep G2: 9.5;NTERA-2: 5.5;REH: 7.3;SH-SY5Y: 17.2;U-2 OS: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067567 Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA067567: AB_2732771" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (2.87e-3)" "unprognostic (1.96e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-1)" "unprognostic (7.19e-2)" "unprognostic (2.34e-3)" "unprognostic (3.58e-2)" "unprognostic (6.82e-2)" "unprognostic (8.48e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-4)" "unprognostic (1.94e-1)" 0.2 0.1 1.5 3.4 2.2 0.2 0.1 1.5 2.0 0.1 10.7 2.0 0.0 12.0 0.2 0.1 0.4 0.1 10.0 0.1 1.0 1.6 0.3 14.2 0.1 0.1 1.2 0.5 0.1 0.1 0.1 0.3 0.2 1.1 0.1 2.3 1.9 0.1 0.2 0.2 0.1 30.3 0.2 0.9 0.2 0.6 0.6 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 1.7 0.0 0.0 5.1 0.2 0.0 0.0 0.0 3.6 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.0 0.0 0.1 2.2 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 5.5 2.4 0.0 7.3 0.6 0.1 0.0 0.1 0.0 17.2 0.2 0.0 0.1 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.2 1.5 2.0 1.0 1.6 1.2 0.5 1.1 0.7 0.0 0.0 0.0 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 EIF2A EIF-2A ENSG00000144895 "Eukaryotic translation initiation factor 2A" Q9BY44 3 150546678-150584242 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036256 Approved Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA036256: AB_10611961" "unprognostic (1.72e-1)" "unprognostic (2.09e-2)" "unprognostic (2.71e-3)" "unprognostic (3.36e-2)" "unprognostic (3.96e-3)" "unprognostic (7.05e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.11e-1)" "unprognostic (7.92e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (6.30e-2)" "unprognostic (3.08e-2)" "unprognostic (3.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (3.39e-1)" 33.5 23.7 12.6 21.4 22.8 27.2 34.3 38.3 23.8 35.1 29.4 12.6 17.3 23.1 31.5 19.9 37.2 20.6 19.0 24.9 11.3 11.9 27.0 44.5 24.7 32.8 16.5 11.7 35.6 39.4 22.6 36.4 26.2 22.7 32.9 23.8 15.4 29.8 23.9 53.3 26.8 33.1 25.0 16.9 28.9 26.5 16.3 17.9 38.5 41.8 33.8 25.8 44.0 26.1 17.0 27.7 7.9 24.6 20.5 26.9 19.0 38.5 14.0 19.7 20.7 25.3 50.4 27.2 23.8 33.0 30.5 33.0 38.8 42.6 50.9 36.5 28.3 39.0 31.3 32.6 33.0 43.5 19.2 21.9 29.8 16.9 30.0 24.3 37.2 28.5 33.6 37.6 22.4 50.1 44.5 37.8 26.3 24.5 30.3 24.6 27.1 27.0 19.7 27.9 38.8 22.2 23.8 25.8 59.0 31.9 24.0 25.0 26.8 14.3 22.9 37.2 23.2 33.6 34.6 22.1 19.3 18.4 27.3 45.7 52.6 27.6 46.8 24.5 32.6 9.6 7.9 22.6 4.7 14.9 23.5 23.3 17.0 21.2 18.2 27.7 14.9 26.9 21.0 1.8 20.5 24.6 13.1 17.3 19.0 12.6 22.8 38.3 23.8 11.3 11.9 16.5 11.7 22.7 17.9 32.8 55.5 71.7 137.7 124.4 27.0 97.7 48.4 41.5 48.9 33.2 25.5 72.1 116.0 60.9 13.8 61.2 56.4 0.0 94.1 85.0 60.9 65.4 74.9 27.6 57.0 22.3 54.5 46.1 95.5 5.0 57.0 72.0 65.8 64.9 76.1 26.1 62.8 40.3 53.0 90.1 30.8 77.6 69.4 29.9 39.0 107.4 100.6 76.1 82.2 109.1 EIF4E2 "4EHP, EIF4EL3, IF4e" ENSG00000135930 "Eukaryotic translation initiation factor 4E family member 2" O60573 2 232550052-232583644 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019253, HPA077074" Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019253: AB_1848092, HPA077074: " "unprognostic (3.44e-2)" "unprognostic (2.70e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-2)" "unprognostic (1.63e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.42e-1)" "unprognostic (5.62e-3)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" "unprognostic (1.21e-2)" "unprognostic (1.36e-2)" "unprognostic (7.74e-2)" "unprognostic (3.34e-3)" "unprognostic (1.88e-1)" "unprognostic (9.38e-2)" 19.0 22.9 27.9 24.0 24.4 25.4 19.4 27.1 38.1 17.6 30.7 18.4 17.0 24.4 26.2 18.2 32.1 18.5 20.0 21.3 25.8 14.8 29.8 43.2 20.4 21.0 18.6 27.2 22.0 26.2 16.3 25.0 26.8 26.3 19.9 35.7 16.1 27.3 15.9 77.6 23.8 25.2 25.3 27.0 25.4 26.7 25.2 21.5 18.1 19.1 24.8 27.1 20.0 21.2 13.5 38.9 49.6 46.8 14.1 24.1 29.7 27.9 23.2 28.4 21.0 20.9 28.6 43.9 37.7 20.4 26.0 26.6 25.6 26.5 27.4 10.7 36.7 30.7 23.9 32.0 32.8 32.7 24.5 26.4 37.5 25.1 33.9 25.4 52.4 35.5 24.5 24.6 27.3 19.7 26.5 42.2 13.4 35.2 9.3 29.3 45.1 21.3 44.5 45.3 31.0 19.4 18.4 63.2 17.9 52.1 33.4 27.7 37.9 20.1 23.3 24.0 32.0 22.2 36.8 38.5 24.4 32.1 25.4 27.8 17.5 16.6 36.1 27.3 28.9 21.1 49.6 45.1 40.7 14.8 46.8 11.8 13.5 15.1 15.4 38.9 12.2 12.9 13.1 29.5 14.1 41.7 15.2 24.1 29.7 27.9 24.4 27.1 38.1 25.8 14.8 18.6 27.2 26.3 21.5 38.7 52.3 42.4 59.6 33.8 19.5 33.6 71.4 34.8 31.8 33.2 17.7 120.6 63.0 146.2 103.8 31.0 104.8 0.0 131.7 170.6 55.5 66.8 42.7 102.9 110.3 19.1 63.4 46.1 84.3 214.1 35.4 81.8 28.7 140.7 94.2 22.7 139.4 87.7 36.4 98.2 18.3 25.8 36.6 47.9 59.9 44.7 152.5 45.7 76.5 86.7 EIF4EBP2 ENSG00000148730 "Eukaryotic translation initiation factor 4E binding protein 2" Q13542 10 70404379-70428618 "Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019415, HPA037410, HPA061665" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB019415: AB_10699019, HPA037410: AB_2675461, HPA061665: AB_2684580" "unprognostic (9.57e-2)" "unprognostic (3.22e-2)" "unprognostic (2.27e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-1)" "unprognostic (3.51e-1)" "unprognostic (3.84e-1)" "unprognostic (7.24e-2)" "unprognostic (8.24e-2)" "unprognostic (8.19e-2)" "unprognostic (2.87e-1)" "unprognostic (1.46e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.53e-1)" "unprognostic (4.61e-2)" 57.3 27.2 22.1 28.2 21.8 20.2 77.1 22.7 23.0 28.7 47.9 16.7 25.9 30.8 24.8 18.3 28.3 22.7 37.9 52.4 18.0 15.8 44.4 40.1 31.8 21.6 19.0 14.7 33.4 28.4 23.2 13.3 36.2 18.6 33.2 31.6 34.8 25.5 50.2 54.5 27.6 51.2 32.4 17.8 30.5 28.7 17.9 16.2 34.8 23.5 29.2 22.1 39.8 64.3 7.0 14.0 20.6 17.5 9.3 14.2 14.2 17.1 5.6 30.7 29.9 59.4 22.6 16.6 10.5 13.1 7.9 8.5 24.5 15.4 17.9 6.4 15.5 4.9 11.1 14.9 9.7 8.9 19.0 7.7 12.9 6.8 9.6 13.9 22.9 9.1 25.1 10.1 9.6 8.7 16.0 11.9 14.8 21.0 16.4 12.1 9.8 19.5 23.6 25.8 17.1 10.2 20.1 12.3 11.5 10.0 17.9 16.6 25.1 14.5 33.5 13.9 21.9 15.2 20.5 12.9 5.1 6.4 8.3 9.3 11.0 21.5 21.1 5.9 34.3 5.2 13.8 15.5 20.6 14.2 13.8 11.6 7.0 11.5 11.7 14.0 6.1 9.8 10.1 17.0 9.3 17.5 4.7 12.5 14.2 22.1 21.8 22.7 23.0 18.0 15.8 19.0 14.7 18.6 16.2 23.8 32.8 41.3 43.1 47.1 42.0 128.1 66.2 17.4 25.0 34.9 19.6 37.6 36.5 37.0 19.7 34.3 154.3 23.3 51.0 104.3 50.6 50.3 11.5 142.1 41.5 22.3 25.4 65.7 88.3 40.0 60.9 37.0 20.3 45.9 79.3 63.3 50.7 84.0 57.7 108.0 15.4 77.6 30.7 32.9 41.7 61.2 47.9 42.4 61.8 85.2 ELK3 "ERP, NET, SAP2" ENSG00000111145 "ELK3, ETS transcription factor" P41970 12 96194382-96269835 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 91.0;Endothelial cells: 133.8;Ito cells: 151.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001600 Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA001600: AB_1078752" "unprognostic (3.11e-1)" "unprognostic (8.81e-3)" "unprognostic (6.38e-2)" "unprognostic (5.77e-2)" "unprognostic (7.18e-3)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-3)" "unprognostic (7.39e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (1.20e-3)" "unprognostic (2.90e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-1)" "unprognostic (2.05e-2)" 36.9 9.3 5.0 20.9 6.7 8.3 23.5 12.9 4.5 29.2 12.6 7.3 12.0 4.6 45.2 15.6 25.7 15.0 16.3 15.5 4.8 5.1 13.3 8.2 17.1 20.6 6.1 2.8 13.3 5.8 6.6 6.0 15.9 8.9 18.1 7.5 15.7 14.1 8.6 10.5 8.7 11.1 20.8 13.1 32.7 9.1 8.6 6.3 17.4 19.7 25.1 32.1 15.9 20.9 11.3 9.4 4.1 12.8 10.5 24.1 6.3 12.9 7.8 8.0 4.2 20.4 38.4 2.0 16.5 31.7 13.2 10.2 0.4 9.7 2.1 5.7 18.5 9.9 4.6 0.9 26.5 23.3 5.6 3.0 0.6 3.3 2.9 6.2 6.3 1.5 22.5 5.0 27.2 20.6 26.9 31.5 1.6 1.5 8.7 44.5 2.0 1.2 4.2 9.8 1.8 10.4 10.3 13.5 2.3 11.3 3.4 0.4 8.5 5.4 2.4 8.2 12.7 1.3 3.4 19.3 36.3 14.2 22.3 14.3 16.7 13.9 0.5 12.8 7.4 25.1 3.3 12.8 0.3 6.2 6.9 24.1 11.3 14.7 8.4 9.4 9.9 8.9 6.5 4.1 10.5 5.9 3.8 23.4 6.3 5.0 6.7 12.9 4.5 4.8 5.1 6.1 2.8 8.9 6.3 6.0 30.6 17.6 31.5 29.0 0.5 4.8 5.1 91.0 54.6 5.2 3.9 0.9 5.0 18.1 0.6 133.8 0.7 0.0 13.5 3.1 34.2 29.1 16.2 3.6 20.8 0.0 1.2 151.0 36.0 1.3 10.6 22.2 11.8 3.6 3.0 4.7 36.9 2.9 9.9 0.0 0.4 12.9 24.3 0.0 14.7 23.6 0.9 15.9 2.9 67.8 ELMOD3 "DFNB88, FLJ21977, RBED1, RBM29" ENSG00000115459 "ELMO domain containing 3" Q96FG2 2 85354394-85391752 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012126 Approved Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA012126: AB_1848130" "unprognostic (1.90e-1)" "unprognostic (9.80e-3)" "unprognostic (1.42e-3)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (1.60e-2)" "unprognostic (1.35e-2)" "unprognostic (1.52e-2)" "unprognostic (4.62e-2)" "unprognostic (5.63e-2)" "prognostic favorable (6.16e-6)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.09e-6)" "unprognostic (5.71e-2)" "unprognostic (1.53e-1)" "unprognostic (9.51e-2)" "prognostic favorable (2.85e-5)" 18.5 14.5 11.0 10.5 17.4 4.9 15.0 15.4 14.7 13.4 12.0 18.4 18.6 9.5 12.7 11.6 8.7 13.8 11.5 9.2 13.2 8.6 10.7 14.4 8.4 9.0 20.2 8.8 12.0 11.4 14.4 15.6 11.7 14.2 13.7 9.7 13.0 11.6 14.5 18.8 9.7 10.6 13.4 11.1 11.1 12.1 12.3 17.4 7.6 13.0 6.8 10.2 11.9 10.7 4.5 4.5 10.8 6.6 6.1 7.6 3.9 4.0 5.2 6.0 8.8 18.7 8.4 3.5 7.5 5.8 11.2 10.3 4.3 2.1 3.1 5.8 6.0 13.7 4.3 8.3 10.3 10.2 11.0 5.8 5.4 2.9 3.0 9.8 4.1 7.2 8.6 9.1 10.6 12.2 9.4 7.9 6.4 5.5 3.7 10.3 3.1 6.0 2.4 2.8 8.4 5.5 4.3 12.2 2.9 5.1 2.5 5.6 2.9 4.6 6.4 6.9 7.1 3.5 3.1 4.4 8.0 4.3 6.9 6.8 4.6 8.2 4.2 8.0 4.8 8.1 9.1 3.9 10.8 7.6 2.6 4.0 4.5 4.9 3.0 4.5 4.1 4.2 7.3 3.5 6.1 6.6 1.2 7.3 3.9 11.0 17.4 15.4 14.7 13.2 8.6 20.2 8.8 14.2 17.4 6.0 5.9 13.7 8.8 4.1 26.2 4.8 12.7 6.7 13.6 10.4 27.5 11.6 6.6 7.1 3.8 7.2 17.8 0.0 7.9 4.9 8.7 10.2 9.2 7.3 7.6 28.6 8.1 9.2 9.2 3.6 17.8 11.0 16.9 12.6 8.9 19.7 7.8 14.0 22.3 4.8 29.2 19.4 6.6 13.0 10.1 5.6 10.4 13.8 11.9 7.1 EML6 FLJ42562 ENSG00000214595 "Echinoderm microtubule associated protein like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2;lymphoid tissue: 11.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 25.5;Cone photoreceptor cells: 53.0;Horizontal cells: 36.5;Rod photoreceptor cells: 32.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Cell line enhanced" "Detected in some" "Daudi: 7.3;SCLC-21H: 20.5;U-698: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA062808: AB_2684872, HPA068759: AB_2686027" "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.1 3.3 1.8 4.0 2.8 0.0 0.2 7.2 4.2 0.0 0.6 0.6 0.0 1.3 0.3 0.4 0.1 0.0 1.9 2.1 1.3 0.2 0.1 7.9 1.5 0.0 0.5 3.0 3.4 1.4 0.4 0.8 0.1 0.4 0.6 0.8 1.8 0.3 0.5 2.7 0.4 1.5 3.1 11.9 0.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 1.1 0.7 0.2 1.5 0.1 0.2 0.2 0.2 0.6 0.2 7.3 0.1 0.4 0.3 0.2 1.0 0.3 0.3 0.7 0.3 0.4 0.6 2.8 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.1 4.0 0.0 1.2 0.0 0.7 1.4 0.2 0.3 0.1 1.2 0.6 0.5 0.6 0.0 0.7 20.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.6 0.4 0.4 5.0 1.3 23.3 1.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.2 1.6 3.3 25.5 1.4 0.0 5.3 5.7 3.5 53.0 0.4 0.0 0.1 12.7 1.7 0.4 0.0 0.4 0.4 0.7 1.5 0.0 0.8 1.0 36.5 2.4 1.8 1.3 9.6 0.6 1.0 0.0 0.0 1.7 19.3 0.1 0.0 0.7 0.5 32.8 0.0 2.1 3.9 1.9 3.9 0.1 0.0 0.2 2.3 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase family member 4" A6NNW6 10 116849512-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1;epididymis: 12.6;fallopian tube: 13.6" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: AB_2675746" "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.7 2.1 4.3 0.6 4.3 0.2 2.2 2.6 3.6 1.7 1.0 8.0 0.9 0.3 4.3 12.6 1.4 13.6 1.3 0.5 6.4 4.7 2.3 2.7 3.9 1.2 4.1 4.8 4.2 3.2 3.7 3.4 0.5 12.1 2.1 0.8 3.0 1.6 1.2 0.2 1.1 0.5 0.9 4.4 0.5 0.8 8.8 1.9 0.2 4.2 0.0 0.6 1.8 0.5 1.8 1.0 0.0 0.6 0.0 1.2 0.1 1.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.1 0.0 0.9 2.1 0.2 2.7 0.0 0.7 0.8 0.0 1.5 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.9 0.1 1.1 0.1 0.0 0.7 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 1.2 0.6 0.9 0.0 2.2 0.1 0.0 1.8 5.2 0.0 0.5 0.0 0.8 0.4 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 1.6 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.2 1.0 1.2 0.1 4.3 4.3 2.6 3.6 6.4 4.7 4.1 4.8 12.1 1.9 0.0 0.0 0.0 0.2 0.1 4.4 0.2 0.0 36.1 0.0 0.0 21.6 0.2 0.0 0.3 11.9 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 4.8 1.7 0.0 0.0 8.8 1.1 0.1 0.0 1.0 0.0 1.3 0.2 0.0 0.7 0.6 9.0 0.0 0.2 7.6 2.7 0.0 0.1 0.0 0.1 0.0 ENY2 "DC6, FLJ20480, Sus1" ENSG00000120533 "ENY2, transcription and export complex 2 subunit" Q9NPA8 8 109334324-109345953 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024648 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA024648: AB_2100208" "unprognostic (2.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.18e-1)" "unprognostic (7.85e-2)" "unprognostic (7.70e-2)" "unprognostic (7.45e-3)" "unprognostic (1.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "prognostic unfavorable (7.17e-6)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (2.66e-1)" 31.9 35.0 28.7 28.1 34.3 44.4 34.8 20.6 31.4 28.2 34.5 18.7 28.3 31.8 24.6 33.8 30.1 22.9 19.1 34.0 31.8 26.2 44.1 58.8 24.7 26.6 27.6 28.3 19.6 27.8 16.5 35.8 30.6 29.1 24.0 33.7 19.9 27.2 25.9 66.7 20.3 31.6 28.4 31.9 30.6 29.0 21.3 24.3 26.1 24.3 29.5 30.3 29.6 23.3 14.0 32.1 30.3 38.9 13.0 14.6 22.6 42.3 35.5 52.8 23.7 20.1 25.8 15.2 33.9 21.9 34.8 44.0 26.2 26.4 27.6 31.9 26.3 15.8 21.7 23.6 24.0 42.5 43.7 27.9 53.0 26.7 53.9 21.5 18.2 33.0 19.5 16.4 22.9 21.7 25.5 52.3 27.3 50.4 15.6 39.5 69.1 55.0 41.4 38.3 49.6 34.6 35.1 23.0 34.2 47.0 32.6 31.9 34.4 21.2 26.7 28.9 30.4 33.9 31.6 35.5 23.4 39.5 24.2 34.3 26.7 28.5 52.2 23.6 30.8 27.2 16.3 35.6 30.3 10.7 37.1 13.2 14.0 14.6 13.0 32.1 9.6 12.1 13.3 19.4 13.0 38.9 26.5 14.2 22.6 28.7 34.3 20.6 31.4 31.8 26.2 27.6 28.3 29.1 24.3 65.5 81.6 148.3 163.4 164.9 66.1 154.2 137.6 89.7 112.6 137.9 115.8 224.8 323.3 190.8 103.7 229.2 183.6 46.7 173.6 235.2 173.8 163.6 89.0 317.8 241.4 42.9 147.9 137.5 200.9 78.7 137.2 217.4 150.1 225.4 166.7 92.6 220.3 192.9 105.7 416.4 119.0 77.6 185.8 187.5 108.4 152.6 139.9 126.9 175.3 175.2 ERAL1 HERA-B ENSG00000132591 "Era like 12S mitochondrial rRNA chaperone 1" O75616 17 28854938-28861067 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "monocytes: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021425, HPA024423" Supported Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA021425: AB_1848228, HPA024423: AB_1848229" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (5.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.55e-1)" "unprognostic (8.37e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (8.20e-2)" "unprognostic (7.04e-2)" "unprognostic (2.70e-1)" "unprognostic (8.57e-3)" "unprognostic (5.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.49e-1)" "unprognostic (2.62e-1)" "unprognostic (5.79e-2)" 16.2 24.8 24.1 13.3 31.6 12.7 19.4 25.1 47.9 18.4 20.9 27.1 15.8 18.0 21.5 19.2 20.6 22.2 17.2 24.5 23.0 22.0 24.9 33.7 14.8 16.0 21.3 20.2 22.0 18.1 29.3 15.4 24.7 27.6 18.0 23.4 17.3 28.2 21.2 34.1 18.3 19.7 21.8 18.4 17.0 18.2 17.3 15.5 20.4 20.3 21.5 23.8 16.1 14.8 20.1 29.0 11.1 23.1 20.8 18.2 14.9 16.2 31.5 18.4 20.9 20.4 14.0 18.0 12.9 18.6 39.4 32.4 30.7 10.5 20.8 15.8 22.3 29.8 18.0 33.7 29.5 32.9 20.6 39.5 16.8 21.0 31.0 26.1 19.9 15.3 18.2 26.4 31.9 30.3 15.5 32.1 26.5 33.3 13.2 21.9 25.4 20.7 30.7 17.0 29.8 15.1 19.1 29.3 26.9 23.8 18.5 19.6 15.8 21.2 52.1 16.7 28.6 36.7 23.4 12.9 16.1 18.1 17.7 27.3 10.6 19.3 22.3 17.5 17.4 16.3 11.1 17.9 7.1 17.8 23.1 13.4 20.1 15.2 13.0 29.0 18.6 17.6 18.2 1.4 20.8 15.6 15.0 16.3 14.9 24.1 31.6 25.1 47.9 23.0 22.0 21.3 20.2 27.6 15.5 6.0 3.2 11.5 12.7 7.1 9.6 6.0 22.9 5.3 3.4 10.4 5.9 59.5 31.5 26.1 1.1 10.9 16.0 23.3 18.8 44.1 11.4 11.1 4.7 20.3 31.0 11.1 20.7 9.8 8.2 3.6 13.3 8.0 10.1 110.0 12.7 14.5 17.0 10.5 14.9 25.0 6.5 19.4 9.5 18.9 22.2 10.2 43.3 10.9 25.2 8.4 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" NA NA Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favorable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 7.7 14.3 5.0 19.0 2.3 10.6 20.4 20.1 15.8 8.8 21.7 10.2 7.2 14.4 13.6 10.7 14.5 8.6 8.9 13.8 12.0 11.5 6.0 9.0 4.0 13.7 13.3 12.4 24.9 21.9 13.2 8.0 13.9 11.4 10.0 9.6 17.0 12.1 10.3 7.0 6.8 11.0 20.7 5.8 8.7 20.0 12.6 5.0 12.4 5.2 5.9 10.5 7.9 4.1 7.4 10.9 3.4 3.6 6.0 3.1 19.1 9.0 7.0 10.3 4.3 5.2 8.9 9.6 8.1 9.0 11.9 7.6 13.6 0.0 7.1 10.0 5.5 10.9 7.7 9.7 10.2 4.8 9.2 5.6 3.4 4.5 16.9 4.1 5.4 10.5 16.1 9.1 6.0 5.5 12.6 4.9 3.5 7.4 8.5 9.7 2.3 6.3 7.6 10.3 9.1 0.0 6.7 6.7 13.2 7.1 13.7 12.2 7.2 15.0 7.0 7.9 20.1 3.6 10.0 8.4 6.0 6.7 4.9 5.7 7.6 0.0 0.0 4.5 6.2 10.9 3.4 2.9 3.3 1.9 6.0 4.1 3.5 3.3 7.4 2.4 4.2 6.0 0.4 3.6 1.7 5.8 2.4 3.1 14.3 19.0 20.4 20.1 13.8 12.0 13.7 13.3 13.9 12.6 11.9 7.5 3.2 4.2 2.9 9.4 10.3 5.1 9.4 9.1 0.0 7.9 7.1 5.0 10.0 2.4 4.4 3.2 0.0 7.6 3.8 4.6 4.8 1.1 4.7 5.6 9.5 5.8 10.4 5.9 1.8 5.8 1.8 3.3 9.0 8.7 6.8 9.0 7.0 11.3 4.8 8.7 0.0 3.9 31.0 8.7 3.8 2.4 0.5 6.9 3.0 EXOC3 "SEC6L1, Sec6p" ENSG00000180104 "Exocyst complex component 3" O60645 5 443158-471937 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037880 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA037880: AB_2675716" "unprognostic (2.94e-1)" "unprognostic (4.74e-3)" "unprognostic (4.82e-3)" "unprognostic (4.10e-1)" "unprognostic (6.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.91e-3)" "unprognostic (1.91e-1)" "unprognostic (6.62e-2)" "unprognostic (3.26e-1)" "prognostic favorable (1.54e-4)" "unprognostic (6.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.82e-1)" "unprognostic (1.70e-1)" 18.7 15.6 22.0 20.7 22.4 19.1 16.5 20.1 28.6 18.1 22.4 22.5 22.3 18.3 22.2 14.9 26.3 19.0 20.9 20.8 22.5 17.3 15.9 14.1 15.6 18.8 23.3 29.5 21.6 23.5 20.8 18.0 17.9 22.7 17.6 13.3 14.5 23.9 20.2 47.5 24.9 17.1 26.7 16.2 18.2 20.8 40.7 21.0 13.3 19.8 20.7 17.4 20.8 17.6 3.6 3.5 31.0 6.2 9.8 6.4 4.4 12.7 21.5 7.3 16.2 12.5 10.8 18.1 11.3 11.8 11.5 13.9 10.8 18.9 10.9 17.7 14.2 14.1 14.6 5.8 9.8 8.4 40.0 10.1 11.7 45.1 8.1 11.7 17.5 29.6 11.0 7.3 12.8 11.3 12.1 12.8 7.2 8.9 7.1 8.9 15.1 12.5 20.8 6.0 7.8 12.9 10.3 8.3 13.9 9.7 16.1 7.3 9.3 28.3 16.1 11.0 7.4 21.7 20.2 9.5 11.4 14.1 8.7 9.1 12.1 8.7 7.7 12.0 21.2 10.3 5.4 5.7 31.0 6.4 6.2 5.4 3.3 5.0 5.1 3.5 3.6 6.4 5.9 7.9 9.8 4.4 2.6 6.4 4.4 22.0 22.4 20.1 28.6 22.5 17.3 23.3 29.5 22.7 21.0 20.8 26.1 14.5 14.7 38.0 13.8 26.6 12.7 33.5 20.5 14.0 33.4 20.2 23.2 23.4 22.8 15.3 23.8 0.0 25.9 19.0 15.8 14.7 23.0 15.7 20.9 60.4 5.2 13.5 24.4 44.8 18.7 21.7 25.3 21.6 18.6 16.9 24.4 20.1 15.9 20.3 19.2 19.4 22.3 30.9 16.2 47.0 28.5 19.1 20.7 20.4 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Proximal tubular cells: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favorable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 10.4 17.0 10.4 6.7 9.9 6.5 9.2 8.6 12.7 6.8 21.7 9.3 8.2 26.7 9.8 10.9 14.8 5.8 10.2 15.8 10.9 11.4 46.8 43.6 5.6 5.2 10.1 9.4 7.9 17.4 9.0 11.1 10.4 9.9 8.1 11.1 8.5 9.1 9.8 20.2 12.4 24.8 6.9 8.8 6.3 14.9 6.9 9.5 4.7 12.5 19.0 5.7 9.9 7.9 18.5 23.1 8.6 27.5 19.6 16.0 13.7 8.4 19.1 9.1 16.1 12.1 8.8 5.7 13.9 6.9 9.3 10.2 12.2 8.8 5.4 11.7 8.6 14.4 17.4 7.1 11.2 8.4 8.2 16.9 4.8 16.5 28.1 11.8 8.3 9.4 11.6 14.7 8.5 5.7 7.9 12.1 6.6 5.0 5.7 11.6 38.7 4.5 12.6 5.4 7.8 14.3 10.4 12.4 15.2 33.4 10.6 17.8 14.8 18.2 14.7 21.8 6.4 21.5 5.7 17.6 15.3 10.9 9.0 7.5 8.2 17.2 6.4 9.7 6.1 6.5 6.5 23.5 8.6 14.4 27.5 13.0 18.5 14.5 15.7 23.1 16.9 16.0 14.9 2.0 19.6 19.1 17.9 14.7 13.7 10.4 9.9 8.6 12.7 10.9 11.4 10.1 9.4 9.9 9.5 23.8 16.0 12.3 12.4 12.5 20.0 37.0 22.9 17.4 17.0 40.1 25.5 18.6 43.1 43.5 88.6 14.7 72.1 23.3 34.0 12.3 14.7 9.4 4.7 30.5 26.4 17.5 28.2 8.0 8.1 38.9 13.6 18.2 15.1 23.4 22.1 16.9 34.9 30.9 14.5 175.3 22.4 12.9 14.1 7.0 8.3 21.0 12.8 10.7 41.2 8.1 FAM110B "C8orf72, MGC39325" ENSG00000169122 "Family with sequence similarity 110 member B" Q8TC76 8 57994509-58204279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4" "Group enriched" "Detected in many" 11 "granulocytes: 13.1;monocytes: 6.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008318, HPA011781" Uncertain Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA008318: AB_1853892, HPA011781: AB_1853891" "unprognostic (2.07e-1)" "unprognostic (6.91e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.88e-8)" "unprognostic (4.09e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "unprognostic (8.72e-2)" "prognostic favorable (1.44e-4)" "unprognostic (1.06e-2)" "prognostic favorable (4.31e-8)" "unprognostic (2.23e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.15e-4)" 6.5 3.1 15.7 4.1 12.2 4.1 9.9 23.7 18.4 8.8 6.1 5.0 24.3 2.3 8.9 6.8 3.0 9.1 7.9 21.7 10.3 14.4 6.6 6.0 4.1 2.0 8.0 5.9 8.2 3.0 16.7 4.1 5.0 7.9 10.0 3.2 9.5 8.5 19.8 17.1 3.0 3.3 10.4 11.5 30.8 5.5 14.7 4.9 0.0 8.6 3.4 2.1 7.9 9.4 0.3 0.9 13.1 6.4 0.0 0.2 0.5 0.0 1.1 4.1 0.1 1.8 0.7 1.6 7.8 9.1 5.5 2.5 0.0 0.1 0.0 1.5 5.5 4.9 0.0 3.7 0.0 4.2 0.0 3.8 0.7 1.2 4.5 6.3 1.0 0.2 6.6 1.5 0.2 3.4 0.7 0.0 1.8 0.0 0.1 4.1 0.1 0.0 2.7 3.9 5.4 1.7 0.0 4.6 0.0 13.5 0.8 4.0 4.4 0.0 0.5 0.2 5.0 3.6 0.4 0.0 3.9 2.5 0.0 2.7 1.7 0.0 0.0 1.8 0.0 4.5 0.0 1.4 13.1 0.0 3.6 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.2 0.5 0.0 6.4 0.0 0.1 0.5 15.7 12.2 23.7 11.8 10.3 14.4 8.0 5.9 7.9 4.9 0.0 5.6 0.0 14.2 8.8 8.8 21.8 2.5 1.4 1.2 22.7 2.0 1.5 6.6 5.9 2.2 4.7 0.0 0.0 2.5 15.0 22.7 10.6 4.6 5.7 4.3 6.4 6.9 15.4 8.1 1.4 9.2 6.3 15.1 0.0 0.0 25.5 2.6 0.0 13.8 6.1 5.4 32.3 22.3 1.7 1.5 3.6 1.3 0.5 0.0 6.7 FAM124B FLJ22746 ENSG00000124019 "Family with sequence similarity 124 member B" Q9H5Z6 2 224378698-224402085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.8;blood: 18.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 4.4;granulocytes: 4.6;Ito cells: 1.3;Kupffer cells: 1.9" "Cancer enriched" "Detected in many" 10 "testis cancer: 7.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 18.0;eosinophil: 11.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "HUVEC TERT2: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA070240 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA070240: AB_2686238" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (6.87e-3)" "unprognostic (2.49e-1)" "unprognostic (7.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.28e-2)" "unprognostic (5.78e-2)" "unprognostic (3.19e-1)" "unprognostic (1.85e-1)" "unprognostic (1.57e-1)" "unprognostic (3.36e-1)" "unprognostic (7.61e-3)" "unprognostic (1.36e-2)" "unprognostic (4.30e-1)" "unprognostic (2.25e-1)" "unprognostic (5.80e-3)" 28.8 0.6 1.6 1.4 1.9 5.9 16.0 0.6 1.8 4.2 2.1 1.6 0.7 1.3 2.4 2.5 2.6 1.8 1.7 2.4 2.2 2.2 1.4 2.6 5.8 0.8 2.0 0.6 2.5 0.5 9.4 0.8 12.5 1.8 3.9 1.5 4.0 1.7 0.6 4.3 2.6 1.5 3.5 2.1 0.8 1.2 2.3 0.2 1.0 2.9 0.8 1.0 3.4 2.6 0.0 5.6 18.0 2.1 3.8 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 49.2 0.0 2.2 0.1 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 2.1 11.6 0.1 1.6 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.1 3.8 0.5 0.0 1.7 0.7 1.6 1.9 0.6 1.8 2.2 2.2 2.0 0.6 1.8 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.1 0.2 0.0 4.6 0.2 0.4 0.0 0.0 1.3 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA058113" Approved Enhanced Mitochondria,Cytosol NA NA 29000 "Mitochondria, Cytosol" "HPA035856: AB_10611965, HPA058113: AB_2683609" "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favorable (3.93e-4)" 13.6 32.8 24.9 18.6 49.9 14.1 18.7 10.7 44.8 21.8 57.8 11.5 19.6 22.7 17.0 25.5 58.7 13.8 25.4 54.2 40.2 21.7 35.9 78.1 12.2 16.5 23.6 27.7 30.2 71.5 24.6 16.1 7.3 31.0 27.3 61.3 16.2 17.7 23.1 56.6 29.2 21.2 27.2 24.4 10.9 25.7 16.9 18.8 8.6 17.9 48.6 16.7 34.6 36.0 26.8 29.4 25.3 24.4 16.4 33.1 12.9 28.8 6.2 9.2 17.1 16.9 15.7 4.7 11.8 10.6 11.3 28.8 15.4 13.3 31.4 20.6 4.0 9.3 20.2 16.6 28.8 30.2 16.2 12.4 25.4 10.7 27.5 11.1 24.8 9.1 18.1 15.1 10.7 22.7 38.0 14.9 31.0 17.1 12.6 16.1 11.3 25.2 30.2 13.6 65.2 32.8 15.2 13.2 40.9 32.7 70.4 13.8 11.0 8.8 21.0 24.1 14.4 13.1 12.2 10.5 11.2 8.0 6.5 12.2 25.0 8.5 31.8 33.2 24.3 5.1 2.6 9.3 25.3 21.7 23.0 32.1 26.8 29.8 27.1 29.4 23.9 32.6 33.1 3.0 16.4 24.4 24.6 27.1 12.9 24.9 49.9 10.7 44.8 40.2 21.7 23.6 27.7 31.0 18.8 26.8 42.4 71.1 131.6 113.8 30.4 312.0 96.8 46.8 43.3 123.9 45.2 42.9 457.6 109.5 73.0 47.4 279.5 23.3 152.7 35.4 52.8 85.5 85.3 207.9 83.9 36.5 102.7 38.1 49.4 23.4 124.5 76.0 99.5 146.9 326.4 45.5 161.9 325.6 139.7 345.2 28.5 103.5 89.6 141.1 55.3 116.1 39.5 54.9 245.2 156.6 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell type enriched" "Detected in many" 6 "Bipolar cells: 137.0" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 25.4;U-138 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.8 4.2 13.1 12.5 9.5 0.1 2.6 4.6 3.2 4.6 7.7 12.6 0.0 0.9 7.3 5.5 0.3 5.7 2.5 4.6 0.0 3.3 2.8 1.3 0.0 1.0 0.8 1.0 12.1 1.0 2.5 2.0 4.2 7.0 2.2 0.0 25.4 6.1 1.6 1.6 0.0 5.6 0.0 2.8 0.0 8.1 0.6 5.0 9.0 13.2 7.2 1.3 0.8 3.5 2.6 1.0 0.6 4.1 17.6 2.3 0.3 1.6 6.8 6.5 0.0 5.4 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 0.0 0.0 0.0 2.1 7.9 137.0 0.8 10.2 0.0 2.3 0.0 13.7 7.9 0.0 0.7 1.4 10.5 0.0 0.0 0.3 0.8 6.6 1.2 0.0 0.0 1.7 22.3 4.6 8.0 0.3 2.5 7.2 1.1 3.3 1.0 0.0 16.5 0.5 0.0 13.1 0.1 15.5 0.0 4.1 0.1 1.4 4.5 6.9 0.0 0.0 0.5 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729941-82733864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 29.6" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 5.2;Distal tubular cells: 3.3;Muller glia cells: 18.0;Smooth muscle cells: 3.1" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 6.7;SH-SY5Y: 3.6;U-2 OS: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Enhanced Approved "Nuclear membrane,Mitochondria" NA NA Mitochondria "Nuclear membrane" "HPA066861: AB_2685738" "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favorable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 1.9 2.9 18.3 1.8 13.3 1.5 1.6 16.9 29.6 2.0 1.7 18.6 0.0 1.9 2.2 1.8 1.5 2.6 1.4 2.0 19.6 11.3 2.0 1.3 1.3 1.4 17.1 13.0 2.7 1.5 1.5 1.1 1.4 17.2 1.9 1.5 0.7 3.2 2.7 1.7 1.7 2.3 1.6 16.9 1.3 1.8 1.7 16.7 0.0 2.1 0.0 1.7 2.2 0.5 0.2 0.0 0.6 0.3 0.3 0.4 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.1 0.3 0.1 0.4 0.0 0.1 0.1 0.5 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.1 0.1 1.2 0.0 0.2 0.1 0.0 0.0 0.2 6.7 1.0 3.6 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.1 3.5 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.6 0.3 0.3 0.0 0.1 0.0 18.3 13.3 16.9 11.4 19.6 11.3 17.1 13.0 17.2 16.7 0.0 0.0 0.0 0.2 0.2 0.2 2.7 0.0 0.0 0.0 5.2 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 18.0 0.0 0.0 0.4 0.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234546-268971 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA 3700000 Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 20.2 19.1 11.3 11.7 24.3 6.4 16.5 12.2 16.2 11.6 20.3 56.0 13.7 36.3 17.4 12.6 26.4 14.0 16.0 31.1 8.3 7.3 18.3 15.6 11.4 10.5 39.8 9.0 13.4 29.6 24.3 19.2 15.4 37.8 16.8 12.4 15.5 14.1 15.4 51.4 14.9 26.8 29.0 42.0 9.7 18.8 13.0 27.2 7.2 16.6 16.2 6.3 19.0 11.7 10.3 17.8 12.5 17.4 14.2 11.5 12.5 9.0 18.7 23.4 54.2 36.4 21.7 12.3 22.0 27.9 13.4 17.3 18.9 26.1 8.2 35.8 27.7 11.9 18.3 7.4 13.2 11.2 11.3 13.1 11.5 11.7 15.2 22.2 6.1 6.9 22.5 20.5 18.9 15.5 37.1 21.6 10.8 12.7 2.1 14.5 37.2 6.9 6.8 29.5 13.2 9.5 20.9 16.5 40.8 23.1 8.8 29.7 24.0 35.6 20.9 18.6 20.5 26.7 10.6 21.5 28.3 8.3 15.1 6.7 5.0 2.0 10.8 19.9 9.8 38.5 11.3 17.4 12.5 10.8 16.9 5.6 8.0 9.6 10.2 17.8 10.3 11.1 11.5 7.6 14.2 16.5 6.3 9.3 12.5 11.3 24.3 12.2 16.2 8.3 7.3 39.8 9.0 37.8 27.2 8.9 13.0 2.2 9.1 0.0 8.6 0.0 10.2 12.0 9.1 29.6 23.6 49.9 6.6 41.4 21.8 13.9 34.2 0.0 23.0 42.1 9.7 12.0 8.1 19.8 22.9 9.5 33.9 20.9 14.5 52.2 15.5 11.9 0.0 57.7 30.3 9.3 17.1 51.6 20.5 15.1 11.9 19.4 0.0 16.4 28.1 0.0 55.4 6.9 42.9 9.8 FAM83F ENSG00000133477 "Family with sequence similarity 83 member F" Q8NEG4 22 39994949-40043529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.4;seminal vesicle: 33.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 31.6;Late spermatids: 52.5;Suprabasal keratinocytes: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 7.1;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 23.0;hTERT-HME1: 7.2;OE19: 10.3;RT4: 11.0;SCLC-21H: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051207, HPA064657" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA051207: AB_2681388, HPA064657: AB_2685313" "unprognostic (2.78e-2)" "unprognostic (3.91e-2)" "prognostic favorable (1.73e-4)" "unprognostic (5.36e-2)" "unprognostic (1.48e-5)" "unprognostic (1.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (4.79e-1)" "unprognostic (2.48e-1)" "prognostic favorable (9.40e-4)" "unprognostic (3.25e-1)" "unprognostic (1.10e-7)" "unprognostic (2.93e-1)" "unprognostic (2.37e-1)" "unprognostic (2.98e-2)" "unprognostic (8.32e-2)" 1.1 0.2 0.1 2.8 0.2 0.8 4.7 0.2 0.3 2.6 6.9 0.1 29.4 3.0 0.2 7.5 15.4 1.1 4.0 1.5 0.2 0.1 4.8 2.1 1.0 0.1 0.2 0.1 0.5 14.4 2.6 2.6 0.5 0.1 6.3 3.1 0.4 7.8 33.3 0.1 13.8 12.5 0.8 0.2 0.1 5.9 24.9 0.1 1.3 12.6 12.8 8.1 3.0 4.1 0.7 0.5 2.7 0.4 0.6 0.3 0.1 4.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 7.1 1.4 0.0 0.0 0.0 0.0 7.6 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 23.0 0.0 7.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.3 0.0 0.0 0.0 0.0 0.1 11.0 24.3 0.0 0.2 2.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.3 2.2 0.6 0.3 0.5 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 11.8 25.4 0.5 5.1 2.5 2.7 1.2 22.7 0.0 0.1 3.3 8.6 20.7 0.8 31.6 0.0 13.2 0.1 1.6 13.1 1.1 1.0 0.2 0.0 12.6 0.0 0.8 52.5 1.7 0.9 1.7 0.0 18.3 1.0 11.4 20.1 2.1 5.0 0.7 0.0 0.8 7.2 2.2 30.2 1.1 0.0 12.7 15.2 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favorable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 13.8 16.8 18.8 15.7 19.0 6.4 10.2 19.0 26.4 18.0 20.6 13.4 20.3 21.2 12.4 14.6 20.3 16.7 16.8 35.7 17.6 12.9 17.7 25.6 9.5 10.4 12.0 15.0 14.4 20.7 20.2 21.8 18.5 12.0 16.8 10.6 14.0 21.7 17.9 89.5 14.4 25.8 11.3 9.2 14.9 14.8 10.6 10.9 11.2 16.8 28.1 16.9 17.4 11.8 15.4 26.0 19.7 22.3 13.1 19.0 14.5 15.9 18.6 5.9 14.2 22.1 10.0 9.9 12.8 17.4 10.9 13.1 12.8 13.7 3.8 17.5 17.3 20.1 10.3 5.7 15.3 2.9 10.9 10.2 4.6 4.6 10.8 28.1 3.2 10.5 13.0 22.5 12.6 9.3 8.9 12.8 9.5 6.8 8.0 12.6 31.9 7.8 9.2 9.9 19.8 21.8 5.2 7.1 11.8 14.8 10.9 7.1 7.4 16.9 26.2 17.0 5.3 14.1 12.7 10.4 13.9 3.0 13.0 11.3 21.4 13.0 2.4 27.7 7.2 15.9 10.5 22.3 19.7 16.4 21.7 17.1 13.7 17.3 16.9 19.4 15.4 19.0 16.3 4.8 13.1 20.8 26.0 18.7 14.5 18.8 19.0 19.0 26.4 17.6 12.9 12.0 15.0 12.0 10.9 0.0 6.5 32.8 35.2 21.9 39.2 16.5 28.1 2.7 12.5 24.4 23.6 42.5 72.9 43.5 7.1 22.2 63.6 0.0 41.8 23.0 34.8 27.1 39.1 31.6 38.4 35.0 43.1 22.7 26.6 11.6 33.6 25.5 89.4 34.3 42.5 51.0 35.5 39.6 32.2 50.2 48.9 12.9 27.8 47.1 68.2 22.1 50.6 38.4 50.8 26.7 FASTKD3 "FLJ23274, MGC5297" ENSG00000124279 "FAST kinase domains 3" Q14CZ7 5 7859159-7869037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068525, HPA074462" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA068525: AB_2685999, HPA074462: AB_2686692" "unprognostic (5.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.87e-5)" "unprognostic (6.66e-3)" "unprognostic (4.56e-3)" "unprognostic (3.19e-2)" "unprognostic (1.61e-2)" "unprognostic (5.82e-3)" "unprognostic (5.68e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "prognostic favorable (8.53e-4)" 7.1 15.5 8.6 9.7 13.3 7.6 12.3 9.1 15.0 8.3 10.7 8.6 7.9 10.4 8.8 10.2 8.9 7.5 6.5 7.2 8.7 7.3 17.8 14.5 8.3 10.0 9.2 13.7 9.3 8.4 13.0 10.8 6.4 8.0 8.6 13.5 8.1 11.1 15.8 10.2 9.0 12.1 7.8 8.8 12.0 9.1 6.0 7.4 12.2 8.9 7.4 12.2 9.1 7.0 9.6 6.7 7.4 7.3 4.8 10.3 4.7 7.1 6.3 6.2 8.0 3.9 4.9 12.1 6.0 5.2 9.5 7.3 9.4 7.7 24.9 12.2 6.3 12.1 7.6 15.1 8.4 13.5 6.8 7.8 8.6 20.6 7.4 5.3 14.2 7.2 5.6 3.6 8.8 5.5 4.3 5.2 10.2 11.8 4.4 7.1 5.1 9.5 8.3 5.6 7.5 9.0 11.1 7.6 5.7 7.7 7.7 4.3 4.1 18.1 8.0 8.8 5.8 7.2 6.6 3.5 9.4 9.6 9.7 9.9 5.1 4.8 15.9 6.2 13.2 7.6 3.8 5.4 7.4 6.1 7.3 8.2 9.6 9.4 6.5 6.7 6.8 10.3 9.7 0.2 4.8 5.7 3.8 10.2 4.7 8.6 13.3 9.1 15.0 8.7 7.3 9.2 13.7 8.0 7.4 14.9 5.1 5.2 1.9 2.3 2.9 3.6 7.6 5.3 0.0 0.0 0.0 6.3 5.0 7.2 0.4 4.3 8.0 0.0 10.3 7.0 4.6 2.3 3.5 9.9 7.3 4.8 6.9 4.9 7.0 0.4 4.9 5.8 1.7 14.4 6.2 3.5 9.3 3.5 4.2 14.9 5.1 0.0 5.1 3.4 5.4 4.8 3.5 6.9 6.6 1.6 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004222-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.7" "Cell type enriched" "Detected in some" 6 "Early spermatids: 18.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Region enhanced" "Detected in many" "pons and medulla: 16.7" "Cell type enriched" "Detected in single" 4 "T-reg: 3.8" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1" "Region enhanced" "Detected in some" "hypothalamus: 7.7" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073369: AB_2686597" "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 0.3 0.5 4.1 0.2 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.2 0.1 6.2 0.0 0.1 0.1 1.8 6.5 0.0 0.0 0.4 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 8.4 0.1 1.8 2.6 3.7 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 2.6 0.0 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.3 11.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.3 4.1 0.6 0.0 0.1 6.2 6.5 0.0 16.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 FP565260.6 ENSG00000280071 21 5079294-5128425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 3.4;Collecting duct cells: 3.5;Hofbauer cells: 7.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA018517 Uncertain Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (4.87e-2)" "unprognostic (2.69e-3)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (2.96e-1)" "unprognostic (6.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.39e-2)" "unprognostic (7.65e-2)" "unprognostic (1.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.33e-2)" "unprognostic (6.67e-4)" "unprognostic (1.88e-2)" "unprognostic (6.80e-2)" "unprognostic (4.25e-1)" "unprognostic (2.84e-2)" 3.9 6.7 2.8 2.0 6.6 1.3 3.4 8.2 7.0 3.0 5.7 5.2 2.5 5.7 2.2 5.0 3.9 3.3 2.8 15.5 3.2 12.9 14.4 4.8 10.5 6.7 4.7 5.6 2.7 4.0 0.9 6.4 4.2 3.0 4.7 4.4 4.9 2.3 17.1 1.3 3.6 2.4 3.0 2.6 2.2 1.4 3.9 1.1 4.2 11.1 2.4 3.9 2.0 47.1 43.8 19.9 46.4 37.1 41.4 46.1 13.2 12.5 13.9 24.4 13.3 12.7 6.8 0.0 2.6 0.8 1.2 2.0 13.6 1.2 15.4 16.3 13.8 9.5 20.0 10.4 1.2 9.1 8.9 51.5 13.3 12.7 12.1 22.1 9.8 20.3 17.6 8.0 14.7 11.9 16.1 17.5 20.2 15.3 9.6 27.8 22.0 24.2 27.2 37.2 20.4 45.2 10.5 48.2 18.2 12.3 14.1 23.7 18.4 34.7 12.9 7.5 35.7 31.1 5.7 8.0 9.9 0.8 8.0 20.7 21.1 8.7 16.4 45.8 6.7 19.9 33.6 16.9 31.6 36.0 31.6 43.9 41.4 32.9 43.8 47.1 39.7 30.2 6.8 37.1 46.4 28.9 40.0 46.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 3.5 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 FRAT2 ENSG00000181274 "FRAT2, WNT signaling pathway regulator" O75474 10 97332497-97334709 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 46.0" "Cancer enhanced" "Detected in all" "testis cancer: 70.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 29.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 29.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049763: AB_2680868" "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favorable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.0 3.8 5.7 8.7 7.5 23.8 9.7 8.6 9.4 5.7 18.8 4.8 10.2 21.9 6.0 5.9 13.2 6.4 7.2 7.7 6.1 4.9 5.8 15.6 12.0 22.4 5.6 2.0 3.0 16.5 4.8 3.2 9.6 7.7 8.8 14.0 5.4 22.4 4.9 8.7 17.8 20.3 3.7 5.9 28.0 11.5 14.9 7.3 9.0 8.1 8.3 11.1 7.9 13.2 1.2 1.9 29.3 3.7 0.6 1.1 1.1 5.3 2.1 3.5 15.7 2.5 2.1 13.0 1.2 4.4 1.9 1.9 3.3 6.2 6.5 4.3 1.2 1.1 10.1 9.1 4.7 1.5 9.7 14.0 8.7 4.5 7.2 1.5 13.9 10.5 1.6 10.1 1.8 5.8 4.0 4.6 5.8 7.5 2.1 0.9 8.7 6.0 17.6 21.7 17.7 8.8 6.2 1.4 9.2 4.5 4.8 6.3 5.2 1.5 9.6 6.0 14.9 14.5 22.0 2.1 1.1 1.4 0.8 3.1 5.8 5.9 3.2 1.3 24.1 0.4 3.3 3.7 7.1 0.6 2.3 0.3 0.5 0.7 0.9 1.9 1.2 1.1 0.7 29.3 0.6 3.5 0.4 0.3 1.1 5.7 7.5 8.6 9.4 6.1 4.9 5.6 2.0 7.7 7.3 0.0 4.6 7.7 21.9 28.2 16.8 5.6 7.6 4.0 2.3 14.0 3.9 4.1 10.0 2.1 31.9 4.7 16.0 0.0 4.5 15.6 4.8 26.8 1.1 8.2 7.7 11.1 13.3 3.1 18.0 31.4 2.0 6.4 10.1 1.0 28.5 4.3 4.1 17.3 2.5 2.2 16.9 0.0 7.6 1.2 3.9 46.0 6.5 5.7 27.3 25.6 FSIP2 FLJ34780 ENSG00000188738 "Fibrous sheath interacting protein 2" Q5CZC0 2 185738895-185833290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 27.6" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 128.1;Alveolar cells type 2: 68.3;Ciliated cells: 83.0;Early spermatids: 179.5;Spermatocytes: 69.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;OE19: 2.0;RT4: 4.7;SuSa: 2.1;U-266/70: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA036139 Approved Microtubules,Mitochondria NA NA Microtubules Mitochondria "HPA036139: AB_10602134" "unprognostic (5.28e-2)" "unprognostic (1.20e-2)" "unprognostic (4.17e-1)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (6.31e-2)" "unprognostic (2.76e-3)" "unprognostic (1.55e-1)" "unprognostic (5.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.79e-3)" "unprognostic (4.89e-3)" "unprognostic (1.28e-1)" "unprognostic (7.52e-2)" "unprognostic (5.17e-2)" "unprognostic (4.64e-5)" 0.4 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.3 0.3 2.7 0.1 0.1 0.0 0.6 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.4 0.6 0.5 0.5 0.3 1.4 0.3 0.2 0.1 0.1 0.3 0.6 0.6 0.1 0.5 3.6 27.6 0.1 0.1 0.4 0.1 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 2.0 0.7 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 128.1 68.3 0.8 0.2 0.5 14.6 3.2 0.0 83.0 56.9 0.0 9.8 0.2 0.0 0.5 179.5 0.6 2.6 0.0 0.2 0.1 0.6 0.3 37.2 0.0 0.3 17.5 7.5 1.8 0.0 20.4 2.0 1.4 1.7 0.0 13.3 5.8 3.2 0.0 3.5 0.0 8.0 0.0 0.5 69.0 2.7 0.3 0.2 0.0 0.6 0.1 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612564 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045920 Uncertain Approved "Nuclear membrane,Mitochondria" "Secreted to blood" NA NA Mitochondria "Nuclear membrane" "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.7 2.2 8.4 1.0 14.6 3.0 1.1 18.5 18.0 1.0 1.6 1.7 0.0 1.1 0.5 2.8 3.1 1.6 0.7 0.6 1.5 3.2 4.8 0.5 2.0 0.4 1.9 10.1 0.8 2.9 7.1 4.0 6.4 2.6 2.9 1.9 1.4 1.4 0.1 1.5 5.3 1.2 0.3 1.0 0.5 2.3 2.8 4.7 0.0 1.3 0.0 1.7 10.2 1.6 2.8 1.2 3.4 1.1 0.8 2.3 1.2 4.4 7.6 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 6.8 0.9 0.3 6.2 0.0 0.8 0.1 0.9 0.2 0.0 0.4 0.3 0.3 7.4 0.6 0.0 0.0 0.4 0.1 1.1 0.0 0.0 0.2 0.0 0.3 3.4 4.0 0.0 7.2 0.8 0.3 8.2 7.8 0.8 0.3 0.7 7.7 0.0 8.4 33.1 0.7 1.7 1.4 0.1 7.8 2.8 0.3 0.2 0.3 1.4 0.4 0.2 11.9 11.8 0.3 0.1 0.0 0.2 3.4 1.1 0.6 1.2 0.4 2.3 2.8 1.7 1.2 0.6 2.6 2.1 1.3 2.4 0.8 0.7 1.2 1.6 1.2 8.4 14.6 18.5 18.0 1.5 3.2 1.9 10.1 2.6 4.7 0.0 1.9 0.0 1.7 1.4 10.3 7.3 0.0 6.7 7.9 0.0 13.7 0.3 0.0 0.2 31.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 8.6 0.0 0.0 13.9 0.3 0.0 10.1 0.0 0.0 3.3 0.8 0.0 0.7 2.3 2.4 6.5 0.0 0.4 0.6 1.4 0.0 0.0 0.0 2.6 FXN "CyaY, FA, FARR, FRDA, X25" ENSG00000165060 Frataxin Q16595 9 69035259-69120427 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022164, HPA068304" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB022164: , HPA068304: AB_2685970" "unprognostic (3.38e-2)" "unprognostic (1.54e-1)" "unprognostic (7.47e-2)" "unprognostic (2.37e-3)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.71e-3)" "unprognostic (1.10e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-1)" "unprognostic (4.74e-2)" 8.7 19.9 10.8 9.1 9.8 21.9 11.8 13.9 11.0 8.3 9.3 12.3 11.6 6.6 12.4 11.7 9.2 9.6 7.2 20.2 8.7 10.1 10.2 40.2 9.5 12.8 11.7 8.5 16.8 25.9 18.8 8.6 8.4 10.5 9.9 11.6 12.1 11.9 13.6 25.1 5.2 7.2 16.6 8.9 12.9 9.2 13.3 9.7 3.7 11.1 9.5 9.6 10.5 7.9 15.8 17.7 2.0 18.5 24.2 28.3 19.1 11.3 9.6 15.8 7.6 7.2 10.7 15.3 8.2 7.3 12.6 9.7 5.1 7.4 20.4 6.4 8.5 13.0 12.4 18.6 18.8 15.9 23.8 21.3 28.6 6.3 37.8 12.4 20.9 12.5 11.9 15.2 12.6 13.7 4.5 16.8 12.6 21.5 20.0 11.6 11.1 5.9 9.2 21.3 23.1 19.2 14.1 10.8 13.9 14.5 9.4 12.2 5.5 8.4 5.5 8.6 11.6 6.2 6.5 10.0 8.3 14.4 10.8 11.9 5.6 4.8 12.1 3.9 17.3 8.2 2.0 16.7 0.1 21.5 18.5 16.3 15.8 22.0 21.2 17.7 10.3 28.3 27.1 0.8 24.2 14.1 15.0 17.0 19.1 10.8 9.8 13.9 11.0 8.7 10.1 11.7 8.5 10.5 9.7 3.0 11.5 20.6 17.3 8.7 6.2 39.9 7.6 5.3 3.4 14.0 3.9 35.6 18.3 16.1 2.0 11.7 3.1 0.0 12.7 16.7 14.6 12.0 6.9 60.1 30.0 0.0 6.9 8.0 14.6 4.6 14.7 15.5 16.9 14.4 11.5 8.3 15.0 0.0 12.4 20.7 1.0 12.9 17.6 3.8 31.7 7.0 12.2 13.1 15.6 11.9 GADD45GIP1 "CKBBP2, CKbetaBP2, CRIF1, MGC4667, MGC4758, PLINP-1, Plinp1, PRG6" ENSG00000179271 "GADD45G interacting protein 1" Q8TAE8 19 12953119-12957236 "Predicted intracellular proteins, Ribosomal proteins" "Cell cycle, Host-virus interaction" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055205, HPA065048, HPA071910" Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA055205: AB_2682736, HPA065048: AB_2685412, HPA071910: " "unprognostic (5.82e-2)" "unprognostic (2.62e-2)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (8.14e-3)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (9.67e-2)" "unprognostic (7.73e-3)" "unprognostic (1.06e-1)" "unprognostic (7.09e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-2)" "unprognostic (1.73e-1)" 23.9 31.8 32.7 22.3 29.1 28.1 19.3 17.2 31.4 16.9 18.9 11.2 17.9 21.1 19.2 20.0 22.3 17.5 25.0 41.9 26.4 27.6 24.3 31.5 15.3 21.0 26.0 23.6 20.7 29.6 10.1 18.5 21.3 17.7 18.7 9.7 13.1 36.2 21.7 85.5 18.4 19.2 19.5 19.3 19.8 20.0 17.2 17.1 14.8 27.0 37.9 14.8 17.5 21.5 34.2 17.7 4.8 14.1 16.1 23.6 10.6 20.1 17.2 7.2 10.1 5.1 6.6 10.1 14.9 7.5 14.9 12.3 23.7 8.2 14.6 24.9 8.9 10.7 14.1 8.8 14.5 3.9 9.5 43.2 10.3 23.2 26.6 12.4 17.1 15.8 7.8 11.8 10.3 8.5 7.9 8.6 14.1 15.6 5.7 9.2 29.6 27.0 36.0 19.9 13.1 54.3 20.1 7.3 23.3 11.4 11.9 22.2 20.3 11.1 15.0 16.8 3.7 11.7 16.2 13.9 28.9 10.1 25.1 27.3 22.7 15.8 15.1 20.1 21.5 16.6 4.1 14.1 4.8 14.4 13.4 14.5 34.2 22.1 22.8 17.7 28.0 23.6 17.4 0.9 16.1 11.3 16.9 17.5 10.6 32.7 29.1 17.2 29.1 26.4 27.6 26.0 23.6 17.7 17.1 38.7 48.8 182.3 139.8 129.1 56.0 138.4 114.7 85.6 58.0 130.9 21.6 278.6 339.8 261.6 30.0 159.5 164.2 116.8 326.4 297.6 155.1 145.6 72.7 225.1 217.4 35.0 133.6 149.8 133.3 39.7 177.2 143.5 170.4 318.4 137.1 65.9 279.8 125.8 160.1 483.6 62.7 187.5 150.4 81.2 152.0 140.6 170.8 107.6 173.2 145.0 GART "GARS-AIRS-GART, PGFT, PRGS" ENSG00000159131 "Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase" P22102 21 33503931-33543491 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Ligase, Multifunctional enzyme, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002119, HPA005779" Approved Approved Mitochondria,Cytosol NA NA 1300000 Cytosol Mitochondria "HPA002119: AB_1849482, HPA005779: AB_1849484" "unprognostic (3.77e-2)" "unprognostic (2.25e-2)" "unprognostic (4.51e-3)" "unprognostic (1.72e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (5.05e-5)" "prognostic unfavorable (9.82e-5)" "unprognostic (2.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.98e-3)" "prognostic unfavorable (3.95e-6)" "unprognostic (1.36e-2)" "unprognostic (2.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" 24.9 24.7 16.0 20.0 22.3 14.2 22.2 14.5 20.3 16.2 20.1 20.5 13.3 18.9 21.7 15.9 28.1 19.9 14.3 19.3 16.4 14.9 19.2 33.6 18.3 24.4 21.9 14.6 21.0 30.6 21.6 22.9 23.1 21.0 16.4 26.9 19.5 18.6 16.1 33.2 17.6 19.1 23.5 17.9 21.4 21.9 47.0 21.7 40.8 20.0 19.4 32.8 21.6 17.6 18.7 19.5 9.7 20.9 27.1 21.1 13.3 30.2 14.4 21.3 23.6 15.7 16.2 24.0 19.6 16.7 23.0 24.4 27.3 25.7 40.3 11.7 13.1 30.1 16.0 44.7 30.8 33.6 21.1 26.6 60.8 17.2 17.8 21.5 33.7 16.0 14.3 21.6 27.1 39.9 11.7 21.7 32.6 70.6 25.9 20.7 14.5 35.6 22.6 46.6 44.2 17.0 29.7 39.8 57.0 18.4 16.2 22.7 20.5 27.2 21.4 25.4 20.6 27.2 21.7 15.9 15.6 18.7 13.5 21.0 25.8 35.6 44.0 16.4 39.7 23.1 5.3 15.2 9.7 17.3 20.9 21.1 18.7 16.9 17.9 19.5 14.4 17.7 17.4 7.0 27.1 17.7 14.7 20.6 13.3 16.0 22.3 14.5 20.3 16.4 14.9 21.9 14.6 21.0 21.7 17.9 17.5 28.9 32.0 40.9 17.7 16.9 2.5 14.7 26.1 14.0 33.4 35.3 19.9 22.6 9.1 20.1 11.8 0.0 20.8 29.3 16.6 18.9 7.0 17.1 21.0 4.8 12.6 16.5 18.7 2.2 16.1 16.9 11.8 17.2 15.1 12.9 24.5 10.5 17.0 11.3 25.4 12.9 25.0 50.8 27.2 40.1 21.4 17.5 20.8 38.9 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 42.1;Cone photoreceptor cells: 45.2;Horizontal cells: 44.5;Rod photoreceptor cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favorable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 12.0 2.7 1.0 0.9 1.2 1.0 5.7 6.1 7.0 4.1 2.7 9.2 1.4 1.3 6.4 4.0 6.4 3.9 11.9 7.9 2.0 4.8 4.3 7.9 1.3 3.9 9.9 2.9 1.3 2.9 6.2 0.7 0.7 3.9 2.3 0.1 3.6 2.9 8.0 0.6 13.9 12.5 10.6 4.1 5.7 1.7 2.0 7.2 11.8 28.9 7.1 2.7 6.0 3.6 11.9 1.3 0.1 8.9 4.1 2.0 2.8 6.1 5.7 4.5 4.0 0.2 9.3 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 6.0 3.2 3.5 6.4 1.5 42.1 4.8 5.1 4.0 3.4 3.5 45.2 0.4 8.3 4.1 4.4 6.4 2.4 0.0 5.2 0.3 2.9 3.7 17.3 1.6 4.1 44.5 19.5 5.5 4.0 0.5 3.7 4.9 1.7 1.0 2.0 18.0 3.6 0.3 5.3 5.0 45.4 0.0 6.6 14.2 11.7 1.1 0.0 1.5 1.4 3.3 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984207-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 165.5;Enterocytes: 236.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: AB_2685038" "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favorable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 9.7 12.2 9.7 15.2 9.9 10.7 14.8 15.2 12.5 8.1 24.8 10.8 15.2 29.6 10.1 10.2 11.0 10.2 16.1 17.8 9.8 9.7 13.7 33.5 17.1 18.1 10.7 9.7 9.4 43.8 19.2 10.9 18.0 8.0 11.9 18.0 10.5 22.5 12.5 27.5 8.3 33.2 9.2 9.6 15.2 12.8 20.0 7.8 7.7 15.1 15.0 11.4 12.4 17.1 16.1 9.1 9.8 12.7 7.8 17.7 7.7 11.4 18.3 15.0 12.2 6.3 12.7 19.5 13.3 13.0 18.8 15.4 26.3 19.2 6.4 18.2 9.9 11.0 17.3 11.4 17.6 11.9 20.0 23.4 8.9 18.0 29.8 11.5 12.9 16.8 8.1 13.7 16.4 14.8 11.9 8.8 13.9 13.8 21.6 13.6 27.0 14.6 13.9 24.1 9.7 18.3 32.1 11.5 20.9 19.1 9.0 13.2 12.6 18.0 38.4 14.2 8.1 18.3 13.8 8.1 18.3 20.4 10.2 22.9 36.7 19.8 18.5 6.1 8.8 15.4 3.1 12.6 9.8 9.2 10.5 9.9 16.1 12.6 15.6 9.1 13.4 11.5 7.9 1.1 7.8 12.7 4.0 17.7 7.7 9.7 9.9 15.2 12.5 9.8 9.7 10.7 9.7 8.0 7.8 3.0 7.0 36.5 18.9 14.2 10.7 14.9 25.5 8.1 1.2 8.7 0.0 34.0 29.9 38.0 165.5 17.1 236.0 23.3 70.3 48.9 16.9 17.7 12.7 53.9 39.8 7.9 26.2 20.9 29.7 100.1 16.1 25.1 21.9 45.1 48.7 7.8 54.6 92.1 11.7 50.8 7.9 12.9 18.9 45.9 23.0 12.9 31.4 35.2 62.4 23.3 GFM1 "EFGM, EGF1, GFM" ENSG00000168827 "G elongation factor mitochondrial 1" Q96RP9 3 158644278-158692575 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034764, HPA034765, HPA061405" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (5.48e-3)" "unprognostic (4.48e-3)" "unprognostic (1.84e-1)" "unprognostic (3.40e-1)" "unprognostic (4.75e-2)" "unprognostic (6.05e-2)" "unprognostic (2.48e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.79e-1)" "prognostic favorable (1.16e-7)" "unprognostic (1.62e-1)" "unprognostic (4.78e-1)" "unprognostic (3.32e-2)" "unprognostic (8.78e-2)" 20.1 23.3 17.6 14.1 18.6 14.7 19.8 32.8 23.4 11.4 20.7 17.8 19.1 18.8 15.4 17.9 16.2 14.3 12.6 27.9 18.0 17.9 34.1 42.2 13.5 13.2 18.9 19.5 13.2 17.0 30.9 16.4 17.4 22.6 15.3 23.3 13.8 16.3 15.4 46.5 15.4 16.0 16.0 18.5 14.2 17.1 19.8 17.8 14.5 21.4 17.6 13.6 15.0 13.2 13.2 16.5 10.8 19.8 16.0 21.1 11.5 30.1 17.3 8.4 10.2 13.5 8.8 11.3 15.6 13.6 21.8 17.1 23.1 18.6 25.9 19.8 11.6 10.4 18.4 18.8 14.5 24.4 14.3 12.7 21.5 11.9 12.8 15.4 27.6 11.7 12.2 17.2 14.1 13.1 6.2 14.6 14.4 22.3 15.9 19.8 16.7 16.2 11.0 19.1 32.4 11.7 15.7 10.1 41.7 17.4 12.7 15.3 14.8 24.6 33.4 26.5 7.0 41.1 22.5 10.7 14.6 7.2 22.8 24.6 30.6 19.3 47.1 13.8 23.2 16.3 10.8 13.2 9.1 16.1 19.8 21.1 13.2 15.0 16.9 16.5 11.9 17.6 18.5 1.9 16.0 14.0 8.6 11.9 11.5 17.6 18.6 32.8 23.4 18.0 17.9 18.9 19.5 22.6 17.8 17.9 14.7 27.9 22.5 19.2 53.1 51.8 17.8 28.1 12.5 12.2 29.5 26.9 10.0 16.6 12.5 28.9 18.2 23.3 21.6 15.7 18.2 17.8 18.5 53.5 25.1 14.3 18.6 25.8 22.5 5.7 21.0 23.4 16.9 31.5 21.4 25.3 16.3 5.8 15.9 31.0 49.5 12.9 21.9 25.1 32.1 18.3 25.7 20.0 24.7 18.2 GFM2 "EFG2, FLJ21661" ENSG00000164347 "G elongation factor mitochondrial 2" Q969S9 5 74721204-74767371 "Predicted intracellular proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036863, HPA069871" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036863: AB_2675354, HPA069871: " "unprognostic (2.58e-3)" "unprognostic (7.04e-2)" "unprognostic (8.54e-3)" "unprognostic (1.98e-1)" "unprognostic (4.49e-2)" "unprognostic (2.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.64e-1)" "unprognostic (1.40e-1)" "unprognostic (3.80e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.33e-5)" "unprognostic (9.55e-2)" "unprognostic (4.15e-1)" "unprognostic (8.52e-3)" "unprognostic (9.82e-2)" 9.7 23.8 14.7 8.7 22.4 12.1 13.1 14.2 24.8 10.7 12.8 12.7 17.8 8.3 12.3 16.8 13.0 21.6 8.7 29.5 18.5 15.6 21.9 30.8 9.1 10.3 13.8 18.1 11.6 12.9 19.8 24.9 12.9 20.4 12.5 15.3 11.6 15.7 11.2 26.4 10.5 10.3 10.4 11.7 10.3 16.3 13.7 10.4 18.0 12.3 12.8 14.2 12.3 12.6 8.3 6.1 17.1 9.8 15.6 7.4 4.6 19.4 16.6 14.0 26.6 10.7 14.5 14.3 21.4 13.0 21.9 23.4 18.2 12.7 20.1 22.9 11.3 34.4 16.3 28.2 29.9 28.5 17.7 16.6 11.9 16.8 12.4 13.6 11.6 13.1 16.3 13.4 17.3 20.8 15.6 14.8 19.9 19.9 16.8 24.8 10.9 16.0 7.1 5.8 7.2 15.1 20.1 22.9 22.9 16.0 12.4 23.7 12.8 24.7 19.0 21.1 15.9 16.5 20.2 11.8 8.4 14.4 10.6 13.5 9.8 18.7 20.4 12.8 16.6 12.8 17.1 6.3 8.0 6.6 6.5 6.4 8.3 5.4 7.2 6.1 7.0 7.4 7.2 3.3 15.6 9.8 4.0 6.2 4.6 14.7 22.4 14.2 24.8 18.5 15.6 13.8 18.1 20.4 10.4 11.9 11.7 3.9 6.5 5.4 9.7 10.0 5.1 69.6 6.8 7.0 5.9 15.7 18.3 8.3 5.7 5.8 7.8 23.3 4.6 13.5 5.0 5.3 2.3 19.6 8.4 15.9 5.2 6.7 9.8 1.4 6.6 5.5 8.5 25.2 8.9 12.0 7.6 8.6 7.1 8.4 8.0 0.0 5.2 15.4 9.5 6.0 13.4 4.6 9.0 6.5 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.6 7.2 0.0 0.1 66.8 0.0 0.0 0.0 0.0 15.9 0.1 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.3 3.8 0.0 0.0 10.6 0.0 0.0 14.5 0.0 0.0 0.5 0.0 0.2 2.7 1.2 0.0 0.1 0.3 0.3 0.2 0.0 7.8 1.2 1.2 0.3 0.0 0.1 27.7 0.3 6.4 3.3 0.0 6.2 0.0 4.1 1.4 0.0 0.9 0.1 0.2 0.8 0.3 0.3 9.2 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 0.0 0.0 4.3 0.0 0.0 0.3 0.6 7.6 0.0 0.0 29.6 0.0 59.4 5.0 0.0 8.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.0 126.2 6.1 0.0 0.0 3.1 2.1 9.0 0.3 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 29.3 0.2 0.0 0.3 4.4 5.0 0.0 38.4 0.5 0.0 0.0 GPATCH8 "GPATC8, KIAA0553" ENSG00000186566 "G-patch domain containing 8" Q9UKJ3 17 44395284-44503430 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044380 Approved Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA044380: AB_10965696" "unprognostic (3.37e-1)" "unprognostic (5.90e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (6.07e-3)" "unprognostic (2.13e-2)" "unprognostic (5.86e-3)" "unprognostic (2.25e-1)" "unprognostic (1.38e-1)" "unprognostic (6.84e-3)" "unprognostic (8.47e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-2)" "unprognostic (1.50e-1)" "unprognostic (9.91e-2)" "unprognostic (7.58e-2)" "unprognostic (2.49e-1)" 8.6 8.5 7.1 12.0 9.3 11.9 7.7 22.2 11.7 8.3 6.5 9.9 6.4 6.9 10.2 4.7 8.5 7.4 6.7 8.1 7.8 5.6 6.4 4.8 7.5 10.0 8.7 6.8 11.2 7.7 14.7 18.1 11.0 9.0 7.1 7.5 9.2 9.1 5.8 21.0 8.3 8.6 8.0 8.3 9.3 6.5 7.6 10.1 9.6 7.7 3.8 9.5 11.6 12.8 10.1 9.6 10.3 16.0 12.4 13.2 6.1 10.4 7.5 8.9 8.6 5.8 7.9 8.8 8.6 10.2 10.7 11.3 10.3 7.0 13.1 5.0 10.6 8.6 6.9 11.9 8.1 13.1 15.5 7.7 15.4 7.0 5.7 4.2 12.7 10.4 8.1 4.4 11.3 10.6 6.9 8.7 8.9 10.5 11.1 6.4 3.3 16.2 1.1 6.0 3.7 7.4 14.5 11.6 9.2 1.5 7.6 8.4 6.5 10.1 4.4 5.9 8.1 6.2 7.0 7.0 6.7 6.1 10.0 10.1 11.5 10.1 14.2 7.5 5.0 6.7 10.3 8.2 6.7 13.2 7.9 12.4 10.1 10.4 9.4 7.9 9.7 9.7 9.7 6.4 12.4 16.0 9.6 5.2 6.1 7.1 9.3 22.2 11.7 7.8 5.6 8.7 6.8 9.0 10.1 20.8 23.8 50.6 42.6 43.3 67.0 29.0 25.5 30.8 42.1 24.4 115.8 36.1 8.3 27.4 11.0 37.3 24.2 0.0 21.4 32.6 47.0 35.6 40.5 17.1 20.3 138.2 37.2 35.0 27.8 3.4 58.4 36.3 21.9 33.3 16.6 56.6 26.2 21.0 40.7 10.2 119.5 51.8 45.7 62.6 70.0 40.9 44.6 77.1 24.9 50.3 GPX4 "MCSP, PHGPx" ENSG00000167468 "Glutathione peroxidase 4" P36969 19 1103926-1106791 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Oxidoreductase, Peroxidase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 13901.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008630, HPA047224, HPA058546" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA 220000 "Nucleoplasm, Mitochondria" "CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749" "unprognostic (8.42e-3)" "prognostic favorable (7.18e-4)" "unprognostic (8.14e-3)" "prognostic favorable (1.84e-5)" "unprognostic (1.00e-1)" "unprognostic (8.72e-2)" "unprognostic (2.53e-3)" "unprognostic (8.49e-2)" "unprognostic (2.69e-2)" "unprognostic (1.47e-1)" "prognostic favorable (7.72e-4)" "unprognostic (1.29e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.61e-2)" "unprognostic (2.20e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 163.0 76.4 63.3 27.1 73.7 33.3 102.3 33.5 83.7 53.3 49.1 42.4 33.8 56.9 27.2 74.7 35.6 38.4 46.9 64.4 54.2 60.2 75.3 119.0 44.7 41.7 74.6 47.3 47.1 35.1 33.1 54.7 46.4 49.3 44.7 25.5 82.3 61.6 46.9 98.2 36.3 58.5 43.6 46.5 32.4 27.7 170.4 36.5 29.9 52.8 49.8 39.2 51.2 47.0 56.7 64.0 85.2 85.2 28.4 58.5 110.5 28.7 32.7 47.3 100.0 143.5 85.1 52.7 22.8 82.3 43.5 44.4 66.7 39.0 10.4 24.9 46.0 36.8 32.4 27.6 33.0 21.3 58.3 49.9 19.6 29.4 94.1 83.5 23.0 31.5 84.4 50.3 22.0 37.1 78.5 60.8 36.5 27.4 26.3 35.9 73.8 38.9 39.5 44.8 64.1 52.8 53.9 6.4 30.1 47.2 71.5 40.8 25.8 44.7 42.4 46.4 30.3 41.4 56.3 51.4 46.3 30.8 79.3 28.5 92.2 62.5 24.3 43.6 46.2 26.5 75.6 85.2 85.2 37.0 62.0 43.0 56.7 54.3 38.6 64.0 47.8 58.5 41.7 42.4 28.4 68.3 44.1 46.8 110.5 63.3 73.7 33.5 83.7 54.2 60.2 74.6 47.3 49.3 36.5 166.7 171.0 287.8 409.7 453.0 334.7 225.6 313.4 467.1 233.2 448.4 92.3 508.2 1349.6 448.1 3338.1 251.8 690.8 163.5 318.5 1086.5 512.4 561.5 339.3 667.2 1047.6 197.0 381.4 302.0 479.7 13901.3 356.4 828.7 642.7 2643.8 270.1 239.3 473.5 361.2 294.2 2040.3 183.4 239.3 381.6 862.4 171.8 408.3 818.0 223.7 258.1 558.8 GREB1 KIAA0575 ENSG00000196208 "Growth regulation by estrogen in breast cancer 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 74.9" "Cell type enhanced" "Detected in many" 18 "Leydig cells: 18.7;Peritubular cells: 51.9" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.1;Hep G2: 14.3;MCF7: 22.4;SH-SY5Y: 15.3;T-47d: 51.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.2 2.0 3.0 0.6 5.0 0.5 11.1 1.3 5.4 13.7 0.5 2.8 3.0 0.7 21.3 15.6 0.6 11.2 1.8 2.3 3.9 3.0 1.3 1.5 0.6 0.6 3.9 3.5 74.9 2.9 0.6 5.0 9.4 3.8 19.2 0.5 2.8 0.7 2.4 2.1 1.2 0.6 7.3 3.2 0.4 0.8 10.9 3.2 0.0 0.5 0.5 0.5 0.8 5.7 0.8 1.0 2.8 0.6 1.0 1.3 0.4 0.0 0.4 15.1 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.0 2.6 0.1 1.1 0.0 0.0 1.8 1.3 0.0 0.1 14.3 0.1 0.1 0.8 0.2 0.8 0.2 0.1 0.1 0.0 1.4 0.1 0.3 0.1 22.4 0.4 0.7 4.9 0.0 0.0 10.4 0.0 0.6 0.0 0.0 4.4 15.3 0.3 0.4 11.1 2.1 51.8 0.2 0.0 1.5 0.7 0.1 0.0 2.2 1.5 8.8 2.6 4.3 0.4 2.6 0.6 0.8 0.7 0.3 0.3 0.5 0.5 0.4 0.4 0.8 0.5 1.3 2.8 1.0 0.5 1.0 0.5 0.4 3.0 5.0 1.3 5.4 3.9 3.0 3.9 3.5 3.8 3.2 0.0 0.3 0.0 1.7 0.7 3.1 7.3 7.6 5.3 1.2 0.0 2.0 0.1 0.0 0.4 0.5 1.4 0.0 0.0 0.2 2.1 5.1 9.8 3.5 6.0 2.5 3.2 0.0 0.6 0.0 1.3 18.7 0.3 5.0 0.0 0.0 0.2 0.5 0.0 51.9 1.9 0.3 0.0 0.8 0.9 1.5 0.3 0.2 0.0 0.0 2.6 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.9" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.6;K-562: 48.4;T-47d: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036365, HPA042090" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036365: AB_10601762, HPA042090: " "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favorable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 15.8 11.1 4.9 18.2 6.6 17.3 21.4 18.0 9.5 13.5 14.9 2.9 14.6 9.7 11.0 11.7 11.6 10.9 16.1 18.7 3.8 5.8 11.1 10.1 23.5 6.5 3.8 5.7 17.8 28.0 34.4 26.9 81.9 3.7 8.7 7.2 18.2 17.7 25.2 22.5 13.3 14.8 8.8 4.2 12.1 13.2 10.4 2.1 59.0 14.9 12.0 17.4 10.2 16.9 3.5 2.5 4.5 6.0 1.9 3.2 1.1 4.5 8.2 5.5 13.8 3.5 3.2 43.6 6.2 4.3 3.5 1.3 7.0 6.3 2.7 7.5 7.0 3.1 4.3 8.7 2.3 1.8 5.0 7.3 19.8 7.7 8.6 4.6 9.1 11.3 6.1 5.7 3.7 1.8 3.6 0.9 16.1 48.4 0.5 1.1 30.7 32.6 8.0 9.6 5.0 2.4 21.5 1.8 6.9 3.2 1.7 35.9 24.9 12.2 22.9 1.1 5.2 49.9 22.8 1.5 7.2 9.0 1.9 1.6 7.5 4.5 15.9 4.1 5.8 6.3 4.0 1.6 4.5 3.2 2.9 3.1 3.5 1.2 2.0 2.5 3.4 0.6 2.4 1.3 1.9 6.0 0.0 0.0 1.1 4.9 6.6 18.0 9.5 3.8 5.8 3.8 5.7 3.7 2.1 62.5 65.7 11.5 7.5 12.5 61.9 31.4 33.1 24.1 29.6 36.6 137.4 45.4 1.7 14.3 3.8 19.0 19.6 46.7 10.5 65.7 18.6 12.3 41.7 26.7 11.0 33.4 57.4 15.4 8.9 4.7 43.7 13.5 10.1 3.6 60.0 5.2 16.5 17.3 57.7 4.4 61.6 6.5 7.1 1.8 17.8 26.2 152.4 17.0 22.4 10.5 GSTP1 "FAEES3, GST3, GSTP" ENSG00000084207 "Glutathione S-transferase pi 1" P09211 11 67583595-67586656 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 252.4;OE19: 379.4" "Low region specificity" "Detected in all" "HPA019779, HPA019869" Enhanced Supported Mitochondria,Cytosol No No 120000000 "Mitochondria, Cytosol" "HPA019779: AB_1849799, HPA019869: AB_1849801" "unprognostic (9.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.24e-2)" "unprognostic (2.72e-2)" "unprognostic (1.06e-2)" "unprognostic (1.30e-3)" "unprognostic (3.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-3)" "unprognostic (2.14e-3)" "unprognostic (9.37e-2)" "unprognostic (5.72e-2)" "unprognostic (7.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.72e-3)" "unprognostic (1.48e-1)" 24.2 25.3 20.2 23.8 21.7 46.2 39.5 15.5 19.8 51.8 51.9 23.5 125.4 35.2 43.5 41.9 181.6 60.8 51.1 45.3 18.3 23.5 44.2 5.9 61.0 39.4 25.5 19.9 33.4 60.7 44.1 33.8 57.9 46.0 37.0 17.9 59.9 50.2 110.8 33.7 58.5 34.0 30.1 22.8 25.1 48.5 15.4 15.4 29.8 91.6 131.5 75.6 40.8 79.5 25.3 191.4 12.4 168.2 70.1 40.7 167.2 57.6 78.7 38.4 59.6 29.7 33.5 35.4 25.2 33.9 38.5 30.0 144.5 60.6 0.1 57.9 39.9 34.5 84.4 103.5 111.0 10.9 40.2 37.6 2.8 57.2 0.0 44.0 18.9 33.7 41.5 252.4 30.7 29.7 28.5 57.8 41.6 62.5 16.1 30.1 0.2 43.4 52.9 73.4 379.4 33.8 40.5 6.4 0.1 61.4 0.1 13.0 37.2 35.3 11.5 114.2 31.7 0.1 31.9 31.1 17.8 45.2 37.2 18.2 10.0 62.4 21.1 20.2 31.4 36.9 2.3 168.2 12.4 40.7 125.7 15.0 25.3 18.4 33.3 191.4 24.3 15.3 27.3 7.0 70.1 79.4 76.2 18.3 167.2 20.2 21.7 15.5 19.8 18.3 23.5 25.5 19.9 46.0 15.4 1072.0 720.7 317.1 1402.4 769.0 173.6 263.2 1108.3 2518.8 1170.4 1167.2 31.4 2000.9 1530.2 1548.4 3.0 432.0 610.1 46.7 1274.3 1522.1 711.2 802.7 262.2 7.2 793.1 66.7 353.7 365.8 595.7 9.3 529.8 867.5 1452.6 2663.7 867.8 370.2 1415.0 772.2 376.2 1617.9 188.6 355.7 676.5 3.2 63.0 928.1 1376.1 396.6 983.6 3031.0 GTF3C4 "KAT12, TFIIIC90" ENSG00000125484 "General transcription factor IIIC subunit 4" Q9UKN8 9 132670035-132694955 "Enzymes, Predicted intracellular proteins" Transcription "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069369 Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA069369: AB_2686130" "unprognostic (7.02e-2)" "unprognostic (9.01e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-2)" "unprognostic (1.58e-1)" "unprognostic (1.76e-1)" "unprognostic (4.77e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.99e-4)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" 6.9 8.5 12.3 6.6 11.6 7.8 11.6 23.8 13.9 10.8 8.0 7.0 5.6 5.3 10.2 9.3 11.4 9.5 7.4 7.8 8.7 8.1 8.7 7.4 8.9 10.9 9.4 11.6 15.0 8.4 16.6 10.1 9.7 8.9 8.9 7.7 7.6 11.3 8.4 11.6 14.5 6.6 8.6 5.6 6.3 8.1 16.9 6.4 11.6 13.3 5.3 9.3 8.8 7.9 2.3 2.1 1.5 1.5 2.1 3.1 0.9 8.5 12.2 15.5 13.3 7.7 9.1 11.2 8.2 10.9 11.7 8.6 14.9 6.4 13.3 5.6 10.7 10.9 19.8 23.7 13.5 13.0 8.0 9.8 11.2 17.6 6.3 7.6 16.5 7.1 7.0 10.3 12.0 15.7 7.1 10.0 8.9 18.2 6.8 8.4 14.0 10.1 7.7 19.7 13.0 11.9 10.0 18.9 11.7 8.6 7.2 21.6 14.6 14.8 15.0 9.1 10.1 20.9 6.8 10.4 19.4 10.9 8.8 12.3 2.8 6.4 14.8 8.2 10.4 11.9 0.1 1.5 1.2 2.5 1.3 2.0 2.3 2.2 3.1 1.2 2.2 2.3 2.4 1.5 2.1 1.2 2.1 2.0 0.9 12.3 11.6 23.8 13.9 8.7 8.1 9.4 11.6 8.9 6.4 17.9 8.6 7.8 6.7 27.2 15.0 11.2 2.5 18.7 6.8 3.5 13.7 6.2 6.6 7.2 4.8 9.0 3.5 0.0 5.4 6.0 11.5 9.1 1.1 7.8 5.4 19.1 12.6 7.4 7.3 2.1 17.5 4.6 3.3 2.8 7.4 11.3 5.8 7.0 18.0 5.6 16.9 0.0 7.6 15.1 12.6 35.0 5.4 6.1 8.0 4.6 GTPBP6 "FLJ20977, PGPL" ENSG00000178605 "GTP binding protein 6 (putative)" X 304529-318819 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013336, CAB034924, HPA035467, HPA055418" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034924: AB_2115410, HPA013336: , HPA035467: AB_10671104, HPA055418: " "unprognostic (5.00e-2)" "unprognostic (5.10e-2)" "unprognostic (1.60e-1)" "unprognostic (1.10e-2)" "unprognostic (4.90e-2)" "unprognostic (2.30e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (1.17e-1)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "prognostic favorable (1.71e-4)" "unprognostic (3.38e-2)" "unprognostic (4.45e-2)" "unprognostic (4.99e-3)" "unprognostic (2.23e-1)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" 6.3 4.9 22.2 5.6 40.5 8.1 33.6 30.5 29.9 18.9 5.2 0.6 0.6 7.0 17.0 0.6 4.7 6.3 3.1 19.7 22.7 5.9 21.1 4.0 4.1 6.0 39.5 15.0 18.2 11.9 2.1 16.6 16.6 26.4 4.1 1.6 0.6 11.2 4.7 22.8 5.7 7.6 1.9 25.5 6.4 7.5 2.4 34.2 0.6 4.1 0.6 1.9 3.7 25.4 7.3 11.1 8.1 6.3 5.3 9.2 3.8 15.2 25.3 5.6 11.7 6.5 7.1 20.9 9.5 7.1 12.1 11.1 38.7 12.8 19.2 13.6 5.3 16.4 9.5 5.9 9.2 2.0 15.9 17.2 15.8 12.4 26.4 17.6 10.6 15.5 8.8 12.3 8.0 5.9 4.5 9.7 12.8 11.6 9.0 4.9 30.2 18.8 14.0 13.7 3.1 18.1 8.4 9.9 30.6 7.0 17.9 15.8 13.5 10.4 11.8 17.5 3.2 10.6 9.3 12.8 17.7 12.3 26.1 14.6 12.3 11.0 29.6 9.2 14.0 8.1 8.1 6.3 6.7 7.8 6.3 7.6 7.3 6.9 8.7 6.1 6.0 8.5 7.7 0.9 5.3 5.8 11.1 9.2 3.8 22.2 40.5 30.5 29.9 22.7 5.9 39.5 15.0 26.4 34.2 17.9 16.3 23.9 39.0 25.0 27.0 16.8 28.1 5.3 10.3 26.2 25.5 20.5 44.7 10.7 0.9 23.7 23.1 0.0 12.8 38.8 22.6 37.4 11.5 32.1 26.3 12.7 17.1 14.1 12.6 1.4 18.1 23.2 25.3 11.8 23.0 15.2 11.3 8.6 17.7 74.7 25.1 6.5 31.3 5.1 12.1 23.2 24.6 27.7 32.2 44.8 GUF1 FLJ13220 ENSG00000151806 "GUF1 homolog, GTPase" Q8N442 4 44678427-44700926 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003934, HPA024222" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003934: AB_1079034, HPA024222: AB_2671488" "unprognostic (1.32e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-2)" "unprognostic (3.65e-3)" "unprognostic (7.56e-2)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.37e-2)" "unprognostic (3.03e-2)" "unprognostic (1.56e-3)" "unprognostic (7.38e-3)" "prognostic favorable (2.66e-6)" "unprognostic (4.98e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.65e-5)" "unprognostic (5.40e-2)" 10.0 11.3 12.7 7.5 16.6 11.4 10.8 9.7 17.7 7.6 11.5 9.4 8.7 9.4 10.2 9.1 13.2 8.9 7.9 12.3 12.6 9.9 15.1 16.0 6.6 10.8 10.4 11.6 10.6 9.3 11.5 11.3 7.8 13.0 10.6 12.4 7.4 10.4 8.0 31.1 11.5 12.5 7.6 11.8 9.7 15.4 11.7 11.1 13.9 11.2 13.1 9.3 11.7 9.2 4.8 4.7 4.6 6.1 5.2 7.0 3.9 7.7 3.9 7.4 9.4 3.1 6.4 16.3 10.6 5.6 11.1 8.6 7.0 5.6 16.9 8.5 5.2 10.1 6.2 12.7 12.3 12.7 5.7 8.1 20.2 3.4 4.8 10.0 21.9 8.7 6.4 5.6 8.2 7.2 5.2 7.9 10.1 20.3 3.3 8.9 3.8 12.2 4.6 4.8 5.6 9.3 8.8 15.3 7.1 3.3 3.0 10.2 7.6 6.8 2.9 7.5 6.0 4.5 6.4 7.9 7.6 8.8 10.1 12.7 12.2 11.1 12.4 8.3 13.1 6.4 1.1 4.6 4.6 4.7 6.1 6.1 4.8 4.7 4.2 4.3 4.4 4.5 4.6 0.1 5.2 4.0 4.7 7.0 3.9 12.7 16.6 9.7 17.7 12.6 9.9 10.4 11.6 13.0 11.1 6.0 7.4 12.1 7.4 3.5 9.7 19.3 2.5 22.7 10.3 7.0 2.0 11.2 11.6 7.9 1.4 6.8 9.1 23.3 8.8 14.4 7.3 8.4 1.1 13.4 10.4 11.1 10.9 10.4 11.7 1.5 5.2 6.6 6.8 6.4 12.4 8.6 11.9 5.8 6.7 8.4 10.2 0.0 8.2 9.2 9.6 6.1 11.2 8.9 11.9 9.1 HCFC1 "CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF" ENSG00000172534 "Host cell factor C1" P51610 X 153947553-153971807 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018312, HPA078588" Supported Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA018312: AB_1850522, HPA078588: " "unprognostic (2.05e-3)" "unprognostic (2.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (2.64e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.62e-5)" "unprognostic (1.45e-1)" "unprognostic (1.29e-3)" "unprognostic (1.99e-2)" "unprognostic (2.12e-1)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" 16.0 19.2 18.2 23.7 18.5 48.3 14.2 24.4 23.3 13.9 20.0 17.3 14.1 16.8 26.3 13.6 18.2 18.8 20.8 14.7 17.0 12.7 15.6 17.2 19.0 24.9 14.6 16.1 20.4 15.6 21.9 26.4 13.8 15.8 17.7 11.2 13.8 21.5 20.6 27.8 18.2 18.3 19.7 20.0 25.2 18.0 15.3 17.9 52.3 16.4 15.6 17.6 17.4 18.3 4.8 8.0 1.7 5.6 2.8 6.7 3.5 15.4 20.1 13.7 17.3 5.7 4.1 20.1 6.3 4.9 7.5 6.9 21.2 10.4 28.1 16.3 8.2 12.4 12.7 14.7 10.4 3.9 14.8 17.3 16.8 16.0 16.6 3.9 20.6 27.9 6.4 6.8 13.1 5.7 4.5 8.0 20.5 23.3 17.8 5.3 21.6 28.5 26.7 17.7 10.1 12.4 33.3 11.3 16.9 5.7 14.4 15.2 16.5 11.7 12.2 6.5 6.9 11.2 18.6 10.5 14.4 17.8 12.4 20.4 28.3 38.7 35.2 11.7 20.1 13.6 1.7 4.0 1.7 6.0 5.6 4.3 4.8 4.8 4.6 4.5 4.4 4.9 6.7 0.8 2.8 4.0 8.0 3.2 3.5 18.2 18.5 24.4 23.3 17.0 12.7 14.6 16.1 15.8 17.9 17.9 19.1 10.4 11.5 14.7 17.2 34.6 17.8 4.0 9.1 12.2 13.7 13.4 3.3 15.2 0.4 15.8 11.7 0.0 14.1 18.9 12.9 17.4 3.5 23.1 18.5 19.1 18.4 19.0 30.2 1.3 16.1 12.5 5.0 16.2 20.4 15.0 16.1 7.0 20.5 8.6 11.5 6.5 13.7 6.5 25.1 12.2 13.3 17.5 20.9 13.1 HDGFL2 "Hdgfrp2, HRP2" ENSG00000167674 "HDGF like 2" Q7Z4V5 19 4472287-4502211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042559, HPA044208" Enhanced Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA042559: AB_2678049, HPA044208: AB_2678858" "unprognostic (1.33e-1)" "unprognostic (2.38e-2)" "unprognostic (5.47e-3)" "unprognostic (6.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.96e-2)" "unprognostic (1.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "prognostic favorable (6.57e-4)" "unprognostic (2.12e-2)" "unprognostic (1.36e-1)" "unprognostic (9.73e-3)" "unprognostic (4.75e-1)" "unprognostic (1.58e-1)" "unprognostic (2.05e-1)" 10.3 9.6 15.4 10.0 13.6 8.1 10.3 15.3 21.0 9.7 8.8 9.0 8.0 10.1 12.3 10.4 6.6 10.2 9.9 8.5 16.6 13.5 9.8 9.9 7.3 10.2 11.9 13.2 15.9 10.6 8.3 10.2 9.6 10.5 10.1 5.0 7.8 11.3 16.8 39.4 10.9 9.2 12.0 8.8 10.3 9.2 49.1 9.5 13.6 7.3 6.2 7.4 7.7 9.0 7.0 2.2 3.6 1.8 2.3 2.4 0.8 27.7 16.4 28.5 26.4 12.4 12.7 19.9 22.4 12.1 24.7 22.0 18.7 12.1 24.5 13.1 16.4 13.0 15.9 18.9 20.4 14.5 27.3 30.0 15.0 12.3 24.6 16.1 14.8 21.5 18.1 11.1 16.9 8.3 17.6 22.5 23.2 17.2 30.9 11.9 19.7 33.4 29.7 32.6 11.2 29.5 33.3 23.5 15.7 15.3 14.2 31.5 31.1 21.8 12.5 18.1 16.3 12.3 23.6 29.7 15.6 21.4 29.3 21.1 38.4 20.0 17.2 21.9 23.9 16.4 0.0 1.8 3.6 1.4 1.1 0.4 1.1 1.5 1.1 1.6 7.0 2.4 0.9 0.5 2.3 0.6 2.2 1.8 0.8 15.4 13.6 15.3 21.0 16.6 13.5 11.9 13.2 10.5 9.5 6.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 17.4 9.1 12.2 0.0 31.1 16.6 22.5 0.0 0.0 0.0 0.0 17.5 24.9 0.0 0.0 1.1 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 26.2 0.0 0.0 19.1 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 HEATR1 "BAP28, FLJ10359, UTP10" ENSG00000119285 "HEAT repeat containing 1" Q9H583 1 236549005-236604504 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046917, HPA062200" Approved Enhanced "Nucleoli fibrillar center,Mitochondria" NA NA 120000 "Nucleoli fibrillar center" Mitochondria "HPA046917: AB_2679863, HPA062200: AB_2684709" "unprognostic (2.61e-1)" "unprognostic (1.44e-3)" "unprognostic (6.26e-2)" "unprognostic (1.34e-3)" "unprognostic (7.18e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (5.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.80e-1)" "unprognostic (4.67e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (8.08e-2)" "unprognostic (3.38e-1)" "unprognostic (3.27e-2)" "unprognostic (4.00e-2)" 14.1 11.0 9.2 14.7 11.3 15.2 13.8 15.0 13.9 10.7 10.6 8.6 8.3 7.6 15.9 9.4 14.7 12.5 8.1 9.4 10.0 5.8 9.9 13.2 10.6 16.5 12.9 6.9 15.8 17.2 13.5 12.8 10.5 11.6 11.1 10.8 8.2 12.6 9.5 12.7 14.5 11.6 13.1 6.6 16.1 11.5 20.3 13.2 18.3 12.0 12.8 17.9 12.7 12.8 9.9 5.9 1.8 4.5 6.4 10.0 2.4 14.5 17.5 9.2 13.9 12.9 14.5 20.6 11.8 7.6 13.6 12.2 17.6 12.4 23.9 13.3 10.8 8.4 17.7 20.9 12.6 18.5 12.0 24.0 17.0 12.5 15.0 11.6 30.3 11.0 11.8 11.4 20.5 17.8 6.6 15.5 11.1 38.4 8.1 13.5 7.8 14.3 8.3 36.7 18.7 7.2 16.0 13.3 22.4 8.7 14.7 8.6 19.2 14.3 10.2 12.2 6.4 12.1 11.4 14.7 13.7 12.9 17.6 29.1 15.4 19.2 28.3 12.2 17.0 20.3 1.8 3.6 1.1 7.3 4.5 6.6 9.9 7.2 7.9 4.3 8.1 10.0 9.4 0.5 6.4 4.3 5.9 5.9 2.4 9.2 11.3 15.0 13.9 10.0 5.8 12.9 6.9 11.6 13.2 3.0 10.9 8.8 9.3 17.5 11.2 3.5 12.7 12.0 14.8 5.2 17.7 7.0 3.3 7.4 5.7 10.0 2.7 0.0 7.1 8.9 9.9 7.4 31.3 8.9 6.6 6.4 4.1 11.1 10.0 0.9 13.0 7.4 1.7 6.4 5.5 4.4 10.4 2.9 9.6 3.5 10.4 0.0 9.2 21.3 30.8 14.8 4.1 10.2 8.3 9.1 HEXDC FLJ23825 ENSG00000169660 "Hexosaminidase D" Q8WVB3 17 82418318-82442645 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 30.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022834, HPA023379, HPA027844" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center, Mitochondria" "HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711" "unprognostic (8.69e-3)" "prognostic favorable (7.70e-4)" "unprognostic (7.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.51e-2)" "prognostic favorable (2.71e-4)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (2.71e-1)" "unprognostic (1.14e-2)" "prognostic favorable (5.57e-4)" "unprognostic (9.04e-3)" "unprognostic (1.83e-1)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.52e-5)" 12.7 8.5 7.1 16.6 9.3 14.3 8.7 13.2 7.3 10.1 7.6 8.8 12.8 8.0 10.0 11.1 7.9 10.3 9.4 5.7 7.2 4.6 9.9 11.6 12.4 11.6 12.8 5.5 13.6 72.9 10.2 14.6 5.7 7.4 14.1 4.2 7.0 13.3 9.2 20.4 11.3 12.3 6.0 6.1 15.6 8.8 4.7 11.4 8.6 11.7 8.6 10.7 8.3 8.8 5.9 30.3 3.3 11.5 11.9 9.8 4.4 3.0 7.7 3.4 5.3 10.4 9.0 10.5 3.9 4.8 4.1 4.7 2.7 10.4 8.1 4.3 1.6 2.8 4.3 2.0 2.3 1.9 5.6 13.1 3.6 6.8 4.5 9.3 2.4 9.3 6.4 2.3 1.1 4.2 5.6 5.3 6.2 4.6 2.8 1.1 7.0 8.4 9.0 3.1 5.6 4.7 10.0 2.9 15.8 3.1 4.6 4.8 10.2 8.1 5.3 7.3 1.6 8.5 9.2 5.3 2.7 5.1 2.0 2.7 12.7 2.4 6.0 2.1 6.9 2.7 3.3 1.7 2.7 9.8 11.5 6.5 4.6 2.2 3.4 2.0 5.9 3.5 5.1 3.0 11.9 4.9 30.3 1.4 4.4 7.1 9.3 13.2 7.3 7.2 4.6 12.8 5.5 7.4 11.4 3.0 8.5 8.3 9.5 4.1 19.2 4.4 12.7 9.4 12.5 17.4 17.7 4.7 8.3 5.4 1.2 8.0 16.8 0.0 8.2 5.3 6.2 10.5 10.3 12.9 13.7 39.7 13.3 16.0 9.5 2.1 33.1 11.5 5.0 16.2 14.4 18.7 5.8 10.1 23.3 6.1 29.0 19.4 6.2 6.0 10.2 2.0 3.3 12.9 12.0 7.5 HEYL "bHLHb33, HESR3, HEY3" ENSG00000163909 "Hes related family bHLH transcription factor with YRPW motif-like" Q9NQ87 1 39624153-39639945 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 66.3" "Cell type enhanced" "Detected in many" 13 "Leydig cells: 24.2;Peritubular cells: 53.4;Sertoli cells: 51.8;Smooth muscle cells: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 6.5;LHCN-M2: 17.6;RH-30: 21.7;THP-1: 5.0;U-266/84: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001438, HPA076960" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA001438: AB_1079052, HPA076960: AB_2732326" "unprognostic (1.98e-2)" "unprognostic (7.92e-2)" "unprognostic (4.19e-3)" "unprognostic (3.49e-1)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (7.20e-2)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (2.35e-1)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.26e-6)" "prognostic unfavorable (3.57e-4)" "unprognostic (2.67e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.63e-5)" 10.0 8.3 2.9 4.7 6.2 0.5 6.5 1.8 4.0 14.7 4.4 2.9 5.1 1.9 21.7 13.2 4.0 11.2 13.9 28.2 3.2 4.8 12.3 3.3 12.5 2.0 6.8 2.9 14.4 66.3 1.7 8.2 22.1 7.1 8.1 2.9 10.9 2.3 11.4 8.9 1.9 2.7 18.9 2.4 4.5 3.4 25.4 4.4 0.0 11.0 6.8 1.9 6.0 8.8 1.1 0.5 0.0 0.3 0.0 0.1 0.0 0.0 2.4 4.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 1.6 0.2 0.0 1.4 0.4 0.0 0.0 2.2 0.0 0.2 0.0 2.6 4.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.5 0.4 0.5 17.6 1.4 0.0 0.0 0.0 0.2 0.1 1.1 21.7 0.1 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.9 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.2 1.8 4.0 3.2 4.8 6.8 2.9 7.1 4.4 0.0 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 0.7 0.0 0.0 3.1 0.2 3.8 0.2 0.0 0.0 0.3 1.6 0.0 1.3 0.0 11.8 24.2 1.1 5.0 0.0 0.0 0.2 4.5 0.0 53.4 0.0 3.7 51.8 35.4 0.1 1.7 0.1 0.2 0.0 0.4 0.1 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689951-92695646 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 71.4" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 94.3;Ductal cells: 86.4;Endothelial cells: 66.2;Hepatocytes: 48.7;Hofbauer cells: 58.0;Ito cells: 65.1;Kupffer cells: 61.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 56.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 46 "basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 26.0;HEL: 28.2;HMC-1: 31.3;HUVEC TERT2: 30.9;K-562: 42.9;NB-4: 28.6;U-937: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051894, HPA055460" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051894: AB_2681653, HPA055460: AB_2682820" "prognostic favorable (8.83e-4)" "prognostic favorable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 6.3 8.2 2.8 12.0 3.6 28.1 13.7 0.9 2.2 4.5 3.2 3.0 1.1 2.3 3.6 3.8 2.9 2.7 18.0 7.3 2.8 2.1 2.8 33.1 15.3 29.7 3.6 0.9 1.9 15.6 0.7 1.5 6.4 2.8 4.3 2.4 2.3 1.9 1.6 2.8 2.2 8.4 9.3 2.9 18.3 2.7 1.9 2.8 1.8 71.4 2.0 11.3 6.5 7.1 25.0 13.5 21.4 17.8 0.3 0.3 4.9 3.1 5.9 3.1 0.0 0.2 0.2 0.0 1.6 13.5 2.2 1.9 1.1 0.7 3.0 26.0 0.2 0.0 0.6 2.7 0.0 2.7 0.0 3.2 28.2 2.4 19.0 6.3 16.4 31.3 0.0 0.0 1.9 0.0 1.1 30.9 0.0 42.9 0.0 0.1 0.9 0.1 28.6 0.0 8.6 3.4 9.6 0.9 0.0 0.2 1.2 1.4 0.3 1.8 0.0 0.0 0.1 0.9 8.7 10.7 0.0 0.1 0.0 0.0 0.7 0.5 6.0 0.0 22.7 14.9 7.9 14.7 21.4 0.3 16.4 0.1 21.4 0.0 0.0 11.3 25.0 0.0 0.0 11.8 0.3 17.8 13.5 0.1 4.9 2.8 3.6 0.9 2.2 2.8 2.1 3.6 0.9 2.8 2.8 0.0 4.8 30.4 1.6 5.7 0.0 2.0 94.3 1.4 2.3 0.0 0.0 0.5 0.0 86.4 0.2 66.2 0.0 0.0 10.0 0.8 2.1 2.9 6.9 48.7 58.0 0.0 5.1 65.1 61.3 0.4 0.3 22.7 6.8 1.8 0.3 0.0 14.5 0.0 1.1 0.0 0.0 0.0 1.9 0.2 1.4 3.1 0.9 5.2 0.2 0.6 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 9.4;testis: 10.4;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.3 0.7 0.0 0.1 0.6 0.1 0.2 0.1 1.4 0.7 0.0 0.6 0.0 0.0 0.1 0.5 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.9 9.4 0.2 0.3 1.9 3.9 0.0 0.1 0.1 0.0 0.0 0.1 0.1 10.4 0.0 0.0 4.6 0.0 0.3 0.2 0.7 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 16.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.3 0.0 18.4 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.1 0.0 9.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.0 0.0 0.0 0.0 0.0 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42784298-42804531 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 535.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 89.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favorable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favorable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 27.7 30.4 50.1 15.5 43.4 9.6 20.4 20.3 56.4 18.3 63.8 25.2 10.8 35.2 15.7 24.8 36.7 13.5 18.8 68.6 43.2 43.3 45.9 78.4 15.3 16.0 54.4 35.9 12.8 12.8 14.7 29.2 17.2 50.9 24.4 67.3 21.8 16.6 26.8 34.9 15.0 28.4 22.8 58.8 13.0 31.6 14.7 20.7 8.9 28.1 30.6 16.9 20.1 25.0 11.9 89.9 25.9 26.6 12.3 18.8 30.1 27.4 15.4 34.3 28.1 87.8 52.5 33.4 37.1 30.5 36.4 33.4 27.2 28.0 16.8 22.3 32.4 22.6 16.6 27.5 40.9 45.5 24.1 30.4 51.9 27.7 50.3 40.1 29.8 24.5 54.4 45.0 27.8 38.8 18.1 31.9 25.6 51.2 18.0 50.7 11.2 16.4 10.9 28.8 23.3 37.6 13.4 24.3 11.9 89.7 68.2 14.5 18.9 32.5 24.7 35.0 35.7 24.7 22.5 27.9 21.5 19.5 60.1 38.3 16.8 34.7 34.7 28.3 31.7 16.6 16.9 14.7 25.9 15.4 22.7 13.7 11.9 15.1 15.1 16.3 8.5 12.9 15.3 14.9 12.3 26.6 89.9 18.8 30.1 50.1 43.4 20.3 56.4 43.2 43.3 54.4 35.9 50.9 20.7 50.6 73.8 43.3 134.0 116.5 33.4 319.5 79.0 48.2 60.3 130.9 9.8 99.0 535.5 105.9 6.7 57.3 183.7 93.5 127.6 162.8 82.5 160.2 92.2 169.5 69.4 27.0 78.7 55.3 46.3 9.1 28.4 70.1 167.0 114.6 120.5 121.0 198.7 300.1 49.1 213.1 25.1 77.6 125.8 135.9 72.8 178.8 250.8 45.7 135.9 173.3 HIGD2A "MGC2198, RCF1B" ENSG00000146066 "HIG1 hypoxia inducible domain family member 2A" Q9BW72 5 176388747-176389771 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042715 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA042715: AB_2678127" "unprognostic (9.24e-2)" "unprognostic (6.31e-3)" "unprognostic (7.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (1.98e-2)" "unprognostic (3.11e-3)" "unprognostic (9.56e-2)" "unprognostic (2.39e-2)" "unprognostic (1.45e-1)" "unprognostic (8.09e-2)" "unprognostic (1.78e-1)" "unprognostic (9.65e-2)" 37.2 38.5 31.4 33.5 36.0 34.9 37.5 21.4 33.2 26.8 43.8 22.5 29.7 36.7 25.7 31.1 47.0 31.5 39.4 80.0 28.5 26.6 46.3 56.1 30.1 54.1 30.3 20.0 33.2 42.6 36.6 28.8 26.4 21.0 41.2 30.9 31.2 64.0 32.6 115.9 27.8 38.1 43.3 25.9 37.3 31.6 28.8 15.0 63.1 42.3 53.8 34.3 42.1 28.7 70.4 104.6 25.5 107.7 31.1 67.6 88.9 17.9 31.7 19.0 32.1 19.9 38.1 49.8 11.3 21.6 33.0 41.6 33.1 38.0 32.7 27.6 20.6 40.3 23.2 28.7 50.7 13.2 76.6 45.1 16.1 32.7 45.3 28.0 25.1 43.9 48.3 42.2 18.6 22.6 24.3 27.7 27.5 17.8 65.9 24.2 59.3 28.5 31.9 22.4 34.6 34.9 27.7 14.1 59.1 51.6 29.9 20.0 26.7 12.9 54.6 55.5 20.3 32.6 42.3 17.3 22.5 23.3 20.6 23.5 30.7 36.6 26.6 29.1 45.1 14.1 25.5 84.5 23.8 46.3 106.5 45.8 70.4 64.9 53.5 104.6 52.2 59.6 55.6 14.4 31.1 107.7 68.6 67.6 88.9 31.4 36.0 21.4 33.2 28.5 26.6 30.3 20.0 21.0 15.0 68.5 61.2 245.0 289.8 206.3 55.1 130.4 180.9 116.4 104.6 172.7 11.8 187.5 452.6 160.5 55.4 114.7 272.4 23.3 206.0 150.2 154.5 216.1 128.0 198.8 329.3 62.0 256.0 111.7 344.3 44.7 129.8 304.5 244.6 408.4 365.8 77.7 132.6 412.7 79.9 405.0 38.4 116.4 130.6 108.0 81.6 196.7 234.3 221.4 328.6 443.0 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Group enriched" "Detected in some" 13 "Early spermatids: 11.0;Late spermatids: 7.1;Spermatocytes: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: AB_2678127" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.0 0.6 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 0.9 0.7 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 15.1 0.9 0.1 0.1 0.0 0.0 0.1 HKR1 ZNF875 ENSG00000181666 "HKR1, GLI-Kruppel zinc finger family member" P10072 19 37312837-37369365 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 102.1;Rod photoreceptor cells: 129.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA036126, HPA044855" Approved Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA036126: AB_10670708, HPA044855: AB_2679113" "unprognostic (1.04e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-1)" "unprognostic (3.58e-1)" "unprognostic (2.78e-1)" "unprognostic (4.81e-2)" "unprognostic (2.29e-1)" "unprognostic (1.02e-3)" "unprognostic (4.92e-3)" "unprognostic (9.82e-2)" "prognostic favorable (4.41e-4)" "prognostic unfavorable (5.18e-5)" "unprognostic (1.34e-1)" "unprognostic (5.04e-2)" "unprognostic (2.00e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" 13.0 25.8 14.6 13.2 22.4 12.6 24.9 29.8 27.2 20.5 14.5 22.9 21.5 7.7 24.8 24.1 12.4 22.9 17.9 26.9 14.6 15.6 19.3 12.3 12.9 14.3 14.9 17.4 22.6 14.2 31.0 35.5 17.2 21.2 27.5 13.8 49.4 18.7 19.3 18.1 27.1 13.4 17.0 13.3 20.2 14.2 22.6 15.5 16.4 30.9 13.7 20.1 15.0 15.6 12.4 7.9 10.0 5.1 9.9 14.8 5.7 4.1 10.4 13.5 17.9 9.9 8.6 9.4 7.0 10.7 13.1 14.2 5.2 4.9 14.6 17.1 7.4 5.9 3.5 8.8 9.4 13.6 7.6 15.0 5.1 12.6 5.6 13.0 4.7 12.5 12.7 11.6 8.8 19.4 13.4 7.9 10.5 0.9 0.9 9.4 8.4 10.5 9.3 27.1 7.2 6.0 7.1 5.9 5.6 11.4 16.8 16.8 22.8 7.0 9.0 8.8 20.6 12.8 9.0 7.1 10.4 7.5 7.8 10.9 18.8 19.7 15.1 1.1 5.8 11.6 10.0 4.2 6.6 8.0 5.1 14.8 10.7 10.6 11.4 6.3 12.4 14.4 12.0 4.0 9.9 3.6 7.9 12.2 5.7 14.6 22.4 29.8 27.2 14.6 15.6 14.9 17.4 21.2 15.5 6.0 2.9 7.8 6.4 4.6 45.3 16.5 2.5 18.7 11.4 10.4 102.1 9.3 16.6 7.7 9.5 11.1 2.9 0.0 6.8 4.6 6.1 9.7 11.5 5.9 6.1 39.7 9.2 9.2 3.7 5.9 11.2 5.5 8.5 9.0 5.0 22.8 5.1 3.5 12.0 10.9 129.7 6.5 7.6 15.5 16.3 5.4 8.2 8.5 5.4 7.3 HMGN5 NSBP1 ENSG00000198157 "High mobility group nucleosome binding domain 5" P82970 X 81113701-81201942 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.0;Karpas-707: 66.4" "Low region specificity" "Detected in all" "HPA000511, HPA076238" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000511: AB_1079505, HPA076238: " "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (3.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (9.63e-3)" "prognostic favorable (6.60e-4)" "unprognostic (2.78e-3)" "unprognostic (1.16e-1)" "unprognostic (2.32e-3)" "unprognostic (3.06e-2)" "unprognostic (1.07e-1)" "unprognostic (6.53e-2)" "unprognostic (1.08e-1)" 5.2 11.4 14.7 3.1 15.6 12.5 6.5 6.0 12.0 8.6 10.6 5.1 12.3 10.2 7.7 30.9 9.8 7.5 4.8 5.4 16.1 14.3 16.2 9.9 3.9 2.0 13.2 10.1 9.5 5.6 11.9 39.8 2.0 10.4 7.0 7.9 3.5 5.6 9.3 3.6 5.2 10.8 7.3 22.1 8.2 5.9 48.6 19.6 10.9 8.1 8.6 2.7 7.8 6.0 6.5 11.0 2.8 3.1 3.4 10.2 3.4 0.2 2.2 5.9 28.8 5.0 1.6 1.2 1.6 2.5 0.4 0.7 0.7 10.9 45.0 5.1 0.7 0.4 1.9 34.8 4.1 1.1 26.3 13.9 18.8 21.2 0.3 0.5 31.2 18.6 1.3 1.1 1.8 1.7 1.6 2.3 29.0 24.8 66.4 2.9 1.0 28.4 11.1 26.2 6.3 7.6 1.1 24.6 21.2 7.1 0.8 0.2 0.7 0.2 0.6 1.9 5.3 3.6 7.4 2.6 0.9 7.7 4.5 6.1 4.6 1.9 7.2 2.8 12.3 1.6 2.0 3.1 1.4 8.5 1.6 7.7 3.6 5.2 4.6 5.3 6.5 10.2 8.7 2.8 3.4 2.5 11.0 1.7 3.4 14.7 15.6 6.0 12.0 16.1 14.3 13.2 10.1 10.4 19.6 8.9 13.1 10.4 21.3 14.2 2.8 11.3 17.8 72.3 14.8 43.6 0.0 0.5 58.0 9.9 14.1 16.1 17.1 70.0 16.2 0.4 10.2 18.1 12.7 74.1 13.2 1.6 16.7 19.0 13.3 43.8 27.3 13.9 8.5 1.0 22.4 20.4 6.7 17.5 38.5 60.3 1.5 45.3 19.4 7.2 8.4 13.0 0.3 7.5 39.1 17.4 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326905-45328533 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 38.4" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 35 "hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8" "HPA031997, HPA057346" Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA031997: AB_10602909, HPA057346: AB_2683415" "prognostic favorable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.9 0.7 2.7 3.1 4.2 3.6 1.0 7.6 3.4 2.0 8.4 2.4 0.0 5.4 1.0 1.3 3.6 1.0 1.8 3.0 2.7 2.4 0.7 0.2 0.8 2.6 2.5 1.8 1.0 0.3 0.2 0.4 5.1 3.1 1.7 7.1 38.4 1.3 0.6 3.3 1.1 4.7 0.9 2.2 2.8 7.8 1.4 0.6 6.4 1.0 4.2 2.3 0.8 1.6 3.1 0.7 0.0 0.3 2.1 1.5 0.8 0.0 0.4 0.1 0.0 0.0 0.1 47.2 0.6 0.0 0.8 0.2 11.7 3.1 2.4 0.1 0.6 0.0 2.8 0.0 0.1 0.2 0.0 0.1 0.2 5.1 0.0 0.3 13.3 0.3 0.5 0.1 0.5 0.0 0.0 0.9 0.0 0.0 2.2 0.1 5.8 8.6 16.6 0.2 9.1 0.0 2.6 0.0 7.7 0.1 0.1 9.3 0.6 6.0 29.8 4.6 0.6 0.0 2.5 0.4 0.0 0.1 0.4 0.0 0.3 0.1 8.3 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 1.5 3.1 0.7 1.2 0.7 0.3 0.9 0.8 0.0 2.1 0.0 0.0 0.4 0.8 2.7 4.2 7.6 3.4 2.7 2.4 2.5 1.8 3.1 0.6 0.0 0.0 1.9 1.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 24.6 3.3 0.5 0.1 0.3 0.7 0.0 0.0 1.7 0.4 0.9 0.0 0.0 2.1 0.0 1.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 3.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.4 0.0 2.1 1.0 4.2 0.0 6.6 1.0 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58318574 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066812, HPA077228" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA066812: AB_2685727, HPA077228: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.9 8.9 9.0 6.6 13.9 6.9 9.4 17.0 11.5 7.4 9.2 6.4 7.1 11.3 8.6 8.5 9.4 7.8 7.1 15.9 7.9 9.3 12.1 16.2 6.9 8.2 8.5 10.7 11.0 12.9 8.8 14.2 6.7 7.8 9.6 10.1 9.7 9.2 9.4 35.2 7.2 9.7 12.6 6.0 9.7 8.6 9.8 6.4 6.8 10.7 19.8 9.2 7.8 8.1 23.9 21.6 23.7 20.4 21.3 26.5 13.5 8.2 6.3 9.6 6.8 8.2 9.2 12.3 11.7 8.9 14.6 12.9 13.7 6.2 16.3 3.5 8.4 11.7 7.2 16.0 10.6 15.0 9.1 11.2 9.8 13.9 11.5 8.9 12.8 9.3 11.3 10.9 15.5 9.4 7.8 12.7 12.1 9.6 15.5 9.1 4.8 8.3 6.5 12.4 8.4 14.2 5.8 6.1 11.7 9.8 12.1 6.0 9.0 7.2 6.8 13.3 10.6 9.1 11.4 7.4 12.4 8.8 11.2 14.3 11.9 21.3 12.7 10.0 9.5 7.5 13.5 17.3 23.7 18.7 20.4 20.1 23.9 18.7 23.5 17.5 23.8 26.5 20.2 18.4 21.3 16.7 21.6 13.4 13.5 9.0 13.9 17.0 11.5 7.9 9.3 8.5 10.7 7.8 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IDH3G ENSG00000067829 "Isocitrate dehydrogenase 3 (NAD(+)) gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 24.5 34.0 27.7 26.8 47.2 37.1 24.1 37.2 61.5 25.0 28.8 25.7 24.6 34.7 26.6 21.3 31.8 29.4 25.6 50.8 35.0 25.2 40.6 29.5 20.9 25.6 27.3 35.6 31.8 40.5 29.1 24.9 22.5 40.5 21.4 25.2 26.0 34.5 29.8 54.9 36.3 34.9 24.8 20.1 26.9 24.8 16.0 23.3 31.2 24.3 37.1 28.2 24.4 21.1 20.6 45.5 43.7 44.4 23.7 28.8 33.6 29.1 26.9 15.9 22.3 24.9 20.7 19.5 15.2 21.4 27.0 28.7 22.2 22.2 37.1 26.3 24.4 22.1 21.8 24.0 20.7 9.9 12.2 30.7 13.9 36.5 17.8 28.3 19.4 29.4 23.2 15.0 20.8 22.7 17.4 20.6 15.5 7.7 20.4 21.7 40.8 22.0 22.8 7.1 27.1 35.6 19.4 13.6 32.3 30.1 18.2 20.3 13.9 9.5 32.2 15.1 6.8 13.3 16.7 18.2 17.1 10.7 25.1 35.9 28.1 7.0 47.3 28.0 24.0 18.9 42.5 43.9 43.7 21.5 44.4 19.9 19.1 22.0 20.9 45.5 20.6 17.6 19.2 16.3 23.7 43.1 27.9 28.8 33.6 27.7 47.2 37.2 61.5 35.0 25.2 27.3 35.6 40.5 23.3 32.8 32.7 56.5 52.5 71.9 33.9 48.4 43.3 30.8 7.9 48.8 27.5 80.9 175.8 81.7 113.6 44.1 164.4 46.7 79.1 82.6 56.8 36.9 91.2 33.0 116.8 17.5 59.8 43.6 88.9 226.7 49.5 66.0 64.1 101.0 81.8 37.0 65.2 122.8 55.2 192.8 37.1 51.8 69.3 14.0 17.0 67.8 92.7 54.5 93.0 43.8 IDNK "bA522I20.2, C9orf103, hGntK" ENSG00000148057 "IDNK, gluconokinase" Q5T6J7 9 83623049-83644130 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.9;liver: 39.1" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 68.0;Proximal tubular cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020378, HPA058429" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA020378: AB_1845794, HPA058429: AB_2683716" "unprognostic (1.49e-3)" "unprognostic (7.94e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (5.41e-3)" "unprognostic (1.81e-2)" "unprognostic (6.08e-2)" "unprognostic (1.57e-1)" "unprognostic (2.61e-2)" "unprognostic (3.00e-1)" "unprognostic (5.86e-3)" "unprognostic (7.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.55e-1)" "unprognostic (3.11e-2)" 4.3 6.1 9.4 2.9 20.3 2.2 4.5 12.3 8.3 2.3 11.3 7.0 3.1 14.2 2.5 7.4 4.1 6.8 4.5 2.8 7.6 8.6 27.2 39.1 3.7 4.7 7.3 6.3 3.2 6.6 3.6 5.2 1.8 6.2 4.2 4.7 5.2 4.6 5.0 1.2 3.3 20.2 3.5 7.0 4.2 4.3 2.0 6.8 14.5 7.0 1.2 4.3 2.8 2.1 17.5 9.6 35.9 20.5 15.0 23.0 11.4 3.4 8.2 1.1 1.3 3.7 5.4 6.0 2.3 6.9 2.6 2.1 2.1 3.0 4.3 4.0 3.7 2.5 5.7 0.9 1.6 2.8 9.5 1.0 1.6 3.2 9.4 16.4 1.0 2.0 3.7 2.2 5.7 5.4 3.9 5.9 10.3 1.3 4.6 3.8 19.0 2.6 1.0 0.9 13.8 3.7 3.2 3.1 2.5 6.9 4.0 5.3 6.8 5.5 4.3 5.8 1.6 4.3 5.8 6.0 1.1 0.8 10.7 4.4 6.6 7.6 0.6 5.9 1.8 2.1 35.9 6.1 8.6 14.7 10.6 12.3 17.5 12.7 12.1 8.5 11.4 10.2 13.8 1.1 15.0 20.5 9.6 23.0 11.4 9.4 20.3 12.3 8.3 7.6 8.6 7.3 6.3 6.2 6.8 11.9 5.4 5.9 2.6 6.1 7.5 8.7 15.3 22.7 9.1 5.2 0.0 6.3 68.0 10.1 0.3 6.0 10.8 0.0 14.3 3.8 8.4 5.2 19.7 37.2 10.0 9.5 7.0 3.1 9.5 1.1 4.0 7.7 11.8 27.9 10.6 17.7 5.2 11.5 3.9 149.6 3.1 0.0 9.5 1.1 1.5 5.1 2.5 17.5 7.8 2.7 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327894-89340971 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 80.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 80.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;BJ hTERT+ SV40 Large T+: 82.1;BJ hTERT+ SV40 Large T+ RasG12V: 95.4" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA059914: AB_2684159" "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 50.5 15.7 14.9 11.3 17.3 22.1 10.6 6.9 17.0 6.8 9.7 7.6 4.1 14.5 8.8 16.8 6.2 10.9 15.1 8.9 14.2 12.9 19.3 17.0 25.9 10.0 13.5 12.4 11.3 4.3 3.8 5.5 22.9 23.0 9.7 5.4 9.2 19.6 8.1 8.1 5.0 11.3 11.1 18.4 26.0 7.2 5.1 12.1 14.3 14.9 5.5 2.9 11.0 5.9 1.6 2.5 80.0 18.4 0.3 2.6 3.2 6.4 0.4 0.1 1.7 7.5 8.1 0.0 4.1 35.1 82.1 95.4 0.3 9.2 0.5 1.8 6.6 19.1 5.8 0.1 0.8 6.1 0.9 0.0 2.4 1.8 0.2 4.3 0.7 2.1 5.0 0.1 7.1 0.6 3.1 0.5 0.2 0.1 1.4 2.1 0.0 1.5 1.9 0.1 0.0 2.0 1.5 0.5 0.4 2.3 3.0 0.0 0.0 0.7 0.1 16.1 0.2 0.2 0.8 0.6 1.3 0.2 2.2 1.0 2.3 1.8 0.1 1.9 3.0 1.3 15.2 7.5 26.6 0.7 16.0 0.1 1.6 1.1 0.5 2.5 1.4 0.7 0.8 80.0 0.3 18.4 0.5 2.6 3.2 14.9 17.3 6.9 17.0 14.2 12.9 13.5 12.4 23.0 12.1 47.6 8.5 5.9 8.9 2.9 7.9 30.7 12.7 16.0 15.9 8.7 3.9 3.4 18.3 47.8 0.3 46.8 13.4 0.0 31.7 6.8 10.8 7.2 12.8 11.0 32.4 57.2 0.0 15.4 21.3 0.0 28.1 21.7 3.3 10.0 2.5 23.1 19.3 5.1 26.5 8.8 1.8 45.3 10.2 0.9 1.0 1.6 1.6 4.9 2.5 5.5 IFT27 "BBS19, RABL4, RAYL" ENSG00000100360 "Intraflagellar transport 27" Q9BW83 22 36758202-36776256 "Disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 246.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "U-138 MG: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018418 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA018418: AB_1856029" "unprognostic (3.04e-2)" "unprognostic (7.25e-3)" "unprognostic (7.06e-2)" "prognostic favorable (1.91e-4)" "unprognostic (9.04e-2)" "unprognostic (6.05e-2)" "unprognostic (6.22e-2)" "unprognostic (1.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.75e-3)" "unprognostic (4.85e-3)" "unprognostic (2.10e-1)" "unprognostic (9.62e-3)" "unprognostic (8.08e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-1)" "prognostic favorable (5.55e-4)" 10.9 17.0 21.1 12.7 27.4 8.5 9.2 13.4 20.6 14.9 12.8 15.8 21.9 13.4 12.5 22.1 10.9 40.5 13.0 18.5 19.3 20.6 16.4 17.4 10.2 9.5 19.4 16.4 14.9 17.6 20.9 30.2 8.9 20.0 16.4 11.0 16.1 15.4 19.6 14.7 9.6 12.9 9.9 17.4 9.3 13.7 20.1 14.5 18.6 23.2 6.0 9.8 11.0 11.8 17.7 27.0 23.3 22.6 14.5 19.9 13.9 6.2 7.9 9.3 10.5 7.5 7.2 5.5 5.2 6.6 6.7 6.0 0.3 5.8 6.9 9.0 4.7 9.8 5.8 5.1 5.7 5.2 13.2 13.5 1.8 1.6 0.0 13.8 2.2 8.6 5.8 9.4 7.2 3.3 5.5 7.1 5.7 3.2 5.7 4.5 11.6 2.7 1.9 5.0 12.3 10.3 13.0 0.0 3.8 6.6 4.1 9.0 9.8 5.4 4.2 12.9 8.2 9.4 3.9 4.2 60.8 3.5 7.8 0.9 13.5 8.2 2.4 9.4 5.5 12.8 8.5 22.6 23.3 18.3 16.4 18.2 16.7 15.2 16.8 27.0 17.7 15.1 14.3 8.1 14.5 19.3 20.9 19.9 13.9 21.1 27.4 13.4 20.6 19.3 20.6 19.4 16.4 20.0 14.5 6.0 17.3 15.2 23.2 20.7 32.7 16.8 20.4 246.3 38.7 38.4 27.5 18.3 89.5 24.7 40.8 18.3 24.3 0.0 20.1 14.0 30.5 29.6 33.4 18.6 34.4 28.6 51.2 27.6 14.9 13.6 25.3 19.2 33.7 9.0 39.8 51.0 18.0 14.4 29.7 43.0 34.6 12.9 18.6 105.4 16.8 29.1 14.6 23.5 29.0 23.3 IMPA2 ENSG00000141401 "Inositol monophosphatase 2" O14732 18 11981025-12030883 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 90.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 14.4;neutrophil: 18.7" "Group enriched" "Detected in many" 14 "dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8" "Cell line enhanced" "Detected in many" "BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029561 Approved Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA029561: AB_10601932" "unprognostic (1.16e-1)" "unprognostic (1.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.50e-2)" "unprognostic (4.25e-2)" "unprognostic (3.25e-3)" "unprognostic (4.26e-3)" "unprognostic (4.08e-2)" "unprognostic (1.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.56e-2)" "unprognostic (4.24e-3)" "prognostic favorable (0.00e+0)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (2.08e-2)" "unprognostic (3.35e-2)" 6.2 2.8 1.5 5.2 1.9 6.9 10.7 0.3 1.5 6.8 12.2 0.7 1.6 5.6 7.3 3.0 40.3 4.1 17.5 20.1 1.4 0.5 41.3 21.0 6.5 4.6 2.2 0.3 3.1 90.1 1.0 5.7 35.6 1.3 17.5 7.8 3.4 9.8 2.5 55.0 30.4 9.2 40.0 1.4 4.8 13.5 1.5 2.0 3.1 8.0 31.4 10.3 22.6 14.7 0.7 5.3 18.7 6.8 0.1 0.6 1.8 6.2 9.7 2.6 4.6 3.4 2.5 60.5 1.6 4.3 0.7 1.0 7.8 5.0 1.3 3.8 2.3 5.7 4.3 3.1 1.6 0.2 7.4 3.8 0.0 12.7 6.7 2.0 10.7 0.5 5.8 8.7 2.3 1.2 2.0 0.9 7.0 1.5 0.0 2.5 6.2 4.3 5.6 9.1 67.8 7.3 7.3 7.3 6.4 29.2 3.5 3.5 0.0 36.5 8.3 3.5 3.4 7.8 13.4 0.0 1.3 2.5 17.9 1.6 5.0 13.3 3.7 5.8 7.2 2.2 3.3 6.8 14.4 0.4 4.9 0.2 0.7 0.4 0.1 5.3 0.2 0.2 0.3 18.7 0.1 3.0 3.7 0.6 1.8 1.5 1.9 0.3 1.5 1.4 0.5 2.2 0.3 1.3 2.0 17.9 25.4 6.9 15.2 93.8 0.2 10.6 45.9 9.4 9.1 21.0 0.0 35.5 373.0 57.8 2.3 5.8 44.1 0.0 96.5 196.1 13.1 33.2 2.3 62.3 36.5 0.0 16.8 8.6 39.4 4.7 4.4 16.7 13.5 4.6 70.8 21.8 73.4 51.8 3.5 383.7 0.9 103.5 9.5 0.4 11.7 123.6 88.9 4.4 78.2 45.7 IRX6 "IRX-3, IRX7" ENSG00000159387 "Iroquois homeobox 6" P78412 16 55323760-55330760 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 5.2;Hofbauer cells: 3.5;Late spermatids: 3.8;Melanocytes: 3.3" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEK 293: 2.9;RPTEC TERT1: 10.6;SK-MEL-30: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA018332 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA018332: AB_1851920" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (4.93e-4)" "unprognostic (2.48e-2)" "unprognostic (6.50e-2)" "unprognostic (3.46e-1)" "prognostic favorable (3.34e-4)" "unprognostic (3.63e-2)" "unprognostic (4.36e-2)" "unprognostic (2.93e-2)" "unprognostic (1.50e-2)" "unprognostic (2.83e-2)" "unprognostic (9.63e-3)" "unprognostic (7.12e-3)" "unprognostic (5.48e-2)" "unprognostic (5.23e-3)" 11.1 0.0 0.2 0.2 1.4 0.0 18.9 0.2 0.5 3.3 0.2 0.2 0.2 0.0 0.6 0.2 0.5 0.0 0.2 11.1 0.2 0.4 1.5 0.2 2.3 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.2 0.0 2.0 2.5 0.2 2.7 9.3 0.2 0.2 0.2 1.6 0.0 0.6 0.2 3.5 0.7 0.2 2.3 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 10.6 0.0 0.2 0.1 0.1 1.8 6.8 0.1 0.6 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.6 1.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.8 0.0 0.0 3.3 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 ISOC2 FLJ23469 ENSG00000063241 "Isochorismatase domain containing 2" Q96AB3 19 55452985-55462343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.9" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 256.8;Proximal tubular cells: 330.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 68.8" "Low region specificity" "Detected in all" HPA043142 Enhanced Approved Mitochondria,Cytosol NA NA 230000 Mitochondria Cytosol "HPA043142: AB_10794653" "unprognostic (2.74e-1)" "unprognostic (8.38e-3)" "unprognostic (7.34e-2)" "unprognostic (3.09e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-1)" "unprognostic (3.09e-1)" "unprognostic (5.82e-2)" "unprognostic (8.59e-2)" "unprognostic (9.90e-3)" "unprognostic (2.24e-1)" "unprognostic (2.42e-1)" "unprognostic (9.20e-2)" "unprognostic (2.09e-2)" 12.7 16.4 13.4 12.8 15.0 10.5 28.1 9.0 15.6 10.9 15.9 9.9 17.1 20.6 8.9 13.5 14.7 10.7 19.2 20.9 13.4 12.9 33.2 93.9 11.2 10.2 15.4 11.2 9.1 23.8 12.8 14.2 5.5 14.6 12.0 10.0 7.2 23.3 21.2 47.2 10.0 20.5 12.0 13.9 15.8 12.9 23.3 13.4 5.9 14.9 22.9 11.8 12.8 8.8 11.5 18.1 0.5 20.0 14.1 10.4 9.1 12.7 19.4 5.4 14.4 3.7 7.8 17.2 9.1 9.6 12.1 12.4 9.6 22.8 24.4 17.0 11.1 11.7 12.9 10.4 12.0 4.0 9.3 68.8 13.8 4.7 31.5 14.9 15.4 42.4 11.5 11.6 7.7 5.9 5.5 10.9 10.0 22.5 16.3 7.7 25.3 0.0 18.1 8.3 29.0 55.4 17.5 11.1 31.9 20.0 12.1 6.4 18.1 8.8 20.0 10.3 3.3 16.7 27.6 7.8 8.8 12.6 9.9 10.9 19.8 17.1 19.0 13.9 19.7 15.2 0.4 9.9 0.5 8.3 20.0 8.2 11.5 7.7 10.4 18.1 8.8 7.8 7.8 0.4 14.1 16.1 14.8 9.1 9.1 13.4 15.0 9.0 15.6 13.4 12.9 15.4 11.2 14.6 13.4 6.0 4.6 47.7 58.7 52.9 10.1 19.8 40.8 6.7 4.5 59.3 2.0 32.1 137.6 59.7 16.0 29.2 194.8 0.0 59.2 95.0 50.3 45.4 46.0 256.8 86.3 12.7 68.5 30.1 38.8 34.9 35.9 49.5 59.1 27.9 102.3 53.5 50.1 94.8 29.0 330.6 8.4 25.8 37.6 55.3 11.7 60.0 18.1 24.9 124.1 54.8 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 95000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 72.5 13.8 9.7 9.7 10.0 0.8 50.1 5.7 8.2 34.2 18.8 14.8 28.0 12.9 31.7 17.2 25.6 13.9 29.1 32.9 9.4 5.1 19.6 22.1 20.4 3.5 12.0 6.2 17.4 12.1 8.9 8.4 36.4 13.0 23.0 10.1 27.1 18.6 23.1 15.9 33.3 16.1 25.1 9.0 18.7 12.4 17.0 8.7 2.8 18.8 16.2 10.9 24.4 27.1 0.1 1.1 0.4 0.6 0.9 2.1 5.8 28.5 71.2 5.1 12.9 48.3 14.1 26.4 30.6 19.0 5.7 9.2 14.2 37.3 0.1 14.9 51.9 28.1 22.9 4.6 15.9 5.0 0.3 3.1 10.1 11.0 14.9 8.4 0.0 18.5 8.4 3.7 14.3 7.5 81.6 19.1 0.0 9.0 15.3 19.5 29.0 0.1 0.1 22.9 16.0 7.9 0.0 8.2 10.7 16.1 6.3 0.1 10.7 22.7 33.8 25.8 9.4 19.1 0.6 49.1 21.5 32.5 18.6 15.8 2.6 2.7 0.1 22.5 0.1 74.2 0.4 0.6 0.2 2.1 0.2 0.0 0.0 0.2 0.0 1.1 0.1 0.3 0.4 0.4 0.9 0.4 0.1 0.0 5.8 9.7 10.0 5.7 8.2 9.4 5.1 12.0 6.2 13.0 8.7 6.0 7.9 2.2 18.8 15.2 6.2 26.4 43.3 5.3 10.3 27.9 3.9 56.6 10.0 34.5 7.5 22.6 19.6 0.0 16.3 4.7 30.7 22.0 0.0 32.1 60.3 33.4 3.4 41.1 27.6 2.3 18.7 16.7 10.1 0.0 13.3 47.4 43.9 27.4 15.6 10.2 15.2 38.8 35.3 1.4 6.4 19.4 46.1 0.0 15.0 12.0 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405795-40435947 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria NA NA 66000 Mitochondria Nucleoplasm "HPA041391: AB_2677449, HPA044250: AB_2678875" "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favorable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 12.3 32.0 15.4 13.2 20.6 6.7 24.3 14.4 18.0 12.7 13.7 20.5 23.3 12.3 11.8 16.6 8.9 17.2 22.7 30.4 13.8 16.1 28.9 71.9 14.2 10.4 16.1 15.9 19.4 18.9 19.5 23.9 7.4 16.3 21.0 13.0 14.4 11.8 31.9 30.6 3.5 9.8 13.7 14.7 11.0 14.4 11.2 15.7 8.6 55.7 12.2 9.0 11.2 7.9 11.6 34.1 14.3 29.8 14.7 13.5 8.6 8.7 5.3 9.7 17.4 15.4 13.5 0.4 13.5 13.2 17.3 10.8 19.8 7.6 0.3 25.8 17.0 14.9 10.3 18.4 19.9 10.7 12.6 14.8 22.7 15.4 19.0 27.1 9.2 22.6 20.6 6.9 9.6 20.2 20.0 17.1 24.4 1.0 1.1 15.5 13.8 11.4 14.3 8.2 0.5 16.9 16.7 13.3 10.4 20.5 23.7 16.6 9.2 18.6 40.5 8.2 9.4 34.9 40.7 14.5 14.4 9.4 10.1 10.8 21.8 14.9 0.3 13.5 9.2 14.1 5.8 10.2 14.3 13.5 16.1 12.6 11.6 7.5 11.4 22.3 9.9 8.4 11.7 1.3 14.7 29.8 34.1 9.7 8.6 15.4 20.6 14.4 18.0 13.8 16.1 16.1 15.9 16.3 15.7 26.8 46.2 14.3 16.6 2.1 24.6 72.6 45.9 42.8 40.9 41.8 13.7 16.5 81.2 15.9 4.4 18.0 17.7 23.3 13.0 4.8 15.4 16.0 32.5 123.8 25.1 15.9 18.9 17.2 20.2 4.9 19.0 13.9 5.0 31.5 22.5 25.1 14.1 3.5 23.3 60.9 18.9 19.4 13.9 19.0 4.3 0.5 8.2 12.2 33.1 11.2 JARID2 JMJ ENSG00000008083 "Jumonji and AT-rich interaction domain containing 2" Q92833 6 15246296-15522040 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.3" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 32.2;SuSa: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063889, CAB069890" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB069890: AB_10000529, HPA063889: AB_2685143" "unprognostic (5.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (4.87e-3)" "unprognostic (6.35e-2)" "unprognostic (2.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (3.26e-3)" "unprognostic (7.04e-2)" "unprognostic (4.48e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-1)" 10.2 5.3 6.9 11.5 8.8 53.3 7.2 40.6 9.3 6.3 8.3 11.4 9.4 6.9 8.8 8.4 15.4 5.0 7.9 5.9 6.8 7.1 4.6 4.4 8.2 12.8 6.8 3.8 7.2 4.4 6.1 8.2 8.4 8.4 5.5 5.9 15.1 10.7 11.9 12.5 14.9 12.5 5.3 6.6 14.2 8.2 17.5 6.5 41.3 5.0 8.9 19.2 6.5 7.7 4.2 4.6 14.4 4.0 4.9 3.9 2.0 5.2 3.6 15.0 8.6 1.8 1.8 14.9 1.5 3.6 2.0 2.5 3.8 4.1 2.8 5.4 3.0 3.0 2.7 3.5 8.7 1.8 5.4 5.3 9.8 4.3 4.8 2.0 9.9 11.5 2.6 5.5 2.9 11.7 6.0 2.1 32.2 12.7 4.7 1.1 5.2 19.7 18.7 16.0 2.6 1.6 8.8 4.6 7.8 1.8 5.5 11.6 6.6 3.1 10.9 13.7 36.6 3.8 10.7 3.6 9.2 5.1 5.0 5.2 3.0 7.2 4.9 3.1 9.3 11.5 9.6 4.0 3.2 3.9 2.6 3.3 2.6 1.9 2.3 3.3 4.2 2.4 3.3 14.4 4.9 2.7 4.6 1.5 2.0 6.9 8.8 40.6 7.9 6.8 7.1 6.8 3.8 8.4 6.5 6.0 10.9 22.2 9.5 71.4 71.0 8.9 10.2 4.0 11.4 5.2 82.5 23.3 1.7 6.8 59.2 24.1 12.3 0.0 3.9 19.3 18.6 5.7 24.3 12.9 21.4 146.2 25.7 14.1 48.4 29.9 8.1 37.2 25.3 20.8 16.0 167.6 11.0 11.5 8.1 2.6 91.1 6.5 25.0 7.0 67.9 132.5 21.1 30.5 13.4 13.6 JTB "hJT, PAR" ENSG00000143543 "Jumping translocation breakpoint" O76095 1 153974269-153977688 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006514 Approved Approved Vesicles,Mitochondria NA NA Vesicles Mitochondria "HPA006514: AB_1079164" "unprognostic (1.33e-1)" "unprognostic (1.77e-1)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.40e-1)" "unprognostic (5.66e-3)" "unprognostic (8.62e-3)" "unprognostic (5.60e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.00e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (1.36e-1)" "unprognostic (4.25e-1)" "unprognostic (5.48e-2)" "unprognostic (2.58e-3)" 23.9 30.2 28.5 23.0 32.7 43.2 32.6 30.7 32.3 31.8 36.0 23.6 51.3 35.9 25.1 41.0 30.4 26.1 37.1 36.2 25.4 23.9 34.2 81.1 27.7 34.7 27.7 19.8 26.9 106.8 24.8 49.8 30.0 24.4 33.4 36.0 24.9 100.6 45.9 42.1 23.4 45.6 21.6 20.5 35.9 42.4 15.3 25.2 30.5 58.5 32.0 34.0 25.2 33.0 47.4 54.1 60.7 43.0 30.4 46.4 30.2 38.4 26.6 11.5 21.0 37.7 23.5 32.4 28.1 27.4 18.8 18.9 25.6 32.0 36.8 39.9 32.5 11.6 35.2 29.0 21.6 15.4 34.7 58.0 21.4 31.7 25.9 39.7 41.0 32.9 22.2 40.9 19.8 23.5 26.0 22.2 42.9 31.6 27.1 13.2 67.0 29.6 52.8 24.6 75.6 47.0 31.3 15.6 73.9 23.8 21.1 31.5 31.9 22.2 64.8 37.6 22.0 40.6 59.7 17.3 9.3 16.1 28.1 35.8 40.4 45.0 39.9 22.9 39.5 20.0 32.6 43.0 60.7 29.4 30.3 35.5 47.4 41.1 46.4 33.4 45.2 42.4 33.7 39.9 30.4 33.4 54.1 33.6 30.2 28.5 32.7 30.7 32.3 25.4 23.9 27.7 19.8 24.4 25.2 74.5 93.5 143.8 144.8 139.2 56.2 87.0 188.5 84.3 73.9 94.2 21.6 271.1 218.8 215.2 5.3 130.2 265.0 46.7 360.4 333.7 188.8 298.2 81.8 277.1 261.0 54.0 203.5 111.1 203.5 13.6 140.4 174.8 161.9 144.3 351.4 98.5 241.9 276.3 116.0 209.1 47.9 103.5 125.2 54.7 68.8 166.2 242.1 188.1 283.1 216.6 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051088: AB_2681340" "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.6 0.0 0.3 2.3 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.6 0.0 0.0 0.1 0.0 1.8 0.0 0.2 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 11.8 0.0 1.8 0.3 0.3 0.0 0.3 0.0 1.1 0.2 0.1 0.0 12.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 0.0 0.3 0.0 0.2 0.1 0.0 0.6 2.5 9.4 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.6 2.4 1.3 0.8 3.6 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.9 2.5 0.3 0.0 1.0 0.0 0.0 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 13.7;Late spermatids: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 11.2;NB-4: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 3.0 2.0 0.7 2.9 0.7 1.2 3.3 0.2 0.6 1.8 2.0 1.9 2.0 2.3 0.7 1.0 2.4 1.8 1.0 0.9 2.2 4.0 1.2 2.9 1.1 1.6 5.3 3.7 2.1 6.6 2.9 2.2 2.7 1.4 0.5 0.6 2.2 1.9 1.5 5.9 2.6 4.5 2.4 2.6 1.9 1.5 3.5 0.3 2.3 0.4 3.6 1.0 0.0 3.0 0.7 1.2 0.0 1.4 1.1 1.9 0.8 0.5 1.3 0.6 6.5 2.6 0.1 3.0 0.6 2.7 1.1 0.0 0.2 1.5 3.8 0.4 11.2 2.9 2.5 1.2 0.2 3.7 1.9 0.6 0.9 0.0 1.0 1.1 0.1 0.4 0.1 1.5 1.8 0.1 7.6 0.0 1.2 2.3 3.3 0.0 0.1 1.0 2.1 1.5 0.4 1.0 1.2 0.7 1.1 3.1 6.1 0.7 0.6 1.1 0.3 0.9 1.0 0.4 3.6 0.6 4.3 0.8 2.3 0.4 0.5 1.0 0.3 0.6 3.5 0.6 0.8 0.1 2.1 0.4 0.7 1.9 3.6 0.1 0.3 0.9 0.0 0.0 2.2 0.8 1.8 0.2 2.3 0.6 2.5 1.4 2.3 0.0 13.7 1.0 0.0 4.3 8.0 2.7 1.5 0.0 3.1 1.0 1.2 1.6 2.3 1.5 1.0 0.0 4.7 1.8 1.6 10.9 2.6 0.8 0.0 1.0 1.3 1.9 2.7 0.0 2.8 0.0 5.3 6.5 1.4 1.6 1.4 0.1 1.0 0.0 1.1 0.7 KCTD6 "KCASH3, MGC27385" ENSG00000168301 "Potassium channel tetramerization domain containing 6" Q8NC69 3 58492114-58502360 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036100, HPA036101" Uncertain Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA036100: AB_10673230, HPA036101: AB_2674941" "unprognostic (8.63e-3)" "unprognostic (1.28e-2)" "unprognostic (3.37e-2)" "unprognostic (5.71e-2)" "unprognostic (9.00e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.19e-2)" "unprognostic (1.81e-1)" "unprognostic (4.67e-3)" "unprognostic (9.36e-3)" "unprognostic (7.48e-2)" "prognostic favorable (8.63e-4)" "unprognostic (1.56e-2)" "unprognostic (1.71e-1)" "unprognostic (3.48e-1)" "unprognostic (2.44e-2)" 7.8 8.4 15.3 4.4 13.2 13.5 11.4 35.9 21.8 11.1 7.9 10.0 6.4 5.6 12.3 28.8 10.9 12.4 8.8 7.7 16.9 11.7 15.4 12.2 6.6 9.1 15.3 10.5 13.1 7.1 10.4 14.4 10.9 11.9 9.2 8.1 14.7 7.3 9.4 6.8 7.5 5.3 11.2 12.5 8.8 5.7 5.7 12.4 6.3 14.1 6.3 7.3 6.4 11.9 13.0 20.2 17.1 14.6 8.2 15.6 6.6 5.5 5.3 15.9 6.8 14.0 10.0 5.9 6.7 6.0 9.9 11.7 5.1 3.1 11.0 2.2 4.8 11.7 3.0 12.8 3.9 8.9 11.3 5.8 5.1 12.1 6.3 6.6 4.0 4.1 6.0 6.2 7.9 5.0 23.6 6.5 3.9 2.8 5.3 8.6 5.2 5.9 6.1 11.7 5.0 10.1 5.9 4.4 7.7 9.4 2.6 9.0 7.8 3.8 8.8 4.8 12.7 35.4 2.9 3.5 9.1 8.2 11.6 10.0 5.8 8.9 13.0 7.8 8.2 6.9 17.1 14.6 9.8 13.7 14.6 15.6 13.0 10.1 12.8 20.2 10.3 11.5 9.8 5.0 8.2 10.5 7.8 9.5 6.6 15.3 13.2 35.9 16.2 16.9 11.7 15.3 10.5 11.9 12.4 3.0 2.4 0.9 10.6 7.9 14.6 7.5 7.6 5.3 10.3 8.7 23.6 8.7 16.6 7.1 3.7 9.0 2.1 0.0 3.7 6.3 12.4 5.1 0.0 4.7 6.2 23.8 8.7 4.9 10.3 1.7 10.0 7.2 11.8 4.6 4.2 19.3 3.3 5.5 11.3 24.5 17.9 0.0 12.0 5.6 20.7 8.8 7.3 0.0 7.0 3.0 KHDC1 "bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1" ENSG00000135314 "KH domain containing 1" Q4VXA5 6 73241314-73310365 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 19.4;Spermatocytes: 29.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA029032 Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA029032: AB_10602914" "unprognostic (3.46e-1)" "unprognostic (2.20e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-4)" "unprognostic (1.95e-1)" "unprognostic (2.18e-1)" "unprognostic (1.20e-1)" "unprognostic (7.54e-2)" "unprognostic (5.76e-2)" "unprognostic (6.27e-2)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" "unprognostic (1.83e-4)" "unprognostic (8.18e-2)" "unprognostic (2.97e-1)" "unprognostic (2.14e-1)" "unprognostic (5.17e-3)" 2.9 2.9 10.3 2.0 12.9 0.9 2.2 8.8 14.6 4.7 1.3 2.6 1.2 0.6 3.9 3.3 2.7 6.2 2.6 3.4 8.5 8.4 1.3 0.4 1.8 3.1 8.6 5.7 7.4 4.4 5.0 9.6 1.5 4.7 4.4 1.4 2.9 1.3 3.6 2.7 1.0 1.1 2.4 6.2 0.9 2.9 8.2 4.1 5.4 5.9 1.7 3.4 2.2 2.1 2.7 2.6 3.8 0.2 2.5 5.2 2.0 2.9 4.2 0.8 2.3 4.0 4.6 2.0 5.7 5.5 8.8 13.1 4.0 2.3 6.2 2.2 2.5 4.5 2.8 5.9 1.2 6.7 5.9 4.2 4.1 3.4 0.0 5.2 2.0 0.1 5.9 2.5 8.7 2.4 3.7 1.9 6.5 3.0 7.5 3.5 6.9 0.4 1.9 3.9 0.5 8.4 0.9 0.0 5.0 1.4 0.1 10.5 2.2 3.2 0.1 0.2 2.9 0.1 6.2 0.1 1.9 4.0 1.1 6.0 12.7 7.6 4.5 0.1 1.7 0.7 3.8 0.2 0.0 4.4 0.0 2.6 2.7 2.8 4.9 0.7 1.9 2.2 3.4 0.0 2.5 0.0 2.6 5.2 2.0 10.3 12.9 8.8 12.4 8.5 8.4 8.6 5.7 4.7 4.1 0.0 1.0 3.0 3.2 0.7 7.8 1.8 0.0 0.0 2.3 3.5 2.0 1.5 1.7 0.8 9.3 0.3 0.0 0.0 3.3 0.3 3.1 1.7 0.0 0.0 0.4 12.7 0.0 0.0 0.0 12.1 2.0 0.0 3.3 1.0 0.5 11.5 2.3 0.0 3.2 0.0 6.8 19.4 1.9 29.8 12.9 0.5 0.1 4.3 0.9 0.4 KIAA0391 "MRPP3, PRORP" ENSG00000100890 KIAA0391 O15091 14 35121846-35277614 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA020459: AB_2670449" "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 13.9 26.1 18.8 17.6 20.1 12.5 17.5 23.1 21.9 17.4 22.4 20.6 15.6 16.6 13.0 19.4 26.1 14.7 13.2 16.7 17.6 16.3 31.1 29.5 20.9 29.5 20.2 17.7 10.8 16.5 29.8 27.4 13.4 19.2 14.1 24.9 15.8 18.0 21.8 22.2 23.0 16.5 15.0 23.0 18.7 15.8 17.1 20.9 31.2 18.9 21.3 24.8 18.2 16.0 10.0 9.7 10.9 5.4 12.1 25.5 12.4 22.8 18.3 12.7 16.8 13.9 16.5 11.2 15.4 13.8 19.7 17.1 17.3 14.2 25.1 20.1 14.6 5.6 17.8 23.3 26.6 22.3 19.7 7.2 11.3 14.1 36.9 14.4 13.9 12.4 17.6 20.5 18.6 17.2 17.0 28.5 21.6 18.2 7.3 24.0 25.9 21.0 15.3 13.6 19.8 18.1 20.2 21.1 14.5 27.7 23.4 11.8 13.4 19.9 22.1 12.8 17.1 32.2 11.5 21.6 15.2 13.7 11.7 13.2 8.0 18.6 26.3 7.7 15.1 15.9 10.9 5.4 3.4 15.4 5.2 22.4 10.0 23.8 16.6 7.2 7.0 21.2 15.6 6.3 12.1 4.3 9.7 25.5 12.4 18.8 20.1 23.1 21.9 17.6 16.3 20.2 17.7 19.2 20.9 3.0 1.3 1.3 0.5 0.0 1.3 1.5 0.0 1.4 2.3 0.0 0.0 0.8 1.7 1.0 0.0 1.0 1.4 0.0 0.8 0.5 0.8 1.0 2.3 1.6 1.0 0.0 0.0 1.8 0.8 0.0 0.6 0.8 0.0 0.0 0.9 1.2 1.5 0.0 0.4 1.4 1.5 0.0 0.3 0.5 1.1 0.0 0.6 0.0 1.6 0.9 KIAA0930 "bK268H5.C22.1, C22orf9" ENSG00000100364 KIAA0930 Q6ICG6 22 45190338-45240769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.8" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 60.5;Kupffer cells: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 9.1;eosinophil: 6.5;intermediate monocyte: 11.1;myeloid DC: 9.8;non-classical monocyte: 12.9;plasmacytoid DC: 8.2" "Group enriched" "Detected in all" 4 "dendritic cells: 9.8;granulocytes: 6.5;monocytes: 12.9" "Cell line enhanced" "Detected in many" "THP-1: 83.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038091 Uncertain Approved "Nuclear membrane,Mitochondria" No No "Nuclear membrane, Mitochondria" "HPA038091: AB_10675627" "unprognostic (4.16e-2)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "prognostic favorable (9.22e-5)" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (6.90e-8)" "unprognostic (2.80e-1)" "unprognostic (2.03e-1)" "unprognostic (3.58e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-1)" "prognostic unfavorable (8.95e-7)" "unprognostic (6.89e-3)" "unprognostic (5.32e-2)" "unprognostic (5.58e-2)" "unprognostic (1.15e-1)" 13.4 18.0 51.3 17.1 50.0 14.4 12.9 9.9 41.3 15.3 11.6 52.8 10.3 9.6 8.3 28.4 14.2 10.0 10.7 6.6 50.2 39.9 5.9 12.7 12.5 16.6 48.2 36.8 6.7 8.2 10.2 5.6 7.9 28.9 9.5 7.6 4.9 8.6 18.1 15.6 34.2 12.9 10.3 29.3 15.4 8.5 10.1 50.0 6.5 5.2 6.7 14.3 14.1 9.6 1.8 9.8 6.5 12.9 1.5 2.2 2.6 12.4 8.1 5.0 9.9 17.2 8.1 5.0 6.9 6.9 7.4 6.4 7.4 6.8 8.3 10.3 10.9 5.9 14.0 7.6 30.6 2.8 8.9 12.0 0.0 10.0 8.5 6.9 22.2 5.1 4.6 15.5 7.1 12.0 5.6 6.9 6.1 2.9 13.8 4.4 14.3 9.8 20.7 4.9 9.0 6.8 12.1 3.4 27.4 11.1 7.6 4.2 7.4 10.9 15.0 18.9 10.1 7.3 83.1 9.3 7.6 13.5 10.3 3.9 11.8 7.9 8.0 8.9 33.9 7.8 0.9 9.1 6.5 2.0 11.1 1.3 1.8 0.8 2.2 9.8 1.6 0.8 1.4 2.2 1.5 12.9 8.2 1.5 2.6 51.3 50.0 9.9 41.3 50.2 39.9 48.2 36.8 28.9 50.0 6.0 9.1 9.0 15.2 46.9 4.4 9.9 7.6 5.3 4.5 17.4 5.9 1.5 0.0 16.3 2.3 10.3 12.9 0.0 17.8 4.7 23.4 14.4 2.3 19.8 60.5 4.8 10.3 20.9 61.7 6.1 10.0 44.0 42.2 22.6 10.8 5.5 15.6 11.6 13.8 11.2 4.7 0.0 16.9 7.5 4.7 50.1 2.3 10.7 10.2 23.7 KLC4 "bA387M24.3, KNSL8" ENSG00000137171 "Kinesin light chain 4" Q9NSK0 6 43040777-43075099 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.7" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 103.2;Paneth cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030168, HPA030169" Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA030168: AB_10599285, HPA030169: AB_10601105" "unprognostic (2.96e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.08e-2)" "unprognostic (3.67e-2)" "unprognostic (5.63e-3)" "unprognostic (6.36e-3)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.30e-1)" "unprognostic (1.47e-2)" "unprognostic (9.22e-2)" "prognostic favorable (6.99e-6)" "unprognostic (2.08e-1)" "unprognostic (3.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" 6.1 9.7 13.1 8.5 11.5 5.3 6.9 25.0 15.2 7.6 35.0 10.2 8.1 35.1 8.5 12.3 5.6 9.3 15.2 12.2 13.8 10.8 13.6 47.2 8.2 5.8 12.2 13.7 11.2 9.1 17.6 13.3 5.9 12.1 8.6 17.4 9.0 11.4 8.4 9.9 8.7 55.7 7.4 9.2 6.6 16.0 22.6 13.2 6.7 10.9 4.5 5.4 10.2 9.9 5.6 12.2 9.0 3.7 6.1 7.0 3.3 3.5 3.2 8.7 10.4 8.6 8.5 7.7 2.9 4.8 5.3 8.2 5.3 6.3 5.3 10.7 7.0 7.0 6.3 8.7 8.2 4.3 5.3 10.6 6.2 9.2 23.4 8.3 3.0 4.9 11.1 10.3 6.4 6.3 16.8 6.7 11.0 4.2 7.1 4.4 7.2 7.9 6.5 3.4 35.5 4.4 6.4 4.9 10.2 8.1 3.6 14.3 7.0 5.7 5.0 11.1 8.3 9.1 7.6 4.8 6.1 7.2 3.0 3.0 14.1 5.0 12.9 3.3 4.5 2.1 2.6 3.7 4.4 4.0 3.6 5.1 5.6 5.5 3.9 4.2 4.3 7.0 4.8 9.0 6.1 3.6 12.2 6.4 3.3 13.1 11.5 25.0 15.2 13.8 10.8 12.2 13.7 12.1 13.2 14.9 11.8 3.9 8.3 3.3 20.8 10.2 22.9 21.4 5.7 14.0 27.5 9.4 16.6 6.6 6.1 4.4 103.2 0.0 8.7 4.1 5.1 5.1 6.9 51.3 5.8 11.1 21.5 5.5 3.7 6.8 9.5 2.5 3.3 6.4 36.2 15.8 6.6 59.6 6.3 20.0 25.7 12.9 4.4 20.9 15.5 4.0 11.3 4.9 35.1 5.0 KLHL29 "KBTBD9, KIAA1921" ENSG00000119771 "Kelch like family member 29" Q96CT2 2 23385217-23708611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 13.5;RH-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049057, HPA057379" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA049057: AB_2680615, HPA057379: AB_2683422" "unprognostic (8.08e-3)" "unprognostic (2.91e-1)" "unprognostic (7.43e-3)" "unprognostic (2.65e-2)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (3.54e-3)" "unprognostic (1.16e-1)" "unprognostic (4.71e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.19e-4)" "unprognostic (2.53e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.12e-2)" "unprognostic (9.06e-2)" "unprognostic (7.44e-2)" "unprognostic (5.25e-4)" 9.5 20.8 8.9 6.4 14.5 0.8 7.4 9.0 11.7 6.7 9.4 2.6 5.2 2.6 10.9 3.5 5.4 4.8 10.7 3.3 6.7 7.5 4.7 5.4 6.2 5.7 3.6 9.0 4.0 4.7 5.8 17.7 7.6 6.3 10.8 3.4 11.7 4.2 11.7 12.0 6.9 4.2 7.2 2.7 10.6 5.5 2.5 3.7 0.5 1.9 1.8 4.0 7.5 6.4 0.1 0.4 0.0 0.0 0.9 0.7 0.0 1.0 0.9 6.0 3.0 5.7 3.8 10.3 6.1 4.7 2.5 1.8 0.0 0.3 3.9 2.1 2.3 13.5 0.2 1.4 5.2 1.7 0.0 6.3 0.0 5.1 0.0 2.0 0.0 7.9 2.7 7.1 3.3 9.3 0.8 4.2 0.1 0.0 0.0 1.3 0.5 1.3 0.0 3.0 0.0 1.8 0.3 15.4 0.0 4.6 1.8 9.0 1.8 0.8 0.6 3.5 2.5 0.0 0.0 4.2 2.5 11.7 5.3 2.1 0.1 0.0 0.0 9.5 0.4 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.7 0.0 0.9 0.0 0.4 0.0 0.0 8.9 14.5 9.0 11.7 6.7 7.5 3.6 9.0 6.3 3.7 6.0 4.0 0.0 9.1 4.1 2.3 2.0 5.1 1.4 1.2 1.8 25.5 0.7 0.0 1.0 1.7 1.4 0.0 0.0 0.2 0.9 1.7 1.7 0.0 0.4 0.2 1.6 4.1 0.6 0.0 0.0 4.6 0.0 1.7 0.0 0.6 1.3 0.4 0.0 3.9 1.3 23.5 6.5 5.1 0.0 1.1 5.1 0.7 0.0 0.2 1.3 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388506-45549421 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612" "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favorable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 9.6 14.3 18.8 9.6 21.8 6.7 8.1 11.9 17.9 9.2 14.8 13.1 8.3 9.6 9.8 8.9 10.4 11.2 8.4 14.2 14.6 13.6 18.9 17.2 7.0 10.3 15.7 9.5 10.2 8.2 20.0 14.0 10.6 12.3 10.8 15.3 10.0 8.7 9.8 14.1 7.8 8.8 11.0 8.8 10.0 8.9 7.3 11.8 16.1 10.5 8.3 12.8 11.3 7.8 5.1 5.9 2.4 3.3 8.4 6.0 3.7 6.4 8.0 9.4 8.9 8.6 9.7 10.1 10.0 10.3 18.7 13.9 14.2 8.9 13.3 8.6 11.6 13.7 7.0 34.9 20.9 14.2 11.6 8.8 14.4 13.0 13.8 9.0 20.8 5.3 12.5 12.9 17.8 9.4 9.7 11.6 16.1 22.3 7.5 11.6 7.0 14.9 7.6 23.5 10.8 14.9 8.5 9.3 14.8 16.6 15.5 7.4 9.3 15.9 9.0 8.3 11.2 14.3 12.2 10.2 11.4 8.5 9.5 12.0 6.0 10.8 14.2 13.5 14.1 10.1 0.6 2.8 2.4 6.0 3.3 5.8 5.1 4.4 5.4 5.9 4.0 4.8 5.4 1.2 8.4 3.0 4.5 3.9 3.7 18.8 21.8 11.9 17.9 14.6 13.6 15.7 9.5 12.3 11.8 0.0 1.3 2.7 1.1 1.0 5.0 7.8 2.5 2.7 1.2 5.2 3.9 4.1 5.0 2.5 0.6 3.8 2.3 0.0 2.4 4.2 1.6 2.2 1.1 6.7 4.4 1.6 4.6 2.5 3.7 1.1 1.1 1.6 1.7 2.8 4.3 3.6 2.8 6.6 2.1 2.1 4.4 0.0 1.2 0.7 2.4 1.1 2.4 1.8 6.3 1.6 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570246-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 800.0;Enterocytes: 838.5;Pancreatic endocrine cells: 476.7;Proximal tubular cells: 1320.5;Undifferentiated cells: 571.4" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5" "Group enriched" "Detected in many" 51 "dendritic cells: 100.5;monocytes: 129.0" "Group enriched" "Detected in some" 4 "CACO-2: 46.8;Hep G2: 26.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 3.1 0.4 0.6 4.3 0.5 1.8 0.6 0.4 0.5 0.5 12.6 0.5 0.4 6.1 1.0 1.9 0.8 0.6 91.7 0.7 0.4 0.4 35.3 1.0 2.3 7.9 0.5 0.4 0.6 87.3 0.0 0.4 0.9 0.5 0.5 13.0 0.5 1.8 0.4 0.4 0.9 43.0 0.4 0.5 8.3 1.5 0.6 0.4 4.5 0.5 1.0 9.6 0.7 0.6 0.6 100.5 2.2 129.0 0.1 0.2 70.1 1.1 0.6 0.4 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.0 46.8 0.0 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 26.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.4 0.2 9.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.7 0.8 1.1 0.2 0.7 0.7 2.7 0.9 0.4 1.9 0.3 0.0 0.1 0.1 1.2 0.0 0.5 0.6 129.0 0.6 0.1 47.0 0.2 0.6 0.1 0.2 100.5 0.2 0.2 0.1 2.2 0.1 2.9 0.8 0.2 70.1 0.6 0.5 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.4 6.0 4.6 32.7 0.1 15.1 0.0 0.1 800.0 1.4 2.3 27.9 0.0 0.1 107.8 20.9 0.0 0.1 838.5 0.0 175.0 0.2 3.5 0.1 2.3 0.6 27.7 0.0 70.9 0.6 23.7 0.0 0.6 71.1 23.6 13.6 374.8 0.0 476.7 354.2 0.0 1320.5 0.0 0.0 6.2 0.0 0.2 10.8 0.2 2.5 571.4 0.1 LIAS LAS ENSG00000121897 "Lipoic acid synthetase" O43766 4 39458587-39485109 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 82.3;Late spermatids: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018842, HPA019076" Approved Supported Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA018842: AB_1852864, HPA019076: AB_1852866" "unprognostic (3.61e-1)" "unprognostic (1.89e-1)" "unprognostic (8.44e-2)" "unprognostic (2.33e-1)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (8.31e-2)" "unprognostic (1.57e-1)" "unprognostic (4.19e-2)" "unprognostic (3.68e-2)" "unprognostic (2.46e-3)" "unprognostic (3.80e-2)" "prognostic favorable (4.11e-7)" "unprognostic (9.41e-3)" "unprognostic (2.35e-1)" "unprognostic (5.45e-2)" "unprognostic (6.98e-2)" 9.8 12.9 9.9 7.0 12.7 10.2 11.3 10.2 13.3 7.0 10.7 12.9 8.1 10.4 9.1 10.7 11.6 11.9 7.4 14.0 10.6 10.6 15.7 15.5 5.7 9.0 12.3 10.5 19.2 12.4 10.0 11.5 6.8 15.7 8.2 12.4 9.0 7.8 7.0 42.7 8.8 9.9 13.6 12.4 8.9 9.9 20.1 13.2 8.7 8.8 13.5 8.3 10.0 7.9 9.6 5.8 3.7 7.1 6.9 16.7 4.3 4.0 3.1 4.0 3.8 8.4 8.2 3.4 4.6 2.6 4.3 2.9 5.0 5.5 14.6 5.3 1.7 10.9 3.6 11.3 6.3 5.8 1.6 2.8 6.1 1.6 5.0 7.7 13.2 4.0 7.9 10.5 5.1 16.2 9.6 4.9 9.1 14.4 3.6 5.2 2.5 7.4 17.0 5.3 10.6 10.1 6.5 10.8 8.8 5.1 2.1 4.4 3.8 2.7 3.6 14.9 5.8 4.0 6.1 1.8 3.5 7.7 4.5 10.7 7.1 10.8 10.2 5.4 15.4 3.0 2.0 6.2 3.7 6.1 7.1 12.6 9.6 8.3 8.0 5.8 8.5 16.7 11.5 3.3 6.9 5.1 5.4 5.2 4.3 9.9 12.7 10.2 13.3 10.6 10.6 12.3 10.5 15.7 13.2 8.9 9.3 13.4 11.9 8.7 24.0 16.5 10.2 20.1 13.6 17.4 9.8 21.5 18.3 10.7 82.3 7.1 13.1 0.0 5.5 12.9 8.0 5.2 17.3 17.0 15.4 9.5 17.4 5.5 11.7 80.7 9.5 10.9 1.7 17.2 12.1 15.2 9.0 10.5 11.7 23.2 23.3 0.0 9.5 47.0 20.9 8.2 8.0 12.9 18.1 8.4 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 28.9 20.6 15.4 15.3 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 7.7 12.7 40.6 42.3 57.8 7.3 15.3 18.0 21.7 28.3 9.4 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 5.8 11.1 45.7 8.9 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 6.0 13.3 13.7 8.7 7.3 24.7 17.9 15.3 9.4 10.3 26.2 5.9 24.8 39.7 28.3 5.3 9.8 24.8 0.0 23.9 27.0 10.5 12.9 5.7 44.0 28.2 20.6 10.9 14.1 11.3 4.0 11.8 15.2 13.5 24.4 21.6 20.9 25.6 14.4 16.3 36.0 22.0 19.4 10.3 9.1 13.4 9.4 29.3 9.2 22.2 9.4 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362685 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 61.7;parathyroid gland: 61.4" "Cell type enhanced" "Detected in many" 23 "Cone photoreceptor cells: 82.5;Cytotrophoblasts: 52.4;Proximal tubular cells: 250.3" "Group enriched" "Detected in many" 6 "breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 21.9;CACO-2: 36.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria No NA "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: AB_2685353" "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.7 0.4 2.7 0.4 12.9 0.5 7.4 0.7 5.7 0.6 0.4 18.5 0.0 0.4 0.5 4.8 0.4 0.4 0.6 0.5 6.2 3.4 61.7 0.6 1.8 0.4 20.7 1.9 0.4 0.4 61.4 0.4 10.5 8.5 0.5 0.4 7.9 1.1 0.5 0.5 0.5 0.4 0.4 17.2 0.4 0.5 0.6 17.0 0.0 18.2 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.7 12.9 0.7 5.7 6.2 3.4 20.7 1.9 8.5 17.0 6.0 39.5 0.0 0.1 0.2 1.9 1.7 2.5 4.0 4.5 3.5 82.5 52.4 14.9 0.0 1.4 0.0 0.0 0.0 0.0 1.9 0.8 0.0 2.3 0.0 4.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 250.3 18.0 0.0 0.0 0.0 0.5 0.0 19.3 0.0 0.0 0.1 LRRC57 FLJ36812 ENSG00000180979 "Leucine rich repeat containing 57" Q8N9N7 15 42537820-42548802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 56.9;Rod photoreceptor cells: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040894 Approved Approved Mitochondria,Cytosol NA NA 230000 "Mitochondria, Cytosol" "HPA040894: AB_10794996" "unprognostic (8.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.84e-2)" "unprognostic (4.77e-2)" "unprognostic (4.16e-2)" "unprognostic (4.78e-2)" "unprognostic (2.57e-1)" "unprognostic (1.32e-1)" "unprognostic (3.31e-2)" "unprognostic (3.73e-2)" "prognostic favorable (2.15e-4)" "unprognostic (7.45e-2)" "unprognostic (7.23e-2)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" 13.9 14.7 15.8 11.6 13.6 32.7 19.2 12.4 19.1 11.8 16.0 10.6 9.7 12.3 15.7 12.2 18.0 15.3 10.2 15.6 18.0 8.4 14.2 11.1 15.9 11.2 11.8 16.5 17.6 14.5 13.2 12.2 14.4 9.9 12.3 18.9 16.4 15.7 11.6 11.0 16.5 14.5 12.8 10.3 13.0 14.1 12.4 11.3 14.9 15.1 10.0 12.8 13.1 15.6 4.8 6.9 22.1 12.0 11.1 6.7 4.3 10.4 7.9 14.4 10.8 12.0 9.5 7.8 15.0 8.0 10.6 11.2 16.3 8.4 4.9 10.5 11.6 12.0 17.2 9.6 11.7 10.8 10.4 9.0 19.5 17.4 7.3 11.6 12.0 12.6 10.4 15.7 9.6 11.9 7.6 16.9 13.0 15.0 11.8 9.6 4.9 7.0 5.4 3.8 17.7 7.1 11.0 13.9 7.7 7.3 17.1 7.4 8.9 17.3 12.5 8.7 9.9 11.6 14.4 17.2 12.8 9.0 13.1 11.1 10.0 24.8 20.3 7.3 12.1 15.6 22.1 6.5 20.5 5.4 9.4 6.7 4.2 5.2 4.9 6.9 4.8 4.3 5.3 8.5 11.1 12.0 4.0 5.2 4.3 15.8 13.6 12.4 19.1 18.0 8.4 11.8 16.5 9.9 11.3 8.9 13.3 5.4 11.0 5.0 13.4 9.5 10.2 21.4 7.9 8.7 56.9 9.9 11.6 9.6 13.9 12.9 11.6 0.0 8.5 15.7 7.4 12.9 13.9 6.4 12.0 19.1 12.0 18.4 11.9 13.2 8.9 12.9 6.8 22.6 13.5 18.4 11.4 10.2 15.2 6.6 81.1 6.5 8.2 5.0 5.3 4.8 13.3 10.9 11.9 10.1 LRRD1 IMAGE:4798971 ENSG00000240720 "Leucine rich repeats and death domain containing 1" A4D1F6 7 92112159-92179531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 19.1" "Group enriched" "Detected in some" 82 "Early spermatids: 257.1;Late spermatids: 670.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055670, HPA079440" Enhanced Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA055670: , HPA079440: " "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (3.72e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.27e-2)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" "unprognostic (1.77e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.13e-3)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 19.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.7 3.8 0.6 0.7 0.8 0.1 0.9 0.2 0.9 0.9 0.4 1.7 0.6 0.8 0.0 0.5 0.4 0.3 1.3 0.9 0.2 0.0 0.5 0.7 0.1 0.0 0.7 0.9 0.9 0.6 1.0 0.3 0.4 3.3 1.1 0.2 0.4 0.7 0.3 0.9 0.5 1.3 1.2 2.4 0.9 2.0 0.8 2.5 0.4 0.1 0.7 0.5 0.9 0.5 0.1 0.7 0.7 0.6 0.1 0.3 0.1 0.7 0.5 0.4 1.3 1.0 1.2 1.0 0.7 1.2 0.3 1.3 0.4 0.9 0.4 3.8 0.6 0.4 0.5 0.3 0.4 0.5 0.5 0.4 0.1 1.0 0.4 0.5 1.9 0.7 0.4 0.7 0.8 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.3 0.2 0.7 0.2 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 257.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.1 0.0 0.1 1.6 0.0 0.0 0.0 670.8 4.4 0.3 0.0 0.0 0.0 0.5 0.0 0.0 2.8 0.0 0.4 0.0 0.1 5.6 2.7 0.3 0.0 0.0 0.0 0.3 LRRK1 "FLJ23119, KIAA1790, RIPK6, Roco1" ENSG00000154237 "Leucine rich repeat kinase 1" Q38SD2 15 100919215-101078254 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 30.0;monocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.2;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.5;Karpas-707: 17.3;U-266/84: 15.6;U-698: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010537 Uncertain Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA010537: AB_1079283" "unprognostic (3.74e-2)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (3.72e-1)" "unprognostic (6.68e-2)" "unprognostic (6.35e-2)" "unprognostic (1.94e-1)" "unprognostic (4.75e-2)" "unprognostic (3.43e-2)" "unprognostic (3.34e-2)" "unprognostic (2.95e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-2)" "unprognostic (3.13e-1)" "unprognostic (5.25e-2)" 6.1 1.9 4.5 26.3 3.9 6.5 5.0 2.1 8.1 6.4 8.0 5.9 2.2 2.9 7.9 6.0 5.4 7.1 4.2 3.4 4.0 1.5 2.7 1.0 4.7 15.0 4.5 4.0 6.3 5.3 2.8 2.3 4.4 2.5 7.1 6.5 2.8 7.7 6.8 1.6 7.3 8.5 5.7 3.7 11.1 3.9 5.1 3.4 1.2 3.5 2.1 17.4 7.5 6.7 2.3 3.3 3.2 1.1 0.0 0.0 0.1 0.8 4.8 0.0 0.0 7.4 7.6 0.0 2.9 2.1 2.7 1.9 0.8 2.1 23.5 1.1 7.8 0.0 4.8 0.7 0.5 1.4 0.4 1.1 7.1 1.1 0.0 0.5 3.8 5.5 6.0 1.0 1.7 1.5 0.7 4.7 0.0 1.2 17.3 0.5 0.0 0.0 2.4 0.2 4.3 2.0 1.7 0.4 6.4 0.0 0.0 0.0 1.7 1.8 2.7 5.4 0.0 0.3 4.6 5.4 0.0 0.8 1.0 0.0 8.8 15.6 15.2 0.3 0.5 4.4 0.0 0.7 3.2 0.0 0.3 0.0 2.3 0.0 0.0 0.9 1.5 0.0 0.0 0.8 0.0 1.1 3.3 0.0 0.1 4.5 3.9 2.1 8.1 4.0 1.5 4.5 4.0 2.5 3.4 14.9 12.8 11.9 6.5 2.9 0.6 2.8 2.5 8.1 7.9 0.0 5.9 8.4 0.0 3.6 3.0 5.7 12.0 0.0 2.7 3.1 3.5 6.3 1.1 0.0 9.5 0.0 13.2 12.3 14.3 2.4 30.0 14.0 3.3 32.5 12.8 0.8 6.7 10.5 20.1 0.3 0.4 6.5 2.1 5.2 1.1 3.0 3.0 0.5 10.8 9.3 LUC7L "hLuc7B1, Luc7, LUC7B1" ENSG00000007392 "LUC7 like" Q9NQ29 16 188969-229463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056424, HPA069321" Supported Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA056424: AB_2683126, HPA069321: AB_2686119" "unprognostic (9.55e-3)" "unprognostic (2.01e-1)" "unprognostic (3.23e-2)" "unprognostic (5.61e-2)" "unprognostic (7.81e-2)" "unprognostic (2.60e-2)" "unprognostic (8.01e-3)" "unprognostic (4.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.30e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.33e-1)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (2.02e-3)" 23.8 24.5 30.4 26.5 30.9 25.3 24.0 42.6 30.0 21.9 20.1 29.9 25.8 21.3 29.4 37.7 15.5 19.2 24.5 12.7 34.1 26.5 26.9 19.9 18.8 31.0 33.1 24.3 29.3 24.2 31.2 40.3 23.1 25.4 35.2 18.2 24.3 25.1 25.2 20.3 28.8 23.9 24.4 29.2 32.1 22.6 29.8 33.1 23.2 40.2 15.9 21.0 16.6 26.3 6.5 11.1 3.5 11.7 3.9 6.9 5.6 5.4 24.4 25.9 9.7 10.0 7.7 11.4 10.1 7.7 16.5 12.0 25.4 6.4 9.9 13.3 5.8 8.7 6.9 30.8 9.2 16.6 17.7 21.1 12.1 16.6 29.7 11.2 14.0 13.6 6.9 10.7 13.3 5.3 14.3 12.7 8.6 14.3 6.4 13.2 26.2 23.0 24.4 38.6 12.3 11.8 19.8 11.3 10.4 23.6 5.8 15.4 17.3 10.9 7.6 9.4 16.0 9.8 7.6 10.3 12.0 18.1 5.0 12.1 7.0 9.3 10.5 3.6 10.0 10.7 0.3 9.1 3.5 6.7 10.4 5.2 6.5 6.3 6.5 9.8 3.0 3.7 2.8 1.2 3.9 11.7 11.1 6.9 5.6 30.4 30.9 42.6 30.0 34.1 26.5 33.1 24.3 25.4 33.1 47.6 61.1 29.6 38.6 47.3 48.4 18.3 12.7 40.2 58.0 22.7 35.3 24.9 10.0 29.4 34.2 45.0 22.2 0.0 18.2 33.5 35.8 31.0 39.4 10.0 21.2 42.9 40.6 25.2 14.5 14.7 30.2 28.9 37.1 35.1 16.5 30.8 22.7 28.1 30.4 11.3 61.8 25.8 46.4 62.1 51.9 47.4 41.8 27.7 17.1 27.1 LYSMD2 MGC35274 ENSG00000140280 "LysM domain containing 2" Q8IV50 15 51723011-51751585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 122.7;monocytes: 101.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040460 Approved Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA040460: AB_10794874" "unprognostic (7.71e-3)" "unprognostic (2.69e-1)" "unprognostic (3.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.11e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.60e-1)" "unprognostic (1.85e-1)" "unprognostic (3.98e-1)" "unprognostic (4.17e-3)" "unprognostic (6.86e-2)" "unprognostic (1.58e-2)" "unprognostic (5.03e-1)" "unprognostic (4.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" 5.3 13.4 17.7 13.8 26.2 7.9 5.1 19.9 35.8 6.5 6.1 7.9 7.2 10.0 6.1 7.5 4.6 6.9 7.6 3.6 17.9 19.1 6.7 13.9 9.3 17.2 14.6 17.6 5.8 8.6 7.1 15.2 6.1 25.2 6.2 6.5 4.1 4.3 9.8 10.9 2.7 8.1 7.8 8.2 12.9 7.7 15.6 5.9 6.1 4.9 2.3 16.7 7.4 4.6 17.0 18.2 38.7 20.4 11.9 16.3 12.2 6.0 4.5 0.8 6.0 2.0 3.5 0.0 7.2 4.2 9.2 11.9 0.5 5.5 23.7 1.0 4.0 10.7 8.6 4.9 4.8 6.5 20.0 2.3 7.0 4.2 0.1 4.4 16.3 3.0 3.9 9.8 3.6 3.9 4.1 5.4 9.1 0.3 0.0 2.8 9.1 6.1 20.5 1.9 0.2 5.1 9.3 0.1 8.8 8.9 5.0 18.2 4.5 6.7 0.1 12.1 1.2 5.1 12.5 3.2 9.0 4.6 9.4 10.0 0.0 0.0 0.1 4.5 33.3 6.7 0.0 13.2 24.4 10.9 15.9 16.3 17.0 11.0 13.1 11.1 16.2 13.3 11.0 38.7 11.9 20.4 18.2 6.4 12.2 17.7 26.2 19.9 35.8 17.9 19.1 14.6 17.6 25.2 5.9 3.0 7.4 58.5 17.6 17.2 14.3 1.8 17.8 2.7 5.7 14.0 0.0 1.0 21.6 16.6 122.7 22.4 5.2 23.3 16.1 0.8 13.6 16.4 12.7 13.4 37.2 30.2 76.7 23.4 39.6 55.5 15.0 28.8 6.8 101.8 13.3 5.6 9.7 15.9 14.9 23.3 3.6 25.8 20.0 3.5 3.8 14.2 0.7 47.3 20.3 17.2 M1AP "C2orf65, D6Mm5e, SPATA37" ENSG00000159374 "Meiosis 1 associated protein" Q8TC57 2 74557883-74648338 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.8;testis: 13.2" "Group enriched" "Detected in some" 4 "Spermatocytes: 8.7;Spermatogonia: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NTERA-2: 6.1;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045420, HPA059302" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045420: AB_10961177, HPA059302: AB_2683972" "unprognostic (1.76e-1)" "unprognostic (6.58e-3)" "unprognostic (1.26e-2)" "unprognostic (2.87e-1)" "unprognostic (9.15e-2)" "unprognostic (1.35e-3)" "unprognostic (1.86e-1)" "unprognostic (2.17e-3)" "unprognostic (3.42e-1)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (6.11e-2)" "unprognostic (7.74e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" 0.7 0.6 5.2 0.2 1.5 3.7 3.7 1.2 3.4 4.6 0.2 0.3 1.0 0.2 2.1 0.5 0.3 4.6 0.5 0.1 0.9 1.8 1.5 0.1 0.6 0.1 0.5 1.6 0.3 0.4 1.7 8.8 1.2 0.9 0.2 0.0 2.0 1.5 1.0 0.1 0.2 0.2 0.2 0.7 0.4 0.7 13.2 0.2 1.0 3.6 0.0 0.5 0.9 0.5 0.0 0.9 0.2 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.2 0.5 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.1 0.8 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 5.2 1.5 1.2 3.4 0.9 1.8 0.5 1.6 0.9 0.2 0.0 1.4 0.0 0.0 0.1 0.3 0.3 0.0 2.7 0.0 3.5 0.0 0.3 0.0 0.2 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 3.5 0.0 0.0 0.0 1.0 3.1 0.0 2.3 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 1.3 0.0 0.0 8.7 22.0 0.0 0.2 0.0 0.0 0.1 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "CAB025341: , HPA055371: AB_2682797" "prognostic favorable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.5 1.2 1.7 2.6 2.7 8.7 7.9 15.3 21.2 7.8 8.4 2.2 6.2 0.2 1.5 6.5 11.8 5.1 0.4 6.1 13.3 1.4 0.2 0.8 0.8 1.9 7.3 0.5 2.7 3.7 10.2 31.3 17.4 7.0 16.4 0.8 1.5 7.3 6.1 1.7 0.3 2.0 1.2 8.4 6.2 0.5 1.4 1.5 7.9 11.6 0.9 1.4 2.3 6.1 37.2 4.4 1.3 0.6 21.4 9.9 7.3 7.3 5.1 2.7 2.8 0.3 15.0 0.6 6.2 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 50.6 43.7 7.5 289.5 111.8 2.2 13.7 33.1 29.4 33.0 10.4 0.0 30.6 6.6 37.6 0.4 35.0 98.6 0.0 21.5 52.9 80.2 257.7 21.9 5.0 23.2 0.0 100.5 14.7 7.8 0.0 9.2 26.4 55.6 17.2 43.3 16.8 51.3 62.0 3.5 2.4 2.0 19.4 116.4 0.9 1.0 90.2 400.7 27.7 35.7 321.4 MANBAL dJ1141E15.2 ENSG00000101363 "Mannosidase beta like" Q9NQG1 20 37289638-37317260 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052348 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA052348: AB_2681795" "unprognostic (1.86e-2)" "unprognostic (9.15e-2)" "unprognostic (1.85e-1)" "unprognostic (2.45e-2)" "unprognostic (3.12e-1)" "unprognostic (2.21e-3)" "prognostic unfavorable (7.07e-4)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (9.61e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "prognostic favorable (3.62e-4)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (8.03e-2)" "unprognostic (2.70e-2)" 17.3 25.2 19.6 10.7 27.6 2.9 29.8 11.4 32.7 22.5 22.1 15.9 21.9 17.0 26.7 29.7 22.1 28.9 23.3 13.9 20.8 20.1 19.0 14.5 15.1 19.3 18.9 23.2 28.5 21.4 15.1 16.9 16.1 22.1 24.0 20.3 27.5 16.6 32.9 7.1 19.8 15.6 33.5 13.4 11.1 18.7 17.6 11.2 9.8 23.2 13.7 13.7 20.5 28.3 18.0 21.7 25.4 19.3 14.5 17.3 11.1 17.2 33.9 17.3 17.4 28.4 20.7 15.0 24.1 25.2 23.4 18.5 39.9 23.6 4.4 29.0 29.3 23.9 23.8 16.3 37.7 16.1 3.3 16.9 4.7 14.2 35.4 30.7 4.9 3.0 22.5 26.8 21.7 36.1 23.6 16.3 5.9 7.5 4.9 23.3 20.3 6.2 6.5 13.7 29.0 31.8 3.7 22.7 5.2 22.2 24.1 16.6 19.0 24.5 36.9 19.8 15.5 24.8 8.0 17.8 43.2 16.2 24.2 18.5 6.6 8.9 3.7 31.0 2.7 22.2 9.2 17.0 23.7 11.8 19.3 13.6 18.0 14.2 14.0 15.5 17.8 17.3 16.6 25.4 14.5 15.1 21.7 9.3 11.1 19.6 27.6 11.4 32.7 20.8 20.1 18.9 23.2 22.1 11.2 23.8 31.4 8.3 66.3 26.8 21.0 16.9 33.1 13.4 25.0 41.8 3.9 82.3 33.2 65.8 4.1 25.8 22.5 0.0 96.6 107.8 49.0 70.0 7.0 18.7 26.4 19.1 29.3 30.7 12.6 5.7 43.4 19.2 43.9 21.6 32.4 50.8 77.2 44.8 64.3 47.6 11.3 19.4 44.2 23.2 48.1 26.6 64.3 10.7 32.7 98.7 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 358.2;Proximal tubular cells: 497.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 10 "monocytes: 1.0;T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Enhanced Mitochondria,Cytosol No No Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970" "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 72.3 11.0 8.2 10.2 7.8 0.3 35.2 3.3 6.1 12.4 85.7 2.8 10.7 53.6 12.5 6.2 36.6 12.0 14.7 37.8 6.7 8.3 77.8 45.9 34.4 5.2 11.1 6.1 14.2 24.4 9.6 1.5 79.8 8.7 26.2 39.9 6.2 49.1 12.9 12.5 11.2 90.1 23.6 3.4 2.1 19.3 5.5 4.7 0.0 68.6 9.7 3.9 35.3 35.1 0.0 0.0 0.1 1.0 0.0 1.3 0.1 0.0 0.8 0.1 2.4 40.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 4.1 1.5 5.4 0.0 0.0 0.6 1.6 0.1 4.3 75.9 0.0 4.1 19.1 21.4 0.0 11.2 0.0 4.8 0.0 0.0 0.1 1.4 0.6 0.0 0.1 0.4 4.9 1.2 0.0 0.0 0.1 5.5 31.3 0.7 1.9 0.0 0.0 0.0 0.1 0.1 0.0 2.1 0.0 2.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.2 7.8 3.3 6.1 6.7 8.3 11.1 6.1 8.7 4.7 65.5 115.2 10.9 141.7 9.7 4.4 90.1 91.7 34.8 50.0 57.6 21.6 9.7 102.8 29.5 19.6 35.3 358.2 0.0 12.0 17.7 14.2 55.4 5.7 169.3 6.2 3.2 36.6 36.8 14.9 22.5 5.2 4.0 10.1 29.7 119.4 23.2 31.4 140.8 0.0 497.3 21.7 6.5 15.1 1.1 0.4 12.5 173.1 3.1 215.1 89.9 MBLAC2 "DKFZp686P15118, MGC46734" ENSG00000176055 "Metallo-beta-lactamase domain containing 2" Q68D91 5 90458203-90474768 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037757, HPA037758" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037757: AB_10670528, HPA037758: " "unprognostic (6.32e-2)" "unprognostic (2.48e-1)" "unprognostic (9.22e-3)" "unprognostic (1.21e-2)" "unprognostic (9.27e-2)" "unprognostic (1.96e-3)" "unprognostic (9.98e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.00e-3)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (3.34e-1)" "unprognostic (6.31e-2)" "unprognostic (1.63e-2)" 5.2 7.4 11.2 5.7 16.8 2.7 9.5 16.7 14.7 8.7 5.7 7.4 7.4 6.1 9.6 6.6 7.2 7.5 5.0 5.2 12.7 14.2 9.3 11.1 5.5 11.1 10.6 9.8 16.3 7.4 21.8 10.0 5.4 9.7 8.6 6.2 4.8 7.8 7.8 4.3 9.5 5.4 7.1 10.7 6.6 4.8 6.1 7.0 8.1 9.7 3.1 7.0 6.5 6.9 5.3 2.9 1.1 3.8 3.3 4.8 2.3 5.8 2.5 4.4 5.5 5.8 7.9 5.4 4.6 4.3 4.0 4.3 1.9 4.4 13.7 2.8 4.1 5.6 6.0 5.7 7.0 6.3 7.7 3.9 6.1 4.1 4.4 6.1 6.0 2.7 6.8 9.4 2.9 11.2 4.7 5.1 7.4 9.2 7.6 6.8 3.6 5.8 8.3 2.8 1.2 12.3 6.3 7.3 18.6 6.1 2.2 7.6 8.9 4.2 6.2 11.2 2.7 5.1 4.5 6.3 5.0 3.5 6.1 6.0 5.4 6.0 6.1 4.3 12.7 6.8 0.0 1.5 1.1 3.2 3.8 3.9 3.1 3.6 3.5 2.9 5.3 4.8 3.7 0.1 3.3 1.9 1.0 1.3 2.3 11.2 16.8 16.7 14.7 12.7 14.2 10.6 9.8 9.7 7.0 3.0 2.2 1.4 0.8 2.4 6.4 4.0 5.1 2.7 1.2 1.8 7.9 3.0 1.7 1.6 0.3 4.4 2.0 0.0 1.1 2.7 2.2 0.8 0.0 4.9 2.2 3.2 4.1 3.7 5.3 0.6 3.7 1.2 1.7 1.0 2.8 5.6 2.0 0.0 4.9 3.9 6.2 0.0 2.7 2.8 4.6 2.9 0.7 2.1 3.5 0.7 METTL27 WBSCR27 ENSG00000165171 "Methyltransferase like 27" Q8N6F8 7 73834590-73842535 "Disease related genes, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 56.2;Collecting duct cells: 19.2;Distal tubular cells: 24.9;Proximal tubular cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.6;RPMI-8226: 40.8;T-47d: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA022420, HPA074662" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA022420: AB_2304370, HPA074662: " "unprognostic (6.70e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.38e-2)" "unprognostic (2.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (1.20e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.86e-1)" "unprognostic (2.15e-2)" "unprognostic (6.49e-2)" "unprognostic (1.24e-2)" 5.7 2.7 1.5 1.4 2.6 0.3 5.2 4.2 3.9 10.2 3.6 3.8 14.5 3.3 5.3 4.4 5.8 9.3 12.4 0.9 1.4 1.3 9.2 2.7 4.7 6.0 1.2 6.0 5.2 11.1 10.0 4.0 8.7 2.8 8.0 1.3 2.4 20.3 12.4 2.3 2.0 4.5 1.3 1.3 5.1 1.7 10.6 0.8 3.0 6.6 0.9 3.1 4.3 3.6 2.4 1.4 2.0 3.4 0.0 9.2 0.3 6.4 7.9 0.0 0.6 1.2 3.5 1.3 0.0 0.1 0.2 0.2 0.4 9.6 1.5 1.5 1.3 5.6 0.6 0.0 2.5 0.1 1.0 0.1 0.0 2.3 2.4 1.4 0.0 0.0 1.4 0.6 4.1 2.0 0.4 1.5 0.5 0.1 1.3 0.9 1.8 0.0 0.0 0.1 5.1 2.0 0.4 1.8 40.8 2.1 1.2 0.7 0.2 0.9 0.7 0.7 1.9 11.9 0.4 1.7 2.5 0.6 4.9 2.5 1.8 0.6 0.0 0.5 0.0 0.8 0.0 1.0 2.0 0.1 3.4 0.0 2.4 0.6 0.0 1.4 1.0 1.2 0.8 1.0 0.0 0.8 1.0 9.2 0.3 1.5 2.6 4.2 3.9 1.4 1.3 1.2 6.0 2.8 0.8 6.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 56.2 4.5 19.2 0.0 3.4 24.9 12.8 0.0 0.0 0.0 0.0 1.9 1.5 0.0 0.0 2.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 7.4 0.0 0.0 40.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 101.3;Extravillous trophoblasts: 117.0;Melanocytes: 185.5" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 59.6;WM-115: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA042149: AB_2677875, HPA043088: AB_2678308" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favorable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavorable (6.61e-4)" "prognostic unfavorable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 25.9 13.0 15.4 19.0 14.4 23.5 9.3 10.4 22.9 8.1 8.9 24.3 11.2 12.5 10.2 12.7 11.1 14.3 10.0 7.6 23.9 12.8 38.0 21.5 13.8 15.2 20.7 10.0 9.7 19.8 15.7 11.9 46.6 15.6 10.2 5.7 13.5 23.7 10.5 8.1 43.6 13.8 9.9 18.6 19.7 14.1 7.5 16.1 37.0 9.1 6.1 11.8 7.9 7.8 2.4 12.9 2.6 7.9 0.5 3.1 1.6 17.0 13.8 3.4 8.9 7.1 5.5 12.3 10.5 5.7 12.3 13.5 5.9 5.8 4.8 8.0 5.5 19.6 10.7 4.4 5.4 4.4 10.5 12.5 2.8 44.2 6.0 8.9 6.0 9.5 4.9 8.2 12.6 2.9 4.7 3.3 7.2 13.4 7.0 3.1 10.2 5.9 10.8 6.4 7.5 11.2 4.3 4.9 20.3 5.1 7.3 12.9 6.5 20.7 9.7 59.6 4.4 3.3 12.6 13.5 5.6 8.2 22.7 11.8 8.0 4.5 4.4 24.6 15.6 113.8 0.1 4.0 2.6 2.1 7.9 2.1 2.4 3.1 1.6 2.8 1.7 2.7 2.1 1.3 0.5 7.6 12.9 0.5 1.6 15.4 14.4 10.4 22.9 23.9 12.8 20.7 10.0 15.6 16.1 6.0 3.2 15.2 3.8 23.6 15.8 1.6 12.7 4.0 4.5 19.2 5.9 10.7 0.0 19.3 101.3 10.8 13.8 0.0 26.4 117.0 8.0 13.6 0.0 19.2 73.9 35.0 26.9 8.6 19.6 20.9 2.3 32.4 185.5 19.8 9.3 8.3 29.4 17.3 3.2 33.8 11.5 12.9 5.0 4.2 9.1 22.2 77.5 7.5 8.6 13.2 MGST1 "GST12, MGST-I" ENSG00000008394 "Microsomal glutathione S-transferase 1" P10620 12 16347142-16609259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 382.8" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 3471.1;Proximal tubular cells: 978.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 46.1;myeloid DC: 34.1" "Group enriched" "Detected in many" 15 "dendritic cells: 34.1;monocytes: 46.1" "Cell line enhanced" "Detected in many" "ASC diff: 342.0;ASC TERT1: 132.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044840 Enhanced Approved "Endoplasmic reticulum,Mitochondria" NA NA Mitochondria "Endoplasmic reticulum" "HPA044840: AB_10965550" "unprognostic (4.57e-2)" "unprognostic (4.80e-3)" "unprognostic (5.82e-2)" "unprognostic (2.92e-3)" "unprognostic (3.97e-3)" "unprognostic (1.03e-1)" "unprognostic (8.19e-2)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (9.90e-2)" "unprognostic (4.61e-1)" "prognostic favorable (1.97e-4)" "unprognostic (4.19e-1)" 127.9 106.0 18.5 10.8 32.6 9.5 116.8 10.3 14.0 9.3 39.7 9.6 2.6 17.0 4.1 6.4 19.5 6.9 26.6 12.1 19.6 13.9 56.9 382.8 42.0 2.7 18.9 8.9 3.1 12.4 0.8 5.3 8.7 18.4 23.5 28.3 3.0 14.7 8.2 8.9 7.0 15.5 11.5 20.1 0.9 10.3 6.8 12.0 0.0 69.9 13.9 3.6 32.6 37.2 0.2 34.1 2.7 46.1 0.0 0.2 13.0 0.0 30.6 7.3 8.5 342.0 132.0 0.0 25.1 25.7 13.7 21.3 11.6 51.3 0.0 3.0 32.1 43.1 0.1 19.0 40.2 12.4 0.0 2.5 10.4 17.0 40.7 79.9 20.2 0.0 85.6 44.8 41.8 44.1 34.0 24.0 0.0 7.3 0.0 29.4 6.2 0.0 8.1 60.9 0.0 24.3 0.0 4.3 13.8 30.8 60.5 1.3 1.1 39.2 25.2 1.0 41.3 27.1 11.4 15.1 14.1 1.9 27.7 32.3 0.0 0.0 0.0 46.4 32.3 0.4 2.7 46.1 0.4 0.0 7.0 0.1 0.2 0.0 0.0 34.1 0.0 0.0 0.0 1.5 0.0 1.5 9.6 0.2 13.0 18.5 32.6 10.3 14.0 19.6 13.9 18.9 8.9 18.4 12.0 247.1 493.0 46.4 120.5 22.8 0.0 5.3 738.8 293.1 502.7 68.0 0.0 2.3 154.2 22.7 20.8 14.2 262.1 46.7 371.4 189.8 162.1 379.2 32.4 3471.1 168.6 0.0 43.8 78.5 223.7 10.9 30.8 51.0 37.1 187.6 224.9 0.0 374.3 135.3 106.4 978.0 1.0 0.0 12.2 0.5 2.2 15.4 6.6 37.4 362.2 564.6 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604214 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: AB_2683821" "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 14.8 32.4 23.9 23.5 23.2 20.9 22.9 28.6 25.4 19.5 25.4 17.3 16.1 18.0 16.7 21.1 19.9 17.8 16.3 41.7 22.9 24.1 52.8 24.5 15.6 16.8 23.4 25.6 17.0 16.9 19.5 30.3 31.2 20.6 20.3 23.9 14.5 16.9 23.6 39.6 15.5 21.0 14.7 28.1 19.4 20.1 17.5 22.6 25.2 26.3 25.6 19.4 15.6 15.4 33.2 21.8 26.5 23.5 22.8 30.7 17.2 11.8 6.8 16.2 10.3 14.5 19.5 14.0 20.1 16.5 21.5 15.0 9.9 19.2 18.5 13.1 19.1 11.1 15.9 15.9 16.9 29.7 18.7 16.5 31.9 7.4 11.4 17.5 23.9 18.6 16.8 16.8 12.1 8.6 19.3 14.3 17.5 11.2 8.3 35.0 10.2 15.9 22.8 11.0 41.9 10.8 17.5 41.4 12.3 42.3 9.7 13.1 10.1 13.7 16.2 13.0 14.8 15.8 22.6 17.6 9.4 8.4 19.0 16.5 6.2 8.2 13.5 9.2 20.0 23.2 22.1 20.1 26.5 26.1 23.5 24.1 33.2 23.0 26.0 21.8 20.8 20.9 26.0 18.7 22.8 19.3 20.1 30.7 17.2 23.9 23.2 28.6 25.4 22.9 24.1 23.4 25.6 20.6 22.6 35.7 23.2 29.6 35.2 26.7 24.7 68.6 30.6 50.9 37.5 48.8 21.6 50.6 122.7 36.4 20.1 21.0 30.6 23.3 23.9 37.2 35.7 25.7 24.3 21.3 32.4 39.7 29.2 19.6 34.1 10.0 31.4 30.0 45.5 39.7 26.0 60.5 29.6 54.7 33.9 82.6 49.4 58.2 27.8 59.5 48.0 22.3 58.8 35.4 29.2 26.8 MIEF1 "FLJ20232, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 232.6;Late spermatids: 280.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" NA NA "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favorable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 14.9 12.6 14.5 15.1 14.9 16.2 12.3 17.3 21.3 10.0 15.1 12.3 12.9 17.5 12.1 12.9 13.9 10.9 14.2 11.6 13.0 12.9 19.6 26.2 10.8 15.5 13.6 15.9 12.1 14.3 16.6 8.3 12.6 12.1 10.6 14.2 12.5 15.6 14.1 16.7 11.5 16.6 10.3 10.8 18.0 11.7 43.1 10.7 15.9 12.6 11.1 16.6 11.5 13.8 7.1 8.1 5.9 8.3 8.7 9.2 7.6 8.0 8.1 9.0 14.2 8.5 9.3 10.3 7.7 9.2 8.9 8.2 13.3 4.2 22.4 6.5 8.3 5.9 10.3 20.2 10.7 11.1 9.5 18.7 9.2 11.4 13.4 16.4 32.5 12.3 12.2 13.1 7.9 16.9 8.6 9.4 7.6 16.2 12.4 8.8 5.4 10.2 9.0 8.3 16.7 8.9 14.1 12.7 22.8 10.2 9.8 8.2 6.8 8.6 14.9 22.0 9.8 6.6 11.8 9.2 8.4 11.9 7.4 9.4 22.7 23.6 22.8 9.7 14.2 12.9 0.6 7.4 5.9 7.6 8.3 9.2 7.0 7.3 7.2 8.1 7.1 8.1 7.5 0.7 8.7 7.8 4.5 6.3 7.6 14.5 14.9 17.3 21.3 13.0 12.9 13.6 15.9 12.1 10.7 11.9 16.0 5.2 10.4 17.3 18.5 15.7 12.7 8.1 5.7 15.7 23.6 16.0 21.6 10.9 232.6 9.8 16.0 0.0 11.7 16.5 10.1 14.5 9.2 34.2 14.0 6.4 9.4 20.3 15.4 280.8 14.4 13.6 15.1 8.2 10.7 19.8 14.0 3.5 13.1 20.3 13.5 0.0 8.5 17.2 27.1 20.1 10.9 7.7 18.9 14.7 MOCOS "FLJ20733, HMCS, MOS" ENSG00000075643 "Molybdenum cofactor sulfurase" Q96EN8 18 36187519-36272157 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.0;liver: 36.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 30.1;monocytes: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 20.8;hTERT-HME1: 25.6;SiHa: 27.4;SK-MEL-30: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039412, HPA047958" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039412: AB_2676496, HPA047958: AB_2680225" "unprognostic (3.07e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (3.18e-3)" "unprognostic (2.55e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.84e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.91e-2)" "prognostic unfavorable (3.03e-12)" "unprognostic (8.98e-2)" "unprognostic (2.37e-1)" "unprognostic (4.09e-1)" "unprognostic (6.35e-2)" 3.7 12.7 0.6 1.6 0.5 0.2 6.4 0.4 0.4 1.4 10.4 0.7 8.0 6.7 1.3 4.6 4.8 1.9 5.8 1.3 0.4 0.5 1.7 36.6 1.8 0.2 0.4 0.1 17.2 3.2 1.1 9.4 11.2 2.2 2.8 1.8 2.1 2.5 7.2 1.3 2.6 33.0 1.0 0.4 0.7 1.7 1.3 0.2 0.0 1.2 2.9 3.5 2.6 1.7 0.4 0.3 1.9 0.3 1.1 0.3 0.1 6.9 2.4 0.1 0.0 2.2 2.9 1.5 4.1 2.3 2.0 5.1 1.5 2.2 0.0 1.3 6.6 0.5 4.3 1.5 6.5 2.8 1.2 1.2 0.1 6.9 5.7 7.6 0.0 2.0 4.5 20.8 7.7 25.6 0.2 0.3 0.0 2.3 0.0 3.2 1.8 0.0 0.0 0.4 1.6 2.0 0.0 0.0 0.0 2.8 9.1 0.0 0.6 27.4 1.7 19.1 0.4 1.3 0.1 1.3 1.6 1.9 3.4 0.7 0.0 0.0 0.0 4.0 0.0 0.7 1.7 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.2 0.3 1.9 1.1 0.2 0.3 0.1 0.1 0.6 0.5 0.4 0.4 0.4 0.5 0.4 0.1 2.2 0.2 11.9 5.3 3.4 1.2 0.6 0.2 0.4 0.0 2.7 6.8 0.0 2.0 0.4 0.0 2.7 5.7 0.9 2.6 0.0 10.9 3.3 1.5 1.2 0.0 30.1 0.5 0.0 2.9 0.0 0.6 1.7 1.7 1.4 3.3 20.8 2.3 7.6 4.3 2.8 8.5 0.0 0.3 0.0 0.5 0.1 0.2 1.1 1.9 0.0 2.8 2.2 MORC3 "KIAA0136, NXP2, ZCW5, ZCWCC3" ENSG00000159256 "MORC family CW-type zinc finger 3" Q14149 21 36320189-36386148 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018406, HPA034848" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA018406: AB_1858988, HPA034848: AB_2674359" "unprognostic (4.01e-3)" "unprognostic (4.86e-2)" "unprognostic (4.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (6.29e-2)" "unprognostic (6.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.53e-1)" "unprognostic (6.40e-2)" "unprognostic (8.61e-2)" "unprognostic (1.18e-3)" "unprognostic (1.38e-2)" "unprognostic (3.91e-1)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" 18.0 11.2 15.6 15.4 16.4 28.0 17.5 30.9 16.3 20.3 15.3 10.1 14.1 10.6 22.5 10.6 23.0 17.9 13.5 12.5 14.6 7.9 11.6 13.0 17.0 20.6 17.5 12.1 29.3 11.3 14.8 25.1 20.6 16.6 16.1 12.1 7.3 20.6 14.2 28.1 20.1 14.8 21.4 21.0 19.1 14.0 10.8 18.2 25.5 15.0 17.6 20.0 22.9 23.5 11.2 7.6 21.9 10.7 8.2 11.9 6.6 12.2 4.7 11.4 7.5 11.8 12.8 16.1 11.6 20.3 13.4 11.1 7.6 8.0 5.9 4.5 13.3 13.3 6.2 8.9 11.6 14.1 11.1 7.0 24.4 5.1 5.6 7.7 12.5 21.8 8.0 14.5 12.8 17.7 14.0 10.7 9.3 19.5 15.1 10.8 4.0 8.0 6.8 9.4 15.0 5.7 9.9 5.7 10.6 5.9 12.8 4.7 12.3 13.5 8.8 13.8 9.2 9.9 10.5 14.3 13.0 3.2 8.7 10.0 6.7 5.9 5.7 8.4 19.9 9.3 21.9 7.5 16.1 8.4 9.4 8.3 10.0 9.2 7.9 7.6 11.2 11.9 8.5 11.7 8.2 10.7 4.9 11.3 6.6 15.6 16.4 30.9 16.3 14.6 7.9 17.5 12.1 16.6 18.2 26.8 20.8 20.5 44.0 60.8 20.0 17.6 12.7 32.1 25.0 21.0 7.9 13.4 3.3 14.1 38.2 20.4 10.1 23.3 10.9 15.8 35.2 39.4 46.2 13.6 15.7 15.9 10.9 12.9 25.7 13.5 17.3 33.9 23.6 21.6 14.7 15.5 17.4 14.4 25.1 5.3 11.9 12.9 20.2 24.7 32.9 71.4 21.1 24.5 9.0 52.9 MORN1 FLJ13941 ENSG00000116151 "MORN repeat containing 1" Q5T089 1 2321253-2391707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 34.8;Rod photoreceptor cells: 21.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005858, HPA070703" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA005858: AB_1848709, HPA070703: AB_2686299" "unprognostic (1.39e-3)" "unprognostic (6.49e-2)" "unprognostic (1.58e-1)" "unprognostic (8.21e-3)" "unprognostic (9.12e-2)" "unprognostic (5.87e-3)" "unprognostic (1.87e-1)" "unprognostic (2.65e-1)" "unprognostic (3.61e-2)" "unprognostic (5.97e-2)" "unprognostic (1.11e-2)" "unprognostic (2.60e-1)" "unprognostic (8.88e-3)" "unprognostic (2.53e-1)" "unprognostic (6.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" 4.2 4.0 6.9 5.6 15.1 2.5 4.9 25.8 6.6 7.3 4.4 6.1 14.4 4.5 9.3 13.9 3.7 23.5 7.4 3.0 5.5 5.7 7.8 4.1 5.8 3.5 3.9 8.0 15.2 8.6 4.9 11.6 2.5 11.7 6.7 3.1 8.8 9.1 11.7 4.7 6.4 4.3 6.0 4.9 4.6 5.4 17.3 4.8 5.8 15.0 3.3 3.8 3.5 4.6 2.1 3.7 4.2 4.3 0.8 2.6 1.0 6.4 7.8 5.4 4.9 1.9 0.9 5.6 2.0 1.4 3.2 2.7 3.7 7.3 1.7 4.2 1.2 2.4 8.0 1.1 3.1 3.1 3.9 8.3 1.7 14.3 4.2 1.6 2.1 0.9 1.1 0.7 3.0 2.7 2.4 2.2 3.4 2.7 2.0 1.1 8.9 2.1 0.8 3.2 3.4 6.9 2.2 5.0 2.7 2.5 2.9 8.9 4.3 5.2 9.5 4.1 2.5 5.0 0.6 0.7 3.7 5.3 2.6 2.3 4.8 1.7 1.1 7.4 1.3 2.5 0.0 0.8 0.2 1.4 0.3 0.8 1.0 1.5 1.1 1.0 2.1 2.6 1.2 4.2 0.8 4.3 3.7 0.1 1.0 6.9 15.1 25.8 6.6 5.5 5.7 3.9 8.0 11.7 4.8 3.0 2.7 1.5 3.6 1.4 8.5 3.2 5.1 34.8 4.5 14.0 19.6 3.1 3.3 1.8 16.8 1.0 2.1 0.0 1.2 1.4 2.1 2.7 5.7 1.0 2.3 9.5 5.2 1.8 0.6 19.5 2.3 0.6 1.7 1.0 0.6 8.4 1.4 0.0 2.8 7.9 21.9 0.0 2.0 19.2 5.9 1.9 1.6 0.8 1.9 2.3 MPDU1 "CDGIf, Lec35, PQLC5, SL15" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" NA NA "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 15.4 24.6 12.6 10.3 16.5 16.6 16.7 9.1 26.2 16.0 27.3 22.8 4.6 18.5 8.2 15.3 20.5 14.2 16.4 9.1 11.6 10.3 36.0 80.1 15.4 12.3 12.9 8.4 10.8 24.3 21.0 9.3 27.4 15.7 15.1 30.0 17.3 17.2 9.6 11.0 14.7 39.0 11.8 13.3 23.8 20.3 9.1 10.9 17.6 21.4 12.5 17.5 15.5 11.3 7.5 19.7 5.5 26.8 6.4 10.0 8.7 12.5 26.3 19.2 12.6 24.3 22.4 11.6 20.8 30.6 39.5 29.0 13.7 21.2 7.5 15.1 36.0 17.0 24.4 29.1 35.7 33.7 15.6 26.6 13.6 17.4 23.4 30.4 11.3 21.2 22.8 29.5 36.8 21.8 18.3 29.8 21.0 22.2 9.7 42.7 18.0 7.4 7.0 20.7 29.3 12.5 17.2 14.8 12.7 39.6 12.3 12.1 22.0 27.1 18.9 7.2 17.9 22.1 9.2 20.0 16.3 8.4 9.5 25.9 4.9 9.0 6.2 23.3 14.7 23.2 5.5 16.2 4.8 6.7 26.8 5.5 7.5 6.5 9.0 19.7 7.5 6.7 7.6 2.6 6.4 24.2 18.5 10.0 8.7 12.6 16.5 9.1 26.2 11.6 10.3 12.9 8.4 15.7 10.9 8.9 26.0 42.4 30.9 9.5 15.5 4.3 40.8 17.4 12.5 22.7 11.8 99.2 29.9 56.7 2.3 16.3 81.1 0.0 66.5 77.5 25.4 35.1 13.9 42.4 70.3 15.9 35.7 27.0 31.6 3.6 15.8 35.1 23.6 39.7 56.4 28.4 60.1 66.6 6.0 39.4 20.1 25.8 11.3 19.7 30.4 11.0 131.8 21.8 53.6 36.1 MPP2 "DKFZp761D0712, DLG2" ENSG00000108852 "Membrane palmitoylated protein 2" Q14168 17 43875357-43909711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 89.3;Early spermatids: 63.3;Horizontal cells: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 14 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "T-47d: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026486, HPA073483" Enhanced Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA026486: AB_1854085, HPA073483: " "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (1.30e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (4.37e-2)" "unprognostic (2.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.34e-1)" "unprognostic (1.25e-1)" "unprognostic (3.69e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.72e-2)" "unprognostic (4.93e-2)" "unprognostic (1.85e-1)" "unprognostic (7.23e-2)" "unprognostic (6.89e-4)" 2.1 5.0 12.1 2.1 11.8 1.1 3.1 19.5 26.3 3.5 5.1 19.8 2.7 1.9 4.6 31.0 4.1 3.3 3.0 9.0 13.8 14.2 2.0 0.9 2.0 1.2 15.3 14.4 2.8 4.4 31.1 8.4 3.4 11.5 7.1 2.0 6.5 2.3 10.7 1.7 2.0 2.0 6.5 20.3 1.3 2.5 13.8 12.3 0.0 4.5 0.0 1.4 3.6 2.8 0.1 0.0 0.0 0.1 0.0 1.9 0.7 4.9 7.2 7.8 11.3 1.1 0.7 4.3 1.7 0.2 6.8 6.4 2.5 3.3 7.1 4.0 1.7 8.7 2.0 10.5 4.1 5.3 0.0 8.0 0.6 6.7 0.1 0.2 0.0 2.1 1.1 0.3 4.9 0.0 3.8 0.4 11.6 2.6 0.0 2.0 1.9 1.0 0.5 14.0 0.6 4.5 5.0 11.2 0.5 0.1 0.1 8.4 7.8 2.1 0.7 2.9 7.3 17.2 3.4 0.1 7.5 9.6 2.9 3.1 2.4 4.9 0.0 11.4 4.8 1.4 0.0 0.1 0.0 1.4 0.0 0.2 0.0 0.5 1.2 0.0 0.1 1.6 1.9 0.0 0.0 0.0 0.0 0.1 0.7 12.1 11.8 19.5 22.5 13.8 14.2 15.3 14.4 11.5 12.3 0.0 0.0 0.0 1.5 0.3 89.3 8.5 0.0 0.0 0.0 0.0 2.0 4.5 0.0 0.5 63.3 0.5 0.0 0.0 0.3 0.3 2.4 0.0 0.0 0.0 0.6 33.4 0.0 0.0 0.0 16.0 3.4 0.0 0.0 0.0 0.0 15.3 0.8 0.0 5.3 0.0 6.4 0.0 2.8 18.2 18.0 0.1 2.3 0.0 0.0 0.0 MPST "MST, TST2, TUM1" ENSG00000128309 "Mercaptopyruvate sulfurtransferase" P25325 22 37019635-37029822 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 780.2;Hepatocytes: 473.7;Paneth cells: 550.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001240 Enhanced Approved Mitochondria,Cytosol NA NA 2800000 Mitochondria Cytosol "HPA001240: AB_1079408" "unprognostic (7.18e-3)" "unprognostic (4.45e-1)" "unprognostic (1.80e-1)" "unprognostic (1.30e-3)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (7.07e-2)" "unprognostic (2.15e-1)" "unprognostic (2.22e-1)" "unprognostic (1.35e-1)" "unprognostic (2.25e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-3)" "unprognostic (3.98e-2)" "unprognostic (3.51e-1)" "unprognostic (2.52e-1)" "prognostic favorable (5.89e-4)" 8.7 7.2 4.5 6.8 6.4 10.5 22.7 2.6 5.4 8.8 39.1 8.0 2.8 36.8 6.1 3.0 19.8 4.3 15.3 14.1 4.6 2.3 14.1 106.2 10.3 5.4 8.8 3.8 12.6 20.7 0.7 2.7 4.2 5.6 6.6 5.7 3.8 13.4 3.9 11.5 15.9 33.7 4.8 4.8 4.1 12.8 24.9 7.1 2.1 6.3 6.2 5.1 8.7 11.6 9.6 37.1 18.5 26.5 28.8 16.1 12.5 14.3 17.0 8.3 17.1 9.8 6.1 13.2 7.8 7.1 8.6 11.5 16.2 6.4 22.6 11.4 5.6 5.7 10.1 7.2 11.4 1.2 13.6 40.3 8.7 7.4 38.0 31.0 9.4 12.2 10.6 22.2 5.6 5.2 7.9 17.3 11.2 15.5 6.6 2.3 11.1 0.8 32.0 15.7 18.8 17.7 24.3 9.9 16.8 8.6 4.7 4.2 32.0 5.2 8.3 14.9 4.4 8.9 15.2 13.3 7.4 21.0 8.1 5.3 11.6 5.3 6.8 2.6 11.5 3.7 15.3 26.5 18.5 11.8 9.4 16.1 9.6 7.7 9.9 37.1 9.6 1.1 4.1 7.9 28.8 4.3 6.0 15.2 12.5 4.5 6.4 2.6 5.4 4.6 2.3 8.8 3.8 5.6 7.1 32.8 55.2 24.6 70.3 72.5 4.6 26.6 188.5 1.4 19.4 57.6 0.0 50.1 112.7 124.1 138.8 35.9 780.2 116.8 129.7 102.0 53.0 67.5 17.3 473.7 65.5 3.2 104.3 84.7 67.1 60.3 84.3 59.9 55.6 57.7 299.4 16.4 119.7 550.6 79.5 318.0 2.6 45.3 28.3 7.9 12.0 133.6 41.9 42.6 311.7 103.6 MRPL2 "CGI-22, MRP-L14, RPML14" ENSG00000112651 "Mitochondrial ribosomal protein L2" Q5T653 6 43054029-43059806 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007455, HPA064814" Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA007455: AB_1079410, HPA064814: AB_2685358" "unprognostic (2.31e-1)" "unprognostic (1.49e-2)" "unprognostic (3.06e-1)" "unprognostic (1.48e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (3.17e-1)" "prognostic favorable (6.01e-4)" "unprognostic (3.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "unprognostic (6.42e-2)" "unprognostic (2.33e-2)" "unprognostic (3.13e-1)" "unprognostic (2.78e-1)" 16.9 19.9 17.4 13.1 22.5 16.0 14.2 13.6 21.8 13.0 15.6 13.3 16.4 20.3 14.1 16.9 13.6 16.2 15.5 31.7 16.0 16.8 20.9 55.0 12.9 16.2 18.8 20.3 15.7 17.4 25.8 17.8 11.7 15.3 12.9 15.0 12.6 21.1 19.6 53.2 13.8 15.2 13.4 12.4 11.5 13.4 21.0 13.2 17.5 15.7 25.5 12.3 12.4 11.9 21.0 26.9 14.3 18.5 17.5 16.9 13.6 10.9 12.6 6.3 11.0 7.7 6.2 9.8 4.9 7.0 12.8 11.5 24.1 3.8 15.5 12.3 6.8 9.5 11.6 13.6 13.1 8.0 9.0 28.2 12.5 10.2 29.1 15.2 10.4 6.1 8.1 13.9 14.8 20.1 6.7 9.0 19.8 20.9 10.4 6.8 21.3 13.4 37.0 5.7 42.2 14.9 15.6 6.3 19.8 9.6 6.9 15.2 7.9 4.8 8.5 15.0 5.6 9.6 18.7 8.1 7.5 10.1 9.9 13.6 12.1 11.0 32.0 5.5 16.8 7.3 6.8 18.5 14.3 13.5 17.2 16.9 20.4 15.6 16.0 25.2 21.0 15.9 16.1 5.5 17.5 13.4 26.9 16.6 13.6 17.4 22.5 13.6 21.8 16.0 16.8 18.8 20.3 15.3 13.2 20.8 15.2 33.7 27.7 21.6 18.7 34.1 35.7 29.4 27.3 57.6 25.5 66.2 157.5 45.9 72.1 31.5 50.7 46.7 46.7 41.8 35.6 25.5 27.7 68.6 44.0 4.8 29.4 30.1 23.0 24.4 50.9 27.0 50.6 45.1 37.0 29.6 38.4 49.5 48.4 109.4 17.2 25.8 39.1 33.4 34.3 23.7 53.1 27.7 57.2 21.0 MRPL21 ENSG00000197345 "Mitochondrial ribosomal protein L21" Q7Z2W9 11 68891276-68903835 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051657 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Nucleoplasm, Mitochondria" "HPA051657: AB_2681565" "unprognostic (1.80e-1)" "unprognostic (6.09e-2)" "unprognostic (4.80e-2)" "unprognostic (8.96e-3)" "unprognostic (9.25e-3)" "prognostic unfavorable (5.97e-4)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (4.84e-2)" "unprognostic (7.36e-2)" "unprognostic (1.26e-2)" "unprognostic (3.73e-2)" "unprognostic (1.72e-1)" "unprognostic (4.36e-2)" "unprognostic (3.12e-1)" 16.5 18.0 30.5 21.4 29.7 25.5 26.5 27.7 28.0 19.6 24.0 13.3 26.8 18.9 20.4 25.2 24.2 23.0 28.3 47.3 24.6 26.1 33.1 33.7 12.4 30.0 27.6 21.0 21.4 23.8 13.2 17.7 16.1 25.6 18.0 21.8 14.4 56.9 39.4 56.6 17.9 25.0 17.6 16.4 14.9 19.3 18.7 21.9 21.3 22.2 40.3 20.4 17.2 16.5 49.1 42.2 20.3 39.3 29.1 36.4 34.6 23.1 32.2 19.6 18.7 13.8 15.1 23.3 16.2 17.4 30.6 21.1 65.9 29.9 35.9 36.2 17.5 28.1 28.9 32.7 30.8 24.1 23.5 24.6 25.3 24.8 39.5 27.6 43.5 19.2 22.2 15.9 30.5 36.3 14.9 21.0 25.6 49.1 27.3 18.2 42.7 20.5 46.1 17.9 68.0 47.5 29.2 23.7 55.8 30.1 26.8 31.9 25.4 20.6 41.4 64.1 16.6 42.8 25.2 17.5 21.0 21.0 45.9 29.5 20.4 31.4 50.5 28.0 26.8 28.4 20.3 39.3 19.4 25.9 39.3 27.2 49.1 34.1 28.7 42.2 33.4 32.7 27.0 10.8 29.1 36.1 31.0 36.4 34.6 30.5 29.7 27.7 28.0 24.6 26.1 27.6 21.0 25.6 21.9 32.8 37.1 55.8 62.8 44.6 34.3 172.9 79.0 53.5 53.4 76.8 7.9 109.3 253.7 83.0 140.3 46.6 123.2 70.0 91.4 93.2 51.5 65.5 62.5 89.7 95.9 11.1 59.3 38.1 59.5 153.5 69.3 54.4 74.2 72.1 93.9 45.9 78.4 86.8 67.8 152.2 34.6 25.8 64.9 54.9 57.3 45.4 68.0 41.5 111.2 58.8 MRPL23 "L23MRP, RPL23L" ENSG00000214026 "Mitochondrial ribosomal protein L23" Q16540 11 1947278-1984522 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 117.7" HPA050406 Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (2.40e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-2)" "unprognostic (8.32e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (1.82e-1)" "unprognostic (6.33e-2)" "unprognostic (7.23e-3)" "unprognostic (4.08e-2)" 19.4 32.7 19.3 21.8 19.3 37.3 22.1 14.0 25.1 18.1 21.0 17.2 22.5 28.7 19.9 31.4 31.5 30.7 29.9 39.8 16.6 16.8 25.1 43.8 17.4 42.9 18.4 16.9 29.4 69.1 22.6 25.8 14.5 17.4 17.9 21.0 21.2 48.7 25.9 61.0 35.5 23.8 15.9 14.3 22.4 25.6 11.1 11.4 32.5 21.1 44.3 30.1 12.7 17.9 24.1 20.2 12.6 14.5 6.8 22.1 3.3 23.6 27.9 15.0 17.9 6.1 17.3 21.9 7.1 10.5 12.1 9.0 1.7 28.8 24.1 14.2 16.4 16.7 23.7 24.2 33.1 5.8 26.8 117.7 8.6 8.7 34.1 16.3 22.7 13.6 13.6 12.9 8.3 2.4 14.3 8.6 14.1 6.5 13.0 17.5 26.0 18.1 4.7 20.5 21.3 21.2 25.0 7.8 25.1 10.7 9.3 30.2 25.6 8.9 21.1 13.1 8.8 0.5 28.7 10.8 16.5 10.2 4.1 15.6 18.2 16.2 22.6 25.7 19.8 0.0 1.9 14.5 12.6 7.0 10.7 5.6 24.1 10.3 7.8 20.2 20.3 22.1 6.7 0.8 6.8 7.8 8.6 14.6 3.3 19.3 19.3 14.0 25.1 16.6 16.8 18.4 16.9 17.4 11.4 11.9 4.6 111.7 57.4 165.5 6.8 63.0 104.4 28.1 33.0 36.6 0.0 122.5 104.5 95.9 8.1 41.5 179.4 93.5 203.3 208.2 58.0 53.8 97.8 151.5 158.7 4.8 130.7 55.3 173.8 10.3 21.3 115.0 190.6 101.8 117.6 20.1 153.1 173.2 34.3 212.5 8.2 38.8 82.9 24.7 40.3 226.1 75.7 66.0 150.6 57.5 MRPL36 "BRIP1, L36mt, MRP-L36, PRPL36, RPMJ" ENSG00000171421 "Mitochondrial ribosomal protein L36" Q9P0J6 5 1798386-1801366 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 90.2" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 359.0;Late spermatids: 373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047238 Approved Supported "Nuclear bodies,Mitochondria" No No "Nuclear bodies, Mitochondria" "HPA047238: AB_10965331" "unprognostic (2.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-2)" "unprognostic (7.83e-3)" "unprognostic (2.03e-2)" "unprognostic (2.01e-2)" "unprognostic (1.09e-3)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (5.39e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.53e-2)" "unprognostic (9.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" 16.8 20.7 14.3 12.9 14.8 8.2 17.9 9.3 15.4 12.3 15.9 9.0 13.7 14.1 13.5 15.1 20.8 12.7 19.0 32.4 13.5 13.0 22.4 44.6 11.6 13.6 14.2 8.6 16.5 28.9 9.0 10.1 13.9 12.3 17.0 10.5 9.6 27.3 12.3 52.5 11.7 16.2 16.1 11.9 11.5 14.4 46.0 11.1 14.1 18.1 35.8 15.3 16.3 14.4 24.5 90.2 12.9 20.3 18.4 25.8 24.1 23.2 34.6 16.1 30.4 29.8 24.7 21.2 20.4 18.0 24.4 23.4 25.0 19.0 31.4 37.1 21.8 35.9 25.5 36.2 33.6 17.7 34.1 40.3 15.2 76.9 39.6 38.2 19.7 12.0 21.7 26.0 27.2 35.3 21.4 23.6 18.6 23.1 20.3 34.6 42.7 23.0 44.5 15.6 25.8 42.6 18.5 12.0 37.8 22.0 19.1 18.0 12.3 44.4 34.7 21.2 15.5 20.3 21.4 14.2 21.2 23.0 14.3 22.5 19.5 24.3 41.3 26.6 36.5 28.8 12.9 20.3 12.5 18.6 19.4 22.1 24.5 21.0 22.4 24.3 17.9 18.6 22.1 5.8 18.4 16.5 90.2 25.8 24.1 14.3 14.8 9.3 15.4 13.5 13.0 14.2 8.6 12.3 11.1 29.8 25.3 33.5 68.7 94.2 19.7 152.3 53.5 38.8 42.1 55.8 5.9 78.6 260.2 71.7 359.0 51.5 50.4 0.0 65.2 52.4 60.6 90.8 27.6 108.3 76.3 14.3 25.3 34.4 38.0 373.3 69.3 34.3 57.3 73.9 47.9 48.5 78.1 49.2 56.3 144.3 22.1 64.7 83.4 78.8 62.6 109.2 73.1 35.2 55.9 94.5 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19431902-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favorable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 4.0 6.6 5.5 2.5 6.6 1.3 3.9 5.1 5.4 4.3 2.6 2.9 3.0 5.0 3.7 5.0 2.9 11.8 4.6 4.7 6.1 10.3 2.2 3.0 5.1 4.7 7.0 6.4 4.9 2.5 4.6 2.2 8.7 4.2 14.8 3.6 2.3 2.4 5.0 2.7 3.1 2.8 8.2 2.8 3.7 2.5 28.1 21.6 10.3 15.1 10.9 16.4 16.6 13.2 9.2 2.2 8.4 13.7 12.7 7.0 10.0 11.6 14.1 17.6 10.8 7.7 11.6 10.4 11.0 8.1 13.1 13.9 15.9 11.9 11.8 21.3 10.5 6.6 13.3 20.2 15.0 7.0 13.1 15.5 10.4 18.6 9.5 9.4 4.4 42.5 11.1 13.6 10.1 7.8 8.9 3.6 18.7 12.5 7.4 14.5 5.3 16.8 5.6 7.6 7.0 15.3 12.9 19.2 5.2 11.4 8.8 11.8 18.8 17.4 7.4 9.7 10.6 14.2 16.9 12.3 10.2 13.6 5.9 13.8 10.3 13.0 15.1 14.0 28.1 13.2 13.5 15.0 25.5 16.4 14.3 1.6 10.9 12.0 21.6 15.0 16.6 41.7 33.6 52.8 60.0 35.8 28.7 83.9 76.5 109.7 53.4 45.4 11.8 118.0 220.5 67.0 81.1 33.6 39.3 0.0 84.9 110.0 43.1 49.9 33.4 122.0 116.9 20.6 33.6 40.5 35.4 118.1 67.0 37.7 81.0 100.0 42.0 80.3 63.8 42.4 67.8 201.9 38.4 45.3 58.7 83.7 70.0 33.6 52.6 34.6 45.0 39.2 MRPL42 "HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31" ENSG00000198015 "Mitochondrial ribosomal protein L42" Q9Y6G3 12 93467488-93516213 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 276.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039398 Approved Supported "Plasma membrane,Mitochondria" NA NA "Plasma membrane, Mitochondria" "HPA039398: AB_10673529" "unprognostic (9.32e-2)" "unprognostic (4.18e-2)" "unprognostic (4.50e-2)" "unprognostic (3.89e-2)" "unprognostic (1.27e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (6.13e-2)" "unprognostic (3.66e-2)" "unprognostic (1.95e-1)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (4.92e-1)" "unprognostic (1.62e-1)" "prognostic favorable (8.12e-4)" 18.4 35.6 16.7 13.9 23.6 14.6 22.5 23.2 24.4 22.0 21.5 16.6 16.3 17.0 18.7 16.5 26.7 20.5 15.1 24.2 16.8 16.4 31.0 28.9 16.0 15.3 21.4 16.7 18.4 16.3 26.1 35.8 18.5 26.2 19.3 26.4 13.7 17.8 19.0 15.1 15.8 18.4 19.8 20.4 18.8 18.1 34.5 17.1 25.7 19.5 14.9 21.5 19.1 21.0 29.9 18.8 23.3 23.1 29.3 32.0 21.0 17.3 18.7 30.1 24.4 18.0 27.1 25.4 21.5 21.8 32.9 26.6 25.1 13.9 24.5 9.4 19.6 15.6 15.7 38.7 29.0 50.4 28.7 29.9 28.2 12.8 31.1 24.6 32.6 14.2 20.0 31.8 28.5 42.3 24.9 31.8 27.6 37.2 13.4 37.4 18.5 36.5 25.5 45.0 27.7 34.4 30.3 15.2 29.9 36.3 35.7 36.9 20.1 18.4 30.8 23.1 25.6 30.5 18.0 15.7 24.2 13.8 15.3 28.8 16.0 23.2 27.0 9.5 25.7 36.2 18.0 17.7 23.3 19.0 23.1 24.4 29.9 24.9 20.9 18.8 23.9 26.1 26.8 7.4 29.3 21.5 13.3 32.0 21.0 16.7 23.6 23.2 24.4 16.8 16.4 21.4 16.7 26.2 17.1 26.8 28.6 54.8 70.8 59.8 33.3 73.5 40.8 62.9 31.8 43.6 56.9 85.2 180.8 81.9 276.9 50.6 37.0 0.0 67.3 120.5 56.8 91.3 58.7 45.9 48.2 44.5 89.3 28.3 38.6 81.3 47.8 37.0 57.3 27.9 49.8 19.9 75.9 42.1 52.6 106.7 35.0 51.8 64.3 114.9 71.6 65.6 79.9 55.1 63.5 104.3 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 34.6 34.5 25.9 20.1 24.2 22.5 25.0 24.0 32.9 26.0 26.1 32.5 25.5 28.5 24.7 29.9 31.8 25.9 30.2 25.0 24.4 20.9 37.2 39.6 20.5 20.3 26.5 19.3 32.7 62.2 16.7 21.4 26.6 22.9 31.9 8.3 30.1 61.4 34.4 100.4 26.8 30.1 25.5 32.1 24.8 32.0 28.6 20.3 23.5 45.2 35.2 25.6 27.6 22.6 36.2 36.6 41.3 32.3 36.4 39.4 33.4 30.1 34.3 7.2 12.7 7.5 9.7 22.4 21.1 19.2 16.4 16.7 19.5 23.7 26.0 28.8 8.8 8.9 18.9 2.6 17.6 2.2 19.6 44.6 20.5 24.9 30.2 16.2 16.1 16.5 15.1 13.8 13.9 6.1 7.8 15.4 16.6 10.1 13.3 4.9 31.9 15.0 36.7 11.6 8.2 32.4 16.2 24.1 17.4 9.1 15.6 8.1 20.9 15.4 7.5 23.6 2.4 40.1 7.8 18.8 15.4 20.6 16.5 22.1 27.9 21.2 13.1 19.7 30.2 11.1 41.3 32.3 35.1 32.3 30.0 33.2 36.2 35.7 32.1 36.6 33.3 34.7 30.9 11.0 36.4 28.8 28.6 39.4 33.4 25.9 24.2 24.0 32.9 24.4 20.9 26.5 19.3 22.9 20.3 41.7 35.1 68.5 70.1 49.5 43.4 32.2 84.1 78.9 51.2 71.5 39.3 112.8 152.5 84.3 53.4 47.0 56.3 70.0 110.7 118.6 57.0 57.6 45.1 59.7 86.2 17.5 58.7 51.5 39.7 31.5 79.1 47.5 60.8 68.5 68.0 64.2 77.6 84.2 69.3 155.7 46.0 51.8 80.4 138.2 73.5 59.8 86.7 61.0 79.0 55.9 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.9 34.6 18.9 23.4 11.8 13.9 46.1 30.7 22.2 27.5 26.2 42.4 61.7 33.5 33.9 21.1 28.0 40.1 15.5 42.5 20.7 35.4 25.5 24.9 13.8 96.1 35.9 39.1 35.9 20.8 29.4 35.6 30.4 21.8 43.6 42.7 25.5 33.4 20.1 61.7 31.6 59.5 34.8 54.8 76.5 39.2 23.6 39.5 28.7 26.3 18.9 24.4 23.8 23.3 32.6 14.1 22.4 37.5 33.5 28.8 33.7 36.0 46.5 33.1 39.0 40.8 26.2 26.9 45.9 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 68.5 78.6 124.3 65.2 107.6 20.6 96.4 201.2 95.0 89.9 129.1 17.7 163.2 235.4 222.3 47.9 83.9 246.5 93.5 272.5 246.5 72.7 86.6 121.1 226.4 208.7 19.1 132.6 105.6 152.4 44.5 51.8 104.0 118.1 247.9 188.7 49.5 303.7 207.0 46.3 360.5 27.7 64.7 84.5 124.7 106.0 130.4 105.4 86.1 183.5 87.8 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 56.1;Distal tubular cells: 48.0;Exocrine glandular cells: 52.2;Proximal tubular cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003634 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003634: AB_1851388" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 12.4 23.4 13.9 18.4 14.8 13.7 17.6 18.1 15.7 10.6 15.2 9.8 17.5 13.1 12.5 15.1 19.4 12.5 16.3 31.2 12.2 12.0 25.7 41.7 10.2 15.2 14.3 14.0 10.5 24.2 13.5 9.1 13.9 14.0 13.6 16.3 10.1 17.7 22.5 57.3 16.5 13.4 14.8 12.9 14.6 15.1 7.6 14.0 13.2 14.8 31.2 15.7 14.3 11.6 18.3 28.9 11.2 22.0 20.0 33.5 20.9 26.1 36.9 12.3 14.1 13.3 13.2 17.2 15.5 16.9 32.4 27.6 28.3 16.5 18.2 12.8 15.4 20.0 18.7 25.2 26.7 34.3 9.3 29.9 14.3 17.5 23.5 25.1 29.8 9.8 14.2 12.8 21.5 34.5 11.0 24.6 18.9 23.0 13.3 18.3 32.7 25.7 20.5 9.3 40.8 50.0 13.3 21.9 26.5 23.8 19.4 11.5 22.0 13.4 24.5 30.1 16.5 32.8 24.6 10.4 17.5 19.2 18.4 29.2 13.9 11.0 20.1 20.0 33.4 14.4 11.2 22.0 10.5 17.3 20.7 14.9 18.3 21.1 17.2 28.9 14.8 15.7 17.6 2.0 20.0 17.4 19.4 33.5 20.9 13.9 14.8 18.1 15.7 12.2 12.0 14.3 14.0 14.0 14.0 29.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 38.8 14.8 24.4 0.0 56.1 48.0 41.8 0.0 0.0 0.0 0.0 52.2 30.7 0.0 0.0 1.1 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 26.2 0.0 0.0 44.8 0.0 0.0 104.5 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 MRPS10 FLJ10567 ENSG00000048544 "Mitochondrial ribosomal protein S10" P82664 6 42206801-42217865 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 79.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029133, HPA029134" Supported Approved "Actin filaments,Mitochondria" NA NA Mitochondria "Actin filaments" "HPA029133: AB_10600084, HPA029134: AB_10600058" "unprognostic (1.06e-1)" "unprognostic (3.90e-2)" "unprognostic (5.55e-2)" "unprognostic (3.77e-3)" "unprognostic (1.70e-1)" "unprognostic (1.78e-3)" "unprognostic (2.37e-2)" "unprognostic (8.65e-2)" "unprognostic (1.50e-3)" "unprognostic (5.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.29e-2)" "unprognostic (3.17e-2)" "unprognostic (8.54e-2)" "unprognostic (3.45e-1)" "unprognostic (3.36e-2)" "unprognostic (5.04e-2)" 17.3 21.0 16.6 14.2 23.3 15.3 16.3 16.4 22.9 15.5 15.0 17.2 8.6 13.9 16.2 14.0 34.3 12.0 11.9 33.4 15.2 16.8 21.7 30.5 11.7 16.2 16.8 14.7 13.7 14.1 13.0 20.3 18.8 22.1 14.1 17.9 17.1 16.9 13.5 47.7 14.7 14.9 18.1 16.2 14.7 14.2 13.3 16.5 19.3 18.7 25.6 21.4 15.6 18.4 22.5 28.4 14.4 22.7 21.2 25.7 20.1 26.3 9.5 10.0 17.0 14.0 13.6 9.0 17.5 17.4 17.0 15.0 10.8 10.5 18.8 11.7 16.3 19.1 9.7 16.5 23.8 23.0 17.1 13.5 16.7 9.3 18.0 14.7 24.6 10.9 11.8 18.4 15.9 34.1 11.6 17.2 20.1 29.0 14.8 20.5 16.9 16.0 17.9 8.5 79.3 15.7 13.8 15.1 17.8 29.2 12.0 15.4 11.3 10.0 13.8 32.2 9.8 22.9 33.6 11.0 14.6 14.4 14.0 26.0 11.1 16.7 40.1 9.9 24.6 14.5 13.4 19.6 14.4 19.3 22.7 22.4 22.5 23.7 22.8 22.0 20.5 24.4 23.7 10.1 21.2 20.4 28.4 25.7 20.1 16.6 23.3 16.4 22.9 15.2 16.8 16.8 14.7 22.1 16.5 20.8 16.3 43.8 41.8 35.9 25.1 113.8 17.8 58.9 15.9 36.6 29.5 90.5 77.9 52.6 6.7 35.8 23.6 23.3 40.9 53.7 40.1 48.9 31.3 52.1 47.5 30.2 14.3 25.8 22.9 4.7 26.7 35.2 28.7 161.5 23.3 46.4 50.7 26.6 34.3 69.7 55.4 19.4 33.3 60.2 77.9 35.5 63.0 30.5 27.3 62.1 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nuclear membrane" "HPA051087: AB_2681339" "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.7 23.6 31.8 11.8 27.6 4.5 23.7 19.6 26.3 19.5 14.9 22.9 18.3 13.8 20.1 25.6 15.4 18.0 15.8 16.6 26.9 26.5 23.4 29.7 14.7 16.0 32.7 14.5 21.8 19.1 28.3 26.1 17.1 22.5 23.6 18.1 15.4 18.4 20.4 13.7 12.7 14.7 17.2 33.5 17.4 15.3 15.8 24.5 22.6 26.5 14.5 16.2 14.3 11.7 14.5 13.6 6.5 12.9 14.3 19.2 11.6 11.0 8.9 21.2 7.5 24.0 17.3 6.8 9.7 11.9 16.6 17.3 11.6 9.8 14.1 11.9 13.0 7.3 9.9 13.1 11.3 17.7 15.5 18.0 11.6 17.5 13.2 10.2 12.8 10.4 18.8 14.0 9.7 6.8 14.7 13.7 12.3 14.0 12.5 11.5 6.1 14.0 9.3 11.6 20.8 4.7 12.2 11.2 16.7 11.4 9.0 17.9 12.6 14.1 13.1 9.3 17.4 15.5 13.7 11.2 5.6 6.3 11.8 8.7 13.8 11.7 17.6 8.1 12.2 11.8 6.5 12.9 6.2 13.4 12.7 18.8 14.5 14.2 14.1 13.6 13.5 19.2 16.2 4.5 14.3 9.7 11.8 15.1 11.6 31.8 27.6 19.6 22.6 26.9 26.5 32.7 14.5 22.5 24.5 26.8 23.2 38.7 45.3 19.6 13.8 73.8 40.8 34.8 34.2 52.4 13.7 85.5 116.0 57.8 11.2 35.8 23.6 46.7 38.9 90.2 43.7 47.0 17.4 59.4 70.3 1.6 30.5 34.4 33.2 8.5 43.1 29.4 47.2 88.4 32.3 32.0 49.2 49.1 40.3 89.3 18.4 38.8 36.4 71.7 37.5 25.6 46.9 31.0 46.9 40.3 MRPS16 CGI-132 ENSG00000182180 "Mitochondrial ribosomal protein S16" Q9Y3D3 10 73248843-73252693 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050081, HPA054538" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA050081: AB_2681007, HPA054538: AB_2682519" "unprognostic (9.19e-2)" "unprognostic (5.19e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.23e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (1.68e-2)" "unprognostic (6.44e-2)" "unprognostic (2.98e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.20e-1)" "unprognostic (5.84e-2)" 16.6 28.4 16.4 16.9 15.8 15.8 28.6 12.6 26.6 13.3 22.1 12.4 18.0 20.8 16.3 16.8 22.7 16.5 20.8 42.2 17.6 15.7 23.4 35.1 17.7 30.0 16.2 16.0 16.5 37.0 15.7 15.5 17.0 15.9 15.4 21.1 14.4 18.4 19.0 53.2 16.8 18.4 18.0 14.7 18.4 18.3 13.7 9.8 32.7 16.9 26.1 20.1 15.5 13.9 30.0 28.3 17.0 24.2 17.7 22.3 24.3 22.8 33.1 12.8 16.9 10.3 8.4 18.8 10.6 18.5 14.8 15.4 39.2 22.5 27.7 11.8 11.1 13.4 21.4 14.7 21.1 9.3 15.6 14.4 17.4 17.9 29.6 17.4 22.5 15.6 12.7 16.1 15.1 36.3 12.9 16.1 24.5 25.5 15.6 15.3 25.4 24.2 20.8 15.5 15.1 62.2 22.0 17.2 20.0 15.5 13.7 8.6 15.9 12.1 50.0 23.2 8.2 35.2 12.0 12.7 14.1 24.6 15.2 20.5 23.4 24.8 21.6 15.4 26.2 9.5 16.7 22.7 17.0 19.0 24.2 20.5 28.7 20.8 17.8 18.5 30.0 22.3 19.6 10.4 17.7 19.1 28.3 20.6 24.3 16.4 15.8 12.6 26.6 17.6 15.7 16.2 16.0 15.9 9.8 6.0 25.9 52.8 58.4 31.1 26.8 89.2 63.7 37.5 47.8 45.4 29.5 103.9 210.5 89.2 46.6 48.4 69.2 23.3 103.5 134.8 44.9 77.2 30.0 123.8 134.2 19.1 52.3 41.7 57.2 29.0 57.5 59.6 62.4 83.0 89.7 45.0 115.2 38.6 39.3 179.3 33.2 0.0 45.3 128.1 75.4 38.6 89.4 44.9 103.6 86.7 MRPS18B "C6orf14, HSPC183, MRPS18-2, PTD017" ENSG00000204568 "Mitochondrial ribosomal protein S18B" Q9Y676 6 30617709-30626395 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043485, HPA050334" Supported Supported "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA043485: AB_2678506, HPA050334: AB_2681091" "unprognostic (8.18e-3)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (2.51e-2)" "unprognostic (4.20e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (2.98e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-2)" "prognostic favorable (3.99e-5)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.39e-2)" 17.1 18.9 9.9 10.3 10.7 5.4 16.0 8.5 13.1 11.6 13.4 12.8 11.9 12.8 9.3 15.5 15.5 16.5 12.3 26.6 9.0 8.0 22.4 49.1 10.5 17.3 13.1 9.3 16.4 21.8 17.4 10.2 11.8 9.1 10.9 16.4 10.1 17.1 18.0 55.4 13.7 14.0 10.4 12.4 14.4 13.5 10.2 11.2 13.5 21.5 31.1 15.6 11.2 9.3 15.7 8.9 6.3 10.2 12.4 15.2 11.2 9.7 5.9 4.7 6.7 7.2 9.7 8.7 3.6 8.4 11.5 7.1 9.2 4.6 10.0 8.4 5.7 8.6 7.8 10.9 10.2 11.3 6.0 11.6 9.7 4.6 10.7 6.3 9.1 4.2 8.4 12.8 9.4 26.1 7.8 6.4 9.5 14.7 9.6 10.4 7.4 6.0 5.6 3.4 7.8 7.6 8.0 6.4 19.1 10.7 4.1 10.3 3.3 3.2 13.6 13.7 4.6 17.6 4.8 3.7 7.5 7.3 4.3 6.2 8.2 9.8 8.5 3.6 13.8 11.0 6.3 8.0 4.0 9.1 10.1 12.3 15.7 12.1 9.8 8.9 14.7 15.2 12.2 0.6 12.4 10.2 8.1 11.4 11.2 9.9 10.7 8.5 13.1 9.0 8.0 13.1 9.3 9.1 11.2 56.6 44.3 53.6 61.6 32.6 43.2 135.7 101.9 53.5 46.6 45.4 60.9 106.9 164.2 89.2 46.6 63.4 48.4 23.3 80.0 101.6 52.1 46.2 36.9 95.6 72.2 41.3 30.1 49.1 44.0 26.6 65.0 42.1 57.3 93.8 55.1 39.2 65.0 59.6 42.1 161.2 51.1 51.8 67.0 22.6 60.7 39.3 80.7 41.7 80.3 30.1 MRPS23 "CGI-138, HSPC329, MRP-S23" ENSG00000181610 "Mitochondrial ribosomal protein S23" Q9Y3D9 17 57834781-57850056 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023453 Supported Supported "Nuclear membrane,Mitochondria" No No Mitochondria "Nuclear membrane" "HPA023453: AB_1854125" "unprognostic (3.84e-3)" "unprognostic (3.36e-1)" "unprognostic (1.75e-2)" "unprognostic (2.00e-2)" "unprognostic (7.96e-2)" "unprognostic (3.06e-3)" "prognostic unfavorable (9.52e-4)" "unprognostic (3.71e-1)" "unprognostic (7.92e-2)" "unprognostic (2.63e-3)" "unprognostic (1.39e-2)" "unprognostic (8.74e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (2.83e-1)" 15.1 28.5 23.0 19.0 27.5 16.0 19.9 16.4 32.0 13.4 16.4 17.6 28.3 18.1 18.0 23.1 18.1 19.3 17.2 53.5 22.5 22.1 36.6 19.9 16.5 21.3 23.6 26.2 16.3 29.9 17.3 16.7 15.5 23.7 28.3 16.0 15.3 16.9 24.7 39.2 14.1 15.5 17.0 19.4 17.4 25.7 21.9 17.2 14.8 28.4 19.8 19.7 15.3 16.5 25.1 30.8 33.4 26.7 23.5 24.3 22.8 32.4 32.8 17.8 18.6 10.8 12.6 20.5 21.1 15.9 29.5 22.8 24.7 19.6 41.2 62.9 16.2 27.3 16.1 28.0 24.9 24.7 32.7 32.5 29.8 13.7 42.6 20.7 39.0 28.9 11.5 22.5 21.8 22.8 13.5 18.5 22.2 44.1 14.9 23.1 27.8 36.1 22.5 21.5 36.9 34.3 26.3 29.7 34.4 22.8 15.6 23.9 37.2 15.9 13.4 42.0 13.6 41.8 29.1 15.7 25.1 32.0 25.0 44.6 32.8 69.1 45.9 23.9 24.5 23.0 24.9 21.8 33.4 22.4 26.7 23.4 23.6 22.4 22.6 30.8 25.1 24.3 24.0 3.5 23.5 18.8 29.0 21.4 22.8 23.0 27.5 16.4 32.0 22.5 22.1 23.6 26.2 23.7 17.2 44.7 28.1 29.0 30.7 29.8 41.5 148.1 33.1 41.5 36.4 45.4 11.8 68.7 126.0 75.4 4.7 33.0 13.5 0.0 86.9 68.6 37.0 43.2 22.0 38.1 75.9 47.7 21.2 24.5 28.2 7.0 30.2 38.1 38.8 71.3 27.2 49.9 70.7 17.5 37.1 149.9 53.1 25.8 28.4 27.1 87.3 28.4 35.6 32.4 38.2 27.8 MRPS26 "C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13" ENSG00000125901 "Mitochondrial ribosomal protein S26" Q9BYN8 20 3045945-3048254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045472, HPA054610" Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045472: AB_10962052, HPA054610: AB_2682541" "unprognostic (1.53e-1)" "unprognostic (2.18e-1)" "unprognostic (3.71e-1)" "unprognostic (4.41e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (8.13e-3)" "unprognostic (3.14e-1)" "unprognostic (6.83e-2)" "unprognostic (8.21e-2)" "unprognostic (9.65e-3)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (3.77e-1)" "unprognostic (4.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.93e-3)" 20.2 30.4 27.1 14.4 29.2 13.4 20.9 25.9 31.7 19.2 19.8 15.3 32.3 22.5 18.1 30.6 19.6 24.4 21.2 25.8 24.4 28.2 28.8 39.6 14.7 15.4 24.6 27.0 28.9 43.4 21.0 28.1 16.4 20.0 31.0 16.4 15.2 32.3 27.9 37.1 22.3 20.1 27.8 19.0 16.2 22.1 13.3 20.7 12.3 28.9 23.0 16.9 18.4 19.2 36.5 28.4 10.3 24.4 29.2 30.8 23.0 26.8 36.2 8.2 14.9 9.0 6.8 21.5 10.5 7.1 12.1 9.3 31.6 12.4 26.7 13.4 5.4 16.0 25.5 16.2 21.7 7.1 6.8 34.6 12.2 13.1 52.4 12.5 19.2 6.0 7.7 16.9 10.0 15.2 8.5 8.9 16.1 19.6 6.3 7.2 23.2 19.8 33.8 40.5 20.5 35.8 22.0 14.2 28.5 11.8 18.0 25.8 33.5 12.1 40.5 24.3 8.5 18.2 10.9 8.4 7.9 12.6 14.2 19.4 28.7 36.9 16.2 5.1 16.1 8.8 7.6 21.4 10.3 24.0 24.4 30.0 36.5 26.6 25.6 28.4 34.9 30.8 26.4 1.7 29.2 19.0 17.2 20.6 23.0 27.1 29.2 25.9 31.7 24.4 28.2 24.6 27.0 20.0 20.7 14.9 23.2 55.8 62.3 72.8 37.0 58.1 63.7 30.8 29.6 52.4 33.4 157.2 177.4 69.1 3.0 39.5 65.6 46.7 47.8 88.9 56.4 71.2 13.9 99.1 71.1 44.5 52.9 30.7 23.5 7.5 63.9 31.3 64.1 32.5 77.7 64.3 51.7 49.1 58.0 189.5 37.6 58.2 67.0 32.2 73.4 80.7 65.7 38.5 105.3 45.7 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219409-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 88.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA071751: AB_2686442" "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 26.9 32.3 19.0 20.9 26.8 13.6 26.1 24.6 31.8 25.1 21.0 20.1 21.8 16.5 28.6 23.7 33.6 26.3 18.0 43.6 18.9 17.5 25.1 30.9 14.9 27.4 18.1 21.7 33.9 25.1 24.5 23.7 17.5 23.5 26.2 26.4 25.5 31.0 26.5 43.7 23.9 17.5 25.0 17.5 22.2 20.9 12.1 12.6 34.2 32.1 26.7 32.4 25.9 21.0 19.6 23.3 6.1 14.1 21.5 21.5 16.1 16.4 22.1 19.7 32.5 25.9 33.5 25.4 15.9 22.8 30.3 24.5 27.5 23.4 42.7 22.3 18.5 33.1 18.4 38.2 56.4 32.9 16.0 23.6 21.9 26.6 30.2 25.9 19.2 17.1 31.3 23.9 31.7 35.6 27.7 32.2 31.5 21.9 12.9 25.0 19.8 28.7 23.3 22.7 12.0 13.9 30.6 32.7 43.8 27.9 17.7 30.5 16.3 26.6 22.0 19.7 19.0 33.7 23.4 18.2 12.4 18.3 17.4 28.5 13.1 19.7 30.1 21.3 31.7 19.5 6.1 12.1 4.1 14.0 14.1 20.6 19.6 17.4 17.0 23.3 16.5 20.3 21.5 1.8 21.5 11.3 8.9 17.8 16.1 19.0 26.8 24.6 31.8 18.9 17.5 18.1 21.7 23.5 12.6 8.9 9.4 25.3 22.2 18.1 10.8 88.0 7.6 10.7 13.6 10.4 15.7 35.7 21.6 16.5 1.7 15.7 8.5 0.0 14.9 37.9 17.7 10.8 7.0 28.9 21.9 9.5 15.5 16.5 33.5 3.0 17.5 13.4 10.1 34.3 21.2 15.6 15.4 17.5 23.7 18.8 12.2 12.9 17.5 8.0 17.4 15.4 24.1 22.3 29.1 12.1 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729135-40771173 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Ciliated cells: 350.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA039083: AB_2676340, HPA046344: AB_2679629" "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 14.2 20.1 19.3 17.9 21.2 13.2 18.2 27.7 22.9 14.4 16.4 16.9 10.7 15.4 18.0 15.4 18.9 16.6 10.9 24.3 18.4 16.9 26.7 29.9 12.1 22.5 17.9 17.1 21.5 15.0 10.7 35.3 13.1 22.1 12.6 17.0 12.4 14.7 12.5 32.5 14.2 16.3 16.3 16.0 16.0 15.3 17.9 23.3 22.9 21.1 17.2 25.1 18.0 15.9 22.2 11.8 17.2 10.4 15.9 25.7 10.9 8.0 7.7 13.1 8.6 9.0 10.6 13.1 10.3 7.2 13.7 9.2 19.8 12.0 47.3 10.1 5.9 18.4 21.3 16.4 12.9 16.3 12.4 12.4 19.6 5.8 12.6 7.5 20.0 9.5 8.5 9.5 11.2 9.5 9.1 10.4 13.6 13.1 5.0 8.7 9.1 15.5 19.6 12.7 27.5 9.2 14.9 10.8 8.8 17.9 9.3 5.7 8.4 7.1 11.9 16.2 16.4 10.4 17.7 6.3 4.3 7.2 9.9 10.7 3.9 7.2 23.8 8.7 14.3 8.1 17.2 9.6 14.4 19.1 9.7 18.6 22.2 21.4 19.2 11.8 18.9 25.7 22.6 7.0 15.9 10.4 11.6 21.4 10.9 19.3 21.2 27.7 22.9 18.4 16.9 17.9 17.1 22.1 23.3 44.7 16.3 16.4 28.7 8.7 32.3 61.3 30.6 350.7 67.1 21.0 17.7 53.8 92.9 37.0 42.6 34.6 21.2 23.3 29.4 40.9 23.6 14.3 22.0 64.5 22.6 39.7 22.4 35.6 18.6 4.9 32.8 19.5 18.6 45.9 31.0 30.1 28.6 21.0 28.7 51.9 47.6 45.3 25.8 51.0 45.1 11.7 56.9 27.4 31.5 26.5 MRPS35 "MDS023, MRPS28" ENSG00000061794 "Mitochondrial ribosomal protein S35" P82673 12 27710773-27756295 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038513 Supported Approved Mitochondria,Cytosol No No Mitochondria Cytosol "HPA038513: AB_10794084" "prognostic unfavorable (9.41e-4)" "unprognostic (8.35e-2)" "prognostic favorable (5.01e-4)" "unprognostic (2.59e-2)" "unprognostic (5.31e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (7.32e-2)" "unprognostic (2.12e-3)" "unprognostic (2.05e-1)" "unprognostic (3.24e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.51e-5)" "unprognostic (4.63e-2)" "unprognostic (2.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" 18.3 32.3 21.0 19.4 22.4 14.2 23.2 21.2 25.7 14.0 31.0 16.3 18.5 27.7 17.1 17.6 25.0 16.1 20.5 31.9 19.5 20.6 42.2 52.1 15.9 20.2 20.1 19.4 17.3 18.4 18.2 11.9 18.8 24.4 17.5 33.2 11.9 17.6 14.8 46.3 15.1 24.5 19.9 18.1 17.3 23.1 13.5 13.5 19.3 28.9 27.6 18.5 17.8 14.3 12.4 17.4 4.2 24.8 14.2 14.7 12.6 23.6 26.0 10.9 16.7 15.7 19.2 40.8 15.8 13.5 22.1 20.2 31.9 33.9 22.1 23.3 16.0 17.2 17.9 22.6 19.9 26.0 18.8 22.3 25.0 11.0 25.8 15.6 34.0 13.4 16.3 24.8 18.6 37.6 20.3 17.8 18.8 27.3 15.2 20.0 14.4 23.9 56.5 41.3 58.3 39.1 25.4 28.5 36.3 33.9 19.5 6.3 12.7 21.7 33.9 26.3 25.6 34.6 27.1 13.9 13.5 14.6 30.6 28.0 6.0 9.0 47.7 18.0 26.3 17.6 4.2 12.2 4.1 9.3 21.4 14.5 12.4 11.7 11.3 17.4 11.9 13.9 12.4 0.7 14.2 24.8 8.1 14.7 12.6 21.0 22.4 21.2 25.7 19.5 20.6 20.1 19.4 24.4 13.5 68.5 32.3 38.3 32.8 42.0 19.5 84.0 50.9 89.7 45.5 48.8 3.9 92.7 205.6 67.5 9.7 23.4 54.6 0.0 51.8 95.3 26.6 44.8 53.1 52.9 64.9 17.5 57.9 16.5 31.2 5.0 23.6 48.6 40.5 65.9 65.4 26.2 51.0 42.1 23.0 153.4 13.6 25.8 33.1 24.4 24.8 45.7 51.6 29.9 92.5 38.4 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 16050.3;Hepatocytes: 4100.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 885.9" "Low region specificity" "Detected in all" HPA075648 Approved Centrosome,Mitochondria NA NA Mitochondria Centrosome "HPA075648: AB_2686760" "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favorable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 97.1 90.4 163.1 166.1 571.6 120.3 71.9 208.6 52.3 32.7 59.8 150.2 89.8 241.1 85.5 140.9 53.6 185.3 25.3 223.3 65.2 94.9 104.4 173.3 885.9 279.0 83.9 178.2 155.8 210.6 228.8 62.4 218.5 246.4 65.5 125.0 95.5 172.9 119.9 173.6 67.7 228.6 41.1 103.4 109.2 39.3 70.3 107.2 174.1 205.2 49.5 67.0 102.3 162.1 69.9 366.4 115.3 224.3 209.4 86.0 107.1 125.8 79.8 156.5 73.2 128.4 61.7 242.4 40.1 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 208.4 153.9 1221.6 193.7 203.1 0.0 16050.3 1630.6 940.9 684.7 307.1 0.0 0.0 76.3 127.4 46.0 141.8 949.6 2499.6 297.1 0.0 116.0 126.2 448.0 4100.6 0.0 0.0 246.6 1665.3 1966.8 217.5 386.3 249.3 243.0 242.5 657.8 0.0 237.0 573.3 217.1 415.7 0.0 342.8 211.1 226.8 167.2 211.8 0.0 631.2 458.3 137.0 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007355 Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA007355: " "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavorable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 13.8 16.4 14.2 15.9 20.1 9.9 22.9 17.8 18.0 14.8 13.8 12.3 17.4 11.9 15.4 23.8 12.6 13.2 12.9 21.9 17.3 15.3 15.9 22.2 18.5 18.3 18.1 16.0 13.7 14.8 18.9 14.1 16.1 23.7 15.5 14.5 9.8 12.1 17.9 28.8 16.1 11.6 21.9 13.2 16.9 12.8 10.9 13.5 16.0 15.0 14.1 18.1 13.9 12.3 15.3 18.0 18.6 11.6 16.7 17.8 7.8 18.9 12.2 18.4 14.5 13.1 13.6 8.4 14.6 12.0 21.5 21.7 8.7 14.1 17.1 30.9 8.5 10.9 10.7 19.0 11.4 26.2 16.4 13.9 24.4 9.4 10.5 18.5 8.2 10.0 13.6 17.1 17.4 16.4 11.1 17.5 18.4 20.5 9.0 21.5 12.3 34.9 24.3 9.6 33.5 19.1 21.2 15.1 13.3 15.7 10.1 12.6 9.9 10.9 3.2 15.5 12.4 16.5 11.6 7.8 15.1 10.2 17.4 12.9 10.3 12.9 19.9 16.4 22.1 19.7 18.6 10.3 4.3 12.4 11.6 17.8 15.3 14.1 14.0 14.8 13.2 16.1 16.1 1.8 16.7 11.0 18.0 13.3 7.8 14.2 20.1 17.8 18.0 17.3 15.3 18.1 16.0 23.7 13.5 3.0 5.8 10.9 13.1 0.0 0.0 27.8 10.2 9.4 10.3 5.2 0.0 26.6 11.6 10.9 4.4 8.2 0.8 23.3 8.6 17.4 15.8 7.5 5.8 7.3 14.3 0.0 0.0 6.2 4.9 3.1 12.7 6.3 0.0 21.6 3.8 0.0 7.5 3.5 13.1 8.7 0.0 12.9 10.0 24.4 18.8 0.0 14.5 4.4 6.2 9.1 MTERF4 "MGC61716, MTERFD2" ENSG00000122085 "Mitochondrial transcription termination factor 4" Q7Z6M4 2 241072169-241102332 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027097 Uncertain Supported Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" "HPA027097: AB_10603879" "unprognostic (4.58e-2)" "unprognostic (3.66e-1)" "unprognostic (2.82e-1)" "unprognostic (5.95e-2)" "unprognostic (1.50e-1)" "unprognostic (6.70e-2)" "unprognostic (1.17e-3)" "unprognostic (2.99e-2)" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "prognostic favorable (3.48e-4)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-1)" 14.2 15.5 14.4 17.6 22.1 17.2 18.6 42.2 21.7 16.2 14.6 25.3 12.5 13.4 23.2 14.1 17.6 17.7 12.1 13.4 14.4 12.1 13.4 16.5 14.2 29.8 19.2 19.4 25.7 20.9 11.7 25.7 11.6 20.4 28.9 17.2 16.3 19.5 18.1 38.8 15.5 19.6 17.3 17.8 20.3 14.7 12.7 22.3 23.7 29.4 20.5 29.7 14.3 15.2 16.6 6.2 11.4 5.4 8.0 24.9 10.2 8.7 8.3 16.5 9.5 22.5 10.1 12.3 14.9 16.6 14.5 20.7 5.7 13.2 13.6 5.4 17.3 16.5 9.9 22.5 21.3 19.7 18.4 16.3 17.4 15.9 25.1 14.8 20.7 13.3 17.2 20.9 17.0 19.7 18.9 16.5 18.6 15.5 6.0 17.4 12.4 15.1 14.3 18.9 18.1 14.3 14.8 18.8 7.7 13.8 17.6 15.2 13.2 12.2 15.2 11.3 11.7 11.2 10.7 22.8 13.4 13.1 15.7 13.3 16.1 4.1 33.2 11.3 13.2 12.3 4.2 5.4 11.4 10.0 5.2 12.5 16.6 15.5 13.7 6.2 15.4 24.9 19.5 1.9 8.0 4.4 4.7 15.8 10.2 14.4 22.1 42.2 21.7 14.4 12.1 19.2 19.4 20.4 22.3 11.9 23.0 29.4 17.6 0.0 0.0 17.5 25.5 32.1 23.9 19.2 0.0 24.9 34.9 21.1 40.5 13.6 19.2 23.3 21.3 22.9 13.5 15.6 10.5 27.2 22.0 0.0 10.5 14.7 21.8 48.5 21.6 18.0 0.0 19.8 26.7 0.0 20.5 25.8 24.8 32.1 0.0 38.8 15.9 42.6 38.1 0.0 19.8 30.5 22.5 14.8 MTFR1 "CHPPR, FAM54A2, KIAA0009" ENSG00000066855 "Mitochondrial fission regulator 1" Q15390 8 65644734-65771261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 350.9;Late spermatids: 606.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "hTERT-HME1: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023152, HPA056120" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA023152: AB_1854176, HPA056120: AB_2683043" "prognostic unfavorable (4.06e-4)" "unprognostic (4.58e-2)" "unprognostic (4.01e-2)" "unprognostic (4.57e-2)" "unprognostic (6.56e-3)" "unprognostic (3.93e-2)" "unprognostic (1.66e-1)" "unprognostic (3.28e-2)" "unprognostic (1.50e-1)" "unprognostic (3.53e-1)" "unprognostic (5.69e-3)" "unprognostic (5.44e-2)" "unprognostic (6.63e-3)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.21e-4)" "unprognostic (8.25e-2)" 10.7 17.7 6.6 5.5 11.7 3.9 9.5 10.1 8.8 9.7 10.7 10.8 14.2 11.1 9.9 11.9 12.3 7.2 6.2 8.7 6.8 5.5 28.4 37.7 7.1 3.9 10.3 5.4 7.9 19.1 8.0 15.0 16.2 9.7 8.1 11.2 14.8 11.0 11.5 11.7 8.3 16.2 8.8 11.3 6.5 13.2 16.8 11.7 5.4 13.0 11.2 9.3 10.5 9.7 1.7 3.1 4.3 2.8 0.8 2.9 1.7 14.1 10.6 8.4 9.8 11.7 11.5 6.8 9.3 8.6 11.6 12.3 9.0 14.8 7.9 3.0 9.0 11.3 9.3 19.1 12.7 15.7 2.8 10.3 9.8 7.8 18.1 14.6 2.5 4.8 7.8 13.7 14.9 47.7 6.6 14.1 5.8 13.3 8.2 13.4 12.7 8.6 6.0 8.9 31.3 9.5 4.4 11.6 6.6 14.3 12.8 3.8 5.6 9.3 15.9 12.4 9.0 17.6 5.6 10.6 7.1 9.8 16.7 8.1 8.0 5.2 5.8 8.6 10.4 9.3 4.3 2.8 1.2 2.0 2.5 2.9 1.7 2.6 2.2 3.1 1.4 2.6 2.9 0.7 0.8 1.2 1.9 2.5 1.7 6.6 11.7 10.1 8.8 6.8 5.5 10.3 5.4 9.7 11.7 17.9 6.0 12.0 9.6 14.9 0.0 6.4 12.7 10.7 3.4 10.4 0.0 20.7 48.0 16.4 350.9 6.4 10.7 23.3 21.3 22.9 9.7 11.6 4.7 33.1 8.6 0.0 4.6 8.6 5.4 606.6 15.5 6.1 13.5 2.8 11.8 0.0 17.5 7.0 11.3 91.0 0.0 6.5 16.5 66.0 16.8 16.9 32.7 5.0 14.1 15.2 MTFR1L FAM54B ENSG00000117640 "Mitochondrial fission regulator 1 like" Q9H019 1 25818640-25832942 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 175.3;Late spermatids: 418.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027124, HPA027130" Approved Approved "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA027124: AB_10600211, HPA027130: AB_10611251" "unprognostic (9.90e-2)" "unprognostic (6.86e-3)" "unprognostic (9.29e-2)" "prognostic favorable (6.81e-4)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.52e-3)" "unprognostic (2.12e-1)" "unprognostic (2.24e-1)" "unprognostic (9.89e-3)" "unprognostic (5.33e-2)" "prognostic favorable (5.89e-12)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.69e-1)" "unprognostic (1.33e-1)" 13.2 43.5 17.8 8.1 23.9 6.2 14.0 19.4 26.5 13.8 20.2 17.1 21.6 18.2 16.7 23.3 19.2 17.1 13.4 58.7 16.8 17.6 27.7 25.1 10.7 9.0 17.7 20.7 26.8 14.5 38.7 16.4 15.6 19.2 19.9 14.8 24.2 16.3 28.8 76.9 11.4 15.3 28.0 13.0 13.4 16.4 46.4 15.0 5.8 16.5 23.1 9.9 21.1 16.6 10.1 21.1 41.1 20.3 10.3 10.6 18.1 7.6 10.6 21.5 21.8 27.9 26.4 9.1 17.9 25.6 18.4 20.3 3.5 16.1 2.6 16.0 31.7 16.2 7.0 17.6 15.3 18.1 17.3 15.8 22.0 17.8 13.9 26.8 18.0 22.1 27.1 14.5 19.6 14.7 27.3 15.1 10.8 13.3 11.8 26.2 8.1 10.2 12.8 11.8 10.1 15.6 10.2 19.4 7.7 18.9 7.0 22.0 20.1 13.4 13.0 26.7 15.1 10.9 16.7 15.6 15.2 12.1 35.5 11.2 12.4 7.4 9.2 26.6 24.5 16.9 20.4 19.4 41.1 10.4 18.8 6.2 10.1 9.9 9.3 21.1 10.0 10.6 9.7 5.2 10.3 20.3 8.5 10.3 18.1 17.8 23.9 19.4 26.5 16.8 17.6 17.7 20.7 19.2 15.0 14.9 23.2 21.5 23.3 11.9 0.0 129.8 15.3 8.1 15.9 21.0 0.0 46.0 87.9 28.6 175.3 16.8 19.0 0.0 29.3 32.3 25.4 13.0 34.7 29.4 29.9 0.0 15.0 16.5 13.4 418.5 31.7 18.9 42.2 59.5 13.1 0.0 23.1 14.8 36.7 58.4 0.0 25.8 29.7 84.9 35.7 11.3 49.7 10.2 18.8 11.5 MTIF3 "IF-3mt, IF3(mt)" ENSG00000122033 "Mitochondrial translational initiation factor 3" Q9H2K0 13 27435643-27450591 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 461.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039791 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA039791: AB_10795296" "unprognostic (1.82e-1)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (3.26e-3)" "unprognostic (1.49e-2)" "unprognostic (8.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (2.40e-1)" "unprognostic (3.24e-2)" "unprognostic (1.13e-1)" "unprognostic (9.27e-2)" "prognostic favorable (8.41e-4)" 36.9 30.4 29.8 21.9 26.3 8.5 28.4 22.8 26.7 21.5 24.8 16.9 25.9 23.7 15.1 38.5 25.5 16.5 20.5 55.7 27.5 22.8 41.5 38.7 15.1 22.2 28.9 19.7 23.1 28.3 14.5 40.3 20.2 28.3 22.7 24.8 17.4 43.3 28.1 46.1 21.6 29.7 18.2 28.7 24.9 22.7 28.3 26.2 29.7 22.9 38.5 24.0 27.8 16.4 25.3 44.3 35.9 26.5 18.5 24.1 19.4 12.6 8.8 19.9 10.0 22.3 33.5 10.1 18.7 20.5 13.8 14.0 11.7 15.7 13.8 12.7 20.3 9.6 10.9 10.7 14.7 19.0 14.5 13.2 17.5 8.1 14.5 21.8 18.1 16.7 18.8 27.1 11.3 14.4 31.2 23.9 13.7 10.0 5.6 20.8 22.3 15.8 22.1 10.3 40.0 10.0 9.3 10.8 15.8 28.4 13.0 14.6 8.9 11.3 16.7 21.2 22.5 13.0 27.3 16.3 9.3 5.5 24.0 12.7 4.3 6.0 8.0 9.7 18.2 13.3 34.2 26.5 35.9 17.1 25.5 18.4 25.3 21.8 17.2 27.9 21.7 19.3 19.6 17.7 18.5 22.1 44.3 24.1 19.4 29.8 26.3 22.8 26.7 27.5 22.8 28.9 19.7 28.3 26.2 26.8 39.6 74.4 31.9 30.2 0.0 153.3 114.7 80.3 53.4 109.9 0.0 82.5 276.8 69.3 461.6 70.4 109.5 70.0 91.1 54.9 56.4 44.1 70.4 186.6 88.5 0.0 61.7 75.5 115.6 139.9 129.5 86.8 101.3 78.5 97.0 0.0 94.2 104.0 117.4 273.1 0.0 122.9 55.6 149.2 77.3 37.1 47.5 55.4 92.5 39.3 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 170.8;Spermatocytes: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 13.2 26.4 21.3 12.0 22.3 5.5 18.8 15.0 44.9 13.0 20.7 18.5 16.6 15.4 15.5 27.9 22.2 20.0 12.0 33.6 23.6 26.3 31.5 20.2 10.6 8.9 21.5 16.5 13.2 16.4 23.7 25.7 17.3 21.8 18.9 24.6 16.3 24.7 16.5 45.0 12.5 14.8 17.6 25.7 9.4 14.6 40.6 14.0 10.2 14.7 19.8 13.6 14.4 13.6 16.2 12.1 4.7 12.6 15.1 13.4 7.9 17.5 10.4 21.2 13.0 14.3 16.5 20.4 18.9 17.7 17.4 20.3 17.9 19.2 22.5 32.1 16.7 28.1 11.8 23.1 23.3 24.0 22.3 16.6 21.4 13.1 31.5 22.6 33.1 7.2 18.4 29.1 18.2 31.4 21.3 24.7 22.0 28.4 17.5 20.4 16.0 11.6 33.7 20.2 34.4 16.5 0.0 15.4 20.0 49.2 31.9 30.3 26.0 15.8 21.1 39.0 42.7 11.7 21.6 21.7 17.4 15.4 18.2 19.7 19.6 20.4 26.9 21.6 16.7 21.0 4.7 7.7 3.2 8.5 12.6 11.5 16.2 10.9 9.6 12.1 11.4 13.2 13.4 0.0 15.1 10.9 9.8 13.4 7.9 21.3 22.3 15.0 44.9 23.6 26.3 21.5 16.5 21.8 14.0 17.9 16.9 20.4 33.1 27.6 0.0 60.5 28.1 33.5 20.5 54.1 0.0 65.7 170.8 45.6 18.6 25.5 29.0 0.0 34.6 53.9 27.4 37.9 42.7 32.0 41.3 0.0 39.9 12.3 17.8 12.3 32.8 24.8 33.7 34.3 41.6 0.0 41.1 17.5 30.8 83.3 0.0 38.8 36.0 167.0 118.7 36.6 54.3 16.2 51.9 46.0 MUT ENSG00000146085 "Methylmalonyl-CoA mutase" P22033 6 49430360-49463191 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Isomerase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.5" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035971, HPA035972" Enhanced Approved Mitochondria,Cytosol NA NA 110000 Cytosol Mitochondria "HPA035971: AB_10696648, HPA035972: AB_2674895" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.17e-2)" "unprognostic (3.72e-2)" "unprognostic (3.18e-3)" "unprognostic (1.20e-1)" "unprognostic (1.16e-2)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (1.89e-2)" "unprognostic (6.57e-2)" "unprognostic (9.89e-2)" "prognostic favorable (8.71e-13)" "unprognostic (5.38e-2)" "unprognostic (3.78e-1)" "unprognostic (6.01e-3)" "unprognostic (1.91e-1)" 10.7 14.3 10.9 5.7 13.4 4.1 9.7 10.0 12.1 8.9 12.7 8.6 9.0 13.6 8.7 8.6 13.2 8.4 7.5 16.6 10.1 10.0 25.5 96.5 7.8 5.7 11.8 9.5 13.1 15.7 15.8 13.5 7.5 12.0 11.2 11.2 8.0 9.3 9.2 13.7 9.0 14.7 11.8 9.7 6.4 10.9 9.1 9.9 8.2 11.2 9.1 5.8 12.8 8.1 9.4 8.9 14.0 15.2 14.2 12.0 6.7 13.4 4.8 14.5 16.9 28.9 27.5 8.0 12.1 16.0 12.8 19.0 5.5 7.0 12.5 9.7 12.9 19.4 7.7 16.1 8.6 18.1 10.6 11.7 6.6 11.0 14.4 21.1 8.5 6.4 16.6 12.8 13.0 15.2 11.5 12.3 13.6 12.0 15.0 15.0 8.4 9.9 8.4 6.2 14.2 3.5 8.9 18.2 17.2 14.8 12.9 13.5 9.4 13.3 9.6 20.0 15.9 8.3 13.6 8.8 11.9 8.8 16.1 16.3 5.9 6.7 10.7 16.8 10.0 10.4 14.0 7.5 12.5 7.9 9.9 9.9 9.4 9.5 9.9 8.9 8.3 12.0 9.0 4.3 14.2 15.2 6.3 11.9 6.7 10.9 13.4 10.0 12.1 10.1 10.0 11.8 9.5 12.0 9.9 17.9 17.4 10.4 16.2 17.7 16.5 60.2 22.9 18.7 21.6 31.4 2.0 21.2 24.9 14.4 5.7 10.0 27.4 0.0 12.8 11.2 13.8 13.3 10.4 117.7 10.8 19.1 50.0 14.1 10.0 2.1 22.2 9.4 8.5 2.8 23.1 28.2 10.5 23.0 26.2 34.2 15.2 32.3 12.2 18.6 14.3 17.6 27.9 7.9 21.2 11.5 MYCBP AMY-1 ENSG00000214114 "MYC binding protein" Q99417 1 38862964-38874105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041188, HPA078331" Supported Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (2.42e-2)" "unprognostic (6.60e-2)" "unprognostic (3.85e-3)" "unprognostic (9.46e-3)" "unprognostic (8.77e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.03e-6)" "unprognostic (7.59e-2)" "unprognostic (3.00e-3)" "unprognostic (5.03e-3)" "unprognostic (4.41e-3)" "unprognostic (2.34e-3)" "unprognostic (5.81e-3)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (2.41e-2)" 8.6 10.5 4.8 13.6 7.4 9.0 14.5 4.6 4.9 11.6 14.9 3.6 21.3 10.5 9.6 18.2 23.4 17.7 15.6 16.8 5.2 4.9 26.5 21.1 16.1 20.7 4.6 3.1 9.3 20.0 13.9 12.5 24.8 11.2 13.6 15.6 6.6 22.9 17.3 11.8 12.0 24.4 14.6 4.9 16.8 13.1 28.9 5.2 16.8 24.3 18.1 19.6 13.0 11.9 9.0 21.7 32.1 15.1 11.0 12.9 8.1 18.5 8.1 7.2 5.2 4.2 7.4 28.7 14.9 4.9 15.1 11.9 9.5 22.3 15.3 16.6 6.8 2.4 13.9 11.2 19.4 18.3 19.2 18.6 16.3 11.6 10.0 1.1 40.4 14.8 6.6 15.5 12.5 7.9 5.8 11.0 17.6 23.6 14.2 15.8 10.9 12.9 19.4 18.2 28.1 20.4 12.4 21.2 21.4 19.7 15.7 13.6 9.3 14.3 19.0 9.6 17.2 13.0 19.5 8.7 7.9 13.3 12.1 17.0 9.5 17.0 16.9 7.9 23.8 10.3 14.8 12.6 32.1 7.8 15.1 8.9 9.0 9.7 9.3 16.0 6.4 8.4 9.3 25.1 11.0 13.5 21.7 12.9 8.1 4.8 7.4 4.6 4.9 5.2 4.9 4.6 3.1 11.2 5.2 8.9 13.3 18.6 14.6 9.4 0.6 7.3 22.9 163.3 36.4 26.2 0.0 96.0 54.7 19.6 63.4 10.8 26.5 23.3 23.9 75.4 7.3 14.2 26.4 13.4 19.0 9.5 9.2 6.2 15.1 16.8 6.6 15.9 18.6 23.4 25.1 3.8 23.0 38.6 8.5 34.2 4.5 6.5 12.2 22.9 68.8 15.6 73.7 21.5 26.9 20.0 MYL3 "CMH8, MLC1SB, MLC1V, VLC1" ENSG00000160808 "Myosin light chain 3" P08590 3 46857872-46882169 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "heart muscle: 398.1;skeletal muscle: 319.8" "Cell type enriched" "Detected in some" 65 "Cardiomyocytes: 3031.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016564, CAB018662, HPA046859, HPA063034" Enhanced Approved Nucleoli,Mitochondria NA NA 15000000 "Nucleoli, Mitochondria" "CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (3.11e-1)" "unprognostic (2.64e-2)" "unprognostic (5.55e-2)" "unprognostic (1.51e-1)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "unprognostic (9.67e-3)" "unprognostic (3.37e-2)" "unprognostic (4.72e-3)" "unprognostic (3.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.88e-2)" "prognostic favorable (1.22e-8)" "unprognostic (1.16e-3)" "unprognostic (9.45e-3)" "unprognostic (7.18e-5)" "unprognostic (2.53e-3)" 0.9 0.2 0.5 0.2 0.4 0.0 0.6 0.2 0.4 0.5 0.1 0.3 0.0 0.0 0.2 10.1 10.5 0.1 0.2 398.1 0.7 0.4 2.3 0.1 0.2 0.1 0.7 0.3 0.3 0.1 0.0 0.0 0.3 0.3 1.6 0.0 0.3 5.5 0.0 319.8 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.4 0.0 1.1 30.1 3.1 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 1.6 0.3 0.1 0.0 0.1 5.9 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.4 0.7 0.4 0.7 0.3 0.3 0.4 0.0 0.0 0.0 0.1 0.7 0.1 3031.1 0.0 0.0 0.0 1.8 0.0 0.4 46.4 0.0 2.0 0.3 0.0 0.0 0.0 5.0 7.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.5 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.7 46.2 0.4 6.5 1.3 0.0 0.4 0.4 0.7 0.0 0.0 0.0 MYO19 "FLJ22865, MYOHD1" ENSG00000278259 "Myosin XIX" Q96H55 17 36495633-36543435 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 50.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021415, HPA059715" Approved Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA021415: AB_2266815, HPA059715: AB_2684111" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (8.44e-3)" "unprognostic (1.46e-1)" "unprognostic (2.02e-1)" "unprognostic (4.89e-3)" "prognostic unfavorable (8.33e-6)" "unprognostic (1.07e-3)" "unprognostic (1.39e-2)" "unprognostic (2.41e-1)" "unprognostic (1.67e-1)" "unprognostic (3.70e-3)" "unprognostic (1.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.57e-1)" "unprognostic (1.89e-1)" "unprognostic (4.17e-2)" 5.2 1.9 3.1 5.4 6.2 7.8 4.7 2.7 6.5 4.7 7.7 7.0 6.8 7.5 4.3 4.1 9.8 3.4 4.1 1.4 4.7 5.7 7.0 3.8 5.2 6.1 3.1 2.9 5.8 9.8 7.2 8.1 5.0 2.8 11.2 4.8 9.5 9.3 6.3 13.1 7.9 5.2 5.4 3.0 8.3 8.0 5.7 5.8 4.2 5.6 7.2 3.3 2.8 2.2 3.4 1.7 1.7 3.7 3.9 1.4 14.0 17.2 8.2 9.4 4.5 4.5 10.0 14.0 11.2 22.3 22.8 17.0 14.7 8.8 5.5 9.5 7.6 21.2 19.4 14.6 15.9 6.3 13.2 14.1 18.8 10.7 3.0 13.6 15.3 4.3 7.3 15.9 17.4 5.3 9.9 10.7 16.5 9.3 11.3 10.6 9.5 11.1 9.1 15.2 10.2 11.1 13.2 10.5 10.4 11.4 14.1 8.8 18.6 11.4 5.9 12.4 18.7 5.6 6.4 12.5 14.2 17.0 24.6 7.2 14.1 8.1 7.8 8.4 14.6 1.7 1.7 1.7 3.8 1.2 2.8 2.2 2.4 2.6 3.4 1.7 1.7 3.9 0.1 3.7 0.5 1.9 2.0 1.4 8.9 8.1 14.1 10.0 26.3 17.4 3.6 15.3 2.7 5.7 5.2 33.4 7.0 1.7 8.7 50.4 9.5 18.8 0.0 11.4 18.5 7.3 9.0 2.3 7.8 9.6 3.2 10.4 6.2 3.9 17.2 11.5 7.5 3.3 10.0 20.3 5.6 12.4 10.5 9.2 3.6 25.6 0.0 8.2 19.0 17.7 20.6 6.1 12.7 27.7 11.1 NACC2 "BEND9, BTBD14A, BTBD31, MGC23427" ENSG00000148411 "NACC family member 2" Q96BF6 9 136006537-136095285 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 71.6;Late spermatids: 228.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047924, HPA052962" Approved Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA047924: AB_2680212, HPA052962: AB_2681998" "unprognostic (1.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-2)" "unprognostic (8.73e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (9.25e-3)" "unprognostic (2.25e-2)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-1)" "prognostic favorable (8.28e-5)" "prognostic favorable (8.63e-4)" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (4.12e-2)" 15.3 9.0 27.4 10.9 26.3 2.7 12.8 16.3 37.3 10.0 15.5 14.5 11.7 8.3 11.4 6.9 11.6 10.1 16.6 16.8 20.7 16.7 8.0 15.2 8.3 7.6 30.3 6.4 10.3 10.0 6.2 3.8 3.9 15.2 12.7 5.5 10.2 9.9 23.8 12.6 5.8 9.5 31.7 33.4 7.8 8.2 7.8 11.0 0.0 5.8 4.7 3.1 21.8 4.6 0.0 2.4 5.7 4.5 0.5 1.7 1.4 3.1 17.3 1.9 26.3 8.5 4.8 2.4 7.7 5.2 2.5 0.8 7.3 5.7 0.0 9.3 12.2 4.0 12.4 4.2 4.2 0.8 9.6 3.8 2.1 16.6 9.1 8.7 0.0 4.0 8.0 3.9 2.3 2.3 10.3 6.9 0.0 6.5 0.0 4.8 10.6 0.0 6.0 5.9 5.0 10.8 0.0 2.0 5.2 10.3 3.6 0.7 0.8 10.9 9.2 9.5 9.2 9.3 19.8 11.4 6.7 7.6 5.6 5.3 0.0 0.0 0.1 8.9 0.7 13.4 2.8 4.5 1.5 1.7 3.6 0.7 0.0 0.6 1.5 2.4 0.0 0.5 0.6 5.7 0.5 3.4 0.3 0.4 1.4 27.4 26.3 16.3 17.7 20.7 16.7 30.3 6.4 15.2 11.0 11.9 5.3 1.5 4.0 4.0 2.1 25.0 10.2 1.4 4.5 5.2 0.0 0.6 0.0 10.1 71.6 13.0 6.8 0.0 11.7 1.6 6.4 8.7 2.3 31.1 6.9 3.2 2.4 17.8 38.6 228.0 16.7 10.8 5.0 5.4 4.1 16.7 15.4 8.6 18.0 12.6 1.8 25.8 18.9 1.8 4.5 4.4 0.3 2.9 4.5 7.0 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA029768: AB_2673192, HPA054359: AB_2682461" "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 33.6 36.4 26.0 27.7 31.4 19.9 32.6 26.6 24.3 18.7 23.4 20.3 28.2 27.5 41.1 27.8 40.0 32.5 36.5 25.6 21.5 37.9 50.4 28.5 66.4 45.5 24.4 43.5 31.7 32.4 34.8 19.9 15.5 30.6 23.2 28.1 15.5 42.7 25.7 59.6 30.9 41.2 38.4 87.9 65.0 31.3 24.8 82.5 56.4 48.0 19.0 25.1 54.7 67.9 36.5 36.6 17.2 51.3 29.9 16.0 16.2 33.2 51.9 39.4 48.8 35.9 29.0 51.7 19.7 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 148.9 173.3 221.0 195.7 189.9 139.0 3052.5 636.9 330.6 205.9 533.9 74.6 331.6 1856.9 408.0 28.1 249.5 1244.9 256.9 444.8 351.6 251.4 215.4 204.5 881.4 567.3 77.9 441.2 254.8 408.9 27.3 272.7 346.6 541.6 587.1 745.3 168.3 446.0 706.9 268.0 1089.7 161.0 213.4 269.6 46.1 78.8 217.9 318.3 243.7 663.1 282.7 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Group enriched" "Detected in all" 5 "Cardiomyocytes: 2083.1;Distal tubular cells: 525.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 41.6 45.3 37.9 26.9 31.1 29.0 28.2 19.9 29.3 43.5 39.5 55.9 21.5 47.9 11.8 30.4 24.1 31.5 38.9 45.9 49.4 41.3 46.7 40.1 37.8 56.3 32.0 56.8 49.0 31.1 58.0 36.4 44.7 45.5 35.6 41.7 37.4 22.3 42.1 60.4 39.3 87.8 28.7 51.2 78.9 30.1 32.8 54.6 42.6 62.6 36.1 21.9 33.7 49.2 25.8 34.2 48.6 37.4 40.6 23.1 23.5 33.5 33.8 36.4 54.0 73.1 13.9 47.6 35.2 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 68.5 58.6 79.6 121.2 96.5 65.8 2083.1 160.5 77.6 45.5 102.9 60.9 215.5 525.6 141.2 192.8 157.8 177.2 46.7 143.2 214.5 94.4 120.9 56.6 123.1 168.7 35.0 81.9 98.8 95.5 70.6 90.3 125.9 151.8 218.2 146.8 79.4 169.8 188.7 125.5 242.6 113.4 103.5 149.9 130.8 119.2 111.7 175.3 96.5 189.4 182.6 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favorable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.9 19.8 9.8 13.0 7.2 7.2 28.3 8.4 8.5 16.3 12.4 42.9 22.1 12.4 4.5 9.1 18.4 18.5 14.1 12.4 10.6 24.0 24.8 12.1 21.1 32.4 15.8 17.6 13.1 9.2 12.1 11.1 15.1 10.1 12.2 17.8 8.4 23.5 12.0 21.3 17.6 20.3 25.2 20.7 16.5 24.9 14.4 12.9 22.4 25.1 7.1 8.0 10.6 28.5 14.7 22.2 5.9 16.9 8.5 12.4 25.2 11.3 19.4 4.6 5.4 20.5 13.0 11.0 13.6 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 26.8 28.0 46.2 52.9 43.0 46.1 165.0 50.9 41.5 36.4 61.1 55.0 100.9 140.9 108.0 102.8 42.7 83.0 23.3 114.3 98.5 39.0 37.2 56.6 65.2 101.8 31.8 45.5 34.4 33.6 461.4 26.2 46.0 52.3 57.7 92.6 40.4 94.0 94.8 34.6 133.6 48.3 19.4 42.6 28.8 28.1 41.3 83.5 45.7 120.3 64.7 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 1253.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054364, HPA076020" Approved Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA054364: AB_2682463, HPA076020: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favorable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 28.2 20.9 26.2 23.3 18.7 20.2 36.4 21.8 16.2 22.0 18.1 18.1 23.0 46.8 35.8 15.7 27.4 23.4 45.5 25.9 17.5 26.5 52.6 25.1 37.5 88.9 19.6 46.6 20.9 18.8 36.0 16.2 17.5 20.7 27.9 42.3 52.6 23.8 23.8 42.8 36.0 70.9 68.0 42.2 48.6 49.6 29.5 63.7 20.2 25.4 36.0 28.1 24.4 44.7 40.7 30.1 36.1 39.0 21.9 20.2 21.2 19.5 29.9 30.4 44.2 52.5 22.6 37.7 22.8 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 92.3 83.8 96.1 105.6 108.4 80.0 1253.7 109.5 175.3 81.9 106.4 43.2 246.2 600.2 140.5 81.4 113.0 204.9 70.0 182.7 251.9 115.6 117.8 83.1 281.9 233.1 49.3 194.3 96.3 110.6 24.0 89.8 100.2 148.5 155.9 210.6 118.9 192.1 168.4 114.2 541.1 90.3 90.5 123.0 114.6 115.3 124.3 187.8 90.6 317.0 150.7 NDUFAF1 "CGI-65, CIA30" ENSG00000137806 "NADH:ubiquinone oxidoreductase complex assembly factor 1" Q9Y375 15 41387349-41402519 "Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039933, HPA040064" Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA039933: AB_10795265, HPA040064: AB_10795687" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.72e-1)" "unprognostic (2.10e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.88e-5)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "prognostic favorable (3.34e-6)" "unprognostic (1.68e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" 11.1 22.0 15.0 6.4 14.0 3.0 9.8 13.3 17.8 7.8 7.7 12.4 5.3 8.4 8.3 10.7 9.6 7.9 7.1 29.7 13.2 13.4 21.9 27.5 7.0 8.5 14.7 14.4 7.0 7.7 11.9 9.7 7.0 13.1 8.5 8.1 8.4 8.5 9.8 38.6 6.2 7.7 10.3 13.5 7.5 8.5 14.1 12.0 6.5 9.6 15.8 9.1 8.8 5.8 14.5 19.1 25.2 16.2 13.9 15.9 8.7 9.2 6.6 8.7 9.0 20.0 20.4 9.6 17.7 14.5 15.6 13.0 12.2 5.1 10.6 24.6 15.5 11.0 15.3 11.8 11.9 14.1 19.9 13.7 15.0 13.9 7.2 17.1 16.0 10.6 22.7 11.4 12.9 13.0 13.6 11.1 19.2 22.8 11.5 22.8 8.5 12.8 13.3 7.0 16.1 11.1 10.0 11.7 21.9 23.8 15.0 10.5 8.3 9.0 20.1 6.7 11.6 16.5 30.9 11.5 12.7 5.9 19.0 14.6 9.4 20.3 16.0 14.2 25.4 12.1 25.2 13.7 16.4 9.6 16.2 9.9 14.5 11.5 12.3 12.1 12.6 13.0 10.3 12.8 13.9 12.4 19.1 15.9 8.7 15.0 14.0 13.3 17.8 13.2 13.4 14.7 14.4 13.1 12.0 11.9 8.5 15.6 13.8 4.1 14.0 56.8 12.7 16.0 5.7 21.0 11.8 32.1 54.7 26.4 36.4 11.3 11.9 0.0 27.1 30.5 15.5 11.6 6.9 25.2 26.1 6.4 6.4 6.7 14.8 5.4 15.3 14.8 10.1 26.2 6.8 19.5 18.8 2.9 15.2 56.4 17.6 25.8 9.9 67.2 17.8 6.8 42.1 10.2 8.1 13.6 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 2033.2;Hepatocytes: 1436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.1 55.1 44.7 28.8 29.3 21.9 20.5 33.5 18.9 19.9 18.4 33.2 46.3 24.5 31.2 18.7 29.1 34.0 25.6 27.2 18.0 38.6 58.5 47.5 86.5 39.5 23.3 37.5 27.2 27.0 16.5 20.8 18.4 47.1 17.7 47.1 25.8 50.5 27.2 102.8 37.0 33.6 22.6 103.1 67.5 33.1 42.5 36.4 49.6 67.3 29.9 21.7 65.6 40.0 42.6 39.3 59.8 58.6 39.5 12.7 24.1 25.3 22.3 40.0 62.3 54.5 38.2 27.8 26.2 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 154.9 246.4 237.3 88.1 114.4 72.8 2033.2 565.6 282.4 178.6 369.9 37.3 225.4 988.2 197.4 98.7 145.0 655.0 280.4 371.9 86.0 164.5 117.3 207.1 1436.2 359.0 52.4 305.2 426.6 707.7 29.0 243.1 282.3 315.5 296.6 433.5 108.9 268.5 512.0 226.7 864.5 130.9 219.9 185.4 133.6 144.5 153.9 172.1 204.2 467.2 90.1 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Uncertain Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA051377: AB_2681460" "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favorable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.0 24.0 52.4 38.6 39.2 34.9 29.9 26.2 31.0 29.6 51.7 41.1 31.3 44.8 36.2 58.7 20.4 21.4 42.1 24.7 52.2 73.6 22.9 57.3 58.1 30.6 35.3 30.9 43.6 36.5 29.4 18.1 26.6 46.1 44.5 38.7 37.9 42.9 122.0 55.3 91.1 55.6 84.7 76.6 31.9 23.4 72.2 62.1 81.8 48.9 48.3 41.0 67.2 35.9 28.6 29.2 40.5 38.4 41.0 24.1 48.4 51.5 36.2 67.2 54.9 62.4 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 175.7 232.0 217.4 229.1 201.1 175.8 3102.3 435.7 235.5 197.9 638.6 92.3 489.8 1692.7 343.0 795.3 237.8 727.9 70.0 273.3 377.8 291.6 360.2 272.6 944.1 632.0 131.9 411.8 215.5 261.6 154.7 206.2 385.8 411.7 381.5 493.4 197.7 268.8 531.3 229.1 1640.6 200.8 194.1 278.2 77.7 190.5 245.3 430.7 214.4 506.9 369.0 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favorable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.4 6.6 16.4 19.9 21.7 29.2 22.2 14.9 18.8 21.3 21.6 19.7 17.1 20.5 45.2 12.6 36.6 26.0 17.7 19.7 21.5 42.4 14.8 22.0 12.0 16.4 19.9 26.3 17.5 26.9 25.5 12.0 20.0 22.1 24.4 20.0 18.6 29.9 22.8 16.7 15.1 20.4 23.7 45.5 26.7 16.8 19.0 63.6 38.6 18.1 11.7 19.6 9.0 50.9 35.1 15.4 77.6 42.9 15.7 14.1 13.4 19.2 35.4 39.8 41.2 30.3 22.8 28.2 20.0 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 44.7 44.0 87.9 92.8 75.7 45.3 340.1 112.1 52.2 53.4 83.7 31.4 192.8 431.0 110.3 85.8 85.1 125.2 0.0 92.5 115.9 83.1 75.7 92.3 108.0 222.8 38.1 112.9 97.6 229.9 13.7 75.1 156.2 128.2 124.4 173.7 74.4 86.7 189.4 65.7 379.0 54.1 71.1 81.4 233.1 125.2 77.5 192.3 81.2 242.9 137.2 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004484, CAB034894" Enhanced Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "CAB034894: AB_2151118, HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favorable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 13.4 22.9 29.7 13.2 46.3 25.5 18.1 23.9 35.0 16.6 28.4 16.5 16.1 31.4 12.7 16.0 19.1 17.3 16.3 45.8 26.0 24.8 34.1 32.0 12.0 13.9 29.4 24.9 12.2 23.0 21.4 17.0 12.0 26.0 13.9 30.9 14.4 20.1 17.4 100.9 15.1 28.9 15.9 17.1 14.2 18.9 15.1 15.4 20.5 16.1 51.6 18.8 14.5 11.7 25.0 36.1 18.7 31.2 16.4 23.8 31.5 11.5 22.0 18.6 19.4 16.1 16.7 15.9 11.0 18.8 27.2 25.9 32.3 20.4 25.8 11.0 15.7 19.3 21.4 26.3 19.8 22.2 13.8 42.5 15.6 30.9 31.2 16.6 38.1 20.3 16.3 14.3 10.3 17.0 11.6 17.1 21.3 22.7 17.8 17.6 35.4 26.1 49.4 26.4 32.0 31.2 31.8 26.9 21.2 23.3 18.1 20.9 15.1 14.1 24.2 24.9 11.6 27.0 36.4 11.9 16.3 18.3 18.9 24.8 20.5 27.1 28.5 16.5 29.3 16.1 12.2 28.6 18.7 18.7 31.2 19.8 25.0 19.7 20.3 33.7 23.1 18.8 20.1 7.5 16.4 25.0 36.1 23.8 31.5 29.7 46.3 23.9 35.0 26.0 24.8 29.4 24.9 26.0 15.4 50.6 35.2 47.4 60.2 58.3 41.3 154.2 96.8 75.0 45.5 66.3 39.3 103.3 343.2 99.0 93.6 59.9 204.6 23.3 97.2 97.6 64.9 43.1 56.6 108.3 166.7 57.2 81.3 52.8 54.3 46.0 62.5 73.9 113.1 83.8 120.8 100.0 80.5 103.7 65.0 231.7 51.0 103.5 79.3 76.9 75.2 66.4 74.5 62.9 167.5 58.5 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 25.9 27.9 14.2 28.5 17.8 17.9 26.6 16.2 15.6 25.4 17.0 52.8 31.5 48.0 34.2 13.9 20.7 35.0 30.0 25.3 8.0 24.4 23.7 19.6 37.9 26.0 25.2 26.7 22.0 26.5 24.6 20.6 18.5 16.1 22.5 35.2 35.7 39.3 15.4 39.0 31.2 52.9 13.9 59.1 35.2 36.3 27.6 77.9 20.6 19.5 22.7 21.4 20.5 71.8 54.1 9.9 36.4 27.2 17.8 24.7 18.4 35.1 17.0 38.4 21.8 23.9 28.7 28.3 23.7 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 56.6 80.9 64.0 70.8 71.3 67.0 408.9 66.2 72.3 67.1 82.0 47.1 180.6 336.5 96.7 57.0 53.7 205.0 23.3 97.8 127.6 79.5 47.7 59.0 122.2 121.6 60.4 94.7 53.4 67.1 159.3 60.7 67.5 108.0 83.8 141.7 63.1 68.4 126.7 55.5 398.9 60.4 45.3 98.9 77.2 78.1 70.4 158.1 71.2 225.4 78.9 NNT ENSG00000112992 "Nicotinamide nucleotide transhydrogenase" Q13423 5 43602692-43707405 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.0" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 303.5;Hepatocytes: 274.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004829, CAB004975" Enhanced Approved Mitochondria,Cytosol NA NA 1100000 Mitochondria Cytosol "CAB004975: AB_425908, HPA004829: AB_1079495" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (4.81e-2)" "unprognostic (5.02e-2)" "unprognostic (1.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.98e-2)" "unprognostic (1.65e-1)" "unprognostic (8.33e-2)" "prognostic favorable (1.22e-15)" "unprognostic (8.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (2.58e-1)" 10.8 10.5 11.7 8.3 14.0 7.3 9.1 8.3 19.0 7.6 11.2 7.3 8.8 9.2 7.1 8.8 7.9 5.4 7.1 62.1 10.8 8.2 26.0 48.5 7.2 9.6 9.2 10.3 5.8 12.2 15.6 6.2 5.8 10.0 8.5 12.1 6.7 14.4 7.8 100.0 6.0 8.9 14.7 6.1 6.5 13.6 4.2 6.1 14.0 14.0 32.6 8.7 10.9 6.2 11.4 25.5 13.1 18.5 18.2 19.1 13.5 8.3 6.2 14.3 26.6 16.7 18.6 4.5 8.4 14.4 10.4 9.4 7.1 13.9 8.6 10.5 16.0 11.0 8.0 56.7 2.0 11.0 13.6 15.3 12.4 33.3 8.7 9.6 20.7 18.5 16.0 6.3 5.9 8.5 18.2 20.5 12.5 8.9 34.4 24.7 5.7 22.3 11.2 2.8 0.0 5.6 25.1 33.8 30.8 19.7 7.4 21.1 17.6 30.9 0.4 19.1 3.1 21.6 20.9 11.2 15.2 14.8 6.3 4.1 18.5 19.0 13.2 3.1 27.7 9.8 9.3 14.2 13.1 14.4 18.4 14.8 11.4 15.6 14.5 25.5 10.3 14.6 13.3 2.4 18.2 18.5 9.2 19.1 13.5 11.7 14.0 8.3 19.0 10.8 8.2 9.2 10.3 10.0 6.1 50.6 27.8 20.7 7.7 10.2 17.5 303.5 28.1 24.1 31.8 26.2 33.4 7.2 23.2 10.7 12.2 12.6 17.2 23.3 9.3 2.1 17.9 10.5 23.3 274.2 21.7 6.4 19.1 20.3 31.4 3.4 13.8 18.2 13.5 10.8 24.6 13.2 9.5 11.5 18.0 21.1 11.9 0.0 15.1 2.1 1.2 7.0 1.7 27.7 25.8 7.6 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267856-90332137 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047050: AB_2679917, HPA050583: AB_2681182" "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 7.3 9.1 7.3 7.7 10.1 16.4 8.0 17.6 9.3 6.9 8.1 10.8 4.4 13.5 14.6 8.0 8.1 7.7 6.3 6.3 6.2 5.4 7.4 9.8 7.1 6.8 8.2 4.2 8.7 7.2 10.6 13.8 11.6 8.5 7.0 6.5 10.8 9.2 6.1 23.5 11.1 9.7 7.3 8.4 8.5 7.9 7.1 8.7 11.3 9.4 4.8 8.3 9.2 10.2 3.3 3.5 6.0 2.7 2.2 2.6 0.6 1.3 2.6 3.6 2.2 0.5 1.9 2.5 2.6 1.8 1.9 2.1 3.2 2.3 2.3 1.4 2.5 2.4 3.4 2.0 3.4 3.5 4.4 3.3 3.0 8.6 2.2 1.0 8.0 4.2 3.5 2.5 1.8 1.1 3.9 1.6 5.9 1.4 3.6 1.7 2.5 3.6 3.4 1.2 1.2 2.1 3.2 5.2 0.9 1.1 5.2 3.3 3.9 1.1 6.9 1.7 1.4 3.0 3.3 2.2 2.9 1.3 1.7 1.1 3.0 3.2 2.5 2.7 1.5 3.3 4.5 2.7 3.4 2.6 1.5 2.0 2.5 1.9 2.1 1.3 3.3 1.9 2.2 6.0 2.2 1.2 3.5 1.6 0.6 7.3 10.1 17.6 9.3 6.2 5.4 8.2 4.2 8.5 8.7 32.8 27.2 20.3 6.2 5.3 73.0 12.2 43.3 12.0 22.7 17.4 82.5 15.8 6.6 13.7 6.1 16.9 26.2 46.7 12.8 11.1 11.2 6.9 37.0 37.6 10.5 50.9 23.7 28.8 15.7 6.7 21.9 12.0 8.5 18.0 20.3 40.1 11.2 16.5 31.1 10.3 104.0 0.0 12.0 20.7 37.9 5.5 21.1 16.6 20.3 5.8 NSD3 "FLJ20353, KMT3F, WHISTLE, WHSC1L1" ENSG00000147548 "Nuclear receptor binding SET domain protein 3" Q9BZ95 8 38269697-38382272 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005659, CAB013721, HPA018893" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833" "unprognostic (6.21e-2)" "unprognostic (3.73e-2)" "unprognostic (2.18e-2)" "unprognostic (4.12e-1)" "unprognostic (2.25e-1)" "unprognostic (1.53e-2)" "unprognostic (4.35e-2)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (5.06e-2)" "unprognostic (5.60e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.60e-2)" 19.2 11.3 31.1 15.8 31.4 36.3 20.1 51.5 37.7 18.5 15.5 16.7 14.0 16.2 16.0 12.5 17.0 16.8 17.0 12.7 24.4 16.6 14.2 11.2 17.9 22.3 25.0 26.8 26.5 16.3 21.0 24.2 22.5 21.9 16.4 18.7 12.3 18.3 17.9 12.3 16.2 17.7 16.0 15.3 17.2 19.7 9.3 25.6 16.7 19.2 6.9 20.4 19.6 23.3 26.7 5.6 26.2 5.1 8.6 18.0 2.9 24.1 13.9 23.9 16.1 16.8 19.3 17.7 20.3 22.4 17.6 20.5 7.4 13.4 28.8 18.7 13.8 17.1 14.6 18.9 16.2 25.2 11.4 11.1 36.7 11.2 8.6 17.2 16.1 13.3 10.3 16.5 15.9 32.4 16.5 20.1 31.9 26.0 19.2 16.7 8.7 47.1 13.7 16.2 18.8 6.6 21.6 26.1 9.1 12.5 18.7 13.5 18.2 16.5 14.5 14.1 16.0 18.2 12.3 19.2 18.3 19.0 27.2 11.9 17.1 20.4 27.8 15.5 16.3 13.2 13.9 5.1 9.1 8.0 2.4 5.3 16.5 12.0 7.1 4.1 26.7 15.0 6.3 26.2 8.6 1.5 5.6 18.0 2.9 31.1 31.4 51.5 37.7 24.4 16.6 25.0 26.8 21.9 25.6 62.5 52.3 0.0 0.0 0.0 0.0 0.0 0.0 62.9 55.7 48.8 0.0 85.7 19.9 60.6 0.0 0.0 0.0 0.0 53.3 142.9 0.0 0.0 8.1 0.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 86.6 0.0 0.0 50.3 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 109.4 0.0 0.0 0.0 NT5DC3 "FLJ11266, TU12B1-TY" ENSG00000111696 "5'-nucleotidase domain containing 3" Q86UY8 12 103770453-103841197 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.0" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.0" "Low region specificity" "Detected in all" HPA041634 Approved Mitochondria,Cytosol "Secreted - unknown location" NA NA Mitochondria Cytosol "HPA041634: AB_10795597" "unprognostic (2.61e-2)" "unprognostic (1.16e-1)" "unprognostic (7.30e-2)" "unprognostic (2.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.57e-1)" "unprognostic (2.19e-1)" "unprognostic (2.45e-2)" "unprognostic (5.43e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.72e-6)" "unprognostic (8.60e-3)" "unprognostic (7.42e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.11e-4)" 4.2 5.4 14.8 3.2 10.5 23.9 5.4 2.7 16.2 12.2 52.0 2.9 9.4 2.0 17.9 8.4 8.9 3.5 2.6 2.2 13.3 5.7 2.2 4.0 2.8 2.3 2.8 11.7 3.8 3.5 1.8 4.2 4.5 10.4 9.8 12.5 3.7 3.9 9.1 7.0 2.8 4.2 32.9 2.1 1.9 6.6 3.5 2.7 0.0 2.9 0.9 2.4 22.4 5.2 4.1 4.9 2.4 1.6 1.5 3.3 0.8 3.3 6.0 3.5 4.0 4.9 3.9 6.5 5.5 3.3 3.9 2.5 4.1 0.9 5.6 1.1 6.5 4.3 3.8 4.9 10.9 5.7 4.1 4.0 7.0 2.2 4.7 2.8 3.7 1.9 3.4 2.4 5.0 22.0 8.0 2.3 2.9 11.0 2.9 8.7 3.0 3.2 6.0 4.3 4.8 6.5 4.5 6.1 2.1 6.2 2.3 4.7 1.9 4.6 5.2 6.5 3.3 2.9 3.5 3.0 3.9 4.7 5.3 11.0 2.6 3.1 4.2 3.7 5.7 5.6 0.8 1.5 0.1 1.7 1.6 3.3 3.5 2.4 1.4 3.8 4.1 2.1 1.8 2.4 1.5 1.0 4.9 0.6 0.8 14.8 10.5 2.7 16.2 13.3 5.7 2.8 11.7 10.4 2.7 0.0 2.9 0.8 17.0 3.9 1.5 2.8 2.5 9.4 2.3 1.8 0.0 4.2 0.0 1.8 8.8 1.6 1.6 0.0 1.8 4.4 3.9 10.0 0.0 4.3 1.7 9.5 39.5 1.3 3.5 7.4 4.6 2.5 0.0 2.8 9.1 0.8 2.3 0.0 7.8 1.5 4.9 0.0 8.0 0.5 3.1 3.9 3.4 0.9 9.0 8.6 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.9;pituitary gland: 13.5" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 17.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.2;U-2 OS: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045531, HPA056945" Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045531: AB_10960749, HPA056945: " "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.8 1.1 10.8 1.0 16.4 1.4 0.7 17.9 11.9 0.6 0.7 0.8 0.0 1.0 0.7 0.7 1.2 0.6 0.8 0.7 8.5 2.5 0.7 0.7 1.9 1.1 2.6 8.5 0.6 0.8 0.6 13.5 0.7 2.5 0.7 0.8 0.0 0.7 0.6 2.6 1.2 0.9 0.6 2.7 0.9 0.8 1.0 2.9 0.0 0.6 0.0 0.8 1.2 0.6 0.5 0.5 2.1 0.3 0.2 0.4 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.7 1.0 2.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.1 0.0 0.5 0.3 0.4 1.2 0.2 0.2 0.5 0.1 0.1 10.8 16.4 17.9 11.9 8.5 2.5 2.6 8.5 2.5 2.9 0.0 2.9 0.0 1.1 1.1 17.8 0.3 0.0 0.0 1.2 0.0 2.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 1.0 0.1 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.2 0.9 0.1 0.0 0.0 0.8 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 208.5" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343" "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 13.5 37.1 25.9 9.1 26.7 20.3 33.8 17.2 39.8 24.7 71.9 22.8 33.9 164.0 21.6 15.5 26.1 14.9 16.0 12.7 25.6 29.8 25.6 36.8 11.6 9.3 27.9 30.1 21.8 12.3 12.1 18.0 14.8 37.8 17.9 15.8 13.3 55.2 29.1 13.7 16.3 208.5 22.5 25.5 8.4 17.3 14.6 19.4 4.9 15.9 23.1 15.2 15.5 18.2 10.2 26.5 23.0 23.6 9.6 20.1 16.3 42.0 7.6 5.0 17.9 51.0 49.3 17.1 25.5 52.1 22.8 25.0 19.5 5.5 0.0 18.6 43.0 21.7 44.8 22.8 47.7 24.8 7.4 31.6 47.1 5.3 14.5 26.3 0.0 31.1 32.2 24.6 20.5 24.0 37.8 26.5 8.7 81.0 9.1 31.8 10.9 12.4 2.6 10.0 12.9 10.8 11.6 19.1 11.4 21.8 0.7 10.5 11.2 16.0 42.8 35.9 30.1 14.2 11.6 20.4 13.0 12.2 21.5 15.8 7.8 8.1 11.4 18.0 12.7 6.2 18.6 23.6 20.7 18.5 20.7 20.1 9.6 15.6 19.4 26.5 10.2 19.6 19.1 23.0 9.6 20.8 5.7 14.4 16.3 25.9 26.7 17.2 39.8 25.6 29.8 27.9 30.1 37.8 19.4 17.9 38.8 36.2 123.3 134.4 27.8 14.0 22.9 44.2 75.1 33.2 25.5 97.9 76.3 32.5 16.9 35.8 49.1 303.7 12.0 67.3 125.7 58.3 43.8 69.3 56.5 41.3 41.3 35.6 32.6 9.0 96.4 49.4 81.0 20.8 48.6 32.0 11.7 36.8 112.8 114.0 21.3 77.6 123.8 32.5 27.0 110.2 40.3 40.6 67.9 76.5 OMA1 "FLJ33782, MPRP-1, YKR087C, ZMPOMA1" ENSG00000162600 "OMA1 zinc metallopeptidase" Q96E52 1 58415384-58546802 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055120 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA055120: AB_2682702" "prognostic favorable (1.63e-4)" "unprognostic (2.67e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-1)" "unprognostic (9.57e-2)" "unprognostic (3.94e-3)" "prognostic favorable (8.52e-4)" "unprognostic (8.22e-3)" "unprognostic (6.91e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (9.54e-3)" "unprognostic (2.52e-2)" "unprognostic (3.93e-2)" "unprognostic (1.74e-2)" "unprognostic (5.24e-3)" 10.2 22.4 13.8 21.5 18.1 9.2 15.8 10.6 14.6 14.5 16.4 14.1 20.1 12.1 15.4 15.1 17.1 15.9 12.1 15.8 12.6 10.0 23.0 23.8 19.1 17.9 16.7 9.6 15.0 18.2 15.7 20.9 8.9 13.0 17.8 16.1 11.3 20.6 22.7 20.9 10.2 16.1 24.2 18.2 17.2 13.9 6.9 19.4 18.4 18.3 14.5 16.4 17.0 20.6 22.5 9.5 18.6 19.5 18.6 22.8 10.2 13.5 5.7 3.8 3.5 19.2 18.0 10.9 5.6 6.1 4.9 6.2 1.6 8.2 30.6 11.9 5.8 17.2 13.9 13.4 13.6 5.8 23.4 7.5 9.5 4.4 6.6 9.5 23.3 6.7 16.9 15.3 4.8 10.0 11.1 4.3 15.3 18.0 9.2 13.4 8.3 7.9 8.3 5.6 20.5 12.4 9.9 12.5 12.8 10.7 9.1 4.0 1.9 11.4 18.8 15.8 18.3 8.5 9.0 2.5 2.5 5.1 12.6 5.8 7.5 9.8 20.1 7.8 18.3 6.2 10.8 9.2 18.6 12.8 14.5 16.5 22.5 15.7 15.0 9.5 21.4 22.8 20.8 10.6 18.6 19.5 5.0 13.9 10.2 13.8 18.1 10.6 14.6 12.6 10.0 16.7 9.6 13.0 19.4 17.9 11.5 14.7 15.7 5.4 7.2 25.0 10.2 54.9 11.4 24.4 11.8 19.1 21.6 7.7 5.0 4.9 6.9 0.0 4.8 7.8 8.6 15.0 5.8 15.5 13.6 1.6 5.8 8.6 10.7 9.7 9.2 10.4 6.8 7.2 15.0 10.0 5.2 10.4 8.1 20.7 19.6 6.5 4.4 11.7 12.1 5.9 15.3 13.8 13.0 17.5 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1, mitochondrial dynamin like GTPase" O60313 3 193593144-193697823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria NA NA 13000 "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: AB_2675388" "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favorable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 17.0 19.7 18.2 13.5 31.7 25.9 15.9 20.2 30.9 13.9 21.8 11.1 12.6 20.0 15.2 11.8 18.8 11.8 12.8 43.9 23.0 19.4 21.8 24.1 10.7 15.3 19.0 22.4 13.2 13.4 20.9 15.6 13.8 28.0 15.5 20.5 9.1 15.7 20.8 38.4 14.6 17.3 16.5 17.0 13.1 16.7 7.6 10.8 18.0 16.8 18.4 14.2 16.5 13.6 8.3 8.8 8.2 17.6 5.0 7.5 5.9 26.0 8.4 8.5 9.3 7.5 11.9 9.0 12.7 11.7 13.9 13.6 20.3 8.8 17.3 27.4 11.9 12.7 17.0 14.8 14.3 24.7 20.8 12.0 29.9 7.5 10.2 11.7 24.6 13.8 13.3 12.8 13.4 19.1 8.6 11.7 7.3 12.7 17.0 13.8 20.6 9.5 13.7 11.9 15.0 28.0 12.5 18.7 18.5 10.4 16.3 18.5 11.3 18.9 21.2 13.4 6.8 27.8 19.5 11.7 12.9 9.8 13.8 26.6 15.4 17.8 33.9 14.3 19.7 12.9 8.2 8.1 7.7 7.2 9.3 6.6 8.3 6.8 6.8 8.8 6.3 6.9 7.3 3.2 5.0 17.6 4.6 7.5 5.9 18.2 31.7 20.2 30.9 23.0 19.4 19.0 22.4 28.0 10.8 14.9 20.0 20.6 13.8 14.2 17.0 130.0 15.3 16.0 20.5 17.4 29.5 16.2 14.9 14.8 7.2 13.5 20.6 70.0 20.7 12.2 15.9 15.5 18.5 30.2 15.9 20.6 22.4 16.0 23.5 10.2 14.7 21.2 20.3 11.8 20.6 15.7 22.7 7.0 13.8 26.9 21.6 6.5 17.5 11.3 15.0 19.6 15.0 12.8 25.8 19.6 OTULIN "FAM105B, FLJ34884" ENSG00000154124 "OTU deubiquitinase with linear linkage specificity" Q96BN8 5 14664664-14699711 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051074 Uncertain Approved "Plasma membrane,Mitochondria" NA NA Mitochondria "Plasma membrane" "HPA051074: AB_2681334" "unprognostic (4.81e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (1.19e-2)" "unprognostic (7.48e-2)" "unprognostic (1.91e-2)" "unprognostic (7.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.02e-1)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.59e-7)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (5.02e-2)" 10.0 7.4 5.9 22.6 7.8 32.3 8.4 7.2 6.6 8.2 9.3 8.3 8.9 10.7 9.5 7.7 13.8 6.1 10.8 15.5 6.7 4.9 8.5 19.5 11.1 16.0 9.6 2.8 9.1 12.2 7.5 9.8 11.8 7.0 11.1 7.0 7.7 10.6 10.8 16.5 18.1 11.7 8.1 10.5 12.5 7.1 11.5 7.4 15.0 7.8 9.7 19.3 8.5 15.8 3.4 2.9 3.1 3.0 1.0 4.6 0.9 6.4 7.5 7.5 8.5 7.0 7.3 8.3 6.5 4.6 9.3 7.0 10.1 4.8 11.6 12.8 4.2 13.4 7.4 9.3 8.5 6.4 20.0 7.7 8.3 23.9 5.4 6.0 7.9 14.3 4.1 10.5 7.6 6.5 5.1 7.8 9.8 8.2 18.6 6.6 4.0 7.8 6.9 4.6 6.8 8.0 12.1 6.8 4.6 6.0 6.7 3.4 5.6 23.1 5.2 5.0 9.6 5.7 9.1 7.2 12.1 13.7 9.0 8.5 8.4 12.7 13.2 6.9 15.1 6.2 0.4 2.0 3.1 1.0 2.2 3.0 0.9 2.5 3.4 2.9 3.4 1.8 3.9 2.2 1.0 3.0 2.5 4.6 0.9 5.9 7.8 7.2 6.6 6.7 4.9 9.6 2.8 7.0 7.4 3.0 8.6 13.4 20.2 0.0 10.9 13.4 15.3 9.4 7.9 5.2 13.7 13.2 6.6 4.2 7.3 8.7 13.9 0.0 5.0 8.6 4.9 19.7 10.3 32.7 12.3 7.9 9.1 8.0 11.8 2.5 9.8 10.6 0.0 13.6 11.6 13.0 7.1 8.4 6.0 8.9 32.3 0.0 6.2 23.8 30.4 0.0 11.9 15.0 8.9 19.3 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favorable (1.35e-4)" "prognostic favorable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.2 13.7 6.7 9.8 10.5 3.7 10.3 8.3 11.9 6.0 11.8 6.2 13.7 10.1 6.4 16.2 10.3 7.7 7.9 13.5 6.6 6.4 14.9 26.1 10.0 7.7 6.6 6.5 6.4 18.7 8.3 13.0 7.3 7.0 8.0 13.8 10.4 15.5 15.6 19.4 8.3 8.9 5.8 6.7 9.6 8.9 19.9 8.0 8.1 11.7 12.3 11.3 7.9 6.4 8.4 9.0 3.7 6.5 10.3 11.8 6.6 7.7 12.9 2.7 7.6 8.0 8.8 8.0 6.2 9.0 11.7 8.3 9.8 9.3 14.3 8.4 5.7 6.8 8.2 11.4 11.9 11.0 8.6 11.5 15.8 10.9 11.8 9.8 12.7 10.1 8.2 14.8 9.3 9.8 7.6 10.0 13.6 16.2 11.6 9.9 11.5 9.3 9.8 0.5 6.2 14.9 12.4 7.2 23.4 17.1 4.8 3.9 7.2 9.9 17.0 12.6 4.6 18.6 11.9 6.1 7.3 8.8 9.6 8.9 11.1 12.8 4.5 10.3 11.2 7.5 2.1 5.4 3.7 9.4 6.0 10.8 8.4 9.7 11.6 8.6 8.2 11.4 11.8 0.9 10.3 6.5 9.0 6.0 6.6 6.7 10.5 8.3 11.9 6.6 6.4 6.6 6.5 7.0 8.0 0.0 10.3 2.9 5.0 2.7 6.2 9.8 7.6 5.3 4.5 10.4 3.9 17.5 10.0 11.3 38.3 4.9 6.3 0.0 5.9 13.9 6.5 5.4 9.3 13.9 7.7 4.8 2.4 6.7 2.7 11.5 6.6 3.7 5.0 6.4 9.8 8.3 7.4 7.6 3.9 16.1 6.5 0.0 3.1 26.1 12.0 3.9 11.8 5.0 9.6 2.4 PARS2 DKFZp727A071 ENSG00000162396 "Prolyl-tRNA synthetase 2, mitochondrial" Q7L3T8 1 54756898-54764514 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028308, HPA028314, HPA028518" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" No No "Nucleoli fibrillar center, Mitochondria" "HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653" "unprognostic (1.95e-1)" "unprognostic (1.10e-1)" "prognostic favorable (1.26e-5)" "unprognostic (1.93e-2)" "unprognostic (1.19e-2)" "unprognostic (1.79e-3)" "prognostic unfavorable (2.34e-4)" "unprognostic (6.48e-2)" "unprognostic (2.72e-1)" "unprognostic (1.14e-1)" "unprognostic (9.42e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.24e-6)" "unprognostic (2.72e-2)" "unprognostic (9.77e-2)" "unprognostic (1.73e-2)" "unprognostic (9.64e-2)" 6.8 8.4 4.7 4.0 8.2 0.5 6.2 5.2 7.9 6.5 9.0 9.5 8.3 6.0 7.9 7.5 7.0 10.4 4.1 6.6 6.5 4.4 9.6 11.3 4.1 5.8 4.5 5.3 11.5 13.6 7.0 6.6 5.6 4.9 7.1 8.3 5.0 7.2 6.9 8.7 6.7 5.1 4.9 4.3 4.9 6.2 11.5 9.4 8.7 6.7 5.9 5.2 6.0 5.2 7.3 8.9 5.3 11.6 8.1 10.5 6.0 4.7 7.8 5.1 6.7 6.3 5.4 11.5 4.0 5.0 7.2 5.2 9.0 3.1 8.3 6.4 3.6 10.5 7.6 9.2 6.4 5.4 5.3 8.3 8.0 4.8 6.6 9.8 4.6 2.8 5.8 9.8 9.3 8.4 6.2 5.3 9.2 14.0 1.1 5.4 5.0 6.4 6.1 11.8 9.0 10.1 5.0 10.1 9.6 6.1 3.4 5.3 5.4 5.8 7.7 10.5 10.3 4.4 5.9 2.8 5.4 5.6 7.6 5.0 8.2 6.9 3.3 4.0 5.5 3.1 1.5 6.6 5.3 6.4 9.7 7.6 6.1 7.0 6.8 8.9 7.3 10.5 7.0 0.6 8.1 11.6 7.1 9.3 6.0 4.7 8.2 5.2 7.9 6.5 4.4 4.5 5.3 4.9 9.4 0.0 0.6 0.5 0.9 0.6 2.1 1.0 2.5 0.0 1.2 0.0 0.0 5.8 8.3 3.9 6.5 0.0 1.7 0.0 2.4 4.0 0.6 1.1 0.0 1.9 2.6 4.8 0.0 0.0 1.2 5.3 3.4 0.7 0.0 1.0 2.5 2.8 2.1 0.0 2.8 4.5 1.3 0.0 0.4 8.1 10.4 0.9 2.7 0.0 4.3 0.6 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1" "Group enriched" "Detected in some" 19 "Basal glandular cells: 7.6;Ciliated cells: 29.4;Club cells: 14.8;Glandular cells: 15.1;Urothelial cells: 10.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "HaCaT: 8.1;HBEC3-KT: 8.1;HDLM-2: 30.7;PC-3: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016239, HPA038462" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB016239: AB_2159984, HPA038462: AB_10672594" "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.0 0.1 3.7 0.4 0.0 0.0 0.0 0.2 0.1 58.6 0.2 0.0 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.0 0.1 0.1 34.6 1.4 0.0 0.1 2.7 0.0 0.1 86.1 0.0 0.1 0.3 0.1 0.4 0.1 0.1 0.2 0.2 0.0 11.8 0.5 27.1 33.2 0.4 3.4 0.1 0.0 0.0 0.0 0.0 2.7 0.1 3.5 1.0 0.0 1.7 1.4 2.4 1.3 0.0 0.1 0.0 0.0 0.7 1.1 0.7 0.4 0.0 0.3 8.1 1.2 8.1 0.0 30.7 5.4 0.5 0.5 0.0 0.0 0.0 2.7 0.5 3.8 0.0 1.2 0.0 0.0 3.5 2.0 0.8 0.1 4.6 0.5 0.0 0.1 1.2 13.2 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.8 4.1 0.9 0.7 3.5 0.0 0.0 0.0 0.5 1.3 0.6 0.0 0.0 3.1 0.4 0.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.8 0.0 0.3 0.0 29.4 14.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.6 15.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.3 0.1 0.0 0.2 10.8 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.9" HPA076190 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA076190: AB_2686785" "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 1.5 0.0 0.7 4.0 0.0 0.0 0.1 0.0 8.4 0.0 0.5 0.0 0.0 0.1 5.5 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.6 0.0 0.0 0.1 0.8 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 PCF11 KIAA0824 ENSG00000165494 "PCF11 cleavage and polyadenylation factor subunit" O94913 11 83156988-83187451 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040779 Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA040779: AB_2677133" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (3.99e-2)" "unprognostic (1.18e-1)" "unprognostic (3.24e-3)" "prognostic favorable (1.34e-4)" "unprognostic (3.74e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-3)" "unprognostic (9.53e-2)" "unprognostic (6.07e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (3.91e-3)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "prognostic favorable (2.03e-5)" 17.6 15.2 21.8 33.5 23.3 32.1 21.1 29.7 21.3 22.1 19.7 13.6 30.8 14.0 25.6 36.8 21.9 23.4 20.8 14.0 21.7 10.0 15.7 14.5 24.0 25.8 26.6 15.4 28.9 16.1 22.4 32.5 18.9 19.2 25.6 17.9 13.8 22.5 28.5 27.0 32.5 21.2 21.4 20.6 27.2 17.7 20.1 27.4 29.4 23.4 22.5 25.1 24.8 29.3 11.4 6.8 17.5 7.2 13.0 10.5 5.3 11.2 8.1 13.1 11.2 15.8 15.5 10.6 10.8 8.0 10.5 8.0 13.7 11.3 25.4 8.2 7.8 9.9 11.4 19.1 7.4 10.1 18.0 6.5 14.8 10.5 9.6 8.9 17.4 16.6 10.9 14.5 7.9 11.6 14.1 10.5 17.1 17.2 12.4 9.7 12.0 16.3 19.4 13.7 19.3 9.1 15.6 16.6 15.2 9.1 16.8 11.0 12.2 13.2 10.6 10.6 12.7 10.5 12.1 10.8 14.9 7.7 11.0 7.1 11.2 18.7 54.0 6.5 11.6 11.5 12.0 7.2 14.2 10.5 6.9 9.1 11.4 7.4 7.6 6.7 10.4 8.6 8.5 17.5 13.0 5.1 6.8 5.1 5.3 21.8 23.3 29.7 21.3 21.7 10.0 26.6 15.4 19.2 27.4 38.7 59.9 50.4 59.3 47.7 46.6 38.1 30.6 25.4 48.9 43.6 31.4 24.8 21.6 18.2 150.1 49.7 50.2 23.3 15.9 22.0 35.6 61.5 34.8 18.3 32.9 52.4 30.6 53.4 42.5 25.5 55.8 46.3 27.0 28.9 46.6 43.9 16.5 42.1 42.5 12.6 55.5 38.8 61.3 43.2 16.6 54.7 33.0 57.3 41.7 58.5 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Rod photoreceptor cells: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA057849: AB_2683544" "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 18.5 22.6 24.2 28.9 24.9 9.7 32.4 49.7 27.3 20.1 14.9 21.1 19.2 14.9 26.0 33.5 15.2 17.2 21.2 26.2 19.8 20.2 22.9 20.2 20.0 25.6 18.5 22.8 38.9 18.1 20.4 21.8 26.3 18.0 19.9 13.6 57.8 20.5 16.9 25.7 42.1 15.7 17.3 19.6 22.1 13.7 17.0 18.2 31.2 19.5 10.5 18.5 17.7 18.1 9.5 7.5 8.3 6.6 14.1 18.1 7.9 10.9 4.0 15.9 12.4 15.4 19.1 15.2 6.8 7.5 9.9 6.1 9.4 17.6 16.4 12.1 8.1 7.8 13.6 8.7 11.0 13.4 3.5 11.9 7.9 17.9 15.7 13.0 8.2 12.1 27.0 15.3 5.2 9.0 17.7 14.3 16.7 14.5 14.8 8.0 7.1 18.8 27.1 11.7 15.2 16.9 15.7 6.3 19.5 15.0 12.7 25.3 29.9 13.0 15.0 17.5 26.0 16.0 16.5 10.4 14.9 5.3 9.5 5.4 18.0 14.6 15.8 9.8 8.7 8.6 7.6 6.6 7.6 8.4 4.5 10.0 8.9 12.5 9.5 7.5 9.5 17.7 12.7 8.3 14.1 4.1 4.7 18.1 7.9 24.2 24.9 49.7 27.3 19.8 20.2 18.5 22.8 18.0 18.2 20.8 21.1 17.1 14.0 18.1 110.9 54.5 20.4 30.8 22.7 27.9 88.4 26.4 19.9 6.5 7.3 34.6 6.7 46.7 7.9 6.2 23.4 15.8 12.7 26.8 12.1 35.0 21.9 52.8 33.3 8.2 39.7 12.8 45.5 5.4 18.1 55.9 9.2 16.7 29.0 18.4 170.0 25.8 19.8 42.9 28.3 18.6 18.3 17.5 14.0 7.8 PCP4L1 IQM1 ENSG00000248485 "Purkinje cell protein 4 like 1" A6NKN8 1 161258727-161285450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;urinary bladder: 33.2" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7" "Group enriched" "Detected in many" 6 "cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8" "Group enriched" "Detected in all" 5 "basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8" "Cell type enhanced" "Detected in single" "T-reg: 3.1" "Lineage enhanced" "Detected in single" "T-cells: 3.1" "Group enriched" "Detected in some" 6 "RT4: 16.1;T-47d: 10.5" "Low region specificity" "Detected in all" HPA052833 Enhanced Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA052833: AB_2681968" "unprognostic (1.81e-2)" "unprognostic (9.39e-2)" "unprognostic (5.25e-2)" "unprognostic (2.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.87e-2)" "unprognostic (2.51e-1)" "prognostic favorable (8.10e-5)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (4.93e-2)" "unprognostic (7.37e-2)" "unprognostic (3.63e-5)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.15e-2)" 3.2 1.0 5.7 1.3 67.7 0.6 2.2 4.4 28.9 4.3 4.3 1.4 1.5 2.2 2.2 3.3 16.5 2.1 3.9 1.3 3.9 6.3 1.0 4.3 5.0 0.7 7.8 4.6 2.6 0.5 0.6 21.9 0.9 30.8 5.5 3.2 5.9 1.2 17.8 1.0 2.8 3.3 6.8 7.5 0.8 1.2 2.3 5.3 0.0 1.0 0.0 3.0 33.2 4.1 0.0 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 16.1 2.2 0.0 0.0 0.3 0.0 0.2 10.5 0.4 0.2 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.7 67.7 4.4 17.9 3.9 6.3 7.8 4.6 30.8 5.3 3.0 5.4 0.0 23.9 0.0 34.5 0.2 0.0 0.0 7.9 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.2 1.8 1.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 1.8 0.0 4.1 19.4 9.5 0.2 0.2 0.3 1.5 0.0 0.0 42.7 PCYOX1L MGC3265 ENSG00000145882 "Prenylcysteine oxidase 1 like" Q8NBM8 5 149358007-149369653 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 11.1;Rod photoreceptor cells: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037463, HPA038402" Approved Approved Nucleoplasm,Mitochondria "Secreted - unknown location" NA NA 930000 "Nucleoplasm, Mitochondria" "HPA037463: AB_10673632, HPA038402: AB_2675997" "unprognostic (1.34e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (7.83e-2)" "unprognostic (5.73e-2)" "unprognostic (4.18e-3)" "unprognostic (7.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.25e-1)" "unprognostic (3.05e-3)" "unprognostic (8.77e-2)" "unprognostic (4.90e-2)" "unprognostic (2.86e-1)" "unprognostic (2.49e-1)" "unprognostic (2.26e-3)" "unprognostic (3.28e-1)" 4.8 6.6 4.5 7.2 13.5 6.9 4.0 15.9 19.0 6.5 4.4 8.2 2.7 2.3 6.2 2.7 4.6 7.9 5.8 5.2 4.6 8.9 3.7 1.2 4.2 9.6 5.5 9.9 7.9 6.7 27.0 6.4 6.2 13.7 6.4 2.1 9.4 3.4 6.6 1.6 6.6 5.6 6.0 4.6 6.3 5.8 11.5 2.4 5.8 3.3 3.1 7.4 5.0 4.7 1.8 13.5 3.9 9.6 4.5 7.2 4.5 2.1 1.5 2.9 6.3 2.4 1.5 2.1 5.1 1.0 2.5 5.3 0.4 3.5 9.7 15.4 1.6 14.7 4.3 3.2 7.2 0.3 4.7 4.7 4.5 0.0 0.3 7.0 2.9 4.2 6.4 1.2 5.0 4.4 3.4 7.9 8.4 2.6 19.2 0.2 3.4 2.7 4.2 2.7 3.2 9.2 5.2 2.3 25.7 1.0 0.6 5.9 7.7 10.0 3.6 7.9 1.4 9.5 5.5 4.6 2.9 3.1 7.2 2.0 11.3 15.2 5.5 6.1 17.8 7.4 3.0 7.1 3.9 3.0 9.6 4.0 1.8 5.7 2.3 13.5 1.2 6.8 4.7 1.2 4.5 9.1 1.3 7.2 4.5 4.5 13.5 15.9 19.0 4.6 8.9 5.5 9.9 13.7 2.4 8.9 1.7 0.0 1.1 0.9 4.5 4.5 5.1 1.4 2.3 1.8 0.0 4.0 0.0 2.2 2.8 3.8 0.9 0.0 2.1 6.2 2.8 0.7 2.3 0.0 6.4 11.1 0.0 2.5 4.7 1.1 3.1 4.8 1.7 3.6 1.7 6.8 1.7 1.1 2.5 0.3 12.8 0.0 1.2 0.9 3.3 1.4 1.0 2.1 2.2 0.6 PDF ENSG00000258429 "Peptide deformylase, mitochondrial" Q9HBH1 16 69328621-69330595 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.2" "Cell type enhanced" "Detected in single" 21 "Alveolar cells type 1: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063409 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No Mitochondria Nucleoplasm "HPA063409: AB_2685007" "unprognostic (4.28e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (2.98e-3)" "prognostic unfavorable (7.35e-4)" "unprognostic (5.84e-2)" "unprognostic (4.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-1)" "prognostic favorable (6.11e-4)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (5.98e-2)" "unprognostic (1.22e-2)" 6.6 7.9 4.8 7.8 4.5 5.3 4.8 3.1 6.9 3.6 7.6 3.8 3.3 7.1 5.3 5.6 8.4 4.4 6.5 3.8 4.6 3.3 14.9 30.2 3.7 7.0 3.0 5.2 5.0 14.2 8.2 3.9 4.9 4.4 5.3 4.1 4.3 12.8 4.6 10.4 6.0 5.2 3.4 2.3 5.0 8.3 3.7 2.0 10.2 7.3 9.2 6.2 3.7 4.0 10.3 3.2 2.5 2.8 1.7 6.9 1.5 9.0 6.1 1.2 2.9 1.8 1.4 10.7 7.6 2.0 5.4 4.7 15.0 6.4 16.7 10.1 2.6 2.5 13.0 3.7 4.0 2.2 4.0 31.0 8.5 5.8 21.4 3.7 11.8 6.8 2.8 7.1 4.8 2.3 0.9 3.1 8.6 20.3 1.9 2.9 11.6 9.2 12.4 7.8 3.3 11.2 21.7 1.9 15.5 4.3 5.7 10.4 8.3 13.1 2.3 6.4 0.5 12.9 3.8 4.7 4.7 8.8 5.4 8.7 15.8 10.5 19.7 3.1 8.8 6.0 0.0 2.8 2.5 1.2 1.6 3.1 4.3 3.9 3.9 3.0 10.3 6.9 2.5 0.0 1.7 1.5 3.2 3.0 1.5 4.8 4.5 3.1 6.9 4.6 3.3 3.0 5.2 4.4 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 beta subunit" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 245.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria No No 6500000 Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favorable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 21.8 34.3 22.5 19.5 28.4 8.6 17.1 15.1 26.2 18.0 21.6 18.4 19.2 16.2 17.2 18.2 22.8 15.0 16.5 64.2 24.1 20.8 38.7 41.8 13.9 18.2 23.7 23.3 11.0 17.2 26.0 20.0 21.6 26.4 19.5 23.9 16.1 17.6 22.1 92.2 14.3 17.3 24.5 22.8 23.2 21.4 21.8 17.5 20.9 16.1 33.8 20.6 17.9 14.4 37.0 50.1 33.6 39.8 43.4 38.6 38.3 19.0 26.7 27.7 20.8 28.2 34.7 33.3 24.1 30.2 35.7 36.8 48.2 18.5 40.8 13.6 30.5 33.1 11.1 33.7 22.1 27.3 23.6 24.8 36.4 50.5 36.3 28.6 29.5 20.5 30.3 20.5 28.7 16.9 41.9 30.7 34.1 18.7 18.4 38.7 18.2 27.9 31.0 38.2 20.2 30.4 13.3 21.6 39.3 56.3 26.2 19.3 21.2 22.3 32.2 24.0 41.8 47.6 31.7 22.5 19.1 25.5 20.0 27.2 25.8 36.6 28.7 29.3 35.1 18.0 16.4 35.4 33.6 31.5 39.8 33.2 37.0 31.2 30.0 50.1 33.3 35.1 31.4 7.0 43.4 35.9 33.7 38.6 38.3 22.5 28.4 15.1 26.2 24.1 20.8 23.7 23.3 26.4 17.5 56.6 28.0 47.4 32.8 24.7 30.0 245.7 48.4 69.6 48.9 33.2 23.6 144.4 195.6 84.1 43.2 62.9 34.8 23.3 63.6 85.4 31.9 17.8 38.1 61.1 74.4 54.0 55.7 43.6 38.0 10.4 55.8 41.0 54.0 89.2 44.3 51.8 51.0 41.3 48.1 105.9 44.7 64.7 61.8 85.0 80.3 26.1 131.5 46.0 47.8 28.8 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favorable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.2 11.1 10.0 11.8 8.9 1.2 7.0 10.4 10.5 10.2 0.8 7.0 8.1 11.7 19.5 7.1 3.1 7.4 2.8 10.3 16.3 10.3 7.2 9.1 6.8 6.3 0.0 7.8 18.7 10.8 6.8 0.5 18.5 9.1 10.4 2.9 8.1 5.9 8.2 6.0 0.0 2.4 19.5 9.0 9.1 24.9 10.9 5.7 5.5 7.4 11.2 9.9 3.1 4.7 14.2 18.3 7.2 4.7 12.3 10.1 8.4 5.1 16.0 15.1 4.4 18.0 2.6 7.9 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 8.9 9.3 13.6 13.9 13.5 20.8 5.0 10.2 1.4 11.4 19.2 5.9 15.1 49.7 8.0 7.3 8.3 46.6 0.0 7.9 3.4 19.5 7.6 1.1 39.8 16.7 41.3 13.3 13.5 13.7 15.0 22.5 7.9 23.6 15.4 45.3 33.6 7.9 43.6 49.5 118.5 9.2 19.4 12.1 3.3 4.4 16.4 6.6 15.8 37.1 8.4 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465221-24539837 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA046583: AB_2679707, HPA072492: AB_2686526" "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 9.6 5.6 5.7 9.8 17.3 16.3 12.8 3.3 23.6 8.0 14.7 5.5 5.6 13.6 7.3 15.7 9.5 13.2 7.0 16.9 12.5 6.8 13.7 11.1 11.2 13.4 6.2 13.7 11.0 7.3 12.8 14.1 7.7 14.9 8.3 10.1 9.9 19.3 5.2 3.9 14.2 15.6 8.6 6.1 17.9 12.7 23.1 4.8 12.5 6.2 4.1 14.9 10.3 9.2 4.5 7.2 36.4 10.9 7.1 11.0 6.7 9.0 4.6 3.9 6.6 0.1 0.0 4.1 2.7 2.4 3.7 6.5 0.4 11.1 9.2 1.9 0.7 10.5 2.1 11.3 6.9 10.0 7.8 5.4 4.9 5.3 2.6 1.3 4.2 4.8 0.7 3.1 0.9 0.9 0.4 5.5 9.6 0.9 14.0 0.5 17.0 7.8 5.4 7.0 9.7 5.4 4.0 7.0 13.5 3.2 17.7 2.5 3.2 14.7 6.0 4.6 6.2 8.3 1.6 0.2 2.6 3.8 4.8 3.2 9.0 6.9 11.0 7.1 6.4 5.4 9.4 8.9 21.3 7.6 10.9 11.0 4.5 6.2 6.2 7.2 4.1 4.9 5.7 36.4 7.1 10.4 2.3 5.1 6.7 5.7 17.3 3.3 23.6 12.5 6.8 6.2 13.7 14.9 4.8 3.0 1.3 2.9 8.6 4.0 3.4 6.3 0.0 1.4 2.3 1.8 0.0 4.0 3.3 3.6 53.4 2.8 4.5 0.0 4.5 26.4 3.2 5.2 5.7 4.2 13.2 7.9 4.1 4.3 18.9 22.4 3.4 9.6 15.1 8.2 2.4 3.2 2.8 0.0 5.3 11.3 3.9 0.0 9.2 6.4 6.3 3.9 14.9 14.9 3.3 7.1 PFKL ENSG00000141959 "Phosphofructokinase, liver type" P17858 21 44300051-44327376 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 285.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030047 Approved Uncertain Nucleoli,Mitochondria NA NA 1800000 "Nucleoli, Mitochondria" "HPA030047: AB_10602815" "unprognostic (6.21e-3)" "unprognostic (2.93e-1)" "unprognostic (4.46e-2)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "unprognostic (6.98e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (4.41e-4)" "unprognostic (5.69e-2)" "unprognostic (5.40e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-1)" "unprognostic (2.49e-1)" "unprognostic (8.06e-2)" "unprognostic (3.01e-2)" 32.0 16.7 28.0 26.0 29.5 26.4 23.1 21.3 46.0 28.3 38.7 40.9 30.1 65.5 21.3 33.5 33.5 22.8 37.5 18.4 28.8 23.4 40.3 31.3 21.0 25.2 32.4 33.0 19.5 27.1 12.3 17.1 31.9 29.1 20.2 17.2 36.3 28.8 28.5 8.3 31.1 59.3 20.5 36.1 28.1 42.7 24.0 29.1 16.4 20.4 15.4 26.0 27.2 23.9 20.3 26.9 5.2 38.0 7.7 25.2 22.8 32.6 14.3 10.2 29.4 16.1 12.0 45.0 24.6 16.0 14.3 14.1 19.2 7.2 19.4 29.3 16.4 13.7 17.8 8.1 22.3 3.3 16.3 18.4 39.2 12.5 31.3 12.4 29.5 25.0 15.7 13.6 14.6 7.2 21.7 21.0 14.2 24.1 22.2 9.7 41.5 12.7 23.0 16.0 29.3 16.1 31.5 9.7 52.6 6.5 36.2 18.0 13.5 35.8 30.4 15.7 4.3 24.1 26.1 30.4 21.7 14.0 14.2 9.4 43.2 11.7 7.9 36.1 23.5 17.3 5.1 22.2 5.2 12.9 37.9 10.8 14.4 17.0 11.8 26.9 20.3 10.2 7.9 4.5 7.7 38.0 17.0 25.2 22.8 28.0 29.5 21.3 46.0 28.8 23.4 32.4 33.0 29.1 29.1 20.8 27.5 37.6 33.4 31.7 71.1 12.6 17.8 21.4 28.4 87.2 62.8 106.3 84.6 68.0 1.8 43.0 285.1 0.0 45.0 147.2 44.6 37.8 41.5 60.1 95.6 28.6 44.5 41.1 58.5 5.2 36.2 60.1 65.8 177.7 107.9 59.6 51.1 112.2 52.3 108.3 44.6 25.8 42.9 1.4 8.7 31.6 134.4 31.9 139.6 44.5 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219704-22232341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.4;skin 1: 37.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 16.8;Smooth muscle cells: 7.8;Suprabasal keratinocytes: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.9;SH-SY5Y: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4" "HPA068030, HPA069318" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068030: AB_2685944, HPA069318: AB_2686117" "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 5.4 18.6 25.0 2.3 71.8 1.3 3.5 58.9 89.4 3.2 2.1 3.0 0.0 2.2 6.0 3.4 7.1 9.8 6.2 2.9 31.2 12.3 2.2 1.4 1.8 1.4 7.3 40.3 2.3 2.2 1.3 5.5 3.0 21.1 3.6 1.7 0.0 1.4 5.9 1.7 37.9 2.4 7.2 3.5 3.6 1.6 5.8 10.4 0.0 2.0 0.0 1.4 7.8 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 0.5 0.0 0.3 0.8 1.1 0.3 1.3 0.4 0.4 0.1 2.0 0.0 2.2 0.6 1.4 3.8 0.0 0.7 0.1 0.0 0.2 0.0 4.0 1.5 1.7 0.0 0.0 0.9 0.0 0.8 0.0 3.6 2.5 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.9 0.7 0.3 0.0 0.2 12.9 0.0 0.0 4.3 5.0 2.9 0.0 3.4 0.3 0.0 0.3 1.1 0.0 2.1 1.6 0.7 1.0 0.2 0.0 2.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 71.8 58.9 82.9 31.2 12.3 7.3 40.3 21.1 10.4 0.0 0.0 0.0 5.1 16.8 0.7 1.2 0.0 0.0 2.3 3.5 0.0 0.1 0.0 0.2 0.6 1.3 0.5 0.0 1.8 0.2 2.3 0.5 0.0 0.9 0.2 0.0 0.0 1.3 0.0 1.3 2.8 0.0 1.7 0.0 0.3 0.4 0.4 0.0 3.5 2.2 0.9 0.0 7.8 0.2 0.0 9.5 1.8 0.0 0.0 3.9 PIK3CA PI3K ENSG00000121879 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" P42336 3 179148114-179240093 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Phagocytosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009985, CAB017804" Approved Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017804: , HPA009985: AB_1079610" "unprognostic (1.81e-1)" "unprognostic (2.77e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-3)" "unprognostic (6.49e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-3)" "unprognostic (5.21e-2)" "unprognostic (4.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.48e-1)" "unprognostic (9.74e-2)" "unprognostic (3.82e-2)" 20.1 12.3 13.7 11.5 13.4 25.7 22.4 17.1 24.5 12.9 14.0 5.2 5.7 6.5 15.3 7.9 11.6 11.1 13.2 14.2 18.4 9.7 11.7 10.8 13.2 13.8 9.8 15.7 15.4 9.2 24.7 11.6 16.5 16.3 10.7 8.9 7.2 10.9 10.9 15.2 12.0 10.5 12.8 14.4 16.2 10.6 9.3 9.8 29.6 11.0 7.3 13.9 15.1 15.7 6.2 2.6 7.8 3.8 2.4 5.0 1.1 14.6 5.0 8.0 7.4 19.0 22.2 5.9 9.4 12.7 9.3 14.7 4.3 10.9 13.4 16.1 11.2 13.2 6.0 6.6 8.1 13.5 22.4 5.8 18.4 5.5 3.8 9.1 10.3 10.5 14.0 8.6 10.2 11.7 10.4 13.3 9.7 9.1 15.0 13.3 5.8 7.9 9.3 6.4 7.3 6.8 12.0 8.1 16.1 7.3 9.0 4.5 7.7 10.2 9.1 12.2 7.3 15.2 8.9 14.0 8.7 5.7 13.7 9.3 7.3 10.3 24.1 7.9 7.8 5.1 2.1 3.8 1.6 5.0 2.9 3.9 5.8 4.2 2.8 2.2 6.2 4.6 3.8 7.8 2.4 3.0 2.6 4.1 1.1 13.7 13.4 17.1 24.5 18.4 9.7 9.8 15.7 16.3 9.8 29.8 23.2 13.7 15.2 13.1 26.3 15.4 7.6 18.7 17.0 7.0 29.5 8.1 1.7 9.8 1.7 21.4 4.9 0.0 11.9 5.0 18.3 27.3 30.1 17.4 9.5 36.5 2.4 29.4 21.2 1.6 30.2 16.4 13.5 16.2 9.6 15.6 13.1 12.7 37.1 11.2 26.2 25.8 22.1 9.6 7.6 13.0 7.3 14.0 9.2 27.6 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;testis: 30.9" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NB-4: 44.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036587, HPA036588, HPA057508" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 1.9 0.6 1.9 1.9 3.1 17.8 2.7 4.1 1.7 2.2 3.8 1.7 1.7 4.5 2.5 1.7 1.7 2.0 3.6 1.7 1.9 1.7 1.7 1.7 1.7 2.5 1.7 1.7 2.2 8.2 0.2 1.7 2.3 1.7 1.7 5.0 1.7 7.6 2.0 1.7 0.8 4.3 1.7 2.5 2.3 3.6 30.9 1.7 1.7 1.7 1.7 1.8 1.7 1.7 0.0 0.8 0.5 2.4 0.3 1.3 1.0 0.1 0.0 0.2 0.0 3.3 2.2 0.2 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 1.3 0.1 0.0 0.4 0.0 0.1 1.2 0.1 0.1 0.3 0.0 1.3 3.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.2 0.1 44.9 0.0 4.4 0.3 0.1 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.4 0.2 0.1 0.0 9.9 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 2.4 0.5 1.0 1.0 0.0 0.0 0.1 0.6 0.8 0.0 1.3 0.4 0.0 0.3 1.0 0.0 0.4 1.0 1.9 3.1 4.1 1.7 1.9 1.7 1.7 1.7 1.7 1.7 0.0 0.3 0.0 0.2 1.1 0.6 1.4 10.2 2.7 2.3 0.0 0.0 3.3 1.7 3.6 2.8 0.5 2.9 0.0 1.8 0.3 0.9 0.4 0.0 0.0 1.5 0.0 0.0 1.3 3.1 1.0 0.3 1.5 0.0 1.0 7.8 0.3 2.7 6.5 1.1 0.6 2.8 0.0 0.8 0.7 1.5 0.1 0.8 0.0 4.7 0.0 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072482-153075018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 21.6;Distal tubular cells: 10.0;Horizontal cells: 22.3;Muller glia cells: 18.8;Proximal tubular cells: 20.3;Rod photoreceptor cells: 7.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "HHSteC: 8.0;HMC-1: 6.9;SK-MEL-30: 6.6;U-2 OS: 15.2;U-698: 8.3" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045007: AB_2679181, HPA052115: AB_2681734" "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favorable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.3 2.0 7.2 0.1 6.2 0.2 0.3 7.0 16.3 3.7 0.2 0.5 1.8 7.0 0.1 1.5 0.9 2.1 6.5 11.0 6.2 7.9 0.1 0.2 5.5 3.1 0.7 0.4 3.9 0.1 0.1 0.1 0.9 0.7 0.0 0.3 0.3 0.6 1.6 0.5 0.5 0.8 1.8 0.2 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 5.3 0.1 1.6 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.9 0.4 0.9 0.0 2.9 0.0 0.0 0.0 0.6 0.0 0.3 0.2 8.0 3.2 6.9 1.2 0.0 0.1 0.0 0.2 0.2 5.7 1.3 0.0 0.1 0.4 1.1 0.0 3.4 5.8 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.9 0.4 0.0 6.6 0.3 0.0 4.1 0.0 0.0 15.2 0.0 0.0 5.8 4.3 8.3 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 2.5 3.2 22.3 0.0 0.6 0.0 0.4 2.6 0.0 0.0 0.0 0.0 18.8 0.4 0.0 2.8 20.3 7.1 0.0 0.2 1.0 2.2 0.0 0.0 0.0 0.0 0.1 PNPT1 "DFNB70, old-35, OLD35, PNPase" ENSG00000138035 "Polyribonucleotide nucleotidyltransferase 1" Q8TCS8 2 55634265-55693910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transport" "Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase" "Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033424, HPA034602, HPA034603" Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130" "unprognostic (9.09e-2)" "unprognostic (7.40e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.57e-4)" "unprognostic (3.40e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.88e-1)" "unprognostic (5.93e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (2.19e-2)" "unprognostic (2.11e-2)" "unprognostic (6.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 11.1 11.7 13.3 6.5 21.7 11.7 10.8 13.3 18.8 5.7 8.2 12.8 5.4 5.7 8.3 8.8 9.5 7.9 5.8 11.0 12.4 10.9 9.8 11.4 9.1 7.1 24.1 7.4 6.9 9.1 7.4 14.3 5.1 15.2 7.7 10.1 4.2 9.0 6.3 23.5 10.1 7.0 7.9 17.6 10.4 7.6 13.5 22.5 9.6 10.0 7.8 5.9 5.3 7.4 9.8 7.4 6.1 6.5 3.8 8.6 4.7 6.8 3.7 5.1 2.3 3.6 6.4 6.8 10.2 6.2 16.2 10.9 10.7 3.2 14.3 4.3 4.7 5.2 5.5 6.5 7.9 7.5 5.1 14.4 8.3 4.7 5.4 9.7 18.6 5.6 7.1 5.5 6.7 5.8 3.9 4.9 6.0 8.7 3.2 6.4 3.9 11.3 13.1 12.3 7.2 6.2 11.3 8.5 12.6 6.8 4.3 12.4 7.4 3.6 11.3 12.4 4.7 3.0 8.3 5.1 3.8 3.2 3.4 10.4 14.5 1.1 3.1 7.4 16.3 6.5 4.2 6.5 6.1 8.1 5.7 4.8 5.4 3.7 8.6 2.8 9.8 6.9 7.9 6.1 3.8 5.1 7.4 2.4 4.7 13.3 21.7 13.3 18.8 12.4 10.9 24.1 7.4 15.2 22.5 44.7 72.6 7.5 15.0 21.5 40.4 23.8 12.7 46.8 69.4 19.2 55.0 17.7 8.3 14.2 15.0 19.3 7.4 0.0 13.8 18.9 14.2 10.3 54.6 14.7 13.8 28.6 9.8 12.9 11.1 1.9 16.1 15.2 15.1 9.0 12.3 27.5 11.7 14.1 17.3 16.7 61.4 25.8 18.4 39.0 20.0 17.7 10.3 17.3 16.4 14.2 POLG2 "HP55, MTPOLB" ENSG00000256525 "DNA polymerase gamma 2, accessory subunit" Q9UHN1 17 64477785-64497036 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017030, HPA023202" Approved Approved "Nuclear bodies,Mitochondria" NA NA "Nuclear bodies" Mitochondria "CAB017030: , HPA023202: AB_1855523" "unprognostic (1.76e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.02e-2)" "unprognostic (6.01e-2)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.38e-2)" "unprognostic (8.46e-2)" "unprognostic (3.14e-1)" "unprognostic (5.17e-3)" "prognostic unfavorable (6.59e-4)" "prognostic unfavorable (1.17e-5)" "unprognostic (5.17e-2)" "unprognostic (1.58e-1)" "unprognostic (2.88e-2)" "unprognostic (4.82e-2)" 6.7 9.3 5.4 17.5 10.0 8.1 8.2 10.9 8.7 7.7 7.8 7.0 11.1 7.9 10.2 6.8 6.4 7.5 7.9 7.3 5.6 4.4 7.8 7.8 10.4 12.2 10.8 5.2 13.0 9.4 5.0 9.9 6.9 8.7 8.0 5.7 5.8 8.6 11.9 10.7 10.5 8.4 9.3 5.6 11.5 6.9 24.2 7.9 9.8 9.6 5.4 13.3 6.6 11.5 12.2 10.5 6.5 8.2 6.0 12.2 4.4 6.9 8.5 6.1 7.5 5.8 4.7 7.4 4.1 3.9 6.3 5.4 8.8 5.5 12.7 5.0 2.2 6.5 5.7 8.3 3.9 7.9 3.5 9.7 8.6 10.3 8.7 6.5 12.1 9.6 4.7 4.5 5.0 7.5 8.7 4.5 7.7 15.1 4.9 6.1 9.2 12.9 16.1 6.4 7.6 9.5 12.0 20.1 13.4 5.7 2.0 8.6 9.6 3.3 7.4 7.6 9.9 7.3 10.2 5.0 6.8 9.0 5.8 10.7 8.7 5.9 9.6 5.3 11.4 4.7 6.5 5.9 6.5 7.9 3.5 7.5 12.2 8.8 7.6 10.5 12.1 12.2 11.6 1.2 6.0 8.2 4.8 8.4 4.4 5.4 10.0 10.9 8.7 5.6 4.4 10.8 5.2 8.7 7.9 11.9 23.4 11.1 7.7 7.2 4.0 15.7 17.8 5.3 14.8 3.5 0.0 10.9 0.0 4.3 9.2 12.4 11.2 0.0 3.2 12.2 9.9 9.7 12.7 3.8 8.2 6.4 10.5 18.4 7.8 5.0 6.1 6.9 6.8 3.6 13.9 3.0 2.7 16.7 2.8 4.3 8.4 6.5 8.6 52.0 8.2 7.5 3.3 10.2 18.2 4.7 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303774-177306959 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 18.9 25.0 21.9 33.9 20.3 30.3 21.6 12.0 31.1 16.9 44.6 14.8 15.4 43.5 18.3 15.5 35.6 17.4 20.6 16.8 19.3 18.6 46.1 62.3 18.9 43.0 20.2 14.7 20.3 91.6 12.3 17.7 29.4 21.0 19.8 35.0 18.9 40.1 16.4 11.9 26.2 70.6 19.0 14.8 43.5 24.6 12.9 13.5 25.2 29.3 27.2 33.7 18.0 18.9 27.1 77.4 111.7 94.2 30.4 26.4 49.2 32.3 30.4 18.5 49.4 16.6 18.0 61.7 23.1 16.2 33.8 32.7 68.1 37.1 27.5 27.3 21.7 36.8 18.4 33.0 61.8 23.1 117.7 45.7 23.8 31.5 45.3 17.5 37.3 33.4 16.2 22.3 26.6 22.8 14.0 41.8 19.8 26.1 39.9 32.8 84.0 23.9 54.6 37.7 37.8 50.4 7.7 37.4 49.4 22.0 27.1 29.6 37.2 21.6 43.1 40.1 24.1 27.8 46.0 23.0 31.0 27.1 25.4 55.3 22.4 38.2 40.0 26.7 50.4 32.1 31.5 75.7 111.7 26.4 94.2 25.8 27.1 21.9 26.2 77.4 21.1 19.3 21.1 55.2 30.4 90.3 28.3 23.3 49.2 21.9 20.3 12.0 31.1 19.3 18.6 20.2 14.7 21.0 13.5 20.8 22.6 181.8 227.7 309.4 61.7 0.3 145.2 13.4 28.4 99.5 21.6 650.2 257.0 407.3 4.8 123.4 610.0 116.8 488.9 446.5 187.8 329.7 110.3 191.7 318.8 57.2 151.0 114.8 245.1 15.2 105.6 182.1 243.0 153.3 210.5 81.8 553.8 343.7 102.6 293.8 49.9 45.3 167.5 80.1 183.7 367.9 738.9 173.0 351.5 462.0 PSMB4 "HN3, PROS26" ENSG00000159377 "Proteasome subunit beta 4" P28070 1 151399534-151401944 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006700, HPA073499" Approved Supported Nucleoplasm,Mitochondria NA NA 15000000 Nucleoplasm Mitochondria "HPA006700: AB_1079704, HPA073499: " "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.63e-1)" "unprognostic (5.74e-2)" "prognostic unfavorable (7.45e-4)" "unprognostic (2.27e-1)" "unprognostic (1.69e-1)" "unprognostic (4.37e-3)" "unprognostic (3.73e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (2.90e-10)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (3.82e-2)" "unprognostic (5.85e-2)" 45.7 64.5 47.4 40.4 49.5 40.2 56.3 39.6 84.0 44.4 44.3 28.5 58.8 41.2 53.5 65.3 55.7 51.2 37.8 66.6 47.0 50.7 57.3 71.9 43.6 81.1 49.2 61.0 52.4 87.0 40.0 45.4 50.9 48.4 42.6 47.5 37.8 46.7 56.1 68.7 45.7 39.7 66.4 55.1 46.6 43.4 31.8 36.3 51.1 46.8 63.3 62.2 58.6 37.7 68.5 106.5 58.6 81.4 72.5 89.0 78.3 52.1 54.7 46.6 55.8 52.8 50.4 64.1 30.8 67.2 89.9 63.1 73.2 70.5 47.5 93.4 51.5 47.8 52.4 47.3 57.9 51.3 66.2 47.8 32.8 41.0 54.7 57.1 45.7 45.2 55.0 55.4 84.4 34.7 45.8 62.7 51.3 53.0 93.0 63.3 139.7 54.8 53.9 119.2 77.4 71.0 52.6 34.1 83.8 73.4 42.7 51.8 61.5 35.8 78.3 103.0 60.3 70.7 72.5 39.7 39.5 42.1 41.9 67.6 92.7 106.1 91.6 58.3 40.7 83.0 54.6 81.4 49.5 63.9 75.2 75.9 68.5 74.9 72.5 96.4 60.8 65.8 68.0 58.6 72.5 56.9 106.5 89.0 78.3 47.4 49.5 39.6 84.0 47.0 50.7 49.2 61.0 48.4 36.3 142.9 125.8 60.3 65.1 68.1 51.9 108.2 81.5 179.3 134.2 68.0 15.7 176.7 87.9 106.1 12.6 85.2 80.0 46.7 168.6 123.7 82.9 62.0 103.4 133.7 108.0 46.1 63.8 90.9 107.2 13.4 96.7 88.1 91.1 226.4 73.7 84.2 122.6 66.6 99.0 122.6 44.8 64.7 80.2 38.6 45.3 66.4 223.6 74.3 80.9 77.2 PSMG4 "C6orf86, PAC4" ENSG00000180822 "Proteasome assembly chaperone 4" Q5JS54 6 3231403-3303373 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067652, HPA074376, HPA075846" Approved Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA067652: AB_2685880, HPA074376: , HPA075846: " "unprognostic (3.13e-3)" "unprognostic (6.00e-2)" "unprognostic (3.60e-1)" "unprognostic (4.11e-2)" "unprognostic (4.11e-1)" "unprognostic (2.20e-1)" "unprognostic (6.52e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-2)" "unprognostic (6.74e-3)" "unprognostic (7.40e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.59e-1)" "unprognostic (8.18e-2)" "unprognostic (2.54e-1)" "unprognostic (3.48e-2)" 13.9 12.7 12.6 13.0 26.1 14.3 16.0 18.5 14.4 15.8 15.1 11.8 11.3 17.3 16.7 23.1 16.9 13.4 18.7 12.9 11.4 14.0 13.1 18.1 11.0 15.2 10.7 12.2 13.8 30.9 8.9 16.2 9.6 10.7 15.5 8.9 13.6 21.0 18.8 36.6 17.9 16.8 18.1 10.6 11.9 17.4 13.3 9.8 13.5 17.2 16.5 14.6 13.1 11.3 25.6 18.5 12.2 20.1 16.2 24.4 13.2 21.5 10.6 6.4 15.7 5.8 8.6 11.0 9.8 7.3 9.4 15.3 8.9 7.5 7.2 26.7 5.8 7.6 10.1 5.3 6.5 6.1 12.2 22.8 5.8 10.9 23.0 6.9 16.7 6.2 7.3 7.3 6.8 10.2 5.4 11.7 14.5 22.5 5.6 5.0 20.6 9.5 31.0 7.8 11.1 20.9 12.8 3.5 40.1 7.4 8.6 27.4 8.0 4.3 6.2 20.9 6.3 7.9 7.5 11.1 8.0 7.6 8.9 9.4 18.2 25.7 13.3 5.6 12.1 10.8 6.2 20.1 12.2 14.8 18.4 17.0 25.3 24.4 17.8 15.5 25.6 24.4 20.9 4.8 16.2 18.1 18.5 20.5 13.2 12.6 26.1 18.5 14.4 11.4 14.0 10.7 12.2 10.7 9.8 20.8 13.9 20.9 23.8 24.7 28.8 18.6 35.7 16.0 19.4 41.8 7.9 32.9 71.3 34.8 24.9 32.9 22.0 0.0 76.0 30.2 26.7 25.6 21.9 55.5 30.7 23.8 21.9 29.4 18.9 9.7 34.2 21.2 28.7 31.5 27.1 15.1 47.9 24.6 21.5 42.5 26.2 45.3 30.9 29.8 76.7 33.4 10.1 20.6 32.0 22.6 PUS1 ENSG00000177192 "Pseudouridylate synthase 1" Q9Y606 12 131929200-131945896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051636, HPA057593" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051636: AB_2681560, HPA057593: AB_2683479" "unprognostic (2.72e-1)" "unprognostic (9.13e-2)" "unprognostic (1.81e-1)" "unprognostic (2.69e-2)" "unprognostic (8.12e-3)" "unprognostic (8.07e-2)" "unprognostic (4.57e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (2.06e-1)" "unprognostic (5.30e-2)" "prognostic unfavorable (3.49e-8)" "unprognostic (1.80e-3)" "unprognostic (8.06e-2)" "unprognostic (8.59e-2)" "unprognostic (1.56e-2)" 12.7 15.8 18.8 19.5 23.3 26.2 11.2 8.8 16.9 8.7 11.9 9.4 11.0 12.4 13.6 18.7 16.5 12.9 25.1 8.6 15.6 8.3 10.7 22.8 11.0 21.4 11.7 15.8 10.1 19.8 7.2 9.5 8.3 11.7 11.7 10.5 7.6 11.4 15.7 13.5 15.4 13.9 9.7 6.2 17.4 13.6 11.9 16.4 11.6 10.3 11.6 15.8 10.8 12.8 5.9 4.6 1.9 2.0 9.1 4.0 1.3 15.4 20.2 4.8 8.5 4.6 7.9 29.5 11.9 5.0 9.1 5.9 22.3 10.1 18.4 13.8 6.5 7.1 19.6 15.8 11.3 5.9 8.1 31.9 18.5 9.8 19.4 12.5 31.7 17.1 8.0 9.2 10.4 8.9 4.4 8.9 12.9 22.9 5.7 5.2 26.8 20.8 28.5 25.3 12.6 30.8 19.9 6.8 19.1 7.4 21.5 13.4 7.5 10.0 13.7 11.0 4.9 15.0 34.3 7.7 7.3 15.6 15.4 17.2 15.6 11.7 21.9 7.5 25.4 10.0 1.2 2.0 0.4 3.2 1.4 2.2 5.9 2.7 3.3 1.6 5.5 4.0 2.1 1.9 9.1 1.3 4.6 2.4 1.3 18.8 23.3 8.8 16.9 15.6 8.3 11.7 15.8 11.7 16.4 0.0 6.7 10.0 16.1 26.3 5.2 4.5 12.7 4.0 3.4 5.2 21.6 12.0 5.0 9.3 0.6 9.0 4.5 0.0 8.2 14.4 9.6 13.4 16.1 11.3 13.6 0.0 13.8 8.0 7.3 2.0 7.2 8.9 6.8 8.2 17.2 4.6 12.7 7.0 8.9 10.4 9.6 6.5 11.8 16.5 22.1 19.8 7.2 7.5 15.5 13.7 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113242-88175467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.5;tongue: 38.1" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 41.2;Cytotrophoblasts: 78.5;Melanocytes: 124.9;Suprabasal keratinocytes: 86.1;Syncytiotrophoblasts: 45.8" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Region enriched" "Detected in single" 5 "pons and medulla: 3.2" "Group enriched" "Detected in many" 5 "NK-cell: 15.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 5 "dendritic cells: 4.2;NK-cells: 15.3" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.4;hTCEpi: 69.6;hTERT-HME1: 62.0;SK-MEL-30: 37.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071701 Uncertain "Nuclear bodies,Mitochondria" NA NA "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favorable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 1.8 15.6 0.4 1.2 0.4 0.4 4.6 0.3 0.6 10.8 1.6 1.2 2.8 1.0 7.0 8.7 29.9 2.8 8.2 1.7 0.6 0.5 2.6 0.8 5.3 0.4 0.5 0.2 3.0 2.3 0.9 4.6 7.7 3.2 4.0 0.4 35.5 4.9 5.2 0.5 24.9 2.4 2.7 0.7 1.3 0.9 5.3 0.1 1.6 6.6 38.1 21.0 4.2 13.3 0.0 4.2 0.5 1.3 15.3 1.8 0.6 2.3 0.3 0.0 0.1 0.0 0.5 0.1 1.4 5.8 2.3 4.3 1.0 1.0 0.1 1.4 1.5 0.2 15.9 1.2 19.4 3.2 0.2 1.1 11.7 1.5 0.0 0.2 0.1 0.1 0.5 69.6 0.3 62.0 2.9 2.7 0.2 0.0 0.2 0.0 0.0 0.1 3.9 1.8 0.1 0.0 0.1 0.0 0.1 4.5 8.9 0.4 0.2 0.0 0.0 37.4 1.4 3.5 1.0 1.5 0.0 1.0 0.0 0.2 0.3 1.4 0.0 0.3 0.4 0.2 0.0 0.6 0.1 1.6 0.6 0.9 0.0 0.5 1.8 1.5 0.0 0.1 0.9 0.5 15.3 1.3 4.2 0.9 0.6 0.4 0.4 0.3 0.6 0.6 0.5 0.5 0.2 3.2 0.1 0.0 4.1 0.0 12.1 41.2 0.0 0.1 0.0 4.0 7.9 0.0 0.0 78.5 3.3 1.3 0.0 1.5 1.1 0.0 1.0 6.8 6.7 2.1 16.1 0.0 14.7 0.0 0.0 0.0 1.0 0.0 3.1 4.9 124.9 10.8 0.0 0.5 1.8 1.1 1.1 3.2 5.9 0.0 2.8 0.0 3.2 86.1 45.8 1.5 2.1 22.8 RALGAPA1 "DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1" ENSG00000174373 "Ral GTPase activating protein catalytic alpha subunit 1" Q6GYQ0 14 35538352-35809304 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 371.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000851 Approved Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA000851: AB_1078945" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (8.90e-2)" "unprognostic (6.76e-2)" "unprognostic (1.85e-1)" "unprognostic (1.19e-2)" "unprognostic (7.65e-2)" "unprognostic (1.17e-2)" "unprognostic (2.88e-1)" "unprognostic (3.38e-2)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "prognostic favorable (9.76e-5)" "unprognostic (2.75e-1)" "unprognostic (2.46e-1)" "unprognostic (3.09e-2)" "unprognostic (1.46e-1)" 13.9 21.8 19.5 13.1 25.6 8.3 22.5 31.7 28.3 20.2 18.3 23.2 13.6 10.7 21.0 19.2 15.1 15.0 13.0 11.7 21.8 22.2 17.1 13.9 13.4 11.7 21.5 17.9 28.1 15.4 43.6 42.6 10.1 28.1 20.4 20.2 14.2 15.0 15.2 15.9 27.0 13.8 17.5 23.6 11.6 14.1 13.7 21.3 14.9 21.3 12.2 13.0 15.0 19.2 1.6 1.5 0.1 1.1 2.3 3.3 0.5 5.7 6.7 9.1 8.0 13.8 10.7 5.8 4.3 4.8 5.4 5.1 4.2 5.1 5.7 6.4 5.7 7.6 9.5 10.8 8.3 5.5 12.2 4.7 5.2 8.7 20.2 7.2 8.7 8.5 7.7 15.0 4.8 12.1 9.1 7.6 11.5 5.0 14.5 5.0 9.2 6.6 4.1 3.9 14.3 10.8 5.3 6.4 3.4 10.9 9.2 8.5 13.8 9.2 15.4 7.4 9.1 14.7 4.3 6.9 5.5 4.1 6.2 5.3 11.8 10.7 7.3 2.6 5.7 5.9 0.0 0.6 0.1 2.4 1.1 3.3 1.6 2.5 3.1 1.1 1.3 1.8 2.5 0.1 2.3 0.9 1.5 2.7 0.5 19.5 25.6 31.7 26.0 21.8 22.2 21.5 17.9 28.1 21.3 14.9 25.7 18.7 22.2 33.9 87.3 18.1 17.8 18.7 31.8 22.7 371.1 9.0 0.0 11.1 12.0 26.1 25.2 0.0 13.7 4.6 28.2 31.9 54.1 13.9 8.1 49.3 29.9 16.0 7.8 4.7 31.7 16.0 18.6 13.6 22.7 37.9 12.8 28.1 27.3 8.2 125.6 38.8 34.0 37.1 36.6 40.4 12.7 20.0 26.9 23.1 RASSF8 "C12orf2, HoJ-1" ENSG00000123094 "Ras association domain family member 8" Q8NHQ8 12 25959029-26079892 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 534.5;Horizontal cells: 406.8;Late spermatids: 509.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038163, HPA038164" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA038163: AB_2675874, HPA038164: AB_10672621" "unprognostic (2.77e-1)" "unprognostic (1.71e-1)" "unprognostic (3.10e-1)" "unprognostic (6.10e-3)" "unprognostic (3.88e-1)" "unprognostic (3.15e-1)" "unprognostic (6.10e-3)" "unprognostic (8.28e-2)" "unprognostic (2.86e-1)" "unprognostic (6.29e-3)" "unprognostic (2.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.00e-2)" "unprognostic (1.32e-3)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" 9.8 14.1 14.6 6.4 14.0 1.3 14.6 8.0 10.4 20.9 12.7 10.3 7.0 2.5 23.9 10.5 6.7 10.0 14.6 11.9 16.0 8.5 19.7 5.2 12.5 2.2 15.1 8.0 26.3 5.2 4.3 16.1 10.6 14.8 14.2 4.6 14.7 4.4 12.7 12.0 3.3 4.4 17.3 19.9 5.0 7.0 44.7 13.6 0.3 9.7 5.2 2.2 10.1 18.8 0.6 4.1 0.9 0.3 1.4 0.6 0.1 3.3 2.7 11.8 1.4 18.3 20.8 16.4 18.2 26.7 7.7 8.5 5.8 1.0 0.2 14.4 19.6 8.6 1.3 2.5 2.1 9.9 1.2 3.4 0.6 6.7 0.3 9.1 2.0 0.1 12.3 2.1 17.1 11.5 12.0 9.2 4.2 0.6 2.4 8.9 4.5 2.4 0.4 11.7 0.0 25.2 3.1 11.4 0.1 4.7 5.0 0.5 8.5 9.6 0.1 8.9 10.7 1.7 1.7 10.8 15.3 7.9 38.7 13.6 1.0 0.7 0.3 14.1 0.2 21.4 0.7 0.3 0.2 0.6 0.1 0.2 0.3 0.2 0.2 0.0 0.6 0.3 0.2 0.9 1.4 0.1 4.1 0.1 0.1 14.6 14.0 8.0 10.4 16.0 8.5 15.1 8.0 14.8 13.6 35.7 16.5 0.0 33.0 6.9 12.8 30.8 17.8 1.4 12.5 21.0 9.8 8.1 11.6 7.5 534.5 18.0 0.0 0.0 3.6 14.5 30.9 26.1 1.1 6.7 4.5 406.8 0.0 9.8 1.8 509.0 16.7 7.4 13.5 0.0 0.0 27.8 4.4 0.0 14.2 17.4 9.6 12.9 18.6 20.9 8.9 4.6 3.8 0.0 0.0 12.6 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 98.8" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 43 "T-cells: 4.8" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 25.3;HDLM-2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053880: AB_2682290" "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 13.7 7.2 13.2 4.3 33.4 0.8 5.9 19.5 51.8 10.9 10.6 13.4 2.3 5.5 7.3 27.6 13.9 7.8 18.0 98.8 14.7 24.2 17.5 4.0 8.3 2.6 38.3 27.1 13.5 6.2 47.7 6.7 1.1 60.3 13.8 12.2 27.9 5.5 14.9 29.3 5.9 7.7 14.2 17.0 4.1 14.0 3.5 11.0 0.0 10.8 14.4 4.1 15.9 8.8 0.0 0.0 0.1 0.1 0.0 4.8 0.8 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 6.1 0.4 0.0 0.0 0.0 0.0 0.3 25.3 0.0 0.0 0.0 0.0 0.1 50.9 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.1 0.2 0.1 5.6 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.6 4.8 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.0 0.8 13.2 33.4 19.5 51.8 14.7 24.2 38.3 27.1 60.3 11.0 6.0 4.3 0.8 3.8 5.6 19.4 229.0 2.5 0.0 0.0 3.5 3.9 0.0 59.7 5.8 22.0 10.8 0.0 0.0 2.1 0.0 5.6 1.7 0.0 0.2 0.1 28.6 24.1 0.0 0.3 11.0 27.0 1.8 30.4 0.0 0.3 167.3 4.3 0.0 47.4 1.4 8.0 97.0 159.7 0.7 0.9 6.5 0.0 0.0 0.1 1.1 RDH13 SDR7C3 ENSG00000160439 "Retinol dehydrogenase 13" Q8NBN7 19 55039108-55071291 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042006 Approved Supported Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA042006: AB_10960270" "unprognostic (9.26e-2)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.15e-2)" "unprognostic (8.74e-2)" "unprognostic (1.08e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-1)" "unprognostic (9.42e-3)" "unprognostic (1.61e-1)" "unprognostic (2.45e-3)" "prognostic favorable (2.09e-4)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.12e-2)" "unprognostic (1.66e-3)" 4.4 6.8 4.0 6.0 6.6 5.5 4.2 8.7 9.4 7.5 8.3 3.5 9.0 5.1 5.0 5.0 17.6 4.2 7.1 11.4 3.0 5.4 8.8 7.5 5.6 5.1 4.7 5.2 3.8 10.7 8.8 6.1 34.0 10.0 5.7 4.0 6.4 11.6 13.1 9.4 18.0 6.9 5.2 2.2 6.8 9.5 4.4 3.0 2.1 7.2 8.6 8.9 8.5 10.2 7.4 6.0 5.4 6.7 6.1 8.5 3.5 3.1 3.6 0.6 1.9 0.4 0.4 5.8 2.9 0.3 2.1 1.5 5.4 3.6 1.8 2.4 0.7 0.4 3.2 3.8 2.3 0.2 1.6 10.1 2.0 4.7 3.7 0.9 4.8 1.4 1.3 0.9 1.9 1.4 0.7 2.8 1.6 4.0 1.0 0.7 5.2 0.8 3.1 0.8 6.9 4.7 2.5 1.0 10.0 1.3 5.5 2.2 2.7 2.8 8.0 3.6 0.6 3.9 4.7 2.9 0.3 1.1 0.2 3.9 2.0 3.6 2.2 1.5 3.4 2.0 4.1 4.1 5.4 8.5 6.7 7.7 6.1 7.0 7.7 4.5 7.4 8.4 6.8 2.6 6.1 5.9 6.0 5.7 3.5 4.0 6.6 8.7 9.4 3.0 5.4 4.7 5.2 10.0 3.0 14.9 16.2 5.1 19.9 9.5 17.3 22.2 28.1 6.7 11.4 14.0 39.3 30.2 10.0 12.3 18.5 6.5 27.1 0.0 5.7 26.9 6.0 23.1 8.1 6.0 9.9 23.8 11.5 16.5 4.1 11.2 3.4 5.0 6.8 1.8 19.8 10.0 11.4 26.2 3.2 3.4 27.0 6.5 5.1 1.4 9.6 15.3 175.4 8.7 21.9 72.9 RGS7 ENSG00000182901 "Regulator of G protein signaling 7" P49802 1 240775515-241357230 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.5;brain: 38.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 19.9;Horizontal cells: 58.8" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.6" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.2;HaCaT: 6.9;hTERT-HME1: 8.4;RH-30: 7.4;SH-SY5Y: 6.5;U-2 OS: 7.4;U-251 MG: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017561 Enhanced Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017561: AB_2285043" "unprognostic (6.48e-2)" "unprognostic (4.30e-2)" "unprognostic (4.67e-2)" "unprognostic (6.65e-2)" "unprognostic (7.84e-3)" "unprognostic (4.09e-2)" "unprognostic (1.49e-2)" "unprognostic (3.61e-1)" "unprognostic (1.42e-2)" "unprognostic (2.51e-4)" "unprognostic (3.54e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (2.28e-1)" 0.7 11.5 9.1 0.8 18.3 0.7 0.9 27.6 38.1 0.9 0.8 1.6 1.7 1.0 1.0 0.8 0.9 0.7 1.3 0.7 11.5 8.3 4.2 0.8 0.9 1.1 3.6 8.9 1.3 1.4 0.7 2.8 0.7 4.7 0.8 0.9 1.3 0.7 1.4 0.7 0.9 0.9 0.7 1.4 1.0 4.6 7.8 1.8 0.0 0.7 0.0 1.0 0.7 0.1 0.7 3.6 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.3 0.9 0.0 2.7 5.3 7.2 0.5 0.0 0.0 0.0 0.4 3.7 4.0 6.9 0.0 0.1 3.6 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.9 0.3 0.2 0.0 7.4 0.0 0.0 0.0 6.0 6.5 0.4 0.3 0.3 0.2 0.0 0.0 2.8 0.0 7.4 0.4 8.0 0.0 4.3 0.0 1.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 9.1 18.3 27.6 20.7 11.5 8.3 3.6 8.9 4.7 1.8 0.0 0.0 0.8 0.0 0.0 19.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 58.8 6.9 0.6 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 2.0 0.0 0.0 6.4 9.3 0.0 0.0 0.0 0.0 0.0 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favorable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 22.9 17.3 29.0 12.4 26.4 16.0 15.5 22.6 29.6 15.2 14.6 20.7 9.3 34.4 10.2 10.5 14.9 15.4 14.7 12.1 27.2 21.1 14.7 28.4 27.8 11.1 26.0 29.3 12.0 21.6 17.6 7.3 15.3 18.4 14.1 6.7 10.6 25.3 13.4 12.7 12.9 39.6 9.6 29.4 9.8 14.4 12.2 22.9 7.8 16.1 11.6 8.5 13.6 10.4 7.6 25.5 2.5 9.7 28.1 14.4 10.6 8.4 7.7 9.3 16.0 7.7 7.3 16.2 22.0 8.6 15.7 11.5 27.7 9.5 7.2 29.4 11.3 11.0 29.2 10.3 16.4 0.6 18.9 14.7 23.1 22.6 13.6 29.0 15.5 18.5 14.1 14.8 11.0 9.2 6.6 10.5 14.4 24.2 20.0 5.9 17.1 11.6 10.0 7.4 20.7 15.4 18.3 11.2 16.7 11.5 14.3 22.4 8.2 17.5 23.7 8.1 3.2 18.5 16.9 16.4 17.1 12.2 22.8 18.4 15.3 17.8 11.5 12.1 16.5 18.6 1.9 6.2 2.5 14.4 8.2 12.6 7.6 10.5 13.0 6.8 6.7 8.2 8.9 1.0 28.1 9.7 25.5 9.1 10.6 29.0 26.4 22.6 26.9 27.2 21.1 26.0 29.3 18.4 22.9 29.8 25.5 4.5 14.2 14.0 19.2 7.0 10.2 26.8 21.6 17.4 3.9 36.6 1.7 25.3 2.0 16.5 16.9 0.0 19.5 23.1 16.9 15.9 18.5 30.9 113.0 17.5 4.7 17.8 15.6 3.1 15.5 10.9 18.6 11.8 11.5 20.0 17.9 14.4 13.4 13.3 15.2 6.5 11.4 31.1 42.8 10.5 52.5 18.5 18.8 19.0 RNF10 "KIAA0262, RIE2" ENSG00000022840 "Ring finger protein 10" Q8N5U6 12 120533480-120577594 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052643 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA052643: AB_2681897" "unprognostic (1.54e-1)" "unprognostic (3.04e-1)" "unprognostic (5.40e-2)" "unprognostic (2.83e-3)" "unprognostic (1.09e-2)" "unprognostic (3.58e-2)" "prognostic unfavorable (5.30e-5)" "unprognostic (5.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.40e-1)" 26.2 37.7 32.6 23.0 34.5 64.3 64.2 33.4 44.0 27.7 30.5 25.3 30.1 23.8 24.1 41.4 40.2 22.5 32.2 79.6 32.4 27.0 36.0 37.9 43.8 44.8 27.2 27.0 25.2 34.0 36.0 27.0 26.5 21.9 25.2 27.7 23.8 26.6 33.8 118.9 26.6 29.5 32.1 26.9 29.0 28.1 46.0 23.5 23.9 25.7 45.0 27.0 28.4 51.7 11.3 17.7 49.7 15.2 13.1 17.2 14.0 29.9 39.7 19.5 31.0 38.3 30.4 23.1 28.2 32.2 23.5 25.1 32.7 13.9 35.6 25.9 46.6 18.4 20.7 35.7 38.3 33.6 34.9 20.0 36.3 22.2 33.6 51.5 32.5 25.7 30.9 44.4 33.0 45.4 40.9 47.5 26.9 36.1 24.7 35.2 34.5 21.4 35.8 29.6 28.0 39.6 19.2 25.1 50.8 46.5 61.7 19.2 20.9 39.3 25.4 21.6 28.3 40.9 18.9 37.7 17.1 19.2 27.3 18.2 21.4 38.2 25.2 28.4 22.2 18.3 41.0 15.2 49.7 14.3 13.2 15.5 11.3 14.1 16.3 17.7 10.0 12.8 12.8 35.1 13.1 14.8 9.1 17.2 14.0 32.6 34.5 33.4 44.0 32.4 27.0 27.2 27.0 21.9 23.5 23.8 27.5 42.7 46.5 55.1 36.2 82.7 25.5 8.1 20.5 45.4 21.6 51.8 139.3 44.1 48.0 40.9 63.6 23.3 51.0 58.9 41.3 56.3 36.8 39.4 32.6 52.4 47.3 42.4 43.0 33.1 52.6 32.9 54.0 43.3 45.8 30.4 52.5 56.8 51.6 53.3 50.7 51.8 51.4 131.6 55.8 57.5 93.5 44.8 40.1 68.6 RNF115 "CL469780, ZNF364" ENSG00000265491 "Ring finger protein 115" Q9Y4L5 1 145738868-145824077 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019130 Approved Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA019130: AB_1859220" "unprognostic (3.44e-2)" "unprognostic (2.47e-3)" "unprognostic (2.24e-1)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (2.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.64e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" "unprognostic (3.23e-1)" "unprognostic (4.77e-2)" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" 7.2 5.2 6.8 4.8 6.8 6.4 7.7 16.2 7.0 6.3 3.4 4.6 5.7 3.5 8.9 5.0 5.8 4.3 4.8 23.5 5.8 5.6 5.1 3.9 5.6 4.7 6.2 4.7 4.5 5.8 5.9 3.5 5.2 6.5 3.8 7.3 3.6 5.6 27.6 3.8 3.1 10.9 4.5 4.2 3.8 3.4 4.5 6.0 5.0 5.4 4.5 4.1 6.3 2.7 2.4 9.0 2.2 3.2 3.2 1.4 11.3 4.7 5.8 4.3 10.7 14.0 4.7 8.6 16.0 6.4 7.8 5.1 4.1 8.0 9.8 12.2 6.3 8.0 6.4 5.9 6.9 8.0 4.2 6.4 6.1 4.7 6.7 9.9 14.8 8.1 5.2 6.4 7.8 7.3 8.1 6.3 6.3 13.1 11.5 8.6 7.2 6.3 7.3 7.2 10.0 7.0 5.8 6.6 12.4 3.8 5.9 8.1 7.0 8.6 6.4 7.5 9.5 9.5 10.0 9.3 7.3 5.6 9.1 11.0 10.4 8.4 4.7 6.7 5.9 9.0 2.2 3.2 3.2 1.5 2.7 2.7 2.2 3.2 1.8 2.4 2.3 3.1 1.7 3.2 1.6 2.4 2.0 1.4 14.9 29.8 29.4 28.9 18.3 96.0 134.9 25.5 24.1 26.1 17.4 108.0 23.1 28.2 34.8 52.4 66.1 14.0 23.3 69.3 24.5 48.2 51.0 31.1 28.7 32.3 77.9 26.0 66.3 32.6 18.4 36.5 29.9 37.1 88.4 19.7 66.7 49.7 20.9 76.0 37.2 104.3 58.2 49.2 78.7 54.1 15.7 16.6 66.0 23.8 32.8 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Cell line enhanced" "Detected in many" "Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.7 3.3 3.6 0.0 0.1 55.9 15.4 0.6 0.2 4.8 0.0 4.7 4.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.8 1.3 4.0 1.5 16.5 1.2 0.0 0.0 0.8 0.5 0.4 0.0 0.5 0.1 0.3 0.2 0.5 3.3 10.0 3.1 0.5 0.0 0.3 7.1 5.3 0.4 8.4 0.1 16.5 2.6 0.5 0.2 0.3 0.0 0.0 47.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 41.7 12.9 4.2 36.0 563.5 0.9 10.4 10.2 21.4 36.4 36.6 2.0 9.7 16.6 8.2 1.6 32.1 1.0 0.0 7.7 2.9 12.4 85.1 3.5 17.4 13.8 0.0 1.2 28.8 98.2 1.6 1.1 68.0 57.3 44.1 1.3 16.0 6.0 2.9 2.8 16.3 1.0 0.0 10.1 1.7 2.6 1312.2 1.3 3.2 2.4 20.3 RPL7L1 dJ475N16.4 ENSG00000146223 "Ribosomal protein L7 like 1" Q6DKI1 6 42879618-42889925 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046049, HPA050478" Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA046049: AB_10964167, HPA050478: AB_2681138" "unprognostic (1.03e-3)" "unprognostic (4.37e-2)" "unprognostic (3.37e-1)" "unprognostic (7.97e-2)" "unprognostic (7.73e-3)" "unprognostic (4.26e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (2.56e-1)" "unprognostic (2.98e-2)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.06e-1)" "unprognostic (7.31e-3)" "unprognostic (4.58e-2)" 17.5 22.1 19.9 14.4 27.5 9.0 19.9 20.5 35.9 14.8 14.2 16.9 16.4 11.9 15.7 17.4 18.9 17.2 10.2 14.4 17.6 16.5 18.8 23.5 11.9 16.5 14.9 20.4 17.4 16.9 22.9 22.4 15.1 17.9 17.0 17.0 13.2 17.4 14.4 19.9 16.3 12.8 16.5 13.9 15.4 13.7 33.0 14.5 25.1 17.8 15.6 20.3 13.7 13.3 15.4 12.5 10.2 13.6 16.4 18.6 10.6 31.3 10.0 17.8 28.5 16.8 21.7 12.1 25.1 18.3 24.4 20.2 24.8 12.0 47.2 22.8 21.1 19.9 15.1 40.4 30.6 40.6 24.7 30.4 25.1 14.1 22.4 18.5 38.7 19.5 22.2 23.5 32.0 31.0 16.6 23.9 20.9 48.5 16.3 22.2 23.1 22.0 25.2 17.9 96.5 14.8 25.3 20.0 29.9 19.0 19.9 34.1 20.8 21.5 16.5 26.4 14.7 22.1 37.5 22.8 23.7 19.8 18.7 43.3 20.6 32.1 71.8 13.2 36.8 24.6 5.6 11.4 10.2 14.9 13.6 18.6 13.3 14.6 15.5 10.8 15.4 15.5 14.9 2.6 16.4 11.9 12.5 12.0 10.6 19.9 27.5 20.5 35.9 17.6 16.5 14.9 20.4 17.9 14.5 71.5 90.2 79.6 70.6 50.7 62.2 36.8 43.3 96.4 85.3 40.1 31.4 75.2 72.9 77.0 9.5 60.8 22.6 93.5 57.9 63.9 52.5 52.0 48.7 57.8 46.3 68.3 90.5 48.5 37.5 8.6 73.4 44.1 28.7 74.9 39.6 69.6 70.8 31.6 67.1 57.2 58.0 51.8 56.9 40.4 84.8 52.7 66.9 64.5 43.4 52.0 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridylate synthase domain containing 4" Q96CM3 11 126202094-126211692 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 7.5 6.8 5.1 7.7 7.8 6.0 7.8 8.2 9.6 6.3 6.0 4.8 7.6 6.4 7.0 6.8 7.8 7.2 5.2 13.2 5.1 4.9 6.3 10.2 5.0 7.7 6.5 8.1 10.1 16.1 5.7 5.1 4.5 7.2 6.9 6.9 5.2 9.5 8.2 72.0 8.9 5.9 8.3 4.8 7.6 9.3 7.0 7.1 6.2 7.7 18.2 9.3 6.2 12.0 9.8 11.0 1.0 8.5 8.4 15.2 8.7 6.6 6.7 8.0 9.6 12.6 16.5 5.7 7.5 10.5 8.2 7.3 20.5 13.2 15.7 7.4 6.7 11.4 11.7 18.3 11.5 8.7 13.1 10.1 36.6 7.1 19.2 8.3 19.2 8.4 15.1 17.4 8.9 11.2 12.3 16.4 12.9 22.8 11.6 9.6 6.5 12.0 22.2 8.8 22.7 11.8 14.1 12.2 14.5 12.5 9.7 13.9 9.5 9.6 14.3 7.0 8.7 21.4 10.2 9.9 9.2 6.4 6.9 8.8 4.9 5.2 13.5 4.2 21.9 9.4 1.0 8.5 0.8 10.8 7.7 14.0 9.8 13.3 10.3 11.0 9.5 15.2 12.2 0.7 8.4 8.3 4.7 12.2 8.7 5.1 7.8 8.2 9.6 5.1 4.9 6.5 8.1 7.2 7.1 3.0 6.7 16.7 17.9 24.5 8.9 30.7 12.7 8.1 5.7 7.0 7.9 11.7 8.3 10.7 1.1 11.3 9.7 0.0 16.9 13.7 10.1 10.5 5.7 11.1 11.8 11.1 14.9 8.6 10.2 1.4 8.9 8.5 10.1 21.6 9.3 4.5 13.0 7.0 8.1 11.8 7.6 6.5 10.8 7.7 15.4 21.0 11.1 15.9 15.7 13.3 RTKN B5 ENSG00000114993 Rhotekin Q9BST9 2 74425836-74442422 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030259 Approved Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA030259: AB_10601484" "unprognostic (4.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.20e-2)" "unprognostic (2.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-3)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (2.57e-2)" "unprognostic (9.43e-3)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (2.96e-2)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.23e-3)" 3.2 4.9 17.1 3.9 24.2 0.4 7.1 3.9 23.6 5.6 8.7 29.7 7.3 21.2 5.1 4.0 8.0 9.0 9.7 7.2 22.2 13.7 27.0 39.0 6.3 1.9 34.8 7.7 3.6 16.3 12.8 5.3 7.9 17.2 6.5 8.8 6.0 17.3 7.0 7.5 21.1 16.4 4.4 36.3 2.2 6.0 1.4 29.4 1.9 7.4 5.3 4.3 3.1 5.6 1.7 9.7 0.0 0.0 3.1 0.4 0.6 16.8 5.2 6.7 19.8 4.1 4.8 29.0 2.6 3.3 3.8 2.8 26.2 9.4 0.1 7.5 2.5 4.7 23.2 2.5 16.9 1.8 3.3 10.9 4.0 0.9 33.0 2.5 0.0 0.0 2.9 13.5 3.3 10.8 7.0 1.9 0.2 2.0 0.1 5.6 12.0 0.6 3.3 7.3 24.5 10.5 3.7 21.0 2.5 18.6 0.1 6.8 6.5 7.2 28.1 14.9 6.5 15.7 1.5 0.2 7.2 5.0 3.2 3.5 1.7 1.1 0.6 6.9 0.0 6.7 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.2 0.3 0.9 1.7 0.0 0.1 0.0 3.1 0.0 9.7 0.0 0.6 17.1 24.2 3.9 14.9 22.2 13.7 34.8 7.7 17.2 29.4 8.9 10.2 1.7 19.9 17.7 0.0 2.5 17.8 2.7 17.0 10.4 2.0 38.3 18.3 38.6 0.8 7.0 35.9 0.0 17.8 4.0 10.3 22.4 1.1 34.6 8.2 0.0 29.6 3.1 2.6 0.4 11.8 0.0 27.0 1.0 15.4 5.8 24.3 31.6 8.1 43.3 0.4 6.5 3.4 1.1 3.4 18.9 27.9 2.9 21.8 14.5 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 1628.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "A-431: 25.5;HaCaT: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 25.5 1.4 13.7 6.3 0.0 0.1 3.3 3.7 4.3 4.2 6.7 10.6 5.1 0.1 1.6 1.4 4.3 20.5 7.6 0.6 4.4 3.6 5.2 4.2 3.1 4.4 0.0 5.7 3.3 0.2 0.3 5.2 0.5 2.3 0.6 6.8 0.2 0.2 5.6 3.2 11.0 7.3 5.8 3.8 5.2 9.5 14.6 0.0 2.7 11.1 7.5 8.6 2.4 8.6 3.5 4.2 7.8 3.1 0.0 1.9 12.5 0.1 9.3 0.1 0.0 9.8 2.5 0.0 3.0 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 1628.8 44.5 0.9 8.3 4.1 0.6 0.4 0.0 4.0 15.9 0.0 0.0 3.0 0.0 1.4 376.8 0.1 0.4 0.0 1.4 4.9 2.5 7.0 3.5 0.0 2.1 0.0 1.7 1.8 0.6 65.6 2.0 2.2 1.7 0.0 5.9 0.4 9.1 0.0 1.8 1.4 0.5 0.0 1.9 21.3 23.6 1.6 1.7 12.7 3.3 87.2 SAMD1 ENSG00000141858 "Sterile alpha motif domain containing 1" 19 14087840-14091036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 79.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041662, HPA049059" Uncertain Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA Cytosol Mitochondria "HPA041662: AB_2677605, HPA049059: AB_2680616" "unprognostic (2.93e-2)" "prognostic favorable (7.41e-4)" "unprognostic (8.43e-2)" "unprognostic (3.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (2.66e-1)" "unprognostic (9.92e-2)" "unprognostic (3.86e-3)" "unprognostic (9.26e-3)" "unprognostic (4.00e-1)" "prognostic unfavorable (7.98e-5)" "prognostic favorable (8.31e-4)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" "unprognostic (2.45e-1)" 16.0 9.5 23.5 17.4 20.2 19.6 47.9 17.2 21.2 15.3 21.3 19.7 12.2 20.6 14.7 9.8 18.2 14.0 12.8 16.8 21.2 17.9 13.1 11.1 15.9 20.1 20.9 10.3 14.5 20.3 7.2 7.3 11.3 16.5 12.7 15.5 7.8 15.4 16.1 27.2 25.9 21.5 12.4 21.3 18.0 16.7 11.4 16.1 79.1 14.8 10.8 17.9 12.9 20.5 3.5 2.3 4.5 2.9 8.0 2.7 1.5 22.8 17.4 15.4 21.7 9.7 9.9 23.5 12.6 3.0 12.9 10.4 13.1 11.3 39.9 17.2 8.1 6.1 18.6 16.8 9.4 6.5 26.7 13.8 17.4 23.1 23.6 8.6 10.2 10.9 6.9 15.6 8.9 3.0 12.5 7.6 25.6 21.1 10.9 7.4 34.4 21.7 40.3 31.6 16.7 15.5 29.6 13.6 28.6 10.9 11.1 28.3 28.3 11.1 15.1 8.4 8.7 9.5 22.0 8.2 22.6 20.8 22.6 15.9 20.7 17.8 32.9 13.5 28.0 9.1 0.3 2.9 4.5 1.7 0.9 2.0 3.5 1.9 2.0 2.3 2.1 2.7 2.0 0.5 8.0 1.0 1.8 2.1 1.5 23.5 20.2 17.2 19.6 21.2 17.9 20.9 10.3 16.5 16.1 3.0 7.9 9.7 3.5 10.2 27.7 10.1 20.4 2.7 2.3 10.4 5.9 1.6 1.7 9.4 0.3 9.0 29.0 23.3 9.6 7.2 8.0 6.8 8.1 13.5 13.4 49.3 23.8 14.7 17.4 0.5 17.8 9.4 10.1 9.0 25.3 18.6 10.9 17.3 17.7 5.0 8.6 12.9 8.4 0.7 16.2 15.1 1.5 4.9 24.7 3.9 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869467-30908761 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 52.5;WM-115: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256" "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favorable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 17.9 48.8 35.4 11.6 44.7 1.9 9.2 10.4 53.1 20.4 20.8 21.7 10.9 6.9 25.6 7.1 9.8 13.7 15.9 11.1 26.8 32.2 4.7 11.5 12.0 15.4 36.1 16.4 6.2 4.4 6.1 5.4 9.7 34.1 14.8 8.1 8.2 8.6 29.2 17.7 5.7 9.1 33.1 28.3 45.3 9.3 2.4 15.5 2.6 5.5 1.7 4.2 14.4 6.0 1.2 1.0 3.2 2.5 2.1 1.2 0.9 2.7 2.0 16.3 7.6 12.6 3.0 3.2 6.8 9.7 3.2 2.0 0.3 2.5 0.2 17.3 19.0 4.6 3.7 1.7 1.5 2.1 1.4 1.4 0.0 0.8 0.4 12.1 0.0 1.8 7.3 7.5 0.2 3.2 17.9 4.0 0.7 1.3 0.2 6.2 2.9 0.1 0.1 8.3 1.9 2.4 0.1 15.6 0.6 4.0 2.9 6.4 4.1 8.6 1.2 52.5 10.9 1.2 1.2 4.4 4.0 6.9 0.5 1.5 0.0 0.1 0.2 0.4 0.0 73.1 3.2 1.3 1.0 0.8 2.5 1.2 0.8 0.8 0.9 0.9 1.2 1.0 1.0 2.5 2.1 1.8 1.0 0.9 0.9 35.4 44.7 10.4 29.5 26.8 32.2 36.1 16.4 34.1 15.5 0.0 2.1 0.8 2.8 2.3 8.1 3.2 15.3 0.0 2.3 45.4 0.0 2.1 0.0 9.0 17.7 8.7 0.0 0.0 2.6 2.8 10.0 6.9 0.0 0.2 13.2 0.0 2.9 28.8 157.7 63.3 2.0 2.2 18.6 5.4 0.9 1.5 6.1 0.6 7.4 0.3 25.6 0.0 5.6 0.7 0.4 1.9 3.0 0.0 1.2 3.7 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-256700 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.1;skeletal muscle: 114.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria No No 780000 Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavorable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favorable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 17.6 31.4 15.3 11.5 20.3 10.6 12.8 18.8 29.0 10.2 29.4 17.3 10.0 44.3 11.3 12.1 15.3 12.6 14.8 100.1 15.8 14.5 36.5 55.4 10.7 11.7 19.6 19.3 14.5 14.7 23.2 9.5 9.2 29.7 10.7 24.6 14.5 17.3 12.0 114.0 11.5 39.9 16.5 13.2 13.9 21.2 14.6 14.8 15.7 12.5 39.6 12.5 13.2 11.1 28.3 31.9 29.1 29.2 27.1 48.9 32.4 18.7 30.4 12.5 20.4 21.6 16.2 34.0 14.5 18.4 25.0 25.5 32.9 25.6 23.2 45.8 16.5 18.9 24.3 22.1 29.6 14.8 49.4 20.2 11.8 84.1 42.8 13.4 14.7 15.4 16.1 19.0 18.6 9.9 19.9 27.0 16.6 19.0 19.3 11.7 28.7 19.4 39.7 4.3 20.5 38.6 25.1 18.2 45.0 53.1 24.9 13.8 7.9 68.2 44.1 17.9 8.1 26.7 18.6 19.5 18.5 18.2 11.0 11.9 20.6 8.8 17.1 17.9 21.2 11.7 17.8 24.4 29.1 36.4 29.2 32.1 28.3 34.8 35.1 31.9 24.5 34.5 31.7 5.9 27.1 24.1 20.5 48.9 32.4 15.3 20.3 18.8 29.0 15.8 14.5 19.6 19.3 29.7 14.8 32.8 63.8 52.9 58.0 54.4 45.7 238.2 76.5 58.9 40.9 71.5 96.2 94.1 121.0 78.8 32.8 37.6 207.8 0.0 39.4 87.2 53.2 29.4 42.7 135.6 60.4 95.3 45.6 43.0 39.1 20.2 63.3 43.9 86.0 78.5 75.8 40.3 44.9 92.8 52.3 129.8 77.8 77.6 45.0 66.5 55.1 31.5 129.4 59.9 128.8 78.3 SDHAF4 "C6orf57, Sdh8" ENSG00000154079 "Succinate dehydrogenase complex assembly factor 4" Q5VUM1 6 70566917-70589569 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031824 Supported Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No Mitochondria Nucleoplasm "HPA031824: AB_10602113" "unprognostic (8.72e-2)" "unprognostic (1.64e-1)" "unprognostic (4.95e-2)" "unprognostic (9.96e-2)" "unprognostic (4.58e-1)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (3.18e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.95e-5)" "unprognostic (2.45e-2)" "unprognostic (9.37e-2)" "unprognostic (3.05e-1)" "unprognostic (9.94e-2)" 13.4 14.5 18.1 6.5 20.1 6.1 14.3 15.7 25.7 8.3 9.5 7.9 10.3 7.9 9.0 14.6 9.8 16.0 8.5 17.6 18.0 21.2 14.9 10.7 8.4 10.6 14.7 17.4 9.7 14.2 10.5 18.3 10.2 15.5 10.6 10.6 11.1 9.7 8.9 30.5 9.7 7.9 8.8 13.0 6.9 8.8 7.3 9.7 7.4 11.5 10.2 7.8 8.1 6.9 10.5 13.4 9.1 10.5 9.6 9.3 6.2 10.0 3.3 14.3 8.8 7.3 10.9 2.8 5.4 4.2 2.6 4.0 2.9 8.5 6.9 10.4 2.8 6.4 1.8 4.9 4.8 3.9 14.4 3.3 4.8 1.4 2.9 12.4 4.7 3.8 7.8 15.4 2.0 11.8 9.2 6.5 11.6 3.2 10.7 8.6 6.9 4.2 11.7 6.8 5.1 3.3 4.7 9.7 8.0 11.4 3.3 13.2 9.6 3.2 1.6 6.8 6.4 7.3 12.2 4.8 2.7 2.1 2.2 5.8 5.0 3.4 2.2 3.0 11.2 6.4 6.0 10.5 9.1 7.7 9.2 8.0 8.7 8.5 9.0 11.3 10.5 9.3 8.5 7.1 9.6 9.5 13.4 9.1 6.2 18.1 20.1 15.7 25.7 18.0 21.2 14.7 17.4 15.5 9.7 11.9 15.2 2.2 7.2 0.0 7.5 17.6 7.6 25.4 10.3 7.0 7.9 8.8 19.9 8.0 4.0 5.2 3.3 0.0 10.1 7.4 5.1 7.1 4.7 11.3 9.1 17.5 3.5 3.7 4.1 2.2 11.5 8.5 0.0 12.6 6.6 9.9 9.8 3.5 6.3 11.8 5.8 12.9 3.1 10.7 5.3 0.0 4.2 4.4 6.4 6.9 SDS SDH ENSG00000135094 "Serine dehydratase" P20132 12 113392445-113426301 "Enzymes, Plasma proteins, Predicted intracellular proteins" Gluconeogenesis Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 276.9" "Group enriched" "Detected in many" 4 "Hepatocytes: 317.5;Hofbauer cells: 211.0;monocytes: 169.5" "Cancer enriched" "Detected in all" 31 "liver cancer: 165.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "myeloid DC: 12.8" "Lineage enriched" "Detected in single" 15 "dendritic cells: 12.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.5;SK-BR-3: 3.4" "Low region specificity" "Detected in single" HPA039230 Uncertain Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA039230: AB_10674281" "unprognostic (1.31e-1)" "prognostic favorable (5.24e-4)" "unprognostic (6.37e-3)" "unprognostic (6.94e-2)" "unprognostic (9.19e-3)" "unprognostic (2.65e-2)" "unprognostic (2.35e-2)" "unprognostic (8.85e-2)" "unprognostic (1.79e-1)" "unprognostic (2.55e-1)" "unprognostic (4.89e-2)" "unprognostic (3.20e-1)" "unprognostic (4.08e-3)" "unprognostic (2.12e-1)" "unprognostic (2.07e-2)" "unprognostic (4.35e-1)" "unprognostic (2.99e-2)" 0.9 0.9 2.2 1.4 5.9 0.5 0.4 0.6 2.1 0.5 0.9 0.8 0.0 0.7 0.4 0.2 0.2 0.2 1.4 0.2 1.7 2.5 0.2 276.9 0.6 0.6 4.2 0.7 0.3 0.4 0.1 0.0 1.0 2.8 0.3 0.8 1.3 0.3 0.2 0.2 0.2 0.7 0.3 1.3 0.5 0.9 0.3 0.8 0.1 0.3 0.0 0.3 0.8 0.0 0.0 12.8 0.6 0.8 0.2 0.0 0.3 0.0 0.4 0.2 1.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.2 0.4 2.3 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.5 1.3 0.6 0.6 0.1 0.8 5.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.6 0.0 1.4 0.1 0.4 0.8 0.0 0.9 0.0 0.8 0.1 0.2 0.6 0.1 0.1 1.6 3.4 0.7 0.1 1.2 1.7 0.6 0.0 0.9 1.1 0.3 0.7 0.4 0.2 1.1 0.8 0.3 0.1 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.6 0.2 0.1 1.3 0.0 0.3 2.2 5.9 0.6 1.6 1.7 2.5 4.2 0.7 2.8 0.8 0.0 1.1 21.2 0.2 2.2 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.7 0.0 2.1 0.0 0.3 0.0 23.3 0.3 0.7 0.8 0.2 0.0 317.5 211.0 0.0 0.0 10.4 27.7 0.0 0.0 55.6 1.7 169.5 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 2.8 2.1 3.3 0.0 0.0 SELENOO SELO ENSG00000073169 "Selenoprotein O" Q9BVL4 22 50200979-50217616 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 22.6;Club cells: 10.3;Distal tubular cells: 13.3;Proximal tubular cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071795, HPA079100" Approved Supported "Mitotic chromosome,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Mitotic chromosome" "HPA071795: , HPA079100: " "unprognostic (1.79e-1)" "unprognostic (2.07e-3)" "unprognostic (1.60e-1)" "unprognostic (2.50e-3)" "unprognostic (3.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.85e-2)" "unprognostic (5.91e-2)" "unprognostic (1.51e-1)" "unprognostic (5.62e-2)" "unprognostic (8.20e-3)" "unprognostic (8.91e-2)" "unprognostic (1.81e-2)" "unprognostic (7.31e-2)" "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "prognostic favorable (8.32e-4)" 8.5 8.7 8.0 5.7 10.5 16.3 10.5 24.5 9.4 5.9 8.0 8.8 8.2 10.6 7.6 4.2 9.6 7.0 5.8 6.3 6.6 3.5 7.7 31.0 5.7 8.2 8.4 5.5 6.9 17.6 3.6 5.8 4.2 7.9 6.9 2.9 6.0 10.0 6.0 13.0 10.7 8.4 3.5 7.5 8.1 8.2 4.9 8.1 5.3 6.4 5.6 7.6 6.9 7.3 0.8 3.4 3.5 3.5 0.3 1.6 0.9 8.3 5.5 3.0 3.4 4.2 3.1 6.3 8.4 4.0 5.1 4.0 7.4 5.3 5.6 6.8 3.3 2.8 18.6 4.7 7.6 1.0 1.6 21.6 4.0 10.9 4.5 2.1 7.3 5.0 4.0 5.3 3.2 2.6 3.3 4.1 3.8 5.4 4.1 2.1 12.9 3.9 11.4 2.6 2.0 11.2 12.3 4.3 8.2 3.2 10.8 6.1 6.8 9.1 8.2 5.1 1.6 6.2 5.2 6.8 4.5 6.2 4.8 5.0 10.2 2.5 3.3 4.9 4.8 2.5 0.0 3.5 3.5 0.6 1.2 1.6 0.1 0.8 1.5 3.4 0.8 0.4 1.4 1.4 0.3 1.1 1.4 0.7 0.9 8.0 10.5 24.5 9.4 6.6 3.5 8.4 5.5 7.9 8.1 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 10.3 8.7 0.0 2.7 13.3 3.2 0.0 0.0 0.0 0.0 4.0 2.0 0.0 0.0 3.5 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 3.6 0.0 0.0 4.9 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 SERPINB7 MEGSIN ENSG00000166396 "Serpin family B member 7" O75635 18 63752935-63805376 "Disease related genes, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 70.6;Ductal cells: 49.1;Extravillous trophoblasts: 68.8;Pancreatic endocrine cells: 169.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 46.7;fHDF/TERT166: 32.9;HaCaT: 80.4;HBEC3-KT: 25.6;HBF TERT88: 44.7;hTERT-HME1: 26.0;U-138 MG: 44.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024200 Enhanced Approved "Endoplasmic reticulum,Mitochondria" NA NA "Endoplasmic reticulum" Mitochondria "HPA024200: AB_1856730" "unprognostic (8.66e-3)" "unprognostic (6.31e-3)" "unprognostic (6.55e-2)" "unprognostic (4.03e-4)" "unprognostic (9.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (9.99e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (2.02e-1)" "unprognostic (6.81e-2)" "unprognostic (1.62e-1)" "unprognostic (3.37e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-3)" 0.2 0.0 0.1 0.1 0.1 0.0 6.6 0.1 0.1 2.0 0.2 0.0 0.0 0.0 0.5 0.0 2.6 0.1 1.3 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.4 0.0 0.1 0.0 0.0 0.6 0.0 0.9 54.6 0.1 0.0 0.1 0.0 0.3 0.3 0.0 6.7 0.1 22.6 16.7 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.7 0.0 46.7 9.4 7.1 5.3 0.0 0.2 0.0 0.0 32.9 12.4 80.4 0.0 25.6 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.6 1.1 26.0 0.3 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 44.0 1.6 0.9 4.4 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 70.6 0.0 0.0 0.0 1.4 1.2 0.0 0.0 1.2 0.0 49.1 0.0 0.0 0.0 0.0 7.8 68.8 1.1 2.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 2.8 0.0 0.0 169.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 19.2 5.1 0.0 0.0 2.5 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: AB_2683261" "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favorable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.4 11.8 9.1 2.8 1.9 4.3 7.0 4.0 11.2 5.9 11.4 8.9 2.1 7.3 7.3 8.1 3.0 9.1 10.1 5.3 8.5 5.9 8.6 7.3 14.9 3.6 4.3 9.4 4.9 2.8 7.8 0.9 4.0 6.5 2.6 7.4 1.8 3.0 6.7 1.2 6.6 14.5 6.7 4.7 8.1 9.7 2.6 6.5 8.2 7.6 2.1 6.5 3.3 2.7 6.7 1.7 2.2 4.7 3.4 11.2 4.8 8.0 3.0 2.9 2.5 11.7 8.1 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 0.0 4.1 8.8 4.0 4.1 24.0 5.4 5.1 0.0 4.5 34.9 31.4 7.6 3.3 4.4 100.9 6.0 15.1 23.3 7.9 1.9 7.5 2.9 0.0 53.3 10.6 19.1 13.2 8.6 4.0 111.2 9.8 7.0 8.5 10.0 5.8 76.6 6.2 5.3 10.6 20.2 38.4 12.9 7.7 7.9 13.0 8.2 3.5 5.7 6.8 1.6 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229327-57234935 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 103.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 158.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 212.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Supported Microtubules,Mitochondria NA NA 160000 Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavorable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 13.0 13.5 5.9 15.0 7.1 12.6 9.5 9.6 9.5 10.5 11.5 6.1 5.0 13.4 10.2 8.5 22.1 8.6 10.3 11.0 6.5 5.4 15.5 103.1 11.8 18.7 8.7 4.6 17.9 38.9 4.5 8.1 16.8 6.5 10.3 9.4 7.1 44.6 5.7 16.5 13.7 11.5 9.9 7.6 23.5 13.4 5.4 6.3 26.1 13.2 19.0 25.6 11.2 13.8 33.6 14.5 6.5 11.7 9.7 48.7 12.3 25.1 11.7 11.8 31.2 9.3 14.3 23.4 13.6 22.2 18.3 16.8 16.7 12.2 46.6 22.6 16.8 7.6 16.1 21.3 22.2 9.9 26.0 19.0 19.2 7.2 11.8 68.7 31.7 17.0 18.3 32.2 14.7 49.2 16.6 18.1 24.8 20.0 44.3 13.8 16.5 25.2 17.4 10.1 10.1 19.0 17.0 212.4 43.1 9.1 11.6 25.3 12.1 7.1 16.8 49.3 4.5 22.8 39.0 11.4 7.4 15.1 9.6 18.5 59.5 32.5 39.5 16.0 29.6 13.3 6.5 9.8 5.9 6.9 11.7 8.0 33.6 12.1 7.4 14.5 32.4 5.3 5.4 0.5 9.7 7.5 4.8 48.7 12.3 5.9 7.1 9.6 9.5 6.5 5.4 8.7 4.6 6.5 6.3 8.9 13.1 58.9 19.1 30.8 6.2 7.5 20.4 9.4 12.5 3.5 0.0 53.0 11.6 41.7 0.4 13.5 11.0 46.7 41.3 42.8 21.6 14.9 28.8 158.5 43.3 7.9 9.2 20.3 38.1 0.2 16.7 22.7 37.1 27.1 21.6 42.4 40.1 21.0 15.2 48.7 4.9 6.5 22.6 2.1 7.2 28.4 31.2 26.2 37.7 17.6 SIAH1 hSIAH1 ENSG00000196470 "Siah E3 ubiquitin protein ligase 1" Q8IUQ4 16 48356364-48448402 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 102.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018724 Enhanced Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB018724: AB_2188865" "unprognostic (7.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-3)" "unprognostic (1.25e-2)" "unprognostic (7.93e-3)" "unprognostic (1.12e-2)" "unprognostic (9.22e-3)" "unprognostic (3.26e-1)" "unprognostic (8.02e-2)" "unprognostic (7.84e-3)" "unprognostic (7.67e-3)" "unprognostic (4.38e-2)" "unprognostic (4.00e-1)" "unprognostic (9.55e-2)" "unprognostic (1.26e-2)" 20.6 11.4 11.9 11.0 13.5 19.2 25.5 15.5 16.6 14.6 13.1 15.0 6.5 12.8 16.8 13.4 12.7 12.9 12.9 11.4 12.6 11.6 12.1 17.5 13.9 10.0 12.8 11.6 16.7 11.4 13.1 9.1 102.6 14.1 14.2 12.2 32.1 13.2 12.1 17.0 16.6 16.0 18.6 12.7 11.3 12.5 17.9 13.0 17.5 14.5 9.3 11.5 15.9 14.8 12.6 8.3 21.9 5.2 5.3 6.1 3.5 8.6 7.8 16.9 15.1 14.6 12.8 17.3 8.1 11.0 12.1 5.9 5.9 11.3 11.2 9.0 10.2 8.4 10.1 11.6 11.8 14.9 4.5 9.4 6.0 6.1 15.4 20.4 5.9 9.3 15.3 21.3 7.0 16.4 13.5 10.1 10.5 9.7 10.7 9.8 5.9 15.9 12.1 20.6 9.6 12.1 18.6 25.4 11.8 11.2 10.9 19.3 17.1 24.0 12.0 20.7 15.2 7.6 13.7 10.7 12.9 11.7 7.0 8.6 14.0 5.8 20.6 9.6 7.4 11.6 6.9 5.2 21.9 2.7 2.2 3.0 12.6 3.0 4.2 8.3 12.1 6.1 4.5 2.9 5.3 1.3 7.9 1.6 3.5 11.9 13.5 15.5 16.6 12.6 11.6 12.8 11.6 14.1 13.0 11.9 11.9 16.4 51.3 76.1 18.3 12.0 10.2 9.4 10.3 15.7 7.9 161.7 26.6 21.4 60.8 27.0 18.8 0.0 19.9 25.3 52.6 43.7 4.6 19.5 29.5 33.4 21.7 28.8 18.3 53.9 21.0 23.2 47.2 38.7 18.3 30.7 19.2 14.4 18.4 21.1 16.5 19.4 37.1 68.6 47.5 66.1 624.0 13.4 16.7 38.7 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777243-45851736 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;fallopian tube: 11.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 6 "EFO-21: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.6 1.3 5.1 0.9 8.3 0.9 0.6 5.6 10.2 4.1 0.6 0.0 0.1 0.8 1.7 2.0 0.6 11.8 0.7 0.6 4.0 2.8 1.7 0.6 0.8 0.8 3.4 6.6 0.7 0.6 0.5 0.4 0.5 8.9 0.6 0.7 2.8 1.7 3.6 0.6 0.8 0.8 0.8 1.3 0.8 0.7 0.8 0.7 0.4 0.6 0.0 0.9 0.7 0.4 0.1 0.1 0.5 0.1 0.2 1.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 5.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.7 0.5 0.2 0.0 0.1 0.0 0.0 5.1 8.3 5.6 10.2 4.0 2.8 3.4 6.6 8.9 0.7 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 4.0 0.0 1.8 2.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.6;lymphoid tissue: 23.8" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 3.7;NB-4: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 13.5 4.7 4.3 14.9 13.3 11.6 2.6 0.6 9.3 1.7 1.8 4.6 0.0 1.3 1.3 2.1 1.4 4.1 3.0 6.5 15.0 2.6 2.1 3.2 37.6 19.9 17.1 0.7 2.4 3.3 1.2 1.9 6.2 11.3 1.7 1.0 1.7 2.0 1.2 2.0 1.0 1.2 4.6 18.1 23.8 1.7 2.4 10.3 0.0 1.8 0.2 1.0 7.1 1.3 0.4 2.4 6.0 7.9 0.2 0.4 2.6 0.3 0.7 0.0 0.4 0.1 0.1 0.9 0.0 0.0 0.1 0.2 1.0 2.1 0.2 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.1 3.8 0.6 0.7 0.1 0.0 3.7 0.3 0.1 0.0 0.2 0.3 0.0 1.2 1.0 0.7 0.1 1.3 0.2 3.1 0.0 0.6 0.2 0.2 0.6 0.4 0.1 0.3 0.8 0.2 0.5 0.4 0.4 0.2 0.3 1.1 0.3 0.7 0.4 0.2 0.0 0.3 0.3 0.7 0.2 0.4 0.4 0.3 7.9 0.6 0.4 5.8 0.3 0.1 0.2 0.2 2.4 0.4 0.4 0.3 6.0 0.2 7.0 0.2 0.2 2.6 4.3 13.3 0.6 9.3 15.0 2.6 17.1 0.7 11.3 10.3 20.8 52.4 3.0 3.9 0.8 3.6 6.3 5.1 17.4 22.7 8.7 0.0 1.6 8.3 0.8 1.2 4.7 1.2 0.0 1.8 7.2 2.4 5.7 24.3 4.7 110.2 1.6 1.2 8.6 163.4 0.4 2.0 201.4 1.7 1.0 4.0 7.6 0.6 0.9 0.7 6.8 3.0 19.4 5.0 0.5 1.7 0.9 6.8 1.7 2.2 2.7 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 579.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.5 1.9 2.2 6.0 13.8 0.0 0.0 0.8 1.9 34.7 1.7 0.0 10.5 0.3 0.3 26.3 6.3 2.8 0.9 0.3 12.9 0.0 0.1 0.0 0.4 0.4 0.1 11.1 13.0 5.3 2.2 0.4 0.0 0.4 0.0 0.1 3.6 0.0 0.0 0.1 2.5 0.0 2.2 0.0 0.1 0.0 0.0 1.4 1.8 0.0 2.1 6.3 0.3 10.5 0.0 1.0 0.0 1.9 3.2 0.0 7.6 0.0 0.0 0.0 8.8 14.5 4.9 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 3.0 0.3 0.5 10.4 9.5 7.7 33.9 0.0 5.3 1.2 0.0 2.0 25.3 0.0 0.4 0.6 1.1 0.0 0.0 0.0 13.5 11.8 3.2 0.0 0.2 38.2 3.2 0.0 1.3 63.4 1.9 4.0 11.0 6.8 3.6 0.0 579.8 0.3 0.0 0.0 0.0 11.3 6.5 4.7 0.2 0.1 6.1 7.7 0.0 0.0 3.3 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 50.4;SK-BR-3: 38.8" HPA023048 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favorable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.2 26.4 2.5 12.6 0.9 0.7 5.0 6.0 2.0 7.8 5.9 16.0 6.1 6.4 4.7 1.4 3.8 9.2 3.6 6.3 1.4 4.7 20.4 5.2 16.1 50.4 1.1 11.7 6.4 0.5 3.3 5.5 1.1 1.5 4.5 9.1 8.7 8.1 2.6 26.8 17.1 12.4 2.6 6.0 19.9 13.0 5.4 20.2 6.9 12.9 16.7 11.3 5.7 38.8 1.3 0.7 16.6 6.5 1.9 6.0 19.8 8.7 11.0 5.0 2.5 3.7 2.6 12.4 5.2 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 0.0 2.1 0.0 5.5 0.0 2.9 3.3 17.8 13.4 5.7 14.0 0.0 11.3 21.6 15.4 23.8 0.5 9.3 0.0 20.3 4.7 0.9 3.9 0.0 37.7 6.8 0.0 4.7 3.1 0.3 65.6 2.0 0.3 0.0 1.0 15.4 1.5 9.6 24.6 1.8 75.1 3.8 0.0 0.2 8.4 2.3 0.0 3.5 1.5 28.8 4.3 SLC25A18 ENSG00000182902 "Solute carrier family 25 member 18" Q9H1K4 22 17563439-17590994 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 13.1;brain: 49.0;liver: 50.0" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6" "Group enriched" "Detected in some" 5 "glioma: 10.6;liver cancer: 11.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;BEWO: 12.9" "Low region specificity" "Detected in all" HPA068110 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068110: " "unprognostic (2.15e-1)" "unprognostic (6.07e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.45e-2)" "unprognostic (2.72e-2)" "unprognostic (8.70e-4)" "unprognostic (1.44e-1)" "unprognostic (3.92e-2)" "unprognostic (1.67e-2)" "unprognostic (1.29e-1)" "unprognostic (5.24e-2)" "unprognostic (1.62e-1)" 13.1 2.2 33.2 1.5 28.0 1.2 2.7 7.5 49.0 1.4 1.4 13.3 0.0 1.5 1.7 1.4 1.5 1.7 2.1 2.3 33.3 15.7 1.8 50.0 1.5 1.5 25.6 19.1 1.9 1.8 1.7 0.0 1.3 17.8 4.8 1.3 0.0 1.6 1.6 2.5 1.4 1.4 1.8 14.9 1.9 1.5 3.4 21.6 0.0 1.5 0.0 1.3 1.4 0.0 0.4 0.4 2.1 0.6 0.0 0.5 0.1 0.5 0.9 3.4 0.6 5.7 0.0 12.9 0.4 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.0 3.7 1.1 0.1 0.0 0.0 0.4 1.4 0.5 0.4 0.8 2.3 0.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.6 0.4 0.0 0.6 0.1 0.8 2.9 1.3 2.1 4.2 1.2 0.0 0.1 0.6 1.2 0.5 0.4 0.6 1.0 2.6 3.7 1.4 0.2 0.2 0.5 0.3 0.4 1.4 1.7 0.0 2.7 0.3 0.5 0.0 0.4 2.1 0.4 0.6 0.0 0.4 0.5 0.1 0.3 0.2 0.1 0.3 0.5 0.0 0.2 0.4 0.1 0.1 33.2 28.0 7.5 25.7 33.3 15.7 25.6 19.1 17.8 21.6 26.8 15.9 0.0 0.2 0.0 0.5 1.4 0.0 28.1 12.5 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.5 4.6 5.8 67.6 0.2 0.0 0.0 2.5 4.6 0.6 0.9 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.5 0.6 3.2 0.0 0.0 2.7 4.8 0.1 1.5 0.0 0.0 0.1 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 35.4;RPMI-8226: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.5 3.6 5.0 11.5 4.4 0.7 8.0 4.3 5.6 5.8 5.6 6.9 6.6 5.7 12.6 6.8 1.4 8.8 3.5 4.2 16.8 4.2 9.2 7.0 7.1 5.2 9.6 17.8 5.6 4.0 7.5 1.2 2.2 7.2 10.1 8.2 35.4 7.3 3.7 10.5 4.8 1.8 8.1 10.2 3.8 2.1 48.7 6.0 3.5 1.4 5.1 7.4 0.0 4.0 5.2 11.3 4.5 5.8 6.4 1.1 9.3 5.8 13.1 9.1 7.7 9.1 6.8 8.4 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 6.0 2.4 7.5 2.3 1.5 1.1 31.1 7.6 5.3 2.3 0.0 5.9 1.7 3.3 3.2 1.1 3.1 38.0 0.0 3.7 1.9 4.1 2.4 1.1 55.2 15.8 0.0 7.0 9.2 13.2 1.0 9.8 7.5 1.7 40.5 10.8 2.8 4.0 13.5 11.7 12.5 1.1 0.0 2.2 7.1 7.0 1.1 1.0 13.8 12.8 2.0 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.4 15.2 8.9 8.0 3.8 6.8 8.4 11.2 9.4 12.5 7.9 15.0 16.1 7.0 8.4 9.3 14.2 20.8 9.8 13.5 2.8 13.2 18.1 6.4 7.5 9.2 16.2 10.4 10.9 6.8 8.2 9.5 10.2 3.9 5.7 8.3 13.1 11.1 5.5 14.2 10.8 9.8 19.3 14.5 23.4 12.8 4.9 16.6 7.4 3.9 44.3 19.9 6.4 15.5 8.0 1.4 7.5 5.3 5.6 14.0 9.4 6.4 10.5 9.7 5.7 9.0 16.8 9.3 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 6.0 10.4 2.2 6.3 11.2 147.0 1.8 5.1 2.7 4.5 8.7 31.4 5.9 3.3 22.2 11.5 4.9 7.0 0.0 17.0 8.9 7.4 13.6 2.3 15.3 4.0 41.3 12.5 1.8 1.8 5.6 4.4 2.6 3.3 6.4 7.3 13.4 14.1 7.0 4.6 5.6 29.9 0.0 6.1 1.4 6.3 11.7 2.6 5.2 5.0 8.1 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favorable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 29.2 15.8 7.3 8.1 12.8 5.5 10.6 8.8 20.0 14.4 7.2 6.3 20.0 7.9 14.6 8.2 22.7 17.5 31.6 5.6 7.6 9.0 9.5 48.4 12.4 6.7 7.5 8.0 13.6 52.6 12.1 19.0 7.6 15.0 8.5 5.5 13.6 7.6 63.5 31.3 9.5 10.0 17.3 8.7 7.8 10.5 7.3 5.3 5.4 10.8 20.2 9.7 8.6 9.6 2.9 4.6 3.8 8.4 1.5 7.6 3.9 5.7 6.1 8.6 12.4 6.5 5.6 5.7 12.0 11.2 10.1 6.7 10.9 6.1 7.5 3.7 5.5 5.6 10.3 6.8 3.9 3.8 8.7 5.6 4.3 12.2 6.5 10.4 5.0 10.0 7.2 3.8 9.9 7.3 3.3 6.8 12.6 15.6 16.2 6.3 13.9 8.7 5.1 8.7 18.7 9.5 8.7 7.4 15.7 3.9 6.0 21.4 9.2 12.6 8.1 16.7 3.5 8.9 2.9 4.3 11.5 6.8 8.6 11.8 14.2 24.8 8.0 7.8 2.7 9.4 3.8 2.3 1.2 4.8 7.3 2.4 1.7 5.3 4.8 4.6 2.9 4.5 7.6 0.4 1.5 8.4 1.5 3.9 3.9 7.3 12.8 8.8 20.0 7.6 9.0 7.5 8.0 15.0 5.3 20.8 41.7 5.2 37.8 23.2 18.1 2.0 33.1 21.4 9.1 19.2 119.8 8.5 10.0 10.3 0.3 33.7 36.7 23.3 10.0 10.4 16.9 26.9 8.1 58.9 8.4 17.5 49.5 19.0 13.3 0.6 8.6 18.9 20.3 18.0 17.3 12.8 10.0 28.1 7.8 8.6 65.5 19.4 63.4 4.1 8.6 37.6 19.2 8.7 15.3 47.7 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295343 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.4" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051720 Uncertain Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA051720: AB_2681584" "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favorable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favorable (1.91e-5)" 6.8 8.2 4.0 10.2 8.3 7.4 8.1 2.6 6.0 13.0 7.2 11.1 18.2 8.3 14.1 11.6 5.3 8.6 7.5 4.4 8.2 3.7 14.4 4.4 7.2 8.2 8.9 5.2 3.4 9.6 6.6 12.9 44.4 9.2 8.2 7.9 11.3 6.2 24.9 3.4 4.2 7.2 6.0 9.7 9.4 9.8 20.2 7.2 9.0 9.1 4.1 7.1 7.2 4.6 3.8 7.2 9.0 11.1 3.2 5.6 2.9 4.5 12.5 2.1 9.4 7.2 2.8 5.2 2.9 2.7 3.3 3.6 1.5 11.7 5.2 3.1 3.4 6.7 10.1 2.7 3.6 1.8 2.8 3.3 4.4 9.2 1.8 2.7 0.5 11.9 5.9 2.1 6.2 1.1 2.3 5.1 6.1 1.2 1.8 2.7 2.5 4.7 2.4 0.7 3.1 4.2 5.1 1.5 2.3 2.5 11.6 1.1 2.8 8.6 5.2 3.7 2.3 11.6 3.3 6.7 2.2 1.7 5.3 2.5 4.0 2.4 1.8 5.7 7.8 5.6 4.5 7.3 9.0 5.5 11.1 4.3 2.6 4.8 5.6 7.2 3.8 1.7 3.5 1.4 3.2 7.8 3.6 4.9 2.9 4.0 8.3 2.6 6.0 8.2 3.7 8.9 5.2 9.2 7.2 0.0 4.8 5.4 1.5 0.7 3.7 1.2 2.5 0.0 1.2 10.4 7.9 7.3 10.0 2.4 2.4 2.2 2.5 0.0 6.2 2.0 1.3 1.8 4.7 2.4 5.9 1.6 8.6 2.5 3.7 3.6 1.4 2.7 0.0 8.2 2.7 6.8 2.6 3.1 1.1 5.7 8.9 0.0 0.7 27.9 0.7 0.3 14.5 3.8 3.0 1.1 SLC25A37 "HT015, MFRN, MFRN1, MSCP" ENSG00000147454 "Solute carrier family 25 member 37" Q9NYZ2 8 23528805-23575463 "Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.8" "Cell type enriched" "Detected in all" 5 "Erythroid cells: 3550.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 28.9" "Lineage enriched" "Detected in many" 18 "granulocytes: 28.9" "Cell line enhanced" "Detected in many" "HEL: 47.7;hTERT-RPE1: 27.9" "Low region specificity" "Detected in all" HPA045680 Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045680: AB_10963693" "unprognostic (6.15e-3)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (5.12e-2)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.58e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (8.27e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 8.2 18.3 5.8 13.7 8.3 88.8 13.1 4.2 8.2 13.4 16.4 6.5 11.7 39.7 10.3 6.8 8.2 9.5 8.5 16.8 6.2 5.2 9.4 11.8 25.7 18.5 12.2 5.1 17.2 14.8 15.6 8.8 23.9 10.3 17.1 5.8 7.9 21.1 17.4 13.8 7.6 17.6 7.9 10.2 28.7 8.0 15.0 8.6 1.9 9.0 5.9 5.7 13.9 33.0 1.2 1.4 28.9 1.6 0.7 1.2 0.8 3.8 4.2 4.5 4.1 5.9 7.3 6.6 3.0 3.9 2.2 2.5 4.1 8.2 6.2 3.7 2.5 14.5 4.9 4.1 8.2 3.0 1.0 2.2 47.7 7.0 1.4 4.9 2.7 1.9 6.2 8.0 4.8 4.8 27.9 3.4 5.0 10.5 3.1 3.5 1.6 3.2 11.3 2.3 4.7 3.3 3.3 2.2 2.4 6.8 2.1 1.4 1.9 4.1 6.4 3.0 4.4 1.8 4.1 5.5 10.9 1.6 6.4 5.8 2.5 0.9 3.9 10.2 6.5 6.8 0.6 1.6 1.4 0.6 0.6 0.6 1.2 0.4 0.3 1.4 0.8 1.2 0.7 28.9 0.7 0.8 0.4 0.7 0.8 5.8 8.3 4.2 8.2 6.2 5.2 12.2 5.1 10.3 8.6 35.7 79.2 39.5 104.8 82.9 35.3 31.5 48.4 21.4 84.2 73.3 64.8 32.1 13.3 81.9 645.6 82.4 66.7 3550.9 197.4 63.8 90.2 258.9 35.8 34.3 36.1 6.4 19.5 100.7 50.6 772.4 48.6 101.8 65.8 8.2 33.2 41.6 177.5 34.5 35.0 24.5 60.7 19.4 95.7 12.5 47.1 47.0 15.3 22.7 43.1 139.3 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 115.9;Late spermatids: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA065411: AB_2685486" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favorable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 14.3 9.0 15.9 9.3 23.1 10.2 8.9 18.6 31.9 9.1 10.4 19.7 6.6 16.8 8.1 11.1 9.0 7.8 10.7 10.6 16.1 16.7 25.9 31.2 10.6 8.7 14.4 18.1 7.1 8.3 17.7 10.9 7.8 22.5 8.7 11.1 9.3 7.0 9.5 12.8 9.1 13.9 10.8 13.5 13.3 8.4 8.9 12.1 10.6 9.7 6.0 11.2 9.7 7.9 3.7 6.3 33.8 9.1 4.2 4.9 5.6 10.3 17.7 8.7 11.5 19.0 10.3 6.8 11.1 16.4 20.3 16.6 17.3 9.4 8.2 9.8 16.6 11.0 15.5 31.7 13.1 18.0 9.4 10.6 7.5 11.3 10.4 14.5 9.7 13.8 14.4 11.5 20.5 12.4 9.8 16.4 10.2 7.8 13.6 13.9 18.6 10.1 6.9 20.5 19.8 18.4 6.5 8.8 14.0 26.5 12.3 13.6 18.3 13.0 23.6 14.8 16.0 17.8 15.9 13.2 11.7 9.9 13.1 13.2 14.0 10.6 12.5 12.9 10.2 11.5 6.5 8.4 8.7 4.7 9.1 4.9 3.7 3.8 4.4 6.3 2.4 3.1 3.7 33.8 4.2 7.1 2.8 3.3 5.6 15.9 23.1 18.6 31.9 16.1 16.7 14.4 18.1 22.5 12.1 11.9 24.8 12.3 4.8 24.6 12.6 30.7 7.6 4.0 14.8 8.7 19.6 4.3 5.0 5.4 115.9 11.7 9.2 0.0 4.9 3.3 17.9 6.1 4.7 29.8 6.5 19.1 5.8 10.4 8.6 71.2 6.6 12.2 11.8 1.8 8.5 7.2 4.9 5.8 5.3 13.9 8.8 19.4 12.2 9.1 7.7 29.7 6.9 7.5 7.5 6.3 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 256.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 49.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038360: AB_2675975, HPA071102: AB_2732171" "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favorable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.1 0.2 49.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 3.0 1.0 1.5 0.2 0.0 12.5 0.3 63.7 0.0 0.0 40.1 9.8 0.0 53.0 18.3 10.9 0.0 32.7 0.0 12.6 0.0 0.2 1.4 0.0 2.8 0.1 20.6 0.0 0.6 0.0 3.3 1.1 0.0 0.0 2.8 3.8 1.6 3.4 7.2 0.4 256.0 11.9 0.0 0.1 0.7 0.3 0.1 0.1 0.0 8.0 0.5 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.5;ASC TERT1: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064714, HPA074007" Enhanced Supported Nucleoplasm,Mitochondria NA NA 270000 Mitochondria Nucleoplasm "HPA064714: AB_2685334, HPA074007: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favorable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.9 5.8 1.6 1.9 73.5 58.1 5.0 5.8 15.3 3.8 5.1 6.2 18.5 9.2 3.0 22.0 4.3 13.8 4.7 8.4 6.5 8.0 3.8 11.5 4.1 7.7 4.9 2.2 5.9 32.2 6.9 7.3 6.6 9.8 12.0 4.8 0.3 19.2 4.3 9.8 9.1 2.6 8.9 12.3 5.6 1.9 6.1 6.9 5.2 16.3 7.7 3.0 8.2 9.1 8.2 9.9 9.0 6.9 10.2 3.8 3.4 4.1 4.2 14.8 9.8 6.9 7.4 5.0 5.0 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 32.8 21.6 15.9 31.4 62.7 7.6 9.3 56.0 14.7 9.1 101.2 221.9 44.4 3.3 16.4 2.4 38.4 140.4 0.0 31.4 7.9 49.9 25.3 98.1 132.6 20.0 6.4 151.0 54.0 50.8 2.9 101.8 39.6 70.9 122.6 158.5 6.7 33.4 123.8 75.0 23.3 44.8 38.8 27.0 1.4 1.7 65.0 59.0 15.3 134.8 29.5 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Cell type enriched" "Detected in many" 6 "Enterocytes: 518.3" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria No NA Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favorable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.8 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.9 0.0 0.1 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 14.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 0.0 0.6 1.5 0.1 0.0 0.0 0.0 2.5 10.7 0.0 0.0 0.0 0.0 11.6 0.0 48.8 0.0 518.3 0.0 0.0 0.0 0.0 0.0 4.6 1.5 0.1 0.0 1.7 0.6 0.0 9.7 0.3 0.0 0.0 0.0 7.7 0.0 0.0 84.2 0.0 54.0 0.0 6.5 0.0 1.5 0.4 0.0 0.1 0.0 19.7 0.0 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;placenta: 41.8" "Group enriched" "Detected in some" 5 "Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in single" 27 "pons and medulla: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 107.1" "Region enriched" "Detected in some" 4 "pons and medulla: 8.2" "Region enriched" "Detected in single" 32 "pons and medulla: 23.1" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 2.4 20.4 0.3 0.1 0.1 0.0 1.8 0.1 0.3 3.2 0.3 0.3 0.1 0.0 4.5 7.2 0.8 0.4 0.4 0.1 0.1 0.0 0.4 1.0 0.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 41.8 9.7 0.5 0.1 0.1 1.6 1.7 0.1 11.4 0.4 1.0 0.2 0.1 0.2 8.3 0.2 0.1 0.2 0.9 0.5 0.5 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 107.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 9.7 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.9 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.4 4.7 0.0 0.0 0.0 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Group enriched" "Detected in many" 7 "Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" NA NA Mitochondria "Centriolar satellite" "HPA058971: AB_2683865, HPA065520: AB_2685502" "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.4 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 0.9 1.3 4.5 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.5 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 1.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 3.0 1.0 1.9 0.5 1.1 1.9 0.8 0.0 0.0 0.0 0.0 15.7 0.4 1.7 0.3 118.1 0.7 0.0 0.0 0.4 0.2 1.5 0.8 0.0 0.0 1.1 3.2 0.0 0.6 4.1 86.8 4.9 0.8 1.7 1.8 0.0 2.7 0.7 0.0 2.8 0.6 5.0 0.0 1.4 121.2 8.1 0.5 0.5 1.0 0.0 0.5 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: AB_2684257" "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favorable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favorable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favorable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.1 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 1.4 2.6 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.3 2.9 5.0 2.1 3.1 5.1 3.5 5.9 4.9 5.3 1.1 5.7 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 1.6 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 77.4 85.3 270.8 168.6 148.1 59.5 296.6 234.4 179.3 92.1 193.7 19.6 251.6 485.7 138.8 92.3 121.8 346.2 0.0 174.6 167.3 105.2 269.9 91.0 309.5 220.1 52.4 331.5 110.5 164.5 80.6 175.2 186.8 200.8 116.4 276.7 86.2 148.7 295.1 140.0 446.7 82.0 122.9 137.7 196.7 54.5 239.6 258.2 167.5 271.3 230.0 SMG9 "C19orf61, FLJ12886" ENSG00000105771 "SMG9, nonsense mediated mRNA decay factor" Q9H0W8 19 43727992-43754990 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 79.9;Late spermatids: 263.1;Syncytiotrophoblasts: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041763, HPA042096" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA041763: AB_2677659, HPA042096: AB_2677845" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (7.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-2)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.71e-1)" "unprognostic (4.11e-2)" "unprognostic (9.24e-3)" "unprognostic (3.88e-2)" "unprognostic (8.76e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "prognostic favorable (8.09e-4)" 10.0 14.6 18.1 16.9 24.5 12.4 14.9 25.0 24.8 13.2 12.0 21.6 11.5 13.4 11.6 13.8 11.2 10.9 11.7 9.4 16.5 15.6 10.2 8.5 11.9 19.3 36.0 14.2 10.2 8.1 14.9 14.2 16.6 23.1 14.7 11.0 9.2 14.0 12.7 9.1 12.3 11.7 13.9 20.4 17.1 14.2 40.9 29.6 13.2 10.8 4.1 19.3 11.1 12.0 9.2 8.0 3.6 12.2 4.6 8.3 10.7 12.5 13.9 10.2 6.5 7.1 10.2 6.8 18.0 10.8 20.1 15.2 9.7 16.7 13.8 8.8 12.3 6.9 5.5 11.8 10.0 13.2 10.5 6.7 24.7 9.9 6.4 8.3 18.6 13.6 5.4 8.6 14.6 15.7 17.0 8.1 12.8 18.5 12.3 9.3 8.9 19.7 5.2 4.9 24.2 9.4 10.5 8.4 6.1 10.7 10.3 17.0 8.4 18.7 14.3 10.6 8.5 8.6 10.3 9.8 31.6 18.5 11.6 13.7 6.0 12.8 16.5 9.5 14.3 25.6 1.0 6.1 3.6 6.3 9.0 5.6 9.2 6.4 5.3 8.0 6.7 8.3 5.7 1.5 4.6 12.2 7.0 4.6 10.7 18.1 24.5 25.0 24.8 16.5 15.6 36.0 14.2 23.1 29.6 29.8 8.8 13.4 13.4 8.2 12.2 3.6 5.1 8.1 3.4 8.7 3.9 39.8 1.7 10.4 79.9 8.0 8.1 0.0 7.6 12.2 8.3 12.6 9.2 2.6 18.5 12.7 4.1 9.2 8.2 263.1 12.0 10.7 10.1 21.6 8.3 5.6 10.0 5.8 11.3 5.7 9.1 6.5 4.7 16.3 15.8 6.1 79.8 10.0 9.0 8.8 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 90.6" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 211.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047771: AB_2680150" "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favorable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favorable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 11.1 47.3 6.8 9.3 12.0 4.1 15.9 10.3 13.4 6.0 8.7 3.2 16.0 7.5 5.2 16.3 5.5 5.0 13.0 90.6 8.4 6.1 12.2 9.3 21.7 26.5 8.5 6.9 19.1 28.3 6.2 22.1 4.1 17.4 10.6 6.7 10.5 25.8 19.1 66.8 6.7 7.9 17.0 9.1 5.7 8.5 14.1 7.6 1.8 17.3 30.8 5.3 7.0 5.3 13.7 26.2 8.8 24.7 11.0 16.9 10.4 23.0 8.1 9.5 24.0 11.2 5.8 19.4 10.5 4.9 12.1 10.6 9.9 6.2 10.0 4.8 4.4 12.2 12.2 3.1 8.4 4.9 6.6 24.6 9.4 23.2 19.9 17.0 11.1 13.1 12.5 5.2 10.2 7.4 6.6 11.0 11.0 12.4 15.0 8.1 10.0 10.3 15.6 16.1 12.7 17.3 7.1 9.1 19.7 6.7 10.1 10.3 13.0 20.5 6.8 19.8 5.6 7.0 9.4 9.7 6.7 22.0 31.6 21.3 17.5 19.0 21.9 36.8 20.9 9.2 3.5 24.7 8.8 10.8 18.7 10.5 13.7 15.6 13.2 26.2 12.5 16.9 15.2 0.9 11.0 7.5 14.0 14.9 10.4 6.8 12.0 10.3 13.4 8.4 6.1 8.5 6.9 17.4 7.6 44.7 44.8 30.4 29.5 24.2 16.1 211.3 61.1 62.9 77.3 50.6 11.8 35.0 180.8 36.8 15.8 36.5 60.3 0.0 74.3 16.7 27.7 17.7 56.7 143.5 98.6 3.2 76.2 60.8 84.6 8.0 60.1 52.8 35.4 17.2 57.4 43.6 50.1 28.1 95.1 134.6 12.7 45.3 51.1 7.7 15.8 30.2 23.1 25.9 67.6 18.2 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266316-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.5;Horizontal cells: 28.6;Rod photoreceptor cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 9 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "GAMG: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA049393: AB_2680744" "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favorable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 2.9 5.0 26.7 3.0 22.5 1.6 1.8 14.4 36.2 3.5 3.5 3.1 5.9 3.1 4.5 3.9 3.6 4.7 4.8 4.7 26.8 15.3 2.1 0.9 2.6 3.1 12.8 17.5 2.4 6.1 6.2 5.8 1.7 17.1 5.5 2.2 3.1 9.9 19.2 6.1 1.9 3.1 8.1 3.8 2.1 5.1 2.7 4.4 0.1 4.5 0.1 2.0 3.6 1.6 0.1 0.4 0.0 0.0 0.0 3.5 1.2 2.2 6.6 0.1 6.7 8.0 4.4 0.0 4.0 5.3 4.5 2.1 0.2 0.7 0.4 2.4 4.9 11.2 1.2 1.0 5.7 0.8 1.4 1.8 4.2 1.1 0.1 4.2 0.0 6.9 2.8 2.8 4.5 0.9 4.5 5.7 4.5 0.8 0.2 4.1 0.0 0.4 0.2 2.4 0.0 5.6 0.0 1.4 0.1 6.0 3.2 0.4 2.0 3.9 0.2 5.8 0.7 0.3 0.1 9.7 7.3 5.4 6.4 1.1 0.6 1.2 0.0 3.9 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.1 0.8 0.9 0.1 0.1 3.5 3.2 0.0 0.0 0.0 0.4 0.4 1.2 26.7 22.5 14.4 36.2 26.8 15.3 12.8 17.5 17.1 4.4 0.0 0.0 0.0 0.1 0.1 19.5 4.3 5.1 0.0 0.0 3.5 5.9 0.0 0.0 0.4 8.3 0.6 0.0 0.0 0.5 0.0 0.8 0.9 0.0 0.0 0.2 28.6 8.1 1.8 0.0 3.2 1.4 0.0 0.0 0.0 0.9 2.9 1.7 0.0 3.9 1.3 19.9 6.5 1.0 0.6 0.1 0.1 0.0 0.0 1.3 0.0 SOX4 ENSG00000124766 "SRY-box 4" Q06945 6 21592768-21598619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.8" "Group enriched" "Detected in all" 4 "dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0" "Cell line enhanced" "Detected in many" "AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2" "Region enriched" "Detected in many" 4 "olfactory region: 66.5" "Low region specificity" "Detected in many" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 4.2 0.7 2.0 1.9 0.9 6.0 6.3 3.0 6.3 6.7 2.8 3.0 18.0 4.1 2.3 4.2 5.5 2.0 1.1 1.8 4.3 1.3 5.1 0.8 0.6 18.1 5.3 0.0 1.8 1.0 4.1 3.7 9.6 1.4 0.3 4.1 2.7 4.9 0.3 1.0 4.4 2.5 3.4 1.4 6.2 3.6 3.1 21.8 12.8 10.0 3.3 1.1 2.0 1.8 5.2 13.3 55.4 4.9 1.2 21.7 0.8 1.7 1.0 0.9 3.5 3.5 0.6 22.2 1.3 0.7 5.4 6.9 3.8 0.7 7.6 14.5 0.5 2.4 2.3 0.8 1.8 0.4 2.1 3.9 0.4 1.6 14.2 15.6 30.0 0.1 0.0 1.1 4.3 47.6 4.5 9.9 2.6 5.0 21.0 1.1 0.0 9.6 16.7 17.4 31.2 7.7 9.0 2.9 17.3 4.4 6.5 11.9 1.5 5.2 0.3 3.9 0.3 0.0 15.4 0.5 6.5 6.1 12.8 9.8 0.9 0.2 5.5 0.0 2.8 0.1 0.1 4.1 3.1 1.1 0.8 0.4 3.3 10.0 21.8 0.9 2.0 184.6 59.8 33.5 82.0 99.9 88.8 228.6 341.4 161.9 235.4 146.5 11.8 61.5 56.3 757.4 3.9 238.0 78.0 0.0 523.0 358.6 243.9 126.1 56.8 5.8 33.0 46.1 327.2 70.6 85.2 8.3 11.2 56.1 231.2 80.2 156.9 228.7 1059.7 155.6 10.6 77.4 25.8 6.5 198.6 3.7 175.2 81.3 25.3 23.5 265.6 178.0 SP140 "LYSP100-A, LYSP100-B" ENSG00000079263 "SP140 nuclear body protein" Q13342 2 230203110-230313215 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.2;lymphoid tissue: 46.8" "Group enriched" "Detected in many" 4 "B-cells: 77.6;Erythroid cells: 23.3;T-cells: 44.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 36.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.0;HDLM-2: 30.1;Karpas-707: 15.0;RPMI-8226: 9.3" "HPA006162, HPA067493" Enhanced Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" Mitochondria "HPA006162: AB_1857403, HPA067493: AB_2685851" "unprognostic (8.15e-3)" "unprognostic (2.25e-3)" "unprognostic (3.90e-3)" "unprognostic (5.72e-4)" "unprognostic (5.66e-2)" "unprognostic (3.33e-4)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (6.05e-2)" "unprognostic (1.12e-3)" "unprognostic (3.89e-2)" "unprognostic (2.88e-1)" "unprognostic (1.20e-9)" "unprognostic (9.12e-2)" "unprognostic (8.50e-2)" "unprognostic (3.66e-1)" "unprognostic (9.30e-3)" 1.9 0.8 0.9 39.1 1.1 2.9 1.1 0.5 0.7 0.7 2.3 0.5 0.0 1.4 0.6 0.9 3.5 0.8 1.4 0.8 0.9 1.0 1.1 1.1 6.3 26.9 1.4 0.0 0.7 0.4 0.0 0.9 0.6 0.6 1.0 2.0 1.0 8.9 0.1 0.3 0.7 13.1 0.3 2.0 34.9 2.3 1.3 0.7 4.0 1.3 1.7 46.8 4.8 0.9 36.2 3.0 12.6 3.6 5.1 10.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 18.0 0.0 0.0 3.1 0.0 0.0 0.0 1.1 30.1 0.0 0.0 0.0 0.4 0.1 2.5 0.1 0.3 0.0 0.3 0.4 0.2 0.0 0.1 0.0 15.0 0.3 0.0 0.0 0.8 0.8 0.0 0.0 0.0 1.7 9.3 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.8 0.0 0.0 5.5 2.2 0.6 1.3 0.4 0.0 0.0 1.3 4.1 9.0 2.6 10.0 36.2 9.0 9.7 3.0 25.1 4.6 6.1 12.6 5.1 3.6 0.2 7.8 3.6 0.9 1.1 0.5 0.7 0.9 1.0 1.4 0.0 0.6 0.7 0.0 2.9 77.6 0.0 0.8 0.7 0.4 0.0 2.7 1.2 0.0 7.9 0.1 0.0 0.0 10.8 0.6 0.0 23.3 0.0 0.1 0.9 0.1 0.0 0.8 10.0 0.0 0.0 3.1 6.3 3.0 0.0 10.1 6.8 10.0 0.0 0.5 0.2 0.0 1.1 0.3 1.6 0.0 0.4 1.4 0.4 1.0 0.2 44.0 0.0 0.1 SRBD1 FLJ10379 ENSG00000068784 "S1 RNA binding domain 1" Q8N5C6 2 45388680-45612165 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030567, HPA030568" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA030567: AB_10611244, HPA030568: AB_10601856" "unprognostic (1.16e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-3)" "unprognostic (2.46e-1)" "unprognostic (8.20e-3)" "unprognostic (4.14e-1)" "unprognostic (8.69e-3)" "unprognostic (9.74e-2)" "unprognostic (7.11e-2)" "unprognostic (9.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.76e-1)" "unprognostic (3.42e-3)" "unprognostic (3.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (2.29e-1)" 11.7 9.8 5.5 12.2 7.5 6.8 10.9 6.3 6.8 13.8 10.4 6.3 15.7 6.7 19.3 14.9 8.0 8.6 7.4 9.4 5.5 5.8 11.6 13.2 8.7 11.0 6.4 4.7 11.2 14.9 25.1 20.9 11.5 8.7 12.7 9.9 8.4 16.6 14.5 9.5 8.4 10.7 8.3 7.3 13.9 9.9 12.2 8.0 16.5 12.5 6.1 11.3 9.7 9.4 6.1 7.0 14.3 13.0 9.2 7.7 4.9 13.7 7.1 14.7 9.8 5.4 12.0 11.6 10.6 9.3 10.2 9.4 5.9 5.9 11.9 7.9 7.5 7.6 6.5 14.4 13.4 18.9 16.2 8.0 15.8 5.7 12.7 6.4 13.1 9.3 7.2 5.6 12.0 14.1 4.5 12.2 4.4 11.2 9.0 15.0 12.4 17.5 10.0 16.7 8.9 7.8 12.1 21.1 10.8 11.6 9.0 12.9 10.5 9.3 10.1 10.3 8.0 6.2 4.8 11.3 14.3 11.4 6.8 9.1 9.6 3.5 7.2 8.0 13.0 10.2 3.4 7.2 14.3 6.6 7.9 5.8 6.1 4.9 7.7 7.0 5.3 6.9 6.2 2.6 9.2 13.0 6.7 5.0 4.9 5.5 7.5 6.3 6.8 5.5 5.8 6.4 4.7 8.7 8.0 17.9 4.8 7.3 3.2 3.2 7.6 8.5 12.7 9.4 13.6 3.5 3.9 7.0 8.3 6.5 2.8 8.7 5.4 0.0 8.0 5.9 6.6 2.8 8.1 11.0 8.7 12.7 6.9 6.7 9.9 1.5 6.9 9.2 6.8 10.0 8.2 14.7 4.6 6.8 6.0 8.5 13.5 12.9 3.4 24.1 26.4 3.3 4.7 9.6 4.7 1.3 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming beta subunit" Q96I99 3 67360460-67654614 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.9" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 290.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Approved "Plasma membrane,Mitochondria" NA NA 290000 Mitochondria "Plasma membrane" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favorable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 17.0 19.3 8.8 26.5 10.0 3.4 12.4 2.4 7.2 15.3 38.9 9.5 16.4 31.4 11.5 18.3 18.6 9.9 27.9 23.6 6.6 6.2 38.3 90.9 14.6 21.1 9.8 6.5 16.5 20.9 5.9 8.5 8.5 7.6 14.0 34.5 9.6 21.0 17.3 57.0 9.3 42.4 23.5 8.6 24.7 25.4 6.5 8.1 9.6 16.4 27.0 16.7 19.9 13.2 19.2 10.2 5.8 18.2 27.1 31.1 18.9 12.8 11.2 11.1 13.5 18.7 32.4 13.5 15.4 22.5 18.1 20.3 12.3 28.7 16.4 5.0 21.6 11.9 6.6 8.6 21.2 23.5 6.9 5.9 14.8 10.1 19.2 24.1 19.5 10.4 24.2 18.5 14.2 32.6 22.5 19.2 12.6 11.3 15.0 39.4 9.0 7.3 6.2 10.4 58.8 6.9 5.1 17.2 24.5 30.7 19.9 2.2 7.5 24.4 28.2 20.3 7.8 21.7 12.5 16.7 18.0 11.9 19.7 18.2 10.3 15.0 11.5 26.5 15.3 21.1 5.8 15.3 5.2 13.8 18.2 16.7 19.2 20.0 17.4 10.2 16.7 31.1 23.7 0.7 27.1 14.8 4.0 18.5 18.9 8.8 10.0 2.4 7.2 6.6 6.2 9.8 6.5 7.6 8.1 32.8 40.3 57.4 34.0 33.0 2.6 146.2 84.1 61.6 42.1 76.8 7.9 46.8 207.2 71.1 2.4 35.8 224.3 46.7 70.7 37.8 47.4 43.6 29.0 290.2 50.0 4.8 55.9 44.8 60.1 4.1 38.3 46.7 40.5 32.5 187.4 22.3 55.1 140.3 44.6 211.1 3.8 32.3 67.3 1.4 6.8 43.2 31.8 55.8 241.0 45.3 TBC1D15 "DKFZp761D0223, FLJ12085" ENSG00000121749 "TBC1 domain family member 15" Q8TC07 12 71839707-71927248 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013388, HPA015592" Supported Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA013388: AB_2199233, HPA015592: AB_1857789" "unprognostic (3.87e-2)" "prognostic favorable (7.06e-4)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "unprognostic (6.13e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-2)" "unprognostic (4.07e-2)" "unprognostic (2.18e-1)" "prognostic favorable (5.34e-4)" "unprognostic (5.73e-2)" "unprognostic (4.34e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" 37.4 27.4 20.2 14.3 22.5 35.2 26.4 19.6 23.7 21.8 20.2 17.0 19.8 15.1 22.9 15.4 20.2 15.1 20.4 15.4 16.9 16.4 22.3 32.9 24.5 19.0 28.9 18.7 22.7 26.3 19.1 38.0 25.4 23.8 18.0 14.8 12.0 20.6 14.4 44.0 19.2 20.8 19.5 26.3 21.4 17.8 19.4 27.5 22.2 25.9 14.5 18.6 27.5 16.3 5.9 6.3 13.9 8.8 7.2 13.5 6.7 13.9 13.9 11.7 12.0 23.5 23.5 17.8 15.1 34.2 18.8 23.8 9.8 11.8 17.7 10.1 13.8 14.4 8.8 14.4 10.5 20.6 15.6 12.2 16.8 13.4 9.9 19.8 21.4 12.3 22.8 13.3 14.4 27.3 26.8 15.6 16.5 16.2 9.9 16.0 10.3 14.2 13.3 24.3 13.4 12.0 11.3 13.4 19.7 14.1 13.5 12.9 11.1 19.9 17.6 16.8 17.5 18.0 15.6 15.7 16.2 7.3 18.4 8.9 25.6 23.5 22.7 9.7 14.1 14.6 2.0 6.8 8.6 8.1 7.0 9.3 5.7 10.1 7.9 6.3 5.9 12.9 11.1 13.9 7.2 8.8 3.8 13.5 6.7 20.2 22.5 19.6 23.7 16.9 16.4 28.9 18.7 23.8 27.5 44.7 61.3 35.0 26.8 52.1 32.3 22.6 17.8 62.9 40.9 17.4 9.8 16.5 11.6 22.6 88.2 47.2 16.6 0.0 22.2 13.1 33.3 37.8 31.4 33.4 20.8 49.3 13.2 81.0 48.0 11.5 32.2 32.3 30.4 19.8 19.1 26.9 22.6 11.5 30.8 28.6 24.5 19.4 30.7 44.0 22.1 59.8 32.0 28.8 14.5 29.8 TEX10 "bA208F1.2, FLJ20287, Ipi1" ENSG00000136891 "Testis expressed 10" Q9NXF1 9 100302077-100352939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045434 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA045434: AB_10965650" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" "unprognostic (1.21e-1)" "unprognostic (8.28e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (2.43e-2)" "unprognostic (3.74e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-1)" "unprognostic (7.39e-2)" "unprognostic (3.27e-1)" "unprognostic (2.66e-3)" "unprognostic (9.63e-3)" 11.1 8.5 7.6 14.0 10.1 12.2 11.3 12.6 11.1 12.2 9.5 7.7 7.5 6.1 14.2 9.9 12.5 12.1 10.3 10.4 7.7 7.1 7.5 7.9 9.7 15.1 7.3 5.9 14.9 10.3 9.8 13.5 25.4 9.4 10.2 8.1 6.3 10.2 9.1 25.4 16.2 8.7 11.8 9.9 14.4 9.2 24.5 7.2 32.9 10.0 10.2 15.0 11.2 11.9 13.0 9.3 12.4 9.0 9.9 12.6 7.2 11.7 12.9 17.0 19.0 6.2 11.1 26.3 14.8 15.4 19.4 18.1 13.2 13.9 33.4 8.0 9.6 17.9 16.0 24.2 19.1 22.8 13.4 10.7 18.1 8.4 11.5 13.4 26.2 13.6 9.6 10.8 19.7 20.9 9.6 10.5 11.9 20.2 11.0 25.0 18.4 19.1 16.8 34.7 22.9 15.6 18.7 29.0 10.1 14.3 7.7 15.1 12.8 8.1 13.5 13.1 10.9 5.6 7.7 10.7 13.0 11.5 17.3 13.8 7.8 13.2 13.4 13.2 11.8 13.4 12.4 7.6 2.5 9.8 9.0 10.7 12.7 10.0 9.8 9.3 13.0 10.7 12.6 1.9 9.9 6.7 5.4 11.4 7.2 7.6 10.1 12.6 11.1 7.7 7.1 7.3 5.9 9.4 7.2 3.0 9.4 10.0 8.3 19.7 6.7 10.6 0.0 6.7 17.0 8.7 11.8 44.5 3.3 5.8 9.9 8.3 2.1 0.0 7.5 12.7 13.0 6.1 16.2 6.8 8.4 7.9 5.1 6.7 3.8 10.0 8.1 7.5 16.9 7.2 5.2 3.4 6.3 5.3 7.4 3.0 5.9 0.0 12.8 28.4 34.5 19.7 38.6 6.5 6.0 7.1 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFAP4 "AP-4, bHLHc41" ENSG00000090447 "Transcription factor AP-4" Q01664 16 4257186-4273075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001912 Supported Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA001912: AB_1080251" "unprognostic (1.61e-2)" "unprognostic (1.36e-1)" "unprognostic (5.10e-2)" "unprognostic (4.42e-3)" "unprognostic (8.61e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (8.05e-2)" "unprognostic (8.97e-2)" "unprognostic (4.60e-1)" "unprognostic (5.75e-2)" "unprognostic (7.68e-2)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "unprognostic (1.30e-1)" 8.2 7.0 9.6 11.8 9.6 3.4 7.3 31.6 15.6 10.0 6.8 6.6 5.7 11.1 10.1 3.7 9.9 12.5 7.0 4.8 8.0 6.3 4.4 6.3 5.5 11.1 11.1 7.1 18.7 22.2 6.3 6.7 6.9 8.8 9.0 3.9 6.1 13.2 7.0 8.6 12.2 10.1 5.5 12.8 10.2 8.3 3.1 14.9 13.0 8.4 4.5 7.3 7.4 11.0 1.7 0.5 0.9 0.1 0.1 1.2 1.0 7.0 7.4 6.4 9.4 2.7 7.3 10.7 2.7 7.3 4.8 5.2 3.8 11.1 24.2 7.2 2.7 2.2 10.5 11.7 9.4 1.5 14.2 8.3 7.4 6.9 9.9 3.8 13.0 4.3 6.7 6.1 5.2 14.7 2.2 3.1 8.2 13.7 6.5 1.8 11.1 18.3 21.5 14.7 7.1 9.8 16.1 14.3 25.1 1.8 5.3 13.3 10.0 9.2 9.8 9.0 1.0 4.8 10.2 2.0 6.6 5.1 22.9 7.1 10.6 8.8 20.4 4.4 13.0 4.5 0.0 0.0 0.9 0.4 0.0 1.2 1.7 0.2 0.0 0.3 0.4 0.3 0.7 0.0 0.1 0.1 0.5 0.2 1.0 9.6 9.6 31.6 15.6 8.0 6.3 11.1 7.1 8.8 14.9 3.0 0.0 9.1 8.8 19.2 4.4 2.0 10.2 1.4 1.2 26.2 0.0 7.1 6.6 3.4 0.0 2.9 5.4 0.0 4.9 10.4 8.4 3.9 0.0 2.4 3.7 0.0 7.5 4.9 4.1 0.0 10.9 2.9 3.3 0.0 13.4 1.9 2.7 3.5 4.9 3.8 2.1 6.5 6.6 0.9 0.7 19.4 1.8 8.7 15.8 3.3 TFCP2L1 "CRTR1, LBP-9" ENSG00000115112 "Transcription factor CP2 like 1" Q9NZI6 2 121216587-121285207 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 7.0" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 7 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA029708 Uncertain Approved "Nucleoli fibrillar center,Mitochondria" Yes NA "Nucleoli fibrillar center" Mitochondria "HPA029708: AB_10602479" "unprognostic (8.85e-3)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (1.48e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (3.25e-2)" "unprognostic (2.72e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "prognostic favorable (7.72e-6)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (6.67e-3)" "unprognostic (2.01e-1)" 1.0 0.2 0.6 4.0 1.1 0.0 12.9 0.6 0.9 8.7 8.5 1.2 6.3 0.2 0.8 8.2 6.0 1.5 8.7 0.1 0.6 0.1 52.2 0.1 12.3 1.5 0.4 0.0 0.6 2.8 0.4 1.5 4.7 7.0 6.1 10.5 0.8 93.5 2.9 2.4 13.1 1.3 0.4 0.4 0.9 6.2 0.8 0.3 0.4 37.3 7.2 6.3 1.4 4.1 0.0 0.1 0.1 0.1 0.4 2.9 0.0 0.0 1.0 0.0 0.1 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.4 0.0 0.4 0.2 2.7 2.7 0.0 0.0 1.9 9.4 0.0 0.0 0.0 0.0 0.3 0.0 10.8 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.3 1.2 26.7 19.3 8.3 0.0 1.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.9 0.6 0.1 0.4 0.0 7.0 0.3 6.0 20.8 0.0 45.7 1.4 0.0 2.2 25.5 0.0 12.5 75.0 0.0 23.2 26.6 2.2 0.1 0.1 75.7 0.0 1.3 1.2 0.6 33.2 0.0 0.2 4.3 0.0 9.8 0.0 5.4 0.0 0.3 2.1 6.8 0.0 37.4 0.4 4.7 34.0 0.0 23.2 0.0 0.0 0.1 0.0 0.2 2.9 16.9 0.0 34.7 33.5 TIMM13 "Tim13, TIMM13B" ENSG00000099800 "Translocase of inner mitochondrial membrane 13" Q9Y5L4 19 2425624-2427894 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048985 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA048985: AB_2680589" "unprognostic (5.47e-2)" "unprognostic (6.63e-2)" "unprognostic (7.15e-2)" "prognostic favorable (4.68e-5)" "unprognostic (8.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.37e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-1)" "unprognostic (1.53e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.91e-2)" "prognostic favorable (3.88e-5)" "unprognostic (4.00e-2)" "unprognostic (3.35e-2)" "unprognostic (4.33e-1)" "unprognostic (2.47e-2)" 18.5 38.2 21.7 21.3 19.9 25.0 15.7 15.9 28.6 14.6 26.4 18.5 19.8 43.0 14.2 20.4 32.5 17.1 22.9 28.1 20.6 19.1 29.4 49.8 13.6 20.7 23.1 19.3 22.5 57.0 9.7 16.9 21.5 21.1 20.6 14.7 16.7 32.7 26.1 56.6 22.3 34.5 13.7 17.3 21.7 25.6 33.3 17.4 23.6 20.0 44.6 18.5 15.7 17.4 21.1 72.7 10.5 36.1 19.6 21.0 24.5 29.0 30.5 11.1 21.9 6.3 6.3 15.3 17.0 6.0 12.5 9.2 43.9 14.8 17.5 6.1 5.6 9.2 21.5 17.2 23.1 3.5 16.1 60.4 14.6 29.6 33.4 18.0 28.2 16.0 14.8 12.5 13.7 9.4 8.6 15.0 23.2 29.5 26.3 4.9 12.1 33.2 38.8 31.0 23.7 44.8 25.1 8.9 47.1 12.1 25.0 41.3 38.0 7.7 31.4 19.5 5.2 20.9 31.4 14.0 14.8 16.4 27.6 33.8 41.5 21.3 18.3 15.2 38.7 22.4 6.3 36.1 10.5 14.5 33.2 17.8 21.1 16.6 15.2 32.6 19.9 21.0 17.9 2.3 19.6 19.5 72.7 16.3 24.5 21.7 19.9 15.9 28.6 20.6 19.1 23.1 19.3 21.1 17.4 47.6 68.0 116.2 113.2 207.0 40.2 121.0 165.6 61.6 52.4 123.9 3.9 298.1 356.4 234.7 53.8 96.6 287.7 46.7 331.2 342.2 152.2 160.2 61.1 358.4 276.3 25.4 184.3 95.2 160.0 96.5 119.0 123.6 214.2 119.0 243.4 60.1 263.5 192.9 93.0 418.3 36.8 51.8 100.2 95.0 119.4 241.4 237.7 84.3 327.1 151.1 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955491-201970661 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavorable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 16.6 27.6 22.7 18.7 23.2 16.9 16.8 16.3 29.3 16.5 19.3 9.9 19.2 17.2 15.0 24.1 17.9 11.8 10.7 39.0 32.3 19.6 25.1 53.7 13.5 15.3 20.6 27.0 11.2 18.7 21.5 14.8 17.4 25.0 14.5 21.8 11.7 24.8 17.1 42.1 11.5 13.0 19.6 13.4 14.4 16.3 13.7 14.2 11.3 21.6 30.4 18.9 15.9 12.7 17.6 28.9 16.0 24.9 15.9 20.6 17.8 26.4 27.0 24.5 29.3 20.7 21.7 41.4 42.3 30.3 34.8 31.3 31.6 27.6 36.7 15.6 36.2 25.5 21.2 44.9 25.3 37.5 26.9 28.1 20.2 35.9 29.9 21.4 43.1 21.8 25.0 28.2 35.5 29.8 25.1 36.3 23.2 51.0 20.6 40.8 16.9 23.1 23.4 31.1 26.7 14.6 22.9 28.5 46.0 42.7 25.2 37.0 26.2 25.9 66.4 39.1 32.5 36.7 29.3 29.0 23.3 24.7 27.0 43.9 31.3 33.7 30.8 24.8 32.9 25.9 8.9 19.0 16.0 13.6 24.9 17.5 17.6 14.9 17.2 28.9 12.7 14.2 16.7 4.4 15.9 24.7 19.3 20.6 17.8 22.7 23.2 16.3 29.3 32.3 19.6 20.6 27.0 25.0 14.2 35.7 37.0 55.2 74.7 81.9 22.9 117.0 40.8 46.8 42.1 36.6 33.4 102.6 116.0 97.2 44.4 41.4 33.9 0.0 74.9 170.0 67.6 57.0 54.3 165.4 105.8 33.4 32.6 35.6 45.4 26.9 31.1 72.6 50.6 99.2 41.2 32.7 83.8 23.0 36.0 93.3 25.4 25.8 62.2 38.1 50.8 86.4 222.1 56.4 49.3 91.8 TIMM17B "DXS9822, JM3" ENSG00000126768 "Translocase of inner mitochondrial membrane 17B" O60830 X 48893447-48898143 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029093 Approved Approved Microtubules,Mitochondria NA NA Microtubules Mitochondria "HPA029093: AB_10600913" "unprognostic (7.87e-2)" "prognostic favorable (6.63e-4)" "unprognostic (8.44e-2)" "unprognostic (3.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-3)" "unprognostic (1.44e-1)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.04e-1)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (9.40e-2)" "unprognostic (5.24e-3)" "unprognostic (8.67e-2)" "prognostic favorable (7.88e-4)" 14.0 21.1 23.6 15.0 24.2 18.6 16.4 15.1 30.8 16.9 22.3 18.9 13.3 19.2 15.1 19.2 27.4 21.0 19.4 40.6 19.8 17.7 26.2 40.1 19.6 18.3 19.0 15.8 17.8 28.7 19.3 22.9 28.2 15.4 22.4 15.0 19.8 21.5 22.8 54.3 16.1 24.8 15.7 20.5 22.1 18.8 16.7 12.5 36.4 31.1 27.2 19.5 21.6 13.7 36.7 41.5 56.2 41.2 22.9 26.7 35.5 18.5 34.4 21.7 21.2 6.8 5.5 17.9 8.4 13.0 22.4 14.7 30.1 25.3 13.9 13.1 7.4 36.3 14.2 34.0 18.3 8.5 29.2 38.3 10.0 19.7 26.5 19.2 14.7 9.8 7.2 18.4 16.8 22.4 11.2 10.3 24.4 14.7 32.5 10.2 48.3 23.1 36.1 28.0 24.7 32.2 16.4 14.1 49.4 21.9 11.0 21.6 19.3 13.1 21.0 12.5 28.6 45.8 25.9 7.0 10.3 20.2 24.7 14.4 30.1 34.9 16.6 14.3 26.4 12.1 44.4 41.2 56.2 23.4 39.0 26.7 36.7 23.7 26.4 39.5 36.1 23.1 21.2 46.5 22.9 31.5 41.5 23.4 35.5 23.6 24.2 15.1 30.8 19.8 17.7 19.0 15.8 15.4 12.5 23.8 27.5 51.4 44.2 26.9 39.2 36.7 45.9 28.1 17.0 69.8 15.7 89.4 157.5 83.6 4.1 21.6 57.2 46.7 63.8 82.3 26.4 51.5 51.8 47.3 83.3 33.4 78.4 21.5 43.0 6.3 22.2 43.6 42.2 101.8 59.2 31.6 75.0 89.2 21.5 129.9 28.0 32.3 40.1 19.4 36.8 30.1 66.6 44.6 55.4 49.4 TIMM29 C19orf52 ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928733-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 31.3;Extravillous trophoblasts: 25.5;Hofbauer cells: 19.8;monocytes: 26.2;Syncytiotrophoblasts: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favorable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favorable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 13.4 11.4 13.8 11.0 18.0 18.4 8.0 19.9 16.4 8.5 9.9 10.3 7.6 17.5 11.3 7.1 13.8 8.6 9.4 12.5 15.1 8.9 10.5 13.5 8.1 11.6 13.5 9.3 8.3 17.1 7.0 10.8 12.2 11.9 9.9 5.1 11.3 16.8 9.5 30.9 12.1 12.4 10.3 8.3 11.7 15.0 11.3 13.2 12.0 9.2 8.9 9.7 10.1 10.6 13.6 10.3 8.7 8.7 10.9 12.0 3.2 10.7 3.9 3.1 5.2 2.7 2.6 8.9 7.5 3.8 5.4 5.0 7.0 3.5 9.1 13.3 3.4 2.9 10.0 1.6 4.4 0.9 10.9 13.1 10.5 4.0 4.7 4.3 7.5 8.0 2.2 4.3 3.7 1.5 2.1 3.2 7.8 11.4 7.7 2.0 8.8 8.5 14.6 11.3 3.2 17.4 11.6 4.5 11.0 2.2 4.1 8.1 8.4 8.6 4.5 8.8 1.2 6.5 8.2 5.4 8.7 5.3 11.1 11.4 26.7 26.0 9.7 5.4 9.6 7.2 3.5 7.9 8.7 5.6 8.7 8.8 13.6 10.8 12.0 5.6 10.6 10.1 8.5 1.7 10.9 6.7 10.3 11.0 3.2 13.8 18.0 19.9 16.4 15.1 8.9 13.5 9.3 11.9 13.2 3.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 15.7 0.0 31.3 16.6 17.6 0.0 0.0 0.0 0.0 9.2 25.5 0.0 0.0 1.1 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 26.2 0.0 0.0 13.2 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 TIMM50 TIM50L ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 445.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: AB_2683137" "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 21.3 20.2 17.9 17.0 25.8 23.0 15.7 14.3 38.2 13.4 18.4 18.0 14.4 18.0 19.0 11.7 22.6 15.8 12.5 42.2 17.6 17.4 23.9 28.0 14.2 16.6 17.8 20.2 16.4 19.8 16.4 13.4 20.0 22.0 15.3 12.0 18.1 18.3 14.6 58.1 14.0 16.1 16.5 12.7 15.1 16.9 40.4 14.7 18.5 24.0 25.5 16.9 16.9 18.2 19.3 27.4 10.3 25.3 17.0 19.9 27.8 26.5 63.9 11.9 29.6 10.5 9.5 21.6 21.0 10.8 25.0 20.4 45.7 18.8 30.1 22.4 14.2 14.0 15.3 23.8 21.7 13.3 26.2 34.6 27.9 18.7 31.6 15.9 54.3 19.3 12.2 15.5 18.7 17.1 7.1 16.2 35.8 44.6 18.1 15.7 35.2 33.2 20.9 20.7 31.3 24.4 33.9 23.7 23.2 17.2 36.7 31.5 17.7 25.3 36.8 43.2 8.6 17.2 29.6 16.2 31.0 28.9 25.5 48.9 17.1 31.4 45.4 23.3 27.3 34.4 10.3 25.3 6.1 16.9 24.0 17.3 19.3 16.2 18.5 27.4 18.1 18.4 17.0 2.1 17.0 22.4 20.6 19.9 27.8 17.9 25.8 14.3 38.2 17.6 17.4 17.8 20.2 22.0 14.7 20.8 24.2 14.2 35.2 23.1 10.0 41.2 22.9 12.0 23.9 24.4 11.8 72.5 56.3 52.0 155.0 24.1 24.2 0.0 44.6 67.0 29.8 28.0 39.2 29.6 59.4 27.0 22.4 19.6 11.8 445.2 21.6 26.0 28.7 22.6 20.3 12.8 42.9 14.4 19.8 53.1 10.4 6.5 34.0 92.9 48.7 23.3 79.1 17.5 42.6 40.9 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498532-119525090 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053214: AB_2682081, HPA055846: AB_2682941" "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 13.6 17.2 18.1 10.4 16.7 5.9 13.8 8.6 16.2 16.4 12.2 20.4 21.5 9.2 13.3 19.4 18.5 13.6 14.9 43.9 15.9 15.4 22.8 20.5 13.0 15.9 20.9 11.9 11.8 12.5 20.4 17.4 21.4 16.4 15.2 14.5 14.0 14.3 21.6 37.2 16.0 15.3 12.7 21.9 14.3 12.3 13.3 15.6 9.9 19.9 20.3 14.5 16.7 11.1 12.4 13.8 16.3 15.5 8.5 15.8 15.5 14.3 13.5 6.7 5.8 26.2 17.7 15.2 4.2 14.1 12.2 14.0 9.1 8.8 10.5 7.3 14.8 8.4 6.8 16.9 13.7 20.0 8.8 6.1 7.7 6.3 10.2 13.8 6.0 5.1 15.5 21.1 9.8 12.8 7.8 17.2 9.9 10.5 10.1 22.4 17.8 6.3 12.7 9.0 12.1 16.8 5.3 4.7 13.8 18.3 7.2 8.9 16.6 4.3 6.6 16.1 9.5 10.8 16.5 8.6 6.9 5.2 6.3 7.3 6.5 6.1 14.3 11.7 15.3 10.8 6.8 13.8 16.3 8.4 13.0 10.1 12.2 8.3 10.3 13.8 12.4 10.4 9.0 3.4 8.5 15.5 11.9 15.8 15.5 18.1 16.7 8.6 16.2 15.9 15.4 20.9 11.9 16.4 15.6 23.8 35.3 16.0 40.6 33.3 24.2 144.4 40.8 61.6 37.5 38.4 13.7 129.0 127.6 61.0 5.3 55.2 40.2 23.3 54.8 92.7 41.0 35.4 40.4 45.5 75.0 20.6 27.6 31.3 30.4 5.2 43.7 39.7 42.2 83.0 41.1 57.9 47.3 40.1 51.2 112.8 25.9 71.1 52.6 99.3 50.0 36.8 148.4 31.6 44.9 43.4 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Cell line enhanced" "Detected in some" "HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria No NA "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 4.0 0.0 0.2 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 0.0 3.6 0.4 0.3 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.9 0.5 7.5 7.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.4 0.0 1.6 0.1 0.0 0.0 7.7 9.5 0.0 0.2 0.4 0.0 1.8 0.2 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 6.0 64.7 0.8 1.1 1.0 0.0 1.2 5.1 2.7 12.5 3.5 0.0 0.1 0.0 4.8 0.3 0.6 0.0 0.0 3.2 0.1 0.9 2.0 3.5 0.9 16.3 0.0 0.0 2.5 106.5 0.0 0.6 52.5 1.7 0.0 0.1 0.0 3.1 0.0 0.4 1.0 0.3 12.9 0.4 0.2 0.4 1.0 0.1 0.7 0.0 1.4 TMCO6 "FLJ39769, PRO1580" ENSG00000113119 "Transmembrane and coiled-coil domains 6" Q96DC7 5 140639427-140645408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037473, HPA037474" Uncertain Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA037473: AB_10671049, HPA037474: AB_10671050" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (3.95e-2)" "unprognostic (1.38e-2)" "unprognostic (6.10e-3)" "unprognostic (1.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.11e-1)" "unprognostic (4.89e-2)" "unprognostic (1.69e-1)" "unprognostic (2.75e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (7.21e-2)" "unprognostic (1.77e-1)" "unprognostic (1.96e-2)" "unprognostic (1.20e-2)" 9.0 15.9 4.0 10.2 6.0 4.9 9.1 9.9 7.9 10.0 10.3 9.6 5.8 5.6 9.6 8.0 9.6 11.8 9.0 5.2 4.4 5.2 6.1 21.4 5.8 9.9 6.1 5.8 13.2 9.9 6.1 7.2 10.5 6.0 7.5 4.3 6.0 16.9 5.9 5.4 7.4 8.5 5.6 6.6 12.0 6.7 19.0 5.2 14.7 8.4 5.5 11.4 7.7 7.7 9.1 7.6 13.4 10.2 4.3 11.3 4.8 3.0 5.9 4.0 5.8 4.0 4.2 14.8 2.5 2.7 3.0 3.2 9.1 5.5 12.1 6.4 1.8 3.5 6.0 3.1 6.7 1.4 4.4 11.2 9.3 2.7 6.3 5.4 5.3 3.5 6.9 1.6 3.8 6.0 2.1 7.1 10.2 3.8 4.0 3.6 5.9 12.1 11.9 4.5 6.9 9.2 10.3 8.3 12.2 3.6 2.7 7.0 2.9 6.9 13.1 6.1 2.5 10.6 6.1 3.3 0.1 2.9 1.1 0.9 7.0 4.1 5.5 1.9 8.2 3.6 10.6 7.3 5.8 6.1 9.9 6.8 9.1 8.1 6.2 7.6 6.4 11.3 4.8 13.4 4.3 10.2 2.1 8.7 4.8 4.0 6.0 9.9 7.9 4.4 5.2 6.1 5.8 6.0 5.2 6.0 1.3 5.1 6.5 1.6 5.0 0.6 2.5 5.3 0.0 10.4 5.9 6.3 0.0 3.2 1.7 4.2 3.5 0.0 2.1 6.8 2.8 3.2 0.0 8.5 4.1 0.0 7.0 6.2 4.1 0.9 3.7 2.7 1.7 4.6 3.7 3.9 3.4 4.3 4.6 1.6 4.2 6.5 2.2 16.6 15.1 1.9 5.3 9.6 6.8 5.7 TMEM141 MGC14141 ENSG00000244187 "Transmembrane protein 141" Q96I45 9 136791355-136793257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 530.6;Enterocytes: 541.1;Paneth cells: 627.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 64.4;T-47d: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014615, HPA050244" Approved Supported "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA014615: AB_2204756, HPA050244: AB_2681061" "unprognostic (2.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (2.00e-1)" "unprognostic (8.53e-3)" "unprognostic (1.52e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.24e-1)" "unprognostic (8.45e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.49e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" 10.0 15.5 15.7 23.4 15.3 15.5 22.9 11.6 28.3 17.2 54.4 21.0 22.4 21.9 9.4 31.1 35.5 22.6 27.9 22.8 15.2 12.2 38.5 43.4 14.4 23.0 19.9 19.3 13.8 46.3 20.6 23.1 31.7 22.0 49.0 51.4 12.5 32.5 27.5 13.5 22.0 25.6 10.5 19.1 14.1 23.3 16.5 13.8 16.3 28.6 26.0 15.2 16.4 16.3 11.1 42.7 9.0 19.4 12.4 11.3 12.2 15.0 11.0 9.8 6.1 12.4 10.0 21.2 8.5 13.4 10.6 8.5 14.5 13.7 14.5 13.3 9.2 9.6 22.6 4.2 25.0 3.4 10.5 7.6 8.1 6.1 16.1 18.1 8.4 10.1 9.6 42.9 8.1 23.0 12.1 15.7 19.3 8.0 7.8 13.8 30.8 11.5 6.5 4.7 64.4 12.4 9.6 10.3 42.7 24.0 8.5 16.5 7.4 9.2 35.1 9.6 8.8 62.6 8.2 10.7 7.6 6.0 13.8 5.5 5.1 7.9 7.7 11.4 12.2 10.8 6.5 13.8 9.0 11.3 19.4 10.2 8.7 7.9 8.1 11.2 11.1 10.9 10.0 3.3 12.4 16.0 42.7 7.5 12.2 15.7 15.3 11.6 28.3 15.2 12.2 19.9 19.3 22.0 13.8 53.6 66.5 48.0 79.9 36.1 13.8 38.7 140.1 40.2 47.8 111.7 7.9 153.9 530.6 139.6 35.4 42.8 541.1 0.0 69.3 125.8 30.6 159.7 40.5 149.9 127.7 4.8 198.8 60.2 56.6 92.7 34.8 37.5 81.0 99.2 409.6 43.5 87.4 627.8 28.0 354.2 22.0 45.3 28.3 48.3 42.6 54.8 229.4 48.4 378.9 92.2 TMEM18 "DKFZp434C1714, lncND" ENSG00000151353 "Transmembrane protein 18" Q96B42 2 667335-677439 "Predicted membrane proteins, Transporters" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040233 Approved Approved "Endoplasmic reticulum,Mitochondria" NA NA Mitochondria "Endoplasmic reticulum" "HPA040233: AB_10794737" "unprognostic (9.01e-3)" "unprognostic (2.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-3)" "unprognostic (2.68e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-2)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (6.05e-2)" "unprognostic (1.86e-1)" "unprognostic (9.45e-2)" "unprognostic (8.20e-2)" "unprognostic (2.49e-1)" "unprognostic (3.65e-1)" "unprognostic (4.98e-3)" "unprognostic (8.08e-2)" 18.9 22.1 13.7 11.3 14.4 12.9 23.4 10.0 18.7 17.6 17.4 16.0 12.0 13.9 19.3 19.5 16.1 15.6 18.1 12.3 13.4 14.5 17.3 18.1 12.2 12.5 14.8 15.6 43.7 31.7 13.2 13.5 19.6 12.3 19.2 9.5 18.3 19.5 16.5 28.3 14.2 15.5 18.4 21.9 12.5 13.4 19.1 11.4 23.9 23.1 19.7 13.8 15.0 14.1 17.3 19.7 5.8 14.4 16.2 14.8 11.2 9.8 9.4 11.6 13.1 12.9 19.8 12.3 13.6 10.8 12.2 11.6 1.8 16.1 14.0 25.6 16.7 6.3 14.0 4.7 15.7 10.1 21.8 11.3 8.2 5.6 20.2 16.6 8.2 7.4 14.1 16.0 20.7 14.1 10.5 3.7 23.8 8.3 8.7 16.3 33.2 19.1 19.8 8.5 8.6 13.9 11.1 6.2 10.6 11.2 10.7 9.6 15.6 7.9 14.6 14.7 5.3 9.8 15.3 11.6 11.2 15.3 7.4 20.5 11.6 19.0 12.1 13.7 9.1 7.8 3.7 14.4 5.8 11.3 13.8 11.8 17.3 12.5 9.2 14.9 13.6 14.8 13.9 1.2 16.2 14.1 19.7 14.4 11.2 13.7 14.4 10.0 18.7 13.4 14.5 14.8 15.6 12.3 11.4 20.8 26.2 26.8 25.3 31.9 18.7 21.3 28.1 34.8 27.3 26.2 7.9 62.0 26.6 32.1 11.2 32.9 25.7 46.7 39.9 50.7 45.7 34.7 28.9 31.8 43.3 19.1 19.0 31.9 30.8 9.1 58.7 29.1 38.8 26.2 36.8 41.0 36.0 43.2 48.1 36.3 27.2 19.4 40.1 80.7 64.7 37.8 67.9 17.3 41.4 31.5 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.2 9.0 7.2 7.5 8.5 7.3 7.4 9.6 8.7 10.7 8.7 8.4 6.5 15.2 8.3 6.4 9.1 10.2 13.8 9.2 12.1 9.8 9.4 15.2 5.9 11.2 8.5 8.2 8.1 6.8 8.6 6.8 3.6 4.1 9.0 7.7 11.4 7.5 11.4 8.3 18.8 15.6 6.7 14.4 11.2 13.3 7.1 12.9 11.3 10.6 16.4 7.3 5.9 43.0 12.1 6.0 8.9 7.6 5.7 6.3 7.6 11.4 9.0 11.2 9.6 14.9 9.1 6.4 6.9 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 14.9 36.2 37.2 32.5 59.8 24.1 39.1 15.3 42.8 23.9 21.0 7.9 61.6 56.3 28.4 11.2 35.3 22.8 0.0 55.5 44.6 47.0 32.0 38.2 44.2 119.9 9.5 13.3 28.3 89.0 5.6 27.6 68.1 38.8 36.1 27.6 19.7 38.3 37.1 27.3 55.5 15.9 38.8 44.8 32.9 28.3 52.1 58.8 34.8 29.0 23.3 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.3 1.7 1.0 1.6 1.2 1.0 25.5 0.6 0.9 1.5 0.9 2.5 3.5 0.7 1.1 1.6 0.8 1.4 1.6 1.4 2.5 3.8 0.6 3.1 1.7 1.9 0.8 2.6 4.5 1.1 1.2 1.9 1.3 0.7 1.8 1.6 2.3 2.7 1.1 1.2 1.1 1.2 1.0 0.3 1.0 1.3 0.5 1.7 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 1.3 3.8 2.5 2.3 2.9 1.2 2.4 2.2 1.4 0.4 2.9 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 0.0 2.2 0.0 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 1.3 0.0 0.7 1.2 0.3 0.2 0.0 0.2 0.8 1.6 0.0 0.6 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.4 0.9 0.4 0.3 2.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.6 0.1 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favorable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favorable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.2 0.0 1.6 16.5 1.2 1.2 26.9 0.6 0.9 7.8 0.0 0.0 0.0 20.4 0.1 0.0 1.1 0.9 1.2 0.0 0.9 0.2 0.8 27.9 0.7 0.0 0.3 7.8 0.2 7.8 0.1 0.5 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.7 9.6 1.7 0.0 4.5 0.0 2.8 0.1 10.7 1.8 0.0 0.0 46.5 1.3 0.0 0.1 0.0 3.9 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.9 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 0.0 17.3 0.0 3.6 55.3 0.6 19.1 2.5 84.3 14.8 8.7 7.9 0.2 0.0 9.9 1.1 2.9 0.0 0.0 0.9 0.0 9.8 18.5 1.1 0.6 0.1 0.0 0.0 0.0 0.0 0.8 10.6 0.2 13.5 0.0 0.0 3.0 7.4 0.0 13.1 18.8 2.5 0.0 5.7 0.9 2.1 70.1 0.0 0.5 0.0 0.5 TOMM40 "C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40" ENSG00000130204 "Translocase of outer mitochondrial membrane 40" O96008 19 44890569-44903689 "Predicted intracellular proteins, Transporters" "Ion transport, Protein transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036231, HPA036232" Supported Enhanced Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA036231: AB_2675010, HPA036232: AB_2675011" "unprognostic (2.14e-1)" "unprognostic (9.58e-3)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (2.37e-1)" "unprognostic (2.17e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-2)" "unprognostic (7.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (5.86e-3)" "unprognostic (5.30e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-1)" 16.0 25.3 13.6 16.9 15.6 19.7 20.6 17.7 27.0 10.2 20.5 10.9 10.1 20.0 11.8 10.5 22.9 13.5 11.4 21.5 15.3 14.9 16.5 36.9 15.1 22.3 15.6 13.3 18.2 19.2 16.2 11.9 15.3 20.2 11.2 16.7 11.5 11.5 13.5 32.3 14.7 15.1 11.6 11.9 12.7 12.6 12.3 8.8 14.2 11.6 18.6 15.6 10.9 12.5 7.3 7.0 5.1 6.8 4.7 8.7 2.0 30.8 52.3 19.1 26.3 7.1 6.4 24.3 22.2 12.3 42.1 30.2 56.8 21.4 45.6 23.9 14.6 23.9 33.4 49.5 31.9 19.2 17.6 44.9 30.6 20.5 44.7 15.2 39.0 27.5 10.1 18.1 32.6 20.7 7.9 14.5 22.0 48.2 15.9 16.4 38.5 42.3 28.7 33.4 44.1 32.6 43.3 21.7 26.5 19.3 42.9 29.8 19.1 23.6 49.8 15.8 11.1 16.7 39.6 11.9 29.2 29.6 20.3 57.8 17.2 35.6 44.7 21.6 41.5 30.7 0.7 5.5 5.1 4.7 6.8 5.2 7.3 4.5 6.5 7.0 4.2 7.9 8.7 1.1 4.7 5.9 6.9 4.8 2.0 13.6 15.6 17.7 27.0 15.3 14.9 15.6 13.3 20.2 8.8 14.9 5.3 28.9 52.0 77.6 63.2 14.2 30.6 0.0 10.3 29.6 27.5 84.7 33.2 54.9 9.5 29.3 31.6 23.3 33.2 145.9 33.4 37.4 19.5 20.8 91.8 66.7 28.2 11.1 20.4 5.6 24.7 36.1 37.1 39.7 43.5 43.9 41.3 28.8 23.0 28.3 55.9 19.4 40.6 53.5 60.1 78.2 61.0 26.6 93.2 64.9 TPPP "p25, p25alpha, TPPP/p25, TPPP1" ENSG00000171368 "Tubulin polymerization promoting protein" O94811 5 659862-693395 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 77.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 35.7;Bipolar cells: 18.7;Horizontal cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.5;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 8.6;AN3-CA: 6.4;SCLC-21H: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036575, HPA036576" Enhanced Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA036575: AB_10673501, HPA036576: AB_2675200" "unprognostic (3.66e-2)" "unprognostic (3.70e-3)" "unprognostic (9.98e-3)" "unprognostic (7.82e-2)" "unprognostic (2.05e-2)" "unprognostic (3.20e-2)" "unprognostic (2.12e-1)" "unprognostic (3.80e-3)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-3)" "unprognostic (5.48e-2)" "prognostic favorable (5.40e-6)" "unprognostic (4.03e-2)" "unprognostic (2.30e-1)" "unprognostic (2.03e-2)" "unprognostic (3.31e-2)" 3.5 5.8 27.0 1.3 29.6 1.0 2.7 17.0 77.5 2.1 3.2 69.0 0.1 4.6 2.3 1.3 9.0 8.6 2.1 6.0 33.9 23.9 3.2 2.3 8.3 1.0 25.8 25.0 1.8 5.2 2.4 4.4 2.4 30.1 2.4 2.2 0.2 4.8 3.7 6.2 5.6 7.5 3.5 24.7 2.7 3.8 1.6 4.3 0.0 6.0 1.9 1.8 3.4 0.6 0.0 0.2 1.5 0.0 1.0 0.5 0.1 0.3 8.6 0.4 6.4 0.9 0.0 1.2 0.2 0.0 0.0 0.0 0.3 1.0 0.2 0.6 0.0 2.2 3.4 3.4 0.0 0.0 1.7 2.9 0.2 3.6 0.2 1.0 0.3 0.4 0.0 0.8 0.0 0.2 0.2 0.1 0.2 0.1 3.2 0.0 0.3 0.2 0.5 0.2 0.9 0.9 0.3 0.1 1.2 0.3 1.2 15.8 1.9 0.9 0.4 4.2 0.4 0.8 0.2 0.1 0.2 3.4 0.1 0.2 1.2 0.3 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.2 0.1 0.1 27.0 29.6 17.0 40.8 33.9 23.9 25.8 25.0 30.1 4.3 35.7 7.7 0.0 1.0 3.7 18.7 16.1 5.1 16.0 9.1 1.8 0.0 0.0 1.7 1.7 6.9 0.0 8.5 0.0 0.6 0.1 0.7 0.6 4.6 2.0 2.5 39.7 9.8 1.3 0.0 3.6 0.3 0.0 1.7 0.0 5.7 0.8 1.0 5.8 0.4 1.1 2.1 0.0 1.9 1.4 0.2 2.8 0.0 0.0 4.1 2.4 TRABD PP2447 ENSG00000170638 "TraB domain containing" Q9H4I3 22 50185915-50199598 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000822 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA000822: AB_10959384" "unprognostic (9.37e-2)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.19e-5)" "unprognostic (2.80e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-3)" "unprognostic (6.12e-2)" "unprognostic (2.40e-1)" "unprognostic (4.68e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.87e-2)" "unprognostic (2.98e-3)" 8.9 10.3 8.3 28.8 13.4 45.5 12.0 15.3 11.4 10.6 14.7 7.4 19.9 15.9 9.3 15.6 19.9 9.2 18.1 10.0 9.0 4.9 13.4 20.0 13.1 25.6 12.4 6.1 10.2 42.9 5.9 12.0 9.6 9.5 14.8 6.0 8.4 24.6 19.5 14.0 13.0 18.3 9.3 9.6 19.5 16.5 9.7 11.8 21.0 13.2 13.2 33.1 11.5 13.1 6.9 33.0 23.0 14.2 14.7 13.6 9.2 22.6 15.0 5.4 8.9 2.9 3.5 13.7 7.9 5.2 6.6 5.6 9.5 10.9 14.1 7.8 3.6 5.2 14.2 6.9 14.0 1.3 9.8 32.5 8.0 23.3 16.0 11.7 16.4 16.1 5.6 8.6 4.8 6.6 3.8 6.4 13.6 9.9 23.0 2.8 25.1 11.3 18.6 7.9 7.6 14.3 31.7 7.4 29.6 5.1 22.0 6.3 10.7 6.8 24.6 11.2 2.4 10.5 16.6 7.1 5.6 13.8 7.2 8.8 28.1 4.9 16.8 6.8 11.4 8.6 7.0 14.2 23.0 10.9 12.5 10.2 6.9 9.8 9.8 15.4 3.6 6.7 7.7 19.5 14.7 7.6 33.0 13.6 9.2 8.3 13.4 15.3 11.4 9.0 4.9 12.4 6.1 9.5 11.8 8.9 22.9 69.8 39.9 37.4 31.1 8.3 12.7 13.4 18.2 31.4 17.7 22.9 23.2 46.8 13.0 20.2 51.8 0.0 54.3 43.7 24.4 43.9 27.6 21.2 42.8 41.3 17.3 12.3 48.9 6.3 30.0 57.1 40.5 126.2 38.4 28.4 67.6 66.2 30.4 24.5 29.9 19.4 25.5 52.8 29.8 39.9 25.6 58.6 43.9 81.4 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36487027-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favorable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 13.0 11.0 12.9 8.5 17.0 31.8 11.9 18.1 15.0 10.6 10.7 13.6 8.2 9.5 12.9 9.8 12.4 11.5 9.4 13.9 9.8 7.1 11.2 12.3 15.2 9.2 14.8 10.6 14.6 11.3 11.0 11.9 10.3 12.7 9.6 10.5 10.5 11.0 9.3 13.9 12.7 12.5 12.1 10.1 13.0 10.3 15.0 12.8 18.5 15.6 6.7 10.8 11.3 13.0 10.6 7.7 27.7 11.4 9.6 13.1 8.5 5.2 6.6 12.9 7.2 12.2 8.9 5.6 7.9 8.6 7.4 9.6 5.8 3.5 6.9 4.9 8.4 8.5 9.9 10.2 8.0 12.2 11.3 11.9 6.6 5.2 5.2 7.8 7.3 8.2 8.2 11.3 3.9 12.1 7.2 10.3 9.3 9.9 7.6 9.2 6.4 11.7 4.0 7.0 6.0 6.1 7.8 17.5 3.9 8.9 10.9 2.1 11.3 7.9 7.7 5.6 9.0 8.9 7.2 8.1 10.5 9.3 9.6 9.6 8.8 7.4 7.5 5.9 5.3 7.8 27.7 8.0 20.9 11.9 11.4 11.7 10.6 10.3 11.6 7.7 8.1 10.0 13.1 11.1 9.6 8.2 4.5 8.0 8.5 12.9 17.0 18.1 15.0 9.8 7.1 14.8 10.6 12.7 12.8 8.9 6.1 5.0 10.6 11.3 2.6 6.9 10.2 1.4 1.2 3.5 5.9 5.6 5.0 7.6 3.2 9.2 7.2 0.0 6.4 5.2 6.0 9.7 18.5 5.6 6.2 7.9 4.1 20.3 8.1 2.7 2.3 6.6 6.8 11.8 5.5 3.9 5.9 5.7 3.9 4.3 2.6 12.9 10.5 9.1 8.3 10.9 5.4 8.5 3.2 10.6 TRIAP1 "HSPC132, MDM35, P53CSV, WF-1" ENSG00000170855 "TP53 regulated inhibitor of apoptosis 1" O43715 12 120443961-120446412 "Predicted intracellular proteins, Transporters" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053640 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA053640: AB_2682213" "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (5.24e-2)" "unprognostic (4.06e-2)" "unprognostic (3.07e-1)" "unprognostic (1.40e-1)" "unprognostic (1.19e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (2.22e-4)" "unprognostic (9.87e-3)" "unprognostic (4.39e-2)" "unprognostic (9.93e-2)" "prognostic unfavorable (8.77e-4)" "unprognostic (8.81e-2)" "unprognostic (2.00e-1)" "unprognostic (6.44e-2)" "unprognostic (4.97e-2)" 11.7 16.8 10.6 12.5 13.1 14.6 20.6 9.1 12.4 9.4 12.5 8.0 12.0 10.0 9.9 11.6 15.4 9.3 12.7 17.3 13.6 8.3 12.5 34.5 14.2 13.6 15.5 11.9 7.7 36.5 5.7 8.6 17.8 13.5 12.4 17.0 6.8 19.3 8.6 29.1 16.8 12.1 11.1 10.4 12.3 12.3 11.2 11.6 11.7 11.2 21.5 13.9 12.0 10.0 17.4 28.2 9.0 24.8 22.2 25.5 19.6 15.9 21.9 20.1 13.7 17.5 27.1 48.2 21.0 15.0 18.7 15.5 18.2 8.9 31.7 17.9 17.1 7.5 11.0 23.3 34.7 19.8 14.0 26.0 19.2 15.3 47.8 26.1 32.2 14.9 27.9 43.8 18.3 26.3 18.8 38.6 17.6 30.7 8.2 27.2 20.1 24.1 43.5 28.7 19.6 17.8 20.1 19.0 32.8 24.0 17.9 19.8 13.0 24.2 8.3 17.9 33.2 27.8 18.9 21.8 12.1 18.2 12.1 12.7 21.2 33.4 34.0 18.5 25.0 21.0 9.0 22.0 8.0 20.7 24.8 24.9 17.4 20.3 19.7 28.2 15.8 25.5 22.0 1.9 22.2 16.5 25.4 17.6 19.6 10.6 13.1 9.1 12.4 13.6 8.3 15.5 11.9 13.5 11.6 3.0 14.6 36.3 21.1 45.4 8.2 10.2 45.9 17.4 6.8 7.0 5.9 113.6 56.3 43.3 5.9 25.3 16.1 0.0 43.5 66.9 27.2 25.9 17.3 49.7 46.9 3.2 21.2 22.7 22.8 3.9 15.3 20.8 37.1 53.3 21.2 9.4 40.3 14.0 17.3 36.6 9.3 19.4 26.9 34.9 34.6 62.4 63.0 29.9 38.3 23.3 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678039-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 43.2" "Group enriched" "Detected in some" 113 "Early spermatids: 249.5;Late spermatids: 89.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 249.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561862-101566446 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favorable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 18.0 21.2 13.1 13.6 14.1 14.4 19.7 16.4 19.1 16.1 15.3 5.5 12.9 11.6 14.6 13.1 20.9 15.0 10.7 20.4 13.0 13.4 26.6 34.6 10.0 19.3 12.5 16.7 18.8 12.1 9.9 19.9 18.2 18.5 16.2 14.2 5.5 14.5 13.0 35.2 15.2 16.5 15.3 14.3 19.6 15.6 14.7 10.6 23.0 16.6 30.5 18.5 15.6 11.3 21.6 15.4 27.4 14.8 12.2 23.1 11.8 21.0 10.3 13.7 13.8 12.6 10.8 12.8 12.6 12.3 16.4 18.4 15.6 14.3 43.8 16.4 7.8 13.3 21.3 26.4 19.2 22.7 15.6 13.0 29.4 8.2 11.3 9.7 25.8 12.5 12.6 20.0 14.3 13.4 8.8 15.9 16.8 24.9 9.8 17.6 14.4 20.6 18.9 25.5 27.4 22.4 15.4 11.2 19.5 21.0 17.9 34.2 19.5 9.8 20.9 27.6 12.6 27.6 28.4 10.5 9.0 17.0 5.9 13.2 11.4 20.8 42.0 15.2 18.6 13.4 27.4 11.2 7.3 13.6 14.4 18.8 21.6 16.8 15.8 13.5 20.4 23.1 21.1 4.9 12.2 14.8 15.4 15.0 11.8 13.1 14.1 16.4 19.1 13.0 13.4 12.5 16.7 18.5 10.6 20.8 20.0 45.2 114.9 83.8 27.3 45.1 15.3 44.2 47.8 27.9 13.7 57.1 44.7 44.7 22.0 33.0 12.7 0.0 29.3 34.7 35.1 33.3 46.1 46.1 28.0 20.6 34.3 28.8 19.4 6.3 34.5 28.4 13.5 36.9 26.7 27.5 31.9 14.0 35.3 55.3 29.1 32.3 41.5 61.4 51.3 91.8 54.8 41.7 40.3 115.3 TRMT12 "FLJ20772, Trm12, TYW2" ENSG00000183665 "TRNA methyltransferase 12 homolog" Q53H54 8 124450820-124462150 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 37.2" "Low region specificity" "Detected in all" HPA023939 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA023939: AB_1848793" "unprognostic (2.54e-2)" "unprognostic (2.20e-1)" "unprognostic (7.81e-2)" "unprognostic (1.02e-2)" "unprognostic (8.75e-2)" "prognostic unfavorable (2.99e-5)" "prognostic unfavorable (5.10e-4)" "unprognostic (6.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.51e-1)" "unprognostic (6.56e-2)" "unprognostic (4.72e-3)" "unprognostic (3.39e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.25e-4)" "unprognostic (1.04e-2)" 10.8 11.6 16.7 8.4 20.9 4.1 15.0 13.8 18.3 11.8 9.5 8.0 6.8 7.5 11.9 10.7 9.6 13.2 8.6 9.9 19.4 9.9 12.9 9.8 9.8 11.8 13.6 14.3 8.8 10.1 14.7 17.7 8.9 14.7 12.0 11.2 7.8 12.0 11.0 18.0 9.9 9.6 14.3 12.9 11.0 10.6 11.7 13.4 9.1 14.9 12.0 10.7 10.2 8.5 5.8 5.0 6.3 6.1 5.1 7.6 4.4 7.4 6.5 5.4 4.2 10.3 5.3 1.3 4.7 5.6 7.0 6.0 4.0 5.2 7.6 6.6 4.8 4.5 5.2 7.7 7.8 8.3 7.5 5.9 7.3 6.2 1.3 8.1 0.0 6.0 6.6 10.4 6.8 8.7 2.0 5.8 8.0 10.2 5.3 4.3 37.2 8.6 3.1 0.0 17.4 6.1 2.7 3.6 5.0 6.4 8.1 9.2 7.4 7.0 26.2 9.8 4.8 7.4 3.1 4.6 4.9 12.8 3.6 5.3 5.5 7.7 2.9 4.4 2.6 3.9 0.5 6.1 6.3 4.5 4.9 5.6 4.0 6.1 4.6 5.0 5.8 7.6 7.4 2.4 5.1 5.5 1.5 3.7 4.4 16.7 20.9 13.8 18.3 19.4 9.9 13.6 14.3 14.7 13.4 8.9 6.9 5.9 5.4 4.6 5.6 2.7 7.6 8.1 1.2 3.5 15.7 5.8 5.0 4.9 11.1 5.2 3.6 0.0 5.4 4.5 3.3 3.4 9.2 5.1 4.5 7.9 2.9 3.7 3.2 14.2 3.7 3.3 5.0 2.8 4.2 3.9 3.6 3.5 5.6 6.6 8.3 0.0 5.5 10.7 3.8 3.8 4.1 4.3 3.7 4.3 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782589-57808071 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 157.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favorable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 14.5 46.2 16.6 14.7 21.5 15.3 18.5 18.2 24.3 12.7 18.8 13.3 17.6 17.8 11.6 13.7 16.1 12.4 10.3 27.7 14.6 15.6 27.0 30.2 10.1 14.6 15.4 20.8 10.3 19.6 17.0 13.1 11.6 17.8 11.7 18.3 11.1 13.5 14.1 33.5 14.7 13.4 17.7 11.6 12.5 14.0 23.2 13.6 11.3 15.4 26.9 13.4 14.4 13.0 18.5 18.7 9.0 16.8 20.0 23.5 16.0 8.4 9.8 5.9 8.8 5.5 5.5 8.6 7.1 6.3 11.6 8.1 11.4 11.2 21.2 13.6 6.2 6.5 10.0 9.9 10.2 8.8 8.6 12.0 12.9 8.3 10.0 8.4 16.4 7.8 6.4 10.5 8.8 5.0 8.9 7.1 12.0 16.6 11.5 8.7 9.8 9.7 17.9 9.1 12.3 13.1 11.8 157.2 19.0 11.0 9.6 12.8 7.9 7.6 13.4 12.9 5.5 23.2 12.0 5.2 6.3 8.9 9.2 7.6 8.5 17.4 16.5 8.9 9.9 7.5 3.7 14.8 9.0 18.6 13.8 23.5 18.5 20.9 18.4 18.7 16.4 21.2 21.7 4.2 20.0 16.8 14.7 18.1 16.0 16.6 21.5 18.2 24.3 14.6 15.6 15.4 20.8 17.8 13.6 17.9 9.6 15.6 12.7 23.0 19.8 29.9 35.7 20.1 13.6 43.6 13.7 59.0 81.2 56.0 69.4 9.6 12.7 23.3 75.2 41.0 20.6 14.1 21.9 32.5 31.6 14.3 13.3 17.8 7.3 33.2 21.0 18.6 25.3 102.8 18.4 20.6 51.6 17.5 22.6 110.7 16.3 58.2 17.6 36.4 60.1 31.7 39.8 15.0 32.8 9.2 TTC27 FLJ20272 ENSG00000018699 "Tetratricopeptide repeat domain 27" Q6P3X3 2 32628032-32821051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031246 Approved Approved Nucleoli,Mitochondria No No 11000 Mitochondria Nucleoli "HPA031246: AB_10603139" "unprognostic (3.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.21e-3)" "unprognostic (6.28e-3)" "unprognostic (8.90e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.42e-5)" "unprognostic (7.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.13e-1)" "unprognostic (2.07e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" 18.4 18.2 7.0 18.8 11.5 9.9 17.8 8.6 10.7 16.4 11.9 16.1 12.0 8.2 25.1 13.6 17.5 14.7 8.5 14.3 8.2 6.9 11.0 15.7 10.8 13.6 12.5 8.1 18.6 17.7 15.7 19.4 11.9 8.9 14.7 13.1 13.2 17.2 14.7 18.7 16.8 11.0 15.3 11.0 19.3 13.4 17.4 10.3 16.4 14.9 15.5 20.4 14.6 14.6 9.6 9.6 0.3 9.0 8.4 12.5 5.7 22.0 10.7 7.4 5.8 6.2 12.7 3.8 9.2 7.6 14.2 12.5 16.5 13.4 19.3 8.3 13.8 14.8 11.1 11.9 14.3 20.9 9.2 14.6 21.9 5.9 22.4 12.1 20.9 11.6 8.4 13.2 17.2 18.7 7.1 12.9 4.9 30.1 5.7 12.7 8.8 16.5 7.3 13.6 10.0 11.2 11.1 16.2 16.9 11.0 12.9 6.2 8.9 7.6 7.2 8.5 9.0 8.8 5.0 10.7 9.1 10.0 10.7 15.7 8.3 2.1 21.9 9.8 16.3 9.7 0.0 4.5 0.0 9.1 9.0 10.0 9.3 10.0 8.9 9.6 9.6 12.5 9.8 0.3 8.4 6.1 4.7 8.7 5.7 7.0 11.5 8.6 10.7 8.2 6.9 12.5 8.1 8.9 10.3 8.9 7.2 4.5 8.0 4.9 5.4 6.7 0.0 16.0 9.1 0.0 3.9 10.8 6.6 7.7 14.7 6.3 1.7 0.0 8.3 10.2 6.2 5.0 11.5 3.9 7.0 3.2 7.0 4.3 7.2 0.9 7.8 4.6 5.0 7.2 4.6 4.6 5.3 5.9 6.7 3.8 5.6 6.5 7.1 18.4 10.4 5.0 5.4 6.1 7.6 5.4 TTC28 KIAA1043 ENSG00000100154 "Tetratricopeptide repeat domain 28" Q96AY4 22 27978014-28679865 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 42.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003099 Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA003099: AB_1079195" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "unprognostic (8.55e-3)" "unprognostic (4.83e-2)" "unprognostic (5.20e-2)" "unprognostic (2.25e-1)" "prognostic favorable (4.30e-4)" "unprognostic (3.91e-2)" "unprognostic (1.18e-2)" "unprognostic (5.40e-2)" "unprognostic (5.10e-2)" "prognostic favorable (5.65e-5)" "unprognostic (5.54e-3)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (4.36e-1)" 4.6 3.0 1.4 1.1 2.0 0.0 4.2 0.6 1.3 6.0 4.1 1.4 7.6 6.5 3.0 5.7 3.7 2.8 1.2 1.0 2.8 2.1 4.7 0.5 0.9 11.8 2.7 3.2 2.4 5.4 3.3 1.3 3.7 4.4 2.6 1.6 2.1 5.3 1.0 1.6 3.1 5.0 4.3 0.2 4.3 3.4 1.0 2.5 0.4 0.2 0.9 0.6 0.5 0.0 5.3 13.8 5.9 8.3 12.4 0.3 4.0 7.5 5.7 5.0 0.4 0.0 0.0 5.6 11.7 1.9 0.8 8.9 0.2 3.1 0.5 5.9 0.8 6.7 5.0 3.8 0.1 5.5 12.3 0.3 3.7 2.6 3.9 10.4 3.6 3.4 0.5 1.3 1.9 0.1 0.4 2.5 0.0 3.4 5.4 3.5 0.1 2.7 0.2 3.9 8.6 5.6 0.2 3.7 4.0 2.8 0.5 9.6 6.8 3.4 4.4 3.0 1.8 0.2 0.1 2.4 0.1 2.9 0.4 0.2 0.1 0.5 0.1 0.3 0.3 0.4 0.3 0.3 1.0 0.6 0.5 0.4 0.9 0.2 2.5 0.1 0.5 3.0 12.2 2.0 4.6 5.4 32.1 8.9 7.6 2.7 2.3 12.2 17.7 4.5 0.0 4.3 7.2 28.6 2.6 0.0 5.2 1.2 19.2 5.3 1.1 12.4 3.2 27.0 8.6 29.4 5.9 5.6 29.1 4.8 10.1 1.0 4.9 12.1 5.1 5.1 42.8 14.1 22.1 12.9 18.6 22.9 11.4 3.3 2.1 4.9 6.7 3.0 TTC32 ENSG00000183891 "Tetratricopeptide repeat domain 32" Q5I0X7 2 19896643-19901986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036024 Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036024: AB_10673493" "unprognostic (2.77e-3)" "unprognostic (5.44e-2)" "unprognostic (8.85e-2)" "unprognostic (8.80e-3)" "unprognostic (1.08e-1)" "unprognostic (2.62e-1)" "unprognostic (5.25e-2)" "prognostic favorable (9.44e-4)" "unprognostic (4.46e-2)" "unprognostic (1.48e-2)" "unprognostic (4.92e-3)" "unprognostic (6.22e-2)" "prognostic unfavorable (5.45e-6)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-2)" "unprognostic (2.27e-2)" 11.8 8.9 12.8 10.8 24.7 30.1 17.4 24.1 18.9 10.8 11.0 17.5 11.9 11.5 13.6 28.5 7.8 11.8 11.8 7.3 14.9 11.8 9.4 12.6 10.1 13.7 29.6 9.2 16.9 8.7 13.4 17.0 8.2 16.9 16.6 10.4 14.5 11.4 13.1 19.6 14.2 12.1 9.4 18.4 13.9 10.6 12.9 23.6 15.5 13.7 12.9 9.5 11.9 11.7 9.3 5.4 21.6 5.9 4.5 12.8 3.8 14.4 9.2 8.3 6.1 3.8 8.3 1.7 3.1 5.3 5.3 3.5 4.6 16.7 9.1 1.8 3.3 6.4 9.2 3.9 10.3 3.4 13.3 15.8 9.3 12.3 8.3 8.2 9.1 16.8 7.8 6.3 5.8 14.1 4.2 4.9 15.0 17.3 18.8 4.4 4.4 6.5 13.5 6.5 5.6 16.3 7.8 5.6 15.3 14.5 5.7 13.7 12.8 10.8 5.8 11.5 10.2 7.9 3.5 3.4 7.4 8.2 7.7 4.2 19.0 17.3 15.4 12.0 8.9 4.3 6.1 5.9 16.5 5.9 4.3 6.7 8.8 9.2 6.1 5.4 9.3 12.8 9.7 21.6 4.5 4.8 3.8 10.9 3.8 12.8 24.7 24.1 18.9 14.9 11.8 29.6 9.2 16.9 23.6 8.9 11.8 18.3 25.0 16.8 36.8 13.2 12.7 44.2 14.8 12.2 13.7 11.6 38.1 9.2 12.5 15.7 9.3 0.0 21.9 9.3 13.9 17.2 8.1 23.3 8.0 39.7 27.2 5.5 7.1 4.6 18.4 17.0 6.8 11.8 16.5 44.9 10.9 15.0 9.2 18.7 34.7 12.9 16.5 86.3 21.3 22.8 8.0 17.3 13.6 17.4 TTLL1 C22orf7 ENSG00000100271 "Tubulin tyrosine ligase like 1" O95922 22 43039644-43089428 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 24.1;Early spermatids: 30.7;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048392 Approved Approved Nucleoli,Mitochondria No No Nucleoli Mitochondria "HPA048392: AB_2680384" "unprognostic (1.02e-1)" "unprognostic (4.06e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.18e-3)" "unprognostic (4.27e-3)" "prognostic unfavorable (2.34e-5)" "unprognostic (8.22e-2)" "unprognostic (2.16e-2)" "unprognostic (3.29e-1)" "unprognostic (4.47e-3)" "unprognostic (1.82e-1)" "prognostic favorable (1.68e-4)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" 4.0 7.3 16.5 3.6 12.0 2.9 6.8 12.8 16.6 7.6 4.6 8.8 0.9 2.5 7.1 12.5 5.7 14.6 5.7 12.5 13.9 12.6 6.1 2.1 5.3 4.9 9.2 14.1 8.3 4.2 8.5 9.8 3.9 13.2 7.7 4.6 6.8 4.7 6.0 4.4 5.8 2.9 5.9 10.0 4.5 5.4 14.0 8.4 4.7 10.3 1.8 4.8 5.4 4.6 4.7 10.4 7.0 6.5 9.9 14.1 6.2 0.8 1.5 12.8 9.7 14.5 12.9 0.6 4.3 4.8 2.5 4.2 0.1 1.9 0.9 3.1 7.9 1.5 0.6 1.1 1.1 2.5 1.1 2.1 1.3 0.7 1.2 10.4 3.2 1.7 10.6 16.6 1.6 4.1 10.7 8.2 10.9 0.3 8.3 9.2 4.2 3.0 5.2 1.7 3.4 0.9 7.4 7.2 0.7 4.6 1.1 3.2 6.1 3.4 1.7 11.8 6.9 5.1 5.4 7.8 2.7 1.8 6.2 0.6 2.9 0.8 0.3 6.8 5.9 4.8 5.2 5.9 7.0 13.0 6.5 12.2 3.1 11.4 14.1 10.4 4.7 9.7 12.2 1.7 9.9 4.9 6.7 6.9 6.2 16.5 12.0 12.8 16.6 13.9 12.6 9.2 14.1 13.2 8.4 0.0 2.4 0.5 2.5 2.1 5.3 4.0 2.5 24.1 4.5 1.8 5.9 2.5 13.3 5.5 30.7 3.3 0.5 0.0 4.2 1.2 5.1 3.2 1.1 0.4 4.3 4.8 0.0 6.7 2.1 14.5 3.7 2.3 8.5 4.6 2.6 5.5 4.4 7.0 5.6 5.7 10.1 6.5 1.4 8.6 37.7 2.4 0.6 2.9 1.5 1.3 UBE3B ENSG00000151148 "Ubiquitin protein ligase E3B" Q7Z3V4 12 109477402-109536705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041012 Approved Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA041012: AB_10964435" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.12e-2)" "unprognostic (7.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.19e-2)" "unprognostic (2.93e-1)" "unprognostic (4.46e-3)" "unprognostic (9.39e-2)" "unprognostic (1.23e-1)" "prognostic favorable (2.49e-5)" "unprognostic (3.35e-1)" "unprognostic (3.35e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" 14.5 19.3 17.2 12.9 21.2 9.2 15.3 19.7 27.8 14.4 17.3 23.3 14.0 14.6 17.4 16.2 20.1 19.3 13.9 28.6 14.6 11.6 19.8 16.4 15.5 13.1 18.6 13.9 18.4 20.3 25.5 15.1 16.8 15.8 17.5 21.2 20.7 15.7 17.4 34.0 21.6 16.3 18.6 15.2 17.0 17.3 24.5 18.3 18.2 21.1 17.6 15.9 19.5 19.6 15.9 14.5 22.4 16.7 14.3 18.2 11.4 10.4 16.5 13.0 9.4 22.2 17.9 11.4 13.8 15.8 16.8 11.3 17.3 10.7 6.5 10.3 22.6 14.3 13.5 13.1 17.7 16.2 14.3 9.3 12.4 10.8 15.6 14.2 10.1 10.4 20.3 16.5 16.2 19.5 25.4 18.1 15.5 13.6 6.2 19.1 16.3 6.9 14.8 13.3 11.7 19.9 11.5 12.2 12.7 14.4 18.8 12.1 22.4 16.1 21.9 10.7 15.9 22.4 10.8 16.5 20.8 6.0 10.6 9.8 13.9 11.5 11.5 20.7 8.5 17.2 22.4 15.3 14.3 15.9 16.7 15.7 15.9 15.3 11.2 14.5 12.9 12.9 17.1 19.5 14.3 13.6 13.5 18.2 11.4 17.2 21.2 19.7 27.8 14.6 11.6 18.6 13.9 15.8 18.3 11.9 10.8 6.7 10.0 4.5 20.4 32.1 10.2 14.7 14.8 15.7 31.4 15.7 10.0 16.0 11.8 13.5 15.1 23.3 13.2 9.3 8.4 15.1 9.2 16.0 11.1 20.6 8.6 12.9 17.1 24.6 11.5 11.0 10.1 14.4 15.8 16.7 18.8 10.5 9.2 17.7 25.0 6.5 8.5 9.6 12.7 6.4 19.8 10.9 13.8 12.2 UQCC2 "bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1" ENSG00000137288 "Ubiquinol-cytochrome c reductase complex assembly factor 2" Q9BRT2 6 33694293-33711727 "Disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 791.0;Late spermatids: 864.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039111 Uncertain Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA039111: AB_2676352" "unprognostic (3.58e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.50e-1)" "unprognostic (2.35e-3)" "unprognostic (2.43e-2)" "unprognostic (5.93e-2)" "unprognostic (2.33e-2)" "unprognostic (7.43e-2)" "unprognostic (5.77e-2)" "unprognostic (3.88e-1)" "unprognostic (1.07e-1)" 13.4 22.9 26.1 13.3 31.4 14.6 17.7 15.0 22.9 12.4 15.8 12.0 12.3 12.8 17.4 23.4 15.2 10.9 9.2 71.0 19.2 23.0 18.3 23.4 8.9 12.3 22.8 22.6 11.5 25.3 7.9 24.5 14.4 20.6 15.7 17.2 18.9 19.6 14.3 76.4 12.2 10.4 20.0 20.0 12.9 15.9 30.9 18.3 12.3 19.0 22.0 14.9 10.9 11.0 39.7 38.9 7.2 39.6 21.9 31.5 34.8 42.7 30.8 34.5 29.9 28.7 28.9 27.2 24.4 24.5 34.0 33.7 49.4 18.1 17.2 39.5 29.4 52.4 23.1 23.4 34.1 30.3 21.9 38.5 33.7 20.4 68.3 47.1 31.4 27.6 29.5 55.0 27.3 44.2 19.7 25.3 33.2 35.9 35.7 39.9 46.0 30.4 65.3 20.9 32.8 35.1 22.0 28.3 58.3 24.1 40.7 59.4 21.1 26.9 41.3 33.7 19.1 36.2 80.0 23.4 39.1 33.2 25.2 50.2 27.5 38.2 29.1 11.8 47.6 45.1 7.2 27.0 5.2 24.0 39.6 29.1 39.7 30.3 27.4 31.9 32.8 31.5 28.4 2.6 21.9 32.7 38.9 31.1 34.8 26.1 31.4 15.0 22.9 19.2 23.0 22.8 22.6 20.6 18.3 26.8 27.7 65.4 71.0 52.0 115.5 791.0 94.3 38.8 39.8 73.3 47.1 122.2 331.5 87.4 273.9 53.4 58.0 93.5 155.9 94.8 61.5 91.6 57.8 134.7 186.1 66.7 95.6 51.5 60.7 864.2 72.8 62.9 79.2 67.7 57.9 48.7 112.6 54.0 78.8 214.9 98.9 0.0 58.5 99.8 96.6 66.7 79.8 40.6 79.2 104.5 WDR70 FLJ10233 ENSG00000082068 "WD repeat domain 70" Q9NW82 5 37379212-37753435 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043064, HPA048149" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA043064: , HPA048149: AB_2680287" "unprognostic (2.55e-2)" "unprognostic (3.39e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (4.40e-2)" "unprognostic (1.38e-2)" "unprognostic (1.20e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (6.34e-2)" "unprognostic (8.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "unprognostic (8.11e-2)" 17.5 13.4 15.4 21.9 22.8 16.3 17.7 30.9 21.1 15.7 16.3 12.0 16.9 10.4 19.6 13.5 15.0 15.6 10.0 13.0 15.8 8.7 11.2 11.8 13.0 18.8 16.2 13.0 18.6 13.9 12.6 14.4 14.0 17.9 13.2 14.3 7.9 15.6 14.4 36.3 17.2 13.3 16.2 18.3 14.0 13.9 12.7 16.5 13.9 13.2 8.4 15.1 17.4 15.7 12.7 15.8 12.6 17.5 11.1 10.3 7.1 9.2 6.1 12.2 15.3 12.4 12.2 16.6 11.8 11.1 13.6 11.6 10.0 9.6 15.1 7.0 11.4 10.6 8.6 10.1 10.8 15.3 14.4 12.6 11.4 18.7 7.0 9.3 19.1 10.2 11.7 8.3 10.4 14.5 10.5 11.2 11.4 14.2 6.3 8.5 6.2 12.3 9.4 8.4 7.4 10.9 14.2 30.5 15.4 6.9 11.1 10.5 9.9 39.1 8.7 8.5 9.7 11.4 12.1 12.8 12.5 12.0 12.1 9.3 8.4 12.5 17.5 8.3 17.1 10.3 6.2 14.5 12.6 8.8 17.5 9.7 11.4 10.3 9.5 15.3 12.7 10.2 9.8 3.5 11.1 15.8 15.8 9.8 7.1 15.4 22.8 30.9 21.1 15.8 8.7 16.2 13.0 17.9 16.5 29.8 26.1 27.6 11.3 8.1 35.4 17.3 12.7 30.8 12.5 8.7 35.3 21.8 16.6 16.0 16.9 15.5 15.1 0.0 18.0 22.3 13.1 6.6 19.6 20.9 16.6 23.8 13.3 18.4 24.4 5.4 27.3 19.8 11.8 21.6 20.9 20.1 14.0 17.5 21.2 10.3 56.8 12.9 11.7 31.2 27.5 6.8 18.5 20.2 23.2 8.6 XPNPEP3 "APP3, ICP55, NPHPL1" ENSG00000196236 "X-prolyl aminopeptidase 3" Q9NQH7 22 40857077-40932815 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 196.2;Late spermatids: 233.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000527 Approved Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA000527: AB_1079266" "prognostic unfavorable (8.19e-4)" "unprognostic (6.77e-2)" "unprognostic (3.22e-3)" "unprognostic (5.03e-3)" "unprognostic (6.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (2.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.24e-1)" 8.2 13.6 7.5 5.8 9.2 4.7 9.7 5.2 7.8 7.3 6.1 10.8 11.6 32.3 10.7 12.3 7.2 9.4 10.5 11.2 7.6 7.1 9.8 19.0 6.6 10.6 7.9 6.1 10.7 10.5 8.0 15.0 6.1 10.7 7.3 6.2 9.3 8.5 13.6 12.0 11.5 20.9 7.1 9.3 7.7 6.8 18.9 8.2 11.5 9.1 7.3 8.8 12.6 8.2 5.9 6.0 6.4 10.0 1.2 4.4 4.0 3.3 4.7 3.2 7.1 9.0 6.0 2.2 4.1 3.1 2.3 2.3 3.9 2.1 6.5 2.3 7.9 9.7 7.6 6.0 3.2 3.4 3.9 12.4 4.2 9.3 7.3 4.1 7.4 0.7 5.3 5.0 7.2 4.3 3.5 4.0 4.6 3.5 5.9 4.9 5.0 3.5 3.9 1.9 6.0 9.6 4.9 4.3 3.7 6.5 4.4 2.8 2.5 4.1 6.1 3.8 3.5 7.1 3.4 4.0 4.7 4.1 4.3 2.4 5.6 4.2 7.9 7.2 9.6 3.2 4.0 4.4 4.4 3.4 3.9 1.8 5.9 2.1 2.2 3.1 3.7 4.4 3.3 6.4 1.2 10.0 6.0 3.0 4.0 7.5 9.2 5.2 7.8 7.6 7.1 7.9 6.1 10.7 8.2 6.0 21.2 6.5 6.9 11.7 14.9 17.6 20.4 29.4 13.6 8.7 17.7 17.8 13.3 11.7 196.2 11.7 4.2 0.0 14.7 16.0 11.3 6.7 13.9 32.1 12.4 15.9 13.3 11.1 13.5 233.7 18.4 13.0 16.9 2.8 9.5 12.1 10.8 9.7 14.5 18.6 19.3 32.3 13.2 50.5 32.5 14.3 16.7 5.0 10.6 6.2 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755902 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavorable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 12.6 15.8 11.0 12.6 15.3 13.9 13.8 11.6 14.9 13.1 11.8 11.5 18.4 9.8 13.3 12.9 17.5 11.3 9.1 12.1 11.9 9.7 12.4 16.3 9.2 15.5 10.8 11.7 13.3 21.0 11.0 16.6 15.9 13.5 12.9 13.7 11.3 17.4 10.0 15.9 12.0 10.8 11.1 12.6 13.3 12.3 12.5 12.6 17.5 12.3 16.0 16.4 13.3 11.8 11.8 9.5 9.4 9.9 12.9 12.7 5.2 9.4 11.4 6.7 7.9 7.3 8.6 21.0 7.2 7.4 9.0 8.8 28.5 12.1 17.1 11.9 7.3 13.0 12.3 13.2 19.1 10.2 7.4 20.7 11.3 8.6 15.8 10.6 12.0 6.6 8.0 12.2 8.5 15.5 11.6 14.2 9.1 15.9 7.9 9.4 7.7 8.9 14.5 36.6 6.3 14.0 10.1 14.2 10.1 11.4 13.6 10.3 5.0 11.1 9.7 7.1 27.1 18.1 10.9 9.5 8.5 9.0 13.8 12.2 4.7 5.0 17.8 7.9 9.0 7.0 9.4 7.0 4.1 10.1 8.9 10.6 8.8 10.7 10.4 9.5 11.8 11.2 12.7 1.4 12.9 9.9 9.3 9.3 5.2 11.0 15.3 11.6 14.9 11.9 9.7 10.8 11.7 13.5 12.6 6.0 4.1 13.7 17.3 9.0 16.5 6.9 2.5 5.3 7.9 10.4 19.6 29.4 6.6 17.0 4.4 5.7 5.2 23.3 14.2 29.0 10.7 7.9 6.9 4.5 17.9 14.3 6.9 5.5 7.0 2.8 9.8 5.5 5.0 19.0 6.6 11.6 12.2 10.4 8.1 9.3 18.8 12.9 6.2 4.9 14.7 7.3 15.0 12.1 11.5 11.4 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 137.6;Syncytiotrophoblasts: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" No No "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 11.8 16.4 9.2 8.3 9.3 13.5 12.9 12.0 16.8 16.0 13.8 11.9 15.3 17.0 14.4 26.7 17.1 17.6 16.7 11.9 9.7 10.6 16.4 34.3 11.8 9.6 10.7 10.3 18.4 56.4 11.1 40.7 35.5 11.9 14.0 8.4 16.6 53.5 20.7 11.1 11.2 14.6 8.8 8.4 10.2 18.4 52.0 10.6 11.0 22.1 12.9 12.5 13.9 13.8 10.8 22.3 16.2 14.7 7.2 9.8 6.7 23.4 8.7 5.8 9.2 14.7 13.8 11.9 18.8 21.8 12.8 18.2 25.8 19.4 4.6 30.7 19.3 6.3 18.3 4.5 18.0 3.6 15.1 16.3 9.1 9.7 13.9 24.0 15.3 19.0 13.5 12.8 9.0 14.0 18.5 9.9 11.6 11.4 25.1 8.7 40.0 9.6 15.6 11.1 16.3 20.9 8.4 5.4 23.4 12.2 11.1 17.4 8.7 13.1 20.9 17.7 5.9 19.9 21.3 14.5 16.1 6.0 23.4 13.3 37.4 14.5 8.5 25.7 26.9 17.1 16.2 13.2 5.6 9.8 14.7 7.6 10.8 7.9 9.0 14.8 7.2 7.0 9.8 2.1 7.2 12.4 22.3 7.8 6.7 9.2 9.3 12.0 16.8 9.7 10.6 10.7 10.3 11.9 10.6 14.9 20.5 9.3 35.0 6.1 17.3 0.4 20.4 21.4 17.0 33.2 15.7 94.1 23.2 58.8 86.2 17.8 35.4 23.3 70.3 97.9 24.7 46.0 21.8 21.7 35.3 17.5 41.7 19.0 13.7 19.8 32.5 13.1 5.0 26.2 53.9 20.9 45.9 45.6 24.1 19.5 15.3 6.5 13.3 137.6 10.6 6.0 145.8 12.8 47.0 38.9 YKT6 ENSG00000106636 "YKT6 v-SNARE homolog" O15498 7 44200968-44214294 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030817, HPA030818" Approved Approved Mitochondria,Cytosol No No Cytosol Mitochondria "HPA030817: AB_10599828, HPA030818: AB_10602102" "unprognostic (1.25e-1)" "unprognostic (7.35e-3)" "unprognostic (1.30e-3)" "unprognostic (7.80e-3)" "unprognostic (7.45e-3)" "prognostic unfavorable (4.64e-4)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.14e-2)" "unprognostic (2.03e-1)" "unprognostic (8.77e-3)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (8.65e-2)" "unprognostic (1.63e-1)" "unprognostic (2.01e-2)" "unprognostic (1.34e-2)" "unprognostic (7.66e-3)" 26.5 21.9 35.1 21.4 30.6 31.1 23.1 19.0 32.2 21.8 27.6 26.5 27.9 21.1 21.0 32.6 31.1 16.0 16.8 22.3 34.9 33.5 24.4 17.3 19.6 25.7 36.1 24.0 14.3 51.2 29.7 21.6 25.7 26.8 21.3 26.7 18.3 39.1 24.6 29.1 21.8 21.7 27.1 31.4 20.5 24.9 27.3 25.1 22.2 21.0 23.4 26.3 17.5 15.5 7.7 11.1 15.7 12.8 7.2 12.4 6.3 22.6 23.9 20.1 28.1 25.3 22.2 16.6 45.7 35.1 25.6 26.0 25.1 18.8 21.6 20.6 44.8 49.3 28.0 24.6 30.2 32.7 26.0 23.5 12.6 17.7 15.7 31.7 26.7 23.1 20.7 29.6 31.2 33.4 22.7 30.8 19.9 29.2 16.0 33.9 23.4 19.9 29.7 49.2 30.4 40.0 21.9 18.2 18.6 21.1 19.1 23.6 46.4 21.7 34.7 24.7 29.8 27.3 27.6 35.2 27.5 34.1 27.2 50.2 42.7 47.1 32.1 37.4 23.7 53.8 5.9 11.2 15.7 7.8 12.8 11.0 6.9 9.2 12.4 10.3 7.7 8.8 8.6 9.5 7.2 12.1 11.1 9.4 6.3 35.1 30.6 19.0 32.2 34.9 33.5 36.1 24.0 26.8 25.1 11.9 10.3 13.7 14.7 23.1 6.4 17.3 7.6 1.4 6.8 19.2 9.8 21.7 21.6 42.1 21.1 14.0 30.8 0.0 71.4 49.0 21.6 29.1 1.1 14.3 36.6 12.7 13.3 11.1 19.6 5.9 9.2 17.2 25.3 55.1 24.1 9.8 58.9 17.5 12.7 18.2 7.7 0.0 18.4 15.6 18.8 22.6 41.2 8.5 18.3 28.6 YME1L1 ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110112-27155266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 27.8 37.3 22.7 25.0 26.2 41.4 39.2 27.8 27.5 27.6 24.3 15.7 29.8 22.3 29.9 35.9 34.5 25.3 24.4 34.1 23.4 21.5 26.8 45.4 26.9 38.7 19.3 25.5 32.5 33.8 27.8 28.6 33.4 22.0 25.9 26.3 23.3 28.1 31.3 79.0 26.8 25.3 34.6 20.2 26.5 24.7 24.7 20.9 41.7 30.9 32.0 28.9 36.4 28.9 55.6 79.2 73.9 53.0 45.5 56.0 45.9 40.9 30.8 36.8 18.2 36.2 38.9 30.1 40.5 23.7 41.5 47.7 41.5 50.4 43.6 26.9 44.6 29.8 39.6 44.2 35.7 45.9 39.6 26.5 41.5 27.4 29.1 39.7 28.3 34.1 31.9 42.3 36.2 36.7 36.7 43.4 39.9 48.1 44.5 45.8 27.7 52.3 16.4 29.2 34.2 14.4 45.3 59.1 40.4 33.9 19.5 28.4 36.4 40.4 31.4 40.5 31.8 30.1 35.5 42.5 25.2 35.2 42.2 36.2 22.4 32.8 55.8 35.8 52.6 19.2 53.0 53.0 55.2 55.3 44.8 56.0 51.4 53.8 51.2 42.6 55.6 49.7 51.9 73.9 45.5 47.3 79.2 52.6 45.9 22.7 26.2 27.8 27.5 23.4 21.5 19.3 25.5 22.0 20.9 62.5 66.8 93.1 70.6 62.3 52.1 93.2 25.5 80.3 70.5 27.9 78.5 53.8 13.3 45.6 37.7 61.8 166.4 0.0 41.6 60.0 62.5 67.3 107.5 64.8 64.5 47.7 48.2 55.3 92.4 21.3 53.5 112.2 54.0 43.3 68.3 59.1 53.7 84.2 40.7 38.2 67.9 71.1 75.6 83.7 30.3 56.8 79.3 84.7 70.3 58.6 ZBTB6 "ZID, ZNF482" ENSG00000186130 "Zinc finger and BTB domain containing 6" Q15916 9 122908056-122913330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054111, HPA076894" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA054111: AB_2682384, HPA076894: AB_2686818" "unprognostic (9.74e-3)" "unprognostic (8.40e-2)" "unprognostic (1.45e-2)" "unprognostic (7.84e-2)" "prognostic favorable (2.06e-5)" "unprognostic (1.81e-1)" "unprognostic (2.39e-3)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (6.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "prognostic favorable (5.08e-4)" "unprognostic (4.31e-2)" "unprognostic (1.53e-1)" "unprognostic (2.67e-1)" "unprognostic (1.92e-2)" 11.9 10.4 10.7 11.8 12.2 5.2 12.9 17.7 13.2 13.7 9.4 9.0 10.7 10.4 12.6 8.2 11.6 9.4 7.3 9.7 10.2 9.4 11.0 9.2 12.4 26.2 15.6 10.3 13.8 10.0 11.6 14.0 14.1 10.5 10.2 9.0 6.3 9.9 11.4 14.0 10.0 15.0 10.0 13.2 14.0 9.7 9.5 14.4 22.7 13.8 10.1 16.0 11.1 9.3 2.1 2.3 11.8 3.9 3.8 4.0 2.4 4.1 4.8 7.9 7.2 8.4 8.1 8.0 7.0 8.6 7.0 6.3 5.0 5.3 6.6 4.4 6.3 6.3 19.0 8.2 8.6 8.8 9.3 6.5 7.0 10.4 4.6 8.3 9.2 12.7 6.6 13.1 6.4 10.7 8.7 6.4 8.4 7.3 8.2 10.1 7.7 9.3 6.2 9.9 12.3 8.3 5.0 21.7 9.2 7.4 6.8 10.0 12.9 10.8 10.6 6.6 8.7 13.3 6.1 6.5 7.7 6.0 7.8 8.0 14.4 17.2 1.8 9.0 6.3 7.8 11.8 2.3 3.3 2.0 2.5 2.7 2.1 2.8 1.9 2.3 1.7 4.0 3.5 3.0 3.8 3.9 1.3 2.9 2.4 10.7 12.2 17.7 12.1 10.2 9.4 15.6 10.3 10.5 14.4 6.0 2.2 0.0 2.7 1.9 7.3 2.8 7.6 4.0 9.1 1.8 9.8 1.7 0.0 2.1 7.6 2.9 2.6 0.0 2.1 1.0 2.5 3.2 7.0 2.4 2.1 6.4 2.9 7.4 9.2 3.2 2.8 5.4 1.7 1.8 4.2 7.4 2.6 3.4 7.4 3.3 9.1 6.5 2.5 5.2 3.0 2.4 1.6 5.1 3.3 2.7 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064170-75079987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 75.7" "Group enriched" "Detected in many" 8 "Ciliated cells: 48.2;Early spermatids: 103.8;Late spermatids: 150.0;Spermatocytes: 54.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" No No "Nuclear speckles" Mitochondria "HPA050928: AB_2681277, HPA065062: AB_2732728" "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favorable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 0.7 2.1 2.3 0.5 5.3 0.2 1.3 1.8 3.4 1.5 2.0 2.3 4.6 2.5 1.0 18.2 1.3 8.2 1.5 2.9 3.0 3.0 4.3 6.8 2.2 0.1 2.3 2.3 0.8 3.6 5.2 10.9 3.3 4.7 1.0 1.8 1.2 2.3 5.7 3.0 1.1 1.9 1.0 1.9 0.6 1.2 75.7 2.3 0.6 5.9 0.5 0.4 1.2 0.4 1.6 0.6 0.8 0.3 3.8 3.8 0.8 6.0 4.7 1.0 5.3 0.3 0.3 2.8 0.5 2.1 2.7 1.2 7.7 11.1 5.6 4.3 0.5 3.7 2.4 0.0 0.1 1.9 5.9 0.6 1.4 1.6 2.7 3.7 0.1 3.7 1.1 0.6 3.4 0.1 3.1 1.6 0.4 8.0 2.5 1.3 1.3 0.6 0.7 1.7 3.5 3.3 0.1 0.3 2.7 6.0 0.4 9.7 2.3 3.5 3.1 2.8 1.0 4.4 1.8 0.8 1.7 1.9 2.9 1.1 5.6 8.3 2.9 2.4 1.0 0.9 0.8 0.3 0.8 1.9 0.0 0.5 1.6 1.6 0.5 0.3 0.8 0.7 0.8 0.4 3.8 0.2 0.6 3.8 0.8 2.3 5.3 1.8 3.4 3.0 3.0 2.3 2.3 4.7 2.3 6.0 8.9 0.9 1.5 1.5 4.4 5.6 5.1 48.2 10.3 10.4 9.8 1.9 3.3 3.2 103.8 1.7 2.6 0.0 1.2 1.0 1.3 2.0 1.1 3.9 1.4 11.1 5.1 1.8 1.0 150.0 2.8 0.9 3.3 1.0 3.1 3.1 1.5 0.0 2.5 5.7 8.4 6.5 0.5 54.1 5.3 0.6 4.2 0.0 3.3 0.8 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 40.7;Hepatocytes: 44.7;Ito cells: 57.1;Leydig cells: 63.6;Peritubular cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 43.5;ASC TERT1: 37.4;BJ hTERT+: 28.5;HSkMC: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 27.9 9.0 30.9 9.5 54.4 1.8 9.8 11.1 36.0 22.9 19.8 56.8 4.2 4.6 18.0 6.9 10.3 15.5 16.8 19.1 30.6 19.7 3.5 13.5 10.2 4.8 56.7 23.5 20.1 4.0 3.9 3.0 11.4 36.2 14.5 6.8 4.5 6.2 20.7 34.8 5.0 5.4 25.6 36.8 7.0 9.0 6.6 51.9 0.0 6.0 2.5 3.2 14.9 7.3 0.0 3.4 0.6 2.4 0.7 0.9 0.5 0.9 0.9 3.2 2.8 43.5 37.4 0.8 7.5 28.5 4.5 5.2 0.8 0.0 0.0 4.1 15.1 1.5 0.0 0.5 0.1 3.8 1.8 2.0 0.4 2.3 0.9 11.3 1.1 0.6 38.8 0.4 4.0 1.1 13.3 0.9 0.2 1.4 1.6 3.8 0.3 0.0 4.4 0.7 0.2 9.3 0.2 3.8 0.6 0.5 1.2 0.1 4.0 2.3 0.3 9.4 3.2 1.1 2.1 0.6 4.3 4.0 11.7 2.5 2.9 1.9 0.0 8.8 1.4 15.3 0.0 2.4 0.6 0.9 1.1 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.2 0.6 0.7 0.1 3.4 0.4 0.5 30.9 54.4 11.1 36.0 30.6 19.7 56.7 23.5 36.2 51.9 0.0 1.6 0.0 1.5 6.8 0.0 16.5 7.6 1.4 1.2 0.0 0.0 0.6 0.0 0.8 1.7 17.0 0.0 0.0 0.7 0.8 40.7 3.6 1.1 44.7 8.5 0.0 0.0 57.1 15.9 3.7 63.6 6.8 15.1 1.0 0.4 16.4 0.7 0.0 61.5 1.4 0.7 12.9 21.2 0.7 1.0 4.0 1.3 4.3 0.0 1.1 ZDHHC14 "FLJ20984, NEW1CP" ENSG00000175048 "Zinc finger DHHC-type containing 14" Q8IZN3 6 157381133-157678146 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 33.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063754 Approved Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA063754: AB_2685113" "unprognostic (1.66e-2)" "unprognostic (1.27e-2)" "unprognostic (1.58e-2)" "unprognostic (3.98e-2)" "unprognostic (1.59e-1)" "unprognostic (6.78e-3)" "unprognostic (1.84e-1)" "unprognostic (6.02e-2)" "unprognostic (2.87e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.93e-4)" "unprognostic (3.94e-2)" "unprognostic (5.01e-3)" "unprognostic (1.89e-1)" "unprognostic (7.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.63e-1)" 6.4 3.9 9.0 4.4 10.8 4.8 3.6 15.6 16.2 7.4 5.3 22.1 2.9 6.2 22.6 2.6 4.2 4.8 5.3 11.1 10.6 8.8 6.9 8.7 6.4 4.8 15.8 7.1 3.3 5.7 12.7 3.7 5.1 15.3 7.9 4.0 9.1 4.6 3.8 4.7 3.3 8.6 13.7 22.0 6.4 8.1 6.3 11.8 0.7 3.8 1.5 5.7 5.3 5.0 1.5 4.2 0.0 0.1 0.4 0.9 0.4 1.7 1.8 0.6 2.6 1.4 1.1 5.9 2.7 2.5 1.9 1.7 2.2 1.3 4.3 0.9 2.2 3.7 0.9 1.5 1.5 1.8 33.4 2.1 8.4 0.7 1.0 1.9 1.1 1.9 0.7 1.6 2.0 0.8 1.7 2.9 1.9 6.7 3.2 1.1 1.1 0.7 2.8 1.1 3.4 2.2 0.1 0.3 2.5 4.0 0.7 4.3 1.3 3.2 2.1 2.3 1.2 0.3 1.3 4.0 2.9 2.1 5.7 3.5 0.7 0.8 0.6 1.0 3.0 3.2 0.0 0.1 0.0 0.5 0.0 0.9 1.5 0.4 0.4 0.0 0.8 0.0 0.3 0.0 0.4 0.0 4.2 0.0 0.4 9.0 10.8 15.6 16.2 10.6 8.8 15.8 7.1 15.3 11.8 3.0 0.0 2.7 2.3 11.4 14.5 14.4 15.3 0.0 1.2 7.0 5.9 8.9 10.0 5.2 7.8 10.5 6.6 0.0 2.8 1.8 7.9 14.3 0.0 21.2 9.2 116.0 2.4 24.5 12.1 4.0 7.5 3.6 10.1 1.8 12.2 4.8 2.5 9.9 9.6 3.3 5.7 0.0 7.2 2.4 4.1 7.3 17.6 5.0 9.7 2.4 ZMAT2 "FLJ31121, hSNU23, Snu23" ENSG00000146007 "Zinc finger matrin-type 2" Q96NC0 5 140698680-140706676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036518 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036518: AB_10671960" "unprognostic (4.00e-1)" "unprognostic (2.43e-3)" "prognostic favorable (7.96e-4)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "unprognostic (1.60e-3)" "unprognostic (1.25e-3)" "unprognostic (2.16e-1)" "unprognostic (2.35e-1)" "unprognostic (3.38e-3)" "unprognostic (6.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.60e-3)" "unprognostic (2.54e-1)" "unprognostic (2.72e-2)" "unprognostic (2.91e-3)" "unprognostic (2.84e-2)" 25.3 25.1 36.7 19.9 50.4 32.1 31.9 31.2 52.4 23.6 26.7 16.0 24.9 17.7 27.7 29.1 29.7 27.1 17.6 18.1 60.2 27.6 31.2 29.4 21.3 25.3 28.4 53.8 26.5 17.6 36.5 21.9 24.1 33.6 22.7 30.0 13.9 24.6 26.5 102.9 25.1 19.9 25.2 36.1 26.2 24.7 15.2 19.8 24.4 23.7 29.8 33.9 20.9 30.7 12.3 11.8 42.5 15.1 11.2 17.1 11.5 22.3 37.6 24.5 41.7 40.2 27.0 33.0 23.4 25.6 32.5 35.6 57.6 37.4 25.2 37.9 40.0 36.5 21.5 34.6 46.7 41.4 27.5 30.8 20.4 45.5 40.0 25.5 47.5 27.1 31.0 36.0 33.5 39.2 32.5 27.4 40.6 22.7 28.1 29.9 34.3 38.4 33.4 18.2 15.8 24.2 26.9 28.9 27.4 28.5 32.8 29.1 22.3 32.9 33.1 34.3 36.3 45.3 41.8 22.7 28.6 15.4 14.8 35.7 18.4 37.3 28.5 30.5 33.2 21.7 20.9 15.1 23.6 13.4 12.3 17.1 12.3 14.8 13.7 10.9 12.0 14.0 14.7 42.5 11.2 12.0 11.8 13.9 11.5 36.7 50.4 31.2 52.4 60.2 27.6 28.4 53.8 33.6 19.8 47.6 66.5 76.7 61.0 50.5 28.3 71.2 79.0 100.4 79.6 66.3 5.9 109.7 99.5 67.5 6.5 62.6 68.8 163.5 58.5 105.3 53.9 57.5 77.7 83.2 72.9 15.9 66.0 46.6 91.4 9.8 52.3 72.0 55.6 129.0 47.6 71.0 61.9 73.7 54.5 126.4 18.0 51.8 51.5 36.1 75.4 55.3 173.5 79.8 53.0 81.0 ZMIZ2 "DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7" ENSG00000122515 "Zinc finger MIZ-type containing 2" Q8NF64 7 44748581-44769881 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040716 Supported Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA040716: AB_10805826" "unprognostic (2.28e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-2)" "unprognostic (2.21e-2)" "unprognostic (9.46e-3)" "unprognostic (1.01e-3)" "prognostic unfavorable (6.82e-5)" "unprognostic (2.47e-1)" "unprognostic (2.36e-1)" "unprognostic (2.73e-1)" "unprognostic (5.89e-2)" "unprognostic (4.58e-2)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (1.66e-1)" "unprognostic (1.15e-1)" "unprognostic (3.15e-3)" 14.3 16.0 31.7 24.5 31.5 19.8 13.3 24.0 43.2 12.7 15.2 22.9 17.5 23.8 16.4 16.8 16.8 17.3 17.3 15.9 28.2 15.4 19.0 10.1 18.3 24.0 17.0 27.2 17.9 32.3 19.8 23.0 11.0 17.0 16.4 12.5 16.5 32.5 23.0 18.7 31.1 22.2 17.9 16.5 28.8 21.3 20.8 17.5 16.7 25.1 14.0 19.1 15.5 13.2 4.9 4.1 1.0 2.4 3.4 2.5 0.9 14.4 16.6 7.8 15.0 5.3 3.5 8.2 7.4 7.1 6.4 7.7 9.4 22.7 9.9 11.7 7.7 15.9 19.8 4.8 8.4 3.8 23.5 9.2 4.0 15.6 7.4 10.9 5.7 8.9 5.4 5.2 10.0 6.6 5.7 11.8 10.8 11.7 22.6 9.3 13.8 12.7 15.9 14.7 11.0 16.2 15.9 4.3 12.9 7.5 11.1 27.7 18.3 10.0 19.6 4.5 7.7 18.6 8.9 17.5 6.1 13.4 16.4 17.0 33.3 10.5 7.7 11.8 10.2 24.9 1.0 1.6 0.7 2.5 2.4 1.6 2.7 1.2 1.8 1.6 4.9 0.8 0.9 0.7 3.4 1.2 4.1 1.1 0.9 31.7 31.5 24.0 43.2 28.2 15.4 17.0 27.2 17.0 17.5 11.9 19.2 10.7 3.8 9.0 10.7 14.5 2.5 8.1 11.4 22.7 13.7 6.7 1.7 15.0 24.7 12.3 15.8 0.0 13.5 2.1 9.7 8.2 13.9 14.5 9.7 11.1 19.1 15.4 17.9 62.4 12.4 14.8 13.5 32.5 17.7 4.9 20.5 14.0 17.0 6.9 6.9 6.5 9.8 4.5 5.3 16.2 6.1 9.6 20.0 8.4 ZNF211 "CH2H2-25, ZNF-25" ENSG00000121417 "Zinc finger protein 211" Q13398 19 57630395-57642779 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA011340, HPA049967" Approved Approved "Mitochondria,Rods & Rings" NA NA Mitochondria "Rods & Rings" "HPA011340: AB_2668488, HPA049967: AB_2680973" "unprognostic (6.47e-2)" "unprognostic (3.28e-2)" "unprognostic (2.83e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-1)" "unprognostic (2.77e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "unprognostic (6.66e-2)" "unprognostic (1.03e-1)" "unprognostic (3.27e-3)" "unprognostic (1.83e-2)" "unprognostic (1.03e-1)" "unprognostic (3.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (4.72e-3)" 8.8 11.3 11.1 10.1 13.5 24.2 11.7 18.3 14.2 10.1 10.0 17.5 14.8 5.2 12.3 13.2 7.2 10.9 9.3 11.5 11.0 10.4 11.3 6.5 11.1 13.3 12.0 12.4 13.4 7.3 25.7 16.7 13.9 12.2 12.6 10.2 15.4 8.7 14.9 6.8 12.0 12.5 10.3 10.7 17.7 17.6 6.1 9.1 17.7 16.5 5.4 15.1 12.9 10.3 10.5 7.6 12.7 6.2 7.0 13.7 6.5 3.9 2.5 11.6 10.4 6.8 6.8 6.8 5.5 6.8 7.9 5.3 2.0 2.3 3.7 2.4 5.8 4.7 0.9 5.5 8.3 16.8 4.6 13.6 7.2 5.7 4.8 5.9 5.0 7.6 6.3 10.1 5.9 5.6 11.7 6.0 6.8 1.6 4.8 9.7 1.8 10.2 3.4 4.7 5.1 6.1 6.3 8.7 3.3 6.8 15.2 5.4 7.5 6.6 3.3 2.5 13.6 3.5 7.1 3.8 8.1 3.9 3.4 4.6 6.7 8.5 7.8 2.2 4.1 4.7 7.9 6.2 12.7 8.4 5.9 13.7 8.8 11.1 12.1 7.6 10.5 13.2 9.3 8.3 7.0 3.9 1.6 11.8 6.5 11.1 13.5 18.3 14.2 11.0 10.4 12.0 12.4 12.2 9.1 3.0 4.3 11.2 1.1 1.0 3.9 4.5 2.5 10.7 1.2 1.8 7.9 6.2 0.0 2.9 0.4 3.8 3.2 0.0 1.0 4.0 1.9 1.8 5.7 1.5 3.4 0.0 1.2 5.5 6.3 0.4 1.1 2.9 1.7 3.6 3.0 4.2 1.3 0.0 2.1 1.0 6.6 12.9 2.5 2.7 3.0 1.5 14.9 7.0 2.4 2.5 ZNF223 ENSG00000178386 "Zinc finger protein 223" Q9UK11 19 44051367-44067991 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 21.6" "HPA067823, HPA079175" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA067823: AB_2685906, HPA079175: " "unprognostic (6.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.42e-1)" "unprognostic (8.36e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (1.85e-1)" "unprognostic (6.32e-2)" "unprognostic (4.33e-1)" "unprognostic (4.95e-2)" "unprognostic (3.67e-1)" "unprognostic (2.58e-4)" 6.5 8.0 6.6 5.9 14.7 3.2 10.1 19.8 17.3 7.6 8.0 9.6 6.0 7.1 7.7 11.3 6.5 7.5 9.5 8.8 9.4 8.5 7.5 4.7 7.0 6.0 6.7 7.4 7.7 6.2 10.8 9.8 9.7 15.3 12.3 10.7 7.1 7.7 9.4 3.5 8.8 9.2 7.8 5.7 8.6 8.8 6.2 7.9 6.7 11.7 4.6 7.6 9.0 6.2 4.4 7.7 11.6 7.1 6.6 9.3 2.6 2.5 1.4 5.5 1.3 3.6 4.6 0.1 3.9 4.3 3.5 5.1 2.6 4.3 0.0 3.7 3.0 2.1 2.5 0.0 4.4 3.8 0.0 4.1 5.1 3.9 3.5 2.7 0.2 0.1 4.5 3.5 3.0 2.9 5.0 3.9 0.1 0.2 0.0 3.9 2.0 0.0 1.8 4.1 1.7 1.9 0.0 2.2 1.2 4.2 21.6 3.4 8.1 6.8 0.9 2.7 7.4 3.9 4.7 3.9 3.3 3.2 1.8 1.4 2.6 4.4 0.0 1.4 0.0 3.2 11.6 5.8 8.7 2.8 7.1 4.3 3.6 4.7 2.4 6.4 4.4 9.3 4.0 0.5 6.6 2.9 7.7 4.0 2.6 6.6 14.7 19.8 17.3 9.4 8.5 6.7 7.4 15.3 7.9 0.0 0.6 0.0 0.5 0.0 2.9 0.8 2.5 1.4 0.0 1.8 2.0 1.6 3.3 1.9 2.7 2.1 0.7 0.0 0.4 0.4 0.2 0.5 0.0 0.6 1.4 3.2 0.0 2.5 1.6 0.8 1.4 1.2 0.0 1.0 2.4 1.5 1.1 0.0 1.8 1.0 1.2 0.0 0.0 1.9 1.9 0.0 0.8 0.0 2.1 0.7 ZNF26 "FLJ20755, KOX20" ENSG00000198393 "Zinc finger protein 26" P17031 12 132986365-133032952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018329, HPA042406" Uncertain Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA018329: AB_1859157, HPA042406: AB_2677982" "unprognostic (7.31e-3)" "unprognostic (7.60e-3)" "unprognostic (7.26e-4)" "unprognostic (5.52e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.52e-3)" "unprognostic (3.00e-2)" "unprognostic (9.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-3)" "unprognostic (2.66e-12)" "unprognostic (8.24e-2)" "unprognostic (7.20e-2)" "unprognostic (1.94e-3)" "unprognostic (7.64e-4)" 9.9 7.7 7.3 10.5 10.6 19.4 13.2 11.1 12.8 7.8 7.7 11.3 10.2 7.8 12.7 18.3 7.6 9.5 11.6 6.7 7.6 6.6 9.1 11.6 9.5 12.8 9.9 8.1 11.4 11.9 7.7 11.9 8.8 9.9 12.4 8.5 11.1 11.2 8.6 7.4 13.0 9.5 8.8 7.5 15.7 7.6 11.8 11.3 12.0 11.6 9.2 12.8 8.6 9.6 7.5 3.5 9.3 2.9 6.5 9.6 5.5 4.3 3.7 4.7 5.6 2.0 3.0 9.5 3.4 4.2 4.9 3.7 1.7 3.5 3.0 5.0 3.4 3.5 3.0 3.3 3.3 6.0 2.2 5.5 7.1 3.5 2.0 3.3 11.8 8.1 3.8 4.0 5.5 7.7 3.9 2.7 4.9 5.4 0.8 4.2 3.8 9.0 8.1 11.5 2.3 6.0 8.7 7.0 5.8 2.4 6.8 5.8 12.6 4.3 3.2 4.2 3.2 9.5 7.7 4.5 6.2 5.9 5.4 5.2 3.5 0.2 14.6 3.8 5.4 7.2 9.3 2.6 6.0 8.2 2.9 8.6 5.5 7.4 6.5 3.5 7.5 9.6 8.0 2.4 6.5 2.2 3.0 6.1 5.5 7.3 10.6 11.1 12.8 7.6 6.6 9.9 8.1 9.9 11.3 20.8 16.5 11.0 7.4 0.0 26.6 4.0 10.2 5.3 14.8 5.2 23.6 5.4 3.3 6.7 0.6 8.4 3.8 0.0 4.9 3.7 4.8 5.2 9.2 4.3 4.5 25.4 8.1 9.8 9.5 1.1 7.5 3.9 0.0 2.8 5.4 8.8 6.6 3.5 5.6 2.3 24.5 0.0 3.2 7.2 9.5 0.0 4.0 13.6 5.6 7.1 ZNF398 "KIAA1339, P51, P71, ZER6" ENSG00000197024 "Zinc finger protein 398" Q8TD17 7 149126416-149182802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071533 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA071533: AB_2686412" "unprognostic (4.11e-1)" "unprognostic (8.56e-2)" "unprognostic (3.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (6.65e-3)" "unprognostic (2.94e-3)" "unprognostic (2.27e-2)" "unprognostic (3.64e-3)" "unprognostic (1.43e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (1.45e-1)" "unprognostic (3.97e-2)" "unprognostic (9.27e-2)" "unprognostic (9.17e-2)" "unprognostic (1.89e-1)" 8.9 8.1 12.7 10.2 12.5 15.6 10.6 25.9 16.0 11.7 10.7 10.2 10.5 8.8 9.8 10.2 14.3 10.4 8.6 9.3 10.9 9.0 9.3 10.7 9.2 10.0 10.7 11.4 11.1 13.4 14.7 20.9 8.6 9.8 12.7 8.6 8.5 11.2 12.5 10.0 17.2 9.5 9.7 9.8 12.6 11.1 18.1 12.6 13.0 8.7 7.4 12.3 9.9 11.1 2.9 1.6 6.1 2.0 1.9 3.8 1.2 7.6 6.4 5.0 9.7 7.5 5.3 6.4 4.7 6.0 5.4 5.9 5.4 3.6 8.9 5.4 7.8 4.8 6.4 8.6 5.9 3.8 5.9 11.9 5.9 5.1 3.5 5.2 6.6 6.2 6.0 8.7 5.8 6.2 3.9 3.6 3.6 9.1 3.2 5.7 9.6 9.8 6.8 36.0 6.4 6.8 7.7 5.7 6.7 4.0 12.8 7.5 8.3 6.5 8.0 3.9 5.6 5.0 7.4 4.8 5.5 1.6 9.8 5.8 10.3 4.9 6.9 7.5 5.5 5.3 5.1 1.6 6.1 3.1 2.0 3.7 2.9 2.1 3.4 1.5 2.5 3.3 3.8 3.1 1.9 1.7 1.6 3.0 1.2 12.7 12.5 25.9 16.0 10.9 9.0 10.7 11.4 9.8 12.6 6.0 2.9 3.7 3.5 6.9 7.4 5.8 0.0 2.7 4.5 5.2 5.9 3.1 0.0 3.6 19.4 4.5 3.3 0.0 2.5 4.0 4.7 4.5 4.6 2.8 3.2 3.2 1.7 4.9 4.7 19.2 6.6 3.4 8.5 2.8 3.3 5.3 4.4 2.6 8.5 2.4 9.7 0.0 2.5 16.6 7.9 7.4 2.6 1.8 3.3 8.1 ZNF428 "C19orf37, MGC51082, Zfp428" ENSG00000131116 "Zinc finger protein 428" Q96B54 19 43607219-43619874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042596, HPA048072" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA042596: AB_2678070, HPA048072: AB_2680249" "unprognostic (2.45e-3)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "unprognostic (6.31e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (3.22e-2)" "unprognostic (2.32e-2)" "unprognostic (2.53e-1)" "unprognostic (6.67e-2)" "prognostic favorable (3.60e-5)" "unprognostic (3.85e-1)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-2)" "unprognostic (4.00e-1)" "unprognostic (2.74e-2)" 18.8 31.2 36.8 15.8 37.6 18.9 9.2 25.9 48.8 13.7 14.2 14.4 8.8 17.0 18.8 14.9 8.8 13.0 18.4 19.9 31.3 28.7 17.4 15.5 13.1 15.5 27.0 31.1 19.2 19.4 9.8 19.2 12.7 18.0 20.1 6.3 14.8 21.7 13.2 37.7 6.6 13.7 17.2 22.2 16.8 16.6 19.7 17.0 17.8 16.6 8.7 8.9 10.0 11.4 7.8 7.1 9.4 3.2 3.1 8.5 1.0 11.2 9.0 14.1 23.3 5.4 4.0 6.6 8.5 3.9 6.0 6.3 5.5 7.5 19.0 19.5 6.5 3.8 2.8 5.6 1.6 2.0 15.9 23.9 20.7 9.4 9.3 10.6 16.2 17.2 7.3 3.6 5.3 2.8 6.2 8.4 13.6 21.6 12.0 6.2 11.9 40.0 29.1 9.4 5.0 6.3 39.9 6.5 13.9 7.2 6.8 27.1 31.6 12.3 7.6 19.0 3.9 4.6 23.3 16.5 7.2 20.5 6.8 13.0 13.4 16.1 33.2 10.4 16.6 15.8 2.5 2.5 9.4 7.8 1.4 4.4 5.2 7.1 7.4 2.7 7.8 8.5 3.7 1.3 3.1 3.2 7.1 4.1 1.0 36.8 37.6 25.9 48.8 31.3 28.7 27.0 31.1 18.0 17.0 0.0 3.8 39.5 61.1 28.5 98.9 17.9 63.7 4.0 3.4 62.8 13.7 115.0 126.0 77.7 112.3 58.4 31.5 0.0 69.0 37.8 99.2 49.9 36.8 47.0 89.6 54.0 155.7 74.9 36.5 48.8 82.3 46.8 108.0 43.3 49.3 108.0 64.6 46.0 85.2 176.5 53.3 71.1 93.7 20.4 56.9 22.6 46.1 73.0 46.0 41.6 ZNF596 ENSG00000172748 "Zinc finger protein 596" Q8TC21 8 232137-264703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.0" "Low region specificity" "Detected in all" HPA055463 Uncertain Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA055463: AB_2682821" "unprognostic (3.30e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.90e-1)" "unprognostic (9.07e-3)" "unprognostic (9.68e-3)" "unprognostic (2.10e-3)" "unprognostic (1.74e-1)" "unprognostic (4.84e-1)" "unprognostic (1.70e-5)" "unprognostic (6.37e-2)" "unprognostic (1.20e-1)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "unprognostic (3.51e-1)" "unprognostic (4.53e-1)" 4.9 6.2 6.3 9.9 7.4 2.6 8.5 18.2 10.1 6.7 4.4 8.3 8.3 4.3 10.4 11.9 4.7 6.7 6.3 5.1 7.5 7.0 6.1 5.3 4.8 5.3 6.8 7.3 7.8 7.1 13.5 10.9 5.5 6.2 6.1 5.3 6.6 4.2 9.4 10.2 6.7 4.1 7.7 7.8 6.8 5.4 22.4 7.8 7.4 9.2 4.2 4.4 4.5 4.8 6.8 4.4 6.4 5.0 2.9 7.3 2.6 1.8 1.1 5.5 14.0 2.9 2.7 4.6 4.2 1.9 1.7 2.9 1.4 2.3 1.8 1.4 3.4 2.3 3.6 1.5 3.3 2.1 1.4 2.1 3.9 3.4 1.3 3.2 1.7 1.9 6.2 0.5 1.9 3.0 2.7 1.3 6.1 2.4 6.0 9.8 5.9 4.3 1.6 2.9 3.6 1.3 2.0 1.2 3.3 5.5 3.3 3.1 8.3 2.8 1.4 2.0 2.9 4.2 5.1 3.3 4.1 1.2 0.3 1.8 2.1 5.3 2.2 4.9 1.5 2.6 6.4 2.8 4.5 4.8 2.3 6.7 6.4 5.2 4.2 3.6 6.8 6.2 7.3 3.1 2.9 5.0 4.4 5.6 2.6 6.3 7.4 18.2 10.1 7.5 7.0 6.8 7.3 6.2 7.8 3.0 2.4 0.0 0.7 0.3 8.1 2.8 0.0 5.3 2.3 1.8 2.0 1.8 3.3 1.5 35.2 2.2 1.0 0.0 1.5 1.2 1.1 0.6 4.7 0.9 0.9 11.1 0.0 3.1 0.6 11.0 3.7 0.5 0.0 0.0 1.5 4.0 1.1 0.0 1.1 1.6 8.5 0.0 0.9 10.2 3.9 0.4 1.3 0.8 1.2 0.1 ZNF608 "DKFZp434M098, KIAA1281, NY-REN-36" ENSG00000168916 "Zinc finger protein 608" Q9ULD9 5 124636913-124748807 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Club cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.2;naive B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.1;AN3-CA: 16.0;REH: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005545, HPA076984" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA005545: AB_1080742, HPA076984: " "unprognostic (3.82e-2)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (3.75e-1)" "unprognostic (2.26e-1)" "unprognostic (3.04e-2)" "unprognostic (5.02e-2)" "unprognostic (7.52e-2)" "unprognostic (5.24e-2)" "unprognostic (3.67e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (6.36e-2)" "unprognostic (2.80e-1)" "unprognostic (3.02e-1)" "unprognostic (9.56e-2)" 8.5 14.7 17.0 7.5 17.2 2.0 10.1 25.5 16.5 11.5 10.4 28.3 2.8 15.7 7.5 7.1 5.4 13.6 10.1 12.5 19.7 8.8 8.2 3.9 15.3 10.8 21.8 10.7 9.6 12.0 9.1 11.6 4.5 18.0 8.5 10.7 14.1 8.3 7.1 8.9 4.8 9.1 6.4 22.9 3.9 9.8 13.0 24.5 4.6 13.4 3.3 11.0 6.6 6.6 3.1 1.1 5.2 0.0 0.0 0.0 0.0 0.1 0.4 25.1 16.0 3.7 6.1 0.0 0.0 0.6 0.1 1.5 2.6 7.5 8.2 8.4 0.0 4.0 0.3 1.7 1.5 0.1 0.0 4.0 0.0 0.0 0.1 5.8 0.0 0.7 6.1 4.5 0.7 0.7 3.8 5.3 0.0 0.8 0.1 1.3 0.0 0.0 0.0 10.6 0.2 0.3 43.6 2.2 0.0 3.6 0.3 3.8 13.2 0.0 0.3 5.6 14.9 1.4 0.7 1.4 5.1 9.8 0.1 1.5 4.0 3.9 14.8 1.3 0.2 7.2 5.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 3.1 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 17.0 17.2 25.5 14.3 19.7 8.8 21.8 10.7 18.0 24.5 29.8 27.0 3.7 10.9 1.1 34.0 19.7 10.2 20.1 60.3 14.0 37.3 0.6 3.3 12.1 10.4 13.7 9.3 0.0 7.7 3.3 4.7 3.1 0.0 0.9 0.6 39.7 38.4 11.6 0.3 5.7 2.0 1.2 6.8 3.6 5.3 38.4 5.6 7.6 1.4 5.7 37.0 0.0 1.6 12.0 5.8 0.6 0.3 0.0 7.0 1.6 ZNF615 FLJ33710 ENSG00000197619 "Zinc finger protein 615" Q8N8J6 19 51991332-52008230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052422 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA052422: AB_2681825" "unprognostic (2.20e-1)" "unprognostic (4.66e-2)" "unprognostic (4.56e-1)" "unprognostic (2.64e-1)" "unprognostic (4.08e-3)" "unprognostic (7.28e-2)" "unprognostic (5.23e-2)" "unprognostic (3.68e-1)" "unprognostic (4.44e-3)" "unprognostic (2.44e-2)" "unprognostic (4.41e-2)" "unprognostic (4.80e-2)" "unprognostic (1.77e-1)" "unprognostic (8.16e-3)" "unprognostic (3.03e-1)" "unprognostic (1.82e-1)" "prognostic favorable (2.98e-4)" 10.2 7.4 11.9 6.0 16.4 7.5 10.1 20.7 12.2 8.2 8.8 7.3 6.9 5.2 12.0 7.8 6.5 9.8 7.6 8.5 8.5 7.1 9.5 6.1 7.6 6.2 11.7 9.8 15.7 7.5 16.6 17.8 8.3 9.9 26.9 5.8 8.0 7.7 11.0 7.2 7.2 6.0 9.6 12.8 7.9 6.7 5.5 13.6 7.3 11.7 3.8 6.1 11.1 8.8 4.7 4.8 6.9 4.4 12.0 7.8 3.8 1.3 5.2 5.8 11.8 10.6 7.7 4.4 3.9 6.6 5.4 5.6 1.1 1.4 2.1 2.2 4.7 3.4 1.4 4.0 2.5 5.0 0.3 8.9 6.7 5.2 3.9 8.3 0.0 4.0 6.5 2.8 8.5 9.1 10.0 2.9 2.1 0.0 0.0 4.1 0.4 0.0 3.5 6.0 0.2 8.8 4.2 9.1 3.7 3.7 9.1 5.2 4.5 4.8 4.5 3.2 6.4 6.5 3.3 5.2 5.1 5.9 3.3 2.8 4.0 10.4 2.6 3.0 0.0 8.2 6.9 3.0 5.8 3.7 4.4 7.8 3.9 6.6 5.3 4.8 4.7 6.6 4.3 4.1 12.0 2.7 2.9 5.7 3.8 11.9 16.4 20.7 12.2 8.5 7.1 11.7 9.8 9.9 13.6 6.0 4.5 3.2 1.9 2.5 7.1 5.9 2.5 4.0 1.2 3.5 5.9 3.2 3.3 1.6 0.9 2.9 1.1 0.0 1.0 2.2 3.8 5.2 0.0 1.9 2.6 3.2 8.6 3.7 3.3 0.9 2.3 3.2 6.8 1.8 2.6 3.0 1.3 3.7 3.9 2.4 6.2 6.5 5.7 2.6 2.1 3.4 4.2 4.4 2.1 1.8 ZNF625 ENSG00000257591 "Zinc finger protein 625" Q96I27 19 12142090-12156729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA074014 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA074014: AB_2686652" "unprognostic (7.88e-3)" "unprognostic (6.74e-2)" "unprognostic (9.56e-2)" "unprognostic (8.75e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-3)" "unprognostic (4.72e-2)" "unprognostic (3.31e-2)" "unprognostic (6.23e-2)" "unprognostic (2.73e-1)" "unprognostic (5.49e-2)" "unprognostic (3.70e-2)" "unprognostic (8.29e-2)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.62e-1)" 4.9 5.2 6.7 3.4 5.4 3.8 8.5 11.2 8.3 7.2 5.1 5.6 7.5 2.8 8.3 10.6 4.7 6.0 4.7 3.7 6.0 8.8 6.0 2.8 4.8 5.2 6.6 5.5 13.1 5.4 6.9 9.4 6.4 6.4 7.3 3.5 7.5 4.0 7.1 2.0 7.3 3.3 6.6 4.7 5.8 3.8 4.6 2.9 1.0 8.7 3.2 3.9 7.3 7.2 1.4 0.4 1.3 0.5 2.9 2.1 0.7 0.7 0.0 6.5 10.8 2.8 2.0 1.1 2.7 3.5 4.0 4.4 0.1 0.2 0.0 5.0 2.1 3.0 0.6 0.0 3.5 3.8 0.0 2.0 2.9 0.0 2.9 1.3 0.2 4.1 1.7 1.4 3.3 2.1 2.8 3.1 0.2 0.0 0.0 6.0 2.1 0.1 1.3 7.8 0.0 3.9 0.2 5.8 0.0 3.4 8.7 4.4 3.0 0.0 0.1 2.2 8.3 4.7 0.2 2.4 9.3 4.2 6.9 3.6 7.1 5.6 0.0 2.2 0.0 3.3 0.7 0.4 0.2 0.7 0.5 0.9 0.5 1.0 1.2 0.4 1.4 1.5 1.2 1.3 2.9 0.1 0.3 2.1 0.7 6.7 5.4 11.2 6.8 6.0 8.8 6.6 5.5 6.4 2.9 3.0 1.0 0.0 0.5 0.3 5.4 0.0 5.1 4.0 0.0 1.8 9.8 3.6 3.3 2.8 0.1 1.5 0.0 0.0 2.7 3.1 1.9 0.5 0.0 0.6 1.2 4.8 1.2 6.2 4.5 1.3 0.6 1.0 0.0 2.8 0.3 4.4 3.1 1.7 1.4 2.1 8.7 0.0 2.3 1.9 8.3 0.6 1.0 0.0 1.2 0.3 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001392-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 79.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 2.6 2.1 5.6 8.7 6.7 4.3 3.2 2.9 5.0 3.1 4.3 6.6 1.7 5.3 3.3 4.1 9.5 2.9 4.8 5.9 3.9 3.5 2.7 3.4 6.4 7.9 4.0 4.1 3.4 79.6 1.5 2.5 3.2 5.0 4.2 4.0 3.5 5.2 2.6 18.3 6.7 4.5 4.3 6.3 8.6 5.9 2.4 4.1 11.7 3.5 5.2 7.0 4.4 4.9 0.3 2.3 3.0 7.9 0.4 0.8 0.9 5.8 6.9 13.3 5.0 1.8 2.7 7.0 6.1 5.7 4.5 5.8 4.9 5.4 6.0 2.9 5.9 4.2 4.0 3.4 8.7 2.5 3.8 6.3 10.9 2.8 8.2 3.7 3.1 17.0 4.4 4.8 9.6 5.3 2.1 7.7 6.6 3.6 4.1 1.7 15.1 7.0 8.8 10.4 7.2 4.5 8.6 3.0 6.5 1.8 7.3 12.2 8.3 8.2 29.5 4.2 3.6 6.4 10.9 11.0 9.3 4.6 2.8 4.7 3.3 1.7 5.8 7.1 9.4 4.8 0.0 2.6 1.8 0.4 5.7 0.3 0.2 0.2 0.3 1.9 0.3 0.8 0.8 3.0 0.4 7.9 2.3 0.7 0.9 5.6 6.7 2.9 4.3 3.9 3.5 4.0 4.1 5.0 4.1 3.0 8.0 1.5 3.9 4.7 1.8 7.6 7.6 1.4 6.8 10.4 2.0 2.0 0.0 2.9 0.6 2.9 3.5 0.0 5.3 2.6 2.7 5.9 1.1 1.0 10.4 3.2 4.6 8.0 13.9 2.9 2.3 12.8 1.7 9.0 8.1 0.9 8.0 10.5 2.8 0.7 0.8 6.5 2.3 0.2 1.9 6.6 1.9 2.9 5.8 12.9 ZNF782 FLJ16636 ENSG00000196597 "Zinc finger protein 782" Q6ZMW2 9 96816472-96875623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 8.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011013 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA011013: AB_1080758" "unprognostic (5.51e-2)" "unprognostic (5.29e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.48e-2)" "unprognostic (2.82e-2)" "unprognostic (9.89e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-2)" "unprognostic (4.68e-3)" "unprognostic (3.63e-3)" "unprognostic (4.84e-2)" "unprognostic (3.55e-1)" "unprognostic (4.95e-1)" "unprognostic (2.61e-2)" "unprognostic (4.39e-2)" 5.3 4.2 7.4 7.4 8.4 2.5 7.6 19.8 8.0 7.5 5.3 6.9 5.9 6.1 7.9 8.5 5.2 5.5 5.8 4.0 6.8 4.5 7.1 5.5 4.4 5.9 5.9 4.8 9.3 12.7 11.8 15.1 4.9 7.7 7.5 6.9 5.4 8.0 7.3 9.2 8.6 7.1 5.3 6.5 6.4 6.6 13.9 8.3 6.0 8.8 2.5 7.4 5.6 10.8 2.3 0.2 0.7 0.5 1.0 2.2 0.4 2.9 2.3 5.8 8.9 1.6 2.2 4.0 2.8 2.8 4.6 3.4 2.7 3.1 5.7 3.7 2.0 5.4 4.1 5.1 1.8 4.5 5.7 2.2 5.3 4.7 2.7 1.7 7.3 3.7 1.3 3.8 3.7 1.9 2.2 1.5 7.0 7.0 5.8 2.7 5.0 7.6 3.6 4.3 5.2 5.1 6.8 7.1 1.9 3.1 1.9 5.9 4.5 3.8 2.3 3.0 4.9 4.3 4.2 3.3 6.0 3.5 6.0 3.1 5.5 3.9 2.7 2.5 1.8 4.3 0.0 0.5 0.2 1.1 0.5 2.2 2.0 1.0 0.0 0.2 2.3 0.9 0.7 0.7 1.0 0.2 0.2 0.6 0.4 7.4 8.4 19.8 8.0 6.8 4.5 5.9 4.8 7.7 8.3 0.0 5.5 0.9 1.4 1.6 5.7 1.4 0.0 1.4 0.0 1.8 7.9 0.7 0.0 1.3 5.6 1.6 1.7 0.0 1.5 0.2 0.5 1.7 5.7 1.0 1.1 3.2 0.0 1.8 0.6 6.9 1.7 0.7 0.0 3.6 1.4 2.2 1.0 0.0 2.8 1.6 6.5 0.0 1.0 8.6 2.4 0.9 0.6 0.7 1.2 1.8 ZZEF1 "FLJ10821, KIAA0399, ZZZ4" ENSG00000074755 "Zinc finger ZZ-type and EF-hand domain containing 1" O43149 17 4004445-4143020 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 92.3;Enterocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031778, HPA031790" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA031778: AB_10599831, HPA031790: AB_10600999" "unprognostic (4.48e-2)" "unprognostic (7.59e-2)" "unprognostic (6.75e-2)" "unprognostic (2.39e-2)" "unprognostic (1.43e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.80e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (2.21e-2)" "prognostic favorable (6.08e-4)" "unprognostic (1.54e-1)" "unprognostic (1.38e-3)" "unprognostic (6.09e-3)" "unprognostic (1.80e-1)" "unprognostic (9.43e-2)" "unprognostic (6.46e-2)" 11.3 11.7 8.0 13.5 10.2 21.1 10.5 14.4 14.3 11.3 23.8 17.5 9.2 17.7 11.6 11.0 12.8 9.9 11.1 10.7 7.7 7.7 8.8 9.6 12.1 15.6 8.3 8.4 12.0 15.3 18.0 12.6 13.1 11.3 11.4 17.3 17.6 10.1 11.8 37.7 13.9 42.4 10.9 7.5 16.1 12.8 8.1 9.7 22.5 12.1 6.5 14.2 12.4 9.8 1.5 1.8 3.8 3.4 1.1 4.2 1.5 10.5 16.5 6.0 8.1 15.0 8.5 7.2 9.2 11.6 10.8 10.5 8.1 3.7 10.1 6.2 12.3 7.2 12.1 12.0 6.3 11.0 11.7 12.5 9.6 13.3 5.3 10.2 8.1 19.2 10.9 8.5 10.6 12.5 5.6 13.8 10.2 7.0 10.3 6.7 7.2 10.1 4.8 3.6 10.2 6.4 11.3 7.3 4.3 6.1 10.9 4.7 7.0 10.4 6.5 8.9 6.2 6.4 6.2 16.2 9.5 4.8 11.8 12.0 4.5 2.4 5.2 9.5 7.3 8.8 2.8 2.3 2.3 3.2 3.2 4.2 1.5 2.2 2.0 1.8 1.3 1.5 2.5 3.8 1.1 3.4 1.7 1.4 1.5 8.0 10.2 14.4 14.3 7.7 7.7 8.3 8.4 11.3 9.7 53.6 63.9 15.9 4.6 6.4 30.7 15.7 20.4 26.8 45.5 8.7 92.3 6.0 0.0 6.4 43.0 14.8 92.3 0.0 9.7 5.4 7.4 9.7 24.4 11.5 10.5 38.1 12.7 24.5 24.0 17.3 13.8 14.5 11.8 7.2 30.4 16.0 11.9 29.4 9.2 4.1 53.7 6.5 10.3 10.4 11.3 8.8 7.4 20.8 24.7 7.6